data_1b8q_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1b8q _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.454 ' CG2' ' N ' ' A' ' 11' ' ' SER . 1.4 tp . . . . . 0 CA--C 1.544 0.723 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.454 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 0.7 OUTLIER -85.66 166.27 16.31 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.475 0.655 . . . . 0.0 112.536 -179.338 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.426 ' CG2' ' HG ' ' A' ' 91' ' ' LEU . 1.6 t -156.05 163.61 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.313 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -149.6 131.97 15.61 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.497 0.665 . . . . 0.0 110.778 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.402 ' O ' ' N ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -135.03 177.46 7.79 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.419 -179.431 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.408 ' CD1' ' O ' ' A' ' 85' ' ' THR . 4.5 t80 -124.1 151.39 43.94 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -81.62 27.15 0.45 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.685 179.453 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.426 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 9.6 tpt180 43.31 31.04 0.35 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.905 0.383 . . . . 0.0 111.916 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER 44.47 23.47 0.07 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.708 -178.642 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.9 m -169.14 34.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 49.0 65.87 2.47 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.746 -178.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -148.19 54.99 0.51 Allowed Glycine 0 C--N 1.331 0.29 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.104 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.423 ' O ' ' CB ' ' A' ' 45' ' ' ALA . 4.1 mp -38.44 -26.96 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 118.35 -4.13 15.66 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 119.954 -1.117 . . . . 0.0 113.815 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.464 ' CE2' HG22 ' A' ' 52' ' ' ILE . 5.1 p90 -152.83 144.53 23.52 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.6 mt -80.19 170.21 16.74 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.3 178.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.0 m -149.32 157.59 6.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 C-N-CA 119.989 -0.685 . . . . 0.0 111.308 177.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -135.22 104.96 6.09 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.348 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.472 ' HB3' ' CG ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -101.64 118.71 37.51 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.738 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -63.6 114.77 4.15 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 121.254 0.55 . . . . 0.0 110.379 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.6 t . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.141 179.98 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.2 tp . . . . . 0 CA--C 1.534 0.343 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.463 ' CG1' ' HB ' ' A' ' 58' ' ' ILE . 28.0 mt -92.67 147.68 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.641 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -113.63 -35.58 5.16 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -166.2 135.64 3.19 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 120.441 -0.504 . . . . 0.0 112.032 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.407 ' CD2' ' HB3' ' A' ' 24' ' ' PHE . 49.3 mt -72.92 79.28 1.16 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.671 0.748 . . . . 0.0 110.489 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.462 ' CG2' ' N ' ' A' ' 42' ' ' ARG . 1.8 tp -32.9 -59.5 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.462 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -95.47 -67.7 0.84 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.218 0.532 . . . . 0.0 112.139 -178.142 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.432 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 106.91 26.52 5.76 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -177.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -128.31 -28.6 0.83 Allowed Glycine 0 C--N 1.339 0.722 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.73 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 22' ' ' LEU . . . -94.12 -83.01 0.34 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.055 0.928 . . . . 0.0 111.582 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.04 -53.82 39.96 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.079 0.466 . . . . 0.0 110.9 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.432 ' HB3' ' HA2' ' A' ' 43' ' ' GLY . 54.1 tt0 -49.86 -47.28 51.89 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.046 0.451 . . . . 0.0 110.463 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.417 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 5.6 tp-100 -59.14 -33.2 70.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.833 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.9 t -55.19 -48.47 73.77 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.622 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.07 -21.85 28.53 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.183 -1.008 . . . . 0.0 114.288 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.12 -3.93 30.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.574 0.687 . . . . 0.0 111.616 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.464 HG22 ' CE2' ' A' ' 24' ' ' PHE . 5.0 mp -103.93 138.87 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-O 120.83 0.347 . . . . 0.0 110.402 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -154.4 158.99 40.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.348 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.41 125.25 26.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.921 0.391 . . . . 0.0 111.115 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.86 14.72 73.32 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.653 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -92.69 -85.37 0.26 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 18.0 mm -148.86 115.78 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.463 ' HB ' ' CG1' ' A' ' 37' ' ' ILE . 0.3 OUTLIER -160.47 113.81 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.674 177.042 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.7 tp -116.6 -67.04 1.02 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.059 0.457 . . . . 0.0 110.584 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.95 160.91 14.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.236 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.3 p -166.95 145.28 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.482 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 44.86 40.0 4.0 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.031 0.444 . . . . 0.0 111.678 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.6 t70 58.67 28.14 16.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.281 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -118.07 97.51 50.8 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.572 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.81 86.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.032 1.821 . . . . 0.0 110.999 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.6 mt -72.46 62.84 0.54 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.985 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.1 m -139.64 -63.57 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -112.49 28.3 8.89 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.08 176.66 5.11 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.6 m -68.09 98.75 0.81 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.472 ' CG ' ' HB3' ' A' ' 28' ' ' GLU . 6.2 t80 -40.83 -55.63 2.4 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.215 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -58.16 -30.88 66.72 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.195 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.6 t -75.54 -43.63 47.73 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.21 -38.89 84.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.417 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.434 HD12 ' CZ ' ' A' ' 71' ' ' TYR . 63.4 mt -68.61 -30.08 68.73 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.023 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -73.32 -40.0 64.83 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 120.981 0.42 . . . . 0.0 109.943 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.7 t -59.87 -42.96 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.739 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.2 pp -79.2 -24.79 42.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.959 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.39 -48.27 67.86 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.101 0.477 . . . . 0.0 110.062 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.01 -22.9 13.84 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.978 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.444 HD11 HG22 ' A' ' 81' ' ' ILE . 55.6 mt -52.76 114.69 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 120.878 0.371 . . . . 0.0 111.149 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.24 -167.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.185 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.2 m -95.4 -172.33 2.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.949 0.404 . . . . 0.0 111.117 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 45.56 30.33 0.75 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.128 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.408 ' O ' ' CD1' ' A' ' 15' ' ' PHE . 1.8 t -123.66 159.15 29.95 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.88 0.847 . . . . 0.0 112.391 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -100.49 176.44 5.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.575 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.402 ' N ' ' O ' ' A' ' 14' ' ' LEU . 2.8 p -153.03 150.06 12.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.584 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 24.0 t -111.39 156.9 12.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -152.57 168.84 24.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.692 0.282 . . . . 0.0 111.222 -178.496 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.405 ' CD1' ' HA ' ' A' ' 11' ' ' SER . 47.1 mm -136.69 128.51 43.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.82 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.426 ' HG ' ' CG2' ' A' ' 12' ' ' VAL . 62.5 mt . . . . . 0 CA--C 1.511 -0.525 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 176.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 CA--C 1.521 -0.154 0 CA-C-O 120.785 0.326 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.32 131.87 51.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.515 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 8.5 p -85.34 119.6 25.89 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.339 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 26.5 m . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.326 -178.824 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.41 ' CG2' ' N ' ' A' ' 11' ' ' SER . 0.7 OUTLIER . . . . . 0 CA--C 1.535 0.394 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.41 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 17.8 p -93.42 171.31 8.99 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.05 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.445 ' CG1' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -158.74 173.62 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.932 -179.594 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.4 ptt85 -153.19 134.67 14.35 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.262 0.553 . . . . 0.0 111.013 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.413 ' CD2' ' CE1' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -131.67 145.43 51.65 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.279 -179.535 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.458 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 2.3 t80 -87.11 148.28 25.29 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.401 ' O ' ' N ' ' A' ' 20' ' ' GLY . 2.0 tptt -84.34 27.67 0.68 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.058 178.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.431 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 0.1 OUTLIER 45.51 29.43 0.62 Allowed 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 178.939 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.458 ' HD3' ' CE1' ' A' ' 15' ' ' PHE . 0.0 OUTLIER 43.5 24.77 0.06 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.074 0.55 . . . . 0.0 112.476 -178.348 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.7 m -165.81 32.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.785 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 48.54 66.9 1.87 Allowed Glycine 0 C--N 1.338 0.677 0 CA-C-N 115.733 -0.667 . . . . 0.0 113.02 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -152.26 65.25 0.36 Allowed Glycine 0 C--N 1.333 0.364 0 N-CA-C 111.698 -0.561 . . . . 0.0 111.698 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.2 mp -48.2 -24.55 1.19 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 40' ' ' LEU . . . 112.6 7.41 22.3 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.241 -0.981 . . . . 0.0 113.578 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.442 ' CD2' ' CG2' ' A' ' 52' ' ' ILE . 0.4 OUTLIER -160.06 139.56 11.13 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 117.98 0.89 . . . . 0.0 113.103 -179.585 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.1 mt -79.69 171.31 15.31 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.391 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.0 m -153.18 152.02 10.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.016 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.8 ptmt -137.39 110.3 7.68 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.394 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.454 ' CB ' ' CD1' ' A' ' 71' ' ' TYR . 1.1 tm-20 -101.96 96.74 7.23 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.34 116.76 3.25 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.311 0.577 . . . . 0.0 111.304 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.6 t . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.626 179.882 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.1 tp . . . . . 0 CA--C 1.535 0.397 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.411 HG23 HD11 ' A' ' 37' ' ' ILE . 33.8 mt -86.18 149.48 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.115 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.859 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.409 ' HB3' ' CG1' ' B' ' 4' ' ' VAL . 1.7 t -114.67 -39.61 3.73 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -173.46 135.74 0.56 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.22 -0.592 . . . . 0.0 112.206 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 24' ' ' PHE . 28.2 mt -70.39 99.42 1.57 Allowed 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.462 ' CG2' ' N ' ' A' ' 42' ' ' ARG . 1.4 tp -54.05 -58.39 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -176.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.462 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.8 OUTLIER -93.2 -68.38 0.8 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.175 0.512 . . . . 0.0 112.269 -177.489 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.465 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 112.01 18.14 7.97 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.618 -178.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.4 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -126.08 -28.0 1.07 Allowed Glycine 0 C--N 1.34 0.786 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.737 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.72 -83.11 0.33 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 117.914 0.857 . . . . 0.0 111.308 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.18 -60.36 3.7 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.5 0.667 . . . . 0.0 111.317 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.465 ' HB3' ' HA2' ' A' ' 43' ' ' GLY . 17.5 tp10 -48.77 -39.63 25.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.71 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.4 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 11.4 tp-100 -61.77 -36.2 80.36 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.3 t -54.06 -47.42 71.67 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.401 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.11 -20.27 33.49 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.302 -0.951 . . . . 0.0 113.905 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.445 ' CD1' ' CG1' ' A' ' 12' ' ' VAL . 0.1 OUTLIER -94.74 -31.01 13.97 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.899 0.38 . . . . 0.0 110.178 179.588 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.442 ' CG2' ' CD2' ' A' ' 24' ' ' PHE . 2.6 mp -80.44 119.6 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.064 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -152.52 155.77 38.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.178 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.98 123.79 21.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.914 0.388 . . . . 0.0 110.875 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.25 2.99 90.73 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.246 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -83.25 -88.94 0.09 Allowed 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 116.997 0.399 . . . . 0.0 110.981 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.6 tp -162.68 126.23 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.408 ' O ' HG22 ' A' ' 58' ' ' ILE . 3.2 tp -149.76 87.99 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.074 177.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.3 tp -81.68 -66.35 0.9 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.721 -178.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.15 158.43 25.94 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.697 0.284 . . . . 0.0 111.594 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.3 t -153.36 148.64 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.967 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.2 p30 44.28 46.67 7.68 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.162 0.506 . . . . 0.0 111.756 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.0 t70 51.99 26.65 3.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.787 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.406 ' O ' ' N ' ' A' ' 66' ' ' LEU . 12.1 mmm180 -111.59 113.79 53.0 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.826 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.22 84.84 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 121.772 1.648 . . . . 0.0 110.733 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.406 ' N ' ' O ' ' A' ' 64' ' ' ARG . 12.7 tp -86.83 66.77 9.59 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.354 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.2 m -128.61 -55.19 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.665 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -140.1 26.03 2.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.788 0.328 . . . . 0.0 111.648 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -94.92 -175.91 3.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.322 -0.399 . . . . 0.0 109.959 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.1 m -71.89 101.52 2.68 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 177.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.454 ' CD1' ' CB ' ' A' ' 28' ' ' GLU . 6.5 t80 -40.54 -58.23 1.64 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -178.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -59.36 -26.59 65.2 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.159 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.3 t -76.21 -42.0 47.58 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.179 0.514 . . . . 0.0 109.95 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.94 -36.92 83.32 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.797 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.423 HD12 ' CZ ' ' A' ' 71' ' ' TYR . 51.0 mt -70.9 -29.64 65.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.162 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -76.75 -37.84 55.25 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.085 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.0 t -62.89 -43.49 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.2 pp -73.81 -26.85 60.83 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.25 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -35.49 81.0 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.0 0.428 . . . . 0.0 110.122 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.97 -19.71 59.26 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.817 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 68.5 mt -58.86 105.63 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-O 120.869 0.366 . . . . 0.0 110.692 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.6 -165.83 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.666 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.5 -171.41 2.37 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.053 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 43.77 31.67 0.5 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.31 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.411 ' O ' ' CD1' ' A' ' 15' ' ' PHE . 1.8 t -128.71 162.4 27.48 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.775 0.798 . . . . 0.0 112.878 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -104.86 176.09 5.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.004 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -146.98 159.21 9.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.036 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.3 t -118.84 158.59 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.23 169.63 22.83 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.758 0.314 . . . . 0.0 110.835 -178.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 47.7 mm -129.45 130.81 67.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.391 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.5 mt . . . . . 0 CA--C 1.517 -0.317 0 CA-C-N 115.478 -0.783 . . . . 0.0 108.978 178.381 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.409 ' CG1' ' HB3' ' A' ' 38' ' ' SER . 19.8 t . . . . . 0 CA--C 1.521 -0.143 0 CA-C-O 120.952 0.406 . . . . 0.0 110.584 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -98.65 129.55 45.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.907 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 8.8 p -83.42 129.24 34.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.39 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 17.2 m . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.133 -179.252 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.425 ' CG2' ' N ' ' A' ' 11' ' ' SER . 1.4 tp . . . . . 0 CA--C 1.536 0.442 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.425 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 8.0 p -92.18 164.48 13.55 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.555 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' A' ' 89' ' ' LEU . 2.3 t -154.14 158.83 3.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.594 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.8 ttp-105 -140.24 144.11 36.33 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.552 0.691 . . . . 0.0 111.103 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.402 ' CB ' ' CG1' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -141.09 177.72 7.88 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.283 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.415 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 3.2 t80 -124.19 148.68 47.09 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.412 ' O ' ' N ' ' A' ' 20' ' ' GLY . 12.6 mtpt -83.77 30.89 0.48 Allowed 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.183 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.428 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 2.2 mmm180 40.78 31.24 0.11 Allowed 'General case' 0 C--N 1.347 0.46 0 CA-C-O 121.086 0.47 . . . . 0.0 111.887 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.438 ' HD3' ' N ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER 43.85 24.68 0.07 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.456 -178.391 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.8 m -166.11 32.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.035 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 50.56 64.54 3.59 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.943 -178.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -148.23 66.18 0.4 Allowed Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.405 ' HA ' ' O ' ' A' ' 15' ' ' PHE . 4.4 mp -49.5 -23.22 1.49 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.417 ' HA2' HG23 ' A' ' 41' ' ' ILE . . . 106.41 8.27 33.38 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.167 -1.016 . . . . 0.0 112.847 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.468 ' CD2' ' CG2' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -160.23 140.4 11.54 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 117.658 0.729 . . . . 0.0 112.483 -179.655 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.426 ' HG ' HD11 ' A' ' 41' ' ' ILE . 14.1 mt -79.05 166.61 22.13 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.909 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.5 m -151.78 143.81 16.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.268 177.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.7 tttp -136.41 120.9 18.2 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.907 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.432 ' HB3' ' CD1' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -113.62 112.01 22.79 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.521 178.488 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.61 124.26 21.89 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.904 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.0 t . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.162 -179.496 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.5 tp . . . . . 0 CA--C 1.533 0.298 0 CA-C-O 120.574 0.226 . . . . 0.0 111.373 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.432 HG23 HD11 ' A' ' 37' ' ' ILE . 17.2 mt -79.53 141.46 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.981 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.9 t -106.24 -39.21 6.01 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -175.23 144.02 0.7 Allowed 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 24' ' ' PHE . 38.1 mt -76.02 101.2 5.17 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.33 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.46 ' CG2' ' N ' ' A' ' 42' ' ' ARG . 0.8 OUTLIER -56.65 -59.22 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -176.525 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.46 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -93.02 -65.73 0.98 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -177.465 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.423 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 110.36 21.49 6.9 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.51 -178.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.94 -28.12 0.89 Allowed Glycine 0 C--N 1.339 0.741 0 C-N-CA 120.825 -0.702 . . . . 0.0 113.704 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.39 -83.17 0.33 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 117.996 0.898 . . . . 0.0 111.727 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.17 -58.56 6.23 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.327 0.584 . . . . 0.0 111.046 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.423 ' HB3' ' HA2' ' A' ' 43' ' ' GLY . 12.1 tp10 -48.77 -42.61 36.16 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.725 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -61.57 -35.12 76.9 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.8 m -53.84 -49.92 67.35 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.97 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 113.52 -31.74 6.46 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.212 -0.994 . . . . 0.0 114.337 178.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 pp -98.63 11.46 38.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.675 0.737 . . . . 0.0 111.715 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.468 ' CG2' ' CD2' ' A' ' 24' ' ' PHE . 4.6 mp -113.28 88.42 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-O 121.016 0.436 . . . . 0.0 110.478 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.404 ' HG3' ' N ' ' A' ' 54' ' ' ALA . 2.2 tp60 -112.69 148.11 35.37 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.611 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.406 ' HA ' ' CG2' ' A' ' 37' ' ' ILE . . . -70.39 140.88 52.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.046 0.45 . . . . 0.0 111.967 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.96 19.09 69.47 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.089 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -105.69 -81.49 0.54 Allowed 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 28.7 mm -152.51 125.92 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 121.503 0.668 . . . . 0.0 112.536 -177.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.456 ' O ' HG22 ' A' ' 58' ' ' ILE . 2.3 tp -161.21 76.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.469 177.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.2 tp -78.69 -63.15 1.48 Allowed 'General case' 0 C--N 1.328 -0.354 0 O-C-N 122.177 -0.327 . . . . 0.0 111.581 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -109.51 149.97 28.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.859 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.413 HG23 ' CD1' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -160.92 143.4 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.473 -179.371 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.402 ' HA ' ' CG2' ' A' ' 87' ' ' VAL . 53.2 m-80 60.89 33.72 19.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.19 0.519 . . . . 0.0 111.879 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 57.91 21.29 7.48 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 178.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.432 ' NH1' ' HB3' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -121.55 124.55 27.14 Favored Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 120.631 -0.428 . . . . 0.0 109.909 177.586 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.16 88.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 122.205 1.936 . . . . 0.0 112.117 -178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.43 67.52 9.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.304 0.573 . . . . 0.0 109.762 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.1 m -126.06 -59.08 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -131.47 25.51 4.79 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -102.5 -172.68 2.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.811 0.338 . . . . 0.0 110.457 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.82 111.47 9.0 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.432 ' CD1' ' HB3' ' A' ' 28' ' ' GLU . 8.0 t80 -43.95 -47.52 8.5 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.902 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -67.68 -32.48 73.18 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.17 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.1 m -70.67 -36.27 73.26 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.341 0.591 . . . . 0.0 109.851 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.09 -49.92 65.89 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.477 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.424 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 48.4 mt -63.42 -28.07 69.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.49 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -71.36 -40.27 70.74 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.6 t -58.38 -42.31 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.61 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.432 ' HB3' ' NH1' ' A' ' 64' ' ' ARG . 0.1 OUTLIER -72.07 -35.28 69.23 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.197 178.774 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.91 -37.12 68.47 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.023 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -58.97 -19.98 47.05 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.84 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.411 HG22 HD11 ' A' ' 81' ' ' ILE . 55.9 mt -66.36 119.43 11.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.938 0.399 . . . . 0.0 111.231 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.65 -162.16 0.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.13 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.5 m -94.76 -171.36 2.44 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.633 0.254 . . . . 0.0 110.739 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 44.61 30.99 0.57 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.929 0.395 . . . . 0.0 111.207 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.413 ' O ' ' CE1' ' A' ' 15' ' ' PHE . 3.1 t -125.81 161.88 26.38 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.956 0.884 . . . . 0.0 112.908 -178.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.15 176.52 5.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.231 -1.35 . . . . 0.0 110.504 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.402 ' CG2' ' HA ' ' A' ' 62' ' ' ASN . 6.3 p -147.65 153.53 11.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.864 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.3 t -113.83 159.72 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.585 0.231 . . . . 0.0 110.65 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -153.15 158.97 42.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.797 0.332 . . . . 0.0 110.932 -178.883 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.414 ' CD1' ' HA ' ' A' ' 11' ' ' SER . 46.9 mm -131.82 124.19 53.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.19 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.52 -0.209 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.291 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 13.2 t . . . . . 0 N--CA 1.461 0.116 0 CA-C-O 120.76 0.314 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -146.75 124.95 12.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.308 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.404 ' CA ' HD22 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -59.48 -58.66 7.65 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.04 179.33 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 31.8 m . . . . . 0 C--O 1.251 1.153 0 CA-C-O 118.389 -0.815 . . . . 0.0 112.808 178.87 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.322 0.582 . . . . 0.0 111.762 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.444 ' HA ' ' CD1' ' A' ' 90' ' ' ILE . 0.2 OUTLIER -97.18 169.92 9.46 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.372 -179.832 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.448 ' HB ' ' CD1' ' A' ' 89' ' ' LEU . 0.7 OUTLIER -156.85 163.33 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.089 -178.131 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.16 120.97 7.58 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.494 0.664 . . . . 0.0 110.584 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.459 ' O ' ' N ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -123.39 178.19 5.27 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.578 -179.64 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.448 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 2.5 t80 -119.31 150.04 40.8 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.4 ' O ' ' N ' ' A' ' 20' ' ' GLY . 14.3 mtpt -86.36 28.71 0.82 Allowed 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.066 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.427 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER 43.81 30.76 0.41 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.968 0.413 . . . . 0.0 111.925 179.532 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.448 ' HD3' ' CE1' ' A' ' 15' ' ' PHE . 0.0 OUTLIER 44.33 23.3 0.06 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.952 -178.716 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.0 m -166.41 33.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 49.54 66.57 2.19 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-N 115.435 -0.802 . . . . 0.0 113.088 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -148.07 61.19 0.45 Allowed Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.4 mp -46.91 -26.78 1.06 Allowed 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.36 5.1 24.92 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.3 -0.953 . . . . 0.0 113.915 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.423 ' CG ' HG22 ' A' ' 52' ' ' ILE . 1.2 p90 -155.95 141.22 17.54 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.237 1.018 . . . . 0.0 113.284 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.8 mt -79.56 168.22 19.7 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.038 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.5 m -149.01 147.21 16.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.737 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.0 ttpt -129.34 118.93 23.03 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.01 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.446 ' HB3' ' CD1' ' A' ' 71' ' ' TYR . 4.1 tm-20 -114.14 97.19 6.21 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.79 -1.095 . . . . 0.0 108.541 177.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.04 120.23 7.66 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.049 0.452 . . . . 0.0 110.932 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.444 -179.84 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.1 tp . . . . . 0 CA--C 1.537 0.461 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.442 HG22 HD11 ' A' ' 37' ' ' ILE . 27.8 mt -84.29 141.25 14.95 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 CA-C-O 120.708 0.29 . . . . 0.0 110.71 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.405 ' HB3' ' CG1' ' B' ' 4' ' ' VAL . 0.1 OUTLIER -108.89 -36.64 6.06 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -179.833 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -169.21 132.61 1.32 Allowed 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.319 -0.552 . . . . 0.0 112.381 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.1 mt -70.26 78.49 0.53 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 121.701 0.762 . . . . 0.0 109.876 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.461 ' CG2' ' N ' ' A' ' 42' ' ' ARG . 1.7 tp -33.06 -58.85 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 -177.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.461 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -94.42 -68.88 0.78 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -177.706 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.412 ' HA2' ' CB ' ' A' ' 47' ' ' GLU . . . 108.7 25.59 5.65 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -178.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.38 -34.08 0.51 Allowed Glycine 0 C--N 1.337 0.609 0 C-N-CA 121.145 -0.55 . . . . 0.0 113.182 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -92.74 -80.43 0.37 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 117.546 0.673 . . . . 0.0 110.908 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.402 ' HB3' ' CG2' ' A' ' 52' ' ' ILE . . . -60.29 -58.04 10.21 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.222 0.534 . . . . 0.0 111.389 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.412 ' CB ' ' HA2' ' A' ' 43' ' ' GLY . 39.2 tt0 -48.7 -46.92 41.27 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.83 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.6 tp-100 -57.87 -33.85 69.14 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.874 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.1 t -55.05 -52.16 64.04 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.752 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 112.27 -22.58 17.64 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.299 -0.953 . . . . 0.0 113.859 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.07 -28.2 14.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.955 0.377 . . . . 0.0 110.728 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.423 HG22 ' CG ' ' A' ' 24' ' ' PHE . 2.3 mp -82.37 121.28 35.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.025 0.441 . . . . 0.0 110.328 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -153.74 156.45 37.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.101 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.52 120.06 12.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.877 0.37 . . . . 0.0 110.954 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.0 -1.73 88.43 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.294 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.34 -91.34 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 117.011 0.406 . . . . 0.0 110.511 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.8 tp -163.98 120.5 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.405 ' HB ' ' CG1' ' A' ' 37' ' ' ILE . 2.0 tp -140.14 88.67 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 18.2 tp -78.33 -70.3 0.5 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.598 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -121.16 165.46 15.35 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.803 0.335 . . . . 0.0 111.109 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -148.3 157.23 8.26 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.267 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.128 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER 56.71 -81.21 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.046 0.538 . . . . 0.0 110.214 -178.589 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 61' ' ' VAL . 14.5 p-10 -175.22 36.99 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.344 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.433 ' O ' ' HD2' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -124.08 130.32 24.43 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.24 179.887 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -63.58 86.41 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 121.206 1.27 . . . . 0.0 110.322 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.402 ' CD2' ' HG3' ' A' ' 28' ' ' GLU . 0.3 OUTLIER -86.71 68.21 10.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.286 0.565 . . . . 0.0 110.916 -178.887 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.7 m -131.62 -61.53 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.73 28.33 5.63 Favored 'General case' 0 C--N 1.333 -0.13 0 O-C-N 121.978 -0.451 . . . . 0.0 111.735 -178.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -99.85 -172.06 2.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.498 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.32 114.63 15.22 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.446 ' CD1' ' HB3' ' A' ' 28' ' ' GLU . 4.0 t80 -44.2 -50.98 8.54 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -64.81 -29.11 70.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.339 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 39.0 t -71.23 -40.57 71.0 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.278 0.561 . . . . 0.0 110.048 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.77 -45.17 83.52 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.368 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.414 HD13 ' CE1' ' A' ' 71' ' ' TYR . 73.9 mt -63.69 -28.73 70.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.868 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -76.41 -36.09 58.24 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.812 0.339 . . . . 0.0 110.177 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.8 t -61.36 -41.43 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.795 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.31 -32.15 58.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.511 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.32 -32.16 72.88 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.795 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.26 -17.59 61.81 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.715 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 29.5 mt -63.25 136.77 25.68 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 CA-C-O 120.867 0.365 . . . . 0.0 110.828 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.46 -165.42 0.78 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.507 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.43 -172.12 2.27 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.098 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 38.0 34.67 0.07 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.105 0.562 . . . . 0.0 111.5 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.416 ' O ' ' CE1' ' A' ' 15' ' ' PHE . 1.8 t -126.37 163.63 22.86 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.925 0.869 . . . . 0.0 113.21 -177.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.3 177.33 5.74 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 114.158 -1.383 . . . . 0.0 110.051 179.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.459 ' N ' ' O ' ' A' ' 14' ' ' LEU . 2.3 p -150.77 145.98 16.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.338 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.475 ' O ' ' N ' ' A' ' 62' ' ' ASN . 21.2 t -101.9 159.3 4.23 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.015 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.448 ' CD1' ' HB ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -155.16 165.91 35.23 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.319 -179.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.444 ' CD1' ' HA ' ' A' ' 11' ' ' SER . 29.6 mm -132.58 130.31 59.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.188 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.024 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.405 ' CG1' ' HB3' ' A' ' 38' ' ' SER . 3.5 t . . . . . 0 N--CA 1.465 0.322 0 CA-C-O 120.878 0.371 . . . . 0.0 111.963 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 58.21 -124.6 1.5 Allowed 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 119.44 -0.314 . . . . 0.0 110.348 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 5.8 p 167.8 127.91 0.01 OUTLIER 'General case' 0 C--N 1.347 0.475 0 CA-C-N 118.605 0.639 . . . . 0.0 110.336 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 4.5 m . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.232 -0.89 . . . . 0.0 111.251 -179.373 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.43 ' CG2' ' N ' ' A' ' 11' ' ' SER . 0.5 OUTLIER . . . . . 0 CA--C 1.537 0.473 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.43 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 13.9 m -77.37 167.76 21.15 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -178.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.418 ' CG2' ' HG ' ' A' ' 91' ' ' LEU . 1.9 t -157.87 157.83 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 114.083 -1.417 . . . . 0.0 107.894 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.3 ttp180 -141.69 141.92 33.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.406 0.622 . . . . 0.0 111.727 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.44 ' CD2' ' CE1' ' A' ' 24' ' ' PHE . 0.8 OUTLIER -142.96 177.44 8.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.876 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.428 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 3.5 t80 -124.49 147.86 48.08 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.403 ' O ' ' N ' ' A' ' 20' ' ' GLY . 1.5 mtpt -84.12 32.62 0.49 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.481 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.443 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 0.3 OUTLIER 40.53 32.13 0.13 Allowed 'General case' 0 C--N 1.344 0.343 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 179.222 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER 45.0 24.66 0.12 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.551 -178.497 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.401 ' CG2' ' O ' ' A' ' 17' ' ' ARG . 1.6 m -169.23 34.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.317 178.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 49.94 63.91 3.89 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 115.56 -0.746 . . . . 0.0 113.062 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -145.97 62.22 0.47 Allowed Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.1 mp -46.24 -24.83 0.52 Allowed 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.423 ' HA2' HG23 ' A' ' 41' ' ' ILE . . . 107.96 6.99 31.8 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.039 -1.076 . . . . 0.0 113.587 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.44 ' CE1' ' CD2' ' A' ' 14' ' ' LEU . 0.6 OUTLIER -157.15 140.78 15.87 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -178.92 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.3 mt -79.92 171.06 15.62 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.671 178.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.5 m -149.85 153.2 10.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.506 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.2 105.13 5.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.479 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.464 ' HB3' ' CG ' ' A' ' 71' ' ' TYR . 0.6 OUTLIER -108.44 139.22 43.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.076 178.93 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.7 mtt-85 -76.6 124.5 27.71 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.05 0.453 . . . . 0.0 110.37 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.7 t . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.042 -179.648 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.4 tp . . . . . 0 CA--C 1.537 0.448 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.425 HG13 ' CG2' ' A' ' 58' ' ' ILE . 24.2 mt -81.27 145.93 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.464 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.402 ' CB ' ' CG1' ' B' ' 4' ' ' VAL . 4.9 t -109.32 -40.58 4.88 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -164.9 131.78 2.98 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.863 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.407 ' CD2' ' HB3' ' A' ' 24' ' ' PHE . 43.1 mt -70.14 76.74 0.51 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.712 0.767 . . . . 0.0 109.698 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.46 ' CG2' ' N ' ' A' ' 42' ' ' ARG . 0.2 OUTLIER -30.58 -59.16 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -177.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.46 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -94.44 -66.25 0.93 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -177.857 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 104.65 23.5 7.86 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -177.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -125.45 -30.1 0.94 Allowed Glycine 0 C--N 1.338 0.687 0 C-N-CA 121.24 -0.505 . . . . 0.0 113.159 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -95.84 -83.25 0.37 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 117.686 0.743 . . . . 0.0 111.932 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.95 -58.79 7.03 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.207 0.527 . . . . 0.0 111.04 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -45.06 -49.42 11.55 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.971 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.434 ' HB2' ' O ' ' A' ' 44' ' ' GLY . 7.6 mt-30 -55.65 -39.04 70.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.493 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.42 -49.9 63.61 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.343 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.4 -26.99 13.21 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.301 -0.952 . . . . 0.0 113.746 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.414 ' HG ' HD11 ' A' ' 52' ' ' ILE . 2.1 pp -95.65 -0.98 51.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.107 0.453 . . . . 0.0 111.471 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.414 HD11 ' HG ' ' A' ' 51' ' ' LEU . 5.0 mp -109.79 123.99 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -150.93 160.12 44.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.735 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.49 129.81 40.74 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.925 0.393 . . . . 0.0 111.265 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.35 13.73 63.13 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.101 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.27 -80.84 0.39 Allowed 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 22.4 mt -155.24 122.7 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.461 ' O ' HG22 ' A' ' 58' ' ' ILE . 3.2 tp -160.25 71.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 114.867 -1.061 . . . . 0.0 109.222 177.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.2 tp -76.93 -54.13 6.97 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.643 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -121.08 160.04 24.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.835 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.407 HG21 ' N ' ' A' ' 62' ' ' ASN . 14.4 p -166.75 146.05 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.043 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.407 ' N ' HG21 ' A' ' 61' ' ' VAL . 0.1 OUTLIER 45.76 41.13 7.15 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.198 0.523 . . . . 0.0 111.56 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.4 t70 59.74 28.44 17.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.221 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -119.61 98.24 49.93 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.572 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.27 85.37 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 121.811 1.674 . . . . 0.0 110.896 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.4 mt -68.75 63.69 0.11 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.508 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.4 m -141.81 -61.09 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -111.7 29.38 7.9 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 122.127 -0.358 . . . . 0.0 111.736 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.19 175.31 6.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.644 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.5 m -72.66 102.33 3.28 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.464 ' CG ' ' HB3' ' A' ' 28' ' ' GLU . 8.5 t80 -40.14 -60.99 0.95 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.363 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.8 p30 -55.49 -28.42 54.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.404 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.8 m -78.07 -39.94 40.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.087 0.47 . . . . 0.0 109.856 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.47 -34.73 74.46 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.294 0.568 . . . . 0.0 109.944 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.417 HD12 ' CZ ' ' A' ' 71' ' ' TYR . 15.1 mt -75.02 -38.04 61.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.242 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -72.07 -38.73 69.39 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.98 0.419 . . . . 0.0 110.19 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.1 t -62.33 -42.93 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.772 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.5 pp -79.85 -21.91 43.55 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.12 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.77 -37.18 84.08 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-O 120.988 0.423 . . . . 0.0 110.335 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -58.27 -19.07 38.07 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.192 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.417 HD11 HG22 ' A' ' 81' ' ' ILE . 70.8 mt -54.27 121.99 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 120.953 0.406 . . . . 0.0 111.006 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.77 -163.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.653 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.3 m -96.42 -171.67 2.34 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.996 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 44.08 30.82 0.46 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.232 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.404 ' O ' ' CE1' ' A' ' 15' ' ' PHE . 1.7 t -125.37 158.76 33.48 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 122.046 0.927 . . . . 0.0 112.737 -178.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.34 176.28 5.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.969 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.405 ' N ' ' O ' ' A' ' 14' ' ' LEU . 4.8 p -148.66 153.14 11.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.22 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.1 t -113.56 160.43 13.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.417 ' CG ' ' HB ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -155.89 172.64 18.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.64 0.257 . . . . 0.0 110.597 -178.736 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 29.6 mm -137.25 126.37 35.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.418 ' HG ' ' CG2' ' A' ' 12' ' ' VAL . 11.6 mt . . . . . 0 CA--C 1.515 -0.396 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.402 ' CG1' ' CB ' ' A' ' 38' ' ' SER . 4.2 t . . . . . 0 N--CA 1.463 0.204 0 CA-C-O 120.823 0.344 . . . . 0.0 110.67 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.28 -98.09 0.07 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.927 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 2.6 p 162.75 130.41 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 122.794 0.438 . . . . 0.0 110.406 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 15.5 m . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.182 -179.765 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.43 ' CG2' ' N ' ' A' ' 11' ' ' SER . 1.5 tp . . . . . 0 CA--C 1.539 0.528 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.437 ' HA ' ' CD1' ' A' ' 90' ' ' ILE . 10.1 m -100.61 168.42 9.72 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 121.572 0.701 . . . . 0.0 112.684 -178.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.424 ' CG2' ' HG ' ' A' ' 91' ' ' LEU . 2.2 t -156.18 164.36 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.961 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.5 tpp85 -149.83 127.69 11.8 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.508 0.67 . . . . 0.0 110.744 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -128.37 178.25 6.4 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.838 -1.073 . . . . 0.0 110.094 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.438 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 4.0 t80 -122.03 151.22 41.07 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 20' ' ' GLY . 2.1 mmpt? -83.37 30.95 0.46 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.405 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.414 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 0.9 OUTLIER 40.91 31.21 0.12 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 122.865 0.466 . . . . 0.0 112.061 179.679 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.438 ' HD3' ' CE1' ' A' ' 15' ' ' PHE . 0.0 OUTLIER 44.15 24.35 0.08 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.286 0.634 . . . . 0.0 112.419 -177.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.6 m -165.98 32.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.108 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 50.45 68.16 1.56 Allowed Glycine 0 C--N 1.337 0.608 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.991 -178.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -155.08 69.48 0.29 Allowed Glycine 0 C--N 1.332 0.327 0 N-CA-C 111.529 -0.629 . . . . 0.0 111.529 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.5 mp -49.4 -21.3 0.86 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.78 5.15 33.82 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.169 -1.015 . . . . 0.0 113.32 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.431 ' CD2' ' CG2' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -157.58 138.12 12.95 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 117.794 0.797 . . . . 0.0 112.844 -179.583 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.47 ' CD2' ' HA ' ' B' ' 6' ' ' SER . 1.8 mt -78.68 165.28 23.81 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.374 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.3 m -147.7 154.31 11.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.161 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -137.7 121.28 17.29 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.259 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.435 ' HB3' ' CD1' ' A' ' 71' ' ' TYR . 0.9 OUTLIER -115.03 95.21 5.1 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.167 178.538 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.9 mtt180 -62.16 116.84 5.31 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.117 0.484 . . . . 0.0 110.493 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.8 t . . . . . 0 C--N 1.328 -0.33 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -179.461 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.401 ' HA ' HG21 ' A' ' 58' ' ' ILE . 0.6 OUTLIER . . . . . 0 CA--C 1.535 0.379 0 CA-C-O 120.855 0.359 . . . . 0.0 111.539 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.443 HG23 HD11 ' A' ' 37' ' ' ILE . 22.1 mt -79.22 142.54 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.773 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.4 t -106.36 -40.45 5.6 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -171.18 142.11 1.72 Allowed 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.145 -0.622 . . . . 0.0 112.429 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.406 ' CD2' ' HB3' ' A' ' 24' ' ' PHE . 46.6 mt -76.21 85.3 3.03 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.995 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 42' ' ' ARG . 1.3 tp -41.98 -58.29 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -177.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.459 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.1 OUTLIER -92.44 -66.23 0.94 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -176.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.441 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 107.42 18.81 9.86 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 -177.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.51 -27.75 0.95 Allowed Glycine 0 C--N 1.34 0.793 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.855 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.06 -83.4 0.33 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.008 0.904 . . . . 0.0 111.69 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.23 -54.68 29.64 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 121.424 0.631 . . . . 0.0 110.782 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.441 ' HB3' ' HA2' ' A' ' 43' ' ' GLY . 3.8 tp10 -49.19 -42.24 39.45 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.368 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.92 -35.52 78.63 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.454 178.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.3 -47.78 65.73 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.655 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.42 -27.0 11.09 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.207 -0.997 . . . . 0.0 114.655 177.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.8 pp -102.26 -11.66 18.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 117.711 0.756 . . . . 0.0 111.944 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.431 ' CG2' ' CD2' ' A' ' 24' ' ' PHE . 5.2 mp -87.78 104.45 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.08 156.53 42.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.833 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.93 133.39 45.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.827 0.346 . . . . 0.0 111.04 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.96 14.37 65.57 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.134 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.17 -82.55 0.34 Allowed 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.6 mp -158.47 120.38 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.462 0.649 . . . . 0.0 111.841 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.431 ' HB ' ' CG1' ' A' ' 37' ' ' ILE . 5.9 tp -152.9 87.19 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.09 177.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.3 tp -79.48 -61.78 1.9 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 121.994 -0.441 . . . . 0.0 111.238 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -127.88 158.88 36.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.909 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.415 HG21 ' CD1' ' A' ' 58' ' ' ILE . 11.7 t -150.63 149.99 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.018 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 49.47 33.82 6.06 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.25 0.547 . . . . 0.0 110.941 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 63.89 23.89 13.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.285 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -111.39 110.93 55.49 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.179 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.49 80.72 0.1 Allowed 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.914 1.743 . . . . 0.0 111.5 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.425 ' HA ' ' CD2' ' A' ' 69' ' ' LEU . 6.8 mt -78.17 65.44 3.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.389 0.614 . . . . 0.0 109.883 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.7 m -122.67 -56.04 2.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.698 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.52 22.47 2.72 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.425 ' CD2' ' HA ' ' A' ' 66' ' ' LEU . 0.7 OUTLIER -96.96 -175.67 3.33 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 178.869 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.3 m -68.86 96.67 0.77 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.435 ' CD1' ' HB3' ' A' ' 28' ' ' GLU . 9.0 t80 -40.77 -57.0 2.04 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -178.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -59.19 -28.22 66.43 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.096 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.7 t -76.6 -44.71 33.23 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.84 -40.84 81.03 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.45 0.643 . . . . 0.0 109.724 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.409 HD12 ' CZ ' ' A' ' 71' ' ' TYR . 99.0 mt -66.02 -36.4 83.17 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.22 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -71.44 -38.7 71.33 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 120.921 0.391 . . . . 0.0 110.283 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.2 t -59.63 -36.85 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.013 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.5 pp -91.89 -24.64 19.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.005 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.27 -44.49 83.44 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 120.507 -0.477 . . . . 0.0 109.803 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -52.85 -22.29 11.84 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.877 -0.677 . . . . 0.0 113.031 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 80.1 mt -49.84 119.39 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 120.855 0.359 . . . . 0.0 111.391 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.15 -168.66 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.473 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 m -96.4 -171.12 2.21 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.115 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 44.13 31.3 0.52 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.074 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.419 ' O ' ' CE1' ' A' ' 15' ' ' PHE . 1.8 t -125.38 160.19 29.99 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.969 0.89 . . . . 0.0 112.789 -178.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -100.95 176.61 5.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.415 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.425 ' N ' ' O ' ' A' ' 14' ' ' LEU . 2.8 p -151.69 150.02 13.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.663 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.1 t -110.2 155.96 11.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.382 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -149.66 155.8 40.83 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.13 -178.353 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.437 ' CD1' ' HA ' ' A' ' 11' ' ' SER . 45.9 mm -130.75 133.36 63.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.02 0.438 . . . . 0.0 111.267 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.424 ' HG ' ' CG2' ' A' ' 12' ' ' VAL . 55.6 mt . . . . . 0 C--N 1.327 -0.398 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.316 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 11.5 t . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.763 0.315 . . . . 0.0 110.734 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.54 -97.11 0.09 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.275 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.47 ' HA ' ' CD2' ' A' ' 25' ' ' LEU . 7.1 t 167.78 -36.36 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 117.851 0.296 . . . . 0.0 110.541 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.414 ' CG2' ' O ' ' B' ' 6' ' ' SER . 20.2 m . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.197 -0.906 . . . . 0.0 112.735 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.41 ' CG2' ' N ' ' A' ' 11' ' ' SER . 1.2 tp . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.425 ' HA ' ' CD1' ' A' ' 90' ' ' ILE . 2.9 t -98.41 164.1 12.42 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.922 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.422 ' HB ' ' CD1' ' A' ' 89' ' ' LEU . 2.1 t -154.17 165.34 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.279 -178.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.1 ttp85 -144.75 140.04 28.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.292 0.568 . . . . 0.0 110.913 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.458 ' CD2' ' CE1' ' A' ' 24' ' ' PHE . 0.6 OUTLIER -139.07 140.99 38.2 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.323 -179.877 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.435 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 2.6 t80 -87.58 145.41 26.22 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 177.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.406 ' O ' ' N ' ' A' ' 20' ' ' GLY . 4.6 mttt -82.17 29.65 0.41 Allowed 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.824 -0.351 . . . . 0.0 111.538 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.423 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER 42.99 31.03 0.3 Allowed 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 179.377 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.435 ' HD3' ' CE1' ' A' ' 15' ' ' PHE . 0.0 OUTLIER 44.12 23.59 0.06 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.586 -178.559 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.9 m -164.75 32.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.017 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 50.47 57.64 10.19 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.81 -178.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -138.8 58.79 0.61 Allowed Glycine 0 C--N 1.332 0.356 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.8 mp -44.61 -25.15 0.24 Allowed 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.423 ' HA2' HG23 ' A' ' 41' ' ' ILE . . . 109.32 5.73 29.95 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.18 -1.009 . . . . 0.0 113.644 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.458 ' CE1' ' CD2' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -158.73 138.14 11.65 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 117.835 0.818 . . . . 0.0 112.48 -179.47 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.411 ' CD2' ' CD1' ' A' ' 41' ' ' ILE . 0.1 OUTLIER -85.04 175.53 8.97 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.594 179.608 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.4 m -146.7 160.92 9.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.924 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -141.95 111.21 6.42 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.846 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.476 ' HB3' ' CG ' ' A' ' 71' ' ' TYR . 1.7 tm-20 -106.19 113.23 26.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.101 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.88 126.72 29.39 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.021 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 96.7 t . . . . . 0 C--N 1.326 -0.428 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.677 179.155 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.414 ' HA ' HG21 ' A' ' 58' ' ' ILE . 1.1 tp . . . . . 0 CA--C 1.537 0.475 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.42 HD12 ' CE2' ' A' ' 24' ' ' PHE . 43.5 mt -88.82 149.83 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.801 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.405 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 16.0 t -111.92 -42.72 3.72 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -175.59 139.39 0.42 Allowed 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 120.151 -0.619 . . . . 0.0 112.308 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.41 ' CD2' ' HB3' ' A' ' 24' ' ' PHE . 30.5 mt -68.83 110.24 4.27 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 178.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.464 ' CG2' ' N ' ' A' ' 42' ' ' ARG . 1.5 tp -65.67 -58.49 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 -176.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.464 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 2.0 tmt_? -93.34 -59.53 2.0 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -177.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.466 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 102.26 22.49 9.8 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.173 -177.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.412 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -125.02 -29.37 1.03 Allowed Glycine 0 C--N 1.338 0.693 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.568 -178.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.35 -83.17 0.35 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 117.855 0.827 . . . . 0.0 111.648 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.83 -62.2 1.96 Allowed 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.238 0.542 . . . . 0.0 111.285 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.466 ' HB3' ' HA2' ' A' ' 43' ' ' GLY . 4.0 tp10 -46.36 -42.2 14.58 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.776 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.412 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 0.3 OUTLIER -58.77 -39.3 80.62 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.616 178.775 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.23 -44.5 68.14 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.492 178.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.91 -26.85 16.17 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.414 -0.898 . . . . 0.0 114.463 177.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.5 pp -104.04 18.6 21.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 117.546 0.673 . . . . 0.0 111.974 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.7 mp -120.15 73.68 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.819 0.342 . . . . 0.0 110.592 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -102.67 141.34 35.65 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.98 143.43 57.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.149 0.499 . . . . 0.0 111.55 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.59 10.7 85.98 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.009 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -97.76 -88.18 0.31 Allowed 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.862 0.331 . . . . 0.0 111.098 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -163.72 121.45 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.414 HG21 ' HA ' ' A' ' 36' ' ' ILE . 2.0 tp -137.98 77.03 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 177.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.0 -62.21 1.73 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 -178.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -116.4 149.54 39.23 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.833 0.349 . . . . 0.0 111.514 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.93 143.71 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.635 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 65.18 -73.22 0.06 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.729 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.3 t0 179.61 37.29 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.945 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.435 ' O ' ' HD2' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -130.75 140.18 37.87 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-O 120.782 0.325 . . . . 0.0 111.029 179.547 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.27 82.58 2.19 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 121.548 1.498 . . . . 0.0 110.703 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.408 ' HG ' ' NH1' ' A' ' 64' ' ' ARG . 0.4 OUTLIER -77.65 68.74 3.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.77 -178.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.2 m -126.71 -59.45 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.919 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.36 26.46 3.17 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.803 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -92.58 -170.14 2.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.869 0.366 . . . . 0.0 110.66 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.3 m -73.71 108.64 6.67 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.476 ' CG ' ' HB3' ' A' ' 28' ' ' GLU . 3.0 t80 -42.57 -55.84 3.34 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -62.93 -27.77 69.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.242 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.4 t -75.32 -39.33 59.59 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.47 -49.49 75.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.945 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.41 HD12 ' CE1' ' A' ' 71' ' ' TYR . 27.2 mt -63.14 -30.68 71.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.916 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -72.78 -38.58 67.22 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.716 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 65.1 t -58.97 -42.83 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.402 ' CD2' ' NH2' ' A' ' 64' ' ' ARG . 0.4 OUTLIER -78.7 -29.92 45.75 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.117 179.185 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -37.91 79.81 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.773 0.32 . . . . 0.0 110.975 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -59.59 -22.32 56.47 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.743 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 49.9 mt -58.23 116.74 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 120.927 0.394 . . . . 0.0 111.041 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.78 -167.18 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.44 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.9 m -96.83 -170.38 2.04 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.093 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 44.25 31.06 0.52 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.13 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.411 ' O ' ' CD1' ' A' ' 15' ' ' PHE . 1.7 t -130.12 162.35 29.01 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.815 0.817 . . . . 0.0 112.804 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -103.41 176.2 5.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.4 -1.273 . . . . 0.0 109.808 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.407 ' N ' ' O ' ' A' ' 14' ' ' LEU . 0.4 OUTLIER -144.9 172.37 5.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.929 0.395 . . . . 0.0 111.305 -179.366 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.8 t -122.73 158.13 27.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.748 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.422 ' CD1' ' HB ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -151.32 147.33 26.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.845 0.355 . . . . 0.0 110.427 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.425 ' CD1' ' HA ' ' A' ' 11' ' ' SER . 41.0 mm -126.36 122.89 62.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.998 0.428 . . . . 0.0 111.465 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.0 mt . . . . . 0 C--O 1.232 0.173 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.242 178.849 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 3.5 t . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.947 0.403 . . . . 0.0 111.59 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -123.79 102.08 7.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.645 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.404 ' HA ' ' CD2' ' A' ' 25' ' ' LEU . 12.9 p -61.05 134.82 57.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.959 0.409 . . . . 0.0 110.728 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 14.6 m . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.142 -0.932 . . . . 0.0 111.149 -179.339 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.453 ' CG2' ' N ' ' A' ' 11' ' ' SER . 1.0 OUTLIER . . . . . 0 CA--C 1.536 0.434 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.453 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 56.1 p -84.6 165.27 18.13 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.652 0.739 . . . . 0.0 111.957 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.435 ' N ' ' O ' ' A' ' 89' ' ' LEU . 1.7 t -156.72 156.15 4.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.748 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -140.4 140.38 35.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.595 0.712 . . . . 0.0 111.154 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -141.88 177.77 7.96 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.833 -179.624 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.453 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 2.6 t80 -122.98 149.82 43.79 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.403 ' O ' ' N ' ' A' ' 20' ' ' GLY . 2.2 mttt -84.2 29.39 0.57 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.738 178.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.41 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER 41.96 31.77 0.25 Allowed 'General case' 0 C--N 1.345 0.378 0 C-N-CA 123.006 0.522 . . . . 0.0 111.853 179.593 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.453 ' HD3' ' CE1' ' A' ' 15' ' ' PHE . 0.0 OUTLIER 44.05 24.16 0.07 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.529 -178.508 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.0 m -164.16 31.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.185 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 50.45 65.57 2.9 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.616 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -151.62 68.26 0.32 Allowed Glycine 0 C--N 1.331 0.273 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.2 mp -52.22 -22.2 4.13 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.409 ' HA2' HG23 ' A' ' 41' ' ' ILE . . . 107.3 11.56 25.33 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.152 -1.023 . . . . 0.0 113.829 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -159.7 141.73 13.27 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 118.008 0.904 . . . . 0.0 113.382 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.423 HD22 HD12 ' A' ' 41' ' ' ILE . 11.5 mt -79.61 172.83 13.25 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.435 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.2 m -153.23 148.97 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.242 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -135.38 106.27 6.61 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.393 -179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.451 ' HB3' ' CD1' ' A' ' 71' ' ' TYR . 7.0 tm-20 -103.54 111.42 23.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.805 178.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -70.62 116.55 11.08 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 121.092 0.472 . . . . 0.0 110.43 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.6 t . . . . . 0 CA--C 1.532 0.267 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.609 -179.559 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.44 ' HA ' HG21 ' A' ' 58' ' ' ILE . 1.2 tp . . . . . 0 CA--C 1.535 0.372 0 CA-C-O 120.699 0.285 . . . . 0.0 111.597 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.456 HG23 HD11 ' A' ' 37' ' ' ILE . 35.9 mt -82.74 145.88 7.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.64 0.257 . . . . 0.0 110.925 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.41 ' CB ' ' CG1' ' B' ' 4' ' ' VAL . 6.3 t -109.55 -38.2 5.5 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -170.54 135.35 1.18 Allowed 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.364 -0.534 . . . . 0.0 112.18 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.4 mt -71.93 84.08 0.95 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.698 0.761 . . . . 0.0 109.781 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.458 ' CG2' ' N ' ' A' ' 42' ' ' ARG . 0.8 OUTLIER -39.91 -59.13 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 114.922 1.452 . . . . 0.0 114.922 -177.515 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.458 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -93.53 -64.78 1.05 Allowed 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -177.632 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 104.41 23.56 7.93 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -177.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.405 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -126.06 -32.37 0.74 Allowed Glycine 0 C--N 1.338 0.666 0 C-N-CA 121.283 -0.484 . . . . 0.0 113.085 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.03 -83.13 0.34 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 117.732 0.766 . . . . 0.0 111.435 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.14 -57.92 10.72 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.232 0.539 . . . . 0.0 111.161 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -48.26 -47.54 36.03 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.871 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.405 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -57.31 -32.97 67.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.09 178.903 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.55 -52.21 66.34 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.89 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 113.75 -30.73 6.99 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.154 -1.022 . . . . 0.0 114.096 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 pp -95.75 -1.47 49.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.291 0.545 . . . . 0.0 111.571 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.406 HD11 ' N ' ' A' ' 52' ' ' ILE . 4.9 mp -105.27 118.36 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-O 120.953 0.406 . . . . 0.0 110.217 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -144.44 162.51 36.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.293 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.81 126.72 30.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.857 0.361 . . . . 0.0 110.787 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.42 11.97 72.51 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.932 -178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.13 -83.95 0.24 Allowed 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 19.7 mt -155.94 125.72 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.44 HG21 ' HA ' ' A' ' 36' ' ' ILE . 5.8 tp -160.42 70.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.596 177.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.413 ' HG ' ' N ' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -78.04 -47.79 17.59 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 122.087 -0.383 . . . . 0.0 111.315 -178.418 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.413 ' N ' ' HG ' ' A' ' 59' ' ' LEU . . . -121.89 150.21 42.3 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.834 0.35 . . . . 0.0 111.368 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.432 ' O ' ' N ' ' A' ' 63' ' ' ASP . 3.0 t -140.33 144.86 26.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.172 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER 53.84 -82.59 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.025 0.53 . . . . 0.0 110.902 -179.118 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 61' ' ' VAL . 2.0 p30 -165.56 33.69 0.05 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.084 0.469 . . . . 0.0 110.272 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.408 ' NH2' ' CD2' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -126.64 105.5 23.61 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.779 179.653 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -58.93 87.4 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 121.701 1.601 . . . . 0.0 110.526 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 29.8 tp -86.44 66.04 9.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.431 0.634 . . . . 0.0 111.397 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.7 m -110.67 -44.28 5.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.027 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.5 p30 -140.24 24.52 2.31 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.513 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.87 174.32 6.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.772 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.46 121.76 14.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.317 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.451 ' CD1' ' HB3' ' A' ' 28' ' ' GLU . 3.7 t80 -54.93 -61.0 2.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.524 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -56.67 -32.76 65.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.237 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.6 m -70.95 -46.35 62.56 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.65 -45.01 77.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.171 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.422 HD13 ' CE1' ' A' ' 71' ' ' TYR . 14.7 mt -64.87 -29.71 70.67 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.15 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -72.34 -36.13 68.73 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.002 0.429 . . . . 0.0 110.017 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.4 t -61.0 -46.04 97.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.524 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.408 ' CD2' ' NH2' ' A' ' 64' ' ' ARG . 1.6 pp -79.12 -27.06 42.83 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.408 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -49.21 77.28 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 121.023 0.439 . . . . 0.0 110.776 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.35 -22.61 15.79 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.997 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 57.1 mt -56.32 118.75 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 120.9 0.381 . . . . 0.0 111.097 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.75 -165.93 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.421 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.2 m -95.47 -169.42 1.96 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.244 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 41.17 32.6 0.2 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.398 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.418 ' O ' ' CE1' ' A' ' 15' ' ' PHE . 1.5 t -125.29 159.95 30.47 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 122.013 0.911 . . . . 0.0 112.775 -178.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.64 176.63 5.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.13 -1.395 . . . . 0.0 109.921 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.424 ' N ' ' O ' ' A' ' 14' ' ' LEU . 4.2 p -149.71 151.78 12.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.541 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.419 ' O ' ' N ' ' A' ' 62' ' ' ASN . 10.7 t -109.61 163.79 6.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.9 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -159.04 164.38 35.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.674 0.273 . . . . 0.0 110.393 -179.723 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.414 HG22 HD11 ' A' ' 90' ' ' ILE . 33.0 mm -135.64 125.5 41.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.421 ' HG ' ' CG2' ' A' ' 12' ' ' VAL . 10.9 mt . . . . . 0 C--O 1.233 0.191 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 177.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.41 ' CG1' ' CB ' ' A' ' 38' ' ' SER . 15.3 t . . . . . 0 CA--C 1.52 -0.178 0 CA-C-O 120.783 0.325 . . . . 0.0 110.454 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.98 -104.65 0.09 Allowed 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.169 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 6.7 t 163.3 105.63 0.0 OUTLIER 'General case' 0 C--N 1.346 0.438 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 m . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.305 -179.173 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.1 tp . . . . . 0 CA--C 1.531 0.241 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.2 p -105.23 159.92 15.5 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.954 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.423 ' CG2' ' HB2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -134.15 102.96 4.61 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.318 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.542 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.0 ttp85 -79.47 106.17 11.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.49 0.662 . . . . 0.0 112.26 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.424 ' HB2' ' CD1' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -116.62 177.23 4.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.604 178.612 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.44 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 2.4 t80 -117.03 151.25 37.16 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.41 ' O ' ' N ' ' A' ' 20' ' ' GLY . 0.8 OUTLIER -85.67 27.27 0.86 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.179 178.691 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.417 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 0.2 OUTLIER 45.48 29.73 0.64 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 179.257 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.44 ' HD3' ' CE1' ' A' ' 15' ' ' PHE . 0.0 OUTLIER 43.13 24.92 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.101 0.56 . . . . 0.0 112.421 -178.431 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.4 ' CG1' ' O ' ' A' ' 18' ' ' LYS . 15.0 m -166.53 32.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 123.948 0.899 . . . . 0.0 108.857 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 48.01 62.55 4.14 Favored Glycine 0 C--N 1.34 0.768 0 CA-C-N 115.818 -0.628 . . . . 0.0 113.154 -178.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -147.9 60.2 0.46 Allowed Glycine 0 C--N 1.333 0.412 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 mp -41.02 -26.63 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.47 1.83 12.11 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.11 -1.043 . . . . 0.0 113.469 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.431 ' CD1' HG22 ' A' ' 52' ' ' ILE . 0.9 OUTLIER -156.94 140.2 15.59 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 117.766 0.783 . . . . 0.0 112.665 -179.561 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.41 ' CD2' ' CD1' ' A' ' 41' ' ' ILE . 0.7 OUTLIER -79.15 171.06 15.71 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.954 179.047 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.7 m -150.8 154.12 9.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.037 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.6 ptmm? -135.79 107.74 7.12 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.275 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.467 ' HB3' ' CG ' ' A' ' 71' ' ' TYR . 3.0 tm-20 -97.41 108.54 21.28 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -59.99 111.6 1.55 Allowed 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 121.104 0.478 . . . . 0.0 110.409 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.1 t . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.839 -179.761 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.408 ' HA ' HG21 ' A' ' 58' ' ' ILE . 1.0 OUTLIER . . . . . 0 CA--C 1.533 0.294 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.443 HD11 HG22 ' A' ' 37' ' ' ILE . 39.3 mt -84.89 149.0 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.94 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.14 -38.6 3.34 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -172.69 135.8 0.69 Allowed 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 119.972 -0.691 . . . . 0.0 112.679 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.414 ' CD2' ' HB3' ' A' ' 24' ' ' PHE . 47.8 mt -67.09 113.6 5.19 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.458 ' CG2' ' N ' ' A' ' 42' ' ' ARG . 2.0 tp -73.49 -55.86 11.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -175.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.458 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 10.9 ttt85 -93.38 -64.84 1.04 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.074 0.464 . . . . 0.0 112.104 -177.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.412 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 105.31 21.19 9.01 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.376 -178.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.407 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -125.85 -30.86 0.85 Allowed Glycine 0 C--N 1.336 0.551 0 C-N-CA 121.072 -0.585 . . . . 0.0 113.206 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.73 -82.66 0.36 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 117.583 0.692 . . . . 0.0 111.302 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.24 -57.38 13.29 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.148 0.499 . . . . 0.0 111.402 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.412 ' HB3' ' HA2' ' A' ' 43' ' ' GLY . 51.2 tt0 -49.85 -45.87 50.8 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.751 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.407 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 1.0 OUTLIER -55.83 -35.29 66.22 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.003 178.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.4 t -58.48 -49.34 77.68 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.63 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.75 -19.14 36.44 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.31 -0.947 . . . . 0.0 113.921 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 pp -96.52 -26.63 15.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.154 0.477 . . . . 0.0 110.814 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.431 HG22 ' CD1' ' A' ' 24' ' ' PHE . 5.0 mp -80.8 98.64 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-O 120.958 0.409 . . . . 0.0 110.42 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -124.53 149.26 47.13 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.646 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.402 ' HA ' ' CG2' ' A' ' 37' ' ' ILE . . . -67.63 128.67 37.32 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.987 0.423 . . . . 0.0 111.273 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.74 2.15 90.62 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.388 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -84.21 -89.1 0.1 Allowed 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.985 0.392 . . . . 0.0 110.902 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.3 tp -163.12 126.32 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.408 HG21 ' HA ' ' A' ' 36' ' ' ILE . 2.7 tp -146.6 90.02 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.4 tp -78.49 -67.09 0.77 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.407 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -128.4 149.78 50.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.16 0.505 . . . . 0.0 112.111 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.427 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 18.8 t -125.97 144.79 34.87 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.893 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.427 ' ND2' ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER 44.2 29.24 0.34 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 120.964 0.411 . . . . 0.0 111.768 -178.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.6 t70 74.02 26.91 1.66 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.403 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.99 102.71 18.61 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.014 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -61.09 82.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 121.946 1.764 . . . . 0.0 111.736 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.82 64.67 8.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.403 0.62 . . . . 0.0 110.284 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.1 m -125.97 -52.63 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.536 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -133.33 24.48 4.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.897 0.38 . . . . 0.0 110.992 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.63 175.23 5.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.313 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.05 102.21 0.78 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.467 ' CG ' ' HB3' ' A' ' 28' ' ' GLU . 8.5 t80 -43.87 -54.75 5.03 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.971 0.415 . . . . 0.0 111.977 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -60.86 -33.73 73.52 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.931 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.1 t -72.64 -43.89 62.61 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.4 -45.61 91.01 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.405 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.438 HD12 ' CZ ' ' A' ' 71' ' ' TYR . 56.0 mt -65.76 -30.21 70.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.271 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -74.01 -42.7 59.95 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.727 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.5 t -60.45 -35.0 60.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.276 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.1 pp -88.42 -22.49 23.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.942 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.1 -39.59 95.14 Favored 'General case' 0 C--N 1.339 0.12 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -55.35 -21.38 26.45 Favored Glycine 0 CA--C 1.522 0.514 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.946 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.4 HG22 HD11 ' A' ' 81' ' ' ILE . 79.0 mt -54.72 108.49 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-O 120.797 0.332 . . . . 0.0 110.733 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.89 -168.3 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.454 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.46 -172.22 2.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.024 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 44.01 31.25 0.5 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.26 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.408 ' O ' ' CE1' ' A' ' 15' ' ' PHE . 1.7 t -124.35 160.94 26.98 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.984 0.897 . . . . 0.0 112.747 -178.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.72 176.7 5.54 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.18 -1.373 . . . . 0.0 110.335 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.415 ' CG2' ' OD1' ' A' ' 62' ' ' ASN . 2.6 p -145.41 157.36 13.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.507 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.7 t -133.27 99.26 3.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.447 0.641 . . . . 0.0 111.626 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.446 ' O ' HD12 ' A' ' 90' ' ' ILE . 6.4 mp -80.71 175.84 10.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.946 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.446 HD12 ' O ' ' A' ' 89' ' ' LEU . 36.2 mm -140.32 125.07 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.802 178.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 49.0 mt . . . . . 0 C--O 1.231 0.128 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.716 -179.623 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 21.2 t . . . . . 0 C--O 1.231 0.13 0 CA-C-O 121.006 0.432 . . . . 0.0 110.992 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.35 116.56 29.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.788 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.406 ' HA ' ' CD2' ' A' ' 25' ' ' LEU . 9.4 p -71.49 121.07 18.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.083 0.468 . . . . 0.0 110.382 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 30.9 m . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.406 -178.692 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.449 ' N ' ' CD1' ' A' ' 10' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--O 1.225 -0.221 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.44 ' HA ' ' CD1' ' A' ' 90' ' ' ILE . 20.0 m -92.25 156.13 17.5 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.405 HG23 ' CD2' ' A' ' 91' ' ' LEU . 2.5 t -149.84 157.61 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.618 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.6 tpp180 -145.54 121.9 10.95 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.516 0.674 . . . . 0.0 110.57 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 87' ' ' VAL . 0.1 OUTLIER -123.71 178.34 5.27 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.555 -179.668 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.413 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 2.7 t80 -115.69 151.95 34.1 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.562 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -86.21 30.12 0.71 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 121.009 -0.277 . . . . 0.0 110.803 178.327 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.443 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 0.1 OUTLIER 42.68 30.67 0.24 Allowed 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 179.518 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER 43.72 24.47 0.07 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.342 -178.358 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.1 m -166.33 32.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 123.942 0.897 . . . . 0.0 109.086 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 49.83 68.64 1.31 Allowed Glycine 0 C--N 1.338 0.655 0 CA-C-N 115.824 -0.625 . . . . 0.0 113.049 -178.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -154.51 67.23 0.31 Allowed Glycine 0 C--N 1.333 0.4 0 N-CA-C 111.686 -0.566 . . . . 0.0 111.686 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.402 ' O ' ' CB ' ' A' ' 45' ' ' ALA . 4.4 mp -48.18 -23.36 0.84 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.64 5.25 24.3 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.711 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.416 ' CD1' HG22 ' A' ' 52' ' ' ILE . 0.9 OUTLIER -154.38 144.45 21.91 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 118.201 1.001 . . . . 0.0 113.322 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.0 mt -78.7 173.36 12.53 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.868 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.4 m -153.52 141.34 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-O 121.313 0.577 . . . . 0.0 111.602 177.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.415 ' CG ' HG21 ' A' ' 36' ' ' ILE . 6.2 ptmt -122.07 104.83 9.77 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.707 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.487 ' HB3' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -102.28 115.76 31.23 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.413 0.625 . . . . 0.0 110.887 179.495 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.52 ' HD3' ' N ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -51.85 129.39 26.51 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.206 178.191 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 t . . . . . 0 C--N 1.319 -0.73 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.201 179.084 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.415 HG21 ' CG ' ' A' ' 27' ' ' LYS . 0.9 OUTLIER . . . . . 0 CA--C 1.539 0.523 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.492 HG22 HD11 ' A' ' 37' ' ' ILE . 20.7 mt -85.15 141.62 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.729 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.409 ' CB ' ' CG1' ' B' ' 4' ' ' VAL . 4.6 t -105.78 -37.83 6.58 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -169.42 135.09 1.55 Allowed 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 118.338 0.517 . . . . 0.0 111.66 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 39.6 mt -70.12 76.84 0.51 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.779 0.8 . . . . 0.0 110.444 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.446 ' CG2' ' N ' ' A' ' 42' ' ' ARG . 0.4 OUTLIER -32.94 -58.68 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -178.51 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.446 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.4 OUTLIER -94.23 -68.49 0.8 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.211 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.07 2.48 33.89 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.022 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -108.57 -26.39 5.37 Favored Glycine 0 C--N 1.34 0.753 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.42 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.402 ' CB ' ' O ' ' A' ' 22' ' ' LEU . . . -95.08 -82.13 0.38 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.86 0.33 . . . . 0.0 110.901 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.53 -63.85 1.06 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.077 0.465 . . . . 0.0 111.648 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -45.38 -43.0 10.73 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.241 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' A' ' 44' ' ' GLY . 21.8 mm-40 -59.34 -39.19 82.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.977 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.0 -44.76 74.8 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.959 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.06 -22.83 37.44 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.334 -0.936 . . . . 0.0 113.275 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.6 pp -93.15 -13.78 28.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.882 0.341 . . . . 0.0 110.837 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.416 HG22 ' CD1' ' A' ' 24' ' ' PHE . 4.9 mp -96.35 147.67 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.14 154.11 1.72 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.979 0.419 . . . . 0.0 111.26 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.409 ' HA ' ' CG2' ' A' ' 37' ' ' ILE . . . -69.45 123.97 22.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.86 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.29 5.54 81.79 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.132 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.81 -86.35 0.12 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.907 0.353 . . . . 0.0 111.025 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -162.55 119.89 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.207 0.527 . . . . 0.0 111.794 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.454 ' O ' HG22 ' A' ' 58' ' ' ILE . 1.5 tp -146.96 80.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 177.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.7 tp -77.84 -66.59 0.82 Allowed 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.782 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -115.24 151.75 33.93 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.97 0.414 . . . . 0.0 111.051 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.3 p -152.61 146.32 15.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.269 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 46.05 40.5 7.14 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.17 0.51 . . . . 0.0 111.336 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.6 t70 58.87 28.44 17.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.07 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -113.73 101.43 53.79 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.672 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -62.32 85.39 0.1 Allowed 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 121.662 1.574 . . . . 0.0 111.072 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.13 63.85 7.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.663 0.744 . . . . 0.0 110.346 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.9 m -124.84 -46.52 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.069 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.418 ' HA ' ' NH2' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -137.65 25.74 2.84 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.444 179.504 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.66 170.69 7.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.904 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.1 119.48 9.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.501 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.487 ' CG ' ' HB3' ' A' ' 28' ' ' GLU . 2.0 t80 -57.32 -47.5 81.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.416 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.48 -30.6 68.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.939 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.6 t -72.8 -42.77 63.54 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.58 -41.13 72.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.195 0.522 . . . . 0.0 110.754 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.429 HD13 ' CE1' ' A' ' 71' ' ' TYR . 70.7 mt -71.62 -35.37 70.42 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.82 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -74.58 -42.1 59.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.925 0.393 . . . . 0.0 110.515 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.7 t -61.94 -36.18 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.031 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.0 pp -85.92 -21.69 27.81 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.42 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.14 -36.48 79.75 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.492 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -55.39 -21.15 25.82 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.021 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.434 HG22 HD11 ' A' ' 81' ' ' ILE . 57.5 mt -56.68 109.74 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-O 120.882 0.372 . . . . 0.0 110.915 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.87 -162.55 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.415 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.2 m -97.25 -174.3 2.91 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 120.788 0.328 . . . . 0.0 111.127 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 44.6 31.44 0.63 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.078 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.7 t -121.28 161.13 22.53 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.847 0.832 . . . . 0.0 112.578 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -101.82 176.62 5.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.405 -1.271 . . . . 0.0 110.312 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.435 ' N ' ' O ' ' A' ' 14' ' ' LEU . 2.5 p -149.23 149.47 14.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.676 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.6 t -108.15 158.99 7.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.076 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.92 161.39 41.43 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.741 0.305 . . . . 0.0 110.985 -178.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.44 ' CD1' ' HA ' ' A' ' 11' ' ' SER . 43.6 mm -133.14 128.14 55.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.963 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.405 ' CD2' HG23 ' A' ' 12' ' ' VAL . 3.7 mt . . . . . 0 CA--C 1.518 -0.266 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.409 ' CG1' ' CB ' ' A' ' 38' ' ' SER . 2.3 t . . . . . 0 N--CA 1.464 0.252 0 CA-C-O 120.699 0.285 . . . . 0.0 110.472 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' ASP . . . . . 0.429 ' O ' ' CB ' ' B' ' 6' ' ' SER . 0.7 OUTLIER -139.88 -91.92 0.17 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.823 179.88 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.429 ' CB ' ' O ' ' B' ' 5' ' ' ASP . 6.1 t 153.57 106.15 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.728 0.811 . . . . 0.0 109.812 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.213 -0.898 . . . . 0.0 111.317 -179.72 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.422 ' CG2' ' N ' ' A' ' 11' ' ' SER . 1.3 tp . . . . . 0 CA--C 1.537 0.445 0 CA-C-O 120.749 0.309 . . . . 0.0 111.61 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.422 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 3.9 m -102.87 173.7 6.2 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.364 0.602 . . . . 0.0 111.75 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -160.88 175.95 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.089 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.47 140.89 22.4 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.432 0.634 . . . . 0.0 110.703 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -141.28 140.94 33.96 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.893 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.468 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 2.3 t80 -90.04 143.37 26.84 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -83.6 33.59 0.47 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.261 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.43 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER 38.6 33.92 0.08 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.274 0.629 . . . . 0.0 111.914 179.933 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.468 ' HD3' ' CE1' ' A' ' 15' ' ' PHE . 0.0 OUTLIER 44.27 25.26 0.11 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.769 -178.672 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.2 m -164.36 31.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.567 178.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 52.7 54.69 26.7 Favored Glycine 0 C--N 1.336 0.539 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.584 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -139.91 66.09 0.52 Allowed Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 mp -49.85 -20.16 0.82 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.407 ' HA2' HG23 ' A' ' 41' ' ' ILE . . . 102.16 9.39 42.19 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.134 -1.031 . . . . 0.0 113.23 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.458 ' CD2' ' CG2' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -159.76 140.47 12.22 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.504 0.668 . . . . 0.0 112.387 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.406 HD22 ' CB ' ' B' ' 6' ' ' SER . 3.7 mt -78.92 173.74 12.23 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.453 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.7 m -153.81 159.44 3.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 114.715 -1.129 . . . . 0.0 109.934 178.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.6 mtpt -134.28 95.41 3.4 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.684 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.481 ' CB ' ' CD1' ' A' ' 71' ' ' TYR . 0.9 OUTLIER -81.31 150.21 28.6 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.681 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.07 130.82 35.91 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-O 121.178 0.513 . . . . 0.0 111.351 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.324 -0.517 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.439 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.2 tp . . . . . 0 CA--C 1.538 0.499 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.412 ' CG1' ' HB ' ' A' ' 58' ' ' ILE . 36.8 mt -89.17 151.18 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.243 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.72 -36.59 3.86 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.402 ' HA ' ' CB ' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -177.99 142.99 0.3 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.315 -179.687 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 36.2 mt -76.27 85.26 3.07 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.604 0.716 . . . . 0.0 110.247 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.456 ' CG2' ' N ' ' A' ' 42' ' ' ARG . 1.5 tp -40.59 -59.55 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 114.457 1.281 . . . . 0.0 114.457 -177.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.456 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 6.3 mmt180 -94.79 -67.18 0.87 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.182 0.515 . . . . 0.0 112.196 -178.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.422 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 109.39 22.26 6.86 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.232 -178.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.405 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -122.71 -28.56 1.4 Allowed Glycine 0 C--N 1.339 0.75 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.388 -179.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.9 -83.93 0.32 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 117.787 0.793 . . . . 0.0 111.567 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.97 -58.87 6.6 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.221 0.534 . . . . 0.0 110.794 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.422 ' HB3' ' HA2' ' A' ' 43' ' ' GLY . 17.9 tt0 -46.51 -46.97 19.5 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.761 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.405 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -55.05 -37.3 66.55 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.799 178.684 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.4 t -54.38 -46.77 73.12 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.454 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.47 -24.19 24.78 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.439 -0.886 . . . . 0.0 114.601 177.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.7 pp -104.16 0.98 30.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.588 0.694 . . . . 0.0 112.3 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.458 ' CG2' ' CD2' ' A' ' 24' ' ' PHE . 4.2 mp -102.19 96.32 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.23 147.68 43.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.421 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.402 ' CB ' ' HA ' ' A' ' 39' ' ' ASP . . . -70.49 140.4 51.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.932 0.396 . . . . 0.0 111.159 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.58 5.2 88.09 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.98 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.16 -90.71 0.13 Allowed 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.466 HG22 HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -164.9 121.93 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 179.629 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.412 ' HB ' ' CG1' ' A' ' 37' ' ' ILE . 1.3 tp -136.25 81.95 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 107.778 -1.194 . . . . 0.0 107.778 176.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.1 tp -77.97 -67.88 0.69 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.209 -177.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -114.9 147.48 39.9 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.112 0.482 . . . . 0.0 112.08 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.1 t -141.62 144.26 26.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.241 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 44.9 40.87 4.73 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.967 0.413 . . . . 0.0 111.629 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.9 t0 53.38 27.56 6.45 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.134 0.493 . . . . 0.0 110.917 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.01 93.24 34.03 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.464 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -43.1 87.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.361 1.232 0 C-N-CA 123.309 2.673 . . . . 0.0 114.106 -178.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.11 70.99 5.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.296 178.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.4 m -123.04 -59.13 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -178.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -136.57 24.72 3.15 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -178.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.53 -173.28 3.15 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.484 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.72 122.65 19.58 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.481 ' CD1' ' CB ' ' A' ' 28' ' ' GLU . 1.0 OUTLIER -50.46 -69.27 0.12 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.709 -179.278 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -51.45 -26.97 9.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.777 0.322 . . . . 0.0 111.451 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.8 t -76.79 -44.19 33.71 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.24 0.543 . . . . 0.0 109.811 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.12 -39.42 82.26 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.069 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.455 ' CD1' ' CE1' ' A' ' 71' ' ' TYR . 46.2 mt -72.91 -33.97 66.33 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.578 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.404 ' HA ' ' HB2' ' A' ' 79' ' ' ARG . 5.0 pt-20 -71.44 -38.18 71.36 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.276 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.5 t -61.66 -46.59 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.4 pp -74.78 -24.35 58.66 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.9 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.404 ' HB2' ' HA ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -63.17 -37.67 88.12 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.225 179.65 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.0 -23.74 17.23 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.862 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 31.1 mt -58.29 106.26 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-O 120.991 0.424 . . . . 0.0 110.672 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.3 -169.68 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.238 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.44 -170.1 2.1 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.28 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 42.98 31.77 0.36 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.136 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.415 ' O ' ' CD1' ' A' ' 15' ' ' PHE . 1.8 t -129.77 159.0 37.87 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 122.095 0.95 . . . . 0.0 113.148 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.12 176.28 5.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.064 -1.426 . . . . 0.0 109.377 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -146.24 159.66 11.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.311 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.2 t -120.29 158.67 22.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.81 162.71 39.71 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.884 -178.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 47.8 mm -128.38 122.99 59.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.112 0.482 . . . . 0.0 111.501 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 22.4 mt . . . . . 0 N--CA 1.453 -0.308 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.193 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 24.3 t . . . . . 0 N--CA 1.465 0.282 0 CA-C-O 120.774 0.321 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -138.58 132.93 31.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.957 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.406 ' CB ' HD22 ' A' ' 25' ' ' LEU . 11.7 p -66.0 -51.37 58.98 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.832 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 22.5 m . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.264 -0.874 . . . . 0.0 112.619 179.223 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.403 ' CG2' ' N ' ' A' ' 11' ' ' SER . 1.0 OUTLIER . . . . . 0 N--CA 1.454 -0.269 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.403 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 1.6 p -101.66 158.44 16.1 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.735 0.778 . . . . 0.0 112.131 -178.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.415 ' HB ' ' CD1' ' A' ' 89' ' ' LEU . 3.1 t -142.01 153.49 18.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 114.411 -1.268 . . . . 0.0 108.815 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.5 ttp-105 -135.2 128.09 31.33 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.677 0.751 . . . . 0.0 111.498 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.437 ' CD2' ' CE1' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -124.79 177.83 5.79 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.39 -1.277 . . . . 0.0 109.608 179.66 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.404 ' O ' ' HA ' ' A' ' 22' ' ' LEU . 3.5 t80 -123.15 151.09 42.47 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 20' ' ' GLY . 3.8 mptp? -83.15 26.54 0.62 Allowed 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.289 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.435 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 0.4 OUTLIER 44.79 29.94 0.49 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.833 0.349 . . . . 0.0 111.868 179.562 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER 44.7 23.86 0.09 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.736 -178.477 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.7 m -168.55 34.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.992 178.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 49.1 63.42 3.97 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.989 -178.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -143.91 54.05 0.58 Allowed Glycine 0 C--N 1.332 0.349 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.015 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.406 ' O ' ' CB ' ' A' ' 45' ' ' ALA . 3.9 mp -39.1 -28.0 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.421 ' HA2' HG23 ' A' ' 41' ' ' ILE . . . 110.2 3.27 29.59 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.819 -1.182 . . . . 0.0 113.776 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.437 ' CE1' ' CD2' ' A' ' 14' ' ' LEU . 0.3 OUTLIER -158.09 141.25 15.06 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.041 0.921 . . . . 0.0 112.933 -179.473 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.401 ' CG ' HD11 ' A' ' 41' ' ' ILE . 0.8 OUTLIER -89.66 174.59 7.65 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.477 179.437 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.6 m -151.41 165.42 2.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.236 178.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.407 ' HG2' ' CG2' ' B' ' 4' ' ' VAL . 15.9 mtpt -140.84 99.88 3.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.737 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.46 ' HB3' ' CG ' ' A' ' 71' ' ' TYR . 0.6 OUTLIER -99.34 112.17 24.4 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 178.158 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.23 119.7 3.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.101 0.477 . . . . 0.0 111.11 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 52.0 t . . . . . 0 C--N 1.323 -0.544 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.317 179.423 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 36' ' ' ILE . 1.2 tp . . . . . 0 C--O 1.221 -0.442 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.428 ' CG1' ' HB ' ' A' ' 58' ' ' ILE . 42.7 mt -82.17 153.3 4.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.35 178.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.414 ' N ' HG21 ' A' ' 37' ' ' ILE . 22.0 t -117.41 -38.06 3.39 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.665 0.616 . . . . 0.0 112.665 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -173.0 140.05 0.87 Allowed 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 120.283 -0.567 . . . . 0.0 112.277 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.413 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 40.2 mt -76.46 87.63 3.2 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.795 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.46 ' CG2' ' N ' ' A' ' 42' ' ' ARG . 1.3 tp -39.85 -60.04 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -177.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.46 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 17.6 ttt85 -94.24 -59.23 2.01 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.974 0.416 . . . . 0.0 112.035 -178.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.404 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 98.07 24.29 11.86 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -177.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.418 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -125.85 -28.61 1.03 Allowed Glycine 0 C--N 1.338 0.666 0 C-N-CA 121.111 -0.566 . . . . 0.0 113.479 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.406 ' CB ' ' O ' ' A' ' 22' ' ' LEU . . . -94.47 -83.44 0.34 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 117.902 0.851 . . . . 0.0 111.459 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.67 -57.97 9.89 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.235 0.541 . . . . 0.0 110.963 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.404 ' HB3' ' HA2' ' A' ' 43' ' ' GLY . 7.8 tm-20 -47.61 -48.07 28.56 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.623 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.418 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -56.5 -34.85 67.38 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.98 178.797 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.14 -45.89 75.65 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 112.17 -28.66 9.02 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.526 -0.845 . . . . 0.0 114.54 177.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 pp -105.0 19.12 21.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.591 0.695 . . . . 0.0 112.051 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 mp -123.23 81.66 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.891 0.377 . . . . 0.0 110.216 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -112.95 141.37 46.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.144 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.8 134.63 57.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.071 0.462 . . . . 0.0 111.303 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.55 2.48 87.11 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.896 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.84 -93.31 0.09 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.843 0.321 . . . . 0.0 110.566 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -163.75 119.64 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.428 ' HB ' ' CG1' ' A' ' 37' ' ' ILE . 5.9 tp -136.95 82.27 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 177.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.6 tp -78.12 -58.43 3.26 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.97 -177.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.94 145.47 44.66 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.911 0.386 . . . . 0.0 111.722 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.0 t -146.8 145.23 19.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.84 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 44.6 41.81 5.16 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.172 0.51 . . . . 0.0 111.995 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.6 t0 57.63 26.32 12.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.541 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 66' ' ' LEU . 19.3 mmt180 -115.57 101.47 54.23 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.116 179.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.48 85.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.331 2.021 . . . . 0.0 111.626 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 64' ' ' ARG . 8.8 mt -78.68 62.15 3.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.738 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.1 m -125.49 -65.6 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -125.74 25.42 6.91 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.4 -179.8 4.22 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.0 m -68.49 96.64 0.7 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.46 ' CG ' ' HB3' ' A' ' 28' ' ' GLU . 8.9 t80 -41.01 -57.05 2.12 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.049 0.452 . . . . 0.0 112.057 -178.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -60.67 -28.4 68.57 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.823 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.0 t -74.24 -43.61 56.36 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.8 -33.93 69.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.501 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.451 ' CD2' ' CE1' ' A' ' 71' ' ' TYR . 3.7 mm? -71.17 -35.99 71.82 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.088 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -74.84 -35.64 62.38 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.035 0.445 . . . . 0.0 109.846 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.4 ' CG1' ' CZ ' ' A' ' 64' ' ' ARG . 8.4 t -61.83 -43.01 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.874 178.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.1 pp -79.05 -24.7 43.41 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.053 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -40.4 94.68 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.882 0.373 . . . . 0.0 110.21 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -57.03 -20.36 34.14 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.879 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 65.6 mt -57.81 110.66 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 120.98 0.419 . . . . 0.0 111.005 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.09 -164.53 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.45 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.81 -170.7 1.97 Allowed 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.809 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 45.18 31.34 0.76 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.116 0.484 . . . . 0.0 110.873 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.5 t -123.54 162.84 22.13 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.838 0.827 . . . . 0.0 112.658 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -102.8 176.27 5.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.362 -1.29 . . . . 0.0 109.977 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.412 ' N ' ' O ' ' A' ' 14' ' ' LEU . 5.7 p -149.29 156.3 7.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.334 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.1 t -114.05 161.51 12.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.553 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.415 ' CD1' ' HB ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -154.71 158.32 39.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.216 -178.617 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 51.5 mm -133.9 134.77 55.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.403 ' HG ' ' CG2' ' A' ' 12' ' ' VAL . 7.2 mt . . . . . 0 C--O 1.233 0.205 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.033 177.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.407 ' CG2' ' HG2' ' A' ' 27' ' ' LYS . 10.5 t . . . . . 0 CA--C 1.519 -0.214 0 CA-C-O 120.802 0.334 . . . . 0.0 110.828 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -63.71 -155.26 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.35 102.56 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.185 0.517 . . . . 0.0 110.145 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 23.0 m . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.238 -179.003 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 CA--C 1.534 0.335 0 CA-C-O 121.37 0.605 . . . . 0.0 112.541 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.424 ' HA ' ' CD1' ' A' ' 90' ' ' ILE . 1.9 m -92.79 173.57 7.69 Favored 'General case' 0 C--O 1.23 0.075 0 CA-C-N 115.158 -0.928 . . . . 0.0 113.439 -178.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.416 ' HB ' ' CD1' ' A' ' 89' ' ' LEU . 1.5 t -159.14 157.47 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 114.29 -1.323 . . . . 0.0 108.786 -179.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -150.75 126.31 10.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.223 0.535 . . . . 0.0 110.837 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.471 HD12 HD12 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -134.45 178.72 6.77 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.297 -179.229 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.411 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 5.0 t80 -116.37 151.99 34.82 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.401 ' O ' ' N ' ' A' ' 20' ' ' GLY . 0.8 OUTLIER -85.32 28.11 0.76 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.541 179.448 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.418 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 7.5 tpt180 43.49 31.8 0.46 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.018 0.437 . . . . 0.0 111.94 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER 43.64 24.98 0.07 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.893 -178.917 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.4 ' CG1' ' O ' ' A' ' 18' ' ' LYS . 5.0 m -167.72 33.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.408 -0.814 . . . . 0.0 108.831 178.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 49.14 61.1 5.63 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.705 -178.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -142.94 55.33 0.58 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.98 -0.629 . . . . 0.0 111.95 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.414 ' O ' ' CB ' ' A' ' 45' ' ' ALA . 3.7 mp -40.49 -27.61 0.05 Allowed 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.417 ' HA2' HG23 ' A' ' 41' ' ' ILE . . . 114.42 2.49 22.96 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 119.911 -1.137 . . . . 0.0 114.418 178.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -154.58 144.37 21.64 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.493 1.147 . . . . 0.0 113.595 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.6 mt -82.05 172.88 12.72 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.683 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.0 m -150.98 154.24 8.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.248 177.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.7 ptmt -135.84 109.64 8.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.959 -179.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.486 ' HB3' ' CG ' ' A' ' 71' ' ' TYR . 0.6 OUTLIER -111.06 142.66 42.92 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.947 179.276 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -75.4 126.94 32.03 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 65.5 t . . . . . 0 C--N 1.327 -0.408 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.912 -179.672 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.424 HD13 ' HA ' ' A' ' 36' ' ' ILE . 1.2 tp . . . . . 0 CA--C 1.536 0.43 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.438 ' CG1' ' HB ' ' A' ' 58' ' ' ILE . 54.4 mt -85.39 147.73 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.135 179.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.413 ' HB3' ' CG1' ' B' ' 4' ' ' VAL . 1.4 t -113.66 -37.07 4.69 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -172.14 141.38 1.28 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.044 -0.663 . . . . 0.0 112.373 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.407 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 51.0 mt -72.55 109.02 5.92 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.526 -0.761 . . . . 0.0 108.978 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.464 ' CG2' ' N ' ' A' ' 42' ' ' ARG . 0.6 OUTLIER -63.52 -59.67 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -176.392 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.464 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -94.15 -67.38 0.86 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.15 0.5 . . . . 0.0 111.985 -178.229 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.411 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 112.55 23.76 5.27 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.517 -178.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -128.17 -30.07 0.75 Allowed Glycine 0 C--N 1.338 0.643 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.613 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 22' ' ' LEU . . . -93.53 -83.33 0.33 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 117.823 0.812 . . . . 0.0 111.512 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.74 -55.22 32.55 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.123 0.487 . . . . 0.0 110.927 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.411 ' HB3' ' HA2' ' A' ' 43' ' ' GLY . 0.3 OUTLIER -50.17 -48.26 54.1 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.975 179.496 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -57.07 -35.84 69.85 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.203 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.2 m -57.3 -46.14 83.45 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.943 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.97 -21.71 44.63 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.392 -0.909 . . . . 0.0 113.011 179.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 pp -82.05 -31.59 30.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.176 0.512 . . . . 0.0 109.643 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.471 HD12 HD12 ' A' ' 14' ' ' LEU . 3.6 mp -82.29 137.51 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.237 179.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -157.71 150.45 22.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.619 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.62 122.08 17.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.882 0.372 . . . . 0.0 110.928 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.58 -6.5 80.14 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.359 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.92 -91.61 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 117.001 0.4 . . . . 0.0 110.818 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 tp -163.28 123.02 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.438 ' HB ' ' CG1' ' A' ' 37' ' ' ILE . 2.4 tp -140.91 84.42 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 176.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 57.5 tp -77.16 -61.02 2.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.789 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -120.85 161.87 20.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.957 0.408 . . . . 0.0 111.439 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.0 p -163.24 145.18 2.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.375 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 45.13 41.91 6.22 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.239 0.542 . . . . 0.0 111.379 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.14 29.1 16.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.06 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -115.58 96.6 46.67 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.415 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.85 86.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 121.856 1.704 . . . . 0.0 110.874 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.96 63.59 0.48 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.423 -178.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.5 m -143.51 -61.35 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -109.32 28.78 8.17 Favored 'General case' 0 CA--C 1.518 -0.266 0 O-C-N 121.966 -0.459 . . . . 0.0 111.997 -178.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.85 174.17 8.12 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.98 107.78 2.81 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.486 ' CG ' ' HB3' ' A' ' 28' ' ' GLU . 7.5 t80 -43.76 -58.4 2.73 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.015 0.436 . . . . 0.0 111.896 -179.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -58.0 -27.34 63.41 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.341 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.8 m -77.29 -38.63 50.36 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.253 0.549 . . . . 0.0 110.019 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.39 -38.52 91.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.825 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.412 HD12 ' CZ ' ' A' ' 71' ' ' TYR . 16.0 mt -73.17 -32.38 64.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.462 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -76.35 -38.82 55.31 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.848 0.356 . . . . 0.0 110.283 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.8 t -61.98 -41.3 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.3 pp -80.14 -22.11 42.39 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.322 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.24 -38.11 81.49 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.464 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.82 -12.77 57.87 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.134 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 84.9 mt -53.13 118.9 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 120.989 0.423 . . . . 0.0 111.169 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.55 -173.99 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.898 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -98.63 -173.28 2.5 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.287 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 42.04 32.31 0.29 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.15 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.5 t -123.94 162.26 23.73 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.881 0.848 . . . . 0.0 112.577 -178.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -97.9 177.11 5.55 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.477 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.463 ' N ' ' O ' ' A' ' 14' ' ' LEU . 2.3 p -151.38 148.25 14.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.329 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.2 t -108.3 162.67 6.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.416 ' CD1' ' HB ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -159.8 172.16 18.18 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -179.435 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.424 ' CD1' ' HA ' ' A' ' 11' ' ' SER . 29.4 mm -131.36 120.96 47.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -178.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.308 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.413 ' CG1' ' HB3' ' A' ' 38' ' ' SER . 21.9 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.924 0.392 . . . . 0.0 110.963 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.71 127.53 45.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.828 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 30.5 t -73.73 149.46 41.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.417 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.382 -179.278 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.453 ' CG2' ' N ' ' A' ' 11' ' ' SER . 1.0 OUTLIER . . . . . 0 CA--C 1.538 0.512 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.453 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 3.6 t -72.64 164.26 26.77 Favored 'General case' 0 CA--C 1.527 0.06 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.594 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.423 ' N ' ' O ' ' A' ' 89' ' ' LEU . 1.7 t -158.27 160.71 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 114.592 -1.185 . . . . 0.0 108.698 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 17.6 ttp180 -143.69 143.8 31.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.564 0.697 . . . . 0.0 111.617 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.443 ' CD2' ' CE1' ' A' ' 24' ' ' PHE . 0.8 OUTLIER -142.63 176.69 8.84 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.821 179.681 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.453 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 3.9 t80 -132.03 148.26 52.49 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.57 34.14 0.43 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.333 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.406 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 0.8 OUTLIER 38.21 32.89 0.05 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.22 0.608 . . . . 0.0 112.259 179.503 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.453 ' HD3' ' CE1' ' A' ' 15' ' ' PHE . 0.0 OUTLIER 44.5 23.67 0.08 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.517 -178.356 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.0 m -164.54 31.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.48 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 52.99 67.25 2.21 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.631 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -153.78 69.38 0.3 Allowed Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 111.599 -0.601 . . . . 0.0 111.599 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.1 mp -52.01 -22.79 4.33 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.48 6.12 44.72 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.25 -0.976 . . . . 0.0 113.735 179.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.451 ' CD2' ' CG2' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -157.95 140.3 14.43 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 117.982 0.891 . . . . 0.0 113.356 -179.529 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.404 ' HB3' ' CG1' ' B' ' 4' ' ' VAL . 14.7 mt -80.16 171.46 15.05 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.118 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.2 m -153.89 153.72 8.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.607 177.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.9 ptmt -140.45 108.08 5.62 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.93 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.446 ' HB3' ' CG ' ' A' ' 71' ' ' TYR . 4.9 tm-20 -106.23 129.97 54.18 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.705 178.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -83.88 121.49 27.42 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.051 0.453 . . . . 0.0 110.689 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.0 t . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.025 -179.665 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.405 ' HA ' HG21 ' A' ' 58' ' ' ILE . 1.1 tp . . . . . 0 CA--C 1.538 0.503 0 CA-C-O 120.582 0.23 . . . . 0.0 111.585 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.419 ' CG1' ' HB ' ' A' ' 58' ' ' ILE . 26.5 mt -79.75 146.75 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 120.737 0.303 . . . . 0.0 111.319 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.0 t -113.98 -36.68 4.7 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -171.84 135.67 0.86 Allowed 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 120.111 -0.636 . . . . 0.0 112.295 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.4 ' CD2' ' HB3' ' A' ' 24' ' ' PHE . 40.6 mt -72.73 77.42 1.11 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 121.788 0.804 . . . . 0.0 109.876 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 42' ' ' ARG . 1.4 tp -33.79 -60.15 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -177.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.467 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 1.5 ttt85 -94.96 -62.25 1.35 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -177.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.79 28.42 7.42 Favored Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -177.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -126.52 -32.25 0.73 Allowed Glycine 0 C--N 1.337 0.592 0 C-N-CA 121.337 -0.459 . . . . 0.0 113.232 -178.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -95.34 -83.33 0.36 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 117.587 0.694 . . . . 0.0 111.906 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.38 -60.06 4.41 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.158 0.504 . . . . 0.0 111.234 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -45.29 -48.26 13.02 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.784 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.421 ' HB2' ' O ' ' A' ' 44' ' ' GLY . 6.6 mm-40 -54.97 -39.69 69.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.276 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.3 m -53.23 -46.2 69.02 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.015 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.08 -21.63 33.18 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.452 -0.88 . . . . 0.0 113.821 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.401 ' HG ' ' CD1' ' A' ' 52' ' ' ILE . 2.9 pp -97.21 -7.8 31.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.064 0.432 . . . . 0.0 111.58 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.451 ' CG2' ' CD2' ' A' ' 24' ' ' PHE . 5.4 mp -104.71 125.12 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-O 120.901 0.382 . . . . 0.0 110.391 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.81 156.28 40.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.667 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.76 127.8 33.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.937 0.399 . . . . 0.0 111.184 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.08 -1.13 89.22 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.087 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.92 -92.97 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 117.039 0.419 . . . . 0.0 109.995 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.9 tp -164.96 119.55 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.419 ' HB ' ' CG1' ' A' ' 37' ' ' ILE . 2.6 tp -135.32 88.15 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.9 tp -78.96 -68.24 0.67 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.061 -178.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -111.44 158.56 18.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.233 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.8 p -162.73 147.39 3.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.306 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 44.79 42.77 6.31 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 121.145 0.498 . . . . 0.0 111.498 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.9 t0 56.81 28.87 15.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.209 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -118.55 95.8 49.22 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.903 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.89 86.67 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 121.819 1.679 . . . . 0.0 111.128 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.86 63.51 7.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.531 0.681 . . . . 0.0 110.463 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.9 m -117.17 -50.91 4.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.986 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -138.65 22.5 2.69 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.814 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.41 172.6 7.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.244 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.6 106.35 1.77 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.454 ' CE1' ' CD1' ' A' ' 75' ' ' LEU . 7.5 t80 -45.18 -60.84 1.9 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.684 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -54.86 -31.92 60.13 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.296 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.3 t -74.57 -44.09 52.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.166 0.507 . . . . 0.0 109.657 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.83 -40.32 88.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.225 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.454 ' CD1' ' CE1' ' A' ' 71' ' ' TYR . 73.5 mt -71.02 -31.38 67.87 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.638 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -75.7 -39.24 57.73 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.126 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.4 t -61.28 -39.84 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.924 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.5 pp -80.58 -25.4 38.55 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.925 179.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -37.61 87.01 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.977 0.418 . . . . 0.0 110.361 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -58.66 -18.73 39.5 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.848 -0.691 . . . . 0.0 113.024 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 48.0 mt -56.23 122.25 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 120.924 0.392 . . . . 0.0 111.114 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.43 -163.38 0.09 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.312 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.36 -169.67 2.02 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.988 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 40.9 33.33 0.2 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.235 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.427 ' O ' ' CE1' ' A' ' 15' ' ' PHE . 1.8 t -123.7 157.71 33.28 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 122.206 1.003 . . . . 0.0 113.122 -177.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -100.11 175.51 5.72 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.877 -1.511 . . . . 0.0 109.712 179.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.411 ' N ' ' O ' ' A' ' 14' ' ' LEU . 5.0 p -150.87 153.9 9.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.083 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.0 t -115.01 158.37 15.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.205 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -154.01 169.72 22.83 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.516 -178.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 34.3 mm -136.28 123.16 32.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.636 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.4 ' HG ' ' CG2' ' A' ' 12' ' ' VAL . 9.4 mt . . . . . 0 CA--C 1.514 -0.429 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 176.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.404 ' CG1' ' HB3' ' A' ' 25' ' ' LEU . 3.4 t . . . . . 0 N--CA 1.461 0.094 0 CA-C-O 120.755 0.312 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -125.56 127.25 46.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.847 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 7.9 p -86.53 116.52 24.71 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.059 0.457 . . . . 0.0 110.925 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 19.6 m . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.251 -0.881 . . . . 0.0 111.226 -179.409 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.414 ' N ' ' O ' ' A' ' 91' ' ' LEU . 1.2 tp . . . . . 0 C--O 1.226 -0.17 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.0 m -90.55 151.39 21.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.501 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.7 t -138.8 160.55 30.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.2 ttp85 -138.3 140.84 39.74 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.616 0.722 . . . . 0.0 112.0 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' A' ' 87' ' ' VAL . 0.6 OUTLIER -142.19 176.24 9.13 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.45 179.331 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.427 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 3.4 t80 -127.65 146.45 50.55 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -80.82 36.49 0.39 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.226 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.402 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 0.6 OUTLIER 35.11 34.03 0.02 OUTLIER 'General case' 0 C--N 1.352 0.707 0 C-N-CA 123.714 0.805 . . . . 0.0 112.502 179.681 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.427 ' HD3' ' CE1' ' A' ' 15' ' ' PHE . 0.0 OUTLIER 43.25 24.82 0.05 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.409 -178.334 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.7 m -164.94 31.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.234 178.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 52.38 68.51 1.54 Allowed Glycine 0 C--N 1.338 0.689 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.376 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -155.27 69.27 0.29 Allowed Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 111.749 -0.541 . . . . 0.0 111.749 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.401 ' HA ' ' O ' ' A' ' 15' ' ' PHE . 4.0 mp -50.08 -22.8 1.77 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.75 4.99 34.01 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.274 -0.965 . . . . 0.0 113.425 179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.435 ' CD2' ' CG2' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -158.59 139.09 12.58 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -179.635 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.4 mt -79.18 169.59 17.92 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.54 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.8 m -152.47 156.93 5.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 120.123 -0.631 . . . . 0.0 111.721 177.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -138.17 107.05 5.95 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.683 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.439 ' HB3' ' CG ' ' A' ' 71' ' ' TYR . 2.1 tm-20 -101.07 111.33 23.51 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -64.45 119.08 9.73 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.026 0.441 . . . . 0.0 110.378 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.4 t . . . . . 0 C--N 1.325 -0.474 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.363 -179.714 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.536 0.41 0 CA-C-O 120.544 0.211 . . . . 0.0 111.11 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.409 ' CG2' ' HA ' ' A' ' 54' ' ' ALA . 20.6 mt -93.16 151.07 3.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.631 0.253 . . . . 0.0 111.059 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.415 ' CB ' ' CG1' ' B' ' 4' ' ' VAL . 2.4 t -116.01 -40.61 3.28 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -167.12 132.99 2.16 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 120.15 -0.62 . . . . 0.0 112.447 -178.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 56.4 mt -69.05 77.29 0.33 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.46 0.648 . . . . 0.0 109.797 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.465 ' CG2' ' N ' ' A' ' 42' ' ' ARG . 1.4 tp -33.28 -59.16 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -177.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.465 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -94.25 -65.88 0.96 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.198 0.523 . . . . 0.0 111.797 -178.263 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.449 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 105.84 13.97 22.37 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.634 -178.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.403 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -117.93 -25.86 2.93 Favored Glycine 0 C--N 1.341 0.812 0 C-N-CA 121.022 -0.609 . . . . 0.0 113.391 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.07 -83.09 0.34 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 117.777 0.789 . . . . 0.0 111.36 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.43 ' CB ' ' CG2' ' A' ' 52' ' ' ILE . . . -62.02 -60.34 3.76 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.187 0.518 . . . . 0.0 111.454 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.449 ' HB3' ' HA2' ' A' ' 43' ' ' GLY . 4.1 tp10 -48.39 -44.37 34.7 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.079 0.466 . . . . 0.0 110.803 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.403 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 5.2 tp-100 -58.62 -34.09 70.77 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.3 t -54.99 -49.68 70.87 Favored 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 115.77 -22.77 11.42 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.251 -0.976 . . . . 0.0 114.639 177.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.403 ' CD1' ' CD1' ' A' ' 91' ' ' LEU . 0.3 OUTLIER -99.26 -32.53 11.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.523 0.662 . . . . 0.0 110.802 -179.58 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.435 ' CG2' ' CD2' ' A' ' 24' ' ' PHE . 4.9 mp -72.12 115.8 13.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.143 0.497 . . . . 0.0 110.631 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -139.41 148.79 43.27 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.851 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.409 ' HA ' ' CG2' ' A' ' 37' ' ' ILE . . . -75.57 145.76 40.97 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.242 0.544 . . . . 0.0 112.186 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.62 18.44 68.02 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.672 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -109.33 -84.11 0.55 Allowed 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 120.421 0.153 . . . . 0.0 111.348 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.3 tt -163.27 133.4 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.403 ' HB ' ' CG1' ' A' ' 37' ' ' ILE . 2.7 tp -155.31 96.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.443 -1.253 . . . . 0.0 107.99 177.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.8 mt -79.27 -68.77 0.63 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.969 -0.292 . . . . 0.0 111.637 -177.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -116.43 160.15 20.97 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.01 0.433 . . . . 0.0 111.692 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.7 t -154.03 147.29 13.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.606 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 42.98 44.16 3.9 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.187 0.518 . . . . 0.0 111.932 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 t70 56.33 29.45 15.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.275 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.401 ' O ' ' N ' ' A' ' 66' ' ' LEU . 3.4 mmp_? -117.55 98.58 51.9 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.418 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -57.08 85.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.058 1.839 . . . . 0.0 111.464 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' A' ' 64' ' ' ARG . 1.2 mt -86.48 61.55 6.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.412 0.625 . . . . 0.0 110.462 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 m -113.81 -47.73 5.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.24 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -145.88 23.77 1.37 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.608 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.77 173.38 7.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.649 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.2 m -64.22 99.64 0.29 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.439 ' CG ' ' HB3' ' A' ' 28' ' ' GLU . 5.8 t80 -42.36 -58.72 2.09 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.307 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -58.13 -32.49 68.19 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.32 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.6 t -74.82 -41.7 59.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.077 0.465 . . . . 0.0 109.767 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.14 -40.75 94.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.308 0.575 . . . . 0.0 110.27 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.409 HD12 ' CZ ' ' A' ' 71' ' ' TYR . 72.5 mt -71.43 -31.89 67.73 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.016 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -74.16 -41.16 61.94 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.023 0.439 . . . . 0.0 109.934 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.0 t -59.58 -41.18 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.045 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.5 pp -82.39 -22.48 35.39 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.541 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.42 -37.49 87.07 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.332 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.4 -20.4 29.75 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.896 -0.668 . . . . 0.0 113.034 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 69.0 mt -56.31 123.07 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-O 120.877 0.37 . . . . 0.0 111.103 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.05 -161.64 0.22 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.259 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.3 m -95.29 -170.19 2.13 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.678 0.275 . . . . 0.0 110.984 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 45.0 30.41 0.57 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.169 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.417 ' O ' ' CE1' ' A' ' 15' ' ' PHE . 1.8 t -127.88 158.27 38.24 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 122.024 0.916 . . . . 0.0 112.967 -178.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -99.98 176.57 5.38 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.106 -1.406 . . . . 0.0 110.374 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.418 ' N ' ' O ' ' A' ' 14' ' ' LEU . 3.9 p -150.32 155.16 7.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.382 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.1 t -114.81 162.34 12.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.51 174.81 14.4 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 -178.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 49.9 mm -134.52 131.83 54.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 10' ' ' ILE . 55.6 mt . . . . . 0 C--O 1.224 -0.244 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.95 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.415 ' CG1' ' CB ' ' A' ' 38' ' ' SER . 3.4 t . . . . . 0 CA--C 1.519 -0.215 0 CA-C-O 120.927 0.394 . . . . 0.0 110.823 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.51 -103.32 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.292 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 4.9 t 162.36 109.45 0.0 OUTLIER 'General case' 0 C--N 1.345 0.409 0 CA-C-O 121.159 0.504 . . . . 0.0 109.843 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 C--O 1.245 0.839 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.892 -179.338 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 112.454 -0.258 . . . . 0.0 112.454 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.6 p -169.13 152.58 5.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.882 0.372 . . . . 0.0 110.91 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.9 m170 60.51 63.34 1.37 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.834 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.4 mtt -132.9 163.33 29.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.719 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.412 ' CG2' ' N ' ' A' ' 6' ' ' GLU . 0.3 OUTLIER -153.89 -164.37 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.578 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.417 ' HB2' ' CD ' ' A' ' 7' ' ' PRO . 7.0 mm-40 -144.84 -67.86 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.534 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.417 ' CD ' ' HB2' ' A' ' 6' ' ' GLU . 5.6 Cg_endo -48.08 176.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.4 2.067 . . . . 0.0 112.685 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -150.09 -74.22 0.16 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.597 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.7 p -161.84 113.37 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.899 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.454 ' CG2' ' N ' ' A' ' 11' ' ' SER . 1.4 tp -161.19 -164.61 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.454 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 0.7 OUTLIER -85.66 166.27 16.31 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.475 0.655 . . . . 0.0 112.536 -179.338 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.426 ' CG2' ' HG ' ' A' ' 91' ' ' LEU . 1.6 t -156.05 163.61 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.313 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -149.6 131.97 15.61 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.497 0.665 . . . . 0.0 110.778 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.402 ' O ' ' N ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -135.03 177.46 7.79 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.419 -179.431 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.408 ' CD1' ' O ' ' A' ' 85' ' ' THR . 4.5 t80 -124.1 151.39 43.94 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -81.62 27.15 0.45 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.685 179.453 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.426 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 9.6 tpt180 43.31 31.04 0.35 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.905 0.383 . . . . 0.0 111.916 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER 44.47 23.47 0.07 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.708 -178.642 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.9 m -169.14 34.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 49.0 65.87 2.47 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.746 -178.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -148.19 54.99 0.51 Allowed Glycine 0 C--N 1.331 0.29 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.104 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.423 ' O ' ' CB ' ' A' ' 45' ' ' ALA . 4.1 mp -38.44 -26.96 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 118.35 -4.13 15.66 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 119.954 -1.117 . . . . 0.0 113.815 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.464 ' CE2' HG22 ' A' ' 52' ' ' ILE . 5.1 p90 -152.83 144.53 23.52 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.6 mt -80.19 170.21 16.74 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.3 178.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.0 m -149.32 157.59 6.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 C-N-CA 119.989 -0.685 . . . . 0.0 111.308 177.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -135.22 104.96 6.09 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.348 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.472 ' HB3' ' CG ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -101.64 118.71 37.51 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.738 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.406 ' CB ' ' HB2' ' A' ' 32' ' ' LYS . 19.2 mmt180 -63.6 114.77 4.15 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 121.254 0.55 . . . . 0.0 110.379 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.6 t -51.95 -18.93 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.141 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.405 ' O ' ' CG ' ' A' ' 32' ' ' LYS . 33.2 m -133.78 32.47 3.54 Favored 'General case' 0 C--N 1.334 -0.07 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.75 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.406 ' HB2' ' CB ' ' A' ' 29' ' ' ARG . 5.7 mtpp -164.73 139.96 4.51 Favored Pre-proline 0 CA--C 1.536 0.406 0 O-C-N 123.132 0.27 . . . . 0.0 110.613 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.408 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 34.5 Cg_exo -59.86 -46.91 17.48 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.33 2.02 . . . . 0.0 113.475 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 33' ' ' PRO . 70.8 Cg_exo -41.89 94.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.708 2.272 . . . . 0.0 114.678 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.0 p -105.77 150.89 8.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.2 tp -157.37 175.64 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -178.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.463 ' CG1' ' HB ' ' A' ' 58' ' ' ILE . 28.0 mt -92.67 147.68 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.641 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -113.63 -35.58 5.16 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -166.2 135.64 3.19 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 120.441 -0.504 . . . . 0.0 112.032 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.407 ' CD2' ' HB3' ' A' ' 24' ' ' PHE . 49.3 mt -72.92 79.28 1.16 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.671 0.748 . . . . 0.0 110.489 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.462 ' CG2' ' N ' ' A' ' 42' ' ' ARG . 1.8 tp -32.9 -59.5 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.462 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -95.47 -67.7 0.84 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.218 0.532 . . . . 0.0 112.139 -178.142 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.432 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 106.91 26.52 5.76 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -177.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -128.31 -28.6 0.83 Allowed Glycine 0 C--N 1.339 0.722 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.73 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 22' ' ' LEU . . . -94.12 -83.01 0.34 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.055 0.928 . . . . 0.0 111.582 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.04 -53.82 39.96 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.079 0.466 . . . . 0.0 110.9 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.432 ' HB3' ' HA2' ' A' ' 43' ' ' GLY . 54.1 tt0 -49.86 -47.28 51.89 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.046 0.451 . . . . 0.0 110.463 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.417 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 5.6 tp-100 -59.14 -33.2 70.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.833 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.9 t -55.19 -48.47 73.77 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.622 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.07 -21.85 28.53 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.183 -1.008 . . . . 0.0 114.288 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.12 -3.93 30.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.574 0.687 . . . . 0.0 111.616 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.464 HG22 ' CE2' ' A' ' 24' ' ' PHE . 5.0 mp -103.93 138.87 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-O 120.83 0.347 . . . . 0.0 110.402 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -154.4 158.99 40.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.348 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.41 125.25 26.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.921 0.391 . . . . 0.0 111.115 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.86 14.72 73.32 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.653 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -92.69 -85.37 0.26 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 18.0 mm -148.86 115.78 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.463 ' HB ' ' CG1' ' A' ' 37' ' ' ILE . 0.3 OUTLIER -160.47 113.81 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.674 177.042 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.7 tp -116.6 -67.04 1.02 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.059 0.457 . . . . 0.0 110.584 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.95 160.91 14.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.236 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.3 p -166.95 145.28 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.482 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 44.86 40.0 4.0 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.031 0.444 . . . . 0.0 111.678 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.6 t70 58.67 28.14 16.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.281 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -118.07 97.51 50.8 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.572 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.81 86.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.032 1.821 . . . . 0.0 110.999 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.6 mt -72.46 62.84 0.54 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.985 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.1 m -139.64 -63.57 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -112.49 28.3 8.89 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.08 176.66 5.11 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.6 m -68.09 98.75 0.81 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.472 ' CG ' ' HB3' ' A' ' 28' ' ' GLU . 6.2 t80 -40.83 -55.63 2.4 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.215 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -58.16 -30.88 66.72 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.195 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.6 t -75.54 -43.63 47.73 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.21 -38.89 84.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.417 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.434 HD12 ' CZ ' ' A' ' 71' ' ' TYR . 63.4 mt -68.61 -30.08 68.73 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.023 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -73.32 -40.0 64.83 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 120.981 0.42 . . . . 0.0 109.943 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.7 t -59.87 -42.96 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.739 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.2 pp -79.2 -24.79 42.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.959 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.39 -48.27 67.86 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.101 0.477 . . . . 0.0 110.062 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.01 -22.9 13.84 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.978 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.444 HD11 HG22 ' A' ' 81' ' ' ILE . 55.6 mt -52.76 114.69 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 120.878 0.371 . . . . 0.0 111.149 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.24 -167.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.185 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.2 m -95.4 -172.33 2.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.949 0.404 . . . . 0.0 111.117 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 45.56 30.33 0.75 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.128 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.408 ' O ' ' CD1' ' A' ' 15' ' ' PHE . 1.8 t -123.66 159.15 29.95 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.88 0.847 . . . . 0.0 112.391 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -100.49 176.44 5.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.575 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.402 ' N ' ' O ' ' A' ' 14' ' ' LEU . 2.8 p -153.03 150.06 12.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.584 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 24.0 t -111.39 156.9 12.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -152.57 168.84 24.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.692 0.282 . . . . 0.0 111.222 -178.496 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.405 ' CD1' ' HA ' ' A' ' 11' ' ' SER . 47.1 mm -136.69 128.51 43.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.82 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.426 ' HG ' ' CG2' ' A' ' 12' ' ' VAL . 62.5 mt -86.55 142.64 28.16 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 176.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.66 157.45 22.13 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.096 0.474 . . . . 0.0 112.278 -178.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 165.23 -147.32 12.28 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.082 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -58.69 -155.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.623 2.215 . . . . 0.0 112.36 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -158.97 -175.84 5.52 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.576 0.227 . . . . 0.0 110.736 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.41 ' O ' ' CD1' ' A' ' 97' ' ' PHE . . . 74.96 16.52 80.49 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.321 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.433 ' HA ' ' O ' ' A' ' 118' ' ' GLN . 61.9 m-85 -153.02 142.24 21.49 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 117.044 0.422 . . . . 0.0 111.849 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.23 117.99 31.88 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 11.0 t -111.53 92.2 3.95 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.433 0.635 . . . . 0.0 111.157 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.6 -159.03 0.08 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.123 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.429 ' N ' ' CD1' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -118.27 140.91 49.1 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.977 0.418 . . . . 0.0 111.321 179.801 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 178.24 169.52 0.78 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.346 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 9.3 t 47.72 -167.95 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.567 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.15 147.52 14.67 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.126 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -63.41 174.65 1.2 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.824 0.345 . . . . 0.0 111.0 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.9 t -174.69 -40.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.979 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -66.96 -56.82 11.01 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.503 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -162.82 36.67 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.819 0.342 . . . . 0.0 110.882 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.14 56.73 6.72 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.618 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.433 ' CB ' ' HD3' ' A' ' 111' ' ' PRO . 1.1 m -112.21 -65.94 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 116.43 0.115 . . . . 0.0 111.213 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.433 ' HD3' ' CB ' ' A' ' 110' ' ' THR . 54.5 Cg_exo -48.32 -64.38 0.24 Allowed 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.07 1.847 . . . . 0.0 111.815 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 70.21 160.53 0.21 Allowed 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.003 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 68.5 m -56.89 -30.6 64.06 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.304 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.479 HG22 HD11 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -95.79 101.3 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.897 178.658 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.12 91.04 0.93 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.021 0.439 . . . . 0.0 111.456 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -162.64 55.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 51.4 m -77.77 129.0 34.92 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.236 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.433 ' O ' ' HA ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -141.3 134.06 14.22 Favored Pre-proline 0 C--O 1.22 -0.458 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.326 179.287 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.76 138.49 53.77 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.152 1.902 . . . . 0.0 113.261 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.39 -70.28 0.63 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.623 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 67.09 76.92 0.33 Allowed Glycine 0 CA--C 1.522 0.489 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.038 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.447 ' N ' ' CD ' ' A' ' 123' ' ' PRO . 33.1 Cg_exo -57.49 -45.39 34.45 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.484 2.123 . . . . 0.0 113.303 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 122' ' ' PRO . 54.4 Cg_exo -50.87 97.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.444 2.096 . . . . 0.0 112.398 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 10.0 t -175.7 59.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.973 0.416 . . . . 0.0 111.21 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -141.13 177.92 7.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.066 0.46 . . . . 0.0 111.089 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 61.16 18.46 9.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.083 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.7 m . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.159 179.968 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 14.4 t . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.686 0.279 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 31.8 m -114.33 27.55 3.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.314 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -137.53 -48.1 0.57 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.962 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 21.8 t -72.09 105.97 2.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.785 0.326 . . . . 0.0 110.844 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.32 131.87 51.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.515 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 8.5 p -85.34 119.6 25.89 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.339 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 26.5 m . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.326 -178.824 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.15 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.14 -68.77 0.78 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.839 0.352 . . . . 0.0 110.755 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 67.78 -71.1 0.11 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.759 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.46 169.33 14.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.671 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.1 tt -58.08 97.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.126 0.488 . . . . 0.0 111.067 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -176.8 142.21 0.53 Allowed Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.287 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.3 -165.32 0.3 Allowed 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.443 2.095 . . . . 0.0 111.59 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.412 ' O ' ' CG2' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -127.16 -66.67 0.88 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.565 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.412 ' CG2' ' O ' ' A' ' 8' ' ' ASN . 72.1 t -161.02 99.07 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.538 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.41 ' CG2' ' N ' ' A' ' 11' ' ' SER . 0.7 OUTLIER -160.71 -175.99 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 120.328 -0.549 . . . . 0.0 112.184 -179.489 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.41 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 17.8 p -93.42 171.31 8.99 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.05 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.445 ' CG1' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -158.74 173.62 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.932 -179.594 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.4 ptt85 -153.19 134.67 14.35 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.262 0.553 . . . . 0.0 111.013 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.413 ' CD2' ' CE1' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -131.67 145.43 51.65 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.279 -179.535 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.458 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 2.3 t80 -87.11 148.28 25.29 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.401 ' O ' ' N ' ' A' ' 20' ' ' GLY . 2.0 tptt -84.34 27.67 0.68 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.058 178.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.431 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 0.1 OUTLIER 45.51 29.43 0.62 Allowed 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 178.939 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.458 ' HD3' ' CE1' ' A' ' 15' ' ' PHE . 0.0 OUTLIER 43.5 24.77 0.06 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.074 0.55 . . . . 0.0 112.476 -178.348 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.7 m -165.81 32.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.785 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 48.54 66.9 1.87 Allowed Glycine 0 C--N 1.338 0.677 0 CA-C-N 115.733 -0.667 . . . . 0.0 113.02 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -152.26 65.25 0.36 Allowed Glycine 0 C--N 1.333 0.364 0 N-CA-C 111.698 -0.561 . . . . 0.0 111.698 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.2 mp -48.2 -24.55 1.19 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 40' ' ' LEU . . . 112.6 7.41 22.3 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.241 -0.981 . . . . 0.0 113.578 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.442 ' CD2' ' CG2' ' A' ' 52' ' ' ILE . 0.4 OUTLIER -160.06 139.56 11.13 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 117.98 0.89 . . . . 0.0 113.103 -179.585 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.1 mt -79.69 171.31 15.31 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.391 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.0 m -153.18 152.02 10.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.016 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.8 ptmt -137.39 110.3 7.68 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.394 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.454 ' CB ' ' CD1' ' A' ' 71' ' ' TYR . 1.1 tm-20 -101.96 96.74 7.23 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.425 ' CB ' ' HB2' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -56.34 116.76 3.25 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.311 0.577 . . . . 0.0 111.304 -178.907 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.6 t -43.29 -25.26 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.626 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.2 m -145.24 79.07 1.57 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.639 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.425 ' HB2' ' CB ' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -176.13 176.85 0.56 Allowed Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.724 -178.914 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.425 ' CB ' ' CD ' ' A' ' 34' ' ' PRO . 75.3 Cg_exo -53.19 -171.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.392 2.062 . . . . 0.0 112.26 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.425 ' CD ' ' CB ' ' A' ' 33' ' ' PRO . 95.9 Cg_exo -45.28 174.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.547 2.165 . . . . 0.0 114.065 -178.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.4 p -78.71 164.55 3.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.307 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.1 tp -144.69 164.87 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 120.074 -0.65 . . . . 0.0 112.584 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.411 HG23 HD11 ' A' ' 37' ' ' ILE . 33.8 mt -86.18 149.48 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.115 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.859 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.409 ' HB3' ' CG1' ' B' ' 4' ' ' VAL . 1.7 t -114.67 -39.61 3.73 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -173.46 135.74 0.56 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.22 -0.592 . . . . 0.0 112.206 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 24' ' ' PHE . 28.2 mt -70.39 99.42 1.57 Allowed 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.462 ' CG2' ' N ' ' A' ' 42' ' ' ARG . 1.4 tp -54.05 -58.39 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -176.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.462 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.8 OUTLIER -93.2 -68.38 0.8 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.175 0.512 . . . . 0.0 112.269 -177.489 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.465 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 112.01 18.14 7.97 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.618 -178.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.4 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -126.08 -28.0 1.07 Allowed Glycine 0 C--N 1.34 0.786 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.737 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.72 -83.11 0.33 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 117.914 0.857 . . . . 0.0 111.308 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.18 -60.36 3.7 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.5 0.667 . . . . 0.0 111.317 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.465 ' HB3' ' HA2' ' A' ' 43' ' ' GLY . 17.5 tp10 -48.77 -39.63 25.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.71 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.4 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 11.4 tp-100 -61.77 -36.2 80.36 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.3 t -54.06 -47.42 71.67 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.401 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.11 -20.27 33.49 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.302 -0.951 . . . . 0.0 113.905 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.445 ' CD1' ' CG1' ' A' ' 12' ' ' VAL . 0.1 OUTLIER -94.74 -31.01 13.97 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.899 0.38 . . . . 0.0 110.178 179.588 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.442 ' CG2' ' CD2' ' A' ' 24' ' ' PHE . 2.6 mp -80.44 119.6 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.064 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -152.52 155.77 38.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.178 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.98 123.79 21.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.914 0.388 . . . . 0.0 110.875 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.25 2.99 90.73 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.246 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -83.25 -88.94 0.09 Allowed 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 116.997 0.399 . . . . 0.0 110.981 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.6 tp -162.68 126.23 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.408 ' O ' HG22 ' A' ' 58' ' ' ILE . 3.2 tp -149.76 87.99 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.074 177.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.3 tp -81.68 -66.35 0.9 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.721 -178.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.15 158.43 25.94 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.697 0.284 . . . . 0.0 111.594 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.3 t -153.36 148.64 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.967 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.2 p30 44.28 46.67 7.68 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.162 0.506 . . . . 0.0 111.756 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.0 t70 51.99 26.65 3.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.787 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.406 ' O ' ' N ' ' A' ' 66' ' ' LEU . 12.1 mmm180 -111.59 113.79 53.0 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.826 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.22 84.84 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 121.772 1.648 . . . . 0.0 110.733 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.406 ' N ' ' O ' ' A' ' 64' ' ' ARG . 12.7 tp -86.83 66.77 9.59 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.354 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.2 m -128.61 -55.19 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.665 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -140.1 26.03 2.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.788 0.328 . . . . 0.0 111.648 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -94.92 -175.91 3.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.322 -0.399 . . . . 0.0 109.959 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.1 m -71.89 101.52 2.68 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 177.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.454 ' CD1' ' CB ' ' A' ' 28' ' ' GLU . 6.5 t80 -40.54 -58.23 1.64 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -178.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -59.36 -26.59 65.2 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.159 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.3 t -76.21 -42.0 47.58 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.179 0.514 . . . . 0.0 109.95 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.94 -36.92 83.32 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.797 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.423 HD12 ' CZ ' ' A' ' 71' ' ' TYR . 51.0 mt -70.9 -29.64 65.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.162 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -76.75 -37.84 55.25 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.085 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.0 t -62.89 -43.49 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.2 pp -73.81 -26.85 60.83 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.25 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -35.49 81.0 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.0 0.428 . . . . 0.0 110.122 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.97 -19.71 59.26 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.817 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 68.5 mt -58.86 105.63 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-O 120.869 0.366 . . . . 0.0 110.692 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.6 -165.83 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.666 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.5 -171.41 2.37 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.053 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 43.77 31.67 0.5 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.31 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.411 ' O ' ' CD1' ' A' ' 15' ' ' PHE . 1.8 t -128.71 162.4 27.48 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.775 0.798 . . . . 0.0 112.878 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -104.86 176.09 5.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.004 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -146.98 159.21 9.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.036 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.3 t -118.84 158.59 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.23 169.63 22.83 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.758 0.314 . . . . 0.0 110.835 -178.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 47.7 mm -129.45 130.81 67.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.391 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.5 mt -104.47 160.84 14.6 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.478 -0.783 . . . . 0.0 108.978 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.39 175.68 11.95 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.591 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 165.36 -117.04 0.73 Allowed Glycine 0 CA--C 1.521 0.465 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.033 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -59.55 -154.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.135 1.89 . . . . 0.0 111.354 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -165.94 155.84 12.39 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.841 0.353 . . . . 0.0 111.285 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.24 -7.6 43.87 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.977 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.429 ' CE2' ' HD3' ' A' ' 119' ' ' PRO . 10.3 m-85 -130.56 127.49 39.18 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 117.717 0.758 . . . . 0.0 112.619 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.429 ' N ' HD21 ' A' ' 120' ' ' LEU . 0.0 OUTLIER -80.43 117.25 21.0 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.408 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 5.1 t -111.26 91.77 3.79 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.166 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -71.77 -167.02 0.24 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.682 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.31 92.05 2.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.806 0.336 . . . . 0.0 111.016 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -144.19 23.02 1.69 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.493 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 52.97 92.17 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.807 0.337 . . . . 0.0 111.55 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.3 m -127.75 11.68 6.72 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -55.16 166.98 0.48 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.987 0.422 . . . . 0.0 111.468 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.2 m -83.15 -58.84 2.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.755 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 163.7 -57.01 0.28 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.691 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -120.32 46.43 1.98 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.892 0.377 . . . . 0.0 111.142 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -149.77 -68.57 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.682 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.0 t -118.22 52.04 1.43 Allowed Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 120.546 0.212 . . . . 0.0 111.519 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.15 102.77 1.5 Allowed 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.367 2.045 . . . . 0.0 112.664 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.39 -172.86 4.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.902 0.382 . . . . 0.0 111.176 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 88.0 m -93.91 -36.58 12.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.795 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.436 HG22 HD11 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -104.88 94.97 3.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.786 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.57 94.65 2.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.099 0.476 . . . . 0.0 111.508 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -159.2 53.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.77 129.48 35.53 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.531 -177.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -145.11 133.11 10.56 Favored Pre-proline 0 N--CA 1.466 0.344 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.324 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.429 ' HD3' ' CE2' ' A' ' 97' ' ' PHE . 13.3 Cg_endo -55.41 124.99 17.65 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.162 1.908 . . . . 0.0 112.801 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.429 HD21 ' N ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -93.5 -80.43 0.39 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.996 179.492 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 106.49 -77.73 0.24 Allowed Glycine 0 CA--C 1.522 0.478 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.402 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -60.44 154.58 52.52 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.565 2.176 . . . . 0.0 112.289 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.58 -168.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.311 2.007 . . . . 0.0 112.366 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 8.6 t -74.8 92.15 2.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.756 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -99.71 40.55 1.22 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.068 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -89.71 13.56 13.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.39 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.9 m . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.247 -0.882 . . . . 0.0 111.048 179.956 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 10.2 p . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 121.042 0.448 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 12.2 p -128.13 158.29 40.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.139 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.415 ' CE ' ' HA ' ' A' ' 29' ' ' ARG . 13.8 mtmm 63.11 19.37 11.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.362 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.409 ' CG1' ' HB3' ' A' ' 38' ' ' SER . 19.8 t -82.81 100.42 6.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.952 0.406 . . . . 0.0 110.584 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -98.65 129.55 45.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.907 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 8.8 p -83.42 129.24 34.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.39 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 17.2 m . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.133 -179.252 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 112.583 -0.207 . . . . 0.0 112.583 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.6 m -67.42 85.8 0.17 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.812 0.339 . . . . 0.0 110.94 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -109.97 -43.61 3.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.728 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 31.6 mtt -105.42 127.06 52.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.599 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.422 ' N ' HG22 ' A' ' 110' ' ' THR . 5.3 mp 60.11 158.9 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.48 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -102.97 159.66 28.6 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -69.66 130.09 18.85 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 123.16 2.573 . . . . 0.0 112.574 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.433 ' N ' ' HA3' ' A' ' 93' ' ' GLY . 9.8 m-80 -142.07 88.47 2.11 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.401 ' N ' ' HA3' ' A' ' 93' ' ' GLY . 7.1 p -85.0 95.8 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 116.548 -0.297 . . . . 0.0 110.914 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.425 ' CG2' ' N ' ' A' ' 11' ' ' SER . 1.4 tp -161.98 -170.84 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.425 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 8.0 p -92.18 164.48 13.55 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.555 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' A' ' 89' ' ' LEU . 2.3 t -154.14 158.83 3.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.594 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.8 ttp-105 -140.24 144.11 36.33 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.552 0.691 . . . . 0.0 111.103 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.402 ' CB ' ' CG1' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -141.09 177.72 7.88 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.283 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.415 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 3.2 t80 -124.19 148.68 47.09 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.412 ' O ' ' N ' ' A' ' 20' ' ' GLY . 12.6 mtpt -83.77 30.89 0.48 Allowed 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.183 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.428 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 2.2 mmm180 40.78 31.24 0.11 Allowed 'General case' 0 C--N 1.347 0.46 0 CA-C-O 121.086 0.47 . . . . 0.0 111.887 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.438 ' HD3' ' N ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER 43.85 24.68 0.07 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.456 -178.391 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.8 m -166.11 32.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.035 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 50.56 64.54 3.59 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.943 -178.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -148.23 66.18 0.4 Allowed Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.405 ' HA ' ' O ' ' A' ' 15' ' ' PHE . 4.4 mp -49.5 -23.22 1.49 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.417 ' HA2' HG23 ' A' ' 41' ' ' ILE . . . 106.41 8.27 33.38 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.167 -1.016 . . . . 0.0 112.847 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.468 ' CD2' ' CG2' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -160.23 140.4 11.54 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 117.658 0.729 . . . . 0.0 112.483 -179.655 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.426 ' HG ' HD11 ' A' ' 41' ' ' ILE . 14.1 mt -79.05 166.61 22.13 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.909 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.5 m -151.78 143.81 16.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.268 177.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.7 tttp -136.41 120.9 18.2 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.907 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.432 ' HB3' ' CD1' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -113.62 112.01 22.79 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.521 178.488 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.447 ' CB ' ' HB2' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -65.61 124.26 21.89 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.904 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.0 t -49.77 -23.11 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.162 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 69.9 m -145.48 71.94 1.3 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.505 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.447 ' HB2' ' CB ' ' A' ' 29' ' ' ARG . 2.1 mmtp -177.51 176.25 0.51 Allowed Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.534 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 32' ' ' LYS . 88.3 Cg_exo -45.74 173.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.506 2.137 . . . . 0.0 113.414 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -44.11 175.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.265 2.643 . . . . 0.0 115.073 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.9 p -79.09 147.48 6.72 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.827 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.5 tp -128.63 161.58 37.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.714 -0.395 . . . . 0.0 111.373 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.432 HG23 HD11 ' A' ' 37' ' ' ILE . 17.2 mt -79.53 141.46 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.981 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.9 t -106.24 -39.21 6.01 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -175.23 144.02 0.7 Allowed 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 24' ' ' PHE . 38.1 mt -76.02 101.2 5.17 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.33 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.46 ' CG2' ' N ' ' A' ' 42' ' ' ARG . 0.8 OUTLIER -56.65 -59.22 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -176.525 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.46 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -93.02 -65.73 0.98 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -177.465 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.423 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 110.36 21.49 6.9 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.51 -178.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.94 -28.12 0.89 Allowed Glycine 0 C--N 1.339 0.741 0 C-N-CA 120.825 -0.702 . . . . 0.0 113.704 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.39 -83.17 0.33 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 117.996 0.898 . . . . 0.0 111.727 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.17 -58.56 6.23 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.327 0.584 . . . . 0.0 111.046 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.423 ' HB3' ' HA2' ' A' ' 43' ' ' GLY . 12.1 tp10 -48.77 -42.61 36.16 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.725 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -61.57 -35.12 76.9 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.8 m -53.84 -49.92 67.35 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.97 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 113.52 -31.74 6.46 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.212 -0.994 . . . . 0.0 114.337 178.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 pp -98.63 11.46 38.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.675 0.737 . . . . 0.0 111.715 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.468 ' CG2' ' CD2' ' A' ' 24' ' ' PHE . 4.6 mp -113.28 88.42 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-O 121.016 0.436 . . . . 0.0 110.478 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.404 ' HG3' ' N ' ' A' ' 54' ' ' ALA . 2.2 tp60 -112.69 148.11 35.37 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.611 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.406 ' HA ' ' CG2' ' A' ' 37' ' ' ILE . . . -70.39 140.88 52.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.046 0.45 . . . . 0.0 111.967 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.96 19.09 69.47 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.089 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -105.69 -81.49 0.54 Allowed 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 28.7 mm -152.51 125.92 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 121.503 0.668 . . . . 0.0 112.536 -177.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.456 ' O ' HG22 ' A' ' 58' ' ' ILE . 2.3 tp -161.21 76.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.469 177.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.2 tp -78.69 -63.15 1.48 Allowed 'General case' 0 C--N 1.328 -0.354 0 O-C-N 122.177 -0.327 . . . . 0.0 111.581 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -109.51 149.97 28.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.859 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.413 HG23 ' CD1' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -160.92 143.4 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.473 -179.371 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.402 ' HA ' ' CG2' ' A' ' 87' ' ' VAL . 53.2 m-80 60.89 33.72 19.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.19 0.519 . . . . 0.0 111.879 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 57.91 21.29 7.48 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 178.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.432 ' NH1' ' HB3' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -121.55 124.55 27.14 Favored Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 120.631 -0.428 . . . . 0.0 109.909 177.586 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.16 88.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 122.205 1.936 . . . . 0.0 112.117 -178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.43 67.52 9.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.304 0.573 . . . . 0.0 109.762 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.1 m -126.06 -59.08 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -131.47 25.51 4.79 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -102.5 -172.68 2.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.811 0.338 . . . . 0.0 110.457 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.82 111.47 9.0 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.432 ' CD1' ' HB3' ' A' ' 28' ' ' GLU . 8.0 t80 -43.95 -47.52 8.5 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.902 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -67.68 -32.48 73.18 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.17 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.1 m -70.67 -36.27 73.26 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.341 0.591 . . . . 0.0 109.851 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.09 -49.92 65.89 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.477 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.424 HD13 ' CZ ' ' A' ' 71' ' ' TYR . 48.4 mt -63.42 -28.07 69.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.49 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -71.36 -40.27 70.74 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.6 t -58.38 -42.31 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.61 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.432 ' HB3' ' NH1' ' A' ' 64' ' ' ARG . 0.1 OUTLIER -72.07 -35.28 69.23 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.197 178.774 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.91 -37.12 68.47 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.023 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -58.97 -19.98 47.05 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.84 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.411 HG22 HD11 ' A' ' 81' ' ' ILE . 55.9 mt -66.36 119.43 11.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.938 0.399 . . . . 0.0 111.231 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.65 -162.16 0.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.13 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.5 m -94.76 -171.36 2.44 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.633 0.254 . . . . 0.0 110.739 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 44.61 30.99 0.57 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.929 0.395 . . . . 0.0 111.207 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.413 ' O ' ' CE1' ' A' ' 15' ' ' PHE . 3.1 t -125.81 161.88 26.38 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.956 0.884 . . . . 0.0 112.908 -178.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.15 176.52 5.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.231 -1.35 . . . . 0.0 110.504 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.402 ' CG2' ' HA ' ' A' ' 62' ' ' ASN . 6.3 p -147.65 153.53 11.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.864 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.3 t -113.83 159.72 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.585 0.231 . . . . 0.0 110.65 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -153.15 158.97 42.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.797 0.332 . . . . 0.0 110.932 -178.883 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.414 ' CD1' ' HA ' ' A' ' 11' ' ' SER . 46.9 mm -131.82 124.19 53.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.19 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.41 160.59 14.17 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.291 178.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.25 150.83 26.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.116 0.484 . . . . 0.0 112.209 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.433 ' HA3' ' N ' ' A' ' 8' ' ' ASN . . . -162.87 -140.43 2.87 Favored Glycine 0 CA--C 1.523 0.58 0 CA-C-N 115.285 -0.871 . . . . 0.0 112.914 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -77.76 -154.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.992 2.461 . . . . 0.0 112.192 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -146.83 127.87 14.59 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.571 0.224 . . . . 0.0 110.441 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.73 -7.58 42.27 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.757 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -131.83 147.21 52.47 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 117.12 0.46 . . . . 0.0 111.778 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.97 116.18 28.6 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.8 t -102.41 92.33 4.64 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.563 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.57 -165.79 0.38 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.443 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.08 130.99 53.51 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.666 0.27 . . . . 0.0 111.538 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 178.92 58.07 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.236 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 14.6 t -176.48 -156.2 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.884 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -165.51 147.32 7.45 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.831 0.348 . . . . 0.0 110.404 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.468 ' HB3' ' HA ' ' A' ' 112' ' ' LYS . 49.3 p90 -74.89 156.52 36.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.116 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.8 t -164.63 168.56 17.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.723 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.41 139.09 48.26 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.615 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 62.27 33.19 16.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.744 0.307 . . . . 0.0 111.036 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -154.9 -62.69 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.35 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.498 ' N ' ' CD ' ' A' ' 111' ' ' PRO . 1.0 OUTLIER 53.47 37.3 0.41 Allowed Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 179.832 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.498 ' CD ' ' N ' ' A' ' 110' ' ' THR . 42.5 Cg_endo -63.63 -29.71 69.89 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 121.857 1.705 . . . . 0.0 111.983 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.468 ' HA ' ' HB3' ' A' ' 105' ' ' PHE . 3.4 tmtt? 74.99 134.25 0.05 Allowed 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.052 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 93.5 m -43.84 -32.83 1.16 Allowed 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 121.354 0.597 . . . . 0.0 110.853 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.6 tp -92.25 93.37 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.142 177.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -160.49 95.11 1.1 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.186 0.517 . . . . 0.0 112.199 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.3 t -156.81 64.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.72 127.17 32.27 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -177.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -133.39 138.68 31.91 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.773 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -52.94 112.95 1.05 Allowed 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.335 2.023 . . . . 0.0 112.169 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.69 -28.93 8.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.103 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 95.93 105.92 2.17 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.907 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -62.07 168.98 8.22 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.108 1.872 . . . . 0.0 112.108 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -51.43 152.67 11.52 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.218 1.946 . . . . 0.0 112.323 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.4 t -166.92 163.36 16.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.951 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -173.76 179.92 1.91 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.899 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 59.93 18.92 7.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.079 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.212 -0.899 . . . . 0.0 111.017 -179.917 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 9.5 m . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.859 0.361 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 25.1 t -135.09 -64.49 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.083 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 21.6 mmtm -85.43 -177.26 6.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.933 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 13.2 t 62.62 120.11 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.952 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -146.75 124.95 12.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.308 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.404 ' CA ' HD22 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -59.48 -58.66 7.65 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.04 179.33 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 31.8 m . . . . . 0 C--O 1.251 1.153 0 CA-C-O 118.389 -0.815 . . . . 0.0 112.808 178.87 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.255 0 N-CA-C 112.542 -0.223 . . . . 0.0 112.542 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 63.91 -80.49 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.664 0.269 . . . . 0.0 110.829 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -108.47 134.27 51.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.656 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 9.1 mtt -86.14 -71.76 0.53 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.195 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER 49.07 -167.56 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.596 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -137.41 156.18 75.21 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-O 120.387 0.136 . . . . 0.0 111.133 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.29 -80.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.546 2.164 . . . . 0.0 112.322 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -115.61 -10.2 11.88 Favored 'General case' 0 N--CA 1.463 0.213 0 O-C-N 122.432 -0.167 . . . . 0.0 111.42 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.4 t -79.62 151.55 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 mp -121.87 146.27 27.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.322 0.582 . . . . 0.0 111.762 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.444 ' HA ' ' CD1' ' A' ' 90' ' ' ILE . 0.2 OUTLIER -97.18 169.92 9.46 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.372 -179.832 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.448 ' HB ' ' CD1' ' A' ' 89' ' ' LEU . 0.7 OUTLIER -156.85 163.33 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.089 -178.131 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.16 120.97 7.58 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.494 0.664 . . . . 0.0 110.584 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.459 ' O ' ' N ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -123.39 178.19 5.27 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.578 -179.64 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.448 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 2.5 t80 -119.31 150.04 40.8 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.4 ' O ' ' N ' ' A' ' 20' ' ' GLY . 14.3 mtpt -86.36 28.71 0.82 Allowed 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.066 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.427 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER 43.81 30.76 0.41 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.968 0.413 . . . . 0.0 111.925 179.532 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.448 ' HD3' ' CE1' ' A' ' 15' ' ' PHE . 0.0 OUTLIER 44.33 23.3 0.06 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.952 -178.716 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.0 m -166.41 33.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 49.54 66.57 2.19 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-N 115.435 -0.802 . . . . 0.0 113.088 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -148.07 61.19 0.45 Allowed Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.4 mp -46.91 -26.78 1.06 Allowed 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.36 5.1 24.92 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.3 -0.953 . . . . 0.0 113.915 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.423 ' CG ' HG22 ' A' ' 52' ' ' ILE . 1.2 p90 -155.95 141.22 17.54 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.237 1.018 . . . . 0.0 113.284 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.8 mt -79.56 168.22 19.7 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.038 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.5 m -149.01 147.21 16.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.737 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.0 ttpt -129.34 118.93 23.03 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.01 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.446 ' HB3' ' CD1' ' A' ' 71' ' ' TYR . 4.1 tm-20 -114.14 97.19 6.21 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.79 -1.095 . . . . 0.0 108.541 177.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.435 ' CB ' ' HB2' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -57.04 120.23 7.66 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.049 0.452 . . . . 0.0 110.932 -179.033 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.9 t -45.98 -23.75 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.444 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.0 m -146.37 75.06 1.39 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.435 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.435 ' HB2' ' CB ' ' A' ' 29' ' ' ARG . 3.0 mmtt -177.95 177.99 0.4 Allowed Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.734 -178.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 32' ' ' LYS . 88.4 Cg_exo -49.99 -177.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.341 2.028 . . . . 0.0 113.41 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -47.65 170.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.142 2.562 . . . . 0.0 114.531 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.417 HG21 ' N ' ' A' ' 36' ' ' ILE . 7.4 p -79.08 146.22 8.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.036 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.417 ' N ' HG21 ' A' ' 35' ' ' VAL . 1.1 tp -126.99 166.62 23.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.442 HG22 HD11 ' A' ' 37' ' ' ILE . 27.8 mt -84.29 141.25 14.95 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 CA-C-O 120.708 0.29 . . . . 0.0 110.71 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.405 ' HB3' ' CG1' ' B' ' 4' ' ' VAL . 0.1 OUTLIER -108.89 -36.64 6.06 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -179.833 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -169.21 132.61 1.32 Allowed 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.319 -0.552 . . . . 0.0 112.381 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.1 mt -70.26 78.49 0.53 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 121.701 0.762 . . . . 0.0 109.876 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.461 ' CG2' ' N ' ' A' ' 42' ' ' ARG . 1.7 tp -33.06 -58.85 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 -177.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.461 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -94.42 -68.88 0.78 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -177.706 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.412 ' HA2' ' CB ' ' A' ' 47' ' ' GLU . . . 108.7 25.59 5.65 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -178.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.38 -34.08 0.51 Allowed Glycine 0 C--N 1.337 0.609 0 C-N-CA 121.145 -0.55 . . . . 0.0 113.182 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -92.74 -80.43 0.37 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 117.546 0.673 . . . . 0.0 110.908 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.402 ' HB3' ' CG2' ' A' ' 52' ' ' ILE . . . -60.29 -58.04 10.21 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.222 0.534 . . . . 0.0 111.389 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.412 ' CB ' ' HA2' ' A' ' 43' ' ' GLY . 39.2 tt0 -48.7 -46.92 41.27 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.83 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.6 tp-100 -57.87 -33.85 69.14 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.874 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.1 t -55.05 -52.16 64.04 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.752 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 112.27 -22.58 17.64 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.299 -0.953 . . . . 0.0 113.859 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.07 -28.2 14.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.955 0.377 . . . . 0.0 110.728 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.423 HG22 ' CG ' ' A' ' 24' ' ' PHE . 2.3 mp -82.37 121.28 35.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.025 0.441 . . . . 0.0 110.328 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -153.74 156.45 37.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.101 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.52 120.06 12.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.877 0.37 . . . . 0.0 110.954 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.0 -1.73 88.43 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.294 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.34 -91.34 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 117.011 0.406 . . . . 0.0 110.511 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.8 tp -163.98 120.5 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.405 ' HB ' ' CG1' ' A' ' 37' ' ' ILE . 2.0 tp -140.14 88.67 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 18.2 tp -78.33 -70.3 0.5 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.598 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -121.16 165.46 15.35 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.803 0.335 . . . . 0.0 111.109 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -148.3 157.23 8.26 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.267 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.128 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER 56.71 -81.21 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.046 0.538 . . . . 0.0 110.214 -178.589 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 61' ' ' VAL . 14.5 p-10 -175.22 36.99 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.344 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.433 ' O ' ' HD2' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -124.08 130.32 24.43 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.24 179.887 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -63.58 86.41 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 121.206 1.27 . . . . 0.0 110.322 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.402 ' CD2' ' HG3' ' A' ' 28' ' ' GLU . 0.3 OUTLIER -86.71 68.21 10.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.286 0.565 . . . . 0.0 110.916 -178.887 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.7 m -131.62 -61.53 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.73 28.33 5.63 Favored 'General case' 0 C--N 1.333 -0.13 0 O-C-N 121.978 -0.451 . . . . 0.0 111.735 -178.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -99.85 -172.06 2.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.498 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.32 114.63 15.22 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.446 ' CD1' ' HB3' ' A' ' 28' ' ' GLU . 4.0 t80 -44.2 -50.98 8.54 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -64.81 -29.11 70.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.339 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 39.0 t -71.23 -40.57 71.0 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.278 0.561 . . . . 0.0 110.048 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.77 -45.17 83.52 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.368 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.414 HD13 ' CE1' ' A' ' 71' ' ' TYR . 73.9 mt -63.69 -28.73 70.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.868 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -76.41 -36.09 58.24 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.812 0.339 . . . . 0.0 110.177 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.8 t -61.36 -41.43 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.795 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.31 -32.15 58.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.511 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.32 -32.16 72.88 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.795 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.26 -17.59 61.81 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.715 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 29.5 mt -63.25 136.77 25.68 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 CA-C-O 120.867 0.365 . . . . 0.0 110.828 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.46 -165.42 0.78 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.507 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.43 -172.12 2.27 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.098 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 38.0 34.67 0.07 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.105 0.562 . . . . 0.0 111.5 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.416 ' O ' ' CE1' ' A' ' 15' ' ' PHE . 1.8 t -126.37 163.63 22.86 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.925 0.869 . . . . 0.0 113.21 -177.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.3 177.33 5.74 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 114.158 -1.383 . . . . 0.0 110.051 179.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.459 ' N ' ' O ' ' A' ' 14' ' ' LEU . 2.3 p -150.77 145.98 16.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.338 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.475 ' O ' ' N ' ' A' ' 62' ' ' ASN . 21.2 t -101.9 159.3 4.23 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.015 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.448 ' CD1' ' HB ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -155.16 165.91 35.23 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.319 -179.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.444 ' CD1' ' HA ' ' A' ' 11' ' ' SER . 29.6 mm -132.58 130.31 59.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.188 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.56 175.35 5.61 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.024 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.16 168.45 19.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.86 0.362 . . . . 0.0 110.925 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -102.67 159.8 17.43 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.765 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.81 -154.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.54 2.16 . . . . 0.0 112.29 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -94.31 93.62 7.83 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.69 12.81 36.62 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.768 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' A' ' 118' ' ' GLN . 42.4 m-85 -137.82 128.41 26.66 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.457 ' N ' ' HB3' ' A' ' 120' ' ' LEU . 0.9 OUTLIER -87.64 174.99 8.1 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.021 179.393 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.456 ' N ' ' CG2' ' A' ' 98' ' ' THR . 0.0 OUTLIER -121.49 92.05 3.66 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.254 178.418 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.28 176.25 9.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.027 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.449 ' N ' ' CD1' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -122.39 -178.88 4.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.156 0.503 . . . . 0.0 111.711 -179.087 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -157.42 31.56 0.28 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.397 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 8.8 t -140.64 -174.51 3.99 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.115 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 50.7 p -93.13 140.36 29.59 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.869 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -76.4 176.99 7.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.973 0.416 . . . . 0.0 111.083 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 99.8 m -76.27 -67.7 0.66 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.316 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -115.07 28.18 8.15 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.066 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 59.53 27.93 17.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.694 0.283 . . . . 0.0 111.047 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -153.18 17.82 0.7 Allowed Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.379 -0.915 . . . . 0.0 113.508 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -163.09 140.36 5.96 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 117.246 0.523 . . . . 0.0 110.448 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.17 177.16 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.002 1.801 . . . . 0.0 112.427 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.442 ' CD ' ' N ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -153.27 -151.96 0.4 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.038 -178.713 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 98.9 m -62.15 88.08 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.43 HG12 ' HA ' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -114.3 140.89 32.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.458 -177.198 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -161.53 92.51 0.88 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.082 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.9 t -160.21 107.6 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.428 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.42 138.17 37.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.79 0.329 . . . . 0.0 110.604 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.446 ' O ' ' HA ' ' A' ' 97' ' ' PHE . 8.2 pt20 -146.66 157.22 48.13 Favored Pre-proline 0 C--O 1.217 -0.614 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.636 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.24 105.95 1.49 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 121.936 1.757 . . . . 0.0 111.317 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.457 ' HB3' ' N ' ' A' ' 98' ' ' THR . 1.4 pp -89.58 -38.71 13.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.856 0.36 . . . . 0.0 111.087 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 50.41 94.43 0.01 OUTLIER Glycine 0 CA--C 1.522 0.48 0 C-N-CA 121.191 -0.528 . . . . 0.0 113.185 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.63 153.4 14.38 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.223 1.949 . . . . 0.0 112.074 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.23 79.54 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.295 1.997 . . . . 0.0 112.634 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 10.1 t -173.03 -176.69 1.44 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.98 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt 62.43 59.54 1.52 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.184 0.516 . . . . 0.0 110.884 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -89.42 12.7 15.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.329 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.9 m . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.253 -0.88 . . . . 0.0 111.032 179.938 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 25.7 t . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.927 0.394 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 2.8 p -175.75 -54.28 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.442 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 25.8 mmtm 58.98 147.46 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.405 ' CG1' ' HB3' ' A' ' 38' ' ' SER . 3.5 t 68.83 -61.84 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.963 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 58.21 -124.6 1.5 Allowed 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 119.44 -0.314 . . . . 0.0 110.348 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 5.8 p 167.8 127.91 0.01 OUTLIER 'General case' 0 C--N 1.347 0.475 0 CA-C-N 118.605 0.639 . . . . 0.0 110.336 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 4.5 m . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.232 -0.89 . . . . 0.0 111.251 -179.373 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.157 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.4 m -138.47 -173.75 3.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.833 0.349 . . . . 0.0 110.852 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 59.4 89.56 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.79 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 17.6 mmt -112.11 -42.79 3.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.0 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.4 tt 44.46 40.33 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.96 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -164.41 151.55 10.06 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.491 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -89.01 -165.03 0.18 Allowed 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.895 2.397 . . . . 0.0 112.311 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 93' ' ' GLY . 8.2 t-20 -140.68 -70.32 0.38 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.403 ' CG2' ' O ' ' A' ' 8' ' ' ASN . 42.0 t -160.71 90.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.43 ' CG2' ' N ' ' A' ' 11' ' ' SER . 0.5 OUTLIER -148.99 -178.49 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 120.166 -0.613 . . . . 0.0 112.218 -178.023 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.43 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 13.9 m -77.37 167.76 21.15 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -178.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.418 ' CG2' ' HG ' ' A' ' 91' ' ' LEU . 1.9 t -157.87 157.83 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 114.083 -1.417 . . . . 0.0 107.894 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.3 ttp180 -141.69 141.92 33.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.406 0.622 . . . . 0.0 111.727 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.44 ' CD2' ' CE1' ' A' ' 24' ' ' PHE . 0.8 OUTLIER -142.96 177.44 8.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.876 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.428 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 3.5 t80 -124.49 147.86 48.08 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.403 ' O ' ' N ' ' A' ' 20' ' ' GLY . 1.5 mtpt -84.12 32.62 0.49 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.481 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.443 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 0.3 OUTLIER 40.53 32.13 0.13 Allowed 'General case' 0 C--N 1.344 0.343 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 179.222 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER 45.0 24.66 0.12 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.551 -178.497 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.401 ' CG2' ' O ' ' A' ' 17' ' ' ARG . 1.6 m -169.23 34.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.317 178.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 49.94 63.91 3.89 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 115.56 -0.746 . . . . 0.0 113.062 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -145.97 62.22 0.47 Allowed Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.1 mp -46.24 -24.83 0.52 Allowed 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.423 ' HA2' HG23 ' A' ' 41' ' ' ILE . . . 107.96 6.99 31.8 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.039 -1.076 . . . . 0.0 113.587 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.44 ' CE1' ' CD2' ' A' ' 14' ' ' LEU . 0.6 OUTLIER -157.15 140.78 15.87 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -178.92 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.3 mt -79.92 171.06 15.62 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.671 178.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.5 m -149.85 153.2 10.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.506 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.2 105.13 5.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.479 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.464 ' HB3' ' CG ' ' A' ' 71' ' ' TYR . 0.6 OUTLIER -108.44 139.22 43.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.076 178.93 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.429 ' CB ' ' HB2' ' A' ' 32' ' ' LYS . 10.7 mtt-85 -76.6 124.5 27.71 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.05 0.453 . . . . 0.0 110.37 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.7 t -52.08 -21.83 2.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.042 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.2 p -141.48 42.44 1.75 Allowed 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.738 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.429 ' HB2' ' CB ' ' A' ' 29' ' ' ARG . 15.6 mttp -167.0 140.87 3.1 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.927 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.41 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 32.0 Cg_exo -58.69 -46.72 21.99 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.526 2.15 . . . . 0.0 113.46 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 33' ' ' PRO . 53.1 Cg_exo -39.8 93.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.803 2.335 . . . . 0.0 114.607 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.4 p -116.8 144.08 25.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 177.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.4 tp -153.64 169.07 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -178.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.425 HG13 ' CG2' ' A' ' 58' ' ' ILE . 24.2 mt -81.27 145.93 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.464 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.402 ' CB ' ' CG1' ' B' ' 4' ' ' VAL . 4.9 t -109.32 -40.58 4.88 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -164.9 131.78 2.98 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.863 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.407 ' CD2' ' HB3' ' A' ' 24' ' ' PHE . 43.1 mt -70.14 76.74 0.51 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.712 0.767 . . . . 0.0 109.698 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.46 ' CG2' ' N ' ' A' ' 42' ' ' ARG . 0.2 OUTLIER -30.58 -59.16 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -177.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.46 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -94.44 -66.25 0.93 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -177.857 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 104.65 23.5 7.86 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -177.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -125.45 -30.1 0.94 Allowed Glycine 0 C--N 1.338 0.687 0 C-N-CA 121.24 -0.505 . . . . 0.0 113.159 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -95.84 -83.25 0.37 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 117.686 0.743 . . . . 0.0 111.932 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.95 -58.79 7.03 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.207 0.527 . . . . 0.0 111.04 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -45.06 -49.42 11.55 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.971 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.434 ' HB2' ' O ' ' A' ' 44' ' ' GLY . 7.6 mt-30 -55.65 -39.04 70.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.493 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.42 -49.9 63.61 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.343 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.4 -26.99 13.21 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.301 -0.952 . . . . 0.0 113.746 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.441 ' CB ' ' CG2' ' A' ' 114' ' ' ILE . 2.1 pp -95.65 -0.98 51.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.107 0.453 . . . . 0.0 111.471 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.414 HD11 ' HG ' ' A' ' 51' ' ' LEU . 5.0 mp -109.79 123.99 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -150.93 160.12 44.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.735 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.49 129.81 40.74 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.925 0.393 . . . . 0.0 111.265 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.35 13.73 63.13 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.101 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.27 -80.84 0.39 Allowed 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 22.4 mt -155.24 122.7 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.461 ' O ' HG22 ' A' ' 58' ' ' ILE . 3.2 tp -160.25 71.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 114.867 -1.061 . . . . 0.0 109.222 177.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.2 tp -76.93 -54.13 6.97 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.643 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -121.08 160.04 24.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.835 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.407 HG21 ' N ' ' A' ' 62' ' ' ASN . 14.4 p -166.75 146.05 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.043 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.407 ' N ' HG21 ' A' ' 61' ' ' VAL . 0.1 OUTLIER 45.76 41.13 7.15 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.198 0.523 . . . . 0.0 111.56 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.4 t70 59.74 28.44 17.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.221 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -119.61 98.24 49.93 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.572 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.27 85.37 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 121.811 1.674 . . . . 0.0 110.896 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.4 mt -68.75 63.69 0.11 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.508 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.4 m -141.81 -61.09 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -111.7 29.38 7.9 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 122.127 -0.358 . . . . 0.0 111.736 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.19 175.31 6.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.644 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.5 m -72.66 102.33 3.28 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.464 ' CG ' ' HB3' ' A' ' 28' ' ' GLU . 8.5 t80 -40.14 -60.99 0.95 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.363 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.8 p30 -55.49 -28.42 54.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.404 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.8 m -78.07 -39.94 40.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.087 0.47 . . . . 0.0 109.856 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.47 -34.73 74.46 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.294 0.568 . . . . 0.0 109.944 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.417 HD12 ' CZ ' ' A' ' 71' ' ' TYR . 15.1 mt -75.02 -38.04 61.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.242 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -72.07 -38.73 69.39 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.98 0.419 . . . . 0.0 110.19 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.1 t -62.33 -42.93 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.772 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.5 pp -79.85 -21.91 43.55 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.12 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.77 -37.18 84.08 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-O 120.988 0.423 . . . . 0.0 110.335 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -58.27 -19.07 38.07 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.192 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.417 HD11 HG22 ' A' ' 81' ' ' ILE . 70.8 mt -54.27 121.99 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 120.953 0.406 . . . . 0.0 111.006 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.77 -163.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.653 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.3 m -96.42 -171.67 2.34 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.996 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 44.08 30.82 0.46 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.232 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.404 ' O ' ' CE1' ' A' ' 15' ' ' PHE . 1.7 t -125.37 158.76 33.48 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 122.046 0.927 . . . . 0.0 112.737 -178.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.34 176.28 5.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.969 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.405 ' N ' ' O ' ' A' ' 14' ' ' LEU . 4.8 p -148.66 153.14 11.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.22 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.1 t -113.56 160.43 13.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.417 ' CG ' ' HB ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -155.89 172.64 18.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.64 0.257 . . . . 0.0 110.597 -178.736 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 29.6 mm -137.25 126.37 35.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.418 ' HG ' ' CG2' ' A' ' 12' ' ' VAL . 11.6 mt -91.17 145.81 24.36 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.96 175.32 5.96 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -178.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 8' ' ' ASN . . . 136.49 60.68 0.06 OUTLIER Glycine 0 CA--C 1.526 0.722 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.907 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.56 125.03 16.76 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.597 2.198 . . . . 0.0 113.024 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.401 ' O ' ' CD1' ' A' ' 97' ' ' PHE . 0.3 OUTLIER -163.86 28.75 0.08 Allowed 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.3 179.906 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.414 ' O ' ' CG ' ' A' ' 97' ' ' PHE . . . 69.23 60.07 5.4 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.942 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.437 ' CB ' ' CG2' ' A' ' 117' ' ' THR . 96.7 m-85 -160.44 129.69 4.97 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.792 0.33 . . . . 0.0 111.873 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.64 127.35 35.9 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.88 91.27 8.61 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -103.9 136.74 43.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.871 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.7 pp -54.07 -177.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.329 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 66.81 87.65 0.12 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.967 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 11.9 t -156.23 170.01 23.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.53 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 40.5 p -125.77 133.9 51.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.93 0.395 . . . . 0.0 111.209 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.405 ' CB ' ' O ' ' A' ' 111' ' ' PRO . 19.7 p90 -115.86 168.4 10.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.943 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 88.7 m -120.52 -76.27 0.58 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.777 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -140.97 -78.97 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.499 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 23.0 p30 -144.33 28.8 1.32 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.857 0.36 . . . . 0.0 111.081 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.75 0.8 4.62 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 120.843 -0.694 . . . . 0.0 113.422 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.441 ' OG1' ' CD ' ' A' ' 111' ' ' PRO . 0.6 OUTLIER -141.83 -172.12 0.3 Allowed Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.492 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.441 ' CD ' ' OG1' ' A' ' 110' ' ' THR . 88.6 Cg_exo -50.31 -175.2 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 121.949 1.766 . . . . 0.0 112.418 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.22 -156.94 0.75 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 10.9 m -58.65 -16.84 17.99 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.562 0.22 . . . . 0.0 110.928 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.441 ' CG2' ' CB ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER -75.59 175.19 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 121.207 0.527 . . . . 0.0 111.514 -179.296 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -79.49 145.81 33.04 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.724 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -85.23 138.14 19.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 121.363 0.601 . . . . 0.0 111.112 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.437 ' CG2' ' CB ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -79.57 121.44 25.25 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.945 -1.025 . . . . 0.0 112.307 -178.078 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.18 130.67 24.48 Favored Pre-proline 0 N--CA 1.477 0.878 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.437 ' HD3' ' CE2' ' A' ' 97' ' ' PHE . 5.2 Cg_exo -38.82 124.13 0.87 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.272 2.648 . . . . 0.0 115.175 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.26 -65.74 0.96 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 157.76 86.62 0.06 OUTLIER Glycine 0 CA--C 1.521 0.457 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.401 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -61.45 172.33 3.54 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.475 2.116 . . . . 0.0 112.512 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.42 175.38 0.1 Allowed 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.384 2.056 . . . . 0.0 112.263 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.0 t -104.27 146.16 29.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.757 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.4 mttp -119.94 54.74 1.01 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.145 0.498 . . . . 0.0 111.028 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -93.01 16.98 11.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.229 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.1 m . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.182 179.976 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.738 0.304 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 11.5 t -128.95 -54.29 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.433 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.415 ' CE ' ' HA ' ' A' ' 29' ' ' ARG . 31.8 mmtm -80.82 -48.22 12.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.585 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.402 ' CG1' ' CB ' ' A' ' 38' ' ' SER . 4.2 t -70.94 106.29 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.67 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.28 -98.09 0.07 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.927 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 2.6 p 162.75 130.41 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 122.794 0.438 . . . . 0.0 110.406 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 15.5 m . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.182 -179.765 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 p -169.23 92.24 0.26 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.882 0.372 . . . . 0.0 110.983 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -165.17 146.04 7.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.716 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.5 ttt -124.82 119.94 30.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.142 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 46.43 -170.69 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.815 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -139.15 162.45 52.07 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.066 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.32 124.88 12.65 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.614 2.21 . . . . 0.0 112.359 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.425 ' N ' ' CA ' ' A' ' 93' ' ' GLY . 14.7 m120 -132.94 88.39 2.5 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.145 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.9 p -91.34 97.03 6.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.879 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.43 ' CG2' ' N ' ' A' ' 11' ' ' SER . 1.5 tp -160.97 -166.97 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.437 ' HA ' ' CD1' ' A' ' 90' ' ' ILE . 10.1 m -100.61 168.42 9.72 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 121.572 0.701 . . . . 0.0 112.684 -178.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.424 ' CG2' ' HG ' ' A' ' 91' ' ' LEU . 2.2 t -156.18 164.36 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.961 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.5 tpp85 -149.83 127.69 11.8 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.508 0.67 . . . . 0.0 110.744 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -128.37 178.25 6.4 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.838 -1.073 . . . . 0.0 110.094 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.438 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 4.0 t80 -122.03 151.22 41.07 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 20' ' ' GLY . 2.1 mmpt? -83.37 30.95 0.46 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.405 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.414 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 0.9 OUTLIER 40.91 31.21 0.12 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 122.865 0.466 . . . . 0.0 112.061 179.679 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.438 ' HD3' ' CE1' ' A' ' 15' ' ' PHE . 0.0 OUTLIER 44.15 24.35 0.08 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.286 0.634 . . . . 0.0 112.419 -177.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.6 m -165.98 32.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.108 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 50.45 68.16 1.56 Allowed Glycine 0 C--N 1.337 0.608 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.991 -178.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -155.08 69.48 0.29 Allowed Glycine 0 C--N 1.332 0.327 0 N-CA-C 111.529 -0.629 . . . . 0.0 111.529 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.5 mp -49.4 -21.3 0.86 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.78 5.15 33.82 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.169 -1.015 . . . . 0.0 113.32 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.431 ' CD2' ' CG2' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -157.58 138.12 12.95 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 117.794 0.797 . . . . 0.0 112.844 -179.583 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.47 ' CD2' ' HA ' ' B' ' 6' ' ' SER . 1.8 mt -78.68 165.28 23.81 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.374 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.3 m -147.7 154.31 11.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.161 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -137.7 121.28 17.29 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.259 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.435 ' HB3' ' CD1' ' A' ' 71' ' ' TYR . 0.9 OUTLIER -115.03 95.21 5.1 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.167 178.538 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.444 ' CB ' ' HB2' ' A' ' 32' ' ' LYS . 8.9 mtt180 -62.16 116.84 5.31 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.117 0.484 . . . . 0.0 110.493 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.8 t -48.49 -20.62 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.6 m -142.1 66.04 1.35 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.694 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.465 ' HB3' ' HD2' ' A' ' 33' ' ' PRO . 4.1 mttp -172.58 176.69 0.88 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.595 -178.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 32' ' ' LYS . 83.4 Cg_exo -49.95 -177.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.166 1.911 . . . . 0.0 113.075 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -46.76 176.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.999 2.466 . . . . 0.0 114.027 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.6 p -77.98 148.82 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.32 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.401 ' HA ' HG21 ' A' ' 58' ' ' ILE . 0.6 OUTLIER -129.87 154.96 41.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 120.855 0.359 . . . . 0.0 111.539 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.443 HG23 HD11 ' A' ' 37' ' ' ILE . 22.1 mt -79.22 142.54 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.773 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.4 t -106.36 -40.45 5.6 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -171.18 142.11 1.72 Allowed 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.145 -0.622 . . . . 0.0 112.429 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.406 ' CD2' ' HB3' ' A' ' 24' ' ' PHE . 46.6 mt -76.21 85.3 3.03 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.995 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 42' ' ' ARG . 1.3 tp -41.98 -58.29 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -177.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.459 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.1 OUTLIER -92.44 -66.23 0.94 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -176.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.441 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 107.42 18.81 9.86 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 -177.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.51 -27.75 0.95 Allowed Glycine 0 C--N 1.34 0.793 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.855 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.06 -83.4 0.33 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.008 0.904 . . . . 0.0 111.69 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.23 -54.68 29.64 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 121.424 0.631 . . . . 0.0 110.782 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.441 ' HB3' ' HA2' ' A' ' 43' ' ' GLY . 3.8 tp10 -49.19 -42.24 39.45 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.368 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.92 -35.52 78.63 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.454 178.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.3 -47.78 65.73 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.655 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.42 -27.0 11.09 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.207 -0.997 . . . . 0.0 114.655 177.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.406 ' CD2' ' CD1' ' A' ' 101' ' ' LEU . 2.8 pp -102.26 -11.66 18.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 117.711 0.756 . . . . 0.0 111.944 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.431 ' CG2' ' CD2' ' A' ' 24' ' ' PHE . 5.2 mp -87.78 104.45 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.08 156.53 42.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.833 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.93 133.39 45.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.827 0.346 . . . . 0.0 111.04 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.96 14.37 65.57 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.134 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.17 -82.55 0.34 Allowed 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.6 mp -158.47 120.38 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.462 0.649 . . . . 0.0 111.841 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.431 ' HB ' ' CG1' ' A' ' 37' ' ' ILE . 5.9 tp -152.9 87.19 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.09 177.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.3 tp -79.48 -61.78 1.9 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 121.994 -0.441 . . . . 0.0 111.238 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -127.88 158.88 36.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.909 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.415 HG21 ' CD1' ' A' ' 58' ' ' ILE . 11.7 t -150.63 149.99 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.018 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 49.47 33.82 6.06 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.25 0.547 . . . . 0.0 110.941 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 63.89 23.89 13.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.285 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -111.39 110.93 55.49 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.179 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.49 80.72 0.1 Allowed 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.914 1.743 . . . . 0.0 111.5 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.425 ' HA ' ' CD2' ' A' ' 69' ' ' LEU . 6.8 mt -78.17 65.44 3.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.389 0.614 . . . . 0.0 109.883 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.7 m -122.67 -56.04 2.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.698 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.52 22.47 2.72 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.425 ' CD2' ' HA ' ' A' ' 66' ' ' LEU . 0.7 OUTLIER -96.96 -175.67 3.33 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 178.869 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.3 m -68.86 96.67 0.77 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.435 ' CD1' ' HB3' ' A' ' 28' ' ' GLU . 9.0 t80 -40.77 -57.0 2.04 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -178.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -59.19 -28.22 66.43 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.096 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.7 t -76.6 -44.71 33.23 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.84 -40.84 81.03 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.45 0.643 . . . . 0.0 109.724 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.409 HD12 ' CZ ' ' A' ' 71' ' ' TYR . 99.0 mt -66.02 -36.4 83.17 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.22 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -71.44 -38.7 71.33 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 120.921 0.391 . . . . 0.0 110.283 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.2 t -59.63 -36.85 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.013 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.5 pp -91.89 -24.64 19.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.005 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.27 -44.49 83.44 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 120.507 -0.477 . . . . 0.0 109.803 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -52.85 -22.29 11.84 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.877 -0.677 . . . . 0.0 113.031 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 80.1 mt -49.84 119.39 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 120.855 0.359 . . . . 0.0 111.391 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.15 -168.66 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.473 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 m -96.4 -171.12 2.21 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.115 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 44.13 31.3 0.52 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.074 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.419 ' O ' ' CE1' ' A' ' 15' ' ' PHE . 1.8 t -125.38 160.19 29.99 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.969 0.89 . . . . 0.0 112.789 -178.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -100.95 176.61 5.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.415 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.425 ' N ' ' O ' ' A' ' 14' ' ' LEU . 2.8 p -151.69 150.02 13.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.663 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.1 t -110.2 155.96 11.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.382 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -149.66 155.8 40.83 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.13 -178.353 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.437 ' CD1' ' HA ' ' A' ' 11' ' ' SER . 45.9 mm -130.75 133.36 63.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.02 0.438 . . . . 0.0 111.267 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.424 ' HG ' ' CG2' ' A' ' 12' ' ' VAL . 55.6 mt -107.46 158.24 17.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.316 178.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.2 156.52 17.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.058 0.456 . . . . 0.0 111.291 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.425 ' CA ' ' N ' ' A' ' 8' ' ' ASN . . . -161.88 -130.22 1.1 Allowed Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.701 -0.682 . . . . 0.0 112.906 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -89.98 -166.72 0.23 Allowed 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.656 2.237 . . . . 0.0 112.519 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -128.98 105.51 8.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.276 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 114.31 10.24 13.82 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.644 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.427 ' HA ' ' O ' ' A' ' 118' ' ' GLN . 34.0 m-85 -141.5 140.53 33.52 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 117.252 0.526 . . . . 0.0 111.638 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.411 ' CG2' ' HB3' ' A' ' 120' ' ' LEU . 0.1 OUTLIER -98.69 119.79 38.03 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.053 179.501 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.405 HG22 ' HB3' ' A' ' 8' ' ' ASN . 2.2 t -102.69 91.96 4.42 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.068 0.461 . . . . 0.0 109.775 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.42 -164.76 0.07 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.923 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.406 ' CD1' ' CD2' ' A' ' 51' ' ' LEU . 2.7 mm? -107.0 127.85 53.82 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.439 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 177.2 122.93 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.424 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -60.78 105.94 0.51 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.854 0.359 . . . . 0.0 110.883 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 p -155.6 136.18 13.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.745 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.412 ' CG ' ' HA ' ' A' ' 111' ' ' PRO . 32.6 p90 -160.31 148.05 16.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.901 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 32.2 m -84.71 113.87 21.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.974 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 66.35 -94.42 0.22 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.492 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -165.78 39.91 0.06 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.927 0.394 . . . . 0.0 110.897 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -104.14 -44.7 1.57 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.741 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.402 ' N ' ' CD ' ' A' ' 111' ' ' PRO . 15.4 t -118.72 50.84 1.33 Allowed Pre-proline 0 CA--C 1.535 0.388 0 CA-C-O 120.592 0.234 . . . . 0.0 111.413 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.412 ' HA ' ' CG ' ' A' ' 105' ' ' PHE . 60.7 Cg_endo -72.14 113.54 3.72 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.281 1.987 . . . . 0.0 112.556 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.27 -168.21 3.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.881 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 88.4 m -103.66 -37.33 7.55 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.085 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.43 HG22 HD11 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -92.44 104.98 16.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.785 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.55 94.79 1.08 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.892 0.377 . . . . 0.0 111.989 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.6 t -158.41 63.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.9 m -77.13 127.74 33.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.153 0.501 . . . . 0.0 112.06 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' A' ' 97' ' ' PHE . 9.8 pt20 -138.39 139.42 25.0 Favored Pre-proline 0 C--O 1.224 -0.28 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.196 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.401 ' HA ' ' CD2' ' A' ' 97' ' ' PHE . 19.3 Cg_endo -58.26 123.32 13.36 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.059 1.84 . . . . 0.0 111.756 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.411 ' HB3' ' CG2' ' A' ' 98' ' ' THR . 1.3 pp -116.21 -34.04 4.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.67 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 60.49 109.71 0.01 OUTLIER Glycine 0 CA--C 1.523 0.579 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.501 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -79.44 152.06 23.11 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.255 1.97 . . . . 0.0 112.413 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -51.95 178.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.203 1.935 . . . . 0.0 112.118 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 27.3 p -58.69 -56.12 26.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.838 0.351 . . . . 0.0 110.967 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 30.2 mtpt -99.83 179.89 4.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.755 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 59.08 20.17 8.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.941 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.452 -179.758 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 21.1 t . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 121.178 0.513 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 11.7 p -117.14 -40.82 2.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.145 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 27.6 mmtm -88.45 -36.39 16.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.23 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 11.5 t -102.29 108.43 23.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.763 0.315 . . . . 0.0 110.734 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.54 -97.11 0.09 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.275 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.47 ' HA ' ' CD2' ' A' ' 25' ' ' LEU . 7.1 t 167.78 -36.36 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 117.851 0.296 . . . . 0.0 110.541 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.414 ' CG2' ' O ' ' B' ' 6' ' ' SER . 20.2 m . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.197 -0.906 . . . . 0.0 112.735 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.172 0 N-CA-C 112.524 -0.231 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.7 t -62.43 -32.47 73.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.822 0.344 . . . . 0.0 111.012 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -72.18 142.58 49.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.264 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -66.56 -67.85 0.42 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.563 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -98.06 -171.63 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.199 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -138.22 157.93 71.83 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-O 120.645 0.26 . . . . 0.0 111.483 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.33 127.34 18.89 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.683 2.255 . . . . 0.0 112.406 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.447 ' N ' ' CA ' ' A' ' 93' ' ' GLY . 20.4 m120 -144.23 87.29 1.88 Allowed 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.405 ' N ' HG23 ' A' ' 99' ' ' THR . 9.5 p -82.44 99.24 5.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 177.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.41 ' CG2' ' N ' ' A' ' 11' ' ' SER . 1.2 tp -161.31 -170.8 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.425 ' HA ' ' CD1' ' A' ' 90' ' ' ILE . 2.9 t -98.41 164.1 12.42 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.922 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.422 ' HB ' ' CD1' ' A' ' 89' ' ' LEU . 2.1 t -154.17 165.34 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.279 -178.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.1 ttp85 -144.75 140.04 28.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.292 0.568 . . . . 0.0 110.913 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.458 ' CD2' ' CE1' ' A' ' 24' ' ' PHE . 0.6 OUTLIER -139.07 140.99 38.2 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.323 -179.877 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.435 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 2.6 t80 -87.58 145.41 26.22 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 177.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.406 ' O ' ' N ' ' A' ' 20' ' ' GLY . 4.6 mttt -82.17 29.65 0.41 Allowed 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.824 -0.351 . . . . 0.0 111.538 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.423 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER 42.99 31.03 0.3 Allowed 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 179.377 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.435 ' HD3' ' CE1' ' A' ' 15' ' ' PHE . 0.0 OUTLIER 44.12 23.59 0.06 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.586 -178.559 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.9 m -164.75 32.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.017 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 50.47 57.64 10.19 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.81 -178.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -138.8 58.79 0.61 Allowed Glycine 0 C--N 1.332 0.356 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.8 mp -44.61 -25.15 0.24 Allowed 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.423 ' HA2' HG23 ' A' ' 41' ' ' ILE . . . 109.32 5.73 29.95 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.18 -1.009 . . . . 0.0 113.644 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.458 ' CE1' ' CD2' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -158.73 138.14 11.65 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 117.835 0.818 . . . . 0.0 112.48 -179.47 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.411 ' CD2' ' CD1' ' A' ' 41' ' ' ILE . 0.1 OUTLIER -85.04 175.53 8.97 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.594 179.608 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.4 m -146.7 160.92 9.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.924 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -141.95 111.21 6.42 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.846 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.476 ' HB3' ' CG ' ' A' ' 71' ' ' TYR . 1.7 tm-20 -106.19 113.23 26.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.101 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.509 ' HB2' ' HB2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -65.88 126.72 29.39 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.021 179.674 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 96.7 t -46.24 -26.26 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.677 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 80.0 p -154.87 89.42 1.23 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.588 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.509 ' HB2' ' HB2' ' A' ' 29' ' ' ARG . 4.5 mmtt 179.37 176.63 0.34 Allowed Pre-proline 0 N--CA 1.469 0.477 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 32' ' ' LYS . 96.1 Cg_exo -46.87 176.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 122.374 2.049 . . . . 0.0 112.696 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -38.93 168.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 123.371 2.714 . . . . 0.0 114.955 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.9 p -77.15 166.57 2.65 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.974 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.414 ' HA ' HG21 ' A' ' 58' ' ' ILE . 1.1 tp -147.07 172.25 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 119.914 -0.715 . . . . 0.0 112.658 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.42 HD12 ' CE2' ' A' ' 24' ' ' PHE . 43.5 mt -88.82 149.83 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.801 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.405 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 16.0 t -111.92 -42.72 3.72 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -175.59 139.39 0.42 Allowed 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 120.151 -0.619 . . . . 0.0 112.308 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.41 ' CD2' ' HB3' ' A' ' 24' ' ' PHE . 30.5 mt -68.83 110.24 4.27 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 178.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.464 ' CG2' ' N ' ' A' ' 42' ' ' ARG . 1.5 tp -65.67 -58.49 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 -176.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.464 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 2.0 tmt_? -93.34 -59.53 2.0 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -177.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.466 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 102.26 22.49 9.8 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.173 -177.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.412 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -125.02 -29.37 1.03 Allowed Glycine 0 C--N 1.338 0.693 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.568 -178.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.35 -83.17 0.35 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 117.855 0.827 . . . . 0.0 111.648 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.83 -62.2 1.96 Allowed 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.238 0.542 . . . . 0.0 111.285 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.466 ' HB3' ' HA2' ' A' ' 43' ' ' GLY . 4.0 tp10 -46.36 -42.2 14.58 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.776 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.412 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 0.3 OUTLIER -58.77 -39.3 80.62 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.616 178.775 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.23 -44.5 68.14 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.492 178.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.91 -26.85 16.17 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.414 -0.898 . . . . 0.0 114.463 177.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.5 pp -104.04 18.6 21.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 117.546 0.673 . . . . 0.0 111.974 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.7 mp -120.15 73.68 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.819 0.342 . . . . 0.0 110.592 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -102.67 141.34 35.65 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.98 143.43 57.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.149 0.499 . . . . 0.0 111.55 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.59 10.7 85.98 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.009 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -97.76 -88.18 0.31 Allowed 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.862 0.331 . . . . 0.0 111.098 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -163.72 121.45 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.414 HG21 ' HA ' ' A' ' 36' ' ' ILE . 2.0 tp -137.98 77.03 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 177.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.0 -62.21 1.73 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 -178.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -116.4 149.54 39.23 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.833 0.349 . . . . 0.0 111.514 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.93 143.71 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.635 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 65.18 -73.22 0.06 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.729 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.3 t0 179.61 37.29 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.945 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.435 ' O ' ' HD2' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -130.75 140.18 37.87 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-O 120.782 0.325 . . . . 0.0 111.029 179.547 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.27 82.58 2.19 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 121.548 1.498 . . . . 0.0 110.703 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.408 ' HG ' ' NH1' ' A' ' 64' ' ' ARG . 0.4 OUTLIER -77.65 68.74 3.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.77 -178.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.2 m -126.71 -59.45 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.919 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.36 26.46 3.17 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.803 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -92.58 -170.14 2.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.869 0.366 . . . . 0.0 110.66 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.3 m -73.71 108.64 6.67 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.476 ' CG ' ' HB3' ' A' ' 28' ' ' GLU . 3.0 t80 -42.57 -55.84 3.34 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -62.93 -27.77 69.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.242 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.4 t -75.32 -39.33 59.59 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.47 -49.49 75.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.945 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.41 HD12 ' CE1' ' A' ' 71' ' ' TYR . 27.2 mt -63.14 -30.68 71.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.916 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -72.78 -38.58 67.22 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.716 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 65.1 t -58.97 -42.83 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.402 ' CD2' ' NH2' ' A' ' 64' ' ' ARG . 0.4 OUTLIER -78.7 -29.92 45.75 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.117 179.185 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -37.91 79.81 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.773 0.32 . . . . 0.0 110.975 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -59.59 -22.32 56.47 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.743 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 49.9 mt -58.23 116.74 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 120.927 0.394 . . . . 0.0 111.041 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.78 -167.18 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.44 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.9 m -96.83 -170.38 2.04 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.093 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 44.25 31.06 0.52 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.13 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.411 ' O ' ' CD1' ' A' ' 15' ' ' PHE . 1.7 t -130.12 162.35 29.01 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.815 0.817 . . . . 0.0 112.804 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -103.41 176.2 5.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.4 -1.273 . . . . 0.0 109.808 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.407 ' N ' ' O ' ' A' ' 14' ' ' LEU . 0.4 OUTLIER -144.9 172.37 5.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.929 0.395 . . . . 0.0 111.305 -179.366 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.8 t -122.73 158.13 27.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.748 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.422 ' CD1' ' HB ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -151.32 147.33 26.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.845 0.355 . . . . 0.0 110.427 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.425 ' CD1' ' HA ' ' A' ' 11' ' ' SER . 41.0 mm -126.36 122.89 62.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.998 0.428 . . . . 0.0 111.465 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.0 mt -107.23 165.29 11.48 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.242 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.408 ' CD ' ' N ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -109.77 163.33 13.61 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.395 0.617 . . . . 0.0 112.532 -178.466 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.447 ' CA ' ' N ' ' A' ' 8' ' ' ASN . . . -164.26 -136.88 2.07 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.595 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -93.73 -164.67 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.997 2.465 . . . . 0.0 112.101 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -129.06 132.13 47.41 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.709 0.29 . . . . 0.0 110.609 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.14 5.09 59.63 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.686 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.418 ' N ' HD22 ' A' ' 120' ' ' LEU . 26.6 m-85 -139.92 127.19 21.23 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 117.537 0.669 . . . . 0.0 112.178 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.412 HG23 HD23 ' A' ' 120' ' ' LEU . 0.1 OUTLIER -79.35 120.76 24.25 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.175 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.427 HG22 ' HB3' ' A' ' 8' ' ' ASN . 8.0 t -107.65 92.27 4.0 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.09 0.471 . . . . 0.0 110.634 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -77.78 -163.76 0.44 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.789 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.4 pp -131.93 121.02 23.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.866 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -175.43 67.66 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.88 0.371 . . . . 0.0 111.619 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -169.7 -175.48 2.13 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.079 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.09 138.84 33.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.56 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.41 ' HB2' ' HA2' ' A' ' 109' ' ' GLY . 35.2 p90 -87.43 150.78 23.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.914 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 98.5 m -136.68 -52.45 0.7 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.003 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.82 66.77 0.63 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.841 -0.695 . . . . 0.0 113.041 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 54.96 30.92 14.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.667 0.27 . . . . 0.0 111.548 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.41 ' HA2' ' HB2' ' A' ' 105' ' ' PHE . . . 88.74 39.3 6.66 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.659 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.474 ' CG2' ' HD3' ' A' ' 111' ' ' PRO . 0.6 OUTLIER -90.28 -44.27 0.4 Allowed Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -179.192 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.474 ' HD3' ' CG2' ' A' ' 110' ' ' THR . 12.4 Cg_exo -72.23 -38.34 3.8 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.276 1.984 . . . . 0.0 110.604 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.7 tptp 70.76 131.19 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.847 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 88.7 m -53.88 -43.76 69.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.233 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.445 HG22 HD11 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -90.82 95.04 5.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.271 0.558 . . . . 0.0 110.14 179.197 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.79 94.08 1.73 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.5 t -156.21 64.12 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.959 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.56 128.89 34.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.833 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.61 135.1 13.56 Favored Pre-proline 0 C--O 1.22 -0.489 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.371 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.406 ' HD3' ' CE2' ' A' ' 97' ' ' PHE . 14.0 Cg_endo -56.03 133.71 59.73 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 121.9 1.733 . . . . 0.0 112.54 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.418 HD22 ' N ' ' A' ' 97' ' ' PHE . 0.2 OUTLIER -76.39 -72.4 0.33 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.137 0.494 . . . . 0.0 110.118 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 104.98 97.52 2.49 Favored Glycine 0 CA--C 1.522 0.481 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.187 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -46.16 161.74 0.15 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.619 2.213 . . . . 0.0 112.936 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -65.23 174.61 4.82 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.359 2.04 . . . . 0.0 112.601 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.8 t -154.2 118.2 4.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.712 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.6 ttmt 61.63 42.99 10.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.048 0.451 . . . . 0.0 110.847 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.35 -13.96 61.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.376 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.114 179.983 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 12.3 p . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.817 0.341 . . . . 0.0 111.002 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 11.8 p -150.61 50.18 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.012 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.417 ' CE ' ' HA ' ' A' ' 29' ' ' ARG . 3.1 mmtm -142.8 -61.66 0.43 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.689 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 3.5 t -57.72 137.5 19.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.947 0.403 . . . . 0.0 111.59 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -123.79 102.08 7.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.645 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.404 ' HA ' ' CD2' ' A' ' 25' ' ' LEU . 12.9 p -61.05 134.82 57.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.959 0.409 . . . . 0.0 110.728 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 14.6 m . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.142 -0.932 . . . . 0.0 111.149 -179.339 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 112.668 -0.173 . . . . 0.0 112.668 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -147.54 39.14 0.96 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.886 0.374 . . . . 0.0 110.659 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -166.44 81.26 0.26 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.178 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 6.3 ttt -109.62 79.36 1.21 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.672 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.6 tt -147.59 33.86 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.146 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.65 -63.7 0.01 OUTLIER Pre-proline 0 N--CA 1.469 0.497 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -50.92 113.41 1.07 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.775 2.317 . . . . 0.0 113.474 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.414 ' N ' ' HA3' ' A' ' 93' ' ' GLY . 0.9 OUTLIER 177.32 94.08 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.744 179.388 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 92' ' ' ARG . 14.7 p -79.77 109.47 14.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.453 ' CG2' ' N ' ' A' ' 11' ' ' SER . 1.0 OUTLIER -163.32 -166.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.101 179.161 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.453 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 56.1 p -84.6 165.27 18.13 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.652 0.739 . . . . 0.0 111.957 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.435 ' N ' ' O ' ' A' ' 89' ' ' LEU . 1.7 t -156.72 156.15 4.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.748 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -140.4 140.38 35.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.595 0.712 . . . . 0.0 111.154 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -141.88 177.77 7.96 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.833 -179.624 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.453 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 2.6 t80 -122.98 149.82 43.79 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.403 ' O ' ' N ' ' A' ' 20' ' ' GLY . 2.2 mttt -84.2 29.39 0.57 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.738 178.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.41 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER 41.96 31.77 0.25 Allowed 'General case' 0 C--N 1.345 0.378 0 C-N-CA 123.006 0.522 . . . . 0.0 111.853 179.593 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.453 ' HD3' ' CE1' ' A' ' 15' ' ' PHE . 0.0 OUTLIER 44.05 24.16 0.07 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.529 -178.508 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.0 m -164.16 31.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.185 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 50.45 65.57 2.9 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.616 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -151.62 68.26 0.32 Allowed Glycine 0 C--N 1.331 0.273 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.2 mp -52.22 -22.2 4.13 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.409 ' HA2' HG23 ' A' ' 41' ' ' ILE . . . 107.3 11.56 25.33 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.152 -1.023 . . . . 0.0 113.829 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -159.7 141.73 13.27 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 118.008 0.904 . . . . 0.0 113.382 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.423 HD22 HD12 ' A' ' 41' ' ' ILE . 11.5 mt -79.61 172.83 13.25 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.435 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.2 m -153.23 148.97 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.242 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -135.38 106.27 6.61 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.393 -179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.451 ' HB3' ' CD1' ' A' ' 71' ' ' TYR . 7.0 tm-20 -103.54 111.42 23.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.805 178.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.447 ' CB ' ' HB2' ' A' ' 32' ' ' LYS . 1.9 mtt180 -70.62 116.55 11.08 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 121.092 0.472 . . . . 0.0 110.43 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.6 t -44.9 -24.69 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.609 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 t -145.22 73.58 1.37 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.368 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.461 ' HB3' ' HD2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -177.19 176.86 0.48 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.31 -178.631 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.461 ' HD2' ' HB3' ' A' ' 32' ' ' LYS . 82.6 Cg_exo -44.8 172.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.416 2.077 . . . . 0.0 113.364 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -43.96 174.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.081 2.521 . . . . 0.0 114.157 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.416 HG21 ' N ' ' A' ' 36' ' ' ILE . 8.1 p -78.41 152.1 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.079 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.44 ' HA ' HG21 ' A' ' 58' ' ' ILE . 1.2 tp -133.88 163.65 36.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.597 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.456 HG23 HD11 ' A' ' 37' ' ' ILE . 35.9 mt -82.74 145.88 7.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.64 0.257 . . . . 0.0 110.925 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.41 ' CB ' ' CG1' ' B' ' 4' ' ' VAL . 6.3 t -109.55 -38.2 5.5 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -170.54 135.35 1.18 Allowed 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.364 -0.534 . . . . 0.0 112.18 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.4 mt -71.93 84.08 0.95 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.698 0.761 . . . . 0.0 109.781 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.458 ' CG2' ' N ' ' A' ' 42' ' ' ARG . 0.8 OUTLIER -39.91 -59.13 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 114.922 1.452 . . . . 0.0 114.922 -177.515 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.458 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -93.53 -64.78 1.05 Allowed 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -177.632 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 104.41 23.56 7.93 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -177.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.405 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -126.06 -32.37 0.74 Allowed Glycine 0 C--N 1.338 0.666 0 C-N-CA 121.283 -0.484 . . . . 0.0 113.085 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.03 -83.13 0.34 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 117.732 0.766 . . . . 0.0 111.435 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.14 -57.92 10.72 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.232 0.539 . . . . 0.0 111.161 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -48.26 -47.54 36.03 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.871 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.405 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -57.31 -32.97 67.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.09 178.903 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.55 -52.21 66.34 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.89 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 113.75 -30.73 6.99 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.154 -1.022 . . . . 0.0 114.096 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 pp -95.75 -1.47 49.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.291 0.545 . . . . 0.0 111.571 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.406 HD11 ' N ' ' A' ' 52' ' ' ILE . 4.9 mp -105.27 118.36 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-O 120.953 0.406 . . . . 0.0 110.217 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -144.44 162.51 36.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.293 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.81 126.72 30.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.857 0.361 . . . . 0.0 110.787 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.42 11.97 72.51 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.932 -178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.13 -83.95 0.24 Allowed 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 19.7 mt -155.94 125.72 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.44 HG21 ' HA ' ' A' ' 36' ' ' ILE . 5.8 tp -160.42 70.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.596 177.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.413 ' HG ' ' N ' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -78.04 -47.79 17.59 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 122.087 -0.383 . . . . 0.0 111.315 -178.418 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.413 ' N ' ' HG ' ' A' ' 59' ' ' LEU . . . -121.89 150.21 42.3 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.834 0.35 . . . . 0.0 111.368 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.432 ' O ' ' N ' ' A' ' 63' ' ' ASP . 3.0 t -140.33 144.86 26.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.172 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER 53.84 -82.59 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.025 0.53 . . . . 0.0 110.902 -179.118 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 61' ' ' VAL . 2.0 p30 -165.56 33.69 0.05 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.084 0.469 . . . . 0.0 110.272 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.408 ' NH2' ' CD2' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -126.64 105.5 23.61 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.779 179.653 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -58.93 87.4 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 121.701 1.601 . . . . 0.0 110.526 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 29.8 tp -86.44 66.04 9.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.431 0.634 . . . . 0.0 111.397 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.7 m -110.67 -44.28 5.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.027 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.5 p30 -140.24 24.52 2.31 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.513 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.87 174.32 6.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.772 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.46 121.76 14.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.317 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.451 ' CD1' ' HB3' ' A' ' 28' ' ' GLU . 3.7 t80 -54.93 -61.0 2.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.524 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -56.67 -32.76 65.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.237 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.6 m -70.95 -46.35 62.56 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.65 -45.01 77.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.171 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.422 HD13 ' CE1' ' A' ' 71' ' ' TYR . 14.7 mt -64.87 -29.71 70.67 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.15 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -72.34 -36.13 68.73 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.002 0.429 . . . . 0.0 110.017 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.4 t -61.0 -46.04 97.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.524 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.408 ' CD2' ' NH2' ' A' ' 64' ' ' ARG . 1.6 pp -79.12 -27.06 42.83 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.408 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -49.21 77.28 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 121.023 0.439 . . . . 0.0 110.776 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.35 -22.61 15.79 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.997 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 57.1 mt -56.32 118.75 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 120.9 0.381 . . . . 0.0 111.097 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.75 -165.93 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.421 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.2 m -95.47 -169.42 1.96 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.244 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 41.17 32.6 0.2 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.398 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.418 ' O ' ' CE1' ' A' ' 15' ' ' PHE . 1.5 t -125.29 159.95 30.47 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 122.013 0.911 . . . . 0.0 112.775 -178.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.64 176.63 5.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.13 -1.395 . . . . 0.0 109.921 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.424 ' N ' ' O ' ' A' ' 14' ' ' LEU . 4.2 p -149.71 151.78 12.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.541 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.419 ' O ' ' N ' ' A' ' 62' ' ' ASN . 10.7 t -109.61 163.79 6.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.9 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -159.04 164.38 35.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.674 0.273 . . . . 0.0 110.393 -179.723 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.414 HG22 HD11 ' A' ' 90' ' ' ILE . 33.0 mm -135.64 125.5 41.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 9' ' ' VAL . 10.9 mt -93.43 169.95 9.98 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 177.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -148.83 144.02 26.68 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -179.104 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.414 ' HA3' ' N ' ' A' ' 8' ' ' ASN . . . -157.0 -107.92 0.26 Allowed Glycine 0 CA--C 1.523 0.569 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.076 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -93.29 -167.05 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.876 2.384 . . . . 0.0 112.471 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -143.54 131.03 21.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.581 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 118.23 7.83 10.91 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.867 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' A' ' 118' ' ' GLN . 16.3 m-85 -136.21 144.37 44.87 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 117.315 0.558 . . . . 0.0 111.766 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 117' ' ' THR . 0.1 OUTLIER -93.07 114.24 26.72 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.886 179.719 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 54.3 p -78.84 93.55 5.02 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.94 149.25 28.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.283 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.413 ' N ' ' CD1' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -54.55 -171.64 0.0 OUTLIER 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.738 -179.66 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 80.34 34.03 0.15 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.999 -178.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 38.0 m -76.92 107.15 9.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.843 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 34.3 m -86.86 4.13 42.57 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 7.2 p90 41.88 75.59 0.09 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.953 0.501 . . . . 0.0 112.275 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 51.7 m -129.11 -95.59 0.4 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.146 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 43.03 -94.07 0.01 OUTLIER Glycine 0 C--N 1.345 1.045 0 C-N-CA 121.464 -0.398 . . . . 0.0 113.575 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -153.62 30.62 0.47 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.832 0.349 . . . . 0.0 110.518 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 114.97 58.09 0.36 Allowed Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.268 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.1 t -118.26 50.3 1.15 Allowed Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -72.53 89.32 0.84 Allowed 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.223 1.949 . . . . 0.0 112.14 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.76 172.65 12.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.091 0.472 . . . . 0.0 111.443 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.9 m -104.01 -10.89 17.74 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.488 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.428 HG12 ' N ' ' A' ' 115' ' ' ARG . 0.0 OUTLIER -76.61 158.21 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.723 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.428 ' N ' HG12 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -75.26 141.27 43.5 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.492 0.663 . . . . 0.0 112.774 -177.183 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.9 t -78.19 135.02 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.156 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 99' ' ' THR . 0.6 OUTLIER -81.45 140.46 34.62 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.519 -179.402 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.446 ' O ' ' HA ' ' A' ' 97' ' ' PHE . 1.6 pp0? -123.97 141.29 36.61 Favored Pre-proline 0 C--O 1.222 -0.363 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.334 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -44.33 107.99 0.11 Allowed 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.74 2.293 . . . . 0.0 112.447 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.57 -40.04 3.45 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.472 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.29 117.15 0.09 OUTLIER Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.259 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.43 160.73 4.68 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.264 1.976 . . . . 0.0 112.331 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.36 160.1 39.32 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.408 2.072 . . . . 0.0 112.512 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.4 t -172.21 161.98 5.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.851 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.4 ttpp -121.79 35.39 4.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.885 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -94.08 19.14 9.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.028 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.7 t . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.134 -179.84 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.921 0.391 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 14.3 p -174.71 37.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.88 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.441 ' CE ' ' HA ' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -116.31 -38.06 3.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.197 -179.773 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.41 ' CG1' ' CB ' ' A' ' 38' ' ' SER . 15.3 t -79.56 111.75 16.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.783 0.325 . . . . 0.0 110.454 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.98 -104.65 0.09 Allowed 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.169 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 6.7 t 163.3 105.63 0.0 OUTLIER 'General case' 0 C--N 1.346 0.438 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 m . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.305 -179.173 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.9 t -174.58 -48.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.968 0.413 . . . . 0.0 110.81 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 25.0 m80 -147.36 147.53 30.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.788 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 36.7 mtt -95.86 -76.55 0.5 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.504 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.409 ' CG2' ' N ' ' A' ' 6' ' ' GLU . 0.3 OUTLIER -81.03 -158.15 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.159 179.802 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.409 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 5.6 mt-10 -167.42 157.78 9.74 Favored Pre-proline 0 CA--C 1.535 0.373 0 O-C-N 122.318 -0.239 . . . . 0.0 111.506 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.95 -162.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.661 2.241 . . . . 0.0 112.863 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.7 m120 63.07 85.96 0.12 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.725 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.429 ' CG2' ' CG2' ' A' ' 90' ' ' ILE . 4.4 p -80.97 123.5 37.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.421 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.1 tp -88.08 160.28 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.116 -178.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.2 p -105.23 159.92 15.5 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.954 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.423 ' CG2' ' HB2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -134.15 102.96 4.61 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.318 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.542 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.0 ttp85 -79.47 106.17 11.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.49 0.662 . . . . 0.0 112.26 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.424 ' HB2' ' CD1' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -116.62 177.23 4.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.604 178.612 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.44 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 2.4 t80 -117.03 151.25 37.16 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.41 ' O ' ' N ' ' A' ' 20' ' ' GLY . 0.8 OUTLIER -85.67 27.27 0.86 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.179 178.691 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.417 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 0.2 OUTLIER 45.48 29.73 0.64 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 179.257 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.44 ' HD3' ' CE1' ' A' ' 15' ' ' PHE . 0.0 OUTLIER 43.13 24.92 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.101 0.56 . . . . 0.0 112.421 -178.431 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.4 ' CG1' ' O ' ' A' ' 18' ' ' LYS . 15.0 m -166.53 32.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 123.948 0.899 . . . . 0.0 108.857 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 48.01 62.55 4.14 Favored Glycine 0 C--N 1.34 0.768 0 CA-C-N 115.818 -0.628 . . . . 0.0 113.154 -178.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -147.9 60.2 0.46 Allowed Glycine 0 C--N 1.333 0.412 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 mp -41.02 -26.63 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.47 1.83 12.11 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.11 -1.043 . . . . 0.0 113.469 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.431 ' CD1' HG22 ' A' ' 52' ' ' ILE . 0.9 OUTLIER -156.94 140.2 15.59 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 117.766 0.783 . . . . 0.0 112.665 -179.561 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.41 ' CD2' ' CD1' ' A' ' 41' ' ' ILE . 0.7 OUTLIER -79.15 171.06 15.71 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.954 179.047 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.7 m -150.8 154.12 9.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.037 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.6 ptmm? -135.79 107.74 7.12 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.275 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.467 ' HB3' ' CG ' ' A' ' 71' ' ' TYR . 3.0 tm-20 -97.41 108.54 21.28 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.455 ' CB ' ' HB2' ' A' ' 32' ' ' LYS . 1.1 mtt180 -59.99 111.6 1.55 Allowed 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 121.104 0.478 . . . . 0.0 110.409 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.1 t -49.85 -22.15 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.839 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.5 t -150.03 69.43 1.01 Allowed 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.516 -0.474 . . . . 0.0 109.983 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.485 ' HB3' ' HD2' ' A' ' 33' ' ' PRO . 0.8 OUTLIER -177.21 -179.12 0.31 Allowed Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.95 -178.0 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 32' ' ' LYS . 77.5 Cg_exo -45.95 175.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.549 2.166 . . . . 0.0 113.816 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 67' ' ' VAL . 79.9 Cg_exo -44.05 175.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 123.387 2.725 . . . . 0.0 114.862 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.5 p -78.47 159.92 4.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.291 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.408 ' HA ' HG21 ' A' ' 58' ' ' ILE . 1.0 OUTLIER -144.29 164.59 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.492 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.443 HD11 HG22 ' A' ' 37' ' ' ILE . 39.3 mt -84.89 149.0 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.94 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.14 -38.6 3.34 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -172.69 135.8 0.69 Allowed 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 119.972 -0.691 . . . . 0.0 112.679 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.414 ' CD2' ' HB3' ' A' ' 24' ' ' PHE . 47.8 mt -67.09 113.6 5.19 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.458 ' CG2' ' N ' ' A' ' 42' ' ' ARG . 2.0 tp -73.49 -55.86 11.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -175.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.458 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 10.9 ttt85 -93.38 -64.84 1.04 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.074 0.464 . . . . 0.0 112.104 -177.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.412 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 105.31 21.19 9.01 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.376 -178.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.407 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -125.85 -30.86 0.85 Allowed Glycine 0 C--N 1.336 0.551 0 C-N-CA 121.072 -0.585 . . . . 0.0 113.206 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.73 -82.66 0.36 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 117.583 0.692 . . . . 0.0 111.302 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.24 -57.38 13.29 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.148 0.499 . . . . 0.0 111.402 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.412 ' HB3' ' HA2' ' A' ' 43' ' ' GLY . 51.2 tt0 -49.85 -45.87 50.8 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.751 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.407 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 1.0 OUTLIER -55.83 -35.29 66.22 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.003 178.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.4 t -58.48 -49.34 77.68 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.63 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.75 -19.14 36.44 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.31 -0.947 . . . . 0.0 113.921 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 pp -96.52 -26.63 15.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.154 0.477 . . . . 0.0 110.814 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.431 HG22 ' CD1' ' A' ' 24' ' ' PHE . 5.0 mp -80.8 98.64 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-O 120.958 0.409 . . . . 0.0 110.42 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -124.53 149.26 47.13 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.646 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.402 ' HA ' ' CG2' ' A' ' 37' ' ' ILE . . . -67.63 128.67 37.32 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.987 0.423 . . . . 0.0 111.273 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.74 2.15 90.62 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.388 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -84.21 -89.1 0.1 Allowed 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.985 0.392 . . . . 0.0 110.902 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.3 tp -163.12 126.32 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.408 HG21 ' HA ' ' A' ' 36' ' ' ILE . 2.7 tp -146.6 90.02 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.4 tp -78.49 -67.09 0.77 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.407 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -128.4 149.78 50.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.16 0.505 . . . . 0.0 112.111 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.427 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 18.8 t -125.97 144.79 34.87 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.893 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.427 ' ND2' ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER 44.2 29.24 0.34 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 120.964 0.411 . . . . 0.0 111.768 -178.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.6 t70 74.02 26.91 1.66 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.403 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.99 102.71 18.61 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.014 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -61.09 82.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 121.946 1.764 . . . . 0.0 111.736 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.82 64.67 8.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.403 0.62 . . . . 0.0 110.284 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 3.1 m -125.97 -52.63 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.536 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -133.33 24.48 4.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.897 0.38 . . . . 0.0 110.992 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.63 175.23 5.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.313 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.05 102.21 0.78 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.467 ' CG ' ' HB3' ' A' ' 28' ' ' GLU . 8.5 t80 -43.87 -54.75 5.03 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.971 0.415 . . . . 0.0 111.977 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -60.86 -33.73 73.52 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.931 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.1 t -72.64 -43.89 62.61 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.4 -45.61 91.01 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.405 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.438 HD12 ' CZ ' ' A' ' 71' ' ' TYR . 56.0 mt -65.76 -30.21 70.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.271 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -74.01 -42.7 59.95 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.727 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.5 t -60.45 -35.0 60.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.276 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.1 pp -88.42 -22.49 23.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.942 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.1 -39.59 95.14 Favored 'General case' 0 C--N 1.339 0.12 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -55.35 -21.38 26.45 Favored Glycine 0 CA--C 1.522 0.514 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.946 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.4 HG22 HD11 ' A' ' 81' ' ' ILE . 79.0 mt -54.72 108.49 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-O 120.797 0.332 . . . . 0.0 110.733 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.89 -168.3 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.454 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.46 -172.22 2.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.024 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 44.01 31.25 0.5 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.26 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.408 ' O ' ' CE1' ' A' ' 15' ' ' PHE . 1.7 t -124.35 160.94 26.98 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.984 0.897 . . . . 0.0 112.747 -178.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.72 176.7 5.54 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.18 -1.373 . . . . 0.0 110.335 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.415 ' CG2' ' OD1' ' A' ' 62' ' ' ASN . 2.6 p -145.41 157.36 13.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.507 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.7 t -133.27 99.26 3.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.447 0.641 . . . . 0.0 111.626 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.446 ' O ' HD12 ' A' ' 90' ' ' ILE . 6.4 mp -80.71 175.84 10.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.946 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.446 HD12 ' O ' ' A' ' 89' ' ' LEU . 36.2 mm -140.32 125.07 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.802 178.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 49.0 mt -130.29 176.77 7.85 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.716 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.95 175.09 9.15 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.749 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 162.83 154.14 7.49 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.082 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -57.1 -168.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.329 2.019 . . . . 0.0 112.317 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -128.36 152.65 47.92 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.846 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.418 ' O ' ' CD1' ' A' ' 97' ' ' PHE . . . 73.62 16.43 79.09 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.969 -178.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.45 ' HB2' ' CG2' ' A' ' 117' ' ' THR . 69.1 m-85 -156.97 142.12 17.21 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.67 111.81 20.43 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.6 t -90.37 93.51 9.35 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.857 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -62.26 -96.11 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.588 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.404 ' HA ' HG12 ' A' ' 114' ' ' ILE . 0.5 OUTLIER -173.88 120.3 0.29 Allowed 'General case' 0 C--N 1.343 0.3 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -179.762 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 169.65 170.97 0.05 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.562 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 69.72 174.84 0.29 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.252 0.548 . . . . 0.0 111.416 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 29.6 p -118.41 -160.27 0.79 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.571 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -135.97 164.08 28.8 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.264 0.554 . . . . 0.0 111.878 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -171.86 150.35 2.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.733 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.4 54.22 4.78 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.211 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.4 t0 73.85 27.84 1.63 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.864 0.364 . . . . 0.0 111.631 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 62.99 60.67 7.31 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.938 -0.648 . . . . 0.0 113.489 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.536 ' CG2' ' HD3' ' A' ' 111' ' ' PRO . 1.5 t -92.31 -41.94 0.36 Allowed Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.536 ' HD3' ' CG2' ' A' ' 110' ' ' THR . 5.5 Cg_exo -75.83 -46.44 0.2 Allowed 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.289 1.993 . . . . 0.0 110.583 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.2 tppt? 80.6 137.01 0.06 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.921 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 61.1 m -47.49 -35.3 8.54 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.649 0.738 . . . . 0.0 110.154 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.424 HD11 HG22 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -97.55 92.95 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.066 177.801 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 13.0 ttt180 -144.8 100.77 3.56 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.335 0.588 . . . . 0.0 111.887 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.8 t -154.54 66.49 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.45 ' CG2' ' HB2' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -76.66 122.23 24.38 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.845 -1.07 . . . . 0.0 113.119 -175.904 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.95 131.17 24.38 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.734 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -44.68 131.31 9.96 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.385 2.057 . . . . 0.0 113.866 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -88.97 -66.0 0.96 Allowed 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -124.03 -124.33 2.87 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.936 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -87.38 139.1 4.92 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.533 2.155 . . . . 0.0 112.27 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.53 57.16 6.39 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.381 2.054 . . . . 0.0 112.331 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.08 88.95 1.62 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.049 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.04 177.73 4.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.959 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 61.16 17.91 8.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.115 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.3 m . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.237 -0.887 . . . . 0.0 111.056 179.842 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 9.6 m . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 121.184 0.516 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 14.6 p -99.49 -32.01 3.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.315 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.453 ' CE ' ' HA ' ' A' ' 29' ' ' ARG . 1.6 mmtp -87.27 -57.26 3.02 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.002 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 21.2 t -64.93 100.42 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.006 0.432 . . . . 0.0 110.992 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.35 116.56 29.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.788 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.406 ' HA ' ' CD2' ' A' ' 25' ' ' LEU . 9.4 p -71.49 121.07 18.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.083 0.468 . . . . 0.0 110.382 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 30.9 m . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.406 -178.692 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.13 0 N-CA-C 112.633 -0.187 . . . . 0.0 112.633 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 76.6 p -141.32 87.77 2.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.787 0.327 . . . . 0.0 110.563 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.67 125.3 37.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.023 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -172.71 -44.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.938 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.3 tt -55.69 161.68 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.802 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -148.18 69.64 10.74 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-O 120.604 0.24 . . . . 0.0 111.389 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -93.77 -164.54 0.11 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.079 2.519 . . . . 0.0 113.006 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -144.87 -64.5 0.34 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.6 t -156.33 74.45 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.105 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.461 HD11 HG23 ' A' ' 99' ' ' THR . 0.5 OUTLIER -95.11 158.37 2.98 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.221 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.783 -178.141 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.44 ' HA ' ' CD1' ' A' ' 90' ' ' ILE . 20.0 m -92.25 156.13 17.5 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.405 HG23 ' CD2' ' A' ' 91' ' ' LEU . 2.5 t -149.84 157.61 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.618 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.6 tpp180 -145.54 121.9 10.95 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.516 0.674 . . . . 0.0 110.57 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 87' ' ' VAL . 0.1 OUTLIER -123.71 178.34 5.27 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.555 -179.668 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.413 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 2.7 t80 -115.69 151.95 34.1 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.562 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -86.21 30.12 0.71 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 121.009 -0.277 . . . . 0.0 110.803 178.327 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.443 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 0.1 OUTLIER 42.68 30.67 0.24 Allowed 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 179.518 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER 43.72 24.47 0.07 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.342 -178.358 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.1 m -166.33 32.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 123.942 0.897 . . . . 0.0 109.086 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 49.83 68.64 1.31 Allowed Glycine 0 C--N 1.338 0.655 0 CA-C-N 115.824 -0.625 . . . . 0.0 113.049 -178.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -154.51 67.23 0.31 Allowed Glycine 0 C--N 1.333 0.4 0 N-CA-C 111.686 -0.566 . . . . 0.0 111.686 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.402 ' O ' ' CB ' ' A' ' 45' ' ' ALA . 4.4 mp -48.18 -23.36 0.84 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.64 5.25 24.3 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.711 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.416 ' CD1' HG22 ' A' ' 52' ' ' ILE . 0.9 OUTLIER -154.38 144.45 21.91 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 118.201 1.001 . . . . 0.0 113.322 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.0 mt -78.7 173.36 12.53 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.868 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.4 m -153.52 141.34 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-O 121.313 0.577 . . . . 0.0 111.602 177.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.415 ' CG ' HG21 ' A' ' 36' ' ' ILE . 6.2 ptmt -122.07 104.83 9.77 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.707 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.487 ' HB3' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -102.28 115.76 31.23 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.413 0.625 . . . . 0.0 110.887 179.495 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.52 ' HD3' ' N ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -51.85 129.39 26.51 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.206 178.191 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 t -44.15 -30.85 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.201 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.411 ' O ' ' CG ' ' A' ' 32' ' ' LYS . 1.1 m 173.17 62.34 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.597 ' CB ' ' CD ' ' A' ' 33' ' ' PRO . 5.7 mttm -160.03 -93.21 0.0 OUTLIER Pre-proline 0 CA--C 1.562 1.429 0 O-C-N 121.603 -0.685 . . . . 0.0 112.684 178.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.597 ' CD ' ' CB ' ' A' ' 32' ' ' LYS . 49.6 Cg_endo -67.18 -165.82 0.11 Allowed 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 122.063 1.842 . . . . 0.0 111.918 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.566 ' CD ' ' HB2' ' A' ' 33' ' ' PRO . 38.2 Cg_endo -95.06 170.19 1.47 Allowed 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.1 1.867 . . . . 0.0 110.593 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.422 ' HB ' ' CG ' ' A' ' 28' ' ' GLU . 6.1 p -78.87 149.8 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.432 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.415 HG21 ' CG ' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -143.51 166.53 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 120.253 -0.579 . . . . 0.0 112.361 -179.551 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.492 HG22 HD11 ' A' ' 37' ' ' ILE . 20.7 mt -85.15 141.62 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.729 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.409 ' CB ' ' CG1' ' B' ' 4' ' ' VAL . 4.6 t -105.78 -37.83 6.58 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -169.42 135.09 1.55 Allowed 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 118.338 0.517 . . . . 0.0 111.66 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 39.6 mt -70.12 76.84 0.51 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.779 0.8 . . . . 0.0 110.444 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.446 ' CG2' ' N ' ' A' ' 42' ' ' ARG . 0.4 OUTLIER -32.94 -58.68 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -178.51 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.446 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.4 OUTLIER -94.23 -68.49 0.8 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.211 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.07 2.48 33.89 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.022 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -108.57 -26.39 5.37 Favored Glycine 0 C--N 1.34 0.753 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.42 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.402 ' CB ' ' O ' ' A' ' 22' ' ' LEU . . . -95.08 -82.13 0.38 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.86 0.33 . . . . 0.0 110.901 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.53 -63.85 1.06 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.077 0.465 . . . . 0.0 111.648 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -45.38 -43.0 10.73 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.241 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' A' ' 44' ' ' GLY . 21.8 mm-40 -59.34 -39.19 82.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.977 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.0 -44.76 74.8 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.959 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.06 -22.83 37.44 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.334 -0.936 . . . . 0.0 113.275 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.404 ' CD2' ' CG2' ' A' ' 113' ' ' THR . 3.6 pp -93.15 -13.78 28.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.882 0.341 . . . . 0.0 110.837 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.416 HG22 ' CD1' ' A' ' 24' ' ' PHE . 4.9 mp -96.35 147.67 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.14 154.11 1.72 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.979 0.419 . . . . 0.0 111.26 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.409 ' HA ' ' CG2' ' A' ' 37' ' ' ILE . . . -69.45 123.97 22.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.86 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.29 5.54 81.79 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.132 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.81 -86.35 0.12 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.907 0.353 . . . . 0.0 111.025 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -162.55 119.89 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.207 0.527 . . . . 0.0 111.794 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.454 ' O ' HG22 ' A' ' 58' ' ' ILE . 1.5 tp -146.96 80.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 177.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.7 tp -77.84 -66.59 0.82 Allowed 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.782 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -115.24 151.75 33.93 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.97 0.414 . . . . 0.0 111.051 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.3 p -152.61 146.32 15.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.269 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 46.05 40.5 7.14 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.17 0.51 . . . . 0.0 111.336 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.6 t70 58.87 28.44 17.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.07 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -113.73 101.43 53.79 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.672 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -62.32 85.39 0.1 Allowed 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 121.662 1.574 . . . . 0.0 111.072 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.13 63.85 7.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.663 0.744 . . . . 0.0 110.346 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.9 m -124.84 -46.52 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.069 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.418 ' HA ' ' NH2' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -137.65 25.74 2.84 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.444 179.504 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.66 170.69 7.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.904 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.1 119.48 9.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.501 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.487 ' CG ' ' HB3' ' A' ' 28' ' ' GLU . 2.0 t80 -57.32 -47.5 81.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.416 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.48 -30.6 68.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.939 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.6 t -72.8 -42.77 63.54 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.58 -41.13 72.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.195 0.522 . . . . 0.0 110.754 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.429 HD13 ' CE1' ' A' ' 71' ' ' TYR . 70.7 mt -71.62 -35.37 70.42 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.82 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -74.58 -42.1 59.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.925 0.393 . . . . 0.0 110.515 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.7 t -61.94 -36.18 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.031 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.0 pp -85.92 -21.69 27.81 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.42 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.14 -36.48 79.75 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.492 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -55.39 -21.15 25.82 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.021 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.434 HG22 HD11 ' A' ' 81' ' ' ILE . 57.5 mt -56.68 109.74 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-O 120.882 0.372 . . . . 0.0 110.915 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.87 -162.55 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.415 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.2 m -97.25 -174.3 2.91 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 120.788 0.328 . . . . 0.0 111.127 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 44.6 31.44 0.63 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.078 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.7 t -121.28 161.13 22.53 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.847 0.832 . . . . 0.0 112.578 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -101.82 176.62 5.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.405 -1.271 . . . . 0.0 110.312 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.435 ' N ' ' O ' ' A' ' 14' ' ' LEU . 2.5 p -149.23 149.47 14.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.676 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.6 t -108.15 158.99 7.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.076 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.92 161.39 41.43 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.741 0.305 . . . . 0.0 110.985 -178.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.44 ' CD1' ' HA ' ' A' ' 11' ' ' SER . 43.6 mm -133.14 128.14 55.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.963 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.405 ' CD2' HG23 ' A' ' 12' ' ' VAL . 3.7 mt -97.65 169.9 9.38 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.11 175.07 10.56 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.022 -0.671 . . . . 0.0 112.657 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 167.05 -127.78 1.63 Allowed Glycine 0 CA--C 1.522 0.515 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.16 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -57.07 -157.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.201 1.934 . . . . 0.0 112.486 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -153.68 137.32 16.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.46 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 127.73 7.7 4.59 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.184 -1.007 . . . . 0.0 113.73 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.423 ' CB ' ' OG1' ' A' ' 117' ' ' THR . 11.2 m-85 -134.08 138.15 45.09 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 118.173 0.987 . . . . 0.0 113.509 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 117' ' ' THR . 0.1 OUTLIER -91.22 114.73 27.34 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 123.604 0.762 . . . . 0.0 110.262 179.665 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 11.7 t -79.56 92.84 5.35 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.607 0.718 . . . . 0.0 111.791 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 56.6 p-80 -101.24 155.39 18.05 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.129 178.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.0 mt -53.0 -174.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.689 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.16 94.11 0.08 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.588 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.97 146.38 54.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.136 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.1 m -139.32 14.43 2.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.212 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -44.38 113.87 0.6 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.889 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.7 t -96.04 -165.57 1.3 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.062 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.72 103.71 0.54 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.075 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.8 t0 56.29 64.69 1.62 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.97 0.414 . . . . 0.0 111.735 179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -136.98 -88.09 0.21 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.257 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.0 53.74 2.12 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-O 120.596 0.236 . . . . 0.0 110.607 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.77 79.98 1.52 Allowed 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.628 2.219 . . . . 0.0 113.394 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.44 -179.18 6.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.931 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.404 ' CG2' ' CD2' ' A' ' 51' ' ' LEU . 15.3 t -99.58 25.36 7.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.028 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.1 pp -95.29 169.3 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.955 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 3.9 mtt-85 -79.48 148.57 31.81 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.3 t -78.86 133.1 30.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.259 0.552 . . . . 0.0 112.087 -178.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 99' ' ' THR . 0.7 OUTLIER -87.49 138.39 31.52 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.59 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.83 134.96 26.89 Favored Pre-proline 0 N--CA 1.475 0.781 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.404 ' HD3' ' CD2' ' A' ' 97' ' ' PHE . 51.4 Cg_exo -36.77 109.54 0.07 OUTLIER 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.926 2.417 . . . . 0.0 114.922 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.425 ' HB3' ' CG2' ' A' ' 98' ' ' THR . 0.2 OUTLIER -101.36 -38.03 8.21 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 177.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 59.38 90.48 0.02 OUTLIER Glycine 0 CA--C 1.521 0.434 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.602 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -60.43 151.23 76.21 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.44 2.094 . . . . 0.0 112.272 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.99 -174.48 1.95 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.382 2.055 . . . . 0.0 112.274 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 85.7 m 58.37 80.67 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.042 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 33.2 pttt -117.32 49.23 1.22 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.129 0.49 . . . . 0.0 110.959 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -92.5 17.8 9.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.225 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.098 179.969 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 22.3 m . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.862 0.363 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 16.8 t -99.59 -37.12 5.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.043 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 9.2 mmtm -74.63 -169.83 0.93 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.069 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.409 ' CG1' ' CB ' ' A' ' 38' ' ' SER . 2.3 t 76.93 141.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.472 -178.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . 0.429 ' O ' ' CB ' ' B' ' 6' ' ' SER . 0.7 OUTLIER -139.88 -91.92 0.17 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.823 179.88 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.429 ' CB ' ' O ' ' B' ' 5' ' ' ASP . 6.1 t 153.57 106.15 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.728 0.811 . . . . 0.0 109.812 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.213 -0.898 . . . . 0.0 111.317 -179.72 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 112.563 -0.215 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.83 119.23 6.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.847 0.356 . . . . 0.0 110.902 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -119.3 -179.82 3.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.012 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.2 -161.5 0.82 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.541 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.78 161.24 3.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.653 0.263 . . . . 0.0 110.429 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -115.89 144.4 32.65 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.733 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.48 135.21 47.33 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 123.102 2.535 . . . . 0.0 113.113 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.417 ' N ' ' HA3' ' A' ' 93' ' ' GLY . 24.0 m-80 -140.84 86.42 2.05 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.423 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.417 ' N ' ' HA3' ' A' ' 93' ' ' GLY . 11.2 p -84.37 87.24 2.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.038 0.447 . . . . 0.0 111.388 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.422 ' CG2' ' N ' ' A' ' 11' ' ' SER . 1.3 tp -154.75 -167.82 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 120.749 0.309 . . . . 0.0 111.61 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.422 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 3.9 m -102.87 173.7 6.2 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.364 0.602 . . . . 0.0 111.75 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -160.88 175.95 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.089 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.47 140.89 22.4 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.432 0.634 . . . . 0.0 110.703 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -141.28 140.94 33.96 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.893 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.468 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 2.3 t80 -90.04 143.37 26.84 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -83.6 33.59 0.47 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.261 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.43 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER 38.6 33.92 0.08 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.274 0.629 . . . . 0.0 111.914 179.933 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.468 ' HD3' ' CE1' ' A' ' 15' ' ' PHE . 0.0 OUTLIER 44.27 25.26 0.11 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.769 -178.672 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.2 m -164.36 31.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.567 178.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 52.7 54.69 26.7 Favored Glycine 0 C--N 1.336 0.539 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.584 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -139.91 66.09 0.52 Allowed Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 mp -49.85 -20.16 0.82 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.407 ' HA2' HG23 ' A' ' 41' ' ' ILE . . . 102.16 9.39 42.19 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.134 -1.031 . . . . 0.0 113.23 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.458 ' CD2' ' CG2' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -159.76 140.47 12.22 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.504 0.668 . . . . 0.0 112.387 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.406 HD22 ' CB ' ' B' ' 6' ' ' SER . 3.7 mt -78.92 173.74 12.23 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.453 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.7 m -153.81 159.44 3.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 114.715 -1.129 . . . . 0.0 109.934 178.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.6 mtpt -134.28 95.41 3.4 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.684 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.481 ' CB ' ' CD1' ' A' ' 71' ' ' TYR . 0.9 OUTLIER -81.31 150.21 28.6 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.681 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.07 130.82 35.91 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-O 121.178 0.513 . . . . 0.0 111.351 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -53.04 -34.59 21.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.439 178.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 164.83 34.95 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.716 178.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.47 ' HB2' ' CD ' ' A' ' 33' ' ' PRO . 38.4 mmtm -155.43 -67.36 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.47 ' CD ' ' HB2' ' A' ' 32' ' ' LYS . 37.6 Cg_endo -65.19 -174.82 0.35 Allowed 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 122.451 2.101 . . . . 0.0 112.733 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.442 ' CD ' ' HB2' ' A' ' 33' ' ' PRO . 89.2 Cg_endo -99.67 154.71 0.56 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.279 2.653 . . . . 0.0 111.48 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.58 140.41 16.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.2 tp -156.63 175.89 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.412 ' CG1' ' HB ' ' A' ' 58' ' ' ILE . 36.8 mt -89.17 151.18 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.243 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.72 -36.59 3.86 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.402 ' HA ' ' CB ' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -177.99 142.99 0.3 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.315 -179.687 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 36.2 mt -76.27 85.26 3.07 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.604 0.716 . . . . 0.0 110.247 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.456 ' CG2' ' N ' ' A' ' 42' ' ' ARG . 1.5 tp -40.59 -59.55 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 114.457 1.281 . . . . 0.0 114.457 -177.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.456 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 6.3 mmt180 -94.79 -67.18 0.87 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.182 0.515 . . . . 0.0 112.196 -178.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.422 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 109.39 22.26 6.86 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.232 -178.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.405 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -122.71 -28.56 1.4 Allowed Glycine 0 C--N 1.339 0.75 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.388 -179.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.9 -83.93 0.32 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 117.787 0.793 . . . . 0.0 111.567 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.97 -58.87 6.6 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.221 0.534 . . . . 0.0 110.794 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.422 ' HB3' ' HA2' ' A' ' 43' ' ' GLY . 17.9 tt0 -46.51 -46.97 19.5 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.761 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.405 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -55.05 -37.3 66.55 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.799 178.684 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.4 t -54.38 -46.77 73.12 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.454 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.47 -24.19 24.78 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.439 -0.886 . . . . 0.0 114.601 177.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.7 pp -104.16 0.98 30.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.588 0.694 . . . . 0.0 112.3 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.458 ' CG2' ' CD2' ' A' ' 24' ' ' PHE . 4.2 mp -102.19 96.32 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.23 147.68 43.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.421 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.402 ' CB ' ' HA ' ' A' ' 39' ' ' ASP . . . -70.49 140.4 51.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.932 0.396 . . . . 0.0 111.159 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.58 5.2 88.09 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.98 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.16 -90.71 0.13 Allowed 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.466 HG22 HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -164.9 121.93 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 179.629 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.412 ' HB ' ' CG1' ' A' ' 37' ' ' ILE . 1.3 tp -136.25 81.95 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 107.778 -1.194 . . . . 0.0 107.778 176.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.1 tp -77.97 -67.88 0.69 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.209 -177.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -114.9 147.48 39.9 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.112 0.482 . . . . 0.0 112.08 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.1 t -141.62 144.26 26.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.241 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 44.9 40.87 4.73 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.967 0.413 . . . . 0.0 111.629 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.9 t0 53.38 27.56 6.45 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.134 0.493 . . . . 0.0 110.917 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.01 93.24 34.03 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.464 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -43.1 87.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.361 1.232 0 C-N-CA 123.309 2.673 . . . . 0.0 114.106 -178.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.11 70.99 5.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.296 178.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.4 m -123.04 -59.13 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -178.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -136.57 24.72 3.15 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -178.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.53 -173.28 3.15 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.484 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.72 122.65 19.58 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.481 ' CD1' ' CB ' ' A' ' 28' ' ' GLU . 1.0 OUTLIER -50.46 -69.27 0.12 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.709 -179.278 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -51.45 -26.97 9.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.777 0.322 . . . . 0.0 111.451 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.8 t -76.79 -44.19 33.71 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.24 0.543 . . . . 0.0 109.811 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.12 -39.42 82.26 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.069 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.455 ' CD1' ' CE1' ' A' ' 71' ' ' TYR . 46.2 mt -72.91 -33.97 66.33 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.578 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.404 ' HA ' ' HB2' ' A' ' 79' ' ' ARG . 5.0 pt-20 -71.44 -38.18 71.36 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.276 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.5 t -61.66 -46.59 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.4 pp -74.78 -24.35 58.66 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.9 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.404 ' HB2' ' HA ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -63.17 -37.67 88.12 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.225 179.65 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.0 -23.74 17.23 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.862 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 31.1 mt -58.29 106.26 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-O 120.991 0.424 . . . . 0.0 110.672 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.3 -169.68 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.238 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.44 -170.1 2.1 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.28 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 42.98 31.77 0.36 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.136 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.415 ' O ' ' CD1' ' A' ' 15' ' ' PHE . 1.8 t -129.77 159.0 37.87 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 122.095 0.95 . . . . 0.0 113.148 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.12 176.28 5.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.064 -1.426 . . . . 0.0 109.377 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -146.24 159.66 11.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.311 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.2 t -120.29 158.67 22.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.81 162.71 39.71 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.884 -178.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 47.8 mm -128.38 122.99 59.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.112 0.482 . . . . 0.0 111.501 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 22.4 mt -99.61 153.95 18.66 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.83 162.01 13.28 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.342 0.591 . . . . 0.0 112.13 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.417 ' HA3' ' N ' ' A' ' 8' ' ' ASN . . . -163.54 -128.85 0.98 Allowed Glycine 0 CA--C 1.525 0.669 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.767 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -91.49 -164.91 0.15 Allowed 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 122.769 2.313 . . . . 0.0 112.692 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -132.46 106.23 7.74 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.429 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 117.26 9.1 10.77 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.65 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.428 ' HA ' ' O ' ' A' ' 118' ' ' GLN . 32.5 m-85 -141.22 135.2 30.5 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 117.21 0.505 . . . . 0.0 112.057 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.61 118.49 28.31 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.571 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.5 t -103.31 92.35 4.46 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.141 0.496 . . . . 0.0 110.126 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -65.13 -162.14 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.697 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.41 ' N ' ' CD1' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -120.71 179.6 4.29 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.677 179.841 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 62.56 114.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.212 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 10.9 t -154.43 179.69 8.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.134 0.492 . . . . 0.0 111.638 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 66.7 p -121.43 115.0 22.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.109 179.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.418 ' CG ' ' HA ' ' A' ' 111' ' ' PRO . 42.4 p90 -96.72 157.85 15.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.153 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.67 -76.09 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.761 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 172.89 -34.1 0.12 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.71 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -136.75 39.37 2.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.823 0.344 . . . . 0.0 111.043 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -139.67 -82.81 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.295 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.1 62.89 1.16 Allowed Pre-proline 0 CA--C 1.534 0.345 0 CA-C-O 120.75 0.31 . . . . 0.0 111.107 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.418 ' HA ' ' CG ' ' A' ' 105' ' ' PHE . 72.7 Cg_endo -73.35 91.2 0.87 Allowed 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.29 1.993 . . . . 0.0 112.988 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.02 178.39 8.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.878 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 58.4 m -106.49 -31.22 8.63 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.396 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.518 HG22 HD11 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -93.08 101.03 12.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.158 -179.797 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -160.82 93.78 1.0 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.853 0.358 . . . . 0.0 111.112 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.5 t -157.68 62.51 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.301 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.23 126.54 31.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.026 0.441 . . . . 0.0 111.146 -179.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.428 ' O ' ' HA ' ' A' ' 97' ' ' PHE . 0.1 OUTLIER -134.89 140.1 34.15 Favored Pre-proline 0 N--CA 1.464 0.229 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.849 -179.173 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.01 117.95 4.06 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.064 1.843 . . . . 0.0 111.855 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.95 -41.95 2.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.854 0.359 . . . . 0.0 110.946 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -117.77 76.33 0.29 Allowed Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.369 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.82 140.46 67.71 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.354 2.036 . . . . 0.0 112.412 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.65 -176.79 2.97 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.357 2.038 . . . . 0.0 112.495 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 11.2 t -148.31 153.9 39.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.801 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.7 mttt -95.87 50.81 1.22 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.14 0.495 . . . . 0.0 111.049 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.44 -12.51 61.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.382 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.8 m . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.284 -0.865 . . . . 0.0 111.146 -179.938 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 32.0 t . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.806 0.336 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 12.7 p -102.09 -1.33 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 112.151 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.436 ' HD2' ' CD2' ' A' ' 71' ' ' TYR . 7.3 tptm -106.96 13.81 27.19 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 24.3 t -130.55 134.2 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.774 0.321 . . . . 0.0 111.013 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -138.58 132.93 31.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.957 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.406 ' CB ' HD22 ' A' ' 25' ' ' LEU . 11.7 p -66.0 -51.37 58.98 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.832 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 22.5 m . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.264 -0.874 . . . . 0.0 112.619 179.223 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 112.721 -0.151 . . . . 0.0 112.721 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 63.33 109.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.911 0.386 . . . . 0.0 111.079 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 39.5 m170 57.85 21.56 7.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.67 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 62.57 -80.28 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.626 0.251 . . . . 0.0 111.376 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.2 mm 62.93 158.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.159 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -102.08 141.27 22.2 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.506 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -88.37 124.87 1.73 Allowed 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.812 2.341 . . . . 0.0 112.806 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.533 ' N ' ' HA3' ' A' ' 93' ' ' GLY . 73.5 m-80 -149.54 90.78 1.75 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.119 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.41 ' N ' ' HA3' ' A' ' 93' ' ' GLY . 14.1 p -82.82 101.79 7.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.403 ' CG2' ' N ' ' A' ' 11' ' ' SER . 1.0 OUTLIER -161.88 -166.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.108 -0.637 . . . . 0.0 112.715 -178.469 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.403 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 1.6 p -101.66 158.44 16.1 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.735 0.778 . . . . 0.0 112.131 -178.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.415 ' HB ' ' CD1' ' A' ' 89' ' ' LEU . 3.1 t -142.01 153.49 18.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 114.411 -1.268 . . . . 0.0 108.815 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.5 ttp-105 -135.2 128.09 31.33 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.677 0.751 . . . . 0.0 111.498 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.437 ' CD2' ' CE1' ' A' ' 24' ' ' PHE . 0.4 OUTLIER -124.79 177.83 5.79 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.39 -1.277 . . . . 0.0 109.608 179.66 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.404 ' O ' ' HA ' ' A' ' 22' ' ' LEU . 3.5 t80 -123.15 151.09 42.47 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 20' ' ' GLY . 3.8 mptp? -83.15 26.54 0.62 Allowed 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.289 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.435 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 0.4 OUTLIER 44.79 29.94 0.49 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.833 0.349 . . . . 0.0 111.868 179.562 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER 44.7 23.86 0.09 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.736 -178.477 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.7 m -168.55 34.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.992 178.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 49.1 63.42 3.97 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.989 -178.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -143.91 54.05 0.58 Allowed Glycine 0 C--N 1.332 0.349 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.015 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.406 ' O ' ' CB ' ' A' ' 45' ' ' ALA . 3.9 mp -39.1 -28.0 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.421 ' HA2' HG23 ' A' ' 41' ' ' ILE . . . 110.2 3.27 29.59 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.819 -1.182 . . . . 0.0 113.776 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.437 ' CE1' ' CD2' ' A' ' 14' ' ' LEU . 0.3 OUTLIER -158.09 141.25 15.06 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.041 0.921 . . . . 0.0 112.933 -179.473 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.401 ' CG ' HD11 ' A' ' 41' ' ' ILE . 0.8 OUTLIER -89.66 174.59 7.65 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.477 179.437 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.6 m -151.41 165.42 2.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.236 178.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.407 ' HG2' ' CG2' ' B' ' 4' ' ' VAL . 15.9 mtpt -140.84 99.88 3.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.737 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.46 ' HB3' ' CG ' ' A' ' 71' ' ' TYR . 0.6 OUTLIER -99.34 112.17 24.4 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 178.158 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.409 ' HB3' ' HB2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -49.23 119.7 3.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.101 0.477 . . . . 0.0 111.11 -179.642 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 52.0 t -59.11 -14.87 5.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.317 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.9 t -141.45 28.89 1.8 Allowed 'General case' 0 C--O 1.231 0.103 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.921 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.409 ' HB2' ' HB3' ' A' ' 29' ' ' ARG . 9.5 mtpt -161.96 147.3 10.27 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.54 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -61.36 -47.44 11.92 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.493 2.129 . . . . 0.0 114.105 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 32' ' ' LYS . 73.8 Cg_exo -41.28 96.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.889 2.393 . . . . 0.0 114.799 -178.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.3 p -114.68 147.0 18.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 177.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 36' ' ' ILE . 1.2 tp -161.02 175.79 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -179.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.428 ' CG1' ' HB ' ' A' ' 58' ' ' ILE . 42.7 mt -82.17 153.3 4.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.35 178.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.414 ' N ' HG21 ' A' ' 37' ' ' ILE . 22.0 t -117.41 -38.06 3.39 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.665 0.616 . . . . 0.0 112.665 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -173.0 140.05 0.87 Allowed 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 120.283 -0.567 . . . . 0.0 112.277 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.413 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 40.2 mt -76.46 87.63 3.2 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.795 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.46 ' CG2' ' N ' ' A' ' 42' ' ' ARG . 1.3 tp -39.85 -60.04 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -177.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.46 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 17.6 ttt85 -94.24 -59.23 2.01 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.974 0.416 . . . . 0.0 112.035 -178.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.404 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 98.07 24.29 11.86 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -177.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.418 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -125.85 -28.61 1.03 Allowed Glycine 0 C--N 1.338 0.666 0 C-N-CA 121.111 -0.566 . . . . 0.0 113.479 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.406 ' CB ' ' O ' ' A' ' 22' ' ' LEU . . . -94.47 -83.44 0.34 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 117.902 0.851 . . . . 0.0 111.459 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.67 -57.97 9.89 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.235 0.541 . . . . 0.0 110.963 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.404 ' HB3' ' HA2' ' A' ' 43' ' ' GLY . 7.8 tm-20 -47.61 -48.07 28.56 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.623 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.418 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -56.5 -34.85 67.38 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.98 178.797 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.14 -45.89 75.65 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 112.17 -28.66 9.02 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.526 -0.845 . . . . 0.0 114.54 177.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 pp -105.0 19.12 21.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.591 0.695 . . . . 0.0 112.051 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 mp -123.23 81.66 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.891 0.377 . . . . 0.0 110.216 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -112.95 141.37 46.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.144 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.8 134.63 57.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.071 0.462 . . . . 0.0 111.303 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.55 2.48 87.11 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.896 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.84 -93.31 0.09 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.843 0.321 . . . . 0.0 110.566 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -163.75 119.64 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.428 ' HB ' ' CG1' ' A' ' 37' ' ' ILE . 5.9 tp -136.95 82.27 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 177.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.6 tp -78.12 -58.43 3.26 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.97 -177.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.94 145.47 44.66 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.911 0.386 . . . . 0.0 111.722 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.0 t -146.8 145.23 19.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.84 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 44.6 41.81 5.16 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.172 0.51 . . . . 0.0 111.995 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.6 t0 57.63 26.32 12.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.541 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 66' ' ' LEU . 19.3 mmt180 -115.57 101.47 54.23 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.116 179.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.48 85.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.331 2.021 . . . . 0.0 111.626 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 64' ' ' ARG . 8.8 mt -78.68 62.15 3.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.738 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.1 m -125.49 -65.6 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -125.74 25.42 6.91 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.4 -179.8 4.22 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.0 m -68.49 96.64 0.7 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.46 ' CG ' ' HB3' ' A' ' 28' ' ' GLU . 8.9 t80 -41.01 -57.05 2.12 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.049 0.452 . . . . 0.0 112.057 -178.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -60.67 -28.4 68.57 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.823 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.0 t -74.24 -43.61 56.36 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.8 -33.93 69.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.501 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.451 ' CD2' ' CE1' ' A' ' 71' ' ' TYR . 3.7 mm? -71.17 -35.99 71.82 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.088 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -74.84 -35.64 62.38 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.035 0.445 . . . . 0.0 109.846 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.4 ' CG1' ' CZ ' ' A' ' 64' ' ' ARG . 8.4 t -61.83 -43.01 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.874 178.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.1 pp -79.05 -24.7 43.41 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.053 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -40.4 94.68 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.882 0.373 . . . . 0.0 110.21 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -57.03 -20.36 34.14 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.879 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 65.6 mt -57.81 110.66 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 120.98 0.419 . . . . 0.0 111.005 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.09 -164.53 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.45 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.81 -170.7 1.97 Allowed 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.809 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 45.18 31.34 0.76 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.116 0.484 . . . . 0.0 110.873 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.5 t -123.54 162.84 22.13 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.838 0.827 . . . . 0.0 112.658 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -102.8 176.27 5.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.362 -1.29 . . . . 0.0 109.977 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.412 ' N ' ' O ' ' A' ' 14' ' ' LEU . 5.7 p -149.29 156.3 7.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.334 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.1 t -114.05 161.51 12.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.553 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.415 ' CD1' ' HB ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -154.71 158.32 39.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.216 -178.617 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 51.5 mm -133.9 134.77 55.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.403 ' HG ' ' CG2' ' A' ' 12' ' ' VAL . 7.2 mt -117.13 167.26 11.34 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.033 177.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.94 160.32 15.11 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.533 ' HA3' ' N ' ' A' ' 8' ' ' ASN . . . -178.75 -147.6 7.16 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-N 114.749 -1.114 . . . . 0.0 112.288 179.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -95.54 167.93 1.4 Allowed 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 123.313 2.675 . . . . 0.0 112.598 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -105.41 154.26 20.55 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.89 19.04 66.27 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.2 -1.0 . . . . 0.0 111.8 -178.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.422 ' HA ' ' O ' ' A' ' 118' ' ' GLN . 53.8 m-85 -150.27 141.8 23.47 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.914 0.357 . . . . 0.0 111.852 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.22 130.83 37.05 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 18.9 p -109.27 93.12 4.34 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.41 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -75.07 -168.62 0.79 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.962 178.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.9 pp -123.05 131.06 53.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.896 0.379 . . . . 0.0 110.907 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -175.28 156.55 2.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.856 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 76.86 179.37 0.15 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.212 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.9 p -148.44 133.9 18.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.224 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.425 ' CG ' ' HA2' ' A' ' 109' ' ' GLY . 49.2 p90 -60.64 -177.36 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.927 0.394 . . . . 0.0 111.067 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.8 t -169.33 -42.66 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.73 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -91.23 73.76 1.68 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.506 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 60.68 42.11 14.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.844 0.354 . . . . 0.0 111.137 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.425 ' HA2' ' CG ' ' A' ' 105' ' ' PHE . . . 64.29 63.98 3.94 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.25 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.438 ' CB ' ' HD3' ' A' ' 111' ' ' PRO . 0.9 OUTLIER -109.46 -62.21 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.382 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.438 ' HD3' ' CB ' ' A' ' 110' ' ' THR . 53.1 Cg_exo -53.31 -32.75 62.73 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.105 1.87 . . . . 0.0 111.762 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.6 tptm 66.84 131.95 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.453 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 79.3 m -64.71 -33.94 77.15 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.862 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.505 HG22 HD11 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -103.08 94.47 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.629 178.584 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -153.55 94.71 1.82 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.96 0.41 . . . . 0.0 111.21 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.3 t -155.57 65.3 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.746 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.25 106.01 10.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.064 -0.517 . . . . 0.0 112.153 -178.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.422 ' O ' ' HA ' ' A' ' 97' ' ' PHE . 3.2 pt20 -114.31 133.35 22.45 Favored Pre-proline 0 N--CA 1.467 0.385 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.494 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -65.93 139.97 58.82 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.318 2.012 . . . . 0.0 114.137 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.88 -68.43 0.78 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.035 179.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 104.39 -77.28 0.27 Allowed Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.268 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.88 172.32 6.11 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.446 2.097 . . . . 0.0 112.158 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -78.41 -166.27 0.39 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.487 2.125 . . . . 0.0 112.332 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.1 t -53.94 -47.43 71.29 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.416 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -177.79 70.42 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.132 0.491 . . . . 0.0 110.93 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.92 -15.63 62.31 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.043 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.8 m . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.089 179.831 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 10.2 t . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 121.114 0.483 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 11.5 p -94.94 -32.1 4.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.194 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 2.2 pptp? -174.35 48.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.461 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.407 ' CG2' ' HG2' ' A' ' 27' ' ' LYS . 10.5 t -74.0 124.89 32.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.828 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -63.71 -155.26 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.35 102.56 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.185 0.517 . . . . 0.0 110.145 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 23.0 m . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.238 -179.003 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.9 t -174.51 -55.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.83 0.347 . . . . 0.0 110.776 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -113.53 120.72 41.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.761 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 7.7 mtt 62.49 160.71 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.619 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.417 ' CD1' ' CD ' ' A' ' 111' ' ' PRO . 4.5 tp 36.8 100.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.467 0.707 . . . . 0.0 112.651 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -161.61 -63.83 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -36.13 138.7 0.17 Allowed 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 123.293 2.662 . . . . 0.0 114.178 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -63.91 -36.55 84.29 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.105 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.42 ' CG1' ' CG2' ' A' ' 90' ' ' ILE . 38.8 t -79.17 148.64 5.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.978 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.7 mp -122.08 159.58 24.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 121.37 0.605 . . . . 0.0 112.541 -177.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.424 ' HA ' ' CD1' ' A' ' 90' ' ' ILE . 1.9 m -92.79 173.57 7.69 Favored 'General case' 0 C--O 1.23 0.075 0 CA-C-N 115.158 -0.928 . . . . 0.0 113.439 -178.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.416 ' HB ' ' CD1' ' A' ' 89' ' ' LEU . 1.5 t -159.14 157.47 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 114.29 -1.323 . . . . 0.0 108.786 -179.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -150.75 126.31 10.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.223 0.535 . . . . 0.0 110.837 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.471 HD12 HD12 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -134.45 178.72 6.77 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.297 -179.229 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.411 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 5.0 t80 -116.37 151.99 34.82 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.401 ' O ' ' N ' ' A' ' 20' ' ' GLY . 0.8 OUTLIER -85.32 28.11 0.76 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.541 179.448 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.418 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 7.5 tpt180 43.49 31.8 0.46 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.018 0.437 . . . . 0.0 111.94 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER 43.64 24.98 0.07 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.893 -178.917 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.4 ' CG1' ' O ' ' A' ' 18' ' ' LYS . 5.0 m -167.72 33.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.408 -0.814 . . . . 0.0 108.831 178.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 49.14 61.1 5.63 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.705 -178.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -142.94 55.33 0.58 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.98 -0.629 . . . . 0.0 111.95 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.414 ' O ' ' CB ' ' A' ' 45' ' ' ALA . 3.7 mp -40.49 -27.61 0.05 Allowed 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.417 ' HA2' HG23 ' A' ' 41' ' ' ILE . . . 114.42 2.49 22.96 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 119.911 -1.137 . . . . 0.0 114.418 178.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -154.58 144.37 21.64 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.493 1.147 . . . . 0.0 113.595 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.6 mt -82.05 172.88 12.72 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.683 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.0 m -150.98 154.24 8.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.248 177.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.7 ptmt -135.84 109.64 8.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.959 -179.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.486 ' HB3' ' CG ' ' A' ' 71' ' ' TYR . 0.6 OUTLIER -111.06 142.66 42.92 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.947 179.276 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.409 ' CB ' ' HB2' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -75.4 126.94 32.03 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.044 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 65.5 t -51.85 -22.41 2.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.912 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.404 ' O ' ' CG ' ' A' ' 32' ' ' LYS . 72.3 p -146.25 44.2 1.23 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.927 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.409 ' HB2' ' CB ' ' A' ' 29' ' ' ARG . 29.6 mttp -166.25 144.35 4.6 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 116.72 -0.218 . . . . 0.0 110.835 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.401 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 39.4 Cg_exo -59.24 -48.0 15.35 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.687 2.258 . . . . 0.0 113.972 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 33' ' ' PRO . 60.4 Cg_exo -38.92 94.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.927 2.418 . . . . 0.0 114.674 -178.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.8 p -118.86 152.64 21.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.131 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.424 HD13 ' HA ' ' A' ' 36' ' ' ILE . 1.2 tp -160.21 174.37 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.438 ' CG1' ' HB ' ' A' ' 58' ' ' ILE . 54.4 mt -85.39 147.73 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.135 179.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.413 ' HB3' ' CG1' ' B' ' 4' ' ' VAL . 1.4 t -113.66 -37.07 4.69 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -172.14 141.38 1.28 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.044 -0.663 . . . . 0.0 112.373 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.407 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 51.0 mt -72.55 109.02 5.92 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.526 -0.761 . . . . 0.0 108.978 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.464 ' CG2' ' N ' ' A' ' 42' ' ' ARG . 0.6 OUTLIER -63.52 -59.67 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -176.392 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.464 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -94.15 -67.38 0.86 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.15 0.5 . . . . 0.0 111.985 -178.229 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.411 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 112.55 23.76 5.27 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.517 -178.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -128.17 -30.07 0.75 Allowed Glycine 0 C--N 1.338 0.643 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.613 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 22' ' ' LEU . . . -93.53 -83.33 0.33 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 117.823 0.812 . . . . 0.0 111.512 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.74 -55.22 32.55 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.123 0.487 . . . . 0.0 110.927 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.411 ' HB3' ' HA2' ' A' ' 43' ' ' GLY . 0.3 OUTLIER -50.17 -48.26 54.1 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.975 179.496 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -57.07 -35.84 69.85 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.203 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.2 m -57.3 -46.14 83.45 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.943 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.97 -21.71 44.63 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.392 -0.909 . . . . 0.0 113.011 179.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.42 ' CD2' ' CG2' ' A' ' 114' ' ' ILE . 2.1 pp -82.05 -31.59 30.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.176 0.512 . . . . 0.0 109.643 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.471 HD12 HD12 ' A' ' 14' ' ' LEU . 3.6 mp -82.29 137.51 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.237 179.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -157.71 150.45 22.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.619 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.62 122.08 17.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.882 0.372 . . . . 0.0 110.928 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.58 -6.5 80.14 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.359 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.92 -91.61 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 117.001 0.4 . . . . 0.0 110.818 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 tp -163.28 123.02 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.438 ' HB ' ' CG1' ' A' ' 37' ' ' ILE . 2.4 tp -140.91 84.42 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 176.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 57.5 tp -77.16 -61.02 2.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.789 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -120.85 161.87 20.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.957 0.408 . . . . 0.0 111.439 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.0 p -163.24 145.18 2.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.375 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 45.13 41.91 6.22 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.239 0.542 . . . . 0.0 111.379 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.14 29.1 16.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.06 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -115.58 96.6 46.67 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.415 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.85 86.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 121.856 1.704 . . . . 0.0 110.874 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.96 63.59 0.48 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.423 -178.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.5 m -143.51 -61.35 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -109.32 28.78 8.17 Favored 'General case' 0 CA--C 1.518 -0.266 0 O-C-N 121.966 -0.459 . . . . 0.0 111.997 -178.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.85 174.17 8.12 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.98 107.78 2.81 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.486 ' CG ' ' HB3' ' A' ' 28' ' ' GLU . 7.5 t80 -43.76 -58.4 2.73 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.015 0.436 . . . . 0.0 111.896 -179.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -58.0 -27.34 63.41 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.341 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.8 m -77.29 -38.63 50.36 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.253 0.549 . . . . 0.0 110.019 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.39 -38.52 91.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.825 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.412 HD12 ' CZ ' ' A' ' 71' ' ' TYR . 16.0 mt -73.17 -32.38 64.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.462 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -76.35 -38.82 55.31 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.848 0.356 . . . . 0.0 110.283 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.8 t -61.98 -41.3 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.3 pp -80.14 -22.11 42.39 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.322 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.24 -38.11 81.49 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.464 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.82 -12.77 57.87 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.134 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 84.9 mt -53.13 118.9 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 120.989 0.423 . . . . 0.0 111.169 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.55 -173.99 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.898 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -98.63 -173.28 2.5 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.287 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 42.04 32.31 0.29 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.15 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.5 t -123.94 162.26 23.73 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.881 0.848 . . . . 0.0 112.577 -178.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -97.9 177.11 5.55 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.477 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.463 ' N ' ' O ' ' A' ' 14' ' ' LEU . 2.3 p -151.38 148.25 14.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.329 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.2 t -108.3 162.67 6.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.416 ' CD1' ' HB ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -159.8 172.16 18.18 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -179.435 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.424 ' CD1' ' HA ' ' A' ' 11' ' ' SER . 29.4 mm -131.36 120.96 47.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -178.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.97 152.49 21.95 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 176.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.78 175.27 6.09 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.782 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.02 170.17 25.96 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.881 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -80.32 54.59 5.29 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.312 2.008 . . . . 0.0 112.903 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 62.01 113.74 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.317 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.85 24.36 17.79 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.211 -0.995 . . . . 0.0 111.22 -178.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 118' ' ' GLN . 37.1 m-85 -138.65 131.02 28.67 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.435 ' N ' ' O ' ' A' ' 118' ' ' GLN . 0.1 OUTLIER -86.07 130.36 34.56 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.202 179.398 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 0.2 OUTLIER -105.29 94.02 5.0 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 177.81 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.478 ' HA ' ' HD2' ' A' ' 115' ' ' ARG . 16.7 t-160 -120.45 113.99 21.13 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.716 -179.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.443 ' N ' ' HB3' ' A' ' 115' ' ' ARG . 1.9 tp -59.29 -86.5 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 121.101 -0.24 . . . . 0.0 110.924 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 173.21 -38.21 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 122.704 0.402 . . . . 0.0 110.044 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 12.4 t -94.56 -164.41 1.16 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.227 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.1 p -132.52 125.47 30.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.999 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -117.49 -176.47 3.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.25 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.9 p -89.18 -106.71 0.08 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 119.459 -0.305 . . . . 0.0 110.743 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 49.51 34.71 20.38 Favored Glycine 0 C--N 1.347 1.17 0 C-N-CA 120.394 -0.908 . . . . 0.0 111.758 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 26.0 t0 73.51 33.37 1.08 Allowed 'General case' 0 C--O 1.231 0.123 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 85.32 74.85 1.25 Allowed Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.912 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -134.25 123.7 16.84 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.417 ' CD ' ' CD1' ' A' ' 5' ' ' ILE . 11.8 Cg_exo -69.01 67.94 1.28 Allowed 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.011 1.808 . . . . 0.0 111.569 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.411 ' CB ' ' CD2' ' A' ' 101' ' ' LEU . 17.3 tppt? 75.11 143.78 0.08 Allowed 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.963 -179.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.0 m -46.88 -67.27 0.29 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.418 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.42 ' CG2' ' CD2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -88.31 155.71 3.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.029 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.478 ' HD2' ' HA ' ' A' ' 100' ' ' HIS . 2.6 mtm-85 -141.22 159.3 42.51 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.94 0.4 . . . . 0.0 111.834 -177.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 99' ' ' THR . 75.5 t -78.93 128.18 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.867 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.11 134.24 35.61 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -178.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.477 ' O ' ' HA ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -143.49 176.51 2.25 Favored Pre-proline 0 C--O 1.204 -1.335 0 N-CA-C 107.111 -1.441 . . . . 0.0 107.111 177.55 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -92.07 131.26 1.15 Allowed 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 121.653 1.569 . . . . 0.0 115.047 -178.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.403 ' HG ' ' CA ' ' A' ' 97' ' ' PHE . 0.2 OUTLIER -110.32 -39.95 4.81 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.092 0.472 . . . . 0.0 109.82 177.381 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -45.43 -66.58 1.5 Allowed Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.611 -0.722 . . . . 0.0 114.003 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -48.5 171.71 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.747 2.298 . . . . 0.0 112.649 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -68.54 82.37 0.54 Allowed 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.409 2.073 . . . . 0.0 112.633 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 38.2 p -85.02 70.89 10.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.694 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -124.29 -174.68 3.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.979 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 62.8 17.67 10.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.078 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.6 p . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.174 179.966 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 120.758 0.313 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 22.8 t -120.54 -38.34 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.494 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 1.9 mmtm -105.96 -41.47 5.38 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.339 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.413 ' CG1' ' HB3' ' A' ' 38' ' ' SER . 21.9 t -75.9 122.46 29.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.924 0.392 . . . . 0.0 110.963 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.71 127.53 45.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.828 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 30.5 t -73.73 149.46 41.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.417 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.382 -179.278 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 112.573 -0.211 . . . . 0.0 112.573 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.61 99.5 12.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.772 0.32 . . . . 0.0 110.87 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -90.54 117.33 29.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.037 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 4.8 tpp -144.85 68.31 1.25 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.689 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.3 tt -150.52 46.39 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.909 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -167.78 157.07 8.94 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.29 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -80.74 -176.43 3.17 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.667 2.245 . . . . 0.0 112.038 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -137.33 -82.11 0.35 Allowed 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.1 p -164.15 106.75 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.474 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.453 ' CG2' ' N ' ' A' ' 11' ' ' SER . 1.0 OUTLIER -162.16 -167.64 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.453 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 3.6 t -72.64 164.26 26.77 Favored 'General case' 0 CA--C 1.527 0.06 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.594 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.423 ' N ' ' O ' ' A' ' 89' ' ' LEU . 1.7 t -158.27 160.71 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 114.592 -1.185 . . . . 0.0 108.698 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 17.6 ttp180 -143.69 143.8 31.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.564 0.697 . . . . 0.0 111.617 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.443 ' CD2' ' CE1' ' A' ' 24' ' ' PHE . 0.8 OUTLIER -142.63 176.69 8.84 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.821 179.681 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.453 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 3.9 t80 -132.03 148.26 52.49 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.57 34.14 0.43 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.333 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.406 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 0.8 OUTLIER 38.21 32.89 0.05 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.22 0.608 . . . . 0.0 112.259 179.503 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.453 ' HD3' ' CE1' ' A' ' 15' ' ' PHE . 0.0 OUTLIER 44.5 23.67 0.08 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.517 -178.356 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.0 m -164.54 31.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.48 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 52.99 67.25 2.21 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.631 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -153.78 69.38 0.3 Allowed Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 111.599 -0.601 . . . . 0.0 111.599 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.1 mp -52.01 -22.79 4.33 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.48 6.12 44.72 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.25 -0.976 . . . . 0.0 113.735 179.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.451 ' CD2' ' CG2' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -157.95 140.3 14.43 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 117.982 0.891 . . . . 0.0 113.356 -179.529 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.404 ' HB3' ' CG1' ' B' ' 4' ' ' VAL . 14.7 mt -80.16 171.46 15.05 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.118 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.2 m -153.89 153.72 8.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.607 177.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.9 ptmt -140.45 108.08 5.62 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.93 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.446 ' HB3' ' CG ' ' A' ' 71' ' ' TYR . 4.9 tm-20 -106.23 129.97 54.18 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.705 178.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.454 ' CB ' ' HB2' ' A' ' 32' ' ' LYS . 1.9 mmm180 -83.88 121.49 27.42 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.051 0.453 . . . . 0.0 110.689 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.0 t -51.41 -23.25 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.025 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.6 t -149.93 63.69 0.98 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.582 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.454 ' HB2' ' CB ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -174.49 172.8 1.2 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.228 -178.825 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.435 ' HD2' ' CB ' ' A' ' 32' ' ' LYS . 10.2 Cg_exo -33.46 160.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.361 1.196 0 C-N-CA 123.936 3.091 . . . . 0.0 114.614 -179.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -41.75 175.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 123.859 3.039 . . . . 0.0 115.171 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.422 HG13 ' CB ' ' A' ' 66' ' ' LEU . 14.0 p -77.51 159.68 4.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.633 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.405 ' HA ' HG21 ' A' ' 58' ' ' ILE . 1.1 tp -146.35 158.72 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.585 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.419 ' CG1' ' HB ' ' A' ' 58' ' ' ILE . 26.5 mt -79.75 146.75 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 120.737 0.303 . . . . 0.0 111.319 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.0 t -113.98 -36.68 4.7 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -171.84 135.67 0.86 Allowed 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 120.111 -0.636 . . . . 0.0 112.295 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.4 ' CD2' ' HB3' ' A' ' 24' ' ' PHE . 40.6 mt -72.73 77.42 1.11 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 121.788 0.804 . . . . 0.0 109.876 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 42' ' ' ARG . 1.4 tp -33.79 -60.15 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -177.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.467 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 1.5 ttt85 -94.96 -62.25 1.35 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -177.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.79 28.42 7.42 Favored Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -177.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -126.52 -32.25 0.73 Allowed Glycine 0 C--N 1.337 0.592 0 C-N-CA 121.337 -0.459 . . . . 0.0 113.232 -178.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -95.34 -83.33 0.36 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 117.587 0.694 . . . . 0.0 111.906 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.38 -60.06 4.41 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.158 0.504 . . . . 0.0 111.234 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -45.29 -48.26 13.02 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.784 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.421 ' HB2' ' O ' ' A' ' 44' ' ' GLY . 6.6 mm-40 -54.97 -39.69 69.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.276 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.3 m -53.23 -46.2 69.02 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.015 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.08 -21.63 33.18 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.452 -0.88 . . . . 0.0 113.821 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.422 ' CB ' ' CG2' ' A' ' 114' ' ' ILE . 2.9 pp -97.21 -7.8 31.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.064 0.432 . . . . 0.0 111.58 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.451 ' CG2' ' CD2' ' A' ' 24' ' ' PHE . 5.4 mp -104.71 125.12 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-O 120.901 0.382 . . . . 0.0 110.391 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.81 156.28 40.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.667 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.76 127.8 33.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.937 0.399 . . . . 0.0 111.184 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.08 -1.13 89.22 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.087 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.92 -92.97 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 117.039 0.419 . . . . 0.0 109.995 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.9 tp -164.96 119.55 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.419 ' HB ' ' CG1' ' A' ' 37' ' ' ILE . 2.6 tp -135.32 88.15 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.9 tp -78.96 -68.24 0.67 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.061 -178.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -111.44 158.56 18.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.233 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.8 p -162.73 147.39 3.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.306 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 44.79 42.77 6.31 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 121.145 0.498 . . . . 0.0 111.498 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.9 t0 56.81 28.87 15.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.209 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -118.55 95.8 49.22 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.903 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.89 86.67 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 121.819 1.679 . . . . 0.0 111.128 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.422 ' CB ' HG13 ' A' ' 35' ' ' VAL . 0.4 OUTLIER -83.86 63.51 7.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.531 0.681 . . . . 0.0 110.463 -179.459 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.9 m -117.17 -50.91 4.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.986 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -138.65 22.5 2.69 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.814 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.41 172.6 7.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.244 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.6 106.35 1.77 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.454 ' CE1' ' CD1' ' A' ' 75' ' ' LEU . 7.5 t80 -45.18 -60.84 1.9 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.684 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -54.86 -31.92 60.13 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.296 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.3 t -74.57 -44.09 52.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.166 0.507 . . . . 0.0 109.657 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.83 -40.32 88.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.225 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.454 ' CD1' ' CE1' ' A' ' 71' ' ' TYR . 73.5 mt -71.02 -31.38 67.87 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.638 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -75.7 -39.24 57.73 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.126 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.4 t -61.28 -39.84 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.924 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.5 pp -80.58 -25.4 38.55 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.925 179.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -37.61 87.01 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.977 0.418 . . . . 0.0 110.361 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -58.66 -18.73 39.5 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.848 -0.691 . . . . 0.0 113.024 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 48.0 mt -56.23 122.25 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 120.924 0.392 . . . . 0.0 111.114 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.43 -163.38 0.09 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.312 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.36 -169.67 2.02 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.988 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 40.9 33.33 0.2 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.235 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.427 ' O ' ' CE1' ' A' ' 15' ' ' PHE . 1.8 t -123.7 157.71 33.28 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 122.206 1.003 . . . . 0.0 113.122 -177.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -100.11 175.51 5.72 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.877 -1.511 . . . . 0.0 109.712 179.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.411 ' N ' ' O ' ' A' ' 14' ' ' LEU . 5.0 p -150.87 153.9 9.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.083 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.0 t -115.01 158.37 15.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.205 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -154.01 169.72 22.83 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.516 -178.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 34.3 mm -136.28 123.16 32.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.636 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.4 ' HG ' ' CG2' ' A' ' 12' ' ' VAL . 9.4 mt -82.35 145.75 29.76 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 176.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.97 153.51 32.5 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -177.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 135.63 71.66 0.07 OUTLIER Glycine 0 CA--C 1.525 0.697 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.141 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -86.12 142.49 7.52 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.736 2.29 . . . . 0.0 113.283 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -157.32 22.84 0.3 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 86.87 43.24 6.09 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.861 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 118' ' ' GLN . 68.6 m-85 -147.53 129.95 15.78 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 117.172 0.486 . . . . 0.0 112.154 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 117' ' ' THR . 0.1 OUTLIER -83.22 114.66 21.52 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.799 179.819 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 29.8 p -79.91 93.22 5.63 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.136 0.494 . . . . 0.0 110.14 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -104.63 128.32 52.62 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.271 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.5 137.97 39.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.138 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -177.1 37.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.728 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 10.9 t -176.82 172.13 2.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.771 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.412 ' O ' ' CD2' ' A' ' 105' ' ' PHE . 6.7 m -139.35 10.68 2.53 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.412 ' CD2' ' O ' ' A' ' 104' ' ' THR . 1.1 p90 57.37 155.17 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.023 0.439 . . . . 0.0 111.206 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.7 t -150.17 -52.92 0.15 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.435 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -59.89 -109.47 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.326 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -99.54 32.23 2.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.919 0.39 . . . . 0.0 110.612 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 65.7 63.65 3.92 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.172 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.429 ' CB ' ' HD3' ' A' ' 111' ' ' PRO . 0.9 OUTLIER -96.56 -59.77 0.16 Allowed Pre-proline 0 CA--C 1.535 0.384 0 O-C-N 122.911 -0.17 . . . . 0.0 111.199 -179.543 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.429 ' HD3' ' CB ' ' A' ' 110' ' ' THR . 51.9 Cg_exo -54.0 -29.62 55.4 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.047 1.831 . . . . 0.0 111.297 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.9 tptt 66.74 135.51 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.223 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 17.1 m -59.53 -20.78 57.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.82 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.422 ' CG2' ' CB ' ' A' ' 51' ' ' LEU . 1.1 pt -77.43 177.36 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 CA-C-O 121.155 0.502 . . . . 0.0 110.864 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 35.9 mtt180 -78.0 128.61 34.15 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.722 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.5 t -78.47 130.89 35.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.153 0.501 . . . . 0.0 110.602 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 99' ' ' THR . 0.6 OUTLIER -78.68 135.21 37.13 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.875 -178.027 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.477 ' O ' ' HA ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -125.05 137.7 30.18 Favored Pre-proline 0 N--CA 1.469 0.5 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.461 -179.81 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -34.78 104.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 123.354 2.703 . . . . 0.0 113.823 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.408 ' HB2' HG23 ' A' ' 98' ' ' THR . 0.3 OUTLIER -116.76 -29.63 6.01 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.943 -179.05 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 99.67 121.52 4.63 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 120.678 -0.773 . . . . 0.0 111.922 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.21 107.66 0.28 Allowed 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.138 1.892 . . . . 0.0 112.507 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.17 75.96 0.68 Allowed 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.177 1.918 . . . . 0.0 112.175 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.21 76.4 1.67 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.843 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.01 46.77 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.068 0.461 . . . . 0.0 110.996 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.37 -9.63 56.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.613 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.5 m . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.172 -179.986 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 24.4 t . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.859 0.362 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 10.6 p -149.58 48.04 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.893 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.414 ' CE ' ' HA ' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -108.78 -41.37 4.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.194 -179.88 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.404 ' CG1' ' HB3' ' A' ' 25' ' ' LEU . 3.4 t -77.69 127.07 38.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.755 0.312 . . . . 0.0 110.912 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -125.56 127.25 46.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.847 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 7.9 p -86.53 116.52 24.71 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.059 0.457 . . . . 0.0 110.925 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 19.6 m . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.251 -0.881 . . . . 0.0 111.226 -179.409 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.4 p -77.86 176.14 9.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.728 0.299 . . . . 0.0 110.783 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 4.8 m170 62.88 124.57 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.004 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.3 mmt -97.47 39.69 1.19 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.679 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.7 tp -168.83 158.6 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.933 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.413 ' HB3' ' CD ' ' A' ' 7' ' ' PRO . 2.7 mt-10 -129.92 177.45 2.19 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.959 -179.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.413 ' CD ' ' HB3' ' A' ' 6' ' ' GLU . 52.5 Cg_exo -56.86 -151.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 122.982 2.455 . . . . 0.0 112.553 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.472 ' HB3' ' N ' ' A' ' 94' ' ' PRO . 2.8 m-20 77.28 86.08 0.08 Allowed 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.425 ' CG1' ' CG2' ' A' ' 90' ' ' ILE . 41.4 t -106.62 157.57 6.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -178.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.525 ' HB ' ' HA3' ' A' ' 93' ' ' GLY . 1.2 tp -157.34 163.24 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.17 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.963 -178.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.0 m -90.55 151.39 21.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.501 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.7 t -138.8 160.55 30.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.2 ttp85 -138.3 140.84 39.74 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.616 0.722 . . . . 0.0 112.0 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' A' ' 87' ' ' VAL . 0.6 OUTLIER -142.19 176.24 9.13 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.45 179.331 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.427 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 3.4 t80 -127.65 146.45 50.55 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -80.82 36.49 0.39 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.226 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.402 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 0.6 OUTLIER 35.11 34.03 0.02 OUTLIER 'General case' 0 C--N 1.352 0.707 0 C-N-CA 123.714 0.805 . . . . 0.0 112.502 179.681 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.427 ' HD3' ' CE1' ' A' ' 15' ' ' PHE . 0.0 OUTLIER 43.25 24.82 0.05 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.409 -178.334 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.7 m -164.94 31.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.234 178.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 52.38 68.51 1.54 Allowed Glycine 0 C--N 1.338 0.689 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.376 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -155.27 69.27 0.29 Allowed Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 111.749 -0.541 . . . . 0.0 111.749 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.401 ' HA ' ' O ' ' A' ' 15' ' ' PHE . 4.0 mp -50.08 -22.8 1.77 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.75 4.99 34.01 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.274 -0.965 . . . . 0.0 113.425 179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.435 ' CD2' ' CG2' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -158.59 139.09 12.58 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -179.635 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.4 mt -79.18 169.59 17.92 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.54 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.8 m -152.47 156.93 5.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 120.123 -0.631 . . . . 0.0 111.721 177.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -138.17 107.05 5.95 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.683 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.439 ' HB3' ' CG ' ' A' ' 71' ' ' TYR . 2.1 tm-20 -101.07 111.33 23.51 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -64.45 119.08 9.73 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.026 0.441 . . . . 0.0 110.378 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.4 t -54.62 -18.1 2.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.363 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.69 46.39 0.55 Allowed 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.388 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.431 ' CB ' ' CD ' ' A' ' 33' ' ' PRO . 9.9 mtpt -153.4 -176.15 0.57 Allowed Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.431 ' CD ' ' CB ' ' A' ' 32' ' ' LYS . 66.2 Cg_exo -43.95 171.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.541 2.161 . . . . 0.0 114.134 -178.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 67' ' ' VAL . 99.2 Cg_exo -46.17 177.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.398 2.732 . . . . 0.0 114.451 -179.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.407 ' HB ' ' CG ' ' A' ' 28' ' ' GLU . 13.7 p -77.73 155.08 5.29 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.914 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -139.12 168.66 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.11 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.409 ' CG2' ' HA ' ' A' ' 54' ' ' ALA . 20.6 mt -93.16 151.07 3.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.631 0.253 . . . . 0.0 111.059 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.415 ' CB ' ' CG1' ' B' ' 4' ' ' VAL . 2.4 t -116.01 -40.61 3.28 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -167.12 132.99 2.16 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 120.15 -0.62 . . . . 0.0 112.447 -178.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 56.4 mt -69.05 77.29 0.33 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.46 0.648 . . . . 0.0 109.797 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.465 ' CG2' ' N ' ' A' ' 42' ' ' ARG . 1.4 tp -33.28 -59.16 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -177.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.465 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -94.25 -65.88 0.96 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.198 0.523 . . . . 0.0 111.797 -178.263 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.449 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 105.84 13.97 22.37 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.634 -178.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.403 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -117.93 -25.86 2.93 Favored Glycine 0 C--N 1.341 0.812 0 C-N-CA 121.022 -0.609 . . . . 0.0 113.391 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.07 -83.09 0.34 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 117.777 0.789 . . . . 0.0 111.36 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.43 ' CB ' ' CG2' ' A' ' 52' ' ' ILE . . . -62.02 -60.34 3.76 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.187 0.518 . . . . 0.0 111.454 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.449 ' HB3' ' HA2' ' A' ' 43' ' ' GLY . 4.1 tp10 -48.39 -44.37 34.7 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.079 0.466 . . . . 0.0 110.803 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.403 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 5.2 tp-100 -58.62 -34.09 70.77 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.3 t -54.99 -49.68 70.87 Favored 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 115.77 -22.77 11.42 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.251 -0.976 . . . . 0.0 114.639 177.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.403 ' CD1' ' CD1' ' A' ' 91' ' ' LEU . 0.3 OUTLIER -99.26 -32.53 11.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.523 0.662 . . . . 0.0 110.802 -179.58 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.435 ' CG2' ' CD2' ' A' ' 24' ' ' PHE . 4.9 mp -72.12 115.8 13.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.143 0.497 . . . . 0.0 110.631 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -139.41 148.79 43.27 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.851 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.409 ' HA ' ' CG2' ' A' ' 37' ' ' ILE . . . -75.57 145.76 40.97 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.242 0.544 . . . . 0.0 112.186 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.62 18.44 68.02 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.672 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -109.33 -84.11 0.55 Allowed 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 120.421 0.153 . . . . 0.0 111.348 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.3 tt -163.27 133.4 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.403 ' HB ' ' CG1' ' A' ' 37' ' ' ILE . 2.7 tp -155.31 96.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.443 -1.253 . . . . 0.0 107.99 177.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.8 mt -79.27 -68.77 0.63 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.969 -0.292 . . . . 0.0 111.637 -177.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -116.43 160.15 20.97 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.01 0.433 . . . . 0.0 111.692 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.7 t -154.03 147.29 13.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.606 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 42.98 44.16 3.9 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.187 0.518 . . . . 0.0 111.932 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 t70 56.33 29.45 15.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.275 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.401 ' O ' ' N ' ' A' ' 66' ' ' LEU . 3.4 mmp_? -117.55 98.58 51.9 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.418 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -57.08 85.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.058 1.839 . . . . 0.0 111.464 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' A' ' 64' ' ' ARG . 1.2 mt -86.48 61.55 6.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.412 0.625 . . . . 0.0 110.462 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 2.8 m -113.81 -47.73 5.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.24 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -145.88 23.77 1.37 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.608 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.77 173.38 7.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.649 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.2 m -64.22 99.64 0.29 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.439 ' CG ' ' HB3' ' A' ' 28' ' ' GLU . 5.8 t80 -42.36 -58.72 2.09 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.307 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -58.13 -32.49 68.19 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.32 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.6 t -74.82 -41.7 59.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.077 0.465 . . . . 0.0 109.767 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.14 -40.75 94.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.308 0.575 . . . . 0.0 110.27 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.409 HD12 ' CZ ' ' A' ' 71' ' ' TYR . 72.5 mt -71.43 -31.89 67.73 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.016 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -74.16 -41.16 61.94 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.023 0.439 . . . . 0.0 109.934 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.0 t -59.58 -41.18 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.045 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.5 pp -82.39 -22.48 35.39 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.541 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.42 -37.49 87.07 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.332 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.4 -20.4 29.75 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.896 -0.668 . . . . 0.0 113.034 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 69.0 mt -56.31 123.07 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-O 120.877 0.37 . . . . 0.0 111.103 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.05 -161.64 0.22 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.259 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.3 m -95.29 -170.19 2.13 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.678 0.275 . . . . 0.0 110.984 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 45.0 30.41 0.57 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.169 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.417 ' O ' ' CE1' ' A' ' 15' ' ' PHE . 1.8 t -127.88 158.27 38.24 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 122.024 0.916 . . . . 0.0 112.967 -178.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -99.98 176.57 5.38 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.106 -1.406 . . . . 0.0 110.374 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.418 ' N ' ' O ' ' A' ' 14' ' ' LEU . 3.9 p -150.32 155.16 7.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.382 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.1 t -114.81 162.34 12.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.51 174.81 14.4 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 -178.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.425 ' CG2' ' CG1' ' A' ' 9' ' ' VAL . 49.9 mm -134.52 131.83 54.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 10' ' ' ILE . 55.6 mt -148.41 177.77 9.17 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.95 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -43.41 156.62 0.05 Allowed 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -177.802 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.525 ' HA3' ' HB ' ' A' ' 10' ' ' ILE . . . 159.31 105.26 0.21 Allowed Glycine 0 C--N 1.348 1.21 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.097 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.472 ' N ' ' HB3' ' A' ' 8' ' ' ASN . 3.2 Cg_exo -77.31 -160.04 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.8 2.333 . . . . 0.0 113.725 -178.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -115.64 122.71 46.41 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.89 -10.16 75.71 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.068 -1.063 . . . . 0.0 110.998 -176.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.443 ' HA ' ' O ' ' A' ' 118' ' ' GLN . 10.5 m-85 -134.02 168.08 19.44 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 120.787 0.327 . . . . 0.0 110.485 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.29 119.92 20.39 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.362 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.5 t -93.7 90.77 6.72 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 176.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -62.23 -90.71 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.38 -177.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -177.22 122.4 0.13 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.964 0.411 . . . . 0.0 111.78 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 169.33 139.78 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.903 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -72.47 99.59 2.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.932 0.396 . . . . 0.0 110.751 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.4 m -140.26 15.17 2.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.127 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -46.82 154.24 0.34 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.951 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 m -68.81 -59.81 2.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.011 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -167.28 -104.25 0.17 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.564 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -104.21 32.5 3.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 0.0 110.893 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -118.37 -57.47 0.28 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.325 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.0 t -121.83 58.31 8.89 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-O 120.613 0.244 . . . . 0.0 111.292 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.46 104.08 1.69 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.323 2.015 . . . . 0.0 112.63 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.18 161.67 36.22 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.796 0.331 . . . . 0.0 111.352 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 95.7 m -70.47 -35.72 73.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.078 0.466 . . . . 0.0 110.382 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.482 HG22 HD11 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -88.29 97.35 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.088 -179.171 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -160.35 92.97 1.01 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.054 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -160.36 68.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 61.6 m -76.29 119.81 20.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.203 -177.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.443 ' O ' ' HA ' ' A' ' 97' ' ' PHE . 7.0 pt20 -130.35 139.49 35.77 Favored Pre-proline 0 C--O 1.222 -0.349 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.099 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.81 136.13 40.7 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.153 1.902 . . . . 0.0 112.791 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.403 HD22 ' N ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -98.34 -60.86 1.47 Allowed 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.637 179.204 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 115.09 -77.98 0.27 Allowed Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.933 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -73.77 154.05 48.64 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.434 2.089 . . . . 0.0 113.153 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -74.13 -165.99 0.3 Allowed 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.721 2.281 . . . . 0.0 112.424 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 84.2 m -53.04 -79.12 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.592 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.02 33.18 14.96 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.968 0.413 . . . . 0.0 110.76 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -93.27 18.35 9.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.195 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.284 -0.865 . . . . 0.0 111.063 179.97 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 6.2 m . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.845 0.355 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 30.3 t -106.25 -45.72 8.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.151 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -97.82 -69.07 0.77 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.352 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.415 ' CG1' ' CB ' ' A' ' 38' ' ' SER . 3.4 t -59.77 93.69 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-O 120.927 0.394 . . . . 0.0 110.823 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.51 -103.32 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.292 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 4.9 t 162.36 109.45 0.0 OUTLIER 'General case' 0 C--N 1.345 0.409 0 CA-C-O 121.159 0.504 . . . . 0.0 109.843 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 C--O 1.245 0.839 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.892 -179.338 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.662 HG23 ' N ' ' A' ' 11' ' ' SER . 1.4 tp . . . . . 0 CA--C 1.544 0.723 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.749 ' HA ' HD13 ' A' ' 90' ' ' ILE . 0.7 OUTLIER -85.66 166.27 16.31 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.475 0.655 . . . . 0.0 112.536 -179.338 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.744 ' CG1' HD12 ' A' ' 89' ' ' LEU . 1.6 t -156.05 163.61 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.313 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -149.6 131.97 15.61 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.497 0.665 . . . . 0.0 110.778 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.804 HD21 ' HB2' ' A' ' 46' ' ' ALA . 0.3 OUTLIER -135.03 177.46 7.79 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.419 -179.431 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.408 ' CD1' ' O ' ' A' ' 85' ' ' THR . 4.5 t80 -124.1 151.39 43.94 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.644 ' HD3' HG21 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -81.62 27.15 0.45 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.685 179.453 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.822 ' O ' HG22 ' A' ' 19' ' ' VAL . 9.6 tpt180 43.31 31.04 0.35 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.905 0.383 . . . . 0.0 111.916 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.704 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 44.47 23.47 0.07 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.708 -178.642 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.822 HG22 ' O ' ' A' ' 17' ' ' ARG . 2.9 m -169.14 34.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 49.0 65.87 2.47 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.746 -178.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . -148.19 54.99 0.51 Allowed Glycine 0 C--N 1.331 0.29 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.104 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.909 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 4.1 mp -38.44 -26.96 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 40' ' ' LEU . . . 118.35 -4.13 15.66 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 119.954 -1.117 . . . . 0.0 113.815 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.927 ' HB3' HD23 ' A' ' 40' ' ' LEU . 5.1 p90 -152.83 144.53 23.52 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.933 HD23 ' HA ' ' B' ' 6' ' ' SER . 1.6 mt -80.19 170.21 16.74 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.3 178.056 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.626 HG22 ' OD1' ' B' ' 5' ' ' ASP . 29.0 m -149.32 157.59 6.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 C-N-CA 119.989 -0.685 . . . . 0.0 111.308 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.473 ' HE3' HG22 ' B' ' 4' ' ' VAL . 1.3 ptpt -135.22 104.96 6.09 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.348 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.498 ' HB3' ' CG ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -101.64 118.71 37.51 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.738 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -63.6 114.77 4.15 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 121.254 0.55 . . . . 0.0 110.379 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.6 t . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.141 179.98 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.465 ' HA ' HG22 ' A' ' 58' ' ' ILE . 1.2 tp . . . . . 0 CA--C 1.534 0.343 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.51 HG23 ' O ' ' A' ' 25' ' ' LEU . 28.0 mt -92.67 147.68 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.641 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.5 ' OG ' HG13 ' B' ' 4' ' ' VAL . 0.8 OUTLIER -113.63 -35.58 5.16 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -179.67 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.545 ' CB ' HD12 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -166.2 135.64 3.19 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 120.441 -0.504 . . . . 0.0 112.032 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.927 HD23 ' HB3' ' A' ' 24' ' ' PHE . 49.3 mt -72.92 79.28 1.16 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.671 0.748 . . . . 0.0 110.489 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.773 HD13 HD21 ' A' ' 25' ' ' LEU . 1.8 tp -32.9 -59.5 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.462 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -95.47 -67.7 0.84 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.218 0.532 . . . . 0.0 112.139 -178.142 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 106.91 26.52 5.76 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -177.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -128.31 -28.6 0.83 Allowed Glycine 0 C--N 1.339 0.722 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.73 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.909 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -94.12 -83.01 0.34 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.055 0.928 . . . . 0.0 111.582 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.804 ' HB2' HD21 ' A' ' 14' ' ' LEU . . . -65.04 -53.82 39.96 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.079 0.466 . . . . 0.0 110.9 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.668 ' CG ' HD13 ' A' ' 40' ' ' LEU . 54.1 tt0 -49.86 -47.28 51.89 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.046 0.451 . . . . 0.0 110.463 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.417 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 5.6 tp-100 -59.14 -33.2 70.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.833 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.9 t -55.19 -48.47 73.77 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.622 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.07 -21.85 28.53 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.183 -1.008 . . . . 0.0 114.288 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.944 HD13 HD11 ' A' ' 91' ' ' LEU . 0.6 OUTLIER -100.12 -3.93 30.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.574 0.687 . . . . 0.0 111.616 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.759 HG21 ' CD2' ' A' ' 24' ' ' PHE . 5.0 mp -103.93 138.87 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-O 120.83 0.347 . . . . 0.0 110.402 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -154.4 158.99 40.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.348 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.424 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -71.41 125.25 26.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.921 0.391 . . . . 0.0 111.115 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.86 14.72 73.32 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.653 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.67 ' O ' HD13 ' A' ' 57' ' ' ILE . 1.5 m-20 -92.69 -85.37 0.26 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.67 HD13 ' O ' ' A' ' 56' ' ' ASP . 18.0 mm -148.86 115.78 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -178.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.508 HG21 HG12 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -160.47 113.81 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.674 177.042 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.416 ' N ' HD13 ' A' ' 58' ' ' ILE . 1.7 tp -116.6 -67.04 1.02 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.059 0.457 . . . . 0.0 110.584 -178.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.511 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . . . -104.95 160.91 14.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.236 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.77 HG12 HD12 ' A' ' 66' ' ' LEU . 14.3 p -166.95 145.28 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.482 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.658 ' ND2' HG22 ' A' ' 61' ' ' VAL . 0.7 OUTLIER 44.86 40.0 4.0 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.031 0.444 . . . . 0.0 111.678 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.6 t70 58.67 28.14 16.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.281 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.651 ' HD3' HG11 ' A' ' 77' ' ' VAL . 15.6 mmm180 -118.07 97.51 50.8 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.572 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.839 ' O ' HD22 ' A' ' 69' ' ' LEU . 31.7 Cg_exo -57.81 86.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.032 1.821 . . . . 0.0 110.999 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.77 HD12 HG12 ' A' ' 61' ' ' VAL . 6.6 mt -72.46 62.84 0.54 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.985 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.595 HG23 ' H ' ' A' ' 68' ' ' ASP . 3.1 m -139.64 -63.57 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.595 ' H ' HG23 ' A' ' 67' ' ' VAL . 7.2 t0 -112.49 28.3 8.89 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -178.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.839 HD22 ' O ' ' A' ' 65' ' ' PRO . 0.3 OUTLIER -118.08 176.66 5.11 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.447 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.6 m -68.09 98.75 0.81 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.671 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 6.2 t80 -40.83 -55.63 2.4 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.215 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -58.16 -30.88 66.72 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.195 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.741 ' O ' HG23 ' A' ' 77' ' ' VAL . 1.6 t -75.54 -43.63 47.73 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.739 ' HB2' HD21 ' A' ' 69' ' ' LEU . . . -60.21 -38.89 84.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.417 178.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.682 HD22 ' OD2' ' B' ' 5' ' ' ASP . 63.4 mt -68.61 -30.08 68.73 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.023 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -73.32 -40.0 64.83 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 120.981 0.42 . . . . 0.0 109.943 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.741 HG23 ' O ' ' A' ' 73' ' ' SER . 14.7 t -59.87 -42.96 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.739 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.552 ' C ' HD12 ' A' ' 78' ' ' LEU . 4.2 pp -79.2 -24.79 42.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.959 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.53 ' N ' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -67.39 -48.27 67.86 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.101 0.477 . . . . 0.0 110.062 179.461 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.01 -22.9 13.84 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.978 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.644 HG21 ' HD3' ' A' ' 16' ' ' LYS . 55.6 mt -52.76 114.69 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 120.878 0.371 . . . . 0.0 111.149 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.24 -167.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.185 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.2 m -95.4 -172.33 2.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.949 0.404 . . . . 0.0 111.117 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 45.56 30.33 0.75 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.128 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.425 HG21 HG22 ' A' ' 81' ' ' ILE . 1.8 t -123.66 159.15 29.95 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.88 0.847 . . . . 0.0 112.391 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -100.49 176.44 5.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.575 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.779 HG12 ' C ' ' A' ' 14' ' ' LEU . 2.8 p -153.03 150.06 12.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.584 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.705 ' O ' HD23 ' A' ' 89' ' ' LEU . 24.0 t -111.39 156.9 12.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.744 HD12 ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -152.57 168.84 24.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.692 0.282 . . . . 0.0 111.222 -178.496 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.749 HD13 ' HA ' ' A' ' 11' ' ' SER . 47.1 mm -136.69 128.51 43.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.82 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.944 HD11 HD13 ' A' ' 51' ' ' LEU . 62.5 mt . . . . . 0 CA--C 1.511 -0.525 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 176.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.614 HG11 HD13 ' A' ' 25' ' ' LEU . 21.8 t . . . . . 0 CA--C 1.521 -0.154 0 CA-C-O 120.785 0.326 . . . . 0.0 110.844 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 5' ' ' ASP . . . . . 0.682 ' OD2' HD22 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -104.32 131.87 51.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.515 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.933 ' HA ' HD23 ' A' ' 25' ' ' LEU . 8.5 p -85.34 119.6 25.89 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.339 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.801 ' O ' HD12 ' A' ' 22' ' ' LEU . 26.5 m . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.326 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.613 HG23 ' N ' ' A' ' 11' ' ' SER . 0.7 OUTLIER . . . . . 0 CA--C 1.535 0.394 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.701 ' HA ' HD13 ' A' ' 90' ' ' ILE . 17.8 p -93.42 171.31 8.99 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.05 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.651 ' CG2' HD12 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -158.74 173.62 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.932 -179.594 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 4.4 ptt85 -153.19 134.67 14.35 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.262 0.553 . . . . 0.0 111.013 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.912 ' HB3' HD23 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -131.67 145.43 51.65 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.279 -179.535 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.479 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 2.3 t80 -87.11 148.28 25.29 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.65 ' HE2' HD12 ' A' ' 81' ' ' ILE . 2.0 tptt -84.34 27.67 0.68 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.058 178.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.908 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.1 OUTLIER 45.51 29.43 0.62 Allowed 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 178.939 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.593 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 43.5 24.77 0.06 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.074 0.55 . . . . 0.0 112.476 -178.348 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.908 HG22 ' O ' ' A' ' 17' ' ' ARG . 10.7 m -165.81 32.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.785 178.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 48.54 66.9 1.87 Allowed Glycine 0 C--N 1.338 0.677 0 CA-C-N 115.733 -0.667 . . . . 0.0 113.02 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -152.26 65.25 0.36 Allowed Glycine 0 C--N 1.333 0.364 0 N-CA-C 111.698 -0.561 . . . . 0.0 111.698 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.912 HD23 ' HB3' ' A' ' 14' ' ' LEU . 4.2 mp -48.2 -24.55 1.19 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 40' ' ' LEU . . . 112.6 7.41 22.3 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.241 -0.981 . . . . 0.0 113.578 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.924 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -160.06 139.56 11.13 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 117.98 0.89 . . . . 0.0 113.103 -179.585 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.882 HD23 ' HA ' ' B' ' 6' ' ' SER . 6.1 mt -79.69 171.31 15.31 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.391 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.0 m -153.18 152.02 10.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.016 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.429 ' HG2' HG22 ' A' ' 36' ' ' ILE . 6.8 ptmt -137.39 110.3 7.68 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.394 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.469 ' HB3' ' CG ' ' A' ' 71' ' ' TYR . 1.1 tm-20 -101.96 96.74 7.23 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.34 116.76 3.25 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.311 0.577 . . . . 0.0 111.304 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.401 ' H ' HG23 ' A' ' 30' ' ' VAL . 39.6 t . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.626 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.46 HD12 ' HA ' ' A' ' 36' ' ' ILE . 1.1 tp . . . . . 0 CA--C 1.535 0.397 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.661 HD12 ' O ' ' A' ' 53' ' ' GLN . 33.8 mt -86.18 149.48 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.115 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.859 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.54 ' CB ' HG13 ' B' ' 4' ' ' VAL . 1.7 t -114.67 -39.61 3.73 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.727 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 6.6 t0 -173.46 135.74 0.56 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.22 -0.592 . . . . 0.0 112.206 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.924 HD23 ' HB3' ' A' ' 24' ' ' PHE . 28.2 mt -70.39 99.42 1.57 Allowed 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.575 HD13 HD21 ' A' ' 25' ' ' LEU . 1.4 tp -54.05 -58.39 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -176.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.462 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.8 OUTLIER -93.2 -68.38 0.8 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.175 0.512 . . . . 0.0 112.269 -177.489 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.49 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 112.01 18.14 7.97 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.618 -178.172 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.4 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -126.08 -28.0 1.07 Allowed Glycine 0 C--N 1.34 0.786 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.737 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.772 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -93.72 -83.11 0.33 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 117.914 0.857 . . . . 0.0 111.308 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.842 ' HB1' HG21 ' A' ' 52' ' ' ILE . . . -62.18 -60.36 3.7 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.5 0.667 . . . . 0.0 111.317 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.631 ' HB2' HD22 ' A' ' 40' ' ' LEU . 17.5 tp10 -48.77 -39.63 25.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.71 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.4 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 11.4 tp-100 -61.77 -36.2 80.36 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.3 t -54.06 -47.42 71.67 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.401 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.11 -20.27 33.49 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.302 -0.951 . . . . 0.0 113.905 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.62 ' CD1' HG11 ' A' ' 12' ' ' VAL . 0.1 OUTLIER -94.74 -31.01 13.97 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.899 0.38 . . . . 0.0 110.178 179.588 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.842 HG21 ' HB1' ' A' ' 46' ' ' ALA . 2.6 mp -80.44 119.6 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.064 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.661 ' O ' HD12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -152.52 155.77 38.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.178 179.756 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.727 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -67.98 123.79 21.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.914 0.388 . . . . 0.0 110.875 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.25 2.99 90.73 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.246 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -83.25 -88.94 0.09 Allowed 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 116.997 0.399 . . . . 0.0 110.981 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.6 tp -162.68 126.23 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.907 HD11 HG22 ' A' ' 61' ' ' VAL . 3.2 tp -149.76 87.99 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.074 177.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.3 tp -81.68 -66.35 0.9 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.721 -178.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.15 158.43 25.94 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.697 0.284 . . . . 0.0 111.594 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.907 HG22 HD11 ' A' ' 58' ' ' ILE . 3.3 t -153.36 148.64 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.967 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.467 HD22 HG12 ' A' ' 61' ' ' VAL . 1.2 p30 44.28 46.67 7.68 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.162 0.506 . . . . 0.0 111.756 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.0 t70 51.99 26.65 3.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.787 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.735 ' HD3' HG11 ' A' ' 77' ' ' VAL . 12.1 mmm180 -111.59 113.79 53.0 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.826 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.685 ' O ' HD22 ' A' ' 69' ' ' LEU . 31.5 Cg_exo -59.22 84.84 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 121.772 1.648 . . . . 0.0 110.733 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.508 HD12 HD21 ' A' ' 69' ' ' LEU . 12.7 tp -86.83 66.77 9.59 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.354 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.503 HG23 ' H ' ' A' ' 68' ' ' ASP . 3.2 m -128.61 -55.19 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.665 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.503 ' H ' HG23 ' A' ' 67' ' ' VAL . 17.5 t70 -140.1 26.03 2.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.788 0.328 . . . . 0.0 111.648 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.955 HD11 ' HB2' ' A' ' 74' ' ' ALA . 1.4 pt? -94.92 -175.91 3.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.322 -0.399 . . . . 0.0 109.959 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.1 m -71.89 101.52 2.68 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 177.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.882 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 6.5 t80 -40.54 -58.23 1.64 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -178.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -59.36 -26.59 65.2 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.159 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.887 ' O ' HG23 ' A' ' 77' ' ' VAL . 16.3 t -76.21 -42.0 47.58 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.179 0.514 . . . . 0.0 109.95 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.955 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -66.94 -36.92 83.32 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.797 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.882 HD11 ' CZ ' ' A' ' 71' ' ' TYR . 51.0 mt -70.9 -29.64 65.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.162 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -76.75 -37.84 55.25 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.085 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.887 HG23 ' O ' ' A' ' 73' ' ' SER . 11.0 t -62.89 -43.49 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.401 ' CD2' ' HA ' ' A' ' 75' ' ' LEU . 1.2 pp -73.81 -26.85 60.83 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.25 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.468 ' NH1' HG12 ' B' ' 7' ' ' VAL . 0.0 OUTLIER -64.24 -35.49 81.0 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.0 0.428 . . . . 0.0 110.122 179.509 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.97 -19.71 59.26 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.817 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.65 HD12 ' HE2' ' A' ' 16' ' ' LYS . 68.5 mt -58.86 105.63 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-O 120.869 0.366 . . . . 0.0 110.692 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.6 -165.83 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.666 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.5 -171.41 2.37 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.053 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 43.77 31.67 0.5 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.31 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.411 ' O ' ' CD1' ' A' ' 15' ' ' PHE . 1.8 t -128.71 162.4 27.48 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.775 0.798 . . . . 0.0 112.878 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -104.86 176.09 5.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.004 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.568 HG21 ' NZ ' ' A' ' 16' ' ' LYS . 0.5 OUTLIER -146.98 159.21 9.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.036 -179.554 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.606 ' C ' HD23 ' A' ' 89' ' ' LEU . 39.3 t -118.84 158.59 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.651 HD12 ' CG2' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -160.23 169.63 22.83 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.758 0.314 . . . . 0.0 110.835 -178.301 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.701 HD13 ' HA ' ' A' ' 11' ' ' SER . 47.7 mm -129.45 130.81 67.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.391 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.409 HD11 HD12 ' A' ' 51' ' ' LEU . 8.5 mt . . . . . 0 CA--C 1.517 -0.317 0 CA-C-N 115.478 -0.783 . . . . 0.0 108.978 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.54 HG13 ' CB ' ' A' ' 38' ' ' SER . 19.8 t . . . . . 0 CA--C 1.521 -0.143 0 CA-C-O 120.952 0.406 . . . . 0.0 110.584 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -98.65 129.55 45.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.907 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.882 ' HA ' HD23 ' A' ' 25' ' ' LEU . 8.8 p -83.42 129.24 34.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.39 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.683 ' OXT' HD12 ' A' ' 22' ' ' LEU . 17.2 m . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.133 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.628 HG23 ' N ' ' A' ' 11' ' ' SER . 1.4 tp . . . . . 0 CA--C 1.536 0.442 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.697 ' HA ' HD13 ' A' ' 90' ' ' ILE . 8.0 p -92.18 164.48 13.55 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.555 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.81 ' CG1' HD12 ' A' ' 89' ' ' LEU . 2.3 t -154.14 158.83 3.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.594 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.8 ttp-105 -140.24 144.11 36.33 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.552 0.691 . . . . 0.0 111.103 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.832 HD21 ' HB2' ' A' ' 46' ' ' ALA . 0.5 OUTLIER -141.09 177.72 7.88 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.283 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.431 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 3.2 t80 -124.19 148.68 47.09 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.412 ' O ' ' N ' ' A' ' 20' ' ' GLY . 12.6 mtpt -83.77 30.89 0.48 Allowed 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.183 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.896 ' O ' HG22 ' A' ' 19' ' ' VAL . 2.2 mmm180 40.78 31.24 0.11 Allowed 'General case' 0 C--N 1.347 0.46 0 CA-C-O 121.086 0.47 . . . . 0.0 111.887 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.621 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 43.85 24.68 0.07 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.456 -178.391 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.896 HG22 ' O ' ' A' ' 17' ' ' ARG . 9.8 m -166.11 32.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.035 178.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 50.56 64.54 3.59 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.943 -178.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -148.23 66.18 0.4 Allowed Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.826 ' CD2' HG11 ' A' ' 87' ' ' VAL . 4.4 mp -49.5 -23.22 1.49 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.459 ' HA2' HG22 ' A' ' 41' ' ' ILE . . . 106.41 8.27 33.38 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.167 -1.016 . . . . 0.0 112.847 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.874 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -160.23 140.4 11.54 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 117.658 0.729 . . . . 0.0 112.483 -179.655 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.728 HD23 ' N ' ' B' ' 6' ' ' SER . 14.1 mt -79.05 166.61 22.13 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.909 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.5 m -151.78 143.81 16.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.268 177.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.7 tttp -136.41 120.9 18.2 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.907 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.598 ' HG3' HD22 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -113.62 112.01 22.79 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.521 178.488 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.61 124.26 21.89 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.904 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.0 t . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.162 -179.496 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 36' ' ' ILE . 1.5 tp . . . . . 0 CA--C 1.533 0.298 0 CA-C-O 120.574 0.226 . . . . 0.0 111.373 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.696 HD12 ' O ' ' A' ' 53' ' ' GLN . 17.2 mt -79.53 141.46 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.981 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.559 ' CB ' HG13 ' B' ' 4' ' ' VAL . 1.9 t -106.24 -39.21 6.01 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.575 ' HB3' HD12 ' A' ' 25' ' ' LEU . 35.8 t0 -175.23 144.02 0.7 Allowed 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.874 HD23 ' HB3' ' A' ' 24' ' ' PHE . 38.1 mt -76.02 101.2 5.17 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.33 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.557 HD13 ' HB2' ' B' ' 6' ' ' SER . 0.8 OUTLIER -56.65 -59.22 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -176.525 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.46 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -93.02 -65.73 0.98 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -177.465 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.448 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 110.36 21.49 6.9 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.51 -178.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.94 -28.12 0.89 Allowed Glycine 0 C--N 1.339 0.741 0 C-N-CA 120.825 -0.702 . . . . 0.0 113.704 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.761 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -93.39 -83.17 0.33 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 117.996 0.898 . . . . 0.0 111.727 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.992 ' HB1' HG21 ' A' ' 52' ' ' ILE . . . -64.17 -58.56 6.23 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.327 0.584 . . . . 0.0 111.046 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.672 ' HB2' HD22 ' A' ' 40' ' ' LEU . 12.1 tp10 -48.77 -42.61 36.16 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.725 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -61.57 -35.12 76.9 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.529 ' HB2' HD13 ' A' ' 52' ' ' ILE . 2.8 m -53.84 -49.92 67.35 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.97 178.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 113.52 -31.74 6.46 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.212 -0.994 . . . . 0.0 114.337 178.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.779 ' O ' HD12 ' A' ' 51' ' ' LEU . 1.9 pp -98.63 11.46 38.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.675 0.737 . . . . 0.0 111.715 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.992 HG21 ' HB1' ' A' ' 46' ' ' ALA . 4.6 mp -113.28 88.42 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-O 121.016 0.436 . . . . 0.0 110.478 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.696 ' O ' HD12 ' A' ' 37' ' ' ILE . 2.2 tp60 -112.69 148.11 35.37 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.611 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.557 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -70.39 140.88 52.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.046 0.45 . . . . 0.0 111.967 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.96 19.09 69.47 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.089 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -105.69 -81.49 0.54 Allowed 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.495 ' CG2' HD13 ' A' ' 91' ' ' LEU . 28.7 mm -152.51 125.92 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 121.503 0.668 . . . . 0.0 112.536 -177.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.568 HG23 ' O ' ' A' ' 58' ' ' ILE . 2.3 tp -161.21 76.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.469 177.151 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.544 ' CD1' HG12 ' A' ' 67' ' ' VAL . 5.2 tp -78.69 -63.15 1.48 Allowed 'General case' 0 C--N 1.328 -0.354 0 O-C-N 122.177 -0.327 . . . . 0.0 111.581 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.638 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . . . -109.51 149.97 28.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.859 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.565 HG22 HD11 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -160.92 143.4 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.473 -179.371 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.427 ' HB3' HD11 ' A' ' 81' ' ' ILE . 53.2 m-80 60.89 33.72 19.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.19 0.519 . . . . 0.0 111.879 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 57.91 21.29 7.48 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 178.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.754 ' NH2' HD12 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -121.55 124.55 27.14 Favored Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 120.631 -0.428 . . . . 0.0 109.909 177.586 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.796 ' O ' HD22 ' A' ' 69' ' ' LEU . 19.2 Cg_endo -58.16 88.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 122.205 1.936 . . . . 0.0 112.117 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.754 HD12 ' NH2' ' A' ' 64' ' ' ARG . 0.6 OUTLIER -87.43 67.52 9.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.304 0.573 . . . . 0.0 109.762 179.566 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.544 HG12 ' CD1' ' A' ' 59' ' ' LEU . 3.1 m -126.06 -59.08 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -178.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.513 ' H ' HG23 ' A' ' 67' ' ' VAL . 2.0 p30 -131.47 25.51 4.79 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.796 HD22 ' O ' ' A' ' 65' ' ' PRO . 1.6 pt? -102.5 -172.68 2.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.811 0.338 . . . . 0.0 110.457 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.82 111.47 9.0 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.558 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 8.0 t80 -43.95 -47.52 8.5 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.902 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -67.68 -32.48 73.18 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.17 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.785 ' O ' HG23 ' A' ' 77' ' ' VAL . 3.1 m -70.67 -36.27 73.26 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.341 0.591 . . . . 0.0 109.851 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.635 ' HB1' ' HG ' ' A' ' 66' ' ' LEU . . . -66.09 -49.92 65.89 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.477 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.558 HD11 ' CZ ' ' A' ' 71' ' ' TYR . 48.4 mt -63.42 -28.07 69.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.49 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -71.36 -40.27 70.74 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 73' ' ' SER . 40.6 t -58.38 -42.31 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.61 178.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.565 ' O ' HD12 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -72.07 -35.28 69.23 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.197 178.774 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.91 -37.12 68.47 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.023 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -58.97 -19.98 47.05 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.84 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.548 HG22 HG21 ' A' ' 85' ' ' THR . 55.9 mt -66.36 119.43 11.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.938 0.399 . . . . 0.0 111.231 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.65 -162.16 0.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.13 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.5 m -94.76 -171.36 2.44 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.633 0.254 . . . . 0.0 110.739 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 44.61 30.99 0.57 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.929 0.395 . . . . 0.0 111.207 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.548 HG21 HG22 ' A' ' 81' ' ' ILE . 3.1 t -125.81 161.88 26.38 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.956 0.884 . . . . 0.0 112.908 -178.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -99.15 176.52 5.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.231 -1.35 . . . . 0.0 110.504 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.826 HG11 ' CD2' ' A' ' 22' ' ' LEU . 6.3 p -147.65 153.53 11.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.864 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.759 ' O ' HD23 ' A' ' 89' ' ' LEU . 25.3 t -113.83 159.72 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.585 0.231 . . . . 0.0 110.65 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.81 HD12 ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -153.15 158.97 42.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.797 0.332 . . . . 0.0 110.932 -178.883 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.697 HD13 ' HA ' ' A' ' 11' ' ' SER . 46.9 mm -131.82 124.19 53.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.19 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.495 HD13 ' CG2' ' A' ' 57' ' ' ILE . 0.2 OUTLIER . . . . . 0 CA--C 1.52 -0.209 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.291 178.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.559 HG13 ' CB ' ' A' ' 38' ' ' SER . 13.2 t . . . . . 0 N--CA 1.461 0.116 0 CA-C-O 120.76 0.314 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 5' ' ' ASP . . . . . 0.551 ' HB3' HG13 ' B' ' 7' ' ' VAL . 29.8 m-20 -146.75 124.95 12.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.308 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.728 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -59.48 -58.66 7.65 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.04 179.33 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.551 HG13 ' HB3' ' B' ' 5' ' ' ASP . 31.8 m . . . . . 0 C--O 1.251 1.153 0 CA-C-O 118.389 -0.815 . . . . 0.0 112.808 178.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.521 ' N ' HD12 ' A' ' 10' ' ' ILE . 2.1 mp . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.322 0.582 . . . . 0.0 111.762 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.796 ' HA ' HD13 ' A' ' 90' ' ' ILE . 0.2 OUTLIER -97.18 169.92 9.46 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.372 -179.832 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.628 ' HB ' HD12 ' A' ' 89' ' ' LEU . 0.7 OUTLIER -156.85 163.33 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.089 -178.131 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.16 120.97 7.58 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.494 0.664 . . . . 0.0 110.584 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.732 ' C ' HG12 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -123.39 178.19 5.27 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.578 -179.64 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.47 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 2.5 t80 -119.31 150.04 40.8 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.412 ' CE ' ' HA2' ' A' ' 20' ' ' GLY . 14.3 mtpt -86.36 28.71 0.82 Allowed 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.066 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.864 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 43.81 30.76 0.41 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.968 0.413 . . . . 0.0 111.925 179.532 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.651 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 44.33 23.3 0.06 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.952 -178.716 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.864 HG22 ' O ' ' A' ' 17' ' ' ARG . 4.0 m -166.41 33.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.069 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.412 ' HA2' ' CE ' ' A' ' 16' ' ' LYS . . . 49.54 66.57 2.19 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-N 115.435 -0.802 . . . . 0.0 113.088 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -148.07 61.19 0.45 Allowed Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.821 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 4.4 mp -46.91 -26.78 1.06 Allowed 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.434 ' HA2' HG22 ' A' ' 41' ' ' ILE . . . 112.36 5.1 24.92 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.3 -0.953 . . . . 0.0 113.915 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.946 ' HB3' HD23 ' A' ' 40' ' ' LEU . 1.2 p90 -155.95 141.22 17.54 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.237 1.018 . . . . 0.0 113.284 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.806 HD23 ' HA ' ' B' ' 6' ' ' SER . 7.8 mt -79.56 168.22 19.7 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.038 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.5 m -149.01 147.21 16.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.737 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.0 ttpt -129.34 118.93 23.03 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.01 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.48 ' HB3' ' CD1' ' A' ' 71' ' ' TYR . 4.1 tm-20 -114.14 97.19 6.21 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.79 -1.095 . . . . 0.0 108.541 177.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.04 120.23 7.66 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.049 0.452 . . . . 0.0 110.932 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.444 -179.84 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.417 HD12 ' HA ' ' A' ' 36' ' ' ILE . 1.1 tp . . . . . 0 CA--C 1.537 0.461 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.542 HD12 ' O ' ' A' ' 53' ' ' GLN . 27.8 mt -84.29 141.25 14.95 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 CA-C-O 120.708 0.29 . . . . 0.0 110.71 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.796 ' CB ' HG13 ' B' ' 4' ' ' VAL . 0.1 OUTLIER -108.89 -36.64 6.06 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -179.833 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.639 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 4.9 t70 -169.21 132.61 1.32 Allowed 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.319 -0.552 . . . . 0.0 112.381 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.946 HD23 ' HB3' ' A' ' 24' ' ' PHE . 54.1 mt -70.26 78.49 0.53 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 121.701 0.762 . . . . 0.0 109.876 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.75 HD13 HD21 ' A' ' 25' ' ' LEU . 1.7 tp -33.06 -58.85 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 -177.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.461 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -94.42 -68.88 0.78 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -177.706 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.425 ' HA2' ' CB ' ' A' ' 47' ' ' GLU . . . 108.7 25.59 5.65 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -178.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.38 -34.08 0.51 Allowed Glycine 0 C--N 1.337 0.609 0 C-N-CA 121.145 -0.55 . . . . 0.0 113.182 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.821 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -92.74 -80.43 0.37 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 117.546 0.673 . . . . 0.0 110.908 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.787 ' HB1' ' CG2' ' A' ' 52' ' ' ILE . . . -60.29 -58.04 10.21 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.222 0.534 . . . . 0.0 111.389 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.425 ' CB ' ' HA2' ' A' ' 43' ' ' GLY . 39.2 tt0 -48.7 -46.92 41.27 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.83 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.6 tp-100 -57.87 -33.85 69.14 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.874 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.1 t -55.05 -52.16 64.04 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.752 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 112.27 -22.58 17.64 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.299 -0.953 . . . . 0.0 113.859 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.488 ' HG ' HD12 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -97.07 -28.2 14.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.955 0.377 . . . . 0.0 110.728 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.787 ' CG2' ' HB1' ' A' ' 46' ' ' ALA . 2.3 mp -82.37 121.28 35.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.025 0.441 . . . . 0.0 110.328 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.619 ' HA ' HD11 ' A' ' 40' ' ' LEU . 1.5 mt-30 -153.74 156.45 37.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.101 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.639 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -66.52 120.06 12.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.877 0.37 . . . . 0.0 110.954 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.0 -1.73 88.43 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.294 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.34 -91.34 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 117.011 0.406 . . . . 0.0 110.511 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.87 ' CG2' HD13 ' A' ' 91' ' ' LEU . 2.8 tp -163.98 120.5 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.592 HG23 ' O ' ' A' ' 58' ' ' ILE . 2.0 tp -140.14 88.67 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 18.2 tp -78.33 -70.3 0.5 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.598 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -121.16 165.46 15.35 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.803 0.335 . . . . 0.0 111.109 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.581 HG22 HD11 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -148.3 157.23 8.26 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.267 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.128 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.54 ' HA ' HG22 ' A' ' 87' ' ' VAL . 0.0 OUTLIER 56.71 -81.21 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.046 0.538 . . . . 0.0 110.214 -178.589 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 61' ' ' VAL . 14.5 p-10 -175.22 36.99 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.344 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.673 ' NH1' ' HB1' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -124.08 130.32 24.43 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.24 179.887 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.504 ' O ' HD22 ' A' ' 69' ' ' LEU . 17.1 Cg_exo -63.58 86.41 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 121.206 1.27 . . . . 0.0 110.322 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.677 ' HG ' ' HB1' ' A' ' 74' ' ' ALA . 0.3 OUTLIER -86.71 68.21 10.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.286 0.565 . . . . 0.0 110.916 -178.887 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.572 HG23 ' H ' ' A' ' 68' ' ' ASP . 2.7 m -131.62 -61.53 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.572 ' H ' HG23 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -127.73 28.33 5.63 Favored 'General case' 0 C--N 1.333 -0.13 0 O-C-N 121.978 -0.451 . . . . 0.0 111.735 -178.644 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' A' ' 74' ' ' ALA . 1.6 pt? -99.85 -172.06 2.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.498 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.32 114.63 15.22 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.642 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 4.0 t80 -44.2 -50.98 8.54 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -64.81 -29.11 70.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.339 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.835 ' O ' HG23 ' A' ' 77' ' ' VAL . 39.0 t -71.23 -40.57 71.0 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.278 0.561 . . . . 0.0 110.048 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.677 ' HB1' ' HG ' ' A' ' 66' ' ' LEU . . . -65.77 -45.17 83.52 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.368 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.642 HD11 ' CZ ' ' A' ' 71' ' ' TYR . 73.9 mt -63.69 -28.73 70.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.868 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -76.41 -36.09 58.24 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.812 0.339 . . . . 0.0 110.177 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.835 HG23 ' O ' ' A' ' 73' ' ' SER . 10.8 t -61.36 -41.43 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.795 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.565 HD21 HG11 ' B' ' 7' ' ' VAL . 0.6 OUTLIER -76.31 -32.15 58.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.511 179.071 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.443 ' NH1' HG12 ' B' ' 7' ' ' VAL . 0.0 OUTLIER -62.32 -32.16 72.88 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.795 -179.468 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.26 -17.59 61.81 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.715 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.478 HD11 ' HB3' ' A' ' 62' ' ' ASN . 29.5 mt -63.25 136.77 25.68 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 CA-C-O 120.867 0.365 . . . . 0.0 110.828 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.46 -165.42 0.78 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.507 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.43 -172.12 2.27 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.098 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 38.0 34.67 0.07 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.105 0.562 . . . . 0.0 111.5 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.416 ' O ' ' CE1' ' A' ' 15' ' ' PHE . 1.8 t -126.37 163.63 22.86 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.925 0.869 . . . . 0.0 113.21 -177.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.403 ' CE1' ' HD2' ' A' ' 15' ' ' PHE . 0.3 OUTLIER -96.3 177.33 5.74 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 114.158 -1.383 . . . . 0.0 110.051 179.016 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.732 HG12 ' C ' ' A' ' 14' ' ' LEU . 2.3 p -150.77 145.98 16.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.338 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.896 ' O ' HD23 ' A' ' 89' ' ' LEU . 21.2 t -101.9 159.3 4.23 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.015 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.896 HD23 ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -155.16 165.91 35.23 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.319 -179.784 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.796 HD13 ' HA ' ' A' ' 11' ' ' SER . 29.6 mm -132.58 130.31 59.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.188 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.87 HD13 ' CG2' ' A' ' 57' ' ' ILE . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.024 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.796 HG13 ' CB ' ' A' ' 38' ' ' SER . 3.5 t . . . . . 0 N--CA 1.465 0.322 0 CA-C-O 120.878 0.371 . . . . 0.0 111.963 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 5' ' ' ASP . . . . . 0.53 ' O ' HD22 ' A' ' 25' ' ' LEU . 0.9 OUTLIER 58.21 -124.6 1.5 Allowed 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 119.44 -0.314 . . . . 0.0 110.348 179.876 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.806 ' HA ' HD23 ' A' ' 25' ' ' LEU . 5.8 p 167.8 127.91 0.01 OUTLIER 'General case' 0 C--N 1.347 0.475 0 CA-C-N 118.605 0.639 . . . . 0.0 110.336 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.565 HG11 HD21 ' A' ' 78' ' ' LEU . 4.5 m . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.232 -0.89 . . . . 0.0 111.251 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.59 HG23 ' N ' ' A' ' 11' ' ' SER . 0.5 OUTLIER . . . . . 0 CA--C 1.537 0.473 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.633 ' HA ' HD13 ' A' ' 90' ' ' ILE . 13.9 m -77.37 167.76 21.15 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -178.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.829 ' CG1' HD12 ' A' ' 89' ' ' LEU . 1.9 t -157.87 157.83 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 114.083 -1.417 . . . . 0.0 107.894 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.465 ' O ' HD12 ' A' ' 14' ' ' LEU . 11.3 ttp180 -141.69 141.92 33.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.406 0.622 . . . . 0.0 111.727 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.905 HD21 ' HB2' ' A' ' 46' ' ' ALA . 0.8 OUTLIER -142.96 177.44 8.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.876 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.444 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 3.5 t80 -124.49 147.86 48.08 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.659 ' HE3' HD11 ' A' ' 22' ' ' LEU . 1.5 mtpt -84.12 32.62 0.49 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.481 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.795 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.3 OUTLIER 40.53 32.13 0.13 Allowed 'General case' 0 C--N 1.344 0.343 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 179.222 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.72 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 45.0 24.66 0.12 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.551 -178.497 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.795 HG22 ' O ' ' A' ' 17' ' ' ARG . 1.6 m -169.23 34.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.317 178.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 49.94 63.91 3.89 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 115.56 -0.746 . . . . 0.0 113.062 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -145.97 62.22 0.47 Allowed Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.844 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 4.1 mp -46.24 -24.83 0.52 Allowed 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -178.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.473 ' HA2' HG22 ' A' ' 41' ' ' ILE . . . 107.96 6.99 31.8 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.039 -1.076 . . . . 0.0 113.587 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.909 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -157.15 140.78 15.87 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -178.92 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.808 HD23 ' HA ' ' B' ' 6' ' ' SER . 7.3 mt -79.92 171.06 15.62 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.671 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.5 m -149.85 153.2 10.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.506 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.2 105.13 5.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.479 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.493 ' HB3' ' CG ' ' A' ' 71' ' ' TYR . 0.6 OUTLIER -108.44 139.22 43.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.076 178.93 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.7 mtt-85 -76.6 124.5 27.71 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.05 0.453 . . . . 0.0 110.37 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.7 t . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.042 -179.648 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.43 HD12 ' HA ' ' A' ' 36' ' ' ILE . 1.4 tp . . . . . 0 CA--C 1.537 0.448 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.8 HD12 ' O ' ' A' ' 53' ' ' GLN . 24.2 mt -81.27 145.93 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.464 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.458 ' CB ' HG13 ' B' ' 4' ' ' VAL . 4.9 t -109.32 -40.58 4.88 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.702 ' CB ' HD12 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -164.9 131.78 2.98 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.863 -179.452 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.909 HD23 ' HB3' ' A' ' 24' ' ' PHE . 43.1 mt -70.14 76.74 0.51 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.712 0.767 . . . . 0.0 109.698 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.476 ' CD1' HD21 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -30.58 -59.16 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -177.999 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.46 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -94.44 -66.25 0.93 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -177.857 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.421 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 104.65 23.5 7.86 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -177.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.444 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -125.45 -30.1 0.94 Allowed Glycine 0 C--N 1.338 0.687 0 C-N-CA 121.24 -0.505 . . . . 0.0 113.159 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.844 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -95.84 -83.25 0.37 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 117.686 0.743 . . . . 0.0 111.932 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.905 ' HB2' HD21 ' A' ' 14' ' ' LEU . . . -59.95 -58.79 7.03 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.207 0.527 . . . . 0.0 111.04 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.421 ' HB3' ' HA2' ' A' ' 43' ' ' GLY . 33.9 tt0 -45.06 -49.42 11.55 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.971 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' A' ' 44' ' ' GLY . 7.6 mt-30 -55.65 -39.04 70.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.493 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.42 -49.9 63.61 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.343 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.4 -26.99 13.21 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.301 -0.952 . . . . 0.0 113.746 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.987 HD13 HD11 ' A' ' 91' ' ' LEU . 2.1 pp -95.65 -0.98 51.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.107 0.453 . . . . 0.0 111.471 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.866 HG21 ' HB1' ' A' ' 46' ' ' ALA . 5.0 mp -109.79 123.99 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.8 ' O ' HD12 ' A' ' 37' ' ' ILE . 1.7 mp0 -150.93 160.12 44.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.735 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.49 129.81 40.74 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.925 0.393 . . . . 0.0 111.265 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.35 13.73 63.13 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.101 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.27 -80.84 0.39 Allowed 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 22.4 mt -155.24 122.7 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.567 HD11 ' HB ' ' A' ' 61' ' ' VAL . 3.2 tp -160.25 71.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 114.867 -1.061 . . . . 0.0 109.222 177.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.47 HD11 HG11 ' A' ' 67' ' ' VAL . 9.2 tp -76.93 -54.13 6.97 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.643 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.642 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . . . -121.08 160.04 24.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.835 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.692 HG12 HD12 ' A' ' 66' ' ' LEU . 14.4 p -166.75 146.05 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.043 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.635 ' ND2' HG22 ' A' ' 61' ' ' VAL . 0.1 OUTLIER 45.76 41.13 7.15 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.198 0.523 . . . . 0.0 111.56 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.4 t70 59.74 28.44 17.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.221 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.49 ' NH2' HG21 ' A' ' 77' ' ' VAL . 25.5 mmm180 -119.61 98.24 49.93 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.572 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.4 ' O ' HD22 ' A' ' 69' ' ' LEU . 22.4 Cg_endo -61.27 85.37 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 121.811 1.674 . . . . 0.0 110.896 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.692 HD12 HG12 ' A' ' 61' ' ' VAL . 13.4 mt -68.75 63.69 0.11 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.508 -178.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.552 HG23 ' H ' ' A' ' 68' ' ' ASP . 3.4 m -141.81 -61.09 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.552 ' H ' HG23 ' A' ' 67' ' ' VAL . 16.4 t0 -111.7 29.38 7.9 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 122.127 -0.358 . . . . 0.0 111.736 -178.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.665 HD21 ' HB2' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -123.19 175.31 6.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.644 179.598 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.5 m -72.66 102.33 3.28 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.748 ' CE1' HD11 ' A' ' 75' ' ' LEU . 8.5 t80 -40.14 -60.99 0.95 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.363 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.515 ' HA ' HD12 ' A' ' 75' ' ' LEU . 6.8 p30 -55.49 -28.42 54.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.404 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.886 ' O ' HG23 ' A' ' 77' ' ' VAL . 43.8 m -78.07 -39.94 40.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.087 0.47 . . . . 0.0 109.856 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.665 ' HB2' HD21 ' A' ' 69' ' ' LEU . . . -60.47 -34.73 74.46 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.294 0.568 . . . . 0.0 109.944 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.748 HD11 ' CE1' ' A' ' 71' ' ' TYR . 15.1 mt -75.02 -38.04 61.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.242 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.41 ' HA ' ' HB2' ' A' ' 79' ' ' ARG . 5.0 pt-20 -72.07 -38.73 69.39 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.98 0.419 . . . . 0.0 110.19 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.886 HG23 ' O ' ' A' ' 73' ' ' SER . 45.1 t -62.33 -42.93 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.772 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.541 ' C ' HD12 ' A' ' 78' ' ' LEU . 4.5 pp -79.85 -21.91 43.55 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.12 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.535 ' N ' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -66.77 -37.18 84.08 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-O 120.988 0.423 . . . . 0.0 110.335 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -58.27 -19.07 38.07 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.192 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.406 ' HB ' ' HD2' ' A' ' 16' ' ' LYS . 70.8 mt -54.27 121.99 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 120.953 0.406 . . . . 0.0 111.006 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.77 -163.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.653 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.3 m -96.42 -171.67 2.34 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.996 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 44.08 30.82 0.46 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.232 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.404 ' O ' ' CE1' ' A' ' 15' ' ' PHE . 1.7 t -125.37 158.76 33.48 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 122.046 0.927 . . . . 0.0 112.737 -178.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -100.34 176.28 5.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.969 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.806 HG12 ' C ' ' A' ' 14' ' ' LEU . 4.8 p -148.66 153.14 11.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.22 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.726 ' O ' HD23 ' A' ' 89' ' ' LEU . 34.1 t -113.56 160.43 13.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.829 HD12 ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -155.89 172.64 18.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.64 0.257 . . . . 0.0 110.597 -178.736 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.642 ' HB ' ' HB3' ' A' ' 60' ' ' ALA . 29.6 mm -137.25 126.37 35.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.987 HD11 HD13 ' A' ' 51' ' ' LEU . 11.6 mt . . . . . 0 CA--C 1.515 -0.396 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.458 HG13 ' CB ' ' A' ' 38' ' ' SER . 4.2 t . . . . . 0 N--CA 1.463 0.204 0 CA-C-O 120.823 0.344 . . . . 0.0 110.67 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 5' ' ' ASP . . . . . 0.515 ' CG ' HD13 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -86.28 -98.09 0.07 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.927 -179.608 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.808 ' HA ' HD23 ' A' ' 25' ' ' LEU . 2.6 p 162.75 130.41 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 122.794 0.438 . . . . 0.0 110.406 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.712 ' OXT' HD12 ' A' ' 22' ' ' LEU . 15.5 m . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.182 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.649 HG23 ' N ' ' A' ' 11' ' ' SER . 1.5 tp . . . . . 0 CA--C 1.539 0.528 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.72 ' HA ' HD13 ' A' ' 90' ' ' ILE . 10.1 m -100.61 168.42 9.72 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 121.572 0.701 . . . . 0.0 112.684 -178.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.73 ' CG1' HD12 ' A' ' 89' ' ' LEU . 2.2 t -156.18 164.36 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.961 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.43 ' H ' HG12 ' A' ' 12' ' ' VAL . 1.5 tpp85 -149.83 127.69 11.8 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.508 0.67 . . . . 0.0 110.744 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.763 ' C ' HG12 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -128.37 178.25 6.4 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.838 -1.073 . . . . 0.0 110.094 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.456 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 4.0 t80 -122.03 151.22 41.07 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 20' ' ' GLY . 2.1 mmpt? -83.37 30.95 0.46 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.405 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.889 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.9 OUTLIER 40.91 31.21 0.12 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 122.865 0.466 . . . . 0.0 112.061 179.679 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.614 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 44.15 24.35 0.08 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.286 0.634 . . . . 0.0 112.419 -177.992 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.889 HG22 ' O ' ' A' ' 17' ' ' ARG . 6.6 m -165.98 32.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.108 178.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 50.45 68.16 1.56 Allowed Glycine 0 C--N 1.337 0.608 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.991 -178.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -155.08 69.48 0.29 Allowed Glycine 0 C--N 1.332 0.327 0 N-CA-C 111.529 -0.629 . . . . 0.0 111.529 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.802 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 4.5 mp -49.4 -21.3 0.86 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -179.007 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.441 ' HA2' HG22 ' A' ' 41' ' ' ILE . . . 107.78 5.15 33.82 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.169 -1.015 . . . . 0.0 113.32 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.913 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -157.58 138.12 12.95 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 117.794 0.797 . . . . 0.0 112.844 -179.583 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.992 HD23 ' HA ' ' B' ' 6' ' ' SER . 1.8 mt -78.68 165.28 23.81 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.374 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.3 m -147.7 154.31 11.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.161 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -137.7 121.28 17.29 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.259 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.465 ' HB3' ' CD1' ' A' ' 71' ' ' TYR . 0.9 OUTLIER -115.03 95.21 5.1 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.167 178.538 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.9 mtt180 -62.16 116.84 5.31 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.117 0.484 . . . . 0.0 110.493 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.8 t . . . . . 0 C--N 1.328 -0.33 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -179.461 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.4 HD12 ' HA ' ' A' ' 36' ' ' ILE . 0.6 OUTLIER . . . . . 0 CA--C 1.535 0.379 0 CA-C-O 120.855 0.359 . . . . 0.0 111.539 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.798 HD12 ' O ' ' A' ' 53' ' ' GLN . 22.1 mt -79.22 142.54 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.773 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.4 ' HB3' ' CG1' ' B' ' 4' ' ' VAL . 2.4 t -106.36 -40.45 5.6 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.624 ' CB ' HD12 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -171.18 142.11 1.72 Allowed 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.145 -0.622 . . . . 0.0 112.429 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.913 HD23 ' HB3' ' A' ' 24' ' ' PHE . 46.6 mt -76.21 85.3 3.03 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.995 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.652 HD13 HD21 ' A' ' 25' ' ' LEU . 1.3 tp -41.98 -58.29 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -177.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.459 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.1 OUTLIER -92.44 -66.23 0.94 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -176.929 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.465 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 107.42 18.81 9.86 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 -177.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.51 -27.75 0.95 Allowed Glycine 0 C--N 1.34 0.793 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.855 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.802 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -94.06 -83.4 0.33 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.008 0.904 . . . . 0.0 111.69 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.85 ' HB1' HG21 ' A' ' 52' ' ' ILE . . . -64.23 -54.68 29.64 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 121.424 0.631 . . . . 0.0 110.782 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.761 ' CD ' HD13 ' A' ' 40' ' ' LEU . 3.8 tp10 -49.19 -42.24 39.45 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.368 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.92 -35.52 78.63 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.454 178.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.3 -47.78 65.73 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.655 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.42 -27.0 11.09 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.207 -0.997 . . . . 0.0 114.655 177.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.647 ' CD1' HD11 ' A' ' 91' ' ' LEU . 2.8 pp -102.26 -11.66 18.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 117.711 0.756 . . . . 0.0 111.944 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.85 HG21 ' HB1' ' A' ' 46' ' ' ALA . 5.2 mp -87.78 104.45 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.798 ' O ' HD12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -128.08 156.53 42.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.833 -179.781 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.532 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -71.93 133.39 45.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.827 0.346 . . . . 0.0 111.04 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.96 14.37 65.57 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.134 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.527 ' C ' HD12 ' A' ' 57' ' ' ILE . 1.2 m-20 -93.17 -82.55 0.34 Allowed 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.909 HG22 HD22 ' A' ' 91' ' ' LEU . 1.6 mp -158.47 120.38 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.462 0.649 . . . . 0.0 111.841 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.973 HD11 HG22 ' A' ' 61' ' ' VAL . 5.9 tp -152.9 87.19 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.09 177.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.3 tp -79.48 -61.78 1.9 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 121.994 -0.441 . . . . 0.0 111.238 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -127.88 158.88 36.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.909 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.973 HG22 HD11 ' A' ' 58' ' ' ILE . 11.7 t -150.63 149.99 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.018 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.505 HD22 HG21 ' A' ' 87' ' ' VAL . 0.0 OUTLIER 49.47 33.82 6.06 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.25 0.547 . . . . 0.0 110.941 179.393 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 63.89 23.89 13.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.285 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -111.39 110.93 55.49 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.179 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.79 ' O ' HD22 ' A' ' 69' ' ' LEU . 29.2 Cg_endo -62.49 80.72 0.1 Allowed 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.914 1.743 . . . . 0.0 111.5 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.604 HD21 ' HB3' ' A' ' 74' ' ' ALA . 6.8 mt -78.17 65.44 3.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.389 0.614 . . . . 0.0 109.883 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.494 HG23 ' H ' ' A' ' 68' ' ' ASP . 2.7 m -122.67 -56.04 2.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.698 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.494 ' H ' HG23 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -138.52 22.47 2.72 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -178.957 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.79 HD22 ' O ' ' A' ' 65' ' ' PRO . 0.7 OUTLIER -96.96 -175.67 3.33 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 178.869 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.3 m -68.86 96.67 0.77 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.864 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 9.0 t80 -40.77 -57.0 2.04 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -178.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -59.19 -28.22 66.43 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.096 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.903 ' O ' HG23 ' A' ' 77' ' ' VAL . 1.7 t -76.6 -44.71 33.23 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.733 ' HB2' HD21 ' A' ' 69' ' ' LEU . . . -57.84 -40.84 81.03 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.45 0.643 . . . . 0.0 109.724 178.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.864 HD11 ' CZ ' ' A' ' 71' ' ' TYR . 99.0 mt -66.02 -36.4 83.17 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.22 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -71.44 -38.7 71.33 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 120.921 0.391 . . . . 0.0 110.283 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.903 HG23 ' O ' ' A' ' 73' ' ' SER . 12.2 t -59.63 -36.85 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.013 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.459 HD11 HG12 ' B' ' 7' ' ' VAL . 4.5 pp -91.89 -24.64 19.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.005 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.27 -44.49 83.44 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 120.507 -0.477 . . . . 0.0 109.803 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -52.85 -22.29 11.84 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.877 -0.677 . . . . 0.0 113.031 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 80.1 mt -49.84 119.39 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 120.855 0.359 . . . . 0.0 111.391 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.15 -168.66 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.473 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 m -96.4 -171.12 2.21 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.115 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 44.13 31.3 0.52 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.074 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.419 ' O ' ' CE1' ' A' ' 15' ' ' PHE . 1.8 t -125.38 160.19 29.99 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.969 0.89 . . . . 0.0 112.789 -178.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.4 ' CE1' ' HD2' ' A' ' 15' ' ' PHE . 0.3 OUTLIER -100.95 176.61 5.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.415 179.405 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.769 HG11 ' CD2' ' A' ' 22' ' ' LEU . 2.8 p -151.69 150.02 13.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.663 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.699 ' C ' HD23 ' A' ' 89' ' ' LEU . 22.1 t -110.2 155.96 11.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.382 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.73 HD12 ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -149.66 155.8 40.83 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.13 -178.353 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.72 HD13 ' HA ' ' A' ' 11' ' ' SER . 45.9 mm -130.75 133.36 63.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.02 0.438 . . . . 0.0 111.267 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.909 HD22 HG22 ' A' ' 57' ' ' ILE . 55.6 mt . . . . . 0 C--N 1.327 -0.398 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.316 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.415 ' CG1' ' HB3' ' A' ' 25' ' ' LEU . 11.5 t . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.763 0.315 . . . . 0.0 110.734 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 5' ' ' ASP . . . . . 0.602 ' CG ' HD13 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -87.54 -97.11 0.09 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.275 -179.43 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.992 ' HA ' HD23 ' A' ' 25' ' ' LEU . 7.1 t 167.78 -36.36 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 117.851 0.296 . . . . 0.0 110.541 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.636 ' O ' HD12 ' A' ' 22' ' ' LEU . 20.2 m . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.197 -0.906 . . . . 0.0 112.735 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.631 HG23 ' N ' ' A' ' 11' ' ' SER . 1.2 tp . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.679 ' HA ' HD13 ' A' ' 90' ' ' ILE . 2.9 t -98.41 164.1 12.42 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.922 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.756 HG11 HD11 ' A' ' 51' ' ' LEU . 2.1 t -154.17 165.34 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.279 -178.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.1 ttp85 -144.75 140.04 28.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.292 0.568 . . . . 0.0 110.913 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.941 HD21 ' HB2' ' A' ' 46' ' ' ALA . 0.6 OUTLIER -139.07 140.99 38.2 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.323 -179.877 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.452 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 2.6 t80 -87.58 145.41 26.22 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 177.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.462 ' CE ' HD12 ' A' ' 78' ' ' LEU . 4.6 mttt -82.17 29.65 0.41 Allowed 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.824 -0.351 . . . . 0.0 111.538 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.866 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 42.99 31.03 0.3 Allowed 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 179.377 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.569 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 44.12 23.59 0.06 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.586 -178.559 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.866 HG22 ' O ' ' A' ' 17' ' ' ARG . 15.9 m -164.75 32.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.017 178.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 50.47 57.64 10.19 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.81 -178.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -138.8 58.79 0.61 Allowed Glycine 0 C--N 1.332 0.356 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.838 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 3.8 mp -44.61 -25.15 0.24 Allowed 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.461 ' HA2' HG22 ' A' ' 41' ' ' ILE . . . 109.32 5.73 29.95 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.18 -1.009 . . . . 0.0 113.644 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.932 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -158.73 138.14 11.65 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 117.835 0.818 . . . . 0.0 112.48 -179.47 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.893 HD21 HD13 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -85.04 175.53 8.97 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.594 179.608 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.512 HG12 HG21 ' A' ' 58' ' ' ILE . 30.4 m -146.7 160.92 9.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.924 177.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -141.95 111.21 6.42 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.846 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.505 ' HB3' ' CG ' ' A' ' 71' ' ' TYR . 1.7 tm-20 -106.19 113.23 26.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.101 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.88 126.72 29.39 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.021 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 96.7 t . . . . . 0 C--N 1.326 -0.428 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.677 179.155 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.469 HD12 ' HA ' ' A' ' 36' ' ' ILE . 1.1 tp . . . . . 0 CA--C 1.537 0.475 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.529 HG13 HG22 ' A' ' 58' ' ' ILE . 43.5 mt -88.82 149.83 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.801 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.427 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 16.0 t -111.92 -42.72 3.72 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.517 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -175.59 139.39 0.42 Allowed 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 120.151 -0.619 . . . . 0.0 112.308 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.932 HD23 ' HB3' ' A' ' 24' ' ' PHE . 30.5 mt -68.83 110.24 4.27 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 178.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.893 HD13 HD21 ' A' ' 25' ' ' LEU . 1.5 tp -65.67 -58.49 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 -176.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.464 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 2.0 tmt_? -93.34 -59.53 2.0 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -177.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.494 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 102.26 22.49 9.8 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.173 -177.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.412 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -125.02 -29.37 1.03 Allowed Glycine 0 C--N 1.338 0.693 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.568 -178.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.838 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -94.35 -83.17 0.35 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 117.855 0.827 . . . . 0.0 111.648 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.941 ' HB2' HD21 ' A' ' 14' ' ' LEU . . . -61.83 -62.2 1.96 Allowed 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.238 0.542 . . . . 0.0 111.285 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.617 ' HB2' HD22 ' A' ' 40' ' ' LEU . 4.0 tp10 -46.36 -42.2 14.58 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.776 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.412 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 0.3 OUTLIER -58.77 -39.3 80.62 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.616 178.775 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.23 -44.5 68.14 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.492 178.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.91 -26.85 16.17 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.414 -0.898 . . . . 0.0 114.463 177.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.756 HD11 HG11 ' A' ' 12' ' ' VAL . 2.5 pp -104.04 18.6 21.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 117.546 0.673 . . . . 0.0 111.974 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.936 HG21 ' HB1' ' A' ' 46' ' ' ALA . 4.7 mp -120.15 73.68 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.819 0.342 . . . . 0.0 110.592 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -102.67 141.34 35.65 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.517 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -62.98 143.43 57.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.149 0.499 . . . . 0.0 111.55 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.59 10.7 85.98 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.009 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -97.76 -88.18 0.31 Allowed 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.862 0.331 . . . . 0.0 111.098 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.688 HG23 HD22 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -163.72 121.45 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -179.879 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.707 HD11 HG22 ' A' ' 61' ' ' VAL . 2.0 tp -137.98 77.03 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 177.048 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.0 -62.21 1.73 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 -178.056 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.481 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . . . -116.4 149.54 39.23 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.833 0.349 . . . . 0.0 111.514 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.707 HG22 HD11 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -146.93 143.71 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.635 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.916 ' HA ' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER 65.18 -73.22 0.06 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.729 -179.505 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.3 t0 179.61 37.29 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.945 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.727 ' NH1' ' HB1' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -130.75 140.18 37.87 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-O 120.782 0.325 . . . . 0.0 111.029 179.547 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.46 ' O ' HD22 ' A' ' 69' ' ' LEU . 74.0 Cg_endo -76.27 82.58 2.19 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 121.548 1.498 . . . . 0.0 110.703 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.716 HD12 ' CZ ' ' A' ' 64' ' ' ARG . 0.4 OUTLIER -77.65 68.74 3.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.77 -178.998 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.535 HG23 ' H ' ' A' ' 68' ' ' ASP . 3.2 m -126.71 -59.45 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.919 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.535 ' H ' HG23 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -136.36 26.46 3.17 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.803 -178.977 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.698 HD21 ' HB2' ' A' ' 74' ' ' ALA . 1.9 pt? -92.58 -170.14 2.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.869 0.366 . . . . 0.0 110.66 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.412 ' N ' ' HG ' ' A' ' 69' ' ' LEU . 3.3 m -73.71 108.64 6.67 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.724 ' CE1' HD11 ' A' ' 75' ' ' LEU . 3.0 t80 -42.57 -55.84 3.34 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -62.93 -27.77 69.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.242 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.859 ' O ' HG23 ' A' ' 77' ' ' VAL . 22.4 t -75.32 -39.33 59.59 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.727 ' HB1' ' NH1' ' A' ' 64' ' ' ARG . . . -62.47 -49.49 75.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.945 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.724 HD11 ' CE1' ' A' ' 71' ' ' TYR . 27.2 mt -63.14 -30.68 71.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.916 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -72.78 -38.58 67.22 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.716 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' ' 73' ' ' SER . 65.1 t -58.97 -42.83 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.64 HD23 ' HA ' ' A' ' 75' ' ' LEU . 0.4 OUTLIER -78.7 -29.92 45.75 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.117 179.185 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -37.91 79.81 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.773 0.32 . . . . 0.0 110.975 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -59.59 -22.32 56.47 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.743 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.547 HD11 ' HB3' ' A' ' 62' ' ' ASN . 49.9 mt -58.23 116.74 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 120.927 0.394 . . . . 0.0 111.041 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.78 -167.18 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.44 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.402 ' O ' HG22 ' A' ' 85' ' ' THR . 3.9 m -96.83 -170.38 2.04 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.093 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 44.25 31.06 0.52 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.13 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.411 ' O ' ' CD1' ' A' ' 15' ' ' PHE . 1.7 t -130.12 162.35 29.01 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.815 0.817 . . . . 0.0 112.804 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -103.41 176.2 5.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.4 -1.273 . . . . 0.0 109.808 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.916 HG22 ' HA ' ' A' ' 62' ' ' ASN . 0.4 OUTLIER -144.9 172.37 5.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.929 0.395 . . . . 0.0 111.305 -179.366 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.802 ' O ' HD23 ' A' ' 89' ' ' LEU . 21.8 t -122.73 158.13 27.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.748 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.802 HD23 ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -151.32 147.33 26.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.845 0.355 . . . . 0.0 110.427 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.679 HD13 ' HA ' ' A' ' 11' ' ' SER . 41.0 mm -126.36 122.89 62.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.998 0.428 . . . . 0.0 111.465 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.702 HD11 ' CD1' ' A' ' 51' ' ' LEU . 10.0 mt . . . . . 0 C--O 1.232 0.173 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.242 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.416 ' CG1' ' HB3' ' A' ' 38' ' ' SER . 3.5 t . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.947 0.403 . . . . 0.0 111.59 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -123.79 102.08 7.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.645 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.825 ' HA ' HD23 ' A' ' 25' ' ' LEU . 12.9 p -61.05 134.82 57.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.959 0.409 . . . . 0.0 110.728 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.629 ' OXT' HD12 ' A' ' 22' ' ' LEU . 14.6 m . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.142 -0.932 . . . . 0.0 111.149 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.662 HG23 ' N ' ' A' ' 11' ' ' SER . 1.0 OUTLIER . . . . . 0 CA--C 1.536 0.434 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.704 ' HA ' HD13 ' A' ' 90' ' ' ILE . 56.1 p -84.6 165.27 18.13 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.652 0.739 . . . . 0.0 111.957 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.881 HG11 HD11 ' A' ' 51' ' ' LEU . 1.7 t -156.72 156.15 4.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.748 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -140.4 140.38 35.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.595 0.712 . . . . 0.0 111.154 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.83 ' C ' HG12 ' A' ' 87' ' ' VAL . 0.5 OUTLIER -141.88 177.77 7.96 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.833 -179.624 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.472 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 2.6 t80 -122.98 149.82 43.79 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.403 ' O ' ' N ' ' A' ' 20' ' ' GLY . 2.2 mttt -84.2 29.39 0.57 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.738 178.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.884 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 41.96 31.77 0.25 Allowed 'General case' 0 C--N 1.345 0.378 0 C-N-CA 123.006 0.522 . . . . 0.0 111.853 179.593 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.571 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 44.05 24.16 0.07 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.529 -178.508 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.884 HG22 ' O ' ' A' ' 17' ' ' ARG . 13.0 m -164.16 31.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.185 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 50.45 65.57 2.9 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.616 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -151.62 68.26 0.32 Allowed Glycine 0 C--N 1.331 0.273 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.822 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 4.2 mp -52.22 -22.2 4.13 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.443 ' HA2' HG22 ' A' ' 41' ' ' ILE . . . 107.3 11.56 25.33 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.152 -1.023 . . . . 0.0 113.829 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.918 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -159.7 141.73 13.27 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 118.008 0.904 . . . . 0.0 113.382 -179.576 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.92 HD23 ' HA ' ' B' ' 6' ' ' SER . 11.5 mt -79.61 172.83 13.25 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.435 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.2 m -153.23 148.97 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.242 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.423 ' HG3' HG22 ' A' ' 36' ' ' ILE . 0.7 OUTLIER -135.38 106.27 6.61 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.393 -179.265 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.482 ' HB3' ' CD1' ' A' ' 71' ' ' TYR . 7.0 tm-20 -103.54 111.42 23.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.805 178.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -70.62 116.55 11.08 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 121.092 0.472 . . . . 0.0 110.43 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.6 t . . . . . 0 CA--C 1.532 0.267 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.609 -179.559 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.485 HD12 ' HA ' ' A' ' 36' ' ' ILE . 1.2 tp . . . . . 0 CA--C 1.535 0.372 0 CA-C-O 120.699 0.285 . . . . 0.0 111.597 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.67 HD12 ' O ' ' A' ' 53' ' ' GLN . 35.9 mt -82.74 145.88 7.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.64 0.257 . . . . 0.0 110.925 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.454 ' CB ' HG13 ' B' ' 4' ' ' VAL . 6.3 t -109.55 -38.2 5.5 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.63 ' HB3' HD12 ' A' ' 25' ' ' LEU . 3.5 t0 -170.54 135.35 1.18 Allowed 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.364 -0.534 . . . . 0.0 112.18 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.918 HD23 ' HB3' ' A' ' 24' ' ' PHE . 45.4 mt -71.93 84.08 0.95 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.698 0.761 . . . . 0.0 109.781 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.458 ' CG2' ' N ' ' A' ' 42' ' ' ARG . 0.8 OUTLIER -39.91 -59.13 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 114.922 1.452 . . . . 0.0 114.922 -177.515 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.458 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -93.53 -64.78 1.05 Allowed 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -177.632 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.427 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 104.41 23.56 7.93 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -177.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.405 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -126.06 -32.37 0.74 Allowed Glycine 0 C--N 1.338 0.666 0 C-N-CA 121.283 -0.484 . . . . 0.0 113.085 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.822 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -94.03 -83.13 0.34 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 117.732 0.766 . . . . 0.0 111.435 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.916 ' HB1' HG21 ' A' ' 52' ' ' ILE . . . -58.14 -57.92 10.72 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.232 0.539 . . . . 0.0 111.161 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.427 ' HB3' ' HA2' ' A' ' 43' ' ' GLY . 39.4 tt0 -48.26 -47.54 36.03 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.871 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.405 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -57.31 -32.97 67.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.09 178.903 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.411 ' HB3' ' CD1' ' A' ' 52' ' ' ILE . 0.4 OUTLIER -57.55 -52.21 66.34 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.89 178.689 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 113.75 -30.73 6.99 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.154 -1.022 . . . . 0.0 114.096 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.938 HD13 HD11 ' A' ' 91' ' ' LEU . 3.7 pp -95.75 -1.47 49.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.291 0.545 . . . . 0.0 111.571 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.916 HG21 ' HB1' ' A' ' 46' ' ' ALA . 4.9 mp -105.27 118.36 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-O 120.953 0.406 . . . . 0.0 110.217 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.67 ' O ' HD12 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -144.44 162.51 36.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.293 179.685 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.573 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -71.81 126.72 30.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.857 0.361 . . . . 0.0 110.787 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.42 11.97 72.51 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.932 -178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.13 -83.95 0.24 Allowed 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 19.7 mt -155.94 125.72 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.787 HD11 HG22 ' A' ' 61' ' ' VAL . 5.8 tp -160.42 70.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.596 177.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.433 ' HG ' ' N ' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -78.04 -47.79 17.59 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 122.087 -0.383 . . . . 0.0 111.315 -178.418 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.502 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . . . -121.89 150.21 42.3 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.834 0.35 . . . . 0.0 111.368 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.788 HG12 ' ND2' ' A' ' 62' ' ' ASN . 3.0 t -140.33 144.86 26.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.172 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.788 ' ND2' HG12 ' A' ' 61' ' ' VAL . 0.0 OUTLIER 53.84 -82.59 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.025 0.53 . . . . 0.0 110.902 -179.118 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 61' ' ' VAL . 2.0 p30 -165.56 33.69 0.05 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.084 0.469 . . . . 0.0 110.272 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.792 ' NH2' HD23 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -126.64 105.5 23.61 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.779 179.653 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -58.93 87.4 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 121.701 1.601 . . . . 0.0 110.526 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.892 HD13 ' HB2' ' A' ' 74' ' ' ALA . 29.8 tp -86.44 66.04 9.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.431 0.634 . . . . 0.0 111.397 -178.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.7 m -110.67 -44.28 5.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.027 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.5 p30 -140.24 24.52 2.31 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.513 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.704 HD23 ' HA ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -99.87 174.32 6.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.772 -179.739 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.646 ' H ' HD12 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -63.46 121.76 14.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.317 179.727 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.648 ' CE1' HD11 ' A' ' 75' ' ' LEU . 3.7 t80 -54.93 -61.0 2.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.524 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.458 ' HA ' HD12 ' A' ' 75' ' ' LEU . 47.7 t0 -56.67 -32.76 65.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.237 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.569 ' O ' HG23 ' A' ' 77' ' ' VAL . 69.6 m -70.95 -46.35 62.56 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.892 ' HB2' HD13 ' A' ' 66' ' ' LEU . . . -55.65 -45.01 77.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.171 178.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.648 HD11 ' CE1' ' A' ' 71' ' ' TYR . 14.7 mt -64.87 -29.71 70.67 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.15 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.407 ' HA ' ' HB2' ' A' ' 79' ' ' ARG . 9.6 mt-10 -72.34 -36.13 68.73 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.002 0.429 . . . . 0.0 110.017 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 73' ' ' SER . 47.4 t -61.0 -46.04 97.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.524 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.792 HD23 ' NH2' ' A' ' 64' ' ' ARG . 1.6 pp -79.12 -27.06 42.83 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.408 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.407 ' HB2' ' HA ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -61.76 -49.21 77.28 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 121.023 0.439 . . . . 0.0 110.776 -179.438 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.35 -22.61 15.79 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.997 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.406 ' CD1' ' HA ' ' A' ' 78' ' ' LEU . 57.1 mt -56.32 118.75 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 120.9 0.381 . . . . 0.0 111.097 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.75 -165.93 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.421 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.2 m -95.47 -169.42 1.96 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.244 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 41.17 32.6 0.2 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.398 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.418 ' O ' ' CE1' ' A' ' 15' ' ' PHE . 1.5 t -125.29 159.95 30.47 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 122.013 0.911 . . . . 0.0 112.775 -178.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.406 ' CE1' ' HD2' ' A' ' 15' ' ' PHE . 0.2 OUTLIER -96.64 176.63 5.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.13 -1.395 . . . . 0.0 109.921 179.061 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.83 HG12 ' C ' ' A' ' 14' ' ' LEU . 4.2 p -149.71 151.78 12.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.541 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.829 ' O ' HD23 ' A' ' 89' ' ' LEU . 10.7 t -109.61 163.79 6.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.9 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.867 HD12 ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -159.04 164.38 35.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.674 0.273 . . . . 0.0 110.393 -179.723 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.704 HD13 ' HA ' ' A' ' 11' ' ' SER . 33.0 mm -135.64 125.5 41.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.938 HD11 HD13 ' A' ' 51' ' ' LEU . 10.9 mt . . . . . 0 C--O 1.233 0.191 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 177.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.458 HG11 HD13 ' A' ' 25' ' ' LEU . 15.3 t . . . . . 0 CA--C 1.52 -0.178 0 CA-C-O 120.783 0.325 . . . . 0.0 110.454 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.98 -104.65 0.09 Allowed 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.169 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.92 ' HA ' HD23 ' A' ' 25' ' ' LEU . 6.7 t 163.3 105.63 0.0 OUTLIER 'General case' 0 C--N 1.346 0.438 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.544 ' O ' HD12 ' A' ' 22' ' ' LEU . 21.3 m . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.305 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.1 tp . . . . . 0 CA--C 1.531 0.241 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.841 ' HA ' HD13 ' A' ' 90' ' ' ILE . 59.2 p -105.23 159.92 15.5 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.954 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.532 HG23 ' HB2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -134.15 102.96 4.61 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.318 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.542 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.0 ttp85 -79.47 106.17 11.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.49 0.662 . . . . 0.0 112.26 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.705 ' C ' HG12 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -116.62 177.23 4.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.604 178.612 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.458 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 2.4 t80 -117.03 151.25 37.16 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.41 ' O ' ' N ' ' A' ' 20' ' ' GLY . 0.8 OUTLIER -85.67 27.27 0.86 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.179 178.691 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.897 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.2 OUTLIER 45.48 29.73 0.64 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 179.257 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.602 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 43.13 24.92 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.101 0.56 . . . . 0.0 112.421 -178.431 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.897 HG22 ' O ' ' A' ' 17' ' ' ARG . 15.0 m -166.53 32.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 123.948 0.899 . . . . 0.0 108.857 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 48.01 62.55 4.14 Favored Glycine 0 C--N 1.34 0.768 0 CA-C-N 115.818 -0.628 . . . . 0.0 113.154 -178.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -147.9 60.2 0.46 Allowed Glycine 0 C--N 1.333 0.412 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.832 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 4.0 mp -41.02 -26.63 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -178.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.412 ' HA2' HG22 ' A' ' 41' ' ' ILE . . . 120.47 1.83 12.11 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.11 -1.043 . . . . 0.0 113.469 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.901 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -156.94 140.2 15.59 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 117.766 0.783 . . . . 0.0 112.665 -179.561 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.867 HD21 HD13 ' A' ' 41' ' ' ILE . 0.7 OUTLIER -79.15 171.06 15.71 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.954 179.047 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.7 m -150.8 154.12 9.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.037 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.442 ' CG ' HG22 ' A' ' 36' ' ' ILE . 7.6 ptmm? -135.79 107.74 7.12 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.275 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.498 ' HB3' ' CG ' ' A' ' 71' ' ' TYR . 3.0 tm-20 -97.41 108.54 21.28 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -59.99 111.6 1.55 Allowed 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 121.104 0.478 . . . . 0.0 110.409 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.1 t . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.839 -179.761 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' A' ' 36' ' ' ILE . 1.0 OUTLIER . . . . . 0 CA--C 1.533 0.294 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.495 HG13 HG22 ' A' ' 58' ' ' ILE . 39.3 mt -84.89 149.0 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.94 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.427 ' OG ' HG13 ' B' ' 4' ' ' VAL . 0.9 OUTLIER -117.14 -38.6 3.34 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.552 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.5 OUTLIER -172.69 135.8 0.69 Allowed 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 119.972 -0.691 . . . . 0.0 112.679 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.901 HD23 ' HB3' ' A' ' 24' ' ' PHE . 47.8 mt -67.09 113.6 5.19 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.867 HD13 HD21 ' A' ' 25' ' ' LEU . 2.0 tp -73.49 -55.86 11.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -175.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.458 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 10.9 ttt85 -93.38 -64.84 1.04 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.074 0.464 . . . . 0.0 112.104 -177.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.446 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 105.31 21.19 9.01 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.376 -178.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.407 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -125.85 -30.86 0.85 Allowed Glycine 0 C--N 1.336 0.551 0 C-N-CA 121.072 -0.585 . . . . 0.0 113.206 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.832 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -94.73 -82.66 0.36 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 117.583 0.692 . . . . 0.0 111.302 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.822 ' HB1' HG21 ' A' ' 52' ' ' ILE . . . -59.24 -57.38 13.29 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.148 0.499 . . . . 0.0 111.402 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.446 ' HB3' ' HA2' ' A' ' 43' ' ' GLY . 51.2 tt0 -49.85 -45.87 50.8 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.751 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.407 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 1.0 OUTLIER -55.83 -35.29 66.22 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.003 178.983 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.4 t -58.48 -49.34 77.68 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.63 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.75 -19.14 36.44 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.31 -0.947 . . . . 0.0 113.921 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.744 ' HG ' HD12 ' A' ' 52' ' ' ILE . 3.3 pp -96.52 -26.63 15.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.154 0.477 . . . . 0.0 110.814 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.822 HG21 ' HB1' ' A' ' 46' ' ' ALA . 5.0 mp -80.8 98.64 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-O 120.958 0.409 . . . . 0.0 110.42 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.418 ' O ' HD12 ' A' ' 37' ' ' ILE . 1.1 mp0 -124.53 149.26 47.13 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.646 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.552 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -67.63 128.67 37.32 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.987 0.423 . . . . 0.0 111.273 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.74 2.15 90.62 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.388 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -84.21 -89.1 0.1 Allowed 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.985 0.392 . . . . 0.0 110.902 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.554 HG23 HD22 ' A' ' 91' ' ' LEU . 6.3 tp -163.12 126.32 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.703 HD11 HG22 ' A' ' 61' ' ' VAL . 2.7 tp -146.6 90.02 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.4 tp -78.49 -67.09 0.77 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.407 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.486 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . . . -128.4 149.78 50.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.16 0.505 . . . . 0.0 112.111 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.703 HG22 HD11 ' A' ' 58' ' ' ILE . 18.8 t -125.97 144.79 34.87 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.893 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.468 ' HB3' HG23 ' A' ' 87' ' ' VAL . 0.0 OUTLIER 44.2 29.24 0.34 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 120.964 0.411 . . . . 0.0 111.768 -178.984 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.6 t70 74.02 26.91 1.66 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.403 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.74 ' NH2' HG12 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -99.99 102.71 18.61 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.014 179.411 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.744 ' O ' HD23 ' A' ' 69' ' ' LEU . 19.8 Cg_endo -61.09 82.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 121.946 1.764 . . . . 0.0 111.736 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.42 ' HG ' ' HB1' ' A' ' 74' ' ' ALA . 0.5 OUTLIER -86.82 64.67 8.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.403 0.62 . . . . 0.0 110.284 -179.766 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.439 HG23 ' H ' ' A' ' 68' ' ' ASP . 3.1 m -125.97 -52.63 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.536 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.439 ' H ' HG23 ' A' ' 67' ' ' VAL . 81.2 m-20 -133.33 24.48 4.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.897 0.38 . . . . 0.0 110.992 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.744 HD23 ' O ' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -105.63 175.23 5.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.313 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.588 ' H ' HD12 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -66.05 102.21 0.78 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.252 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.717 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 8.5 t80 -43.87 -54.75 5.03 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.971 0.415 . . . . 0.0 111.977 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -60.86 -33.73 73.52 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.931 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.873 ' O ' HG23 ' A' ' 77' ' ' VAL . 41.1 t -72.64 -43.89 62.61 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.733 ' HB2' HD21 ' A' ' 69' ' ' LEU . . . -59.4 -45.61 91.01 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.405 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.717 HD11 ' CZ ' ' A' ' 71' ' ' TYR . 56.0 mt -65.76 -30.21 70.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.271 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -74.01 -42.7 59.95 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.727 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.873 HG23 ' O ' ' A' ' 73' ' ' SER . 28.5 t -60.45 -35.0 60.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.276 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.589 HD21 HD23 ' A' ' 75' ' ' LEU . 4.1 pp -88.42 -22.49 23.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.942 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.1 -39.59 95.14 Favored 'General case' 0 C--N 1.339 0.12 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -55.35 -21.38 26.45 Favored Glycine 0 CA--C 1.522 0.514 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.946 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.42 HD11 HH12 ' A' ' 64' ' ' ARG . 79.0 mt -54.72 108.49 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-O 120.797 0.332 . . . . 0.0 110.733 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.89 -168.3 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.454 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.46 -172.22 2.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.024 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 44.01 31.25 0.5 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.26 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.408 ' O ' ' CE1' ' A' ' 15' ' ' PHE . 1.7 t -124.35 160.94 26.98 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.984 0.897 . . . . 0.0 112.747 -178.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.72 176.7 5.54 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.18 -1.373 . . . . 0.0 110.335 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.719 HG11 ' CD2' ' A' ' 22' ' ' LEU . 2.6 p -145.41 157.36 13.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.507 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.7 t -133.27 99.26 3.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.447 0.641 . . . . 0.0 111.626 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.651 HD23 ' CD1' ' A' ' 58' ' ' ILE . 6.4 mp -80.71 175.84 10.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.946 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.841 HD13 ' HA ' ' A' ' 11' ' ' SER . 36.2 mm -140.32 125.07 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.802 178.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.554 HD22 HG23 ' A' ' 57' ' ' ILE . 49.0 mt . . . . . 0 C--O 1.231 0.128 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.716 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.564 HG11 HD13 ' A' ' 25' ' ' LEU . 21.2 t . . . . . 0 C--O 1.231 0.13 0 CA-C-O 121.006 0.432 . . . . 0.0 110.992 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.35 116.56 29.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.788 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.867 ' HA ' HD23 ' A' ' 25' ' ' LEU . 9.4 p -71.49 121.07 18.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.083 0.468 . . . . 0.0 110.382 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.768 ' OXT' HD12 ' A' ' 22' ' ' LEU . 30.9 m . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.406 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.623 HD13 ' N ' ' A' ' 10' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--O 1.225 -0.221 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.72 ' HA ' HD13 ' A' ' 90' ' ' ILE . 20.0 m -92.25 156.13 17.5 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.796 ' CG1' HD12 ' A' ' 89' ' ' LEU . 2.5 t -149.84 157.61 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.618 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.6 tpp180 -145.54 121.9 10.95 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.516 0.674 . . . . 0.0 110.57 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.738 ' C ' HG12 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -123.71 178.34 5.27 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.555 -179.668 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.428 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 2.7 t80 -115.69 151.95 34.1 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.562 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.605 ' HD3' HG21 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -86.21 30.12 0.71 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 121.009 -0.277 . . . . 0.0 110.803 178.327 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.901 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.1 OUTLIER 42.68 30.67 0.24 Allowed 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 179.518 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.596 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 43.72 24.47 0.07 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.342 -178.358 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.901 HG22 ' O ' ' A' ' 17' ' ' ARG . 14.1 m -166.33 32.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 123.942 0.897 . . . . 0.0 109.086 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 49.83 68.64 1.31 Allowed Glycine 0 C--N 1.338 0.655 0 CA-C-N 115.824 -0.625 . . . . 0.0 113.049 -178.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -154.51 67.23 0.31 Allowed Glycine 0 C--N 1.333 0.4 0 N-CA-C 111.686 -0.566 . . . . 0.0 111.686 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.932 ' CD2' HG11 ' A' ' 87' ' ' VAL . 4.4 mp -48.18 -23.36 0.84 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.433 ' HA2' HG22 ' A' ' 41' ' ' ILE . . . 112.64 5.25 24.3 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.711 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.87 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -154.38 144.45 21.91 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 118.201 1.001 . . . . 0.0 113.322 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.846 HD23 ' HA ' ' B' ' 6' ' ' SER . 20.0 mt -78.7 173.36 12.53 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.868 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.4 m -153.52 141.34 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-O 121.313 0.577 . . . . 0.0 111.602 177.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.473 ' CG ' HG22 ' A' ' 36' ' ' ILE . 6.2 ptmt -122.07 104.83 9.77 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.707 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.566 ' HG3' HD23 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -102.28 115.76 31.23 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.413 0.625 . . . . 0.0 110.887 179.495 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.535 ' HD3' ' N ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -51.85 129.39 26.51 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.206 178.191 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 t . . . . . 0 C--N 1.319 -0.73 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.201 179.084 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.473 HG22 ' CG ' ' A' ' 27' ' ' LYS . 0.9 OUTLIER . . . . . 0 CA--C 1.539 0.523 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.774 HD12 ' O ' ' A' ' 53' ' ' GLN . 20.7 mt -85.15 141.62 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.729 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.613 ' CB ' HG13 ' B' ' 4' ' ' VAL . 4.6 t -105.78 -37.83 6.58 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.546 ' CB ' HD12 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -169.42 135.09 1.55 Allowed 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 118.338 0.517 . . . . 0.0 111.66 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.87 HD23 ' HB3' ' A' ' 24' ' ' PHE . 39.6 mt -70.12 76.84 0.51 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.779 0.8 . . . . 0.0 110.444 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.446 ' CG2' ' N ' ' A' ' 42' ' ' ARG . 0.4 OUTLIER -32.94 -58.68 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -178.51 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.446 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.4 OUTLIER -94.23 -68.49 0.8 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.211 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.401 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 108.07 2.48 33.89 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.022 -178.152 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -108.57 -26.39 5.37 Favored Glycine 0 C--N 1.34 0.753 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.42 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.741 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -95.08 -82.13 0.38 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.86 0.33 . . . . 0.0 110.901 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.739 ' HB1' HG21 ' A' ' 52' ' ' ILE . . . -56.53 -63.85 1.06 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.077 0.465 . . . . 0.0 111.648 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.586 ' CD ' HD13 ' A' ' 40' ' ' LEU . 5.1 tp10 -45.38 -43.0 10.73 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.241 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 44' ' ' GLY . 21.8 mm-40 -59.34 -39.19 82.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.977 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.0 -44.76 74.8 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.959 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.06 -22.83 37.44 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.334 -0.936 . . . . 0.0 113.275 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.987 HD13 HD11 ' A' ' 91' ' ' LEU . 3.6 pp -93.15 -13.78 28.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.882 0.341 . . . . 0.0 110.837 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.739 HG21 ' HB1' ' A' ' 46' ' ' ALA . 4.9 mp -96.35 147.67 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.774 ' O ' HD12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -175.14 154.11 1.72 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.979 0.419 . . . . 0.0 111.26 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.494 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -69.45 123.97 22.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.86 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.29 5.54 81.79 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.132 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.81 -86.35 0.12 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.907 0.353 . . . . 0.0 111.025 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.441 HG22 HD22 ' A' ' 91' ' ' LEU . 0.5 OUTLIER -162.55 119.89 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.207 0.527 . . . . 0.0 111.794 -179.797 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.578 HG23 ' O ' ' A' ' 58' ' ' ILE . 1.5 tp -146.96 80.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 177.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.7 tp -77.84 -66.59 0.82 Allowed 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.782 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.59 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . . . -115.24 151.75 33.93 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.97 0.414 . . . . 0.0 111.051 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.633 HG22 ' ND2' ' A' ' 62' ' ' ASN . 14.3 p -152.61 146.32 15.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.269 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.633 ' ND2' HG22 ' A' ' 61' ' ' VAL . 0.2 OUTLIER 46.05 40.5 7.14 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.17 0.51 . . . . 0.0 111.336 -179.79 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.6 t70 58.87 28.44 17.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.07 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.664 ' O ' HD12 ' A' ' 66' ' ' LEU . 15.1 mmm180 -113.73 101.43 53.79 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.672 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -62.32 85.39 0.1 Allowed 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 121.662 1.574 . . . . 0.0 111.072 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.664 HD12 ' O ' ' A' ' 64' ' ' ARG . 1.0 OUTLIER -84.13 63.85 7.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.663 0.744 . . . . 0.0 110.346 -179.526 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.401 HG23 ' N ' ' A' ' 68' ' ' ASP . 2.9 m -124.84 -46.52 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.069 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.437 ' HA ' ' NH2' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -137.65 25.74 2.84 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.444 179.504 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.599 HD12 ' H ' ' A' ' 70' ' ' SER . 0.1 OUTLIER -107.66 170.69 7.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.904 -179.483 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.599 ' H ' HD12 ' A' ' 69' ' ' LEU . 0.4 OUTLIER -63.1 119.48 9.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.501 179.536 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.516 ' CG ' ' HB3' ' A' ' 28' ' ' GLU . 2.0 t80 -57.32 -47.5 81.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.416 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.48 -30.6 68.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.939 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.878 ' O ' HG23 ' A' ' 77' ' ' VAL . 43.6 t -72.8 -42.77 63.54 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.551 ' HB1' HD11 ' A' ' 66' ' ' LEU . . . -55.58 -41.13 72.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.195 0.522 . . . . 0.0 110.754 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.485 HD11 ' CE1' ' A' ' 71' ' ' TYR . 70.7 mt -71.62 -35.37 70.42 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.82 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -74.58 -42.1 59.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.925 0.393 . . . . 0.0 110.515 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 73' ' ' SER . 19.7 t -61.94 -36.18 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.031 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.545 ' C ' HD12 ' A' ' 78' ' ' LEU . 4.0 pp -85.92 -21.69 27.81 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.42 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.401 ' N ' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -68.14 -36.48 79.75 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.492 179.582 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -55.39 -21.15 25.82 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.021 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.658 HG22 HG21 ' A' ' 85' ' ' THR . 57.5 mt -56.68 109.74 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-O 120.882 0.372 . . . . 0.0 110.915 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.87 -162.55 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.415 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.2 m -97.25 -174.3 2.91 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 120.788 0.328 . . . . 0.0 111.127 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 44.6 31.44 0.63 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.078 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.658 HG21 HG22 ' A' ' 81' ' ' ILE . 1.7 t -121.28 161.13 22.53 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.847 0.832 . . . . 0.0 112.578 -178.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -101.82 176.62 5.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.405 -1.271 . . . . 0.0 110.312 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.932 HG11 ' CD2' ' A' ' 22' ' ' LEU . 2.5 p -149.23 149.47 14.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.676 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.832 ' O ' HD23 ' A' ' 89' ' ' LEU . 11.6 t -108.15 158.99 7.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.076 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.832 HD23 ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -154.92 161.39 41.43 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.741 0.305 . . . . 0.0 110.985 -178.533 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.72 HD13 ' HA ' ' A' ' 11' ' ' SER . 43.6 mm -133.14 128.14 55.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.963 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.987 HD11 HD13 ' A' ' 51' ' ' LEU . 3.7 mt . . . . . 0 CA--C 1.518 -0.266 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.613 HG13 ' CB ' ' A' ' 38' ' ' SER . 2.3 t . . . . . 0 N--CA 1.464 0.252 0 CA-C-O 120.699 0.285 . . . . 0.0 110.472 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 5' ' ' ASP . . . . . 0.429 ' O ' ' CB ' ' B' ' 6' ' ' SER . 0.7 OUTLIER -139.88 -91.92 0.17 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.823 179.88 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.846 ' HA ' HD23 ' A' ' 25' ' ' LEU . 6.1 t 153.57 106.15 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.728 0.811 . . . . 0.0 109.812 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.573 ' OXT' HD12 ' A' ' 22' ' ' LEU . 27.1 m . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.213 -0.898 . . . . 0.0 111.317 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.643 HG23 ' N ' ' A' ' 11' ' ' SER . 1.3 tp . . . . . 0 CA--C 1.537 0.445 0 CA-C-O 120.749 0.309 . . . . 0.0 111.61 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.704 ' HA ' HD13 ' A' ' 90' ' ' ILE . 3.9 m -102.87 173.7 6.2 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.364 0.602 . . . . 0.0 111.75 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.791 HG11 HD11 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -160.88 175.95 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.089 -179.397 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.477 ' O ' HD12 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -150.47 140.89 22.4 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.432 0.634 . . . . 0.0 110.703 179.841 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.815 ' HB3' HD23 ' A' ' 22' ' ' LEU . 0.7 OUTLIER -141.28 140.94 33.96 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.893 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.492 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 2.3 t80 -90.04 143.37 26.84 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.62 ' HE2' HD13 ' A' ' 81' ' ' ILE . 1.7 mptp? -83.6 33.59 0.47 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.261 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.892 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 38.6 33.92 0.08 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.274 0.629 . . . . 0.0 111.914 179.933 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.591 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 44.27 25.26 0.11 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.769 -178.672 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.892 HG22 ' O ' ' A' ' 17' ' ' ARG . 5.2 m -164.36 31.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.567 178.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 52.7 54.69 26.7 Favored Glycine 0 C--N 1.336 0.539 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.584 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -139.91 66.09 0.52 Allowed Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.815 HD23 ' HB3' ' A' ' 14' ' ' LEU . 3.7 mp -49.85 -20.16 0.82 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -178.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.439 ' HA2' HG22 ' A' ' 41' ' ' ILE . . . 102.16 9.39 42.19 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.134 -1.031 . . . . 0.0 113.23 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.92 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -159.76 140.47 12.22 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.504 0.668 . . . . 0.0 112.387 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.86 HD23 ' CA ' ' B' ' 6' ' ' SER . 3.7 mt -78.92 173.74 12.23 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.453 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.423 HG12 HG21 ' A' ' 58' ' ' ILE . 26.7 m -153.81 159.44 3.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 114.715 -1.129 . . . . 0.0 109.934 178.015 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.824 ' HG2' HG22 ' B' ' 4' ' ' VAL . 15.6 mtpt -134.28 95.41 3.4 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.684 -179.041 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.49 ' HB2' ' CD1' ' A' ' 71' ' ' TYR . 0.9 OUTLIER -81.31 150.21 28.6 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.681 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.07 130.82 35.91 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-O 121.178 0.513 . . . . 0.0 111.351 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.324 -0.517 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.439 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.467 HD12 ' HA ' ' A' ' 36' ' ' ILE . 1.2 tp . . . . . 0 CA--C 1.538 0.499 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.567 HG13 HG22 ' A' ' 58' ' ' ILE . 36.8 mt -89.17 151.18 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.243 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.426 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 0.5 OUTLIER -116.72 -36.59 3.86 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -179.613 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.578 ' CB ' HD12 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -177.99 142.99 0.3 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.315 -179.687 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.92 HD23 ' HB3' ' A' ' 24' ' ' PHE . 36.2 mt -76.27 85.26 3.07 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.604 0.716 . . . . 0.0 110.247 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.822 HD13 HD21 ' A' ' 25' ' ' LEU . 1.5 tp -40.59 -59.55 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 114.457 1.281 . . . . 0.0 114.457 -177.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.456 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 6.3 mmt180 -94.79 -67.18 0.87 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.182 0.515 . . . . 0.0 112.196 -178.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.461 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 109.39 22.26 6.86 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.232 -178.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.405 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -122.71 -28.56 1.4 Allowed Glycine 0 C--N 1.339 0.75 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.388 -179.118 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -93.9 -83.93 0.32 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 117.787 0.793 . . . . 0.0 111.567 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.885 ' HB1' HG21 ' A' ' 52' ' ' ILE . . . -60.97 -58.87 6.6 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.221 0.534 . . . . 0.0 110.794 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.506 ' HB2' HD22 ' A' ' 40' ' ' LEU . 17.9 tt0 -46.51 -46.97 19.5 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.761 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.405 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -55.05 -37.3 66.55 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.799 178.684 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.404 ' HB3' HD13 ' A' ' 52' ' ' ILE . 2.4 t -54.38 -46.77 73.12 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.454 178.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.47 -24.19 24.78 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.439 -0.886 . . . . 0.0 114.601 177.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.791 HD11 HG11 ' A' ' 12' ' ' VAL . 1.7 pp -104.16 0.98 30.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.588 0.694 . . . . 0.0 112.3 -179.291 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.885 HG21 ' HB1' ' A' ' 46' ' ' ALA . 4.2 mp -102.19 96.32 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.23 147.68 43.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.421 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.551 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -70.49 140.4 51.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.932 0.396 . . . . 0.0 111.159 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.58 5.2 88.09 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.98 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.16 -90.71 0.13 Allowed 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.582 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -164.9 121.93 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 179.629 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 1.022 HD11 HG22 ' A' ' 61' ' ' VAL . 1.3 tp -136.25 81.95 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 107.778 -1.194 . . . . 0.0 107.778 176.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.516 ' HB2' HD11 ' A' ' 57' ' ' ILE . 7.1 tp -77.97 -67.88 0.69 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.209 -177.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -114.9 147.48 39.9 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.112 0.482 . . . . 0.0 112.08 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 1.022 HG22 HD11 ' A' ' 58' ' ' ILE . 3.1 t -141.62 144.26 26.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.241 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.722 HD22 HG12 ' A' ' 61' ' ' VAL . 0.1 OUTLIER 44.9 40.87 4.73 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.967 0.413 . . . . 0.0 111.629 -179.629 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.9 t0 53.38 27.56 6.45 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.134 0.493 . . . . 0.0 110.917 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.596 ' NH1' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -115.01 93.24 34.03 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.464 -179.588 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.421 ' O ' HD23 ' A' ' 69' ' ' LEU . 82.6 Cg_exo -43.1 87.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.361 1.232 0 C-N-CA 123.309 2.673 . . . . 0.0 114.106 -178.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.936 ' CD1' ' HB1' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -92.11 70.99 5.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.296 178.501 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.536 HG23 ' H ' ' A' ' 68' ' ' ASP . 3.4 m -123.04 -59.13 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -178.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.536 ' H ' HG23 ' A' ' 67' ' ' VAL . 74.7 m-20 -136.57 24.72 3.15 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -178.193 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.596 HD22 ' NH1' ' A' ' 64' ' ' ARG . 0.2 OUTLIER -93.53 -173.28 3.15 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.484 179.306 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.72 122.65 19.58 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.749 ' CE1' HD11 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -50.46 -69.27 0.12 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.709 -179.278 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -51.45 -26.97 9.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.777 0.322 . . . . 0.0 111.451 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.889 ' O ' HG23 ' A' ' 77' ' ' VAL . 22.8 t -76.79 -44.19 33.71 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.24 0.543 . . . . 0.0 109.811 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.936 ' HB1' ' CD1' ' A' ' 66' ' ' LEU . . . -59.12 -39.42 82.26 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.069 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.749 HD11 ' CE1' ' A' ' 71' ' ' TYR . 46.2 mt -72.91 -33.97 66.33 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.578 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.412 ' HA ' ' HB2' ' A' ' 79' ' ' ARG . 5.0 pt-20 -71.44 -38.18 71.36 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.276 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.889 HG23 ' O ' ' A' ' 73' ' ' SER . 6.5 t -61.66 -46.59 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.611 HD21 HD23 ' A' ' 75' ' ' LEU . 4.4 pp -74.78 -24.35 58.66 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.9 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.412 ' HB2' ' HA ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -63.17 -37.67 88.12 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.225 179.65 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.0 -23.74 17.23 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.862 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.62 HD13 ' HE2' ' A' ' 16' ' ' LYS . 31.1 mt -58.29 106.26 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-O 120.991 0.424 . . . . 0.0 110.672 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.3 -169.68 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.238 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.44 -170.1 2.1 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.28 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 42.98 31.77 0.36 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.136 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.415 ' O ' ' CD1' ' A' ' 15' ' ' PHE . 1.8 t -129.77 159.0 37.87 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 122.095 0.95 . . . . 0.0 113.148 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -101.12 176.28 5.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.064 -1.426 . . . . 0.0 109.377 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.529 HG13 HD23 ' A' ' 89' ' ' LEU . 0.5 OUTLIER -146.24 159.66 11.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.311 -179.551 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.679 ' C ' HD23 ' A' ' 89' ' ' LEU . 11.2 t -120.29 158.67 22.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.679 HD23 ' C ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -156.81 162.71 39.71 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.884 -178.007 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.704 HD13 ' HA ' ' A' ' 11' ' ' SER . 47.8 mm -128.38 122.99 59.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.112 0.482 . . . . 0.0 111.501 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 22.4 mt . . . . . 0 N--CA 1.453 -0.308 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.193 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.824 HG22 ' HG2' ' A' ' 27' ' ' LYS . 24.3 t . . . . . 0 N--CA 1.465 0.282 0 CA-C-O 120.774 0.321 . . . . 0.0 111.013 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 5' ' ' ASP . . . . . 0.434 ' HB3' HG13 ' B' ' 7' ' ' VAL . 1.6 m-20 -138.58 132.93 31.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.957 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.86 ' CA ' HD23 ' A' ' 25' ' ' LEU . 11.7 p -66.0 -51.37 58.98 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.832 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.707 HG11 HD22 ' A' ' 75' ' ' LEU . 22.5 m . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.264 -0.874 . . . . 0.0 112.619 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.636 HG23 ' N ' ' A' ' 11' ' ' SER . 1.0 OUTLIER . . . . . 0 N--CA 1.454 -0.269 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.668 ' HA ' HD13 ' A' ' 90' ' ' ILE . 1.6 p -101.66 158.44 16.1 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.735 0.778 . . . . 0.0 112.131 -178.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.857 ' CG1' HD12 ' A' ' 89' ' ' LEU . 3.1 t -142.01 153.49 18.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 114.411 -1.268 . . . . 0.0 108.815 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.5 ttp-105 -135.2 128.09 31.33 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.677 0.751 . . . . 0.0 111.498 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.91 HD21 ' HB2' ' A' ' 46' ' ' ALA . 0.4 OUTLIER -124.79 177.83 5.79 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.39 -1.277 . . . . 0.0 109.608 179.66 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.418 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 3.5 t80 -123.15 151.09 42.47 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.524 ' NZ ' HD11 ' A' ' 22' ' ' LEU . 3.8 mptp? -83.15 26.54 0.62 Allowed 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.289 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.841 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.4 OUTLIER 44.79 29.94 0.49 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.833 0.349 . . . . 0.0 111.868 179.562 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.684 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 44.7 23.86 0.09 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.736 -178.477 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.841 HG22 ' O ' ' A' ' 17' ' ' ARG . 2.7 m -168.55 34.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.992 178.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 49.1 63.42 3.97 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.989 -178.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -143.91 54.05 0.58 Allowed Glycine 0 C--N 1.332 0.349 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.015 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.877 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 3.9 mp -39.1 -28.0 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.478 ' HA2' HG22 ' A' ' 41' ' ' ILE . . . 110.2 3.27 29.59 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.819 -1.182 . . . . 0.0 113.776 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.899 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -158.09 141.25 15.06 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.041 0.921 . . . . 0.0 112.933 -179.473 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.954 HD21 HD13 ' A' ' 41' ' ' ILE . 0.8 OUTLIER -89.66 174.59 7.65 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.477 179.437 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.777 HG12 HG21 ' A' ' 58' ' ' ILE . 26.6 m -151.41 165.42 2.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.236 178.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.807 ' HG2' HG22 ' B' ' 4' ' ' VAL . 15.9 mtpt -140.84 99.88 3.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.737 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.489 ' HB3' ' CG ' ' A' ' 71' ' ' TYR . 0.6 OUTLIER -99.34 112.17 24.4 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 178.158 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.23 119.7 3.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.101 0.477 . . . . 0.0 111.11 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.4 ' O ' HG12 ' A' ' 30' ' ' VAL . 52.0 t . . . . . 0 C--N 1.323 -0.544 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.317 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.494 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.2 tp . . . . . 0 C--O 1.221 -0.442 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.5 HG13 HG22 ' A' ' 58' ' ' ILE . 42.7 mt -82.17 153.3 4.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.35 178.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.741 ' HB3' HG11 ' B' ' 4' ' ' VAL . 22.0 t -117.41 -38.06 3.39 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.665 0.616 . . . . 0.0 112.665 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.555 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 1.2 t0 -173.0 140.05 0.87 Allowed 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 120.283 -0.567 . . . . 0.0 112.277 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.899 HD23 ' HB3' ' A' ' 24' ' ' PHE . 40.2 mt -76.46 87.63 3.2 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.795 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.954 HD13 HD21 ' A' ' 25' ' ' LEU . 1.3 tp -39.85 -60.04 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -177.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.46 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 17.6 ttt85 -94.24 -59.23 2.01 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.974 0.416 . . . . 0.0 112.035 -178.184 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.436 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 98.07 24.29 11.86 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -177.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.418 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -125.85 -28.61 1.03 Allowed Glycine 0 C--N 1.338 0.666 0 C-N-CA 121.111 -0.566 . . . . 0.0 113.479 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.877 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -94.47 -83.44 0.34 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 117.902 0.851 . . . . 0.0 111.459 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.91 ' HB2' HD21 ' A' ' 14' ' ' LEU . . . -61.67 -57.97 9.89 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.235 0.541 . . . . 0.0 110.963 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.814 ' CG ' HD13 ' A' ' 40' ' ' LEU . 7.8 tm-20 -47.61 -48.07 28.56 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.623 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.418 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -56.5 -34.85 67.38 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.98 178.797 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.14 -45.89 75.65 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 112.17 -28.66 9.02 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.526 -0.845 . . . . 0.0 114.54 177.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.547 ' CD1' HD11 ' A' ' 91' ' ' LEU . 2.4 pp -105.0 19.12 21.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.591 0.695 . . . . 0.0 112.051 -179.353 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.884 HG21 ' HB1' ' A' ' 46' ' ' ALA . 4.9 mp -123.23 81.66 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.891 0.377 . . . . 0.0 110.216 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.498 ' HA ' HD11 ' A' ' 40' ' ' LEU . 3.7 mp0 -112.95 141.37 46.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.144 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.555 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -58.8 134.63 57.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.071 0.462 . . . . 0.0 111.303 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.55 2.48 87.11 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.896 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.84 -93.31 0.09 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.843 0.321 . . . . 0.0 110.566 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.685 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -163.75 119.64 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 179.613 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.981 HD11 HG22 ' A' ' 61' ' ' VAL . 5.9 tp -136.95 82.27 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 177.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.6 tp -78.12 -58.43 3.26 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.97 -177.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.702 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . . . -117.94 145.47 44.66 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.911 0.386 . . . . 0.0 111.722 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.981 HG22 HD11 ' A' ' 58' ' ' ILE . 5.0 t -146.8 145.23 19.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.84 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.539 ' ND2' HG12 ' A' ' 61' ' ' VAL . 0.2 OUTLIER 44.6 41.81 5.16 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.172 0.51 . . . . 0.0 111.995 179.211 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.6 t0 57.63 26.32 12.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.541 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 66' ' ' LEU . 19.3 mmt180 -115.57 101.47 54.23 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.116 179.068 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.901 ' O ' HD22 ' A' ' 69' ' ' LEU . 51.0 Cg_exo -53.48 85.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.331 2.021 . . . . 0.0 111.626 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 64' ' ' ARG . 8.8 mt -78.68 62.15 3.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.738 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.632 HG23 ' H ' ' A' ' 68' ' ' ASP . 3.1 m -125.49 -65.6 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.632 ' H ' HG23 ' A' ' 67' ' ' VAL . 4.6 p30 -125.74 25.42 6.91 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.065 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.901 HD22 ' O ' ' A' ' 65' ' ' PRO . 0.6 OUTLIER -100.4 -179.8 4.22 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.666 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.0 m -68.49 96.64 0.7 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.736 ' CE1' HD21 ' A' ' 75' ' ' LEU . 8.9 t80 -41.01 -57.05 2.12 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.049 0.452 . . . . 0.0 112.057 -178.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -60.67 -28.4 68.57 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.823 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.914 ' O ' HG23 ' A' ' 77' ' ' VAL . 5.0 t -74.24 -43.61 56.36 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.649 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -57.8 -33.93 69.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.501 177.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.736 HD21 ' CE1' ' A' ' 71' ' ' TYR . 3.7 mm? -71.17 -35.99 71.82 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.088 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -74.84 -35.64 62.38 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.035 0.445 . . . . 0.0 109.846 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.914 HG23 ' O ' ' A' ' 73' ' ' SER . 8.4 t -61.83 -43.01 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.874 178.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.658 HD21 HD13 ' A' ' 75' ' ' LEU . 4.1 pp -79.05 -24.7 43.41 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.053 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -40.4 94.68 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.882 0.373 . . . . 0.0 110.21 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -57.03 -20.36 34.14 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.879 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.498 HG22 HG21 ' A' ' 85' ' ' THR . 65.6 mt -57.81 110.66 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 120.98 0.419 . . . . 0.0 111.005 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.09 -164.53 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.45 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.81 -170.7 1.97 Allowed 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.809 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 45.18 31.34 0.76 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.116 0.484 . . . . 0.0 110.873 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.498 HG21 HG22 ' A' ' 81' ' ' ILE . 1.5 t -123.54 162.84 22.13 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.838 0.827 . . . . 0.0 112.658 -178.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -102.8 176.27 5.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.362 -1.29 . . . . 0.0 109.977 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.807 HG11 ' CD2' ' A' ' 22' ' ' LEU . 5.7 p -149.29 156.3 7.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.334 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.845 ' O ' HD23 ' A' ' 89' ' ' LEU . 2.1 t -114.05 161.51 12.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.553 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.857 HD12 ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -154.71 158.32 39.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.216 -178.617 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.702 ' HB ' ' HB3' ' A' ' 60' ' ' ALA . 51.5 mm -133.9 134.77 55.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.547 HD11 ' CD1' ' A' ' 51' ' ' LEU . 7.2 mt . . . . . 0 C--O 1.233 0.205 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.033 177.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.807 HG22 ' HG2' ' A' ' 27' ' ' LYS . 10.5 t . . . . . 0 CA--C 1.519 -0.214 0 CA-C-O 120.802 0.334 . . . . 0.0 110.828 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 5' ' ' ASP . . . . . 0.727 ' OD2' HD11 ' A' ' 75' ' ' LEU . 10.8 p-10 -63.71 -155.26 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.585 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -177.35 102.56 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.185 0.517 . . . . 0.0 110.145 179.543 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.729 ' O ' HD12 ' A' ' 22' ' ' LEU . 23.0 m . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.238 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.444 ' O ' HG23 ' A' ' 90' ' ' ILE . 1.7 mp . . . . . 0 CA--C 1.534 0.335 0 CA-C-O 121.37 0.605 . . . . 0.0 112.541 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.748 ' HA ' HD13 ' A' ' 90' ' ' ILE . 1.9 m -92.79 173.57 7.69 Favored 'General case' 0 C--O 1.23 0.075 0 CA-C-N 115.158 -0.928 . . . . 0.0 113.439 -178.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.886 ' CG1' HD12 ' A' ' 89' ' ' LEU . 1.5 t -159.14 157.47 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 114.29 -1.323 . . . . 0.0 108.786 -179.083 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -150.75 126.31 10.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.223 0.535 . . . . 0.0 110.837 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.754 ' C ' HG12 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -134.45 178.72 6.77 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.297 -179.229 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.428 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 5.0 t80 -116.37 151.99 34.82 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.12 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.433 ' NZ ' HD11 ' A' ' 22' ' ' LEU . 0.8 OUTLIER -85.32 28.11 0.76 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.541 179.448 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.868 ' O ' HG22 ' A' ' 19' ' ' VAL . 7.5 tpt180 43.49 31.8 0.46 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.018 0.437 . . . . 0.0 111.94 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.671 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 43.64 24.98 0.07 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.893 -178.917 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.868 HG22 ' O ' ' A' ' 17' ' ' ARG . 5.0 m -167.72 33.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.408 -0.814 . . . . 0.0 108.831 178.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.405 ' HA2' ' HE2' ' A' ' 16' ' ' LYS . . . 49.14 61.1 5.63 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.705 -178.348 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -142.94 55.33 0.58 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.98 -0.629 . . . . 0.0 111.95 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.859 ' CD2' HG11 ' A' ' 87' ' ' VAL . 3.7 mp -40.49 -27.61 0.05 Allowed 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 40' ' ' LEU . . . 114.42 2.49 22.96 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 119.911 -1.137 . . . . 0.0 114.418 178.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.781 ' HB3' HD23 ' A' ' 40' ' ' LEU . 1.6 p90 -154.58 144.37 21.64 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.493 1.147 . . . . 0.0 113.595 -179.152 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.736 HD23 ' HA ' ' B' ' 6' ' ' SER . 7.6 mt -82.05 172.88 12.72 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.683 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.609 HG12 HG21 ' A' ' 58' ' ' ILE . 33.0 m -150.98 154.24 8.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.248 177.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.419 ' HD3' HG22 ' A' ' 36' ' ' ILE . 11.7 ptmt -135.84 109.64 8.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.959 -179.083 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.515 ' HB3' ' CG ' ' A' ' 71' ' ' TYR . 0.6 OUTLIER -111.06 142.66 42.92 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.947 179.276 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -75.4 126.94 32.03 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.044 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 65.5 t . . . . . 0 C--N 1.327 -0.408 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.912 -179.672 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 36' ' ' ILE . 1.2 tp . . . . . 0 CA--C 1.536 0.43 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.523 HG13 HG22 ' A' ' 58' ' ' ILE . 54.4 mt -85.39 147.73 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.135 179.093 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.457 ' CB ' HG13 ' B' ' 4' ' ' VAL . 1.4 t -113.66 -37.07 4.69 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.691 ' CB ' HD12 ' A' ' 25' ' ' LEU . 1.5 t0 -172.14 141.38 1.28 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.044 -0.663 . . . . 0.0 112.373 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.781 HD23 ' HB3' ' A' ' 24' ' ' PHE . 51.0 mt -72.55 109.02 5.92 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.526 -0.761 . . . . 0.0 108.978 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.542 ' CD1' HD21 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -63.52 -59.67 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -176.392 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.464 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -94.15 -67.38 0.86 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.15 0.5 . . . . 0.0 111.985 -178.229 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 112.55 23.76 5.27 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.517 -178.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -128.17 -30.07 0.75 Allowed Glycine 0 C--N 1.338 0.643 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.613 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.854 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -93.53 -83.33 0.33 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 117.823 0.812 . . . . 0.0 111.512 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.779 ' HB1' HG21 ' A' ' 52' ' ' ILE . . . -61.74 -55.22 32.55 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.123 0.487 . . . . 0.0 110.927 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.663 ' HG3' HD13 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -50.17 -48.26 54.1 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.975 179.496 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -57.07 -35.84 69.85 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.203 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.2 m -57.3 -46.14 83.45 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.943 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.97 -21.71 44.63 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.392 -0.909 . . . . 0.0 113.011 179.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.844 ' HG ' HD12 ' A' ' 52' ' ' ILE . 2.1 pp -82.05 -31.59 30.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.176 0.512 . . . . 0.0 109.643 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.844 HD12 ' HG ' ' A' ' 51' ' ' LEU . 3.6 mp -82.29 137.51 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.237 179.147 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.433 ' O ' HD12 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -157.71 150.45 22.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.619 179.798 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.591 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -68.62 122.08 17.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.882 0.372 . . . . 0.0 110.928 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.58 -6.5 80.14 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.359 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.92 -91.61 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 117.001 0.4 . . . . 0.0 110.818 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.561 HG23 HD22 ' A' ' 91' ' ' LEU . 1.1 tp -163.28 123.02 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.609 HG21 HG12 ' A' ' 26' ' ' VAL . 2.4 tp -140.91 84.42 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 176.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.551 HD11 HG11 ' A' ' 67' ' ' VAL . 57.5 tp -77.16 -61.02 2.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.789 -178.013 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.721 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . . . -120.85 161.87 20.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.957 0.408 . . . . 0.0 111.439 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.796 HG12 HD12 ' A' ' 66' ' ' LEU . 14.0 p -163.24 145.18 2.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.375 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.639 ' ND2' HG22 ' A' ' 61' ' ' VAL . 0.1 OUTLIER 45.13 41.91 6.22 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.239 0.542 . . . . 0.0 111.379 -179.777 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.14 29.1 16.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.06 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.4 ' HD2' HG11 ' A' ' 77' ' ' VAL . 6.6 mmp_? -115.58 96.6 46.67 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.415 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.83 ' O ' HD22 ' A' ' 69' ' ' LEU . 18.4 Cg_endo -59.85 86.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 121.856 1.704 . . . . 0.0 110.874 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.796 HD12 HG12 ' A' ' 61' ' ' VAL . 0.7 OUTLIER -71.96 63.59 0.48 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.423 -178.68 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.551 HG11 HD11 ' A' ' 59' ' ' LEU . 3.5 m -143.51 -61.35 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.543 ' H ' HG23 ' A' ' 67' ' ' VAL . 2.2 p30 -109.32 28.78 8.17 Favored 'General case' 0 CA--C 1.518 -0.266 0 O-C-N 121.966 -0.459 . . . . 0.0 111.997 -178.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.83 HD22 ' O ' ' A' ' 65' ' ' PRO . 0.3 OUTLIER -124.85 174.17 8.12 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.515 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.98 107.78 2.81 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.796 ' CE1' HD11 ' A' ' 75' ' ' LEU . 7.5 t80 -43.76 -58.4 2.73 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.015 0.436 . . . . 0.0 111.896 -179.207 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -58.0 -27.34 63.41 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.341 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.891 ' O ' HG23 ' A' ' 77' ' ' VAL . 4.8 m -77.29 -38.63 50.36 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.253 0.549 . . . . 0.0 110.019 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.726 ' HB2' HD21 ' A' ' 69' ' ' LEU . . . -63.39 -38.52 91.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.825 178.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.796 HD11 ' CE1' ' A' ' 71' ' ' TYR . 16.0 mt -73.17 -32.38 64.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.462 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 73' ' ' SER . 5.0 pt-20 -76.35 -38.82 55.31 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.848 0.356 . . . . 0.0 110.283 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.891 HG23 ' O ' ' A' ' 73' ' ' SER . 48.8 t -61.98 -41.3 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.55 ' C ' HD12 ' A' ' 78' ' ' LEU . 4.3 pp -80.14 -22.11 42.39 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.322 179.214 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.482 ' N ' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -68.24 -38.11 81.49 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.464 179.782 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.82 -12.77 57.87 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.134 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 84.9 mt -53.13 118.9 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 120.989 0.423 . . . . 0.0 111.169 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.55 -173.99 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.898 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -98.63 -173.28 2.5 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.287 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 42.04 32.31 0.29 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.15 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.5 t -123.94 162.26 23.73 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.881 0.848 . . . . 0.0 112.577 -178.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -97.9 177.11 5.55 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.477 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.859 HG11 ' CD2' ' A' ' 22' ' ' LEU . 2.3 p -151.38 148.25 14.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.329 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.839 ' O ' HD23 ' A' ' 89' ' ' LEU . 6.2 t -108.3 162.67 6.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.886 HD12 ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -159.8 172.16 18.18 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -179.435 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.748 HD13 ' HA ' ' A' ' 11' ' ' SER . 29.4 mm -131.36 120.96 47.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -178.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.561 HD22 HG23 ' A' ' 57' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.308 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 176.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.473 HG11 HD13 ' A' ' 25' ' ' LEU . 21.9 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.924 0.392 . . . . 0.0 110.963 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.71 127.53 45.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.828 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.736 ' HA ' HD23 ' A' ' 25' ' ' LEU . 30.5 t -73.73 149.46 41.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.417 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.443 HG23 HD13 ' A' ' 22' ' ' LEU . 27.0 m . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.382 -179.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.667 HG23 ' N ' ' A' ' 11' ' ' SER . 1.0 OUTLIER . . . . . 0 CA--C 1.538 0.512 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.712 ' HA ' HD13 ' A' ' 90' ' ' ILE . 3.6 t -72.64 164.26 26.77 Favored 'General case' 0 CA--C 1.527 0.06 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.594 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.791 ' CG1' HD12 ' A' ' 89' ' ' LEU . 1.7 t -158.27 160.71 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 114.592 -1.185 . . . . 0.0 108.698 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.485 ' O ' HD12 ' A' ' 14' ' ' LEU . 17.6 ttp180 -143.69 143.8 31.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.564 0.697 . . . . 0.0 111.617 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.856 HD21 ' HB2' ' A' ' 46' ' ' ALA . 0.8 OUTLIER -142.63 176.69 8.84 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.821 179.681 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.473 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 3.9 t80 -132.03 148.26 52.49 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.57 34.14 0.43 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.333 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.898 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.8 OUTLIER 38.21 32.89 0.05 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.22 0.608 . . . . 0.0 112.259 179.503 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.589 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 44.5 23.67 0.08 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.517 -178.356 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.898 HG22 ' O ' ' A' ' 17' ' ' ARG . 8.0 m -164.54 31.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.48 178.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 52.99 67.25 2.21 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.631 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -153.78 69.38 0.3 Allowed Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 111.599 -0.601 . . . . 0.0 111.599 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.878 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 4.1 mp -52.01 -22.79 4.33 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.429 ' HA2' HG22 ' A' ' 41' ' ' ILE . . . 103.48 6.12 44.72 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.25 -0.976 . . . . 0.0 113.735 179.098 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.892 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -157.95 140.3 14.43 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 117.982 0.891 . . . . 0.0 113.356 -179.529 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.841 HD23 ' HA ' ' B' ' 6' ' ' SER . 14.7 mt -80.16 171.46 15.05 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.118 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.439 HG12 HG21 ' A' ' 58' ' ' ILE . 35.2 m -153.89 153.72 8.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.607 177.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.9 ptmt -140.45 108.08 5.62 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.93 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.482 ' HB3' ' CD1' ' A' ' 71' ' ' TYR . 4.9 tm-20 -106.23 129.97 54.18 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.705 178.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -83.88 121.49 27.42 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.051 0.453 . . . . 0.0 110.689 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.0 t . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.025 -179.665 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.702 HD11 HD12 ' A' ' 57' ' ' ILE . 1.1 tp . . . . . 0 CA--C 1.538 0.503 0 CA-C-O 120.582 0.23 . . . . 0.0 111.585 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.7 HD12 ' O ' ' A' ' 53' ' ' GLN . 26.5 mt -79.75 146.75 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 120.737 0.303 . . . . 0.0 111.319 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.48 ' CB ' HG13 ' B' ' 4' ' ' VAL . 4.0 t -113.98 -36.68 4.7 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.597 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -171.84 135.67 0.86 Allowed 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 120.111 -0.636 . . . . 0.0 112.295 -179.707 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.892 HD23 ' HB3' ' A' ' 24' ' ' PHE . 40.6 mt -72.73 77.42 1.11 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 121.788 0.804 . . . . 0.0 109.876 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.571 HD13 ' CD2' ' A' ' 25' ' ' LEU . 1.4 tp -33.79 -60.15 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -177.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.467 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 1.5 ttt85 -94.96 -62.25 1.35 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -177.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.431 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 99.79 28.42 7.42 Favored Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -177.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -126.52 -32.25 0.73 Allowed Glycine 0 C--N 1.337 0.592 0 C-N-CA 121.337 -0.459 . . . . 0.0 113.232 -178.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.878 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -95.34 -83.33 0.36 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 117.587 0.694 . . . . 0.0 111.906 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.856 ' HB2' HD21 ' A' ' 14' ' ' LEU . . . -60.38 -60.06 4.41 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.158 0.504 . . . . 0.0 111.234 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.678 ' CG ' HD13 ' A' ' 40' ' ' LEU . 7.7 tm-20 -45.29 -48.26 13.02 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.784 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 44' ' ' GLY . 6.6 mm-40 -54.97 -39.69 69.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.276 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.3 m -53.23 -46.2 69.02 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.015 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.08 -21.63 33.18 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.452 -0.88 . . . . 0.0 113.821 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.726 HD13 HD11 ' A' ' 91' ' ' LEU . 2.9 pp -97.21 -7.8 31.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.064 0.432 . . . . 0.0 111.58 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.75 HG21 ' HB1' ' A' ' 46' ' ' ALA . 5.4 mp -104.71 125.12 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-O 120.901 0.382 . . . . 0.0 110.391 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.7 ' O ' HD12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -150.81 156.28 40.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.667 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.597 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -71.76 127.8 33.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.937 0.399 . . . . 0.0 111.184 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.08 -1.13 89.22 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.087 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.92 -92.97 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 117.039 0.419 . . . . 0.0 109.995 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.702 HD12 HD11 ' A' ' 36' ' ' ILE . 6.9 tp -164.96 119.55 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.569 HG23 ' O ' ' A' ' 58' ' ' ILE . 2.6 tp -135.32 88.15 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.9 tp -78.96 -68.24 0.67 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.061 -178.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.418 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . . . -111.44 158.56 18.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.233 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.711 HG23 HD22 ' A' ' 89' ' ' LEU . 14.8 p -162.73 147.39 3.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.306 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.583 ' ND2' HG22 ' A' ' 61' ' ' VAL . 0.3 OUTLIER 44.79 42.77 6.31 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 121.145 0.498 . . . . 0.0 111.498 -179.5 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.9 t0 56.81 28.87 15.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.209 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.544 ' O ' HD12 ' A' ' 66' ' ' LEU . 6.2 mmp_? -118.55 95.8 49.22 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.903 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.518 ' O ' HD23 ' A' ' 69' ' ' LEU . 18.5 Cg_endo -59.89 86.67 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 121.819 1.679 . . . . 0.0 111.128 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.544 HD12 ' O ' ' A' ' 64' ' ' ARG . 0.4 OUTLIER -83.86 63.51 7.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.531 0.681 . . . . 0.0 110.463 -179.459 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.418 HG23 ' N ' ' A' ' 68' ' ' ASP . 3.9 m -117.17 -50.91 4.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.986 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.418 ' N ' HG23 ' A' ' 67' ' ' VAL . 2.8 m-20 -138.65 22.5 2.69 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.814 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.776 HD21 ' HB2' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -100.41 172.6 7.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.244 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.442 ' H ' HD12 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -66.6 106.35 1.77 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.216 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.917 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 7.5 t80 -45.18 -60.84 1.9 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.684 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -54.86 -31.92 60.13 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.296 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.8 ' O ' HG23 ' A' ' 77' ' ' VAL . 6.3 t -74.57 -44.09 52.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.166 0.507 . . . . 0.0 109.657 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.776 ' HB2' HD21 ' A' ' 69' ' ' LEU . . . -59.83 -40.32 88.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.225 178.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.917 HD11 ' CZ ' ' A' ' 71' ' ' TYR . 73.5 mt -71.02 -31.38 67.87 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.638 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -75.7 -39.24 57.73 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.126 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 73' ' ' SER . 39.4 t -61.28 -39.84 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.924 179.014 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.607 HD12 ' N ' ' A' ' 79' ' ' ARG . 4.5 pp -80.58 -25.4 38.55 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.925 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.607 ' N ' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -62.63 -37.61 87.01 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.977 0.418 . . . . 0.0 110.361 179.645 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -58.66 -18.73 39.5 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.848 -0.691 . . . . 0.0 113.024 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.491 HG22 HG21 ' A' ' 85' ' ' THR . 48.0 mt -56.23 122.25 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 120.924 0.392 . . . . 0.0 111.114 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.43 -163.38 0.09 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.312 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.36 -169.67 2.02 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.988 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 40.9 33.33 0.2 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.235 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.491 HG21 HG22 ' A' ' 81' ' ' ILE . 1.8 t -123.7 157.71 33.28 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 122.206 1.003 . . . . 0.0 113.122 -177.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -100.11 175.51 5.72 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.877 -1.511 . . . . 0.0 109.712 179.029 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.805 HG12 ' C ' ' A' ' 14' ' ' LEU . 5.0 p -150.87 153.9 9.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.083 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.621 ' O ' HD23 ' A' ' 89' ' ' LEU . 25.0 t -115.01 158.37 15.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.205 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.853 HD21 ' HB2' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -154.01 169.72 22.83 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.516 -178.916 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.712 HD13 ' HA ' ' A' ' 11' ' ' SER . 34.3 mm -136.28 123.16 32.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.636 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.726 HD11 HD13 ' A' ' 51' ' ' LEU . 9.4 mt . . . . . 0 CA--C 1.514 -0.429 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 176.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.48 HG13 ' CB ' ' A' ' 38' ' ' SER . 3.4 t . . . . . 0 N--CA 1.461 0.094 0 CA-C-O 120.755 0.312 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -125.56 127.25 46.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.847 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.841 ' HA ' HD23 ' A' ' 25' ' ' LEU . 7.9 p -86.53 116.52 24.71 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.059 0.457 . . . . 0.0 110.925 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.559 HG23 HD13 ' A' ' 22' ' ' LEU . 19.6 m . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.251 -0.881 . . . . 0.0 111.226 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.414 ' N ' ' O ' ' A' ' 91' ' ' LEU . 1.2 tp . . . . . 0 C--O 1.226 -0.17 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.588 ' HA ' HD13 ' A' ' 90' ' ' ILE . 5.0 m -90.55 151.39 21.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.501 178.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.818 HG21 ' HG ' ' A' ' 91' ' ' LEU . 2.7 t -138.8 160.55 30.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.2 ttp85 -138.3 140.84 39.74 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.616 0.722 . . . . 0.0 112.0 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.801 ' C ' HG12 ' A' ' 87' ' ' VAL . 0.6 OUTLIER -142.19 176.24 9.13 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.45 179.331 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.446 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 3.4 t80 -127.65 146.45 50.55 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -80.82 36.49 0.39 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.226 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.891 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.6 OUTLIER 35.11 34.03 0.02 OUTLIER 'General case' 0 C--N 1.352 0.707 0 C-N-CA 123.714 0.805 . . . . 0.0 112.502 179.681 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.568 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 43.25 24.82 0.05 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.409 -178.334 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.891 HG22 ' O ' ' A' ' 17' ' ' ARG . 15.7 m -164.94 31.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.234 178.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 52.38 68.51 1.54 Allowed Glycine 0 C--N 1.338 0.689 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.376 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -155.27 69.27 0.29 Allowed Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 111.749 -0.541 . . . . 0.0 111.749 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.816 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 4.0 mp -50.08 -22.8 1.77 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 40' ' ' LEU . . . 107.75 4.99 34.01 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.274 -0.965 . . . . 0.0 113.425 179.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.907 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -158.59 139.09 12.58 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -179.635 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.908 HD23 ' HA ' ' B' ' 6' ' ' SER . 5.4 mt -79.18 169.59 17.92 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.54 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.8 m -152.47 156.93 5.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 120.123 -0.631 . . . . 0.0 111.721 177.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.469 ' CG ' HG22 ' A' ' 36' ' ' ILE . 13.3 ptmt -138.17 107.05 5.95 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.683 -178.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.465 ' HB3' ' CG ' ' A' ' 71' ' ' TYR . 2.1 tm-20 -101.07 111.33 23.51 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -64.45 119.08 9.73 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.026 0.441 . . . . 0.0 110.378 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 30' ' ' VAL . 53.4 t . . . . . 0 C--N 1.325 -0.474 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.363 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.469 HG22 ' CG ' ' A' ' 27' ' ' LYS . 0.7 OUTLIER . . . . . 0 CA--C 1.536 0.41 0 CA-C-O 120.544 0.211 . . . . 0.0 111.11 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.738 HD12 ' O ' ' A' ' 53' ' ' GLN . 20.6 mt -93.16 151.07 3.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.631 0.253 . . . . 0.0 111.059 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.537 ' CB ' HG13 ' B' ' 4' ' ' VAL . 2.4 t -116.01 -40.61 3.28 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.656 ' CB ' HD12 ' A' ' 25' ' ' LEU . 1.3 t0 -167.12 132.99 2.16 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 120.15 -0.62 . . . . 0.0 112.447 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.907 HD23 ' HB3' ' A' ' 24' ' ' PHE . 56.4 mt -69.05 77.29 0.33 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.46 0.648 . . . . 0.0 109.797 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.568 HD13 ' HG ' ' A' ' 25' ' ' LEU . 1.4 tp -33.28 -59.16 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -177.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.465 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -94.25 -65.88 0.96 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.198 0.523 . . . . 0.0 111.797 -178.263 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.488 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 105.84 13.97 22.37 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.634 -178.061 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.403 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -117.93 -25.86 2.93 Favored Glycine 0 C--N 1.341 0.812 0 C-N-CA 121.022 -0.609 . . . . 0.0 113.391 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.816 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -94.07 -83.09 0.34 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 117.777 0.789 . . . . 0.0 111.36 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.829 ' HB1' HG21 ' A' ' 52' ' ' ILE . . . -62.02 -60.34 3.76 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.187 0.518 . . . . 0.0 111.454 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.718 ' HB2' HD13 ' A' ' 40' ' ' LEU . 4.1 tp10 -48.39 -44.37 34.7 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.079 0.466 . . . . 0.0 110.803 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.403 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 5.2 tp-100 -58.62 -34.09 70.77 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.3 t -54.99 -49.68 70.87 Favored 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 115.77 -22.77 11.42 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.251 -0.976 . . . . 0.0 114.639 177.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.856 HD11 ' CD1' ' A' ' 91' ' ' LEU . 0.3 OUTLIER -99.26 -32.53 11.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.523 0.662 . . . . 0.0 110.802 -179.58 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.829 HG21 ' HB1' ' A' ' 46' ' ' ALA . 4.9 mp -72.12 115.8 13.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.143 0.497 . . . . 0.0 110.631 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.738 ' O ' HD12 ' A' ' 37' ' ' ILE . 2.0 tt0 -139.41 148.79 43.27 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.851 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.423 ' CB ' ' HA ' ' A' ' 39' ' ' ASP . . . -75.57 145.76 40.97 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.242 0.544 . . . . 0.0 112.186 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.62 18.44 68.02 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.672 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -109.33 -84.11 0.55 Allowed 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 120.421 0.153 . . . . 0.0 111.348 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.613 HD11 HD21 ' A' ' 59' ' ' LEU . 2.3 tt -163.27 133.4 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.785 HD11 HG22 ' A' ' 61' ' ' VAL . 2.7 tp -155.31 96.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.443 -1.253 . . . . 0.0 107.99 177.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.613 HD21 HD11 ' A' ' 57' ' ' ILE . 2.8 mt -79.27 -68.77 0.63 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.969 -0.292 . . . . 0.0 111.637 -177.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.599 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . . . -116.43 160.15 20.97 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.01 0.433 . . . . 0.0 111.692 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.785 HG22 HD11 ' A' ' 58' ' ' ILE . 2.7 t -154.03 147.29 13.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.606 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 42.98 44.16 3.9 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.187 0.518 . . . . 0.0 111.932 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 t70 56.33 29.45 15.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.275 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.401 ' O ' ' N ' ' A' ' 66' ' ' LEU . 3.4 mmp_? -117.55 98.58 51.9 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.418 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.507 ' O ' HD23 ' A' ' 69' ' ' LEU . 38.3 Cg_exo -57.08 85.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.058 1.839 . . . . 0.0 111.464 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.55 HD21 ' HB3' ' A' ' 74' ' ' ALA . 1.2 mt -86.48 61.55 6.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.412 0.625 . . . . 0.0 110.462 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 m -113.81 -47.73 5.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.24 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -145.88 23.77 1.37 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.608 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.748 HD21 ' HB2' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -96.77 173.38 7.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.649 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.645 ' H ' HD12 ' A' ' 69' ' ' LEU . 49.2 m -64.22 99.64 0.29 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.734 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 5.8 t80 -42.36 -58.72 2.09 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.307 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -58.13 -32.49 68.19 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.32 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.901 ' O ' HG23 ' A' ' 77' ' ' VAL . 3.6 t -74.82 -41.7 59.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.077 0.465 . . . . 0.0 109.767 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.748 ' HB2' HD21 ' A' ' 69' ' ' LEU . . . -61.14 -40.75 94.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.308 0.575 . . . . 0.0 110.27 178.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.734 HD11 ' CZ ' ' A' ' 71' ' ' TYR . 72.5 mt -71.43 -31.89 67.73 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.016 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -74.16 -41.16 61.94 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.023 0.439 . . . . 0.0 109.934 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 73' ' ' SER . 22.0 t -59.58 -41.18 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.045 178.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.589 HD21 HD23 ' A' ' 75' ' ' LEU . 4.5 pp -82.39 -22.48 35.39 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.541 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.4 ' N ' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -65.42 -37.49 87.07 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.332 179.604 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.4 -20.4 29.75 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.896 -0.668 . . . . 0.0 113.034 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 69.0 mt -56.31 123.07 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-O 120.877 0.37 . . . . 0.0 111.103 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.05 -161.64 0.22 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.259 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.3 m -95.29 -170.19 2.13 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.678 0.275 . . . . 0.0 110.984 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 45.0 30.41 0.57 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.169 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.417 ' O ' ' CE1' ' A' ' 15' ' ' PHE . 1.8 t -127.88 158.27 38.24 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 122.024 0.916 . . . . 0.0 112.967 -178.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -99.98 176.57 5.38 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.106 -1.406 . . . . 0.0 110.374 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.801 HG12 ' C ' ' A' ' 14' ' ' LEU . 3.9 p -150.32 155.16 7.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.382 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.796 ' O ' HD23 ' A' ' 89' ' ' LEU . 5.1 t -114.81 162.34 12.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.796 HD23 ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -154.51 174.81 14.4 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 -178.747 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.678 ' O ' HD23 ' A' ' 91' ' ' LEU . 49.9 mm -134.52 131.83 54.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.856 ' CD1' HD11 ' A' ' 51' ' ' LEU . 55.6 mt . . . . . 0 C--O 1.224 -0.244 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.95 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.537 HG13 ' CB ' ' A' ' 38' ' ' SER . 3.4 t . . . . . 0 CA--C 1.519 -0.215 0 CA-C-O 120.927 0.394 . . . . 0.0 110.823 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.51 -103.32 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.292 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.908 ' HA ' HD23 ' A' ' 25' ' ' LEU . 4.9 t 162.36 109.45 0.0 OUTLIER 'General case' 0 C--N 1.345 0.409 0 CA-C-O 121.159 0.504 . . . . 0.0 109.843 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.738 ' O ' HD12 ' A' ' 22' ' ' LEU . 27.8 m . . . . . 0 C--O 1.245 0.839 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.892 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 112.454 -0.258 . . . . 0.0 112.454 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.6 p -169.13 152.58 5.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.882 0.372 . . . . 0.0 110.91 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.7 m80 60.51 63.34 1.37 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.834 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.4 mtt -132.9 163.33 29.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.719 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.643 HG23 ' N ' ' A' ' 6' ' ' GLU . 0.3 OUTLIER -153.89 -164.37 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.578 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.643 ' N ' HG23 ' A' ' 5' ' ' ILE . 7.0 mm-40 -144.84 -67.86 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.534 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.745 ' HB3' HD12 ' A' ' 114' ' ' ILE . 5.6 Cg_endo -48.08 176.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.4 2.067 . . . . 0.0 112.685 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -150.09 -74.22 0.16 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.597 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.561 HG23 ' HA ' ' A' ' 92' ' ' ARG . 14.7 p -161.84 113.37 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.899 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.662 HG23 ' N ' ' A' ' 11' ' ' SER . 1.4 tp -161.19 -164.61 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.749 ' HA ' HD13 ' A' ' 90' ' ' ILE . 0.7 OUTLIER -85.66 166.27 16.31 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.475 0.655 . . . . 0.0 112.536 -179.338 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.744 ' CG1' HD12 ' A' ' 89' ' ' LEU . 1.6 t -156.05 163.61 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.313 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -149.6 131.97 15.61 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.497 0.665 . . . . 0.0 110.778 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.804 HD21 ' HB2' ' A' ' 46' ' ' ALA . 0.3 OUTLIER -135.03 177.46 7.79 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.419 -179.431 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.408 ' CD1' ' O ' ' A' ' 85' ' ' THR . 4.5 t80 -124.1 151.39 43.94 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.644 ' HD3' HG21 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -81.62 27.15 0.45 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.685 179.453 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.822 ' O ' HG22 ' A' ' 19' ' ' VAL . 9.6 tpt180 43.31 31.04 0.35 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.905 0.383 . . . . 0.0 111.916 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.704 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 44.47 23.47 0.07 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.708 -178.642 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.822 HG22 ' O ' ' A' ' 17' ' ' ARG . 2.9 m -169.14 34.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 49.0 65.87 2.47 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.746 -178.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . -148.19 54.99 0.51 Allowed Glycine 0 C--N 1.331 0.29 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.104 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.909 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 4.1 mp -38.44 -26.96 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 40' ' ' LEU . . . 118.35 -4.13 15.66 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 119.954 -1.117 . . . . 0.0 113.815 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.927 ' HB3' HD23 ' A' ' 40' ' ' LEU . 5.1 p90 -152.83 144.53 23.52 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.933 HD23 ' HA ' ' B' ' 6' ' ' SER . 1.6 mt -80.19 170.21 16.74 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.3 178.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.626 HG22 ' OD1' ' B' ' 5' ' ' ASP . 29.0 m -149.32 157.59 6.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 C-N-CA 119.989 -0.685 . . . . 0.0 111.308 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.473 ' HE3' HG22 ' B' ' 4' ' ' VAL . 1.3 ptpt -135.22 104.96 6.09 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.348 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.498 ' HB3' ' CG ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -101.64 118.71 37.51 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.738 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.423 ' CB ' ' HB2' ' A' ' 32' ' ' LYS . 19.2 mmt180 -63.6 114.77 4.15 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 121.254 0.55 . . . . 0.0 110.379 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.6 t -51.95 -18.93 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.141 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.405 ' O ' ' CG ' ' A' ' 32' ' ' LYS . 33.2 m -133.78 32.47 3.54 Favored 'General case' 0 C--N 1.334 -0.07 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.75 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.423 ' HB2' ' CB ' ' A' ' 29' ' ' ARG . 5.7 mtpp -164.73 139.96 4.51 Favored Pre-proline 0 CA--C 1.536 0.406 0 O-C-N 123.132 0.27 . . . . 0.0 110.613 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.425 ' O ' HG12 ' A' ' 67' ' ' VAL . 34.5 Cg_exo -59.86 -46.91 17.48 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.33 2.02 . . . . 0.0 113.475 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 33' ' ' PRO . 70.8 Cg_exo -41.89 94.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.708 2.272 . . . . 0.0 114.678 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.459 HG11 ' O ' ' A' ' 66' ' ' LEU . 13.0 p -105.77 150.89 8.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.465 ' HA ' HG22 ' A' ' 58' ' ' ILE . 1.2 tp -157.37 175.64 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -178.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.51 HG23 ' O ' ' A' ' 25' ' ' LEU . 28.0 mt -92.67 147.68 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.641 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.5 ' OG ' HG13 ' B' ' 4' ' ' VAL . 0.8 OUTLIER -113.63 -35.58 5.16 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -179.67 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.545 ' CB ' HD12 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -166.2 135.64 3.19 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 120.441 -0.504 . . . . 0.0 112.032 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.927 HD23 ' HB3' ' A' ' 24' ' ' PHE . 49.3 mt -72.92 79.28 1.16 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.671 0.748 . . . . 0.0 110.489 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.773 HD13 HD21 ' A' ' 25' ' ' LEU . 1.8 tp -32.9 -59.5 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.462 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -95.47 -67.7 0.84 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.218 0.532 . . . . 0.0 112.139 -178.142 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 106.91 26.52 5.76 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -177.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -128.31 -28.6 0.83 Allowed Glycine 0 C--N 1.339 0.722 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.73 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.909 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -94.12 -83.01 0.34 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.055 0.928 . . . . 0.0 111.582 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.804 ' HB2' HD21 ' A' ' 14' ' ' LEU . . . -65.04 -53.82 39.96 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.079 0.466 . . . . 0.0 110.9 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.668 ' CG ' HD13 ' A' ' 40' ' ' LEU . 54.1 tt0 -49.86 -47.28 51.89 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.046 0.451 . . . . 0.0 110.463 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.417 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 5.6 tp-100 -59.14 -33.2 70.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.833 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.9 t -55.19 -48.47 73.77 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.622 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.07 -21.85 28.53 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.183 -1.008 . . . . 0.0 114.288 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.944 HD13 HD11 ' A' ' 91' ' ' LEU . 0.6 OUTLIER -100.12 -3.93 30.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.574 0.687 . . . . 0.0 111.616 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.759 HG21 ' CD2' ' A' ' 24' ' ' PHE . 5.0 mp -103.93 138.87 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-O 120.83 0.347 . . . . 0.0 110.402 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -154.4 158.99 40.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.348 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.424 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -71.41 125.25 26.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.921 0.391 . . . . 0.0 111.115 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.86 14.72 73.32 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.653 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.67 ' O ' HD13 ' A' ' 57' ' ' ILE . 1.5 m-20 -92.69 -85.37 0.26 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.67 HD13 ' O ' ' A' ' 56' ' ' ASP . 18.0 mm -148.86 115.78 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -178.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.508 HG21 HG12 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -160.47 113.81 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.674 177.042 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.416 ' N ' HD13 ' A' ' 58' ' ' ILE . 1.7 tp -116.6 -67.04 1.02 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.059 0.457 . . . . 0.0 110.584 -178.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.511 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . . . -104.95 160.91 14.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.236 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.77 HG12 HD12 ' A' ' 66' ' ' LEU . 14.3 p -166.95 145.28 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.482 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.658 ' ND2' HG22 ' A' ' 61' ' ' VAL . 0.7 OUTLIER 44.86 40.0 4.0 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.031 0.444 . . . . 0.0 111.678 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.6 t70 58.67 28.14 16.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.281 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.651 ' HD3' HG11 ' A' ' 77' ' ' VAL . 15.6 mmm180 -118.07 97.51 50.8 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.572 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.839 ' O ' HD22 ' A' ' 69' ' ' LEU . 31.7 Cg_exo -57.81 86.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.032 1.821 . . . . 0.0 110.999 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.77 HD12 HG12 ' A' ' 61' ' ' VAL . 6.6 mt -72.46 62.84 0.54 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.985 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.595 HG23 ' H ' ' A' ' 68' ' ' ASP . 3.1 m -139.64 -63.57 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.595 ' H ' HG23 ' A' ' 67' ' ' VAL . 7.2 t0 -112.49 28.3 8.89 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -178.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.839 HD22 ' O ' ' A' ' 65' ' ' PRO . 0.3 OUTLIER -118.08 176.66 5.11 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.447 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.6 m -68.09 98.75 0.81 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.671 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 6.2 t80 -40.83 -55.63 2.4 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.215 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -58.16 -30.88 66.72 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.195 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.741 ' O ' HG23 ' A' ' 77' ' ' VAL . 1.6 t -75.54 -43.63 47.73 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.739 ' HB2' HD21 ' A' ' 69' ' ' LEU . . . -60.21 -38.89 84.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.417 178.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.682 HD22 ' OD2' ' B' ' 5' ' ' ASP . 63.4 mt -68.61 -30.08 68.73 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.023 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -73.32 -40.0 64.83 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 120.981 0.42 . . . . 0.0 109.943 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.741 HG23 ' O ' ' A' ' 73' ' ' SER . 14.7 t -59.87 -42.96 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.739 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.552 ' C ' HD12 ' A' ' 78' ' ' LEU . 4.2 pp -79.2 -24.79 42.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.959 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.53 ' N ' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -67.39 -48.27 67.86 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.101 0.477 . . . . 0.0 110.062 179.461 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.01 -22.9 13.84 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.978 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.644 HG21 ' HD3' ' A' ' 16' ' ' LYS . 55.6 mt -52.76 114.69 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 120.878 0.371 . . . . 0.0 111.149 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.24 -167.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.185 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.2 m -95.4 -172.33 2.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.949 0.404 . . . . 0.0 111.117 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 45.56 30.33 0.75 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.128 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.425 HG21 HG22 ' A' ' 81' ' ' ILE . 1.8 t -123.66 159.15 29.95 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.88 0.847 . . . . 0.0 112.391 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -100.49 176.44 5.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.575 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.779 HG12 ' C ' ' A' ' 14' ' ' LEU . 2.8 p -153.03 150.06 12.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.584 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.705 ' O ' HD23 ' A' ' 89' ' ' LEU . 24.0 t -111.39 156.9 12.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.744 HD12 ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -152.57 168.84 24.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.692 0.282 . . . . 0.0 111.222 -178.496 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.749 HD13 ' HA ' ' A' ' 11' ' ' SER . 47.1 mm -136.69 128.51 43.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.82 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.944 HD11 HD13 ' A' ' 51' ' ' LEU . 62.5 mt -86.55 142.64 28.16 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 176.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.561 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -113.66 157.45 22.13 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.096 0.474 . . . . 0.0 112.278 -178.567 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 165.23 -147.32 12.28 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.082 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -58.69 -155.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.623 2.215 . . . . 0.0 112.36 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -158.97 -175.84 5.52 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.576 0.227 . . . . 0.0 110.736 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.41 ' O ' ' CD1' ' A' ' 97' ' ' PHE . . . 74.96 16.52 80.49 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.321 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.468 ' HB3' HG23 ' A' ' 117' ' ' THR . 61.9 m-85 -153.02 142.24 21.49 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 117.044 0.422 . . . . 0.0 111.849 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.724 HG22 HD22 ' A' ' 120' ' ' LEU . 0.1 OUTLIER -96.23 117.99 31.88 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.453 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.606 HG23 ' O ' ' A' ' 99' ' ' THR . 11.0 t -111.53 92.2 3.95 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.433 0.635 . . . . 0.0 111.157 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.519 ' C ' HG23 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -74.6 -159.03 0.08 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.123 179.356 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.684 ' N ' HD13 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -118.27 140.91 49.1 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.977 0.418 . . . . 0.0 111.321 179.801 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.534 ' O ' HG22 ' A' ' 103' ' ' THR . 5.0 tt0 178.24 169.52 0.78 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.346 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 102' ' ' GLU . 9.3 t 47.72 -167.95 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.567 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.15 147.52 14.67 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.126 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.403 ' CG ' ' HA2' ' A' ' 109' ' ' GLY . 39.1 p90 -63.41 174.65 1.2 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.824 0.345 . . . . 0.0 111.0 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.9 t -174.69 -40.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.979 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -66.96 -56.82 11.01 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.503 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -162.82 36.67 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.819 0.342 . . . . 0.0 110.882 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.403 ' HA2' ' CG ' ' A' ' 105' ' ' PHE . . . 71.14 56.73 6.72 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.618 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.498 ' HB ' ' HD3' ' A' ' 111' ' ' PRO . 1.1 m -112.21 -65.94 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 116.43 0.115 . . . . 0.0 111.213 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.498 ' HD3' ' HB ' ' A' ' 110' ' ' THR . 54.5 Cg_exo -48.32 -64.38 0.24 Allowed 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.07 1.847 . . . . 0.0 111.815 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 111' ' ' PRO . 0.3 OUTLIER 70.21 160.53 0.21 Allowed 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.003 179.547 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 68.5 m -56.89 -30.6 64.06 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.304 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.745 HD12 ' HB3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -95.79 101.3 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.897 178.658 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.504 ' O ' HG22 ' A' ' 116' ' ' VAL . 0.0 OUTLIER -160.12 91.04 0.93 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.021 0.439 . . . . 0.0 111.456 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.519 HG23 ' C ' ' A' ' 100' ' ' HIS . 0.2 OUTLIER -162.64 55.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.459 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.468 HG23 ' HB3' ' A' ' 97' ' ' PHE . 51.4 m -77.77 129.0 34.92 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.236 -178.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.467 ' CD ' HG23 ' A' ' 98' ' ' THR . 0.0 OUTLIER -141.3 134.06 14.22 Favored Pre-proline 0 C--O 1.22 -0.458 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.326 179.287 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.76 138.49 53.77 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.152 1.902 . . . . 0.0 113.261 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.724 HD22 HG22 ' A' ' 98' ' ' THR . 0.2 OUTLIER -87.39 -70.28 0.63 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.623 179.608 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 67.09 76.92 0.33 Allowed Glycine 0 CA--C 1.522 0.489 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.038 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.636 ' O ' HG22 ' A' ' 124' ' ' THR . 33.1 Cg_exo -57.49 -45.39 34.45 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.484 2.123 . . . . 0.0 113.303 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 122' ' ' PRO . 54.4 Cg_exo -50.87 97.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.444 2.096 . . . . 0.0 112.398 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.636 HG22 ' O ' ' A' ' 122' ' ' PRO . 10.0 t -175.7 59.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.973 0.416 . . . . 0.0 111.21 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -141.13 177.92 7.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.066 0.46 . . . . 0.0 111.089 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 61.16 18.46 9.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.083 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.7 m . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.159 179.968 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 14.4 t . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.686 0.279 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 31.8 m -114.33 27.55 3.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.314 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -137.53 -48.1 0.57 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.962 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.614 HG11 HD13 ' A' ' 25' ' ' LEU . 21.8 t -72.09 105.97 2.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.785 0.326 . . . . 0.0 110.844 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ASP . . . . . 0.682 ' OD2' HD22 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -104.32 131.87 51.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.515 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.933 ' HA ' HD23 ' A' ' 25' ' ' LEU . 8.5 p -85.34 119.6 25.89 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.339 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.801 ' O ' HD12 ' A' ' 22' ' ' LEU . 26.5 m . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.326 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.15 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.14 -68.77 0.78 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.839 0.352 . . . . 0.0 110.755 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 67.78 -71.1 0.11 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.759 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.46 169.33 14.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.671 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.612 HG23 ' O ' ' A' ' 5' ' ' ILE . 9.1 tt -58.08 97.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.126 0.488 . . . . 0.0 111.067 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -176.8 142.21 0.53 Allowed Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.287 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.499 ' HB3' HD12 ' A' ' 114' ' ' ILE . 73.7 Cg_endo -76.3 -165.32 0.3 Allowed 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.443 2.095 . . . . 0.0 111.59 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.708 ' H ' HG21 ' A' ' 99' ' ' THR . 0.2 OUTLIER -127.16 -66.67 0.88 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.565 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.657 ' O ' HD12 ' A' ' 10' ' ' ILE . 72.1 t -161.02 99.07 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.538 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.657 HD12 ' O ' ' A' ' 9' ' ' VAL . 0.7 OUTLIER -160.71 -175.99 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 120.328 -0.549 . . . . 0.0 112.184 -179.489 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.701 ' HA ' HD13 ' A' ' 90' ' ' ILE . 17.8 p -93.42 171.31 8.99 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.05 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.651 ' CG2' HD12 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -158.74 173.62 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.932 -179.594 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 4.4 ptt85 -153.19 134.67 14.35 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.262 0.553 . . . . 0.0 111.013 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.912 ' HB3' HD23 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -131.67 145.43 51.65 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.279 -179.535 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.479 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 2.3 t80 -87.11 148.28 25.29 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.65 ' HE2' HD12 ' A' ' 81' ' ' ILE . 2.0 tptt -84.34 27.67 0.68 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.058 178.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.908 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.1 OUTLIER 45.51 29.43 0.62 Allowed 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 178.939 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.593 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 43.5 24.77 0.06 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.074 0.55 . . . . 0.0 112.476 -178.348 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.908 HG22 ' O ' ' A' ' 17' ' ' ARG . 10.7 m -165.81 32.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.785 178.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 48.54 66.9 1.87 Allowed Glycine 0 C--N 1.338 0.677 0 CA-C-N 115.733 -0.667 . . . . 0.0 113.02 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -152.26 65.25 0.36 Allowed Glycine 0 C--N 1.333 0.364 0 N-CA-C 111.698 -0.561 . . . . 0.0 111.698 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.912 HD23 ' HB3' ' A' ' 14' ' ' LEU . 4.2 mp -48.2 -24.55 1.19 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 40' ' ' LEU . . . 112.6 7.41 22.3 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.241 -0.981 . . . . 0.0 113.578 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.924 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -160.06 139.56 11.13 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 117.98 0.89 . . . . 0.0 113.103 -179.585 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.882 HD23 ' HA ' ' B' ' 6' ' ' SER . 6.1 mt -79.69 171.31 15.31 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.391 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.0 m -153.18 152.02 10.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.016 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.429 ' HG2' HG22 ' A' ' 36' ' ' ILE . 6.8 ptmt -137.39 110.3 7.68 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.394 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.469 ' HB3' ' CG ' ' A' ' 71' ' ' TYR . 1.1 tm-20 -101.96 96.74 7.23 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.452 ' CB ' ' HB2' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -56.34 116.76 3.25 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.311 0.577 . . . . 0.0 111.304 -178.907 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.665 HG23 ' HD3' ' B' ' 3' ' ' LYS . 39.6 t -43.29 -25.26 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.626 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.2 m -145.24 79.07 1.57 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.639 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.453 ' HB3' ' HD2' ' A' ' 33' ' ' PRO . 0.3 OUTLIER -176.13 176.85 0.56 Allowed Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.724 -178.914 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.453 ' HD2' ' HB3' ' A' ' 32' ' ' LYS . 75.3 Cg_exo -53.19 -171.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.392 2.062 . . . . 0.0 112.26 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.582 ' HB3' HD12 ' A' ' 59' ' ' LEU . 95.9 Cg_exo -45.28 174.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.547 2.165 . . . . 0.0 114.065 -178.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.704 HG13 ' O ' ' A' ' 58' ' ' ILE . 12.4 p -78.71 164.55 3.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.307 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.469 ' N ' HG22 ' A' ' 35' ' ' VAL . 1.1 tp -144.69 164.87 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 120.074 -0.65 . . . . 0.0 112.584 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.661 HD12 ' O ' ' A' ' 53' ' ' GLN . 33.8 mt -86.18 149.48 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.115 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.859 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.54 ' CB ' HG13 ' B' ' 4' ' ' VAL . 1.7 t -114.67 -39.61 3.73 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.727 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 6.6 t0 -173.46 135.74 0.56 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.22 -0.592 . . . . 0.0 112.206 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.924 HD23 ' HB3' ' A' ' 24' ' ' PHE . 28.2 mt -70.39 99.42 1.57 Allowed 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.575 HD13 HD21 ' A' ' 25' ' ' LEU . 1.4 tp -54.05 -58.39 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -176.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.462 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.8 OUTLIER -93.2 -68.38 0.8 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.175 0.512 . . . . 0.0 112.269 -177.489 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.49 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 112.01 18.14 7.97 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.618 -178.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.4 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -126.08 -28.0 1.07 Allowed Glycine 0 C--N 1.34 0.786 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.737 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.772 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -93.72 -83.11 0.33 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 117.914 0.857 . . . . 0.0 111.308 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.842 ' HB1' HG21 ' A' ' 52' ' ' ILE . . . -62.18 -60.36 3.7 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.5 0.667 . . . . 0.0 111.317 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.631 ' HB2' HD22 ' A' ' 40' ' ' LEU . 17.5 tp10 -48.77 -39.63 25.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.71 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.4 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 11.4 tp-100 -61.77 -36.2 80.36 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.3 t -54.06 -47.42 71.67 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.401 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.11 -20.27 33.49 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.302 -0.951 . . . . 0.0 113.905 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.093 HD22 HG22 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -94.74 -31.01 13.97 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.899 0.38 . . . . 0.0 110.178 179.588 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.842 HG21 ' HB1' ' A' ' 46' ' ' ALA . 2.6 mp -80.44 119.6 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.064 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.661 ' O ' HD12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -152.52 155.77 38.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.178 179.756 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.727 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -67.98 123.79 21.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.914 0.388 . . . . 0.0 110.875 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.25 2.99 90.73 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.246 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -83.25 -88.94 0.09 Allowed 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 116.997 0.399 . . . . 0.0 110.981 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.629 HD11 ' NH1' ' A' ' 92' ' ' ARG . 6.6 tp -162.68 126.23 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.907 HD11 HG22 ' A' ' 61' ' ' VAL . 3.2 tp -149.76 87.99 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.074 177.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.582 HD12 ' HB3' ' A' ' 34' ' ' PRO . 11.3 tp -81.68 -66.35 0.9 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.721 -178.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.15 158.43 25.94 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.697 0.284 . . . . 0.0 111.594 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.907 HG22 HD11 ' A' ' 58' ' ' ILE . 3.3 t -153.36 148.64 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.967 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.467 HD22 HG12 ' A' ' 61' ' ' VAL . 1.2 p30 44.28 46.67 7.68 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.162 0.506 . . . . 0.0 111.756 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.0 t70 51.99 26.65 3.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.787 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.735 ' HD3' HG11 ' A' ' 77' ' ' VAL . 12.1 mmm180 -111.59 113.79 53.0 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.826 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.685 ' O ' HD22 ' A' ' 69' ' ' LEU . 31.5 Cg_exo -59.22 84.84 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 121.772 1.648 . . . . 0.0 110.733 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.576 ' O ' HG12 ' A' ' 35' ' ' VAL . 12.7 tp -86.83 66.77 9.59 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.354 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.503 HG23 ' H ' ' A' ' 68' ' ' ASP . 3.2 m -128.61 -55.19 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.665 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.503 ' H ' HG23 ' A' ' 67' ' ' VAL . 17.5 t70 -140.1 26.03 2.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.788 0.328 . . . . 0.0 111.648 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.955 HD11 ' HB2' ' A' ' 74' ' ' ALA . 1.4 pt? -94.92 -175.91 3.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.322 -0.399 . . . . 0.0 109.959 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.1 m -71.89 101.52 2.68 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 177.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.882 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 6.5 t80 -40.54 -58.23 1.64 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -178.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -59.36 -26.59 65.2 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.159 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.887 ' O ' HG23 ' A' ' 77' ' ' VAL . 16.3 t -76.21 -42.0 47.58 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.179 0.514 . . . . 0.0 109.95 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.955 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -66.94 -36.92 83.32 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.797 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.882 HD11 ' CZ ' ' A' ' 71' ' ' TYR . 51.0 mt -70.9 -29.64 65.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.162 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -76.75 -37.84 55.25 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.085 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.887 HG23 ' O ' ' A' ' 73' ' ' SER . 11.0 t -62.89 -43.49 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.401 ' CD2' ' HA ' ' A' ' 75' ' ' LEU . 1.2 pp -73.81 -26.85 60.83 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.25 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.468 ' NH1' HG12 ' B' ' 7' ' ' VAL . 0.0 OUTLIER -64.24 -35.49 81.0 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.0 0.428 . . . . 0.0 110.122 179.509 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.97 -19.71 59.26 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.817 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.65 HD12 ' HE2' ' A' ' 16' ' ' LYS . 68.5 mt -58.86 105.63 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-O 120.869 0.366 . . . . 0.0 110.692 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.6 -165.83 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.666 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.5 -171.41 2.37 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.053 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 43.77 31.67 0.5 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.31 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.411 ' O ' ' CD1' ' A' ' 15' ' ' PHE . 1.8 t -128.71 162.4 27.48 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.775 0.798 . . . . 0.0 112.878 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -104.86 176.09 5.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.004 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.568 HG21 ' NZ ' ' A' ' 16' ' ' LYS . 0.5 OUTLIER -146.98 159.21 9.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.036 -179.554 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.606 ' C ' HD23 ' A' ' 89' ' ' LEU . 39.3 t -118.84 158.59 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.651 HD12 ' CG2' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -160.23 169.63 22.83 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.758 0.314 . . . . 0.0 110.835 -178.301 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.701 HD13 ' HA ' ' A' ' 11' ' ' SER . 47.7 mm -129.45 130.81 67.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.391 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.409 HD11 HD12 ' A' ' 51' ' ' LEU . 8.5 mt -104.47 160.84 14.6 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.478 -0.783 . . . . 0.0 108.978 178.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.629 ' NH1' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -161.39 175.68 11.95 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.591 -179.413 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 165.36 -117.04 0.73 Allowed Glycine 0 CA--C 1.521 0.465 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.033 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 8' ' ' ASN . 32.6 Cg_exo -59.55 -154.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.135 1.89 . . . . 0.0 111.354 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -165.94 155.84 12.39 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.841 0.353 . . . . 0.0 111.285 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 119' ' ' PRO . . . 105.24 -7.6 43.87 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.977 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.925 ' HB3' HG22 ' A' ' 117' ' ' THR . 10.3 m-85 -130.56 127.49 39.18 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 117.717 0.758 . . . . 0.0 112.619 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.485 HG22 HD22 ' A' ' 120' ' ' LEU . 0.0 OUTLIER -80.43 117.25 21.0 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.408 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.708 HG21 ' H ' ' A' ' 8' ' ' ASN . 5.1 t -111.26 91.77 3.79 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.166 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.491 ' O ' HG23 ' A' ' 116' ' ' VAL . 94.5 m-70 -71.77 -167.02 0.24 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.682 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.542 HD23 ' N ' ' A' ' 101' ' ' LEU . 0.3 OUTLIER -137.31 92.05 2.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.806 0.336 . . . . 0.0 111.016 179.899 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -144.19 23.02 1.69 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.493 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.522 HG22 ' CE2' ' A' ' 105' ' ' PHE . 0.3 OUTLIER 52.97 92.17 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.807 0.337 . . . . 0.0 111.55 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.41 ' O ' HG22 ' A' ' 104' ' ' THR . 4.3 m -127.75 11.68 6.72 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.522 ' CE2' HG22 ' A' ' 103' ' ' THR . 18.7 p90 -55.16 166.98 0.48 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.987 0.422 . . . . 0.0 111.468 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.2 m -83.15 -58.84 2.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.755 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 163.7 -57.01 0.28 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.691 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -120.32 46.43 1.98 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.892 0.377 . . . . 0.0 111.142 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -149.77 -68.57 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.682 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.626 HG21 HH11 ' A' ' 115' ' ' ARG . 15.0 t -118.22 52.04 1.43 Allowed Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 120.546 0.212 . . . . 0.0 111.519 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.15 102.77 1.5 Allowed 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.367 2.045 . . . . 0.0 112.664 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.39 -172.86 4.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.902 0.382 . . . . 0.0 111.176 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.516 ' HB ' HD21 ' A' ' 51' ' ' LEU . 88.0 m -93.91 -36.58 12.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.795 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 1.093 HG22 HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -104.88 94.97 3.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.786 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.626 HH11 HG21 ' A' ' 110' ' ' THR . 0.0 OUTLIER -151.57 94.65 2.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.099 0.476 . . . . 0.0 111.508 -179.829 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 100' ' ' HIS . 0.6 OUTLIER -159.2 53.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.426 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.925 HG22 ' HB3' ' A' ' 97' ' ' PHE . 0.2 OUTLIER -77.77 129.48 35.53 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.531 -177.896 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 97' ' ' PHE . 4.8 pt20 -145.11 133.11 10.56 Favored Pre-proline 0 N--CA 1.466 0.344 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.324 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 96' ' ' GLY . 13.3 Cg_endo -55.41 124.99 17.65 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.162 1.908 . . . . 0.0 112.801 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.485 HD22 HG22 ' A' ' 98' ' ' THR . 0.0 OUTLIER -93.5 -80.43 0.39 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.996 179.492 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 106.49 -77.73 0.24 Allowed Glycine 0 CA--C 1.522 0.478 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.402 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -60.44 154.58 52.52 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.565 2.176 . . . . 0.0 112.289 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.58 -168.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.311 2.007 . . . . 0.0 112.366 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 124' ' ' THR . 8.6 t -74.8 92.15 2.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.756 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -99.71 40.55 1.22 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.068 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -89.71 13.56 13.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.39 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.9 m . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.247 -0.882 . . . . 0.0 111.048 179.956 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.567 ' O ' HG13 ' B' ' 1' ' ' VAL . 10.2 p . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 121.042 0.448 . . . . 0.0 110.995 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.48 HG22 ' N ' ' B' ' 3' ' ' LYS . 12.2 p -128.13 158.29 40.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.139 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.665 ' HD3' HG23 ' A' ' 30' ' ' VAL . 13.8 mtmm 63.11 19.37 11.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.362 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.54 HG13 ' CB ' ' A' ' 38' ' ' SER . 19.8 t -82.81 100.42 6.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.952 0.406 . . . . 0.0 110.584 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -98.65 129.55 45.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.907 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.882 ' HA ' HD23 ' A' ' 25' ' ' LEU . 8.8 p -83.42 129.24 34.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.39 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.683 ' OXT' HD12 ' A' ' 22' ' ' LEU . 17.2 m . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.133 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 112.583 -0.207 . . . . 0.0 112.583 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.6 m -67.42 85.8 0.17 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.812 0.339 . . . . 0.0 110.94 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -109.97 -43.61 3.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.728 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.627 ' HB3' HD12 ' A' ' 5' ' ' ILE . 31.6 mtt -105.42 127.06 52.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.599 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.679 HG23 ' CG ' ' A' ' 112' ' ' LYS . 5.3 mp 60.11 158.9 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.48 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.422 ' N ' HG22 ' A' ' 5' ' ' ILE . 6.5 mm-40 -102.97 159.66 28.6 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -69.66 130.09 18.85 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 123.16 2.573 . . . . 0.0 112.574 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.874 ' HA ' HG21 ' A' ' 99' ' ' THR . 9.8 m-80 -142.07 88.47 2.11 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.632 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.1 p -85.0 95.8 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 116.548 -0.297 . . . . 0.0 110.914 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.628 HG23 ' N ' ' A' ' 11' ' ' SER . 1.4 tp -161.98 -170.84 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.697 ' HA ' HD13 ' A' ' 90' ' ' ILE . 8.0 p -92.18 164.48 13.55 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.555 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.81 ' CG1' HD12 ' A' ' 89' ' ' LEU . 2.3 t -154.14 158.83 3.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.594 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.8 ttp-105 -140.24 144.11 36.33 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.552 0.691 . . . . 0.0 111.103 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.832 HD21 ' HB2' ' A' ' 46' ' ' ALA . 0.5 OUTLIER -141.09 177.72 7.88 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.283 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.431 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 3.2 t80 -124.19 148.68 47.09 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.412 ' O ' ' N ' ' A' ' 20' ' ' GLY . 12.6 mtpt -83.77 30.89 0.48 Allowed 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.183 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.896 ' O ' HG22 ' A' ' 19' ' ' VAL . 2.2 mmm180 40.78 31.24 0.11 Allowed 'General case' 0 C--N 1.347 0.46 0 CA-C-O 121.086 0.47 . . . . 0.0 111.887 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.621 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 43.85 24.68 0.07 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.456 -178.391 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.896 HG22 ' O ' ' A' ' 17' ' ' ARG . 9.8 m -166.11 32.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.035 178.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 50.56 64.54 3.59 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.943 -178.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -148.23 66.18 0.4 Allowed Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.826 ' CD2' HG11 ' A' ' 87' ' ' VAL . 4.4 mp -49.5 -23.22 1.49 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.459 ' HA2' HG22 ' A' ' 41' ' ' ILE . . . 106.41 8.27 33.38 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.167 -1.016 . . . . 0.0 112.847 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.874 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -160.23 140.4 11.54 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 117.658 0.729 . . . . 0.0 112.483 -179.655 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.728 HD23 ' N ' ' B' ' 6' ' ' SER . 14.1 mt -79.05 166.61 22.13 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.909 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.5 m -151.78 143.81 16.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.268 177.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.802 ' C ' HG23 ' A' ' 35' ' ' VAL . 1.7 tttp -136.41 120.9 18.2 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.907 -178.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.598 ' HG3' HD22 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -113.62 112.01 22.79 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.521 178.488 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.482 ' CB ' ' HB2' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -65.61 124.26 21.89 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.904 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.0 t -49.77 -23.11 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.162 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 69.9 m -145.48 71.94 1.3 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.505 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.482 ' HB2' ' CB ' ' A' ' 29' ' ' ARG . 2.1 mmtp -177.51 176.25 0.51 Allowed Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.534 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 32' ' ' LYS . 88.3 Cg_exo -45.74 173.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.506 2.137 . . . . 0.0 113.414 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -44.11 175.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.265 2.643 . . . . 0.0 115.073 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.802 HG23 ' C ' ' A' ' 27' ' ' LYS . 14.9 p -79.09 147.48 6.72 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.827 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 36' ' ' ILE . 1.5 tp -128.63 161.58 37.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.714 -0.395 . . . . 0.0 111.373 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.696 HD12 ' O ' ' A' ' 53' ' ' GLN . 17.2 mt -79.53 141.46 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.981 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.559 ' CB ' HG13 ' B' ' 4' ' ' VAL . 1.9 t -106.24 -39.21 6.01 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.575 ' HB3' HD12 ' A' ' 25' ' ' LEU . 35.8 t0 -175.23 144.02 0.7 Allowed 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.874 HD23 ' HB3' ' A' ' 24' ' ' PHE . 38.1 mt -76.02 101.2 5.17 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.33 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.557 HD13 ' HB2' ' B' ' 6' ' ' SER . 0.8 OUTLIER -56.65 -59.22 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -176.525 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.46 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -93.02 -65.73 0.98 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -177.465 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.448 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 110.36 21.49 6.9 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.51 -178.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.94 -28.12 0.89 Allowed Glycine 0 C--N 1.339 0.741 0 C-N-CA 120.825 -0.702 . . . . 0.0 113.704 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.761 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -93.39 -83.17 0.33 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 117.996 0.898 . . . . 0.0 111.727 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.992 ' HB1' HG21 ' A' ' 52' ' ' ILE . . . -64.17 -58.56 6.23 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.327 0.584 . . . . 0.0 111.046 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.672 ' HB2' HD22 ' A' ' 40' ' ' LEU . 12.1 tp10 -48.77 -42.61 36.16 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.725 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -61.57 -35.12 76.9 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.529 ' HB2' HD13 ' A' ' 52' ' ' ILE . 2.8 m -53.84 -49.92 67.35 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.97 178.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 113.52 -31.74 6.46 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.212 -0.994 . . . . 0.0 114.337 178.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.779 ' O ' HD12 ' A' ' 51' ' ' LEU . 1.9 pp -98.63 11.46 38.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.675 0.737 . . . . 0.0 111.715 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.992 HG21 ' HB1' ' A' ' 46' ' ' ALA . 4.6 mp -113.28 88.42 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-O 121.016 0.436 . . . . 0.0 110.478 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.696 ' O ' HD12 ' A' ' 37' ' ' ILE . 2.2 tp60 -112.69 148.11 35.37 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.611 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.557 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -70.39 140.88 52.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.046 0.45 . . . . 0.0 111.967 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.96 19.09 69.47 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.089 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -105.69 -81.49 0.54 Allowed 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.495 ' CG2' HD13 ' A' ' 91' ' ' LEU . 28.7 mm -152.51 125.92 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 121.503 0.668 . . . . 0.0 112.536 -177.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.568 HG23 ' O ' ' A' ' 58' ' ' ILE . 2.3 tp -161.21 76.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.469 177.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.902 HD22 ' NE ' ' A' ' 92' ' ' ARG . 5.2 tp -78.69 -63.15 1.48 Allowed 'General case' 0 C--N 1.328 -0.354 0 O-C-N 122.177 -0.327 . . . . 0.0 111.581 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.638 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . . . -109.51 149.97 28.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.859 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.565 HG22 HD11 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -160.92 143.4 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.473 -179.371 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.427 ' HB3' HD11 ' A' ' 81' ' ' ILE . 53.2 m-80 60.89 33.72 19.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.19 0.519 . . . . 0.0 111.879 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 57.91 21.29 7.48 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 178.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.754 ' NH2' HD12 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -121.55 124.55 27.14 Favored Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 120.631 -0.428 . . . . 0.0 109.909 177.586 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.796 ' O ' HD22 ' A' ' 69' ' ' LEU . 19.2 Cg_endo -58.16 88.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 122.205 1.936 . . . . 0.0 112.117 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.754 HD12 ' NH2' ' A' ' 64' ' ' ARG . 0.6 OUTLIER -87.43 67.52 9.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.304 0.573 . . . . 0.0 109.762 179.566 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.544 HG12 ' CD1' ' A' ' 59' ' ' LEU . 3.1 m -126.06 -59.08 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -178.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.513 ' H ' HG23 ' A' ' 67' ' ' VAL . 2.0 p30 -131.47 25.51 4.79 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.796 HD22 ' O ' ' A' ' 65' ' ' PRO . 1.6 pt? -102.5 -172.68 2.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.811 0.338 . . . . 0.0 110.457 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.82 111.47 9.0 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.558 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 8.0 t80 -43.95 -47.52 8.5 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.902 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -67.68 -32.48 73.18 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.17 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.785 ' O ' HG23 ' A' ' 77' ' ' VAL . 3.1 m -70.67 -36.27 73.26 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.341 0.591 . . . . 0.0 109.851 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.635 ' HB1' ' HG ' ' A' ' 66' ' ' LEU . . . -66.09 -49.92 65.89 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.477 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.558 HD11 ' CZ ' ' A' ' 71' ' ' TYR . 48.4 mt -63.42 -28.07 69.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.49 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -71.36 -40.27 70.74 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 73' ' ' SER . 40.6 t -58.38 -42.31 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.61 178.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.565 ' O ' HD12 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -72.07 -35.28 69.23 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.197 178.774 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.91 -37.12 68.47 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.023 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -58.97 -19.98 47.05 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.84 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.548 HG22 HG21 ' A' ' 85' ' ' THR . 55.9 mt -66.36 119.43 11.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.938 0.399 . . . . 0.0 111.231 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.65 -162.16 0.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.13 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.5 m -94.76 -171.36 2.44 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.633 0.254 . . . . 0.0 110.739 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 44.61 30.99 0.57 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.929 0.395 . . . . 0.0 111.207 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.548 HG21 HG22 ' A' ' 81' ' ' ILE . 3.1 t -125.81 161.88 26.38 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.956 0.884 . . . . 0.0 112.908 -178.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -99.15 176.52 5.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.231 -1.35 . . . . 0.0 110.504 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.826 HG11 ' CD2' ' A' ' 22' ' ' LEU . 6.3 p -147.65 153.53 11.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.864 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.759 ' O ' HD23 ' A' ' 89' ' ' LEU . 25.3 t -113.83 159.72 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.585 0.231 . . . . 0.0 110.65 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.81 HD12 ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -153.15 158.97 42.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.797 0.332 . . . . 0.0 110.932 -178.883 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.697 HD13 ' HA ' ' A' ' 11' ' ' SER . 46.9 mm -131.82 124.19 53.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.19 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.495 HD13 ' CG2' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -99.41 160.59 14.17 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.291 178.705 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.902 ' NE ' HD22 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -107.25 150.83 26.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.116 0.484 . . . . 0.0 112.209 -179.108 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.457 ' HA3' ' N ' ' A' ' 8' ' ' ASN . . . -162.87 -140.43 2.87 Favored Glycine 0 CA--C 1.523 0.58 0 CA-C-N 115.285 -0.871 . . . . 0.0 112.914 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -77.76 -154.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.992 2.461 . . . . 0.0 112.192 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -146.83 127.87 14.59 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.571 0.224 . . . . 0.0 110.441 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.73 -7.58 42.27 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.757 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.87 ' HB3' HG22 ' A' ' 117' ' ' THR . 11.4 m-85 -131.83 147.21 52.47 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 117.12 0.46 . . . . 0.0 111.778 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.488 HG23 ' HG3' ' A' ' 118' ' ' GLN . 0.1 OUTLIER -93.97 116.18 28.6 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.361 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.874 HG21 ' HA ' ' A' ' 8' ' ' ASN . 3.8 t -102.41 92.33 4.64 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.563 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.431 ' O ' HD12 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -74.57 -165.79 0.38 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.443 179.081 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.08 130.99 53.51 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.666 0.27 . . . . 0.0 111.538 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.414 ' O ' ' HB ' ' A' ' 103' ' ' THR . 3.8 tt0 178.92 58.07 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.236 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' A' ' 102' ' ' GLU . 14.6 t -176.48 -156.2 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.884 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -165.51 147.32 7.45 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.831 0.348 . . . . 0.0 110.404 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.483 ' HB3' ' HA ' ' A' ' 112' ' ' LYS . 49.3 p90 -74.89 156.52 36.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.116 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.8 t -164.63 168.56 17.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.723 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.41 139.09 48.26 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.615 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 62.27 33.19 16.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.744 0.307 . . . . 0.0 111.036 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.597 ' O ' HG22 ' A' ' 110' ' ' THR . . . -154.9 -62.69 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.35 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.597 HG22 ' O ' ' A' ' 109' ' ' GLY . 1.0 OUTLIER 53.47 37.3 0.41 Allowed Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 179.832 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.498 ' CD ' ' N ' ' A' ' 110' ' ' THR . 42.5 Cg_endo -63.63 -29.71 69.89 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 121.857 1.705 . . . . 0.0 111.983 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.679 ' CG ' HG23 ' A' ' 5' ' ' ILE . 3.4 tmtt? 74.99 134.25 0.05 Allowed 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.052 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 93.5 m -43.84 -32.83 1.16 Allowed 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 121.354 0.597 . . . . 0.0 110.853 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.617 HG23 ' O ' ' A' ' 114' ' ' ILE . 7.6 tp -92.25 93.37 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.142 177.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -160.49 95.11 1.1 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.186 0.517 . . . . 0.0 112.199 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.3 t -156.81 64.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.87 HG22 ' HB3' ' A' ' 97' ' ' PHE . 0.2 OUTLIER -76.72 127.17 32.27 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -177.035 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.488 ' HG3' HG23 ' A' ' 98' ' ' THR . 7.1 pt20 -133.39 138.68 31.91 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.773 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -52.94 112.95 1.05 Allowed 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.335 2.023 . . . . 0.0 112.169 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.753 HD23 ' C ' ' A' ' 97' ' ' PHE . 0.6 OUTLIER -109.69 -28.93 8.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.103 -179.652 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 95.93 105.92 2.17 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.907 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -62.07 168.98 8.22 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.108 1.872 . . . . 0.0 112.108 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -51.43 152.67 11.52 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.218 1.946 . . . . 0.0 112.323 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.4 t -166.92 163.36 16.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.951 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -173.76 179.92 1.91 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.899 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 59.93 18.92 7.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.079 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.477 HG13 ' OXT' ' A' ' 127' ' ' VAL . 11.6 p . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.212 -0.899 . . . . 0.0 111.017 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 9.5 m . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.859 0.361 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 25.1 t -135.09 -64.49 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.083 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 21.6 mmtm -85.43 -177.26 6.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.933 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.559 HG13 ' CB ' ' A' ' 38' ' ' SER . 13.2 t 62.62 120.11 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.952 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' ASP . . . . . 0.551 ' HB3' HG13 ' B' ' 7' ' ' VAL . 29.8 m-20 -146.75 124.95 12.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.308 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.728 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -59.48 -58.66 7.65 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.04 179.33 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.551 HG13 ' HB3' ' B' ' 5' ' ' ASP . 31.8 m . . . . . 0 C--O 1.251 1.153 0 CA-C-O 118.389 -0.815 . . . . 0.0 112.808 178.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.255 0 N-CA-C 112.542 -0.223 . . . . 0.0 112.542 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 63.91 -80.49 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.664 0.269 . . . . 0.0 110.829 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.4 p-80 -108.47 134.27 51.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.656 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 9.1 mtt -86.14 -71.76 0.53 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.195 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.522 HG23 ' N ' ' A' ' 6' ' ' GLU . 0.3 OUTLIER 49.07 -167.56 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.596 -179.838 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.522 ' N ' HG23 ' A' ' 5' ' ' ILE . 4.2 mt-10 -137.41 156.18 75.21 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-O 120.387 0.136 . . . . 0.0 111.133 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.29 -80.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.546 2.164 . . . . 0.0 112.322 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -115.61 -10.2 11.88 Favored 'General case' 0 N--CA 1.463 0.213 0 O-C-N 122.432 -0.167 . . . . 0.0 111.42 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.728 ' C ' HD12 ' A' ' 10' ' ' ILE . 33.4 t -79.62 151.55 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.728 HD12 ' C ' ' A' ' 9' ' ' VAL . 2.1 mp -121.87 146.27 27.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.322 0.582 . . . . 0.0 111.762 -178.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.796 ' HA ' HD13 ' A' ' 90' ' ' ILE . 0.2 OUTLIER -97.18 169.92 9.46 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.372 -179.832 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.628 ' HB ' HD12 ' A' ' 89' ' ' LEU . 0.7 OUTLIER -156.85 163.33 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.089 -178.131 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.16 120.97 7.58 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.494 0.664 . . . . 0.0 110.584 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.732 ' C ' HG12 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -123.39 178.19 5.27 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.578 -179.64 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.47 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 2.5 t80 -119.31 150.04 40.8 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.412 ' CE ' ' HA2' ' A' ' 20' ' ' GLY . 14.3 mtpt -86.36 28.71 0.82 Allowed 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.066 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.864 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 43.81 30.76 0.41 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.968 0.413 . . . . 0.0 111.925 179.532 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.651 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 44.33 23.3 0.06 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.952 -178.716 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.864 HG22 ' O ' ' A' ' 17' ' ' ARG . 4.0 m -166.41 33.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.412 ' HA2' ' CE ' ' A' ' 16' ' ' LYS . . . 49.54 66.57 2.19 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-N 115.435 -0.802 . . . . 0.0 113.088 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -148.07 61.19 0.45 Allowed Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.821 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 4.4 mp -46.91 -26.78 1.06 Allowed 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.434 ' HA2' HG22 ' A' ' 41' ' ' ILE . . . 112.36 5.1 24.92 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.3 -0.953 . . . . 0.0 113.915 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.946 ' HB3' HD23 ' A' ' 40' ' ' LEU . 1.2 p90 -155.95 141.22 17.54 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.237 1.018 . . . . 0.0 113.284 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.806 HD23 ' HA ' ' B' ' 6' ' ' SER . 7.8 mt -79.56 168.22 19.7 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.038 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.5 m -149.01 147.21 16.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.737 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.826 ' C ' HG23 ' A' ' 35' ' ' VAL . 17.0 ttpt -129.34 118.93 23.03 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.01 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.513 ' N ' HG23 ' A' ' 35' ' ' VAL . 4.1 tm-20 -114.14 97.19 6.21 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.79 -1.095 . . . . 0.0 108.541 177.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.473 ' CB ' ' HB2' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -57.04 120.23 7.66 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.049 0.452 . . . . 0.0 110.932 -179.033 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.9 t -45.98 -23.75 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.444 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.0 m -146.37 75.06 1.39 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.435 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.474 ' HB3' ' HD2' ' A' ' 33' ' ' PRO . 3.0 mmtt -177.95 177.99 0.4 Allowed Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.734 -178.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 32' ' ' LYS . 88.4 Cg_exo -49.99 -177.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.341 2.028 . . . . 0.0 113.41 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.45 ' HB3' HG12 ' A' ' 67' ' ' VAL . 80.2 Cg_exo -47.65 170.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.142 2.562 . . . . 0.0 114.531 -178.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.918 HG11 HD13 ' A' ' 66' ' ' LEU . 7.4 p -79.08 146.22 8.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.036 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.417 HD12 ' HA ' ' A' ' 36' ' ' ILE . 1.1 tp -126.99 166.62 23.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.542 HD12 ' O ' ' A' ' 53' ' ' GLN . 27.8 mt -84.29 141.25 14.95 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 CA-C-O 120.708 0.29 . . . . 0.0 110.71 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.796 ' CB ' HG13 ' B' ' 4' ' ' VAL . 0.1 OUTLIER -108.89 -36.64 6.06 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -179.833 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.639 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 4.9 t70 -169.21 132.61 1.32 Allowed 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.319 -0.552 . . . . 0.0 112.381 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.946 HD23 ' HB3' ' A' ' 24' ' ' PHE . 54.1 mt -70.26 78.49 0.53 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 121.701 0.762 . . . . 0.0 109.876 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.75 HD13 HD21 ' A' ' 25' ' ' LEU . 1.7 tp -33.06 -58.85 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 -177.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.461 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -94.42 -68.88 0.78 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -177.706 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.425 ' HA2' ' CB ' ' A' ' 47' ' ' GLU . . . 108.7 25.59 5.65 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -178.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.38 -34.08 0.51 Allowed Glycine 0 C--N 1.337 0.609 0 C-N-CA 121.145 -0.55 . . . . 0.0 113.182 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.821 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -92.74 -80.43 0.37 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 117.546 0.673 . . . . 0.0 110.908 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.787 ' HB1' ' CG2' ' A' ' 52' ' ' ILE . . . -60.29 -58.04 10.21 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.222 0.534 . . . . 0.0 111.389 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.425 ' CB ' ' HA2' ' A' ' 43' ' ' GLY . 39.2 tt0 -48.7 -46.92 41.27 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.83 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.6 tp-100 -57.87 -33.85 69.14 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.874 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.1 t -55.05 -52.16 64.04 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.752 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 112.27 -22.58 17.64 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.299 -0.953 . . . . 0.0 113.859 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.488 ' HG ' HD12 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -97.07 -28.2 14.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.955 0.377 . . . . 0.0 110.728 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.787 ' CG2' ' HB1' ' A' ' 46' ' ' ALA . 2.3 mp -82.37 121.28 35.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.025 0.441 . . . . 0.0 110.328 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.619 ' HA ' HD11 ' A' ' 40' ' ' LEU . 1.5 mt-30 -153.74 156.45 37.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.101 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.639 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -66.52 120.06 12.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.877 0.37 . . . . 0.0 110.954 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.0 -1.73 88.43 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.294 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.34 -91.34 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 117.011 0.406 . . . . 0.0 110.511 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.87 ' CG2' HD13 ' A' ' 91' ' ' LEU . 2.8 tp -163.98 120.5 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.592 HG23 ' O ' ' A' ' 58' ' ' ILE . 2.0 tp -140.14 88.67 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.77 HD13 ' NE ' ' A' ' 92' ' ' ARG . 18.2 tp -78.33 -70.3 0.5 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.598 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -121.16 165.46 15.35 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.803 0.335 . . . . 0.0 111.109 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.581 HG22 HD11 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -148.3 157.23 8.26 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.267 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.128 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.54 ' HA ' HG22 ' A' ' 87' ' ' VAL . 0.0 OUTLIER 56.71 -81.21 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.046 0.538 . . . . 0.0 110.214 -178.589 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 61' ' ' VAL . 14.5 p-10 -175.22 36.99 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.344 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.673 ' NH1' ' HB1' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -124.08 130.32 24.43 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.24 179.887 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.504 ' O ' HD22 ' A' ' 69' ' ' LEU . 17.1 Cg_exo -63.58 86.41 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 121.206 1.27 . . . . 0.0 110.322 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.918 HD13 HG11 ' A' ' 35' ' ' VAL . 0.3 OUTLIER -86.71 68.21 10.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.286 0.565 . . . . 0.0 110.916 -178.887 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.572 HG23 ' H ' ' A' ' 68' ' ' ASP . 2.7 m -131.62 -61.53 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.572 ' H ' HG23 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -127.73 28.33 5.63 Favored 'General case' 0 C--N 1.333 -0.13 0 O-C-N 121.978 -0.451 . . . . 0.0 111.735 -178.644 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' A' ' 74' ' ' ALA . 1.6 pt? -99.85 -172.06 2.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.498 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.32 114.63 15.22 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.642 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 4.0 t80 -44.2 -50.98 8.54 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -64.81 -29.11 70.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.339 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.835 ' O ' HG23 ' A' ' 77' ' ' VAL . 39.0 t -71.23 -40.57 71.0 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.278 0.561 . . . . 0.0 110.048 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.677 ' HB1' ' HG ' ' A' ' 66' ' ' LEU . . . -65.77 -45.17 83.52 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.368 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.642 HD11 ' CZ ' ' A' ' 71' ' ' TYR . 73.9 mt -63.69 -28.73 70.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.868 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -76.41 -36.09 58.24 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.812 0.339 . . . . 0.0 110.177 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.835 HG23 ' O ' ' A' ' 73' ' ' SER . 10.8 t -61.36 -41.43 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.795 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.565 HD21 HG11 ' B' ' 7' ' ' VAL . 0.6 OUTLIER -76.31 -32.15 58.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.511 179.071 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.443 ' NH1' HG12 ' B' ' 7' ' ' VAL . 0.0 OUTLIER -62.32 -32.16 72.88 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.795 -179.468 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.26 -17.59 61.81 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.715 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.478 HD11 ' HB3' ' A' ' 62' ' ' ASN . 29.5 mt -63.25 136.77 25.68 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 CA-C-O 120.867 0.365 . . . . 0.0 110.828 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.46 -165.42 0.78 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.507 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.43 -172.12 2.27 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.098 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 38.0 34.67 0.07 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.105 0.562 . . . . 0.0 111.5 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.416 ' O ' ' CE1' ' A' ' 15' ' ' PHE . 1.8 t -126.37 163.63 22.86 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.925 0.869 . . . . 0.0 113.21 -177.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.403 ' CE1' ' HD2' ' A' ' 15' ' ' PHE . 0.3 OUTLIER -96.3 177.33 5.74 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 114.158 -1.383 . . . . 0.0 110.051 179.016 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.732 HG12 ' C ' ' A' ' 14' ' ' LEU . 2.3 p -150.77 145.98 16.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.338 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.896 ' O ' HD23 ' A' ' 89' ' ' LEU . 21.2 t -101.9 159.3 4.23 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.015 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.896 HD23 ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -155.16 165.91 35.23 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.319 -179.784 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.796 HD13 ' HA ' ' A' ' 11' ' ' SER . 29.6 mm -132.58 130.31 59.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.188 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.87 HD13 ' CG2' ' A' ' 57' ' ' ILE . 0.9 OUTLIER -116.56 175.35 5.61 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.024 178.871 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.77 ' NE ' HD13 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -140.16 168.45 19.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.86 0.362 . . . . 0.0 110.925 179.529 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -102.67 159.8 17.43 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.765 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.81 -154.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.54 2.16 . . . . 0.0 112.29 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -94.31 93.62 7.83 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.69 12.81 36.62 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.768 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.868 ' C ' HD23 ' A' ' 120' ' ' LEU . 42.4 m-85 -137.82 128.41 26.66 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.481 ' CB ' ' HB3' ' A' ' 120' ' ' LEU . 0.9 OUTLIER -87.64 174.99 8.1 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.021 179.393 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.456 ' N ' ' CG2' ' A' ' 98' ' ' THR . 0.0 OUTLIER -121.49 92.05 3.66 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.254 178.418 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.43 ' O ' HD11 ' A' ' 114' ' ' ILE . 0.3 OUTLIER -79.28 176.25 9.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.027 179.39 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.685 ' N ' HD13 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -122.39 -178.88 4.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.156 0.503 . . . . 0.0 111.711 -179.087 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -157.42 31.56 0.28 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.397 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.908 HG23 ' HE2' ' A' ' 112' ' ' LYS . 8.8 t -140.64 -174.51 3.99 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.115 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 50.7 p -93.13 140.36 29.59 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.869 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.42 ' N ' ' HE3' ' A' ' 112' ' ' LYS . 5.5 m-85 -76.4 176.99 7.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.973 0.416 . . . . 0.0 111.083 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 99.8 m -76.27 -67.7 0.66 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.316 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -115.07 28.18 8.15 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.066 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 59.53 27.93 17.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.694 0.283 . . . . 0.0 111.047 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -153.18 17.82 0.7 Allowed Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.379 -0.915 . . . . 0.0 113.508 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.405 ' HA ' ' HD3' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -163.09 140.36 5.96 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 117.246 0.523 . . . . 0.0 110.448 179.892 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 110' ' ' THR . 50.0 Cg_exo -55.17 177.16 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.002 1.801 . . . . 0.0 112.427 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.908 ' HE2' HG23 ' A' ' 103' ' ' THR . 0.0 OUTLIER -153.27 -151.96 0.4 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.038 -178.713 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 98.9 m -62.15 88.08 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.681 HG22 ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -114.3 140.89 32.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.458 -177.198 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -161.53 92.51 0.88 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.082 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.9 t -160.21 107.6 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.428 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.598 HG22 ' HB3' ' A' ' 97' ' ' PHE . 0.2 OUTLIER -79.42 138.17 37.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.79 0.329 . . . . 0.0 110.604 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.454 ' O ' ' HA ' ' A' ' 97' ' ' PHE . 8.2 pt20 -146.66 157.22 48.13 Favored Pre-proline 0 C--O 1.217 -0.614 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.636 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.24 105.95 1.49 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 121.936 1.757 . . . . 0.0 111.317 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.868 HD23 ' C ' ' A' ' 97' ' ' PHE . 1.4 pp -89.58 -38.71 13.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.856 0.36 . . . . 0.0 111.087 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 50.41 94.43 0.01 OUTLIER Glycine 0 CA--C 1.522 0.48 0 C-N-CA 121.191 -0.528 . . . . 0.0 113.185 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.63 153.4 14.38 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.223 1.949 . . . . 0.0 112.074 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.23 79.54 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.295 1.997 . . . . 0.0 112.634 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 10.1 t -173.03 -176.69 1.44 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.98 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt 62.43 59.54 1.52 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.184 0.516 . . . . 0.0 110.884 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -89.42 12.7 15.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.329 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.9 m . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.253 -0.88 . . . . 0.0 111.032 179.938 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 25.7 t . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.927 0.394 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.45 HG13 ' H ' ' B' ' 3' ' ' LYS . 2.8 p -175.75 -54.28 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.442 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.45 ' H ' HG13 ' B' ' 2' ' ' VAL . 25.8 mmtm 58.98 147.46 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.796 HG13 ' CB ' ' A' ' 38' ' ' SER . 3.5 t 68.83 -61.84 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.963 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' ASP . . . . . 0.53 ' O ' HD22 ' A' ' 25' ' ' LEU . 0.9 OUTLIER 58.21 -124.6 1.5 Allowed 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 119.44 -0.314 . . . . 0.0 110.348 179.876 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.806 ' HA ' HD23 ' A' ' 25' ' ' LEU . 5.8 p 167.8 127.91 0.01 OUTLIER 'General case' 0 C--N 1.347 0.475 0 CA-C-N 118.605 0.639 . . . . 0.0 110.336 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.565 HG11 HD21 ' A' ' 78' ' ' LEU . 4.5 m . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.232 -0.89 . . . . 0.0 111.251 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.157 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.4 m -138.47 -173.75 3.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.833 0.349 . . . . 0.0 110.852 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 59.4 89.56 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.79 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.428 ' O ' HG22 ' A' ' 5' ' ' ILE . 17.6 mmt -112.11 -42.79 3.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.0 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.692 HD12 ' N ' ' A' ' 110' ' ' THR . 8.4 tt 44.46 40.33 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.96 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -164.41 151.55 10.06 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.491 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -89.01 -165.03 0.18 Allowed 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.895 2.397 . . . . 0.0 112.311 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.547 ' O ' HG23 ' A' ' 9' ' ' VAL . 8.2 t-20 -140.68 -70.32 0.38 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.691 ' O ' HD12 ' A' ' 10' ' ' ILE . 42.0 t -160.71 90.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.691 HD12 ' O ' ' A' ' 9' ' ' VAL . 0.5 OUTLIER -148.99 -178.49 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 120.166 -0.613 . . . . 0.0 112.218 -178.023 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.633 ' HA ' HD13 ' A' ' 90' ' ' ILE . 13.9 m -77.37 167.76 21.15 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -178.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.829 ' CG1' HD12 ' A' ' 89' ' ' LEU . 1.9 t -157.87 157.83 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 114.083 -1.417 . . . . 0.0 107.894 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.465 ' O ' HD12 ' A' ' 14' ' ' LEU . 11.3 ttp180 -141.69 141.92 33.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.406 0.622 . . . . 0.0 111.727 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.905 HD21 ' HB2' ' A' ' 46' ' ' ALA . 0.8 OUTLIER -142.96 177.44 8.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.876 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.444 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 3.5 t80 -124.49 147.86 48.08 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.659 ' HE3' HD11 ' A' ' 22' ' ' LEU . 1.5 mtpt -84.12 32.62 0.49 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.481 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.795 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.3 OUTLIER 40.53 32.13 0.13 Allowed 'General case' 0 C--N 1.344 0.343 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 179.222 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.72 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 45.0 24.66 0.12 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.551 -178.497 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.795 HG22 ' O ' ' A' ' 17' ' ' ARG . 1.6 m -169.23 34.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.317 178.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 49.94 63.91 3.89 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 115.56 -0.746 . . . . 0.0 113.062 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -145.97 62.22 0.47 Allowed Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.844 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 4.1 mp -46.24 -24.83 0.52 Allowed 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -178.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.473 ' HA2' HG22 ' A' ' 41' ' ' ILE . . . 107.96 6.99 31.8 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.039 -1.076 . . . . 0.0 113.587 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.909 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -157.15 140.78 15.87 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -178.92 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.808 HD23 ' HA ' ' B' ' 6' ' ' SER . 7.3 mt -79.92 171.06 15.62 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.671 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.5 m -149.85 153.2 10.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.506 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.2 105.13 5.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.479 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.597 ' CA ' HG23 ' A' ' 35' ' ' VAL . 0.6 OUTLIER -108.44 139.22 43.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.076 178.93 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.453 ' CB ' ' HB2' ' A' ' 32' ' ' LYS . 10.7 mtt-85 -76.6 124.5 27.71 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.05 0.453 . . . . 0.0 110.37 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.7 t -52.08 -21.83 2.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.042 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.2 p -141.48 42.44 1.75 Allowed 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.738 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.453 ' HB2' ' CB ' ' A' ' 29' ' ' ARG . 15.6 mttp -167.0 140.87 3.1 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.927 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.433 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 32.0 Cg_exo -58.69 -46.72 21.99 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.526 2.15 . . . . 0.0 113.46 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 33' ' ' PRO . 53.1 Cg_exo -39.8 93.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.803 2.335 . . . . 0.0 114.607 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.597 HG23 ' CA ' ' A' ' 28' ' ' GLU . 11.4 p -116.8 144.08 25.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 177.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.43 HD12 ' HA ' ' A' ' 36' ' ' ILE . 1.4 tp -153.64 169.07 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.8 HD12 ' O ' ' A' ' 53' ' ' GLN . 24.2 mt -81.27 145.93 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.464 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.458 ' CB ' HG13 ' B' ' 4' ' ' VAL . 4.9 t -109.32 -40.58 4.88 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.702 ' CB ' HD12 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -164.9 131.78 2.98 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.863 -179.452 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.909 HD23 ' HB3' ' A' ' 24' ' ' PHE . 43.1 mt -70.14 76.74 0.51 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.712 0.767 . . . . 0.0 109.698 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.476 ' CD1' HD21 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -30.58 -59.16 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -177.999 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.46 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -94.44 -66.25 0.93 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -177.857 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.421 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 104.65 23.5 7.86 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -177.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.444 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -125.45 -30.1 0.94 Allowed Glycine 0 C--N 1.338 0.687 0 C-N-CA 121.24 -0.505 . . . . 0.0 113.159 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.844 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -95.84 -83.25 0.37 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 117.686 0.743 . . . . 0.0 111.932 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.905 ' HB2' HD21 ' A' ' 14' ' ' LEU . . . -59.95 -58.79 7.03 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.207 0.527 . . . . 0.0 111.04 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.421 ' HB3' ' HA2' ' A' ' 43' ' ' GLY . 33.9 tt0 -45.06 -49.42 11.55 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.971 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' A' ' 44' ' ' GLY . 7.6 mt-30 -55.65 -39.04 70.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.493 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.42 -49.9 63.61 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.343 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.4 -26.99 13.21 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.301 -0.952 . . . . 0.0 113.746 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.048 HD22 HG22 ' A' ' 114' ' ' ILE . 2.1 pp -95.65 -0.98 51.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.107 0.453 . . . . 0.0 111.471 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.866 HG21 ' HB1' ' A' ' 46' ' ' ALA . 5.0 mp -109.79 123.99 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.8 ' O ' HD12 ' A' ' 37' ' ' ILE . 1.7 mp0 -150.93 160.12 44.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.735 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.49 129.81 40.74 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.925 0.393 . . . . 0.0 111.265 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.35 13.73 63.13 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.101 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.27 -80.84 0.39 Allowed 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 22.4 mt -155.24 122.7 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.567 HD11 ' HB ' ' A' ' 61' ' ' VAL . 3.2 tp -160.25 71.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 114.867 -1.061 . . . . 0.0 109.222 177.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.535 HD22 ' HB3' ' A' ' 92' ' ' ARG . 9.2 tp -76.93 -54.13 6.97 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.643 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.642 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . . . -121.08 160.04 24.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.835 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.692 HG12 HD12 ' A' ' 66' ' ' LEU . 14.4 p -166.75 146.05 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.043 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.635 ' ND2' HG22 ' A' ' 61' ' ' VAL . 0.1 OUTLIER 45.76 41.13 7.15 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.198 0.523 . . . . 0.0 111.56 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.4 t70 59.74 28.44 17.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.221 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.49 ' NH2' HG21 ' A' ' 77' ' ' VAL . 25.5 mmm180 -119.61 98.24 49.93 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.572 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.4 ' O ' HD22 ' A' ' 69' ' ' LEU . 22.4 Cg_endo -61.27 85.37 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 121.811 1.674 . . . . 0.0 110.896 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.692 HD12 HG12 ' A' ' 61' ' ' VAL . 13.4 mt -68.75 63.69 0.11 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.508 -178.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.552 HG23 ' H ' ' A' ' 68' ' ' ASP . 3.4 m -141.81 -61.09 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.552 ' H ' HG23 ' A' ' 67' ' ' VAL . 16.4 t0 -111.7 29.38 7.9 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 122.127 -0.358 . . . . 0.0 111.736 -178.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.665 HD21 ' HB2' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -123.19 175.31 6.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.644 179.598 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.5 m -72.66 102.33 3.28 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.748 ' CE1' HD11 ' A' ' 75' ' ' LEU . 8.5 t80 -40.14 -60.99 0.95 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.363 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.515 ' HA ' HD12 ' A' ' 75' ' ' LEU . 6.8 p30 -55.49 -28.42 54.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.404 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.886 ' O ' HG23 ' A' ' 77' ' ' VAL . 43.8 m -78.07 -39.94 40.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.087 0.47 . . . . 0.0 109.856 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.665 ' HB2' HD21 ' A' ' 69' ' ' LEU . . . -60.47 -34.73 74.46 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.294 0.568 . . . . 0.0 109.944 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.748 HD11 ' CE1' ' A' ' 71' ' ' TYR . 15.1 mt -75.02 -38.04 61.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.242 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.41 ' HA ' ' HB2' ' A' ' 79' ' ' ARG . 5.0 pt-20 -72.07 -38.73 69.39 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.98 0.419 . . . . 0.0 110.19 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.886 HG23 ' O ' ' A' ' 73' ' ' SER . 45.1 t -62.33 -42.93 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.772 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.541 ' C ' HD12 ' A' ' 78' ' ' LEU . 4.5 pp -79.85 -21.91 43.55 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.12 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.535 ' N ' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -66.77 -37.18 84.08 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-O 120.988 0.423 . . . . 0.0 110.335 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -58.27 -19.07 38.07 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.192 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.406 ' HB ' ' HD2' ' A' ' 16' ' ' LYS . 70.8 mt -54.27 121.99 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 120.953 0.406 . . . . 0.0 111.006 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.77 -163.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.653 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.3 m -96.42 -171.67 2.34 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.996 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 44.08 30.82 0.46 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.232 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.404 ' O ' ' CE1' ' A' ' 15' ' ' PHE . 1.7 t -125.37 158.76 33.48 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 122.046 0.927 . . . . 0.0 112.737 -178.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -100.34 176.28 5.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.969 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.806 HG12 ' C ' ' A' ' 14' ' ' LEU . 4.8 p -148.66 153.14 11.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.22 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.726 ' O ' HD23 ' A' ' 89' ' ' LEU . 34.1 t -113.56 160.43 13.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.829 HD12 ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -155.89 172.64 18.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.64 0.257 . . . . 0.0 110.597 -178.736 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.642 ' HB ' ' HB3' ' A' ' 60' ' ' ALA . 29.6 mm -137.25 126.37 35.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.987 HD11 HD13 ' A' ' 51' ' ' LEU . 11.6 mt -91.17 145.81 24.36 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.535 ' HB3' HD22 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -119.96 175.32 5.96 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -178.185 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 8' ' ' ASN . . . 136.49 60.68 0.06 OUTLIER Glycine 0 CA--C 1.526 0.722 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.907 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.56 125.03 16.76 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.597 2.198 . . . . 0.0 113.024 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.401 ' O ' ' CD1' ' A' ' 97' ' ' PHE . 0.3 OUTLIER -163.86 28.75 0.08 Allowed 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.3 179.906 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.414 ' O ' ' CG ' ' A' ' 97' ' ' PHE . . . 69.23 60.07 5.4 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.942 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.718 ' CB ' HG22 ' A' ' 117' ' ' THR . 96.7 m-85 -160.44 129.69 4.97 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.792 0.33 . . . . 0.0 111.873 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.662 HG22 HD22 ' A' ' 120' ' ' LEU . 0.1 OUTLIER -89.64 127.35 35.9 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.105 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.799 HG22 ' O ' ' A' ' 115' ' ' ARG . 0.1 OUTLIER -86.88 91.27 8.61 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.772 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -103.9 136.74 43.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.871 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.7 pp -54.07 -177.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.329 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 66.81 87.65 0.12 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.967 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 11.9 t -156.23 170.01 23.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.53 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 40.5 p -125.77 133.9 51.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.93 0.395 . . . . 0.0 111.209 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.53 ' HA ' HG23 ' A' ' 110' ' ' THR . 19.7 p90 -115.86 168.4 10.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.943 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.534 ' H ' HG22 ' A' ' 110' ' ' THR . 88.7 m -120.52 -76.27 0.58 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.777 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -140.97 -78.97 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.499 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 23.0 p30 -144.33 28.8 1.32 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.857 0.36 . . . . 0.0 111.081 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.515 ' C ' HD12 ' A' ' 5' ' ' ILE . . . -132.75 0.8 4.62 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 120.843 -0.694 . . . . 0.0 113.422 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.692 ' N ' HD12 ' A' ' 5' ' ' ILE . 0.6 OUTLIER -141.83 -172.12 0.3 Allowed Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.492 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.518 ' HD2' HG23 ' A' ' 110' ' ' THR . 88.6 Cg_exo -50.31 -175.2 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 121.949 1.766 . . . . 0.0 112.418 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.406 ' HD3' ' N ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -152.22 -156.94 0.75 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 -179.415 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 10.9 m -58.65 -16.84 17.99 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.562 0.22 . . . . 0.0 110.928 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 1.048 HG22 HD22 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -75.59 175.19 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 121.207 0.527 . . . . 0.0 111.514 -179.296 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.871 ' O ' HD12 ' A' ' 114' ' ' ILE . 16.8 mmt180 -79.49 145.81 33.04 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.724 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.488 HG23 ' HB3' ' A' ' 111' ' ' PRO . 1.0 OUTLIER -85.23 138.14 19.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 121.363 0.601 . . . . 0.0 111.112 -179.334 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.718 HG22 ' CB ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -79.57 121.44 25.25 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.945 -1.025 . . . . 0.0 112.307 -178.078 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.419 ' O ' HG23 ' A' ' 98' ' ' THR . 0.0 OUTLIER -123.18 130.67 24.48 Favored Pre-proline 0 N--CA 1.477 0.878 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 179.633 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.441 ' HD3' ' CE2' ' A' ' 97' ' ' PHE . 5.2 Cg_exo -38.82 124.13 0.87 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.272 2.648 . . . . 0.0 115.175 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.669 HD21 ' C ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.26 -65.74 0.96 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.369 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 157.76 86.62 0.06 OUTLIER Glycine 0 CA--C 1.521 0.457 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.401 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -61.45 172.33 3.54 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.475 2.116 . . . . 0.0 112.512 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.42 175.38 0.1 Allowed 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.384 2.056 . . . . 0.0 112.263 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.0 t -104.27 146.16 29.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.757 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.4 mttp -119.94 54.74 1.01 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.145 0.498 . . . . 0.0 111.028 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -93.01 16.98 11.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.229 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.1 m . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.182 179.976 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.738 0.304 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 11.5 t -128.95 -54.29 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.433 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.43 ' CE ' ' HA ' ' A' ' 29' ' ' ARG . 31.8 mmtm -80.82 -48.22 12.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.585 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.458 HG13 ' CB ' ' A' ' 38' ' ' SER . 4.2 t -70.94 106.29 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.67 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' ASP . . . . . 0.515 ' CG ' HD13 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -86.28 -98.09 0.07 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.927 -179.608 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.808 ' HA ' HD23 ' A' ' 25' ' ' LEU . 2.6 p 162.75 130.41 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 122.794 0.438 . . . . 0.0 110.406 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.712 ' OXT' HD12 ' A' ' 22' ' ' LEU . 15.5 m . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.182 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 p -169.23 92.24 0.26 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.882 0.372 . . . . 0.0 110.983 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -165.17 146.04 7.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.716 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.5 ttt -124.82 119.94 30.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.142 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.752 HG21 HD11 ' A' ' 57' ' ' ILE . 0.1 OUTLIER 46.43 -170.69 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.815 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.545 ' N ' HG23 ' A' ' 5' ' ' ILE . 5.5 mm-40 -139.15 162.45 52.07 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.066 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.415 ' CA ' ' HA2' ' A' ' 93' ' ' GLY . 16.8 Cg_exo -67.32 124.88 12.65 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.614 2.21 . . . . 0.0 112.359 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.899 ' HA ' HG21 ' A' ' 99' ' ' THR . 14.7 m120 -132.94 88.39 2.5 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.145 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.841 HG12 ' HD2' ' A' ' 94' ' ' PRO . 9.9 p -91.34 97.03 6.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.879 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.649 HG23 ' N ' ' A' ' 11' ' ' SER . 1.5 tp -160.97 -166.97 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.72 ' HA ' HD13 ' A' ' 90' ' ' ILE . 10.1 m -100.61 168.42 9.72 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 121.572 0.701 . . . . 0.0 112.684 -178.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.73 ' CG1' HD12 ' A' ' 89' ' ' LEU . 2.2 t -156.18 164.36 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.961 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.43 ' H ' HG12 ' A' ' 12' ' ' VAL . 1.5 tpp85 -149.83 127.69 11.8 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.508 0.67 . . . . 0.0 110.744 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.763 ' C ' HG12 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -128.37 178.25 6.4 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.838 -1.073 . . . . 0.0 110.094 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.456 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 4.0 t80 -122.03 151.22 41.07 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 20' ' ' GLY . 2.1 mmpt? -83.37 30.95 0.46 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.405 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.889 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.9 OUTLIER 40.91 31.21 0.12 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 122.865 0.466 . . . . 0.0 112.061 179.679 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.614 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 44.15 24.35 0.08 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.286 0.634 . . . . 0.0 112.419 -177.992 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.889 HG22 ' O ' ' A' ' 17' ' ' ARG . 6.6 m -165.98 32.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.108 178.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 50.45 68.16 1.56 Allowed Glycine 0 C--N 1.337 0.608 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.991 -178.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -155.08 69.48 0.29 Allowed Glycine 0 C--N 1.332 0.327 0 N-CA-C 111.529 -0.629 . . . . 0.0 111.529 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.802 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 4.5 mp -49.4 -21.3 0.86 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -179.007 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.441 ' HA2' HG22 ' A' ' 41' ' ' ILE . . . 107.78 5.15 33.82 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.169 -1.015 . . . . 0.0 113.32 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.913 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -157.58 138.12 12.95 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 117.794 0.797 . . . . 0.0 112.844 -179.583 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.992 HD23 ' HA ' ' B' ' 6' ' ' SER . 1.8 mt -78.68 165.28 23.81 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.374 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.3 m -147.7 154.31 11.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.161 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.763 ' C ' HG23 ' A' ' 35' ' ' VAL . 26.5 ttpt -137.7 121.28 17.29 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.259 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.465 ' HB3' ' CD1' ' A' ' 71' ' ' TYR . 0.9 OUTLIER -115.03 95.21 5.1 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.167 178.538 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.475 ' CB ' ' HB2' ' A' ' 32' ' ' LYS . 8.9 mtt180 -62.16 116.84 5.31 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.117 0.484 . . . . 0.0 110.493 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.8 t -48.49 -20.62 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.6 m -142.1 66.04 1.35 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.694 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.5 ' HB3' ' HD2' ' A' ' 33' ' ' PRO . 4.1 mttp -172.58 176.69 0.88 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.595 -178.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.5 ' HD2' ' HB3' ' A' ' 32' ' ' LYS . 83.4 Cg_exo -49.95 -177.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.166 1.911 . . . . 0.0 113.075 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.541 ' HB3' HG12 ' A' ' 67' ' ' VAL . 89.5 Cg_exo -46.76 176.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.999 2.466 . . . . 0.0 114.027 -179.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.763 HG23 ' C ' ' A' ' 27' ' ' LYS . 14.6 p -77.98 148.82 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.32 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.4 HD12 ' HA ' ' A' ' 36' ' ' ILE . 0.6 OUTLIER -129.87 154.96 41.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 120.855 0.359 . . . . 0.0 111.539 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.798 HD12 ' O ' ' A' ' 53' ' ' GLN . 22.1 mt -79.22 142.54 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.773 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.4 ' HB3' ' CG1' ' B' ' 4' ' ' VAL . 2.4 t -106.36 -40.45 5.6 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.624 ' CB ' HD12 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -171.18 142.11 1.72 Allowed 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.145 -0.622 . . . . 0.0 112.429 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.913 HD23 ' HB3' ' A' ' 24' ' ' PHE . 46.6 mt -76.21 85.3 3.03 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.995 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.652 HD13 HD21 ' A' ' 25' ' ' LEU . 1.3 tp -41.98 -58.29 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -177.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.459 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.1 OUTLIER -92.44 -66.23 0.94 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -176.929 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.465 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 107.42 18.81 9.86 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 -177.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.51 -27.75 0.95 Allowed Glycine 0 C--N 1.34 0.793 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.855 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.802 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -94.06 -83.4 0.33 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.008 0.904 . . . . 0.0 111.69 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.85 ' HB1' HG21 ' A' ' 52' ' ' ILE . . . -64.23 -54.68 29.64 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 121.424 0.631 . . . . 0.0 110.782 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.761 ' CD ' HD13 ' A' ' 40' ' ' LEU . 3.8 tp10 -49.19 -42.24 39.45 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.368 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.92 -35.52 78.63 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.454 178.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.3 -47.78 65.73 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.655 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.42 -27.0 11.09 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.207 -0.997 . . . . 0.0 114.655 177.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.78 HD22 ' HB ' ' A' ' 114' ' ' ILE . 2.8 pp -102.26 -11.66 18.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 117.711 0.756 . . . . 0.0 111.944 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.85 HG21 ' HB1' ' A' ' 46' ' ' ALA . 5.2 mp -87.78 104.45 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.798 ' O ' HD12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -128.08 156.53 42.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.833 -179.781 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.532 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -71.93 133.39 45.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.827 0.346 . . . . 0.0 111.04 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.96 14.37 65.57 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.134 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.527 ' C ' HD12 ' A' ' 57' ' ' ILE . 1.2 m-20 -93.17 -82.55 0.34 Allowed 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.909 HG22 HD22 ' A' ' 91' ' ' LEU . 1.6 mp -158.47 120.38 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.462 0.649 . . . . 0.0 111.841 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.973 HD11 HG22 ' A' ' 61' ' ' VAL . 5.9 tp -152.9 87.19 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.09 177.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.3 tp -79.48 -61.78 1.9 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 121.994 -0.441 . . . . 0.0 111.238 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -127.88 158.88 36.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.909 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.973 HG22 HD11 ' A' ' 58' ' ' ILE . 11.7 t -150.63 149.99 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.018 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.505 HD22 HG21 ' A' ' 87' ' ' VAL . 0.0 OUTLIER 49.47 33.82 6.06 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.25 0.547 . . . . 0.0 110.941 179.393 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 63.89 23.89 13.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.285 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -111.39 110.93 55.49 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.179 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.79 ' O ' HD22 ' A' ' 69' ' ' LEU . 29.2 Cg_endo -62.49 80.72 0.1 Allowed 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.914 1.743 . . . . 0.0 111.5 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.604 HD21 ' HB3' ' A' ' 74' ' ' ALA . 6.8 mt -78.17 65.44 3.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.389 0.614 . . . . 0.0 109.883 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.541 HG12 ' HB3' ' A' ' 34' ' ' PRO . 2.7 m -122.67 -56.04 2.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.698 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.494 ' H ' HG23 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -138.52 22.47 2.72 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -178.957 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.79 HD22 ' O ' ' A' ' 65' ' ' PRO . 0.7 OUTLIER -96.96 -175.67 3.33 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 178.869 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.3 m -68.86 96.67 0.77 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.864 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 9.0 t80 -40.77 -57.0 2.04 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -178.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -59.19 -28.22 66.43 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.096 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.903 ' O ' HG23 ' A' ' 77' ' ' VAL . 1.7 t -76.6 -44.71 33.23 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.733 ' HB2' HD21 ' A' ' 69' ' ' LEU . . . -57.84 -40.84 81.03 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.45 0.643 . . . . 0.0 109.724 178.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.864 HD11 ' CZ ' ' A' ' 71' ' ' TYR . 99.0 mt -66.02 -36.4 83.17 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.22 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -71.44 -38.7 71.33 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 120.921 0.391 . . . . 0.0 110.283 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.903 HG23 ' O ' ' A' ' 73' ' ' SER . 12.2 t -59.63 -36.85 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.013 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.459 HD11 HG12 ' B' ' 7' ' ' VAL . 4.5 pp -91.89 -24.64 19.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.005 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.27 -44.49 83.44 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 120.507 -0.477 . . . . 0.0 109.803 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -52.85 -22.29 11.84 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.877 -0.677 . . . . 0.0 113.031 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 80.1 mt -49.84 119.39 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 120.855 0.359 . . . . 0.0 111.391 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.15 -168.66 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.473 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 m -96.4 -171.12 2.21 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.115 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 44.13 31.3 0.52 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.074 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.419 ' O ' ' CE1' ' A' ' 15' ' ' PHE . 1.8 t -125.38 160.19 29.99 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.969 0.89 . . . . 0.0 112.789 -178.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.4 ' CE1' ' HD2' ' A' ' 15' ' ' PHE . 0.3 OUTLIER -100.95 176.61 5.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.415 179.405 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.769 HG11 ' CD2' ' A' ' 22' ' ' LEU . 2.8 p -151.69 150.02 13.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.663 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.699 ' C ' HD23 ' A' ' 89' ' ' LEU . 22.1 t -110.2 155.96 11.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.382 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.73 HD12 ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -149.66 155.8 40.83 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.13 -178.353 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.72 HD13 ' HA ' ' A' ' 11' ' ' SER . 45.9 mm -130.75 133.36 63.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.02 0.438 . . . . 0.0 111.267 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.909 HD22 HG22 ' A' ' 57' ' ' ILE . 55.6 mt -107.46 158.24 17.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.316 178.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.2 156.52 17.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.058 0.456 . . . . 0.0 111.291 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.425 ' CA ' ' N ' ' A' ' 8' ' ' ASN . . . -161.88 -130.22 1.1 Allowed Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.701 -0.682 . . . . 0.0 112.906 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.841 ' HD2' HG12 ' A' ' 9' ' ' VAL . 88.4 Cg_endo -89.98 -166.72 0.23 Allowed 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.656 2.237 . . . . 0.0 112.519 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -128.98 105.51 8.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.276 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 114.31 10.24 13.82 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.644 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.606 ' C ' HD23 ' A' ' 120' ' ' LEU . 34.0 m-85 -141.5 140.53 33.52 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 117.252 0.526 . . . . 0.0 111.638 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.534 HG23 ' HG3' ' A' ' 118' ' ' GLN . 0.1 OUTLIER -98.69 119.79 38.03 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.053 179.501 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.899 HG21 ' HA ' ' A' ' 8' ' ' ASN . 2.2 t -102.69 91.96 4.42 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.068 0.461 . . . . 0.0 109.775 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.453 ' C ' HD22 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -69.42 -164.76 0.07 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.923 -179.744 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.736 HD13 HG12 ' A' ' 114' ' ' ILE . 2.7 mm? -107.0 127.85 53.82 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.439 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 177.2 122.93 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.424 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -60.78 105.94 0.51 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.854 0.359 . . . . 0.0 110.883 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 p -155.6 136.18 13.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.745 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -160.31 148.05 16.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.901 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 32.2 m -84.71 113.87 21.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.974 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 66.35 -94.42 0.22 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.492 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -165.78 39.91 0.06 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.927 0.394 . . . . 0.0 110.897 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -104.14 -44.7 1.57 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.741 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.455 HG23 ' O ' ' A' ' 110' ' ' THR . 15.4 t -118.72 50.84 1.33 Allowed Pre-proline 0 CA--C 1.535 0.388 0 CA-C-O 120.592 0.234 . . . . 0.0 111.413 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.402 ' CD ' ' N ' ' A' ' 110' ' ' THR . 60.7 Cg_endo -72.14 113.54 3.72 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.281 1.987 . . . . 0.0 112.556 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.27 -168.21 3.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.881 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 88.4 m -103.66 -37.33 7.55 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.085 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.78 ' HB ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -92.44 104.98 16.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.785 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.55 94.79 1.08 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.892 0.377 . . . . 0.0 111.989 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.6 t -158.41 63.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.518 HG22 ' HB3' ' A' ' 97' ' ' PHE . 2.9 m -77.13 127.74 33.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.153 0.501 . . . . 0.0 112.06 -178.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.534 ' HG3' HG23 ' A' ' 98' ' ' THR . 9.8 pt20 -138.39 139.42 25.0 Favored Pre-proline 0 C--O 1.224 -0.28 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.196 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.26 123.32 13.36 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.059 1.84 . . . . 0.0 111.756 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.606 HD23 ' C ' ' A' ' 97' ' ' PHE . 1.3 pp -116.21 -34.04 4.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.67 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 60.49 109.71 0.01 OUTLIER Glycine 0 CA--C 1.523 0.579 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.501 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -79.44 152.06 23.11 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.255 1.97 . . . . 0.0 112.413 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -51.95 178.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.203 1.935 . . . . 0.0 112.118 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 27.3 p -58.69 -56.12 26.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.838 0.351 . . . . 0.0 110.967 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 30.2 mtpt -99.83 179.89 4.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.755 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 59.08 20.17 8.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.941 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.452 -179.758 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 21.1 t . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 121.178 0.513 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.405 HG13 ' N ' ' B' ' 3' ' ' LYS . 11.7 p -117.14 -40.82 2.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.145 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.405 ' N ' HG13 ' B' ' 2' ' ' VAL . 27.6 mmtm -88.45 -36.39 16.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.23 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.415 ' CG1' ' HB3' ' A' ' 25' ' ' LEU . 11.5 t -102.29 108.43 23.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.763 0.315 . . . . 0.0 110.734 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' ASP . . . . . 0.602 ' CG ' HD13 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -87.54 -97.11 0.09 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.275 -179.43 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.992 ' HA ' HD23 ' A' ' 25' ' ' LEU . 7.1 t 167.78 -36.36 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 117.851 0.296 . . . . 0.0 110.541 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.636 ' O ' HD12 ' A' ' 22' ' ' LEU . 20.2 m . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.197 -0.906 . . . . 0.0 112.735 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.172 0 N-CA-C 112.524 -0.231 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.7 t -62.43 -32.47 73.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.822 0.344 . . . . 0.0 111.012 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -72.18 142.58 49.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.264 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -66.56 -67.85 0.42 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.563 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.463 HG22 ' H ' ' A' ' 6' ' ' GLU . 0.2 OUTLIER -98.06 -171.63 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.199 179.49 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.463 ' H ' HG22 ' A' ' 5' ' ' ILE . 25.3 mm-40 -138.22 157.93 71.83 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-O 120.645 0.26 . . . . 0.0 111.483 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.414 ' CA ' ' HA2' ' A' ' 93' ' ' GLY . 24.0 Cg_exo -64.33 127.34 18.89 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.683 2.255 . . . . 0.0 112.406 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.81 ' HA ' HG21 ' A' ' 99' ' ' THR . 20.4 m120 -144.23 87.29 1.88 Allowed 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.632 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.5 p -82.44 99.24 5.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 177.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.631 HG23 ' N ' ' A' ' 11' ' ' SER . 1.2 tp -161.31 -170.8 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.679 ' HA ' HD13 ' A' ' 90' ' ' ILE . 2.9 t -98.41 164.1 12.42 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.922 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.756 HG11 HD11 ' A' ' 51' ' ' LEU . 2.1 t -154.17 165.34 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.279 -178.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.1 ttp85 -144.75 140.04 28.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.292 0.568 . . . . 0.0 110.913 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.941 HD21 ' HB2' ' A' ' 46' ' ' ALA . 0.6 OUTLIER -139.07 140.99 38.2 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.323 -179.877 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.452 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 2.6 t80 -87.58 145.41 26.22 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 177.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.462 ' CE ' HD12 ' A' ' 78' ' ' LEU . 4.6 mttt -82.17 29.65 0.41 Allowed 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.824 -0.351 . . . . 0.0 111.538 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.866 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 42.99 31.03 0.3 Allowed 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 179.377 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.569 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 44.12 23.59 0.06 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.586 -178.559 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.866 HG22 ' O ' ' A' ' 17' ' ' ARG . 15.9 m -164.75 32.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.017 178.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 50.47 57.64 10.19 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.81 -178.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -138.8 58.79 0.61 Allowed Glycine 0 C--N 1.332 0.356 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.838 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 3.8 mp -44.61 -25.15 0.24 Allowed 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.461 ' HA2' HG22 ' A' ' 41' ' ' ILE . . . 109.32 5.73 29.95 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.18 -1.009 . . . . 0.0 113.644 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.932 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -158.73 138.14 11.65 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 117.835 0.818 . . . . 0.0 112.48 -179.47 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.893 HD21 HD13 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -85.04 175.53 8.97 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.594 179.608 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.512 HG12 HG21 ' A' ' 58' ' ' ILE . 30.4 m -146.7 160.92 9.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.924 177.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -141.95 111.21 6.42 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.846 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.594 ' CA ' HG23 ' A' ' 35' ' ' VAL . 1.7 tm-20 -106.19 113.23 26.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.101 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.526 ' HB2' ' HB2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -65.88 126.72 29.39 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.021 179.674 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 96.7 t -46.24 -26.26 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.677 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 80.0 p -154.87 89.42 1.23 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.588 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.526 ' HB2' ' HB2' ' A' ' 29' ' ' ARG . 4.5 mmtt 179.37 176.63 0.34 Allowed Pre-proline 0 N--CA 1.469 0.477 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 32' ' ' LYS . 96.1 Cg_exo -46.87 176.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 122.374 2.049 . . . . 0.0 112.696 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.413 ' HD2' ' HB3' ' A' ' 33' ' ' PRO . 43.5 Cg_exo -38.93 168.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 123.371 2.714 . . . . 0.0 114.955 -178.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.624 ' CB ' HD22 ' A' ' 66' ' ' LEU . 8.9 p -77.15 166.57 2.65 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.974 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.469 HD12 ' HA ' ' A' ' 36' ' ' ILE . 1.1 tp -147.07 172.25 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 119.914 -0.715 . . . . 0.0 112.658 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.529 HG13 HG22 ' A' ' 58' ' ' ILE . 43.5 mt -88.82 149.83 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.801 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.427 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 16.0 t -111.92 -42.72 3.72 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.517 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -175.59 139.39 0.42 Allowed 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 120.151 -0.619 . . . . 0.0 112.308 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.932 HD23 ' HB3' ' A' ' 24' ' ' PHE . 30.5 mt -68.83 110.24 4.27 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 178.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.893 HD13 HD21 ' A' ' 25' ' ' LEU . 1.5 tp -65.67 -58.49 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 -176.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.464 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 2.0 tmt_? -93.34 -59.53 2.0 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -177.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.494 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 102.26 22.49 9.8 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.173 -177.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.412 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -125.02 -29.37 1.03 Allowed Glycine 0 C--N 1.338 0.693 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.568 -178.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.838 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -94.35 -83.17 0.35 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 117.855 0.827 . . . . 0.0 111.648 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.941 ' HB2' HD21 ' A' ' 14' ' ' LEU . . . -61.83 -62.2 1.96 Allowed 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.238 0.542 . . . . 0.0 111.285 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.617 ' HB2' HD22 ' A' ' 40' ' ' LEU . 4.0 tp10 -46.36 -42.2 14.58 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.776 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.412 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 0.3 OUTLIER -58.77 -39.3 80.62 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.616 178.775 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.23 -44.5 68.14 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.492 178.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.91 -26.85 16.17 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.414 -0.898 . . . . 0.0 114.463 177.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.756 HD11 HG11 ' A' ' 12' ' ' VAL . 2.5 pp -104.04 18.6 21.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 117.546 0.673 . . . . 0.0 111.974 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.936 HG21 ' HB1' ' A' ' 46' ' ' ALA . 4.7 mp -120.15 73.68 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.819 0.342 . . . . 0.0 110.592 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -102.67 141.34 35.65 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.517 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -62.98 143.43 57.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.149 0.499 . . . . 0.0 111.55 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.59 10.7 85.98 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.009 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -97.76 -88.18 0.31 Allowed 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.862 0.331 . . . . 0.0 111.098 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.688 HG23 HD22 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -163.72 121.45 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -179.879 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.707 HD11 HG22 ' A' ' 61' ' ' VAL . 2.0 tp -137.98 77.03 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 177.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.416 HD13 ' HD3' ' A' ' 92' ' ' ARG . 0.3 OUTLIER -77.0 -62.21 1.73 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 -178.056 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.481 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . . . -116.4 149.54 39.23 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.833 0.349 . . . . 0.0 111.514 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.707 HG22 HD11 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -146.93 143.71 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.635 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.916 ' HA ' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER 65.18 -73.22 0.06 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.729 -179.505 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.3 t0 179.61 37.29 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.945 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.727 ' NH1' ' HB1' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -130.75 140.18 37.87 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-O 120.782 0.325 . . . . 0.0 111.029 179.547 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.46 ' O ' HD22 ' A' ' 69' ' ' LEU . 74.0 Cg_endo -76.27 82.58 2.19 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 121.548 1.498 . . . . 0.0 110.703 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.716 HD12 ' CZ ' ' A' ' 64' ' ' ARG . 0.4 OUTLIER -77.65 68.74 3.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.77 -178.998 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.535 HG23 ' H ' ' A' ' 68' ' ' ASP . 3.2 m -126.71 -59.45 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.919 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.535 ' H ' HG23 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -136.36 26.46 3.17 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.803 -178.977 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.698 HD21 ' HB2' ' A' ' 74' ' ' ALA . 1.9 pt? -92.58 -170.14 2.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.869 0.366 . . . . 0.0 110.66 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.412 ' N ' ' HG ' ' A' ' 69' ' ' LEU . 3.3 m -73.71 108.64 6.67 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.724 ' CE1' HD11 ' A' ' 75' ' ' LEU . 3.0 t80 -42.57 -55.84 3.34 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -62.93 -27.77 69.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.242 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.859 ' O ' HG23 ' A' ' 77' ' ' VAL . 22.4 t -75.32 -39.33 59.59 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.727 ' HB1' ' NH1' ' A' ' 64' ' ' ARG . . . -62.47 -49.49 75.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.945 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.724 HD11 ' CE1' ' A' ' 71' ' ' TYR . 27.2 mt -63.14 -30.68 71.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.916 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -72.78 -38.58 67.22 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.716 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' ' 73' ' ' SER . 65.1 t -58.97 -42.83 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.64 HD23 ' HA ' ' A' ' 75' ' ' LEU . 0.4 OUTLIER -78.7 -29.92 45.75 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.117 179.185 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -37.91 79.81 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.773 0.32 . . . . 0.0 110.975 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -59.59 -22.32 56.47 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.743 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.547 HD11 ' HB3' ' A' ' 62' ' ' ASN . 49.9 mt -58.23 116.74 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 120.927 0.394 . . . . 0.0 111.041 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.78 -167.18 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.44 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.402 ' O ' HG22 ' A' ' 85' ' ' THR . 3.9 m -96.83 -170.38 2.04 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.093 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 44.25 31.06 0.52 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.13 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.411 ' O ' ' CD1' ' A' ' 15' ' ' PHE . 1.7 t -130.12 162.35 29.01 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.815 0.817 . . . . 0.0 112.804 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -103.41 176.2 5.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.4 -1.273 . . . . 0.0 109.808 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.916 HG22 ' HA ' ' A' ' 62' ' ' ASN . 0.4 OUTLIER -144.9 172.37 5.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.929 0.395 . . . . 0.0 111.305 -179.366 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.802 ' O ' HD23 ' A' ' 89' ' ' LEU . 21.8 t -122.73 158.13 27.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.748 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.802 HD23 ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -151.32 147.33 26.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.845 0.355 . . . . 0.0 110.427 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.679 HD13 ' HA ' ' A' ' 11' ' ' SER . 41.0 mm -126.36 122.89 62.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.998 0.428 . . . . 0.0 111.465 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.702 HD11 ' CD1' ' A' ' 51' ' ' LEU . 10.0 mt -107.23 165.29 11.48 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.242 178.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.416 ' HD3' HD13 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -109.77 163.33 13.61 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.395 0.617 . . . . 0.0 112.532 -178.466 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.447 ' CA ' ' N ' ' A' ' 8' ' ' ASN . . . -164.26 -136.88 2.07 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.595 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -93.73 -164.67 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.997 2.465 . . . . 0.0 112.101 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -129.06 132.13 47.41 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.709 0.29 . . . . 0.0 110.609 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.14 5.09 59.63 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.686 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.942 ' HB3' HG22 ' A' ' 117' ' ' THR . 26.6 m-85 -139.92 127.19 21.23 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 117.537 0.669 . . . . 0.0 112.178 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.637 HG22 HD22 ' A' ' 120' ' ' LEU . 0.1 OUTLIER -79.35 120.76 24.25 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.175 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.81 HG21 ' HA ' ' A' ' 8' ' ' ASN . 8.0 t -107.65 92.27 4.0 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.09 0.471 . . . . 0.0 110.634 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -77.78 -163.76 0.44 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.789 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.497 ' O ' HD12 ' A' ' 101' ' ' LEU . 2.4 pp -131.93 121.02 23.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.866 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -175.43 67.66 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.88 0.371 . . . . 0.0 111.619 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -169.7 -175.48 2.13 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.079 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.09 138.84 33.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.56 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.422 ' HB2' ' HD2' ' A' ' 111' ' ' PRO . 35.2 p90 -87.43 150.78 23.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.914 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 98.5 m -136.68 -52.45 0.7 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.003 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.82 66.77 0.63 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.841 -0.695 . . . . 0.0 113.041 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 54.96 30.92 14.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.667 0.27 . . . . 0.0 111.548 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.421 ' HA2' ' HB2' ' A' ' 105' ' ' PHE . . . 88.74 39.3 6.66 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.659 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.796 HG22 ' HD3' ' A' ' 111' ' ' PRO . 0.6 OUTLIER -90.28 -44.27 0.4 Allowed Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -179.192 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.796 ' HD3' HG22 ' A' ' 110' ' ' THR . 12.4 Cg_exo -72.23 -38.34 3.8 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.276 1.984 . . . . 0.0 110.604 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.459 ' HE3' HG21 ' A' ' 5' ' ' ILE . 6.7 tptp 70.76 131.19 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.847 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 88.7 m -53.88 -43.76 69.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.233 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.639 ' HB ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -90.82 95.04 5.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.271 0.558 . . . . 0.0 110.14 179.197 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.79 94.08 1.73 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 99' ' ' THR . 1.5 t -156.21 64.12 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.959 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.942 HG22 ' HB3' ' A' ' 97' ' ' PHE . 0.2 OUTLIER -77.56 128.89 34.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.833 -178.677 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.404 ' O ' ' HA ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -142.61 135.1 13.56 Favored Pre-proline 0 C--O 1.22 -0.489 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.371 -179.782 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.03 133.71 59.73 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 121.9 1.733 . . . . 0.0 112.54 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.637 HD22 HG22 ' A' ' 98' ' ' THR . 0.2 OUTLIER -76.39 -72.4 0.33 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.137 0.494 . . . . 0.0 110.118 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 104.98 97.52 2.49 Favored Glycine 0 CA--C 1.522 0.481 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.187 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -46.16 161.74 0.15 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.619 2.213 . . . . 0.0 112.936 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -65.23 174.61 4.82 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.359 2.04 . . . . 0.0 112.601 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.8 t -154.2 118.2 4.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.712 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.6 ttmt 61.63 42.99 10.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.048 0.451 . . . . 0.0 110.847 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.35 -13.96 61.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.376 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.114 179.983 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.56 ' O ' HG13 ' B' ' 1' ' ' VAL . 12.3 p . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.817 0.341 . . . . 0.0 111.002 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.557 HG22 ' O ' ' B' ' 2' ' ' VAL . 11.8 p -150.61 50.18 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.012 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.421 ' CE ' ' HA ' ' A' ' 29' ' ' ARG . 3.1 mmtm -142.8 -61.66 0.43 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.689 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.416 ' CG1' ' HB3' ' A' ' 38' ' ' SER . 3.5 t -57.72 137.5 19.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.947 0.403 . . . . 0.0 111.59 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -123.79 102.08 7.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.645 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.825 ' HA ' HD23 ' A' ' 25' ' ' LEU . 12.9 p -61.05 134.82 57.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.959 0.409 . . . . 0.0 110.728 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.629 ' OXT' HD12 ' A' ' 22' ' ' LEU . 14.6 m . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.142 -0.932 . . . . 0.0 111.149 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 112.668 -0.173 . . . . 0.0 112.668 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -147.54 39.14 0.96 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.886 0.374 . . . . 0.0 110.659 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -166.44 81.26 0.26 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.178 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 6.3 ttt -109.62 79.36 1.21 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.672 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.6 tt -147.59 33.86 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.146 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.401 ' HG3' ' HD2' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -165.65 -63.7 0.01 OUTLIER Pre-proline 0 N--CA 1.469 0.497 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.693 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.41 ' HA ' ' HA3' ' A' ' 93' ' ' GLY . 9.2 Cg_endo -50.92 113.41 1.07 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.775 2.317 . . . . 0.0 113.474 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.429 ' N ' ' HA3' ' A' ' 93' ' ' GLY . 0.3 OUTLIER 177.32 94.08 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.744 179.388 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.567 ' O ' HG13 ' A' ' 9' ' ' VAL . 14.7 p -79.77 109.47 14.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.662 HG23 ' N ' ' A' ' 11' ' ' SER . 1.0 OUTLIER -163.32 -166.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.101 179.161 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.704 ' HA ' HD13 ' A' ' 90' ' ' ILE . 56.1 p -84.6 165.27 18.13 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.652 0.739 . . . . 0.0 111.957 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.881 HG11 HD11 ' A' ' 51' ' ' LEU . 1.7 t -156.72 156.15 4.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.748 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -140.4 140.38 35.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.595 0.712 . . . . 0.0 111.154 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.83 ' C ' HG12 ' A' ' 87' ' ' VAL . 0.5 OUTLIER -141.88 177.77 7.96 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.833 -179.624 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.472 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 2.6 t80 -122.98 149.82 43.79 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.403 ' O ' ' N ' ' A' ' 20' ' ' GLY . 2.2 mttt -84.2 29.39 0.57 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.738 178.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.884 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 41.96 31.77 0.25 Allowed 'General case' 0 C--N 1.345 0.378 0 C-N-CA 123.006 0.522 . . . . 0.0 111.853 179.593 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.571 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 44.05 24.16 0.07 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.529 -178.508 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.884 HG22 ' O ' ' A' ' 17' ' ' ARG . 13.0 m -164.16 31.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.185 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 50.45 65.57 2.9 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.616 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -151.62 68.26 0.32 Allowed Glycine 0 C--N 1.331 0.273 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.822 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 4.2 mp -52.22 -22.2 4.13 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.443 ' HA2' HG22 ' A' ' 41' ' ' ILE . . . 107.3 11.56 25.33 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.152 -1.023 . . . . 0.0 113.829 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.918 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -159.7 141.73 13.27 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 118.008 0.904 . . . . 0.0 113.382 -179.576 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.92 HD23 ' HA ' ' B' ' 6' ' ' SER . 11.5 mt -79.61 172.83 13.25 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.435 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.2 m -153.23 148.97 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.242 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.423 ' HG3' HG22 ' A' ' 36' ' ' ILE . 0.7 OUTLIER -135.38 106.27 6.61 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.393 -179.265 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.482 ' HB3' ' CD1' ' A' ' 71' ' ' TYR . 7.0 tm-20 -103.54 111.42 23.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.805 178.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.484 ' CB ' ' HB2' ' A' ' 32' ' ' LYS . 1.9 mtt180 -70.62 116.55 11.08 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 121.092 0.472 . . . . 0.0 110.43 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.6 t -44.9 -24.69 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.609 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 t -145.22 73.58 1.37 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.368 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.502 ' HB3' ' HD2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -177.19 176.86 0.48 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.31 -178.631 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.502 ' HD2' ' HB3' ' A' ' 32' ' ' LYS . 82.6 Cg_exo -44.8 172.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.416 2.077 . . . . 0.0 113.364 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.404 ' HB3' HG12 ' A' ' 67' ' ' VAL . 98.7 Cg_exo -43.96 174.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.081 2.521 . . . . 0.0 114.157 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.673 HG13 ' O ' ' A' ' 58' ' ' ILE . 8.1 p -78.41 152.1 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.079 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.485 HD12 ' HA ' ' A' ' 36' ' ' ILE . 1.2 tp -133.88 163.65 36.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.597 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.67 HD12 ' O ' ' A' ' 53' ' ' GLN . 35.9 mt -82.74 145.88 7.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.64 0.257 . . . . 0.0 110.925 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.454 ' CB ' HG13 ' B' ' 4' ' ' VAL . 6.3 t -109.55 -38.2 5.5 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.63 ' HB3' HD12 ' A' ' 25' ' ' LEU . 3.5 t0 -170.54 135.35 1.18 Allowed 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.364 -0.534 . . . . 0.0 112.18 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.918 HD23 ' HB3' ' A' ' 24' ' ' PHE . 45.4 mt -71.93 84.08 0.95 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.698 0.761 . . . . 0.0 109.781 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.458 ' CG2' ' N ' ' A' ' 42' ' ' ARG . 0.8 OUTLIER -39.91 -59.13 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 114.922 1.452 . . . . 0.0 114.922 -177.515 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.458 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -93.53 -64.78 1.05 Allowed 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -177.632 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.427 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 104.41 23.56 7.93 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -177.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.405 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -126.06 -32.37 0.74 Allowed Glycine 0 C--N 1.338 0.666 0 C-N-CA 121.283 -0.484 . . . . 0.0 113.085 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.822 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -94.03 -83.13 0.34 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 117.732 0.766 . . . . 0.0 111.435 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.916 ' HB1' HG21 ' A' ' 52' ' ' ILE . . . -58.14 -57.92 10.72 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.232 0.539 . . . . 0.0 111.161 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.427 ' HB3' ' HA2' ' A' ' 43' ' ' GLY . 39.4 tt0 -48.26 -47.54 36.03 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.871 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.405 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -57.31 -32.97 67.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.09 178.903 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.497 ' O ' HG21 ' A' ' 113' ' ' THR . 0.4 OUTLIER -57.55 -52.21 66.34 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.89 178.689 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 113.75 -30.73 6.99 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.154 -1.022 . . . . 0.0 114.096 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.938 HD13 HD11 ' A' ' 91' ' ' LEU . 3.7 pp -95.75 -1.47 49.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.291 0.545 . . . . 0.0 111.571 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.916 HG21 ' HB1' ' A' ' 46' ' ' ALA . 4.9 mp -105.27 118.36 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-O 120.953 0.406 . . . . 0.0 110.217 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.67 ' O ' HD12 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -144.44 162.51 36.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.293 179.685 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.573 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -71.81 126.72 30.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.857 0.361 . . . . 0.0 110.787 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.42 11.97 72.51 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.932 -178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.13 -83.95 0.24 Allowed 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 19.7 mt -155.94 125.72 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.787 HD11 HG22 ' A' ' 61' ' ' VAL . 5.8 tp -160.42 70.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.596 177.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.433 ' HG ' ' N ' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -78.04 -47.79 17.59 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 122.087 -0.383 . . . . 0.0 111.315 -178.418 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.502 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . . . -121.89 150.21 42.3 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.834 0.35 . . . . 0.0 111.368 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.788 HG12 ' ND2' ' A' ' 62' ' ' ASN . 3.0 t -140.33 144.86 26.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.172 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.788 ' ND2' HG12 ' A' ' 61' ' ' VAL . 0.0 OUTLIER 53.84 -82.59 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.025 0.53 . . . . 0.0 110.902 -179.118 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 61' ' ' VAL . 2.0 p30 -165.56 33.69 0.05 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.084 0.469 . . . . 0.0 110.272 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.792 ' NH2' HD23 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -126.64 105.5 23.61 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.779 179.653 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -58.93 87.4 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 121.701 1.601 . . . . 0.0 110.526 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.892 HD13 ' HB2' ' A' ' 74' ' ' ALA . 29.8 tp -86.44 66.04 9.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.431 0.634 . . . . 0.0 111.397 -178.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.404 HG12 ' HB3' ' A' ' 34' ' ' PRO . 2.7 m -110.67 -44.28 5.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.027 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.5 p30 -140.24 24.52 2.31 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.513 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.704 HD23 ' HA ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -99.87 174.32 6.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.772 -179.739 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.646 ' H ' HD12 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -63.46 121.76 14.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.317 179.727 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.648 ' CE1' HD11 ' A' ' 75' ' ' LEU . 3.7 t80 -54.93 -61.0 2.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.524 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.458 ' HA ' HD12 ' A' ' 75' ' ' LEU . 47.7 t0 -56.67 -32.76 65.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.237 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.569 ' O ' HG23 ' A' ' 77' ' ' VAL . 69.6 m -70.95 -46.35 62.56 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.892 ' HB2' HD13 ' A' ' 66' ' ' LEU . . . -55.65 -45.01 77.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.171 178.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.648 HD11 ' CE1' ' A' ' 71' ' ' TYR . 14.7 mt -64.87 -29.71 70.67 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.15 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.407 ' HA ' ' HB2' ' A' ' 79' ' ' ARG . 9.6 mt-10 -72.34 -36.13 68.73 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.002 0.429 . . . . 0.0 110.017 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 73' ' ' SER . 47.4 t -61.0 -46.04 97.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.524 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.792 HD23 ' NH2' ' A' ' 64' ' ' ARG . 1.6 pp -79.12 -27.06 42.83 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.408 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.407 ' HB2' ' HA ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -61.76 -49.21 77.28 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 121.023 0.439 . . . . 0.0 110.776 -179.438 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.35 -22.61 15.79 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.997 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.406 ' CD1' ' HA ' ' A' ' 78' ' ' LEU . 57.1 mt -56.32 118.75 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 120.9 0.381 . . . . 0.0 111.097 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.75 -165.93 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.421 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.2 m -95.47 -169.42 1.96 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.244 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 41.17 32.6 0.2 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.398 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.418 ' O ' ' CE1' ' A' ' 15' ' ' PHE . 1.5 t -125.29 159.95 30.47 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 122.013 0.911 . . . . 0.0 112.775 -178.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.406 ' CE1' ' HD2' ' A' ' 15' ' ' PHE . 0.2 OUTLIER -96.64 176.63 5.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.13 -1.395 . . . . 0.0 109.921 179.061 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.83 HG12 ' C ' ' A' ' 14' ' ' LEU . 4.2 p -149.71 151.78 12.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.541 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.829 ' O ' HD23 ' A' ' 89' ' ' LEU . 10.7 t -109.61 163.79 6.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.9 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.867 HD12 ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -159.04 164.38 35.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.674 0.273 . . . . 0.0 110.393 -179.723 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.704 HD13 ' HA ' ' A' ' 11' ' ' SER . 33.0 mm -135.64 125.5 41.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.938 HD11 HD13 ' A' ' 51' ' ' LEU . 10.9 mt -93.43 169.95 9.98 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 177.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -148.83 144.02 26.68 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -179.104 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.429 ' HA3' ' N ' ' A' ' 8' ' ' ASN . . . -157.0 -107.92 0.26 Allowed Glycine 0 CA--C 1.523 0.569 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.076 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -93.29 -167.05 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.876 2.384 . . . . 0.0 112.471 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -143.54 131.03 21.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.581 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 118.23 7.83 10.91 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.867 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.797 ' C ' HD23 ' A' ' 120' ' ' LEU . 16.3 m-85 -136.21 144.37 44.87 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 117.315 0.558 . . . . 0.0 111.766 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 117' ' ' THR . 0.1 OUTLIER -93.07 114.24 26.72 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.886 179.719 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 54.3 p -78.84 93.55 5.02 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.94 149.25 28.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.283 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.665 HD22 ' N ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -54.55 -171.64 0.0 OUTLIER 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.738 -179.66 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.665 ' N ' HD22 ' A' ' 101' ' ' LEU . 0.5 OUTLIER 80.34 34.03 0.15 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.999 -178.709 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.568 HG23 HG23 ' A' ' 116' ' ' VAL . 38.0 m -76.92 107.15 9.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.843 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.527 ' O ' HG22 ' A' ' 104' ' ' THR . 34.3 m -86.86 4.13 42.57 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.548 ' HA ' HG23 ' A' ' 110' ' ' THR . 7.2 p90 41.88 75.59 0.09 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.953 0.501 . . . . 0.0 112.275 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.471 HG22 ' N ' ' A' ' 107' ' ' GLY . 51.7 m -129.11 -95.59 0.4 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.146 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.471 ' N ' HG22 ' A' ' 106' ' ' THR . . . 43.03 -94.07 0.01 OUTLIER Glycine 0 C--N 1.345 1.045 0 C-N-CA 121.464 -0.398 . . . . 0.0 113.575 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -153.62 30.62 0.47 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.832 0.349 . . . . 0.0 110.518 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 114.97 58.09 0.36 Allowed Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.268 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.548 HG23 ' HA ' ' A' ' 105' ' ' PHE . 13.1 t -118.26 50.3 1.15 Allowed Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -72.53 89.32 0.84 Allowed 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.223 1.949 . . . . 0.0 112.14 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.76 172.65 12.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.091 0.472 . . . . 0.0 111.443 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.497 HG21 ' O ' ' A' ' 49' ' ' SER . 3.9 m -104.01 -10.89 17.74 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.488 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.443 HG12 ' N ' ' A' ' 115' ' ' ARG . 0.0 OUTLIER -76.61 158.21 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.723 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.443 ' N ' HG12 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -75.26 141.27 43.5 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.492 0.663 . . . . 0.0 112.774 -177.183 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.568 HG23 HG23 ' A' ' 103' ' ' THR . 3.9 t -78.19 135.02 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.156 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 99' ' ' THR . 0.6 OUTLIER -81.45 140.46 34.62 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.519 -179.402 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.46 ' O ' ' HA ' ' A' ' 97' ' ' PHE . 1.6 pp0? -123.97 141.29 36.61 Favored Pre-proline 0 C--O 1.222 -0.363 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.334 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -44.33 107.99 0.11 Allowed 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.74 2.293 . . . . 0.0 112.447 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.797 HD23 ' C ' ' A' ' 97' ' ' PHE . 0.4 OUTLIER -115.57 -40.04 3.45 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.472 -179.182 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.41 ' O ' HD12 ' A' ' 120' ' ' LEU . . . 74.29 117.15 0.09 OUTLIER Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.259 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.43 160.73 4.68 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.264 1.976 . . . . 0.0 112.331 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.36 160.1 39.32 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.408 2.072 . . . . 0.0 112.512 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.4 t -172.21 161.98 5.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.851 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.4 ttpp -121.79 35.39 4.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.885 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -94.08 19.14 9.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.028 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.7 t . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.134 -179.84 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.921 0.391 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.597 HG22 ' O ' ' B' ' 2' ' ' VAL . 14.3 p -174.71 37.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.88 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.461 ' CE ' ' HA ' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -116.31 -38.06 3.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.197 -179.773 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.458 HG11 HD13 ' A' ' 25' ' ' LEU . 15.3 t -79.56 111.75 16.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.783 0.325 . . . . 0.0 110.454 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.98 -104.65 0.09 Allowed 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.169 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.92 ' HA ' HD23 ' A' ' 25' ' ' LEU . 6.7 t 163.3 105.63 0.0 OUTLIER 'General case' 0 C--N 1.346 0.438 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.544 ' O ' HD12 ' A' ' 22' ' ' LEU . 21.3 m . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.305 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.9 t -174.58 -48.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.968 0.413 . . . . 0.0 110.81 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 25.0 m80 -147.36 147.53 30.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.788 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 36.7 mtt -95.86 -76.55 0.5 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.504 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.631 HG23 ' N ' ' A' ' 6' ' ' GLU . 0.3 OUTLIER -81.03 -158.15 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.159 179.802 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.631 ' N ' HG23 ' A' ' 5' ' ' ILE . 5.6 mt-10 -167.42 157.78 9.74 Favored Pre-proline 0 CA--C 1.535 0.373 0 O-C-N 122.318 -0.239 . . . . 0.0 111.506 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.95 -162.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.661 2.241 . . . . 0.0 112.863 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.7 m120 63.07 85.96 0.12 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.725 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.476 HG22 ' CG2' ' A' ' 90' ' ' ILE . 4.4 p -80.97 123.5 37.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.421 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.1 tp -88.08 160.28 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.116 -178.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.841 ' HA ' HD13 ' A' ' 90' ' ' ILE . 59.2 p -105.23 159.92 15.5 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.954 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.532 HG23 ' HB2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -134.15 102.96 4.61 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.318 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.542 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.0 ttp85 -79.47 106.17 11.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.49 0.662 . . . . 0.0 112.26 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.705 ' C ' HG12 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -116.62 177.23 4.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.604 178.612 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.458 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 2.4 t80 -117.03 151.25 37.16 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.41 ' O ' ' N ' ' A' ' 20' ' ' GLY . 0.8 OUTLIER -85.67 27.27 0.86 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.179 178.691 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.897 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.2 OUTLIER 45.48 29.73 0.64 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 179.257 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.602 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 43.13 24.92 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.101 0.56 . . . . 0.0 112.421 -178.431 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.897 HG22 ' O ' ' A' ' 17' ' ' ARG . 15.0 m -166.53 32.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 123.948 0.899 . . . . 0.0 108.857 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 48.01 62.55 4.14 Favored Glycine 0 C--N 1.34 0.768 0 CA-C-N 115.818 -0.628 . . . . 0.0 113.154 -178.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -147.9 60.2 0.46 Allowed Glycine 0 C--N 1.333 0.412 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.832 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 4.0 mp -41.02 -26.63 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -178.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.412 ' HA2' HG22 ' A' ' 41' ' ' ILE . . . 120.47 1.83 12.11 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.11 -1.043 . . . . 0.0 113.469 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.901 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -156.94 140.2 15.59 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 117.766 0.783 . . . . 0.0 112.665 -179.561 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.867 HD21 HD13 ' A' ' 41' ' ' ILE . 0.7 OUTLIER -79.15 171.06 15.71 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.954 179.047 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.7 m -150.8 154.12 9.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.037 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.442 ' CG ' HG22 ' A' ' 36' ' ' ILE . 7.6 ptmm? -135.79 107.74 7.12 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.275 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.498 ' HB3' ' CG ' ' A' ' 71' ' ' TYR . 3.0 tm-20 -97.41 108.54 21.28 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.515 ' CB ' ' HB2' ' A' ' 32' ' ' LYS . 1.1 mtt180 -59.99 111.6 1.55 Allowed 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 121.104 0.478 . . . . 0.0 110.409 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.1 t -49.85 -22.15 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.839 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.5 t -150.03 69.43 1.01 Allowed 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.516 -0.474 . . . . 0.0 109.983 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.532 ' HB3' ' HD2' ' A' ' 33' ' ' PRO . 0.8 OUTLIER -177.21 -179.12 0.31 Allowed Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.95 -178.0 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.532 ' HD2' ' HB3' ' A' ' 32' ' ' LYS . 77.5 Cg_exo -45.95 175.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.549 2.166 . . . . 0.0 113.816 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.738 ' HB3' HG12 ' A' ' 67' ' ' VAL . 79.9 Cg_exo -44.05 175.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 123.387 2.725 . . . . 0.0 114.862 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.822 HG13 ' O ' ' A' ' 58' ' ' ILE . 12.5 p -78.47 159.92 4.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.291 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' A' ' 36' ' ' ILE . 1.0 OUTLIER -144.29 164.59 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.492 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.495 HG13 HG22 ' A' ' 58' ' ' ILE . 39.3 mt -84.89 149.0 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.94 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.427 ' OG ' HG13 ' B' ' 4' ' ' VAL . 0.9 OUTLIER -117.14 -38.6 3.34 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.552 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.5 OUTLIER -172.69 135.8 0.69 Allowed 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 119.972 -0.691 . . . . 0.0 112.679 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.901 HD23 ' HB3' ' A' ' 24' ' ' PHE . 47.8 mt -67.09 113.6 5.19 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.867 HD13 HD21 ' A' ' 25' ' ' LEU . 2.0 tp -73.49 -55.86 11.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -175.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.458 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 10.9 ttt85 -93.38 -64.84 1.04 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.074 0.464 . . . . 0.0 112.104 -177.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.446 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 105.31 21.19 9.01 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.376 -178.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.407 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -125.85 -30.86 0.85 Allowed Glycine 0 C--N 1.336 0.551 0 C-N-CA 121.072 -0.585 . . . . 0.0 113.206 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.832 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -94.73 -82.66 0.36 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 117.583 0.692 . . . . 0.0 111.302 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.822 ' HB1' HG21 ' A' ' 52' ' ' ILE . . . -59.24 -57.38 13.29 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.148 0.499 . . . . 0.0 111.402 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.446 ' HB3' ' HA2' ' A' ' 43' ' ' GLY . 51.2 tt0 -49.85 -45.87 50.8 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.751 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.407 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 1.0 OUTLIER -55.83 -35.29 66.22 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.003 178.983 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.4 t -58.48 -49.34 77.68 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.63 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.75 -19.14 36.44 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.31 -0.947 . . . . 0.0 113.921 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.744 ' HG ' HD12 ' A' ' 52' ' ' ILE . 3.3 pp -96.52 -26.63 15.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.154 0.477 . . . . 0.0 110.814 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.822 HG21 ' HB1' ' A' ' 46' ' ' ALA . 5.0 mp -80.8 98.64 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-O 120.958 0.409 . . . . 0.0 110.42 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.418 ' O ' HD12 ' A' ' 37' ' ' ILE . 1.1 mp0 -124.53 149.26 47.13 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.646 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.552 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -67.63 128.67 37.32 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.987 0.423 . . . . 0.0 111.273 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.74 2.15 90.62 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.388 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -84.21 -89.1 0.1 Allowed 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.985 0.392 . . . . 0.0 110.902 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.554 HG23 HD22 ' A' ' 91' ' ' LEU . 6.3 tp -163.12 126.32 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.822 ' O ' HG13 ' A' ' 35' ' ' VAL . 2.7 tp -146.6 90.02 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.442 HD13 ' NH2' ' A' ' 92' ' ' ARG . 6.4 tp -78.49 -67.09 0.77 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.407 -177.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.486 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . . . -128.4 149.78 50.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.16 0.505 . . . . 0.0 112.111 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.703 HG22 HD11 ' A' ' 58' ' ' ILE . 18.8 t -125.97 144.79 34.87 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.893 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.468 ' HB3' HG23 ' A' ' 87' ' ' VAL . 0.0 OUTLIER 44.2 29.24 0.34 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 120.964 0.411 . . . . 0.0 111.768 -178.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.6 t70 74.02 26.91 1.66 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.403 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.74 ' NH2' HG12 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -99.99 102.71 18.61 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.014 179.411 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.744 ' O ' HD23 ' A' ' 69' ' ' LEU . 19.8 Cg_endo -61.09 82.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 121.946 1.764 . . . . 0.0 111.736 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.42 ' HG ' ' HB1' ' A' ' 74' ' ' ALA . 0.5 OUTLIER -86.82 64.67 8.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.403 0.62 . . . . 0.0 110.284 -179.766 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.738 HG12 ' HB3' ' A' ' 34' ' ' PRO . 3.1 m -125.97 -52.63 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.536 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.439 ' H ' HG23 ' A' ' 67' ' ' VAL . 81.2 m-20 -133.33 24.48 4.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.897 0.38 . . . . 0.0 110.992 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.744 HD23 ' O ' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -105.63 175.23 5.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.313 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.588 ' H ' HD12 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -66.05 102.21 0.78 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.252 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.717 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 8.5 t80 -43.87 -54.75 5.03 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.971 0.415 . . . . 0.0 111.977 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -60.86 -33.73 73.52 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.931 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.873 ' O ' HG23 ' A' ' 77' ' ' VAL . 41.1 t -72.64 -43.89 62.61 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.733 ' HB2' HD21 ' A' ' 69' ' ' LEU . . . -59.4 -45.61 91.01 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.405 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.717 HD11 ' CZ ' ' A' ' 71' ' ' TYR . 56.0 mt -65.76 -30.21 70.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.271 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -74.01 -42.7 59.95 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.727 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.873 HG23 ' O ' ' A' ' 73' ' ' SER . 28.5 t -60.45 -35.0 60.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.276 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.589 HD21 HD23 ' A' ' 75' ' ' LEU . 4.1 pp -88.42 -22.49 23.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.942 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.1 -39.59 95.14 Favored 'General case' 0 C--N 1.339 0.12 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -55.35 -21.38 26.45 Favored Glycine 0 CA--C 1.522 0.514 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.946 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.42 HD11 HH12 ' A' ' 64' ' ' ARG . 79.0 mt -54.72 108.49 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-O 120.797 0.332 . . . . 0.0 110.733 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.89 -168.3 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.454 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.46 -172.22 2.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.024 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 44.01 31.25 0.5 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.26 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.408 ' O ' ' CE1' ' A' ' 15' ' ' PHE . 1.7 t -124.35 160.94 26.98 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.984 0.897 . . . . 0.0 112.747 -178.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.72 176.7 5.54 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.18 -1.373 . . . . 0.0 110.335 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.719 HG11 ' CD2' ' A' ' 22' ' ' LEU . 2.6 p -145.41 157.36 13.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.507 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.7 t -133.27 99.26 3.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.447 0.641 . . . . 0.0 111.626 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.651 HD23 ' CD1' ' A' ' 58' ' ' ILE . 6.4 mp -80.71 175.84 10.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.946 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.841 HD13 ' HA ' ' A' ' 11' ' ' SER . 36.2 mm -140.32 125.07 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.802 178.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.554 HD22 HG23 ' A' ' 57' ' ' ILE . 49.0 mt -130.29 176.77 7.85 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.716 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.442 ' NH2' HD13 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -75.95 175.09 9.15 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.749 -179.419 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.684 ' HA3' HG21 ' A' ' 99' ' ' THR . . . 162.83 154.14 7.49 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.082 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.48 ' HB2' HG21 ' A' ' 117' ' ' THR . 32.6 Cg_exo -57.1 -168.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.329 2.019 . . . . 0.0 112.317 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -128.36 152.65 47.92 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.846 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.418 ' O ' ' CD1' ' A' ' 97' ' ' PHE . . . 73.62 16.43 79.09 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.969 -178.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.754 ' HB2' HG22 ' A' ' 117' ' ' THR . 69.1 m-85 -156.97 142.12 17.21 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.65 HG22 HD22 ' A' ' 120' ' ' LEU . 0.1 OUTLIER -85.67 111.81 20.43 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.355 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.684 HG21 ' HA3' ' A' ' 93' ' ' GLY . 3.6 t -90.37 93.51 9.35 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.857 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -62.26 -96.11 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.588 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.409 HD13 HD23 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -173.88 120.3 0.29 Allowed 'General case' 0 C--N 1.343 0.3 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -179.762 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 169.65 170.97 0.05 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.562 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.494 HG23 ' N ' ' A' ' 104' ' ' THR . 0.5 OUTLIER 69.72 174.84 0.29 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.252 0.548 . . . . 0.0 111.416 179.134 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.494 ' N ' HG23 ' A' ' 103' ' ' THR . 29.6 p -118.41 -160.27 0.79 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.571 179.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.696 ' O ' HG23 ' A' ' 106' ' ' THR . 20.2 p90 -135.97 164.08 28.8 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.264 0.554 . . . . 0.0 111.878 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.696 HG23 ' O ' ' A' ' 105' ' ' PHE . 0.8 OUTLIER -171.86 150.35 2.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.733 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.4 54.22 4.78 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.211 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.4 t0 73.85 27.84 1.63 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.864 0.364 . . . . 0.0 111.631 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 62.99 60.67 7.31 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.938 -0.648 . . . . 0.0 113.489 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.762 HG22 ' HD3' ' A' ' 111' ' ' PRO . 1.5 t -92.31 -41.94 0.36 Allowed Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.762 ' HD3' HG22 ' A' ' 110' ' ' THR . 5.5 Cg_exo -75.83 -46.44 0.2 Allowed 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.289 1.993 . . . . 0.0 110.583 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.491 ' HG3' HG22 ' A' ' 114' ' ' ILE . 4.2 tppt? 80.6 137.01 0.06 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.921 178.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.468 HG22 ' HA ' ' A' ' 51' ' ' LEU . 61.1 m -47.49 -35.3 8.54 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.649 0.738 . . . . 0.0 110.154 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.62 HD11 ' O ' ' A' ' 99' ' ' THR . 0.0 OUTLIER -97.55 92.95 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.066 177.801 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 13.0 ttt180 -144.8 100.77 3.56 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.335 0.588 . . . . 0.0 111.887 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.8 t -154.54 66.49 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.754 HG22 ' HB2' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -76.66 122.23 24.38 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.845 -1.07 . . . . 0.0 113.119 -175.904 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.44 ' HG3' HG23 ' A' ' 98' ' ' THR . 0.1 OUTLIER -122.95 131.17 24.38 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.734 178.749 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -44.68 131.31 9.96 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.385 2.057 . . . . 0.0 113.866 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.702 HD21 ' C ' ' A' ' 97' ' ' PHE . 0.7 OUTLIER -88.97 -66.0 0.96 Allowed 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.872 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.402 ' HA3' ' HD3' ' A' ' 122' ' ' PRO . . . -124.03 -124.33 2.87 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.936 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.402 ' HD3' ' HA3' ' A' ' 121' ' ' GLY . 9.7 Cg_endo -87.38 139.1 4.92 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.533 2.155 . . . . 0.0 112.27 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.53 57.16 6.39 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.381 2.054 . . . . 0.0 112.331 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.08 88.95 1.62 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.049 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.04 177.73 4.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.959 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 61.16 17.91 8.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.115 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.3 m . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.237 -0.887 . . . . 0.0 111.056 179.842 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 9.6 m . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 121.184 0.516 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 14.6 p -99.49 -32.01 3.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.315 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.464 ' CE ' ' HA ' ' A' ' 29' ' ' ARG . 1.6 mmtp -87.27 -57.26 3.02 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.002 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.564 HG11 HD13 ' A' ' 25' ' ' LEU . 21.2 t -64.93 100.42 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.006 0.432 . . . . 0.0 110.992 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.35 116.56 29.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.788 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.867 ' HA ' HD23 ' A' ' 25' ' ' LEU . 9.4 p -71.49 121.07 18.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.083 0.468 . . . . 0.0 110.382 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.768 ' OXT' HD12 ' A' ' 22' ' ' LEU . 30.9 m . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.406 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.13 0 N-CA-C 112.633 -0.187 . . . . 0.0 112.633 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 76.6 p -141.32 87.77 2.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.787 0.327 . . . . 0.0 110.563 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.67 125.3 37.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.023 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -172.71 -44.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.938 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.734 HD12 ' CE ' ' A' ' 112' ' ' LYS . 12.3 tt -55.69 161.68 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.802 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -148.18 69.64 10.74 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-O 120.604 0.24 . . . . 0.0 111.389 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.424 ' HD2' ' HD2' ' A' ' 94' ' ' PRO . 22.1 Cg_endo -93.77 -164.54 0.11 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.079 2.519 . . . . 0.0 113.006 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.404 ' C ' HG23 ' A' ' 9' ' ' VAL . 17.4 t30 -144.87 -64.5 0.34 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.405 ' C ' HD13 ' A' ' 10' ' ' ILE . 60.6 t -156.33 74.45 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.105 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.871 HG23 HG21 ' A' ' 99' ' ' THR . 0.5 OUTLIER -95.11 158.37 2.98 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.221 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.783 -178.141 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.72 ' HA ' HD13 ' A' ' 90' ' ' ILE . 20.0 m -92.25 156.13 17.5 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.796 ' CG1' HD12 ' A' ' 89' ' ' LEU . 2.5 t -149.84 157.61 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.618 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.6 tpp180 -145.54 121.9 10.95 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.516 0.674 . . . . 0.0 110.57 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.738 ' C ' HG12 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -123.71 178.34 5.27 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.555 -179.668 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.428 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 2.7 t80 -115.69 151.95 34.1 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.562 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.605 ' HD3' HG21 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -86.21 30.12 0.71 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 121.009 -0.277 . . . . 0.0 110.803 178.327 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.901 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.1 OUTLIER 42.68 30.67 0.24 Allowed 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 179.518 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.596 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 43.72 24.47 0.07 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.342 -178.358 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.901 HG22 ' O ' ' A' ' 17' ' ' ARG . 14.1 m -166.33 32.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 123.942 0.897 . . . . 0.0 109.086 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 49.83 68.64 1.31 Allowed Glycine 0 C--N 1.338 0.655 0 CA-C-N 115.824 -0.625 . . . . 0.0 113.049 -178.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -154.51 67.23 0.31 Allowed Glycine 0 C--N 1.333 0.4 0 N-CA-C 111.686 -0.566 . . . . 0.0 111.686 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.932 ' CD2' HG11 ' A' ' 87' ' ' VAL . 4.4 mp -48.18 -23.36 0.84 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.433 ' HA2' HG22 ' A' ' 41' ' ' ILE . . . 112.64 5.25 24.3 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.711 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.87 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -154.38 144.45 21.91 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 118.201 1.001 . . . . 0.0 113.322 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.846 HD23 ' HA ' ' B' ' 6' ' ' SER . 20.0 mt -78.7 173.36 12.53 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.868 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.4 m -153.52 141.34 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-O 121.313 0.577 . . . . 0.0 111.602 177.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.473 ' CG ' HG22 ' A' ' 36' ' ' ILE . 6.2 ptmt -122.07 104.83 9.77 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.707 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.566 ' HG3' HD23 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -102.28 115.76 31.23 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.413 0.625 . . . . 0.0 110.887 179.495 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.535 ' HD3' ' N ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -51.85 129.39 26.51 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.206 178.191 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 t -44.15 -30.85 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.201 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.434 ' HA ' ' NH2' ' A' ' 29' ' ' ARG . 1.1 m 173.17 62.34 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.597 ' CB ' ' CD ' ' A' ' 33' ' ' PRO . 5.7 mttm -160.03 -93.21 0.0 OUTLIER Pre-proline 0 CA--C 1.562 1.429 0 O-C-N 121.603 -0.685 . . . . 0.0 112.684 178.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.597 ' CD ' ' CB ' ' A' ' 32' ' ' LYS . 49.6 Cg_endo -67.18 -165.82 0.11 Allowed 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 122.063 1.842 . . . . 0.0 111.918 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.579 ' CD ' ' HB2' ' A' ' 33' ' ' PRO . 38.2 Cg_endo -95.06 170.19 1.47 Allowed 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.1 1.867 . . . . 0.0 110.593 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.687 HG13 ' O ' ' A' ' 58' ' ' ILE . 6.1 p -78.87 149.8 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.432 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.473 HG22 ' CG ' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -143.51 166.53 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 120.253 -0.579 . . . . 0.0 112.361 -179.551 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.774 HD12 ' O ' ' A' ' 53' ' ' GLN . 20.7 mt -85.15 141.62 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.729 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.613 ' CB ' HG13 ' B' ' 4' ' ' VAL . 4.6 t -105.78 -37.83 6.58 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.546 ' CB ' HD12 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -169.42 135.09 1.55 Allowed 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 118.338 0.517 . . . . 0.0 111.66 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.87 HD23 ' HB3' ' A' ' 24' ' ' PHE . 39.6 mt -70.12 76.84 0.51 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.779 0.8 . . . . 0.0 110.444 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.446 ' CG2' ' N ' ' A' ' 42' ' ' ARG . 0.4 OUTLIER -32.94 -58.68 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -178.51 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.446 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.4 OUTLIER -94.23 -68.49 0.8 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.211 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.401 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 108.07 2.48 33.89 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.022 -178.152 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -108.57 -26.39 5.37 Favored Glycine 0 C--N 1.34 0.753 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.42 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.741 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -95.08 -82.13 0.38 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.86 0.33 . . . . 0.0 110.901 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.739 ' HB1' HG21 ' A' ' 52' ' ' ILE . . . -56.53 -63.85 1.06 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.077 0.465 . . . . 0.0 111.648 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.586 ' CD ' HD13 ' A' ' 40' ' ' LEU . 5.1 tp10 -45.38 -43.0 10.73 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.241 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 44' ' ' GLY . 21.8 mm-40 -59.34 -39.19 82.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.977 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.0 -44.76 74.8 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.959 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.06 -22.83 37.44 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.334 -0.936 . . . . 0.0 113.275 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.994 HD23 HG23 ' A' ' 113' ' ' THR . 3.6 pp -93.15 -13.78 28.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.882 0.341 . . . . 0.0 110.837 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.739 HG21 ' HB1' ' A' ' 46' ' ' ALA . 4.9 mp -96.35 147.67 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.774 ' O ' HD12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -175.14 154.11 1.72 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.979 0.419 . . . . 0.0 111.26 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.494 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -69.45 123.97 22.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.86 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.29 5.54 81.79 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.132 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.81 -86.35 0.12 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.907 0.353 . . . . 0.0 111.025 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.441 HG22 HD22 ' A' ' 91' ' ' LEU . 0.5 OUTLIER -162.55 119.89 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.207 0.527 . . . . 0.0 111.794 -179.797 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.687 ' O ' HG13 ' A' ' 35' ' ' VAL . 1.5 tp -146.96 80.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 177.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.639 HD13 ' HG2' ' A' ' 92' ' ' ARG . 7.7 tp -77.84 -66.59 0.82 Allowed 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.782 -178.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.59 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . . . -115.24 151.75 33.93 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.97 0.414 . . . . 0.0 111.051 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.633 HG22 ' ND2' ' A' ' 62' ' ' ASN . 14.3 p -152.61 146.32 15.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.269 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.633 ' ND2' HG22 ' A' ' 61' ' ' VAL . 0.2 OUTLIER 46.05 40.5 7.14 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.17 0.51 . . . . 0.0 111.336 -179.79 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.6 t70 58.87 28.44 17.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.07 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.664 ' O ' HD12 ' A' ' 66' ' ' LEU . 15.1 mmm180 -113.73 101.43 53.79 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.672 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -62.32 85.39 0.1 Allowed 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 121.662 1.574 . . . . 0.0 111.072 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.664 HD12 ' O ' ' A' ' 64' ' ' ARG . 1.0 OUTLIER -84.13 63.85 7.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.663 0.744 . . . . 0.0 110.346 -179.526 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.401 HG23 ' N ' ' A' ' 68' ' ' ASP . 2.9 m -124.84 -46.52 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.069 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.437 ' HA ' ' NH2' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -137.65 25.74 2.84 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.444 179.504 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.599 HD12 ' H ' ' A' ' 70' ' ' SER . 0.1 OUTLIER -107.66 170.69 7.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.904 -179.483 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.599 ' H ' HD12 ' A' ' 69' ' ' LEU . 0.4 OUTLIER -63.1 119.48 9.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.501 179.536 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.516 ' CG ' ' HB3' ' A' ' 28' ' ' GLU . 2.0 t80 -57.32 -47.5 81.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.416 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.48 -30.6 68.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.939 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.878 ' O ' HG23 ' A' ' 77' ' ' VAL . 43.6 t -72.8 -42.77 63.54 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.551 ' HB1' HD11 ' A' ' 66' ' ' LEU . . . -55.58 -41.13 72.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.195 0.522 . . . . 0.0 110.754 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.485 HD11 ' CE1' ' A' ' 71' ' ' TYR . 70.7 mt -71.62 -35.37 70.42 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.82 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -74.58 -42.1 59.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.925 0.393 . . . . 0.0 110.515 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 73' ' ' SER . 19.7 t -61.94 -36.18 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.031 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.545 ' C ' HD12 ' A' ' 78' ' ' LEU . 4.0 pp -85.92 -21.69 27.81 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.42 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.401 ' N ' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -68.14 -36.48 79.75 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.492 179.582 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -55.39 -21.15 25.82 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.021 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.658 HG22 HG21 ' A' ' 85' ' ' THR . 57.5 mt -56.68 109.74 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-O 120.882 0.372 . . . . 0.0 110.915 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.87 -162.55 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.415 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.2 m -97.25 -174.3 2.91 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 120.788 0.328 . . . . 0.0 111.127 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 44.6 31.44 0.63 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.078 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.658 HG21 HG22 ' A' ' 81' ' ' ILE . 1.7 t -121.28 161.13 22.53 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.847 0.832 . . . . 0.0 112.578 -178.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -101.82 176.62 5.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.405 -1.271 . . . . 0.0 110.312 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.932 HG11 ' CD2' ' A' ' 22' ' ' LEU . 2.5 p -149.23 149.47 14.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.676 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.832 ' O ' HD23 ' A' ' 89' ' ' LEU . 11.6 t -108.15 158.99 7.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.076 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.832 HD23 ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -154.92 161.39 41.43 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.741 0.305 . . . . 0.0 110.985 -178.533 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.72 HD13 ' HA ' ' A' ' 11' ' ' SER . 43.6 mm -133.14 128.14 55.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.963 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.987 HD11 HD13 ' A' ' 51' ' ' LEU . 3.7 mt -97.65 169.9 9.38 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.639 ' HG2' HD13 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -164.11 175.07 10.56 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.022 -0.671 . . . . 0.0 112.657 -179.273 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 167.05 -127.78 1.63 Allowed Glycine 0 CA--C 1.522 0.515 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.16 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.424 ' HD2' ' HD2' ' A' ' 7' ' ' PRO . 51.0 Cg_exo -57.07 -157.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.201 1.934 . . . . 0.0 112.486 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -153.68 137.32 16.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.46 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 119' ' ' PRO . . . 127.73 7.7 4.59 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.184 -1.007 . . . . 0.0 113.73 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.568 ' HB3' HG23 ' A' ' 117' ' ' THR . 11.2 m-85 -134.08 138.15 45.09 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 118.173 0.987 . . . . 0.0 113.509 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.793 HG22 ' HB3' ' A' ' 120' ' ' LEU . 0.1 OUTLIER -91.22 114.73 27.34 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 123.604 0.762 . . . . 0.0 110.262 179.665 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.871 HG21 HG23 ' A' ' 10' ' ' ILE . 11.7 t -79.56 92.84 5.35 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.607 0.718 . . . . 0.0 111.791 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 56.6 p-80 -101.24 155.39 18.05 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.129 178.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.0 mt -53.0 -174.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.689 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.16 94.11 0.08 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.588 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.97 146.38 54.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.136 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.502 ' O ' HG22 ' A' ' 104' ' ' THR . 11.1 m -139.32 14.43 2.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.212 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -44.38 113.87 0.6 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.889 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.7 t -96.04 -165.57 1.3 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.062 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.72 103.71 0.54 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.075 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.8 t0 56.29 64.69 1.62 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.97 0.414 . . . . 0.0 111.735 179.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -136.98 -88.09 0.21 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.257 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.439 HG23 HG13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -119.0 53.74 2.12 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-O 120.596 0.236 . . . . 0.0 110.607 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.77 79.98 1.52 Allowed 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.628 2.219 . . . . 0.0 113.394 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.734 ' CE ' HD12 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -147.44 -179.18 6.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.931 179.545 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.994 HG23 HD23 ' A' ' 51' ' ' LEU . 15.3 t -99.58 25.36 7.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.028 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.944 HG22 HD22 ' A' ' 51' ' ' LEU . 1.1 pp -95.29 169.3 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.955 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.894 ' O ' HD12 ' A' ' 114' ' ' ILE . 3.9 mtt-85 -79.48 148.57 31.81 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.3 t -78.86 133.1 30.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.259 0.552 . . . . 0.0 112.087 -178.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.568 HG23 ' HB3' ' A' ' 97' ' ' PHE . 0.7 OUTLIER -87.49 138.39 31.52 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.59 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.513 ' O ' HG23 ' A' ' 98' ' ' THR . 0.0 OUTLIER -128.83 134.96 26.89 Favored Pre-proline 0 N--CA 1.475 0.781 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.047 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 96' ' ' GLY . 51.4 Cg_exo -36.77 109.54 0.07 OUTLIER 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.926 2.417 . . . . 0.0 114.922 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.793 ' HB3' HG22 ' A' ' 98' ' ' THR . 0.2 OUTLIER -101.36 -38.03 8.21 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 177.891 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 59.38 90.48 0.02 OUTLIER Glycine 0 CA--C 1.521 0.434 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.602 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -60.43 151.23 76.21 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.44 2.094 . . . . 0.0 112.272 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.99 -174.48 1.95 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.382 2.055 . . . . 0.0 112.274 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 85.7 m 58.37 80.67 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.042 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 33.2 pttt -117.32 49.23 1.22 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.129 0.49 . . . . 0.0 110.959 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -92.5 17.8 9.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.225 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.098 179.969 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 22.3 m . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.862 0.363 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 16.8 t -99.59 -37.12 5.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.043 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.491 ' C ' HG23 ' B' ' 4' ' ' VAL . 9.2 mmtm -74.63 -169.83 0.93 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.069 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.613 HG13 ' CB ' ' A' ' 38' ' ' SER . 2.3 t 76.93 141.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.472 -178.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' ASP . . . . . 0.429 ' O ' ' CB ' ' B' ' 6' ' ' SER . 0.7 OUTLIER -139.88 -91.92 0.17 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.823 179.88 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.846 ' HA ' HD23 ' A' ' 25' ' ' LEU . 6.1 t 153.57 106.15 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.728 0.811 . . . . 0.0 109.812 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.573 ' OXT' HD12 ' A' ' 22' ' ' LEU . 27.1 m . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.213 -0.898 . . . . 0.0 111.317 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 112.563 -0.215 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.83 119.23 6.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.847 0.356 . . . . 0.0 110.902 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -119.3 -179.82 3.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.012 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.2 -161.5 0.82 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.541 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.447 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -81.78 161.24 3.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.653 0.263 . . . . 0.0 110.429 179.57 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.641 ' OE2' HG21 ' A' ' 110' ' ' THR . 8.2 pt-20 -115.89 144.4 32.65 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.733 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.408 ' CB ' ' HA2' ' A' ' 93' ' ' GLY . 10.2 Cg_endo -51.48 135.21 47.33 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 123.102 2.535 . . . . 0.0 113.113 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.823 ' HA ' HG21 ' A' ' 99' ' ' THR . 24.0 m-80 -140.84 86.42 2.05 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.423 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.75 HG12 ' HD2' ' A' ' 94' ' ' PRO . 11.2 p -84.37 87.24 2.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.038 0.447 . . . . 0.0 111.388 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.643 HG23 ' N ' ' A' ' 11' ' ' SER . 1.3 tp -154.75 -167.82 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 120.749 0.309 . . . . 0.0 111.61 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.704 ' HA ' HD13 ' A' ' 90' ' ' ILE . 3.9 m -102.87 173.7 6.2 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.364 0.602 . . . . 0.0 111.75 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.791 HG11 HD11 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -160.88 175.95 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.089 -179.397 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.477 ' O ' HD12 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -150.47 140.89 22.4 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.432 0.634 . . . . 0.0 110.703 179.841 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.815 ' HB3' HD23 ' A' ' 22' ' ' LEU . 0.7 OUTLIER -141.28 140.94 33.96 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.893 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.492 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 2.3 t80 -90.04 143.37 26.84 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.62 ' HE2' HD13 ' A' ' 81' ' ' ILE . 1.7 mptp? -83.6 33.59 0.47 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.261 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.892 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 38.6 33.92 0.08 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.274 0.629 . . . . 0.0 111.914 179.933 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.591 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 44.27 25.26 0.11 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.769 -178.672 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.892 HG22 ' O ' ' A' ' 17' ' ' ARG . 5.2 m -164.36 31.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.567 178.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 52.7 54.69 26.7 Favored Glycine 0 C--N 1.336 0.539 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.584 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -139.91 66.09 0.52 Allowed Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.815 HD23 ' HB3' ' A' ' 14' ' ' LEU . 3.7 mp -49.85 -20.16 0.82 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -178.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.439 ' HA2' HG22 ' A' ' 41' ' ' ILE . . . 102.16 9.39 42.19 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.134 -1.031 . . . . 0.0 113.23 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.92 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -159.76 140.47 12.22 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.504 0.668 . . . . 0.0 112.387 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.86 HD23 ' CA ' ' B' ' 6' ' ' SER . 3.7 mt -78.92 173.74 12.23 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.453 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.423 HG12 HG21 ' A' ' 58' ' ' ILE . 26.7 m -153.81 159.44 3.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 114.715 -1.129 . . . . 0.0 109.934 178.015 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.824 ' HG2' HG22 ' B' ' 4' ' ' VAL . 15.6 mtpt -134.28 95.41 3.4 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.684 -179.041 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.49 ' HB2' ' CD1' ' A' ' 71' ' ' TYR . 0.9 OUTLIER -81.31 150.21 28.6 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.681 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.405 ' HD3' ' CA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -79.07 130.82 35.91 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-O 121.178 0.513 . . . . 0.0 111.351 -179.172 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -53.04 -34.59 21.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.439 178.217 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.405 ' CA ' ' HD3' ' A' ' 29' ' ' ARG . 0.5 OUTLIER 164.83 34.95 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.716 178.876 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.498 ' HB2' ' CD ' ' A' ' 33' ' ' PRO . 38.4 mmtm -155.43 -67.36 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.498 ' CD ' ' HB2' ' A' ' 32' ' ' LYS . 37.6 Cg_endo -65.19 -174.82 0.35 Allowed 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 122.451 2.101 . . . . 0.0 112.733 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.439 ' CD ' ' HB2' ' A' ' 33' ' ' PRO . 89.2 Cg_endo -99.67 154.71 0.56 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.279 2.653 . . . . 0.0 111.48 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.56 HG11 HD23 ' A' ' 66' ' ' LEU . 21.3 t -79.58 140.41 16.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.467 HD12 ' HA ' ' A' ' 36' ' ' ILE . 1.2 tp -156.63 175.89 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.567 HG13 HG22 ' A' ' 58' ' ' ILE . 36.8 mt -89.17 151.18 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.243 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.426 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 0.5 OUTLIER -116.72 -36.59 3.86 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -179.613 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.578 ' CB ' HD12 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -177.99 142.99 0.3 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.315 -179.687 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.92 HD23 ' HB3' ' A' ' 24' ' ' PHE . 36.2 mt -76.27 85.26 3.07 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.604 0.716 . . . . 0.0 110.247 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.822 HD13 HD21 ' A' ' 25' ' ' LEU . 1.5 tp -40.59 -59.55 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 114.457 1.281 . . . . 0.0 114.457 -177.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.456 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 6.3 mmt180 -94.79 -67.18 0.87 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.182 0.515 . . . . 0.0 112.196 -178.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.461 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 109.39 22.26 6.86 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.232 -178.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.405 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -122.71 -28.56 1.4 Allowed Glycine 0 C--N 1.339 0.75 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.388 -179.118 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -93.9 -83.93 0.32 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 117.787 0.793 . . . . 0.0 111.567 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.885 ' HB1' HG21 ' A' ' 52' ' ' ILE . . . -60.97 -58.87 6.6 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.221 0.534 . . . . 0.0 110.794 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.506 ' HB2' HD22 ' A' ' 40' ' ' LEU . 17.9 tt0 -46.51 -46.97 19.5 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.761 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.405 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -55.05 -37.3 66.55 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.799 178.684 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.404 ' HB3' HD13 ' A' ' 52' ' ' ILE . 2.4 t -54.38 -46.77 73.12 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.454 178.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.47 -24.19 24.78 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.439 -0.886 . . . . 0.0 114.601 177.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.791 HD11 HG11 ' A' ' 12' ' ' VAL . 1.7 pp -104.16 0.98 30.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.588 0.694 . . . . 0.0 112.3 -179.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.885 HG21 ' HB1' ' A' ' 46' ' ' ALA . 4.2 mp -102.19 96.32 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.23 147.68 43.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.421 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.551 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -70.49 140.4 51.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.932 0.396 . . . . 0.0 111.159 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.58 5.2 88.09 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.98 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.16 -90.71 0.13 Allowed 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.582 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -164.9 121.93 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 179.629 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 1.022 HD11 HG22 ' A' ' 61' ' ' VAL . 1.3 tp -136.25 81.95 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 107.778 -1.194 . . . . 0.0 107.778 176.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.516 ' HB2' HD11 ' A' ' 57' ' ' ILE . 7.1 tp -77.97 -67.88 0.69 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.209 -177.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -114.9 147.48 39.9 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.112 0.482 . . . . 0.0 112.08 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 1.022 HG22 HD11 ' A' ' 58' ' ' ILE . 3.1 t -141.62 144.26 26.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.241 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.722 HD22 HG12 ' A' ' 61' ' ' VAL . 0.1 OUTLIER 44.9 40.87 4.73 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.967 0.413 . . . . 0.0 111.629 -179.629 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.9 t0 53.38 27.56 6.45 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.134 0.493 . . . . 0.0 110.917 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.596 ' NH1' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -115.01 93.24 34.03 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.464 -179.588 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.421 ' O ' HD23 ' A' ' 69' ' ' LEU . 82.6 Cg_exo -43.1 87.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.361 1.232 0 C-N-CA 123.309 2.673 . . . . 0.0 114.106 -178.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.936 ' CD1' ' HB1' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -92.11 70.99 5.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.296 178.501 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.536 HG23 ' H ' ' A' ' 68' ' ' ASP . 3.4 m -123.04 -59.13 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -178.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.536 ' H ' HG23 ' A' ' 67' ' ' VAL . 74.7 m-20 -136.57 24.72 3.15 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -178.193 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.596 HD22 ' NH1' ' A' ' 64' ' ' ARG . 0.2 OUTLIER -93.53 -173.28 3.15 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.484 179.306 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.72 122.65 19.58 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.749 ' CE1' HD11 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -50.46 -69.27 0.12 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.709 -179.278 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -51.45 -26.97 9.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.777 0.322 . . . . 0.0 111.451 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.889 ' O ' HG23 ' A' ' 77' ' ' VAL . 22.8 t -76.79 -44.19 33.71 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.24 0.543 . . . . 0.0 109.811 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.936 ' HB1' ' CD1' ' A' ' 66' ' ' LEU . . . -59.12 -39.42 82.26 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.069 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.749 HD11 ' CE1' ' A' ' 71' ' ' TYR . 46.2 mt -72.91 -33.97 66.33 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.578 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.412 ' HA ' ' HB2' ' A' ' 79' ' ' ARG . 5.0 pt-20 -71.44 -38.18 71.36 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.276 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.889 HG23 ' O ' ' A' ' 73' ' ' SER . 6.5 t -61.66 -46.59 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.611 HD21 HD23 ' A' ' 75' ' ' LEU . 4.4 pp -74.78 -24.35 58.66 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.9 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.412 ' HB2' ' HA ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -63.17 -37.67 88.12 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.225 179.65 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.0 -23.74 17.23 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.862 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.62 HD13 ' HE2' ' A' ' 16' ' ' LYS . 31.1 mt -58.29 106.26 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-O 120.991 0.424 . . . . 0.0 110.672 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.3 -169.68 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.238 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.44 -170.1 2.1 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.28 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 42.98 31.77 0.36 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.136 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.415 ' O ' ' CD1' ' A' ' 15' ' ' PHE . 1.8 t -129.77 159.0 37.87 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 122.095 0.95 . . . . 0.0 113.148 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -101.12 176.28 5.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.064 -1.426 . . . . 0.0 109.377 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.529 HG13 HD23 ' A' ' 89' ' ' LEU . 0.5 OUTLIER -146.24 159.66 11.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.311 -179.551 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.679 ' C ' HD23 ' A' ' 89' ' ' LEU . 11.2 t -120.29 158.67 22.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.679 HD23 ' C ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -156.81 162.71 39.71 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.884 -178.007 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.704 HD13 ' HA ' ' A' ' 11' ' ' SER . 47.8 mm -128.38 122.99 59.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.112 0.482 . . . . 0.0 111.501 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 22.4 mt -99.61 153.95 18.66 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.83 162.01 13.28 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.342 0.591 . . . . 0.0 112.13 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.436 ' HA3' ' N ' ' A' ' 8' ' ' ASN . . . -163.54 -128.85 0.98 Allowed Glycine 0 CA--C 1.525 0.669 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.767 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.75 ' HD2' HG12 ' A' ' 9' ' ' VAL . 61.1 Cg_endo -91.49 -164.91 0.15 Allowed 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 122.769 2.313 . . . . 0.0 112.692 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -132.46 106.23 7.74 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.429 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 117.26 9.1 10.77 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.65 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.876 ' HB3' HG22 ' A' ' 117' ' ' THR . 32.5 m-85 -141.22 135.2 30.5 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 117.21 0.505 . . . . 0.0 112.057 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.403 ' CG2' ' HB3' ' A' ' 120' ' ' LEU . 0.0 OUTLIER -88.61 118.49 28.31 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.571 178.646 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.823 HG21 ' HA ' ' A' ' 8' ' ' ASN . 3.5 t -103.31 92.35 4.46 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.141 0.496 . . . . 0.0 110.126 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -65.13 -162.14 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.697 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.667 ' N ' HD13 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -120.71 179.6 4.29 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.677 179.841 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 62.56 114.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.212 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.728 HG21 ' CB ' ' A' ' 115' ' ' ARG . 10.9 t -154.43 179.69 8.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.134 0.492 . . . . 0.0 111.638 -179.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 66.7 p -121.43 115.0 22.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.109 179.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.425 ' CG ' ' HA ' ' A' ' 111' ' ' PRO . 42.4 p90 -96.72 157.85 15.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.153 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.67 -76.09 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.761 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 172.89 -34.1 0.12 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.71 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -136.75 39.37 2.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.823 0.344 . . . . 0.0 111.043 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -139.67 -82.81 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.295 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.762 HG22 ' CD ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -114.1 62.89 1.16 Allowed Pre-proline 0 CA--C 1.534 0.345 0 CA-C-O 120.75 0.31 . . . . 0.0 111.107 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.425 ' HA ' ' CG ' ' A' ' 105' ' ' PHE . 72.7 Cg_endo -73.35 91.2 0.87 Allowed 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.29 1.993 . . . . 0.0 112.988 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.762 ' CD ' HG22 ' A' ' 110' ' ' THR . 0.0 OUTLIER -150.02 178.39 8.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.878 179.415 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.422 ' O ' HG22 ' A' ' 103' ' ' THR . 58.4 m -106.49 -31.22 8.63 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.396 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.645 HG23 ' O ' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -93.08 101.03 12.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.158 -179.797 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.728 ' CB ' HG21 ' A' ' 103' ' ' THR . 4.3 tmt_? -160.82 93.78 1.0 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.853 0.358 . . . . 0.0 111.112 179.056 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.5 t -157.68 62.51 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.301 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.876 HG22 ' HB3' ' A' ' 97' ' ' PHE . 0.2 OUTLIER -77.23 126.54 31.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.026 0.441 . . . . 0.0 111.146 -179.15 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.434 ' O ' ' HA ' ' A' ' 97' ' ' PHE . 0.1 OUTLIER -134.89 140.1 34.15 Favored Pre-proline 0 N--CA 1.464 0.229 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.849 -179.173 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.01 117.95 4.06 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.064 1.843 . . . . 0.0 111.855 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.516 HD23 ' C ' ' A' ' 97' ' ' PHE . 0.4 OUTLIER -119.95 -41.95 2.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.854 0.359 . . . . 0.0 110.946 -179.653 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -117.77 76.33 0.29 Allowed Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.369 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.82 140.46 67.71 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.354 2.036 . . . . 0.0 112.412 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.65 -176.79 2.97 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.357 2.038 . . . . 0.0 112.495 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 11.2 t -148.31 153.9 39.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.801 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.7 mttt -95.87 50.81 1.22 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.14 0.495 . . . . 0.0 111.049 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.44 -12.51 61.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.382 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.8 m . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.284 -0.865 . . . . 0.0 111.146 -179.938 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 32.0 t . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.806 0.336 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.547 HG22 ' O ' ' B' ' 2' ' ' VAL . 12.7 p -102.09 -1.33 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 112.151 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.457 ' HD2' ' CD2' ' A' ' 71' ' ' TYR . 7.3 tptm -106.96 13.81 27.19 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.824 HG22 ' HG2' ' A' ' 27' ' ' LYS . 24.3 t -130.55 134.2 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.774 0.321 . . . . 0.0 111.013 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 5' ' ' ASP . . . . . 0.434 ' HB3' HG13 ' B' ' 7' ' ' VAL . 1.6 m-20 -138.58 132.93 31.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.957 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.86 ' CA ' HD23 ' A' ' 25' ' ' LEU . 11.7 p -66.0 -51.37 58.98 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.832 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.707 HG11 HD22 ' A' ' 75' ' ' LEU . 22.5 m . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.264 -0.874 . . . . 0.0 112.619 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 112.721 -0.151 . . . . 0.0 112.721 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 63.33 109.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.911 0.386 . . . . 0.0 111.079 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 39.5 m170 57.85 21.56 7.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.67 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 62.57 -80.28 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.626 0.251 . . . . 0.0 111.376 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.473 HG22 ' N ' ' A' ' 6' ' ' GLU . 34.2 mm 62.93 158.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.159 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.473 ' N ' HG22 ' A' ' 5' ' ' ILE . 9.7 mm-40 -102.08 141.27 22.2 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.506 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -88.37 124.87 1.73 Allowed 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.812 2.341 . . . . 0.0 112.806 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.833 ' HA ' HG21 ' A' ' 99' ' ' THR . 73.5 m-80 -149.54 90.78 1.75 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.119 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.625 ' O ' HG13 ' A' ' 9' ' ' VAL . 14.1 p -82.82 101.79 7.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.636 HG23 ' N ' ' A' ' 11' ' ' SER . 1.0 OUTLIER -161.88 -166.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.108 -0.637 . . . . 0.0 112.715 -178.469 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.668 ' HA ' HD13 ' A' ' 90' ' ' ILE . 1.6 p -101.66 158.44 16.1 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.735 0.778 . . . . 0.0 112.131 -178.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.857 ' CG1' HD12 ' A' ' 89' ' ' LEU . 3.1 t -142.01 153.49 18.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 114.411 -1.268 . . . . 0.0 108.815 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.5 ttp-105 -135.2 128.09 31.33 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.677 0.751 . . . . 0.0 111.498 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.91 HD21 ' HB2' ' A' ' 46' ' ' ALA . 0.4 OUTLIER -124.79 177.83 5.79 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.39 -1.277 . . . . 0.0 109.608 179.66 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.418 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 3.5 t80 -123.15 151.09 42.47 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.524 ' NZ ' HD11 ' A' ' 22' ' ' LEU . 3.8 mptp? -83.15 26.54 0.62 Allowed 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.289 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.841 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.4 OUTLIER 44.79 29.94 0.49 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.833 0.349 . . . . 0.0 111.868 179.562 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.684 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 44.7 23.86 0.09 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.736 -178.477 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.841 HG22 ' O ' ' A' ' 17' ' ' ARG . 2.7 m -168.55 34.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.992 178.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 49.1 63.42 3.97 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.989 -178.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -143.91 54.05 0.58 Allowed Glycine 0 C--N 1.332 0.349 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.015 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.877 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 3.9 mp -39.1 -28.0 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.478 ' HA2' HG22 ' A' ' 41' ' ' ILE . . . 110.2 3.27 29.59 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.819 -1.182 . . . . 0.0 113.776 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.899 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -158.09 141.25 15.06 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.041 0.921 . . . . 0.0 112.933 -179.473 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.954 HD21 HD13 ' A' ' 41' ' ' ILE . 0.8 OUTLIER -89.66 174.59 7.65 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.477 179.437 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.777 HG12 HG21 ' A' ' 58' ' ' ILE . 26.6 m -151.41 165.42 2.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.236 178.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.807 ' HG2' HG22 ' B' ' 4' ' ' VAL . 15.9 mtpt -140.84 99.88 3.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.737 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.631 ' CA ' HG23 ' A' ' 35' ' ' VAL . 0.6 OUTLIER -99.34 112.17 24.4 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 178.158 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.425 ' HB3' ' HB2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -49.23 119.7 3.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.101 0.477 . . . . 0.0 111.11 -179.642 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.4 ' O ' HG12 ' A' ' 30' ' ' VAL . 52.0 t -59.11 -14.87 5.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.317 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.9 t -141.45 28.89 1.8 Allowed 'General case' 0 C--O 1.231 0.103 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.921 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 29' ' ' ARG . 9.5 mtpt -161.96 147.3 10.27 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.54 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 26.4 Cg_exo -61.36 -47.44 11.92 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.493 2.129 . . . . 0.0 114.105 -178.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 32' ' ' LYS . 73.8 Cg_exo -41.28 96.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.889 2.393 . . . . 0.0 114.799 -178.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.828 HG11 ' O ' ' A' ' 66' ' ' LEU . 11.3 p -114.68 147.0 18.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 177.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.494 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.2 tp -161.02 175.79 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -179.087 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.5 HG13 HG22 ' A' ' 58' ' ' ILE . 42.7 mt -82.17 153.3 4.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.35 178.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.741 ' HB3' HG11 ' B' ' 4' ' ' VAL . 22.0 t -117.41 -38.06 3.39 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.665 0.616 . . . . 0.0 112.665 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.555 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 1.2 t0 -173.0 140.05 0.87 Allowed 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 120.283 -0.567 . . . . 0.0 112.277 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.899 HD23 ' HB3' ' A' ' 24' ' ' PHE . 40.2 mt -76.46 87.63 3.2 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.795 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.954 HD13 HD21 ' A' ' 25' ' ' LEU . 1.3 tp -39.85 -60.04 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -177.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.46 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 17.6 ttt85 -94.24 -59.23 2.01 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.974 0.416 . . . . 0.0 112.035 -178.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.436 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 98.07 24.29 11.86 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -177.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.418 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -125.85 -28.61 1.03 Allowed Glycine 0 C--N 1.338 0.666 0 C-N-CA 121.111 -0.566 . . . . 0.0 113.479 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.877 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -94.47 -83.44 0.34 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 117.902 0.851 . . . . 0.0 111.459 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.91 ' HB2' HD21 ' A' ' 14' ' ' LEU . . . -61.67 -57.97 9.89 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.235 0.541 . . . . 0.0 110.963 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.814 ' CG ' HD13 ' A' ' 40' ' ' LEU . 7.8 tm-20 -47.61 -48.07 28.56 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.623 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.418 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -56.5 -34.85 67.38 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.98 178.797 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.14 -45.89 75.65 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.677 ' HA3' HG21 ' A' ' 113' ' ' THR . . . 112.17 -28.66 9.02 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.526 -0.845 . . . . 0.0 114.54 177.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.685 HD22 ' HB ' ' A' ' 114' ' ' ILE . 2.4 pp -105.0 19.12 21.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.591 0.695 . . . . 0.0 112.051 -179.353 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.884 HG21 ' HB1' ' A' ' 46' ' ' ALA . 4.9 mp -123.23 81.66 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.891 0.377 . . . . 0.0 110.216 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.498 ' HA ' HD11 ' A' ' 40' ' ' LEU . 3.7 mp0 -112.95 141.37 46.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.144 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.555 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -58.8 134.63 57.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.071 0.462 . . . . 0.0 111.303 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.55 2.48 87.11 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.896 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.84 -93.31 0.09 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.843 0.321 . . . . 0.0 110.566 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.685 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -163.75 119.64 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 179.613 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.981 HD11 HG22 ' A' ' 61' ' ' VAL . 5.9 tp -136.95 82.27 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 177.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.744 HD22 ' NE ' ' A' ' 92' ' ' ARG . 3.6 tp -78.12 -58.43 3.26 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.97 -177.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.702 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . . . -117.94 145.47 44.66 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.911 0.386 . . . . 0.0 111.722 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.981 HG22 HD11 ' A' ' 58' ' ' ILE . 5.0 t -146.8 145.23 19.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.84 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.539 ' ND2' HG12 ' A' ' 61' ' ' VAL . 0.2 OUTLIER 44.6 41.81 5.16 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.172 0.51 . . . . 0.0 111.995 179.211 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.6 t0 57.63 26.32 12.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.541 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 66' ' ' LEU . 19.3 mmt180 -115.57 101.47 54.23 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.116 179.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.901 ' O ' HD22 ' A' ' 69' ' ' LEU . 51.0 Cg_exo -53.48 85.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.331 2.021 . . . . 0.0 111.626 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.828 ' O ' HG11 ' A' ' 35' ' ' VAL . 8.8 mt -78.68 62.15 3.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.738 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.632 HG23 ' H ' ' A' ' 68' ' ' ASP . 3.1 m -125.49 -65.6 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.632 ' H ' HG23 ' A' ' 67' ' ' VAL . 4.6 p30 -125.74 25.42 6.91 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.901 HD22 ' O ' ' A' ' 65' ' ' PRO . 0.6 OUTLIER -100.4 -179.8 4.22 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.666 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.0 m -68.49 96.64 0.7 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.736 ' CE1' HD21 ' A' ' 75' ' ' LEU . 8.9 t80 -41.01 -57.05 2.12 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.049 0.452 . . . . 0.0 112.057 -178.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -60.67 -28.4 68.57 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.823 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.914 ' O ' HG23 ' A' ' 77' ' ' VAL . 5.0 t -74.24 -43.61 56.36 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.649 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -57.8 -33.93 69.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.501 177.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.736 HD21 ' CE1' ' A' ' 71' ' ' TYR . 3.7 mm? -71.17 -35.99 71.82 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.088 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -74.84 -35.64 62.38 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.035 0.445 . . . . 0.0 109.846 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.914 HG23 ' O ' ' A' ' 73' ' ' SER . 8.4 t -61.83 -43.01 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.874 178.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.658 HD21 HD13 ' A' ' 75' ' ' LEU . 4.1 pp -79.05 -24.7 43.41 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.053 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -40.4 94.68 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.882 0.373 . . . . 0.0 110.21 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -57.03 -20.36 34.14 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.879 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.498 HG22 HG21 ' A' ' 85' ' ' THR . 65.6 mt -57.81 110.66 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 120.98 0.419 . . . . 0.0 111.005 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.09 -164.53 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.45 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.81 -170.7 1.97 Allowed 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.809 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 45.18 31.34 0.76 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.116 0.484 . . . . 0.0 110.873 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.498 HG21 HG22 ' A' ' 81' ' ' ILE . 1.5 t -123.54 162.84 22.13 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.838 0.827 . . . . 0.0 112.658 -178.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -102.8 176.27 5.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.362 -1.29 . . . . 0.0 109.977 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.807 HG11 ' CD2' ' A' ' 22' ' ' LEU . 5.7 p -149.29 156.3 7.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.334 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.845 ' O ' HD23 ' A' ' 89' ' ' LEU . 2.1 t -114.05 161.51 12.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.553 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.857 HD12 ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -154.71 158.32 39.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.216 -178.617 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.702 ' HB ' ' HB3' ' A' ' 60' ' ' ALA . 51.5 mm -133.9 134.77 55.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.547 HD11 ' CD1' ' A' ' 51' ' ' LEU . 7.2 mt -117.13 167.26 11.34 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.033 177.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.744 ' NE ' HD22 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -104.94 160.32 15.11 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.272 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.568 ' HA3' ' N ' ' A' ' 8' ' ' ASN . . . -178.75 -147.6 7.16 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-N 114.749 -1.114 . . . . 0.0 112.288 179.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.539 ' O ' HG12 ' A' ' 9' ' ' VAL . 61.7 Cg_endo -95.54 167.93 1.4 Allowed 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 123.313 2.675 . . . . 0.0 112.598 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -105.41 154.26 20.55 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.89 19.04 66.27 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.2 -1.0 . . . . 0.0 111.8 -178.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.792 ' HB3' HG22 ' A' ' 117' ' ' THR . 53.8 m-85 -150.27 141.8 23.47 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.914 0.357 . . . . 0.0 111.852 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.681 HG22 HD22 ' A' ' 120' ' ' LEU . 0.2 OUTLIER -91.22 130.83 37.05 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.327 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.833 HG21 ' HA ' ' A' ' 8' ' ' ASN . 18.9 p -109.27 93.12 4.34 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.41 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -75.07 -168.62 0.79 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.962 178.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.9 pp -123.05 131.06 53.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.896 0.379 . . . . 0.0 110.907 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.641 ' O ' HG22 ' A' ' 103' ' ' THR . 0.1 OUTLIER -175.28 156.55 2.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.856 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.641 HG22 ' O ' ' A' ' 102' ' ' GLU . 0.5 OUTLIER 76.86 179.37 0.15 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.212 179.86 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.9 p -148.44 133.9 18.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.224 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.438 ' CG ' ' HA2' ' A' ' 109' ' ' GLY . 49.2 p90 -60.64 -177.36 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.927 0.394 . . . . 0.0 111.067 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.8 t -169.33 -42.66 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.73 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -91.23 73.76 1.68 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.506 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 60.68 42.11 14.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.844 0.354 . . . . 0.0 111.137 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.438 ' HA2' ' CG ' ' A' ' 105' ' ' PHE . . . 64.29 63.98 3.94 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.25 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.475 ' HB ' ' HD3' ' A' ' 111' ' ' PRO . 0.9 OUTLIER -109.46 -62.21 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.382 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.475 ' HD3' ' HB ' ' A' ' 110' ' ' THR . 53.1 Cg_exo -53.31 -32.75 62.73 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.105 1.87 . . . . 0.0 111.762 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.6 tptm 66.84 131.95 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.453 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.677 HG21 ' HA3' ' A' ' 50' ' ' GLY . 79.3 m -64.71 -33.94 77.15 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.862 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.685 ' HB ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -103.08 94.47 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.629 178.584 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -153.55 94.71 1.82 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.96 0.41 . . . . 0.0 111.21 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.3 t -155.57 65.3 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.746 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.792 HG22 ' HB3' ' A' ' 97' ' ' PHE . 0.2 OUTLIER -79.25 106.01 10.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.064 -0.517 . . . . 0.0 112.153 -178.654 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.419 ' O ' ' HA ' ' A' ' 97' ' ' PHE . 3.2 pt20 -114.31 133.35 22.45 Favored Pre-proline 0 N--CA 1.467 0.385 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.494 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -65.93 139.97 58.82 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.318 2.012 . . . . 0.0 114.137 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.681 HD22 HG22 ' A' ' 98' ' ' THR . 0.2 OUTLIER -89.88 -68.43 0.78 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.035 179.148 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 104.39 -77.28 0.27 Allowed Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.268 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.88 172.32 6.11 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.446 2.097 . . . . 0.0 112.158 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.459 ' CG ' ' HB2' ' A' ' 126' ' ' ALA . 88.3 Cg_endo -78.41 -166.27 0.39 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.487 2.125 . . . . 0.0 112.332 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.1 t -53.94 -47.43 71.29 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.416 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -177.79 70.42 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.132 0.491 . . . . 0.0 110.93 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.459 ' HB2' ' CG ' ' A' ' 123' ' ' PRO . . . -64.92 -15.63 62.31 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.043 178.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.448 ' OXT' HG23 ' A' ' 127' ' ' VAL . 3.8 m . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.089 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 10.2 t . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 121.114 0.483 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.742 HG13 ' HG3' ' B' ' 3' ' ' LYS . 11.5 p -94.94 -32.1 4.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.194 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.742 ' HG3' HG13 ' B' ' 2' ' ' VAL . 2.2 pptp? -174.35 48.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.461 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.807 HG22 ' HG2' ' A' ' 27' ' ' LYS . 10.5 t -74.0 124.89 32.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.828 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 5' ' ' ASP . . . . . 0.727 ' OD2' HD11 ' A' ' 75' ' ' LEU . 10.8 p-10 -63.71 -155.26 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.585 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -177.35 102.56 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.185 0.517 . . . . 0.0 110.145 179.543 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.729 ' O ' HD12 ' A' ' 22' ' ' LEU . 23.0 m . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.238 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.9 t -174.51 -55.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.83 0.347 . . . . 0.0 110.776 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -113.53 120.72 41.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.761 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 7.7 mtt 62.49 160.71 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.619 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.775 HD13 ' CD ' ' A' ' 111' ' ' PRO . 4.5 tp 36.8 100.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.467 0.707 . . . . 0.0 112.651 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -161.61 -63.83 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -36.13 138.7 0.17 Allowed 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 123.293 2.662 . . . . 0.0 114.178 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -63.91 -36.55 84.29 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.105 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.619 ' C ' HD12 ' A' ' 10' ' ' ILE . 38.8 t -79.17 148.64 5.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.978 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.892 HD13 ' OG1' ' A' ' 99' ' ' THR . 1.7 mp -122.08 159.58 24.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 121.37 0.605 . . . . 0.0 112.541 -177.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.748 ' HA ' HD13 ' A' ' 90' ' ' ILE . 1.9 m -92.79 173.57 7.69 Favored 'General case' 0 C--O 1.23 0.075 0 CA-C-N 115.158 -0.928 . . . . 0.0 113.439 -178.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.886 ' CG1' HD12 ' A' ' 89' ' ' LEU . 1.5 t -159.14 157.47 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 114.29 -1.323 . . . . 0.0 108.786 -179.083 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -150.75 126.31 10.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.223 0.535 . . . . 0.0 110.837 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.754 ' C ' HG12 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -134.45 178.72 6.77 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.297 -179.229 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.428 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 5.0 t80 -116.37 151.99 34.82 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.12 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.433 ' NZ ' HD11 ' A' ' 22' ' ' LEU . 0.8 OUTLIER -85.32 28.11 0.76 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.541 179.448 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.868 ' O ' HG22 ' A' ' 19' ' ' VAL . 7.5 tpt180 43.49 31.8 0.46 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.018 0.437 . . . . 0.0 111.94 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.671 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 43.64 24.98 0.07 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.893 -178.917 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.868 HG22 ' O ' ' A' ' 17' ' ' ARG . 5.0 m -167.72 33.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.408 -0.814 . . . . 0.0 108.831 178.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.405 ' HA2' ' HE2' ' A' ' 16' ' ' LYS . . . 49.14 61.1 5.63 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.705 -178.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -142.94 55.33 0.58 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.98 -0.629 . . . . 0.0 111.95 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.859 ' CD2' HG11 ' A' ' 87' ' ' VAL . 3.7 mp -40.49 -27.61 0.05 Allowed 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 40' ' ' LEU . . . 114.42 2.49 22.96 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 119.911 -1.137 . . . . 0.0 114.418 178.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.781 ' HB3' HD23 ' A' ' 40' ' ' LEU . 1.6 p90 -154.58 144.37 21.64 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.493 1.147 . . . . 0.0 113.595 -179.152 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.736 HD23 ' HA ' ' B' ' 6' ' ' SER . 7.6 mt -82.05 172.88 12.72 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.683 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.609 HG12 HG21 ' A' ' 58' ' ' ILE . 33.0 m -150.98 154.24 8.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.248 177.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.419 ' HD3' HG22 ' A' ' 36' ' ' ILE . 11.7 ptmt -135.84 109.64 8.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.959 -179.083 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.515 ' HB3' ' CG ' ' A' ' 71' ' ' TYR . 0.6 OUTLIER -111.06 142.66 42.92 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.947 179.276 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.431 ' CB ' ' HB2' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -75.4 126.94 32.03 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.044 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 65.5 t -51.85 -22.41 2.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.912 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.404 ' O ' ' CG ' ' A' ' 32' ' ' LYS . 72.3 p -146.25 44.2 1.23 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.927 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.431 ' HB2' ' CB ' ' A' ' 29' ' ' ARG . 29.6 mttp -166.25 144.35 4.6 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 116.72 -0.218 . . . . 0.0 110.835 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.423 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 39.4 Cg_exo -59.24 -48.0 15.35 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.687 2.258 . . . . 0.0 113.972 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 33' ' ' PRO . 60.4 Cg_exo -38.92 94.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.927 2.418 . . . . 0.0 114.674 -178.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.544 HG11 ' O ' ' A' ' 66' ' ' LEU . 14.8 p -118.86 152.64 21.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.131 178.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 36' ' ' ILE . 1.2 tp -160.21 174.37 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.523 HG13 HG22 ' A' ' 58' ' ' ILE . 54.4 mt -85.39 147.73 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.135 179.093 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.457 ' CB ' HG13 ' B' ' 4' ' ' VAL . 1.4 t -113.66 -37.07 4.69 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.691 ' CB ' HD12 ' A' ' 25' ' ' LEU . 1.5 t0 -172.14 141.38 1.28 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.044 -0.663 . . . . 0.0 112.373 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.781 HD23 ' HB3' ' A' ' 24' ' ' PHE . 51.0 mt -72.55 109.02 5.92 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.526 -0.761 . . . . 0.0 108.978 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.542 ' CD1' HD21 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -63.52 -59.67 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -176.392 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.464 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -94.15 -67.38 0.86 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.15 0.5 . . . . 0.0 111.985 -178.229 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 112.55 23.76 5.27 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.517 -178.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -128.17 -30.07 0.75 Allowed Glycine 0 C--N 1.338 0.643 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.613 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.854 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -93.53 -83.33 0.33 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 117.823 0.812 . . . . 0.0 111.512 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.779 ' HB1' HG21 ' A' ' 52' ' ' ILE . . . -61.74 -55.22 32.55 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.123 0.487 . . . . 0.0 110.927 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.663 ' HG3' HD13 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -50.17 -48.26 54.1 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.975 179.496 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -57.07 -35.84 69.85 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.203 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.2 m -57.3 -46.14 83.45 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.943 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.97 -21.71 44.63 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.392 -0.909 . . . . 0.0 113.011 179.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.926 HD22 HG21 ' A' ' 114' ' ' ILE . 2.1 pp -82.05 -31.59 30.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.176 0.512 . . . . 0.0 109.643 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.844 HD12 ' HG ' ' A' ' 51' ' ' LEU . 3.6 mp -82.29 137.51 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.237 179.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.433 ' O ' HD12 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -157.71 150.45 22.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.619 179.798 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.591 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -68.62 122.08 17.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.882 0.372 . . . . 0.0 110.928 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.58 -6.5 80.14 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.359 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.92 -91.61 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 117.001 0.4 . . . . 0.0 110.818 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.561 HG23 HD22 ' A' ' 91' ' ' LEU . 1.1 tp -163.28 123.02 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.609 HG21 HG12 ' A' ' 26' ' ' VAL . 2.4 tp -140.91 84.42 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 176.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.551 HD11 HG11 ' A' ' 67' ' ' VAL . 57.5 tp -77.16 -61.02 2.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.789 -178.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.721 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . . . -120.85 161.87 20.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.957 0.408 . . . . 0.0 111.439 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.796 HG12 HD12 ' A' ' 66' ' ' LEU . 14.0 p -163.24 145.18 2.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.375 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.639 ' ND2' HG22 ' A' ' 61' ' ' VAL . 0.1 OUTLIER 45.13 41.91 6.22 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.239 0.542 . . . . 0.0 111.379 -179.777 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.14 29.1 16.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.06 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.4 ' HD2' HG11 ' A' ' 77' ' ' VAL . 6.6 mmp_? -115.58 96.6 46.67 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.415 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.83 ' O ' HD22 ' A' ' 69' ' ' LEU . 18.4 Cg_endo -59.85 86.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 121.856 1.704 . . . . 0.0 110.874 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.796 HD12 HG12 ' A' ' 61' ' ' VAL . 0.7 OUTLIER -71.96 63.59 0.48 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.423 -178.68 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.551 HG11 HD11 ' A' ' 59' ' ' LEU . 3.5 m -143.51 -61.35 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.543 ' H ' HG23 ' A' ' 67' ' ' VAL . 2.2 p30 -109.32 28.78 8.17 Favored 'General case' 0 CA--C 1.518 -0.266 0 O-C-N 121.966 -0.459 . . . . 0.0 111.997 -178.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.83 HD22 ' O ' ' A' ' 65' ' ' PRO . 0.3 OUTLIER -124.85 174.17 8.12 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.515 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.98 107.78 2.81 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.796 ' CE1' HD11 ' A' ' 75' ' ' LEU . 7.5 t80 -43.76 -58.4 2.73 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.015 0.436 . . . . 0.0 111.896 -179.207 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -58.0 -27.34 63.41 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.341 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.891 ' O ' HG23 ' A' ' 77' ' ' VAL . 4.8 m -77.29 -38.63 50.36 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.253 0.549 . . . . 0.0 110.019 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.726 ' HB2' HD21 ' A' ' 69' ' ' LEU . . . -63.39 -38.52 91.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.825 178.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.796 HD11 ' CE1' ' A' ' 71' ' ' TYR . 16.0 mt -73.17 -32.38 64.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.462 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 73' ' ' SER . 5.0 pt-20 -76.35 -38.82 55.31 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.848 0.356 . . . . 0.0 110.283 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.891 HG23 ' O ' ' A' ' 73' ' ' SER . 48.8 t -61.98 -41.3 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.55 ' C ' HD12 ' A' ' 78' ' ' LEU . 4.3 pp -80.14 -22.11 42.39 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.322 179.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.482 ' N ' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -68.24 -38.11 81.49 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.464 179.782 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.82 -12.77 57.87 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.134 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 84.9 mt -53.13 118.9 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 120.989 0.423 . . . . 0.0 111.169 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.55 -173.99 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.898 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -98.63 -173.28 2.5 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.287 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 42.04 32.31 0.29 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.15 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.5 t -123.94 162.26 23.73 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.881 0.848 . . . . 0.0 112.577 -178.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -97.9 177.11 5.55 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.477 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.859 HG11 ' CD2' ' A' ' 22' ' ' LEU . 2.3 p -151.38 148.25 14.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.329 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.839 ' O ' HD23 ' A' ' 89' ' ' LEU . 6.2 t -108.3 162.67 6.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.886 HD12 ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -159.8 172.16 18.18 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -179.435 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.748 HD13 ' HA ' ' A' ' 11' ' ' SER . 29.4 mm -131.36 120.96 47.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -178.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.729 HD12 ' CG1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -103.97 152.49 21.95 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 176.948 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.555 ' CZ ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -168.78 175.27 6.09 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.782 -179.881 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.02 170.17 25.96 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.881 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -80.32 54.59 5.29 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.312 2.008 . . . . 0.0 112.903 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 62.01 113.74 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.317 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.604 ' HA2' HD12 ' A' ' 120' ' ' LEU . . . 94.85 24.36 17.79 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.211 -0.995 . . . . 0.0 111.22 -178.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.667 ' HB3' HG22 ' A' ' 117' ' ' THR . 37.1 m-85 -138.65 131.02 28.67 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.827 HG22 ' HB3' ' A' ' 120' ' ' LEU . 0.1 OUTLIER -86.07 130.36 34.56 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.202 179.398 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.892 ' OG1' HD13 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -105.29 94.02 5.0 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 177.81 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.504 ' HA ' ' HD2' ' A' ' 115' ' ' ARG . 16.7 t-160 -120.45 113.99 21.13 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.716 -179.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.964 HD22 ' CB ' ' A' ' 112' ' ' LYS . 1.9 tp -59.29 -86.5 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 121.101 -0.24 . . . . 0.0 110.924 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 173.21 -38.21 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 122.704 0.402 . . . . 0.0 110.044 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.942 HG22 ' CD2' ' A' ' 101' ' ' LEU . 12.4 t -94.56 -164.41 1.16 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.227 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.1 p -132.52 125.47 30.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.999 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -117.49 -176.47 3.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.25 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.9 p -89.18 -106.71 0.08 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 119.459 -0.305 . . . . 0.0 110.743 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 49.51 34.71 20.38 Favored Glycine 0 C--N 1.347 1.17 0 C-N-CA 120.394 -0.908 . . . . 0.0 111.758 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 26.0 t0 73.51 33.37 1.08 Allowed 'General case' 0 C--O 1.231 0.123 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 85.32 74.85 1.25 Allowed Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.912 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.501 HG23 ' NH1' ' A' ' 115' ' ' ARG . 0.9 OUTLIER -134.25 123.7 16.84 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 -179.337 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.775 ' CD ' HD13 ' A' ' 5' ' ' ILE . 11.8 Cg_exo -69.01 67.94 1.28 Allowed 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.011 1.808 . . . . 0.0 111.569 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.964 ' CB ' HD22 ' A' ' 101' ' ' LEU . 17.3 tppt? 75.11 143.78 0.08 Allowed 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.963 -179.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.59 HG22 ' HA ' ' A' ' 12' ' ' VAL . 2.0 m -46.88 -67.27 0.29 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.418 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.926 HG21 HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -88.31 155.71 3.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.029 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.714 ' O ' HG22 ' A' ' 99' ' ' THR . 2.6 mtm-85 -141.22 159.3 42.51 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.94 0.4 . . . . 0.0 111.834 -177.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 99' ' ' THR . 75.5 t -78.93 128.18 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.867 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.667 HG22 ' HB3' ' A' ' 97' ' ' PHE . 0.2 OUTLIER -81.11 134.24 35.61 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -178.745 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.474 ' O ' ' CA ' ' A' ' 97' ' ' PHE . 0.6 OUTLIER -143.49 176.51 2.25 Favored Pre-proline 0 C--O 1.204 -1.335 0 N-CA-C 107.111 -1.441 . . . . 0.0 107.111 177.55 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 97' ' ' PHE . 96.1 Cg_endo -92.07 131.26 1.15 Allowed 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 121.653 1.569 . . . . 0.0 115.047 -178.002 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.827 ' HB3' HG22 ' A' ' 98' ' ' THR . 0.2 OUTLIER -110.32 -39.95 4.81 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.092 0.472 . . . . 0.0 109.82 177.381 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -45.43 -66.58 1.5 Allowed Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.611 -0.722 . . . . 0.0 114.003 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -48.5 171.71 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.747 2.298 . . . . 0.0 112.649 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -68.54 82.37 0.54 Allowed 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.409 2.073 . . . . 0.0 112.633 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 38.2 p -85.02 70.89 10.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.694 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -124.29 -174.68 3.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.979 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 62.8 17.67 10.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.078 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.6 p . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.174 179.966 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 120.758 0.313 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 22.8 t -120.54 -38.34 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.494 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 1.9 mmtm -105.96 -41.47 5.38 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.339 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.473 HG11 HD13 ' A' ' 25' ' ' LEU . 21.9 t -75.9 122.46 29.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.924 0.392 . . . . 0.0 110.963 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.71 127.53 45.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.828 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.736 ' HA ' HD23 ' A' ' 25' ' ' LEU . 30.5 t -73.73 149.46 41.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.417 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.443 HG23 HD13 ' A' ' 22' ' ' LEU . 27.0 m . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.382 -179.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 112.573 -0.211 . . . . 0.0 112.573 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.61 99.5 12.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.772 0.32 . . . . 0.0 110.87 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -90.54 117.33 29.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.037 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 4.8 tpp -144.85 68.31 1.25 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.689 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.3 tt -150.52 46.39 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.909 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -167.78 157.07 8.94 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.29 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.766 ' HB3' HD13 ' A' ' 114' ' ' ILE . 93.7 Cg_endo -80.74 -176.43 3.17 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.667 2.245 . . . . 0.0 112.038 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -137.33 -82.11 0.35 Allowed 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.876 HG23 ' HA ' ' A' ' 92' ' ' ARG . 13.1 p -164.15 106.75 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.474 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.667 HG23 ' N ' ' A' ' 11' ' ' SER . 1.0 OUTLIER -162.16 -167.64 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.979 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.712 ' HA ' HD13 ' A' ' 90' ' ' ILE . 3.6 t -72.64 164.26 26.77 Favored 'General case' 0 CA--C 1.527 0.06 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.594 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.791 ' CG1' HD12 ' A' ' 89' ' ' LEU . 1.7 t -158.27 160.71 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 114.592 -1.185 . . . . 0.0 108.698 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.485 ' O ' HD12 ' A' ' 14' ' ' LEU . 17.6 ttp180 -143.69 143.8 31.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.564 0.697 . . . . 0.0 111.617 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.856 HD21 ' HB2' ' A' ' 46' ' ' ALA . 0.8 OUTLIER -142.63 176.69 8.84 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.821 179.681 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.473 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 3.9 t80 -132.03 148.26 52.49 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.57 34.14 0.43 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.333 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.898 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.8 OUTLIER 38.21 32.89 0.05 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.22 0.608 . . . . 0.0 112.259 179.503 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.589 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 44.5 23.67 0.08 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.517 -178.356 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.898 HG22 ' O ' ' A' ' 17' ' ' ARG . 8.0 m -164.54 31.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.48 178.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 52.99 67.25 2.21 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.631 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -153.78 69.38 0.3 Allowed Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 111.599 -0.601 . . . . 0.0 111.599 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.878 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 4.1 mp -52.01 -22.79 4.33 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.429 ' HA2' HG22 ' A' ' 41' ' ' ILE . . . 103.48 6.12 44.72 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.25 -0.976 . . . . 0.0 113.735 179.098 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.892 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -157.95 140.3 14.43 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 117.982 0.891 . . . . 0.0 113.356 -179.529 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.841 HD23 ' HA ' ' B' ' 6' ' ' SER . 14.7 mt -80.16 171.46 15.05 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.118 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.439 HG12 HG21 ' A' ' 58' ' ' ILE . 35.2 m -153.89 153.72 8.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.607 177.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.9 ptmt -140.45 108.08 5.62 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.93 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.482 ' HB3' ' CD1' ' A' ' 71' ' ' TYR . 4.9 tm-20 -106.23 129.97 54.18 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.705 178.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.495 ' CB ' ' HB2' ' A' ' 32' ' ' LYS . 1.9 mmm180 -83.88 121.49 27.42 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.051 0.453 . . . . 0.0 110.689 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.0 t -51.41 -23.25 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.025 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.6 t -149.93 63.69 0.98 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.582 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.495 ' HB2' ' CB ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -174.49 172.8 1.2 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.228 -178.825 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.446 ' HD2' ' CB ' ' A' ' 32' ' ' LYS . 10.2 Cg_exo -33.46 160.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.361 1.196 0 C-N-CA 123.936 3.091 . . . . 0.0 114.614 -179.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -41.75 175.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 123.859 3.039 . . . . 0.0 115.171 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.838 HG13 ' O ' ' A' ' 58' ' ' ILE . 14.0 p -77.51 159.68 4.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.633 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.702 HD11 HD12 ' A' ' 57' ' ' ILE . 1.1 tp -146.35 158.72 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.585 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.7 HD12 ' O ' ' A' ' 53' ' ' GLN . 26.5 mt -79.75 146.75 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 120.737 0.303 . . . . 0.0 111.319 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.48 ' CB ' HG13 ' B' ' 4' ' ' VAL . 4.0 t -113.98 -36.68 4.7 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.597 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -171.84 135.67 0.86 Allowed 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 120.111 -0.636 . . . . 0.0 112.295 -179.707 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.892 HD23 ' HB3' ' A' ' 24' ' ' PHE . 40.6 mt -72.73 77.42 1.11 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 121.788 0.804 . . . . 0.0 109.876 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.571 HD13 ' CD2' ' A' ' 25' ' ' LEU . 1.4 tp -33.79 -60.15 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -177.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.467 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 1.5 ttt85 -94.96 -62.25 1.35 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -177.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.431 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 99.79 28.42 7.42 Favored Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -177.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -126.52 -32.25 0.73 Allowed Glycine 0 C--N 1.337 0.592 0 C-N-CA 121.337 -0.459 . . . . 0.0 113.232 -178.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.878 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -95.34 -83.33 0.36 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 117.587 0.694 . . . . 0.0 111.906 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.856 ' HB2' HD21 ' A' ' 14' ' ' LEU . . . -60.38 -60.06 4.41 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.158 0.504 . . . . 0.0 111.234 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.678 ' CG ' HD13 ' A' ' 40' ' ' LEU . 7.7 tm-20 -45.29 -48.26 13.02 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.784 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 44' ' ' GLY . 6.6 mm-40 -54.97 -39.69 69.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.276 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.3 m -53.23 -46.2 69.02 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.015 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.08 -21.63 33.18 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.452 -0.88 . . . . 0.0 113.821 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.871 HD22 HG22 ' A' ' 114' ' ' ILE . 2.9 pp -97.21 -7.8 31.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.064 0.432 . . . . 0.0 111.58 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.75 HG21 ' HB1' ' A' ' 46' ' ' ALA . 5.4 mp -104.71 125.12 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-O 120.901 0.382 . . . . 0.0 110.391 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.7 ' O ' HD12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -150.81 156.28 40.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.667 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.597 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -71.76 127.8 33.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.937 0.399 . . . . 0.0 111.184 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.08 -1.13 89.22 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.087 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.92 -92.97 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 117.039 0.419 . . . . 0.0 109.995 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.702 HD12 HD11 ' A' ' 36' ' ' ILE . 6.9 tp -164.96 119.55 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.838 ' O ' HG13 ' A' ' 35' ' ' VAL . 2.6 tp -135.32 88.15 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.465 HD22 ' HB3' ' A' ' 92' ' ' ARG . 4.9 tp -78.96 -68.24 0.67 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.061 -178.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.418 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . . . -111.44 158.56 18.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.233 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.711 HG23 HD22 ' A' ' 89' ' ' LEU . 14.8 p -162.73 147.39 3.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.306 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.583 ' ND2' HG22 ' A' ' 61' ' ' VAL . 0.3 OUTLIER 44.79 42.77 6.31 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 121.145 0.498 . . . . 0.0 111.498 -179.5 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.9 t0 56.81 28.87 15.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.209 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.544 ' O ' HD12 ' A' ' 66' ' ' LEU . 6.2 mmp_? -118.55 95.8 49.22 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.903 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.518 ' O ' HD23 ' A' ' 69' ' ' LEU . 18.5 Cg_endo -59.89 86.67 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 121.819 1.679 . . . . 0.0 111.128 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.544 HD12 ' O ' ' A' ' 64' ' ' ARG . 0.4 OUTLIER -83.86 63.51 7.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.531 0.681 . . . . 0.0 110.463 -179.459 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.418 HG23 ' N ' ' A' ' 68' ' ' ASP . 3.9 m -117.17 -50.91 4.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.986 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.418 ' N ' HG23 ' A' ' 67' ' ' VAL . 2.8 m-20 -138.65 22.5 2.69 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.814 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.776 HD21 ' HB2' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -100.41 172.6 7.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.244 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.442 ' H ' HD12 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -66.6 106.35 1.77 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.216 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.917 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 7.5 t80 -45.18 -60.84 1.9 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.684 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -54.86 -31.92 60.13 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.296 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.8 ' O ' HG23 ' A' ' 77' ' ' VAL . 6.3 t -74.57 -44.09 52.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.166 0.507 . . . . 0.0 109.657 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.776 ' HB2' HD21 ' A' ' 69' ' ' LEU . . . -59.83 -40.32 88.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.225 178.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.917 HD11 ' CZ ' ' A' ' 71' ' ' TYR . 73.5 mt -71.02 -31.38 67.87 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.638 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -75.7 -39.24 57.73 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.126 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 73' ' ' SER . 39.4 t -61.28 -39.84 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.924 179.014 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.607 HD12 ' N ' ' A' ' 79' ' ' ARG . 4.5 pp -80.58 -25.4 38.55 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.925 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.607 ' N ' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -62.63 -37.61 87.01 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.977 0.418 . . . . 0.0 110.361 179.645 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -58.66 -18.73 39.5 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.848 -0.691 . . . . 0.0 113.024 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.491 HG22 HG21 ' A' ' 85' ' ' THR . 48.0 mt -56.23 122.25 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 120.924 0.392 . . . . 0.0 111.114 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.43 -163.38 0.09 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.312 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.36 -169.67 2.02 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.988 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 40.9 33.33 0.2 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.235 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.491 HG21 HG22 ' A' ' 81' ' ' ILE . 1.8 t -123.7 157.71 33.28 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 122.206 1.003 . . . . 0.0 113.122 -177.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -100.11 175.51 5.72 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.877 -1.511 . . . . 0.0 109.712 179.029 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.805 HG12 ' C ' ' A' ' 14' ' ' LEU . 5.0 p -150.87 153.9 9.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.083 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.621 ' O ' HD23 ' A' ' 89' ' ' LEU . 25.0 t -115.01 158.37 15.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.205 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.853 HD21 ' HB2' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -154.01 169.72 22.83 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.516 -178.916 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.712 HD13 ' HA ' ' A' ' 11' ' ' SER . 34.3 mm -136.28 123.16 32.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.636 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.726 HD11 HD13 ' A' ' 51' ' ' LEU . 9.4 mt -82.35 145.75 29.76 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 176.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.876 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -116.97 153.51 32.5 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -177.496 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 135.63 71.66 0.07 OUTLIER Glycine 0 CA--C 1.525 0.697 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.141 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.533 ' HB3' HG11 ' A' ' 9' ' ' VAL . 77.9 Cg_endo -86.12 142.49 7.52 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.736 2.29 . . . . 0.0 113.283 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -157.32 22.84 0.3 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 86.87 43.24 6.09 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.861 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.854 ' C ' HD23 ' A' ' 120' ' ' LEU . 68.6 m-85 -147.53 129.95 15.78 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 117.172 0.486 . . . . 0.0 112.154 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.47 HG22 ' HB2' ' A' ' 120' ' ' LEU . 0.1 OUTLIER -83.22 114.66 21.52 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.799 179.819 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 29.8 p -79.91 93.22 5.63 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.136 0.494 . . . . 0.0 110.14 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -104.63 128.32 52.62 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.271 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.5 137.97 39.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.138 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -177.1 37.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.728 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.702 HG21 ' HB3' ' A' ' 111' ' ' PRO . 10.9 t -176.82 172.13 2.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.771 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.451 ' O ' HG22 ' A' ' 104' ' ' THR . 6.7 m -139.35 10.68 2.53 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.412 ' CD2' ' O ' ' A' ' 104' ' ' THR . 1.1 p90 57.37 155.17 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.023 0.439 . . . . 0.0 111.206 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.406 HG23 ' H ' ' A' ' 107' ' ' GLY . 1.7 t -150.17 -52.92 0.15 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.435 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.406 ' H ' HG23 ' A' ' 106' ' ' THR . . . -59.89 -109.47 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.326 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -99.54 32.23 2.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.919 0.39 . . . . 0.0 110.612 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 65.7 63.65 3.92 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.172 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.445 ' HB ' ' HD3' ' A' ' 111' ' ' PRO . 0.9 OUTLIER -96.56 -59.77 0.16 Allowed Pre-proline 0 CA--C 1.535 0.384 0 O-C-N 122.911 -0.17 . . . . 0.0 111.199 -179.543 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.702 ' HB3' HG21 ' A' ' 103' ' ' THR . 51.9 Cg_exo -54.0 -29.62 55.4 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.047 1.831 . . . . 0.0 111.297 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.9 tptt 66.74 135.51 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.223 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 17.1 m -59.53 -20.78 57.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.82 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.871 HG22 HD22 ' A' ' 51' ' ' LEU . 1.1 pt -77.43 177.36 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 CA-C-O 121.155 0.502 . . . . 0.0 110.864 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.467 ' O ' HD12 ' A' ' 114' ' ' ILE . 35.9 mtt180 -78.0 128.61 34.15 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.722 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.5 t -78.47 130.89 35.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.153 0.501 . . . . 0.0 110.602 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.572 HG23 ' HB3' ' A' ' 97' ' ' PHE . 0.6 OUTLIER -78.68 135.21 37.13 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.875 -178.027 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.504 ' O ' ' HA ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -125.05 137.7 30.18 Favored Pre-proline 0 N--CA 1.469 0.5 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.461 -179.81 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -34.78 104.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 123.354 2.703 . . . . 0.0 113.823 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.854 HD23 ' C ' ' A' ' 97' ' ' PHE . 0.3 OUTLIER -116.76 -29.63 6.01 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.943 -179.05 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 99.67 121.52 4.63 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 120.678 -0.773 . . . . 0.0 111.922 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.21 107.66 0.28 Allowed 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.138 1.892 . . . . 0.0 112.507 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.17 75.96 0.68 Allowed 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.177 1.918 . . . . 0.0 112.175 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.21 76.4 1.67 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.843 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.01 46.77 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.068 0.461 . . . . 0.0 110.996 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.37 -9.63 56.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.613 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.5 m . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.172 -179.986 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 24.4 t . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.859 0.362 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.577 HG22 ' O ' ' B' ' 2' ' ' VAL . 10.6 p -149.58 48.04 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.893 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.432 ' CE ' ' HA ' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -108.78 -41.37 4.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.194 -179.88 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.48 HG13 ' CB ' ' A' ' 38' ' ' SER . 3.4 t -77.69 127.07 38.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.755 0.312 . . . . 0.0 110.912 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -125.56 127.25 46.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.847 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.841 ' HA ' HD23 ' A' ' 25' ' ' LEU . 7.9 p -86.53 116.52 24.71 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.059 0.457 . . . . 0.0 110.925 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.559 HG23 HD13 ' A' ' 22' ' ' LEU . 19.6 m . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.251 -0.881 . . . . 0.0 111.226 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.4 p -77.86 176.14 9.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.728 0.299 . . . . 0.0 110.783 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 4.8 m170 62.88 124.57 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.004 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.3 mmt -97.47 39.69 1.19 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.679 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.575 HD11 ' HD3' ' A' ' 92' ' ' ARG . 9.7 tp -168.83 158.6 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.933 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.434 ' HB3' ' CD ' ' A' ' 7' ' ' PRO . 2.7 mt-10 -129.92 177.45 2.19 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.959 -179.115 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.434 ' CD ' ' HB3' ' A' ' 6' ' ' GLU . 52.5 Cg_exo -56.86 -151.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 122.982 2.455 . . . . 0.0 112.553 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.507 ' O ' ' HA ' ' A' ' 92' ' ' ARG . 2.8 m-20 77.28 86.08 0.08 Allowed 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 10' ' ' ILE . 41.4 t -106.62 157.57 6.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -178.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.547 ' HB ' ' HA3' ' A' ' 93' ' ' GLY . 1.2 tp -157.34 163.24 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.17 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.963 -178.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.588 ' HA ' HD13 ' A' ' 90' ' ' ILE . 5.0 m -90.55 151.39 21.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.501 178.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.818 HG21 ' HG ' ' A' ' 91' ' ' LEU . 2.7 t -138.8 160.55 30.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.2 ttp85 -138.3 140.84 39.74 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.616 0.722 . . . . 0.0 112.0 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.801 ' C ' HG12 ' A' ' 87' ' ' VAL . 0.6 OUTLIER -142.19 176.24 9.13 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.45 179.331 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.446 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 3.4 t80 -127.65 146.45 50.55 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -80.82 36.49 0.39 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.226 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.891 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.6 OUTLIER 35.11 34.03 0.02 OUTLIER 'General case' 0 C--N 1.352 0.707 0 C-N-CA 123.714 0.805 . . . . 0.0 112.502 179.681 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.568 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 43.25 24.82 0.05 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.409 -178.334 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.891 HG22 ' O ' ' A' ' 17' ' ' ARG . 15.7 m -164.94 31.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.234 178.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 52.38 68.51 1.54 Allowed Glycine 0 C--N 1.338 0.689 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.376 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -155.27 69.27 0.29 Allowed Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 111.749 -0.541 . . . . 0.0 111.749 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.816 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 4.0 mp -50.08 -22.8 1.77 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 40' ' ' LEU . . . 107.75 4.99 34.01 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.274 -0.965 . . . . 0.0 113.425 179.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.907 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -158.59 139.09 12.58 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -179.635 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.908 HD23 ' HA ' ' B' ' 6' ' ' SER . 5.4 mt -79.18 169.59 17.92 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.54 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.8 m -152.47 156.93 5.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 120.123 -0.631 . . . . 0.0 111.721 177.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.469 ' CG ' HG22 ' A' ' 36' ' ' ILE . 13.3 ptmt -138.17 107.05 5.95 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.683 -178.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.465 ' HB3' ' CG ' ' A' ' 71' ' ' TYR . 2.1 tm-20 -101.07 111.33 23.51 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.413 ' HB3' ' CG ' ' A' ' 32' ' ' LYS . 20.4 mmt180 -64.45 119.08 9.73 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.026 0.441 . . . . 0.0 110.378 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 30' ' ' VAL . 53.4 t -54.62 -18.1 2.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.363 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.69 46.39 0.55 Allowed 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.388 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.477 ' HB3' ' HD2' ' A' ' 33' ' ' PRO . 9.9 mtpt -153.4 -176.15 0.57 Allowed Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 32' ' ' LYS . 66.2 Cg_exo -43.95 171.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.541 2.161 . . . . 0.0 114.134 -178.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.497 ' HB3' HG12 ' A' ' 67' ' ' VAL . 99.2 Cg_exo -46.17 177.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.398 2.732 . . . . 0.0 114.451 -179.131 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.781 HG13 ' O ' ' A' ' 58' ' ' ILE . 13.7 p -77.73 155.08 5.29 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.914 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.469 HG22 ' CG ' ' A' ' 27' ' ' LYS . 0.7 OUTLIER -139.12 168.66 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.11 -179.735 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.738 HD12 ' O ' ' A' ' 53' ' ' GLN . 20.6 mt -93.16 151.07 3.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.631 0.253 . . . . 0.0 111.059 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.537 ' CB ' HG13 ' B' ' 4' ' ' VAL . 2.4 t -116.01 -40.61 3.28 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.656 ' CB ' HD12 ' A' ' 25' ' ' LEU . 1.3 t0 -167.12 132.99 2.16 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 120.15 -0.62 . . . . 0.0 112.447 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.907 HD23 ' HB3' ' A' ' 24' ' ' PHE . 56.4 mt -69.05 77.29 0.33 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.46 0.648 . . . . 0.0 109.797 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.568 HD13 ' HG ' ' A' ' 25' ' ' LEU . 1.4 tp -33.28 -59.16 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -177.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.465 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -94.25 -65.88 0.96 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.198 0.523 . . . . 0.0 111.797 -178.263 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.488 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 105.84 13.97 22.37 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.634 -178.061 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.403 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -117.93 -25.86 2.93 Favored Glycine 0 C--N 1.341 0.812 0 C-N-CA 121.022 -0.609 . . . . 0.0 113.391 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.816 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -94.07 -83.09 0.34 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 117.777 0.789 . . . . 0.0 111.36 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.829 ' HB1' HG21 ' A' ' 52' ' ' ILE . . . -62.02 -60.34 3.76 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.187 0.518 . . . . 0.0 111.454 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.718 ' HB2' HD13 ' A' ' 40' ' ' LEU . 4.1 tp10 -48.39 -44.37 34.7 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.079 0.466 . . . . 0.0 110.803 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.403 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 5.2 tp-100 -58.62 -34.09 70.77 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.3 t -54.99 -49.68 70.87 Favored 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 115.77 -22.77 11.42 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.251 -0.976 . . . . 0.0 114.639 177.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.856 HD11 ' CD1' ' A' ' 91' ' ' LEU . 0.3 OUTLIER -99.26 -32.53 11.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.523 0.662 . . . . 0.0 110.802 -179.58 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.829 HG21 ' HB1' ' A' ' 46' ' ' ALA . 4.9 mp -72.12 115.8 13.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.143 0.497 . . . . 0.0 110.631 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.738 ' O ' HD12 ' A' ' 37' ' ' ILE . 2.0 tt0 -139.41 148.79 43.27 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.851 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.423 ' CB ' ' HA ' ' A' ' 39' ' ' ASP . . . -75.57 145.76 40.97 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.242 0.544 . . . . 0.0 112.186 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.62 18.44 68.02 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.672 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -109.33 -84.11 0.55 Allowed 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 120.421 0.153 . . . . 0.0 111.348 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.613 HD11 HD21 ' A' ' 59' ' ' LEU . 2.3 tt -163.27 133.4 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.785 HD11 HG22 ' A' ' 61' ' ' VAL . 2.7 tp -155.31 96.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.443 -1.253 . . . . 0.0 107.99 177.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.613 HD21 HD11 ' A' ' 57' ' ' ILE . 2.8 mt -79.27 -68.77 0.63 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.969 -0.292 . . . . 0.0 111.637 -177.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.599 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . . . -116.43 160.15 20.97 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.01 0.433 . . . . 0.0 111.692 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.785 HG22 HD11 ' A' ' 58' ' ' ILE . 2.7 t -154.03 147.29 13.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.606 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 42.98 44.16 3.9 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.187 0.518 . . . . 0.0 111.932 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 t70 56.33 29.45 15.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.275 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.401 ' O ' ' N ' ' A' ' 66' ' ' LEU . 3.4 mmp_? -117.55 98.58 51.9 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.418 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.507 ' O ' HD23 ' A' ' 69' ' ' LEU . 38.3 Cg_exo -57.08 85.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.058 1.839 . . . . 0.0 111.464 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.55 HD21 ' HB3' ' A' ' 74' ' ' ALA . 1.2 mt -86.48 61.55 6.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.412 0.625 . . . . 0.0 110.462 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.497 HG12 ' HB3' ' A' ' 34' ' ' PRO . 2.8 m -113.81 -47.73 5.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.24 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -145.88 23.77 1.37 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.608 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.748 HD21 ' HB2' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -96.77 173.38 7.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.649 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.645 ' H ' HD12 ' A' ' 69' ' ' LEU . 49.2 m -64.22 99.64 0.29 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.734 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 5.8 t80 -42.36 -58.72 2.09 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.307 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -58.13 -32.49 68.19 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.32 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.901 ' O ' HG23 ' A' ' 77' ' ' VAL . 3.6 t -74.82 -41.7 59.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.077 0.465 . . . . 0.0 109.767 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.748 ' HB2' HD21 ' A' ' 69' ' ' LEU . . . -61.14 -40.75 94.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.308 0.575 . . . . 0.0 110.27 178.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.734 HD11 ' CZ ' ' A' ' 71' ' ' TYR . 72.5 mt -71.43 -31.89 67.73 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.016 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -74.16 -41.16 61.94 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.023 0.439 . . . . 0.0 109.934 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 73' ' ' SER . 22.0 t -59.58 -41.18 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.045 178.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.589 HD21 HD23 ' A' ' 75' ' ' LEU . 4.5 pp -82.39 -22.48 35.39 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.541 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.4 ' N ' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -65.42 -37.49 87.07 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.332 179.604 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.4 -20.4 29.75 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.896 -0.668 . . . . 0.0 113.034 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 69.0 mt -56.31 123.07 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-O 120.877 0.37 . . . . 0.0 111.103 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.05 -161.64 0.22 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.259 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.3 m -95.29 -170.19 2.13 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.678 0.275 . . . . 0.0 110.984 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 45.0 30.41 0.57 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.169 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.417 ' O ' ' CE1' ' A' ' 15' ' ' PHE . 1.8 t -127.88 158.27 38.24 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 122.024 0.916 . . . . 0.0 112.967 -178.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -99.98 176.57 5.38 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.106 -1.406 . . . . 0.0 110.374 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.801 HG12 ' C ' ' A' ' 14' ' ' LEU . 3.9 p -150.32 155.16 7.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.382 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.796 ' O ' HD23 ' A' ' 89' ' ' LEU . 5.1 t -114.81 162.34 12.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.796 HD23 ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -154.51 174.81 14.4 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 -178.747 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.678 ' O ' HD23 ' A' ' 91' ' ' LEU . 49.9 mm -134.52 131.83 54.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.856 ' CD1' HD11 ' A' ' 51' ' ' LEU . 55.6 mt -148.41 177.77 9.17 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.95 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.746 ' HB3' HG21 ' A' ' 99' ' ' THR . 0.0 OUTLIER -43.41 156.62 0.05 Allowed 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -177.802 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.872 ' HA2' HG22 ' A' ' 99' ' ' THR . . . 159.31 105.26 0.21 Allowed Glycine 0 C--N 1.348 1.21 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.097 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.486 ' N ' ' HB3' ' A' ' 8' ' ' ASN . 3.2 Cg_exo -77.31 -160.04 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.8 2.333 . . . . 0.0 113.725 -178.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -115.64 122.71 46.41 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.89 -10.16 75.71 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.068 -1.063 . . . . 0.0 110.998 -176.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.454 ' HA ' ' O ' ' A' ' 118' ' ' GLN . 10.5 m-85 -134.02 168.08 19.44 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 120.787 0.327 . . . . 0.0 110.485 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.698 HG23 ' HG3' ' A' ' 118' ' ' GLN . 0.2 OUTLIER -133.29 119.92 20.39 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.362 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.872 HG22 ' HA2' ' A' ' 93' ' ' GLY . 4.5 t -93.7 90.77 6.72 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 176.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -62.23 -90.71 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.38 -177.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -177.22 122.4 0.13 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.964 0.411 . . . . 0.0 111.78 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.454 ' HB2' HG21 ' A' ' 116' ' ' VAL . 0.6 OUTLIER 169.33 139.78 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.903 179.399 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -72.47 99.59 2.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.932 0.396 . . . . 0.0 110.751 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.479 ' O ' HG22 ' A' ' 104' ' ' THR . 7.4 m -140.26 15.17 2.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.127 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -46.82 154.24 0.34 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.951 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 m -68.81 -59.81 2.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.011 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -167.28 -104.25 0.17 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.564 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -104.21 32.5 3.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 0.0 110.893 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -118.37 -57.47 0.28 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.325 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.568 HG23 ' O ' ' A' ' 110' ' ' THR . 15.0 t -121.83 58.31 8.89 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-O 120.613 0.244 . . . . 0.0 111.292 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.46 104.08 1.69 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.323 2.015 . . . . 0.0 112.63 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.18 161.67 36.22 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.796 0.331 . . . . 0.0 111.352 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 95.7 m -70.47 -35.72 73.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.078 0.466 . . . . 0.0 110.382 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.747 HD11 ' O ' ' A' ' 99' ' ' THR . 0.0 OUTLIER -88.29 97.35 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.088 -179.171 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.418 ' O ' HG22 ' A' ' 116' ' ' VAL . 2.7 tmt_? -160.35 92.97 1.01 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.054 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.454 HG21 ' HB2' ' A' ' 102' ' ' GLU . 0.5 OUTLIER -160.36 68.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.448 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 61.6 m -76.29 119.81 20.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.203 -177.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.698 ' HG3' HG23 ' A' ' 98' ' ' THR . 7.0 pt20 -130.35 139.49 35.77 Favored Pre-proline 0 C--O 1.222 -0.349 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.099 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.81 136.13 40.7 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.153 1.902 . . . . 0.0 112.791 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.499 ' CD2' HG22 ' A' ' 98' ' ' THR . 0.0 OUTLIER -98.34 -60.86 1.47 Allowed 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.637 179.204 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 115.09 -77.98 0.27 Allowed Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.933 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -73.77 154.05 48.64 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.434 2.089 . . . . 0.0 113.153 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -74.13 -165.99 0.3 Allowed 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.721 2.281 . . . . 0.0 112.424 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.745 HG22 ' H ' ' A' ' 126' ' ' ALA . 84.2 m -53.04 -79.12 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.592 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.02 33.18 14.96 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.968 0.413 . . . . 0.0 110.76 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.745 ' H ' HG22 ' A' ' 124' ' ' THR . . . -93.27 18.35 9.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.195 179.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.284 -0.865 . . . . 0.0 111.063 179.97 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 6.2 m . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.845 0.355 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 30.3 t -106.25 -45.72 8.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.151 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.4 ' CE ' ' HA ' ' A' ' 29' ' ' ARG . 36.7 mmtm -97.82 -69.07 0.77 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.352 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.537 HG13 ' CB ' ' A' ' 38' ' ' SER . 3.4 t -59.77 93.69 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-O 120.927 0.394 . . . . 0.0 110.823 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.51 -103.32 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.292 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.908 ' HA ' HD23 ' A' ' 25' ' ' LEU . 4.9 t 162.36 109.45 0.0 OUTLIER 'General case' 0 C--N 1.345 0.409 0 CA-C-O 121.159 0.504 . . . . 0.0 109.843 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.738 ' O ' HD12 ' A' ' 22' ' ' LEU . 27.8 m . . . . . 0 C--O 1.245 0.839 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.892 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.662 HG23 ' N ' ' A' ' 11' ' ' SER . 1.4 tp . . . . . 0 CA--C 1.544 0.723 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.749 ' HA ' HD13 ' A' ' 90' ' ' ILE . 0.7 OUTLIER -85.66 166.27 16.31 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.475 0.655 . . . . 0.0 112.536 -179.338 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.744 ' CG1' HD12 ' A' ' 89' ' ' LEU . 1.6 t -156.05 163.61 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.313 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -149.6 131.97 15.61 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.497 0.665 . . . . 0.0 110.778 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.804 HD21 ' HB2' ' A' ' 46' ' ' ALA . 0.3 OUTLIER -135.03 177.46 7.79 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.419 -179.431 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.408 ' CD1' ' O ' ' A' ' 85' ' ' THR . 4.5 t80 -124.1 151.39 43.94 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.644 ' HD3' HG21 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -81.62 27.15 0.45 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.685 179.453 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.822 ' O ' HG22 ' A' ' 19' ' ' VAL . 9.6 tpt180 43.31 31.04 0.35 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.905 0.383 . . . . 0.0 111.916 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.704 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 44.47 23.47 0.07 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.708 -178.642 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.822 HG22 ' O ' ' A' ' 17' ' ' ARG . 2.9 m -169.14 34.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 49.0 65.87 2.47 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.746 -178.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . -148.19 54.99 0.51 Allowed Glycine 0 C--N 1.331 0.29 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.104 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.909 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 4.1 mp -38.44 -26.96 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 40' ' ' LEU . . . 118.35 -4.13 15.66 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 119.954 -1.117 . . . . 0.0 113.815 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.927 ' HB3' HD23 ' A' ' 40' ' ' LEU . 5.1 p90 -152.83 144.53 23.52 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.933 HD23 ' HA ' ' B' ' 6' ' ' SER . 1.6 mt -80.19 170.21 16.74 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.3 178.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.626 HG22 ' OD1' ' B' ' 5' ' ' ASP . 29.0 m -149.32 157.59 6.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 C-N-CA 119.989 -0.685 . . . . 0.0 111.308 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.473 ' HE3' HG22 ' B' ' 4' ' ' VAL . 1.3 ptpt -135.22 104.96 6.09 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.348 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.498 ' HB3' ' CG ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -101.64 118.71 37.51 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.738 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -63.6 114.77 4.15 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 121.254 0.55 . . . . 0.0 110.379 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.6 t . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.141 179.98 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.465 ' HA ' HG22 ' A' ' 58' ' ' ILE . 1.2 tp . . . . . 0 CA--C 1.534 0.343 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.51 HG23 ' O ' ' A' ' 25' ' ' LEU . 28.0 mt -92.67 147.68 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.641 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.5 ' OG ' HG13 ' B' ' 4' ' ' VAL . 0.8 OUTLIER -113.63 -35.58 5.16 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -179.67 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.545 ' CB ' HD12 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -166.2 135.64 3.19 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 120.441 -0.504 . . . . 0.0 112.032 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.927 HD23 ' HB3' ' A' ' 24' ' ' PHE . 49.3 mt -72.92 79.28 1.16 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.671 0.748 . . . . 0.0 110.489 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.773 HD13 HD21 ' A' ' 25' ' ' LEU . 1.8 tp -32.9 -59.5 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.462 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -95.47 -67.7 0.84 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.218 0.532 . . . . 0.0 112.139 -178.142 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 106.91 26.52 5.76 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -177.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -128.31 -28.6 0.83 Allowed Glycine 0 C--N 1.339 0.722 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.73 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.909 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -94.12 -83.01 0.34 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.055 0.928 . . . . 0.0 111.582 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.804 ' HB2' HD21 ' A' ' 14' ' ' LEU . . . -65.04 -53.82 39.96 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.079 0.466 . . . . 0.0 110.9 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.668 ' CG ' HD13 ' A' ' 40' ' ' LEU . 54.1 tt0 -49.86 -47.28 51.89 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.046 0.451 . . . . 0.0 110.463 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.417 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 5.6 tp-100 -59.14 -33.2 70.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.833 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.9 t -55.19 -48.47 73.77 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.622 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.07 -21.85 28.53 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.183 -1.008 . . . . 0.0 114.288 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.944 HD13 HD11 ' A' ' 91' ' ' LEU . 0.6 OUTLIER -100.12 -3.93 30.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.574 0.687 . . . . 0.0 111.616 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.759 HG21 ' CD2' ' A' ' 24' ' ' PHE . 5.0 mp -103.93 138.87 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-O 120.83 0.347 . . . . 0.0 110.402 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -154.4 158.99 40.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.348 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.424 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -71.41 125.25 26.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.921 0.391 . . . . 0.0 111.115 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.86 14.72 73.32 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.653 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.67 ' O ' HD13 ' A' ' 57' ' ' ILE . 1.5 m-20 -92.69 -85.37 0.26 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.67 HD13 ' O ' ' A' ' 56' ' ' ASP . 18.0 mm -148.86 115.78 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -178.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.508 HG21 HG12 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -160.47 113.81 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.674 177.042 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.416 ' N ' HD13 ' A' ' 58' ' ' ILE . 1.7 tp -116.6 -67.04 1.02 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.059 0.457 . . . . 0.0 110.584 -178.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.511 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . . . -104.95 160.91 14.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.236 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.77 HG12 HD12 ' A' ' 66' ' ' LEU . 14.3 p -166.95 145.28 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.482 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.658 ' ND2' HG22 ' A' ' 61' ' ' VAL . 0.7 OUTLIER 44.86 40.0 4.0 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.031 0.444 . . . . 0.0 111.678 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.6 t70 58.67 28.14 16.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.281 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.651 ' HD3' HG11 ' A' ' 77' ' ' VAL . 15.6 mmm180 -118.07 97.51 50.8 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.572 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.839 ' O ' HD22 ' A' ' 69' ' ' LEU . 31.7 Cg_exo -57.81 86.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.032 1.821 . . . . 0.0 110.999 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.77 HD12 HG12 ' A' ' 61' ' ' VAL . 6.6 mt -72.46 62.84 0.54 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.985 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.595 HG23 ' H ' ' A' ' 68' ' ' ASP . 3.1 m -139.64 -63.57 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.595 ' H ' HG23 ' A' ' 67' ' ' VAL . 7.2 t0 -112.49 28.3 8.89 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -178.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.839 HD22 ' O ' ' A' ' 65' ' ' PRO . 0.3 OUTLIER -118.08 176.66 5.11 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.447 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.6 m -68.09 98.75 0.81 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.671 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 6.2 t80 -40.83 -55.63 2.4 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.215 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -58.16 -30.88 66.72 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.195 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.741 ' O ' HG23 ' A' ' 77' ' ' VAL . 1.6 t -75.54 -43.63 47.73 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.739 ' HB2' HD21 ' A' ' 69' ' ' LEU . . . -60.21 -38.89 84.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.417 178.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.682 HD22 ' OD2' ' B' ' 5' ' ' ASP . 63.4 mt -68.61 -30.08 68.73 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.023 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -73.32 -40.0 64.83 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 120.981 0.42 . . . . 0.0 109.943 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.741 HG23 ' O ' ' A' ' 73' ' ' SER . 14.7 t -59.87 -42.96 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.739 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.552 ' C ' HD12 ' A' ' 78' ' ' LEU . 4.2 pp -79.2 -24.79 42.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.959 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.53 ' N ' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -67.39 -48.27 67.86 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.101 0.477 . . . . 0.0 110.062 179.461 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.01 -22.9 13.84 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.978 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.644 HG21 ' HD3' ' A' ' 16' ' ' LYS . 55.6 mt -52.76 114.69 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 120.878 0.371 . . . . 0.0 111.149 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.24 -167.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.185 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.2 m -95.4 -172.33 2.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.949 0.404 . . . . 0.0 111.117 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 45.56 30.33 0.75 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.128 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.425 HG21 HG22 ' A' ' 81' ' ' ILE . 1.8 t -123.66 159.15 29.95 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.88 0.847 . . . . 0.0 112.391 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -100.49 176.44 5.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.575 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.779 HG12 ' C ' ' A' ' 14' ' ' LEU . 2.8 p -153.03 150.06 12.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.584 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.705 ' O ' HD23 ' A' ' 89' ' ' LEU . 24.0 t -111.39 156.9 12.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.744 HD12 ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -152.57 168.84 24.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.692 0.282 . . . . 0.0 111.222 -178.496 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.749 HD13 ' HA ' ' A' ' 11' ' ' SER . 47.1 mm -136.69 128.51 43.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.82 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.944 HD11 HD13 ' A' ' 51' ' ' LEU . 62.5 mt . . . . . 0 CA--C 1.511 -0.525 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 176.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.614 HG11 HD13 ' A' ' 25' ' ' LEU . 21.8 t . . . . . 0 CA--C 1.521 -0.154 0 CA-C-O 120.785 0.326 . . . . 0.0 110.844 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' ASP . . . . . 0.682 ' OD2' HD22 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -104.32 131.87 51.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.515 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.933 ' HA ' HD23 ' A' ' 25' ' ' LEU . 8.5 p -85.34 119.6 25.89 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.339 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.801 ' O ' HD12 ' A' ' 22' ' ' LEU . 26.5 m . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.326 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.613 HG23 ' N ' ' A' ' 11' ' ' SER . 0.7 OUTLIER . . . . . 0 CA--C 1.535 0.394 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.701 ' HA ' HD13 ' A' ' 90' ' ' ILE . 17.8 p -93.42 171.31 8.99 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.05 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.651 ' CG2' HD12 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -158.74 173.62 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.932 -179.594 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 4.4 ptt85 -153.19 134.67 14.35 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.262 0.553 . . . . 0.0 111.013 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.912 ' HB3' HD23 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -131.67 145.43 51.65 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.279 -179.535 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.479 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 2.3 t80 -87.11 148.28 25.29 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.65 ' HE2' HD12 ' A' ' 81' ' ' ILE . 2.0 tptt -84.34 27.67 0.68 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.058 178.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.908 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.1 OUTLIER 45.51 29.43 0.62 Allowed 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 178.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.593 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 43.5 24.77 0.06 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.074 0.55 . . . . 0.0 112.476 -178.348 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.908 HG22 ' O ' ' A' ' 17' ' ' ARG . 10.7 m -165.81 32.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.785 178.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 48.54 66.9 1.87 Allowed Glycine 0 C--N 1.338 0.677 0 CA-C-N 115.733 -0.667 . . . . 0.0 113.02 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -152.26 65.25 0.36 Allowed Glycine 0 C--N 1.333 0.364 0 N-CA-C 111.698 -0.561 . . . . 0.0 111.698 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.912 HD23 ' HB3' ' A' ' 14' ' ' LEU . 4.2 mp -48.2 -24.55 1.19 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 40' ' ' LEU . . . 112.6 7.41 22.3 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.241 -0.981 . . . . 0.0 113.578 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.924 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -160.06 139.56 11.13 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 117.98 0.89 . . . . 0.0 113.103 -179.585 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.882 HD23 ' HA ' ' B' ' 6' ' ' SER . 6.1 mt -79.69 171.31 15.31 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.391 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.0 m -153.18 152.02 10.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.016 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.429 ' HG2' HG22 ' A' ' 36' ' ' ILE . 6.8 ptmt -137.39 110.3 7.68 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.394 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.469 ' HB3' ' CG ' ' A' ' 71' ' ' TYR . 1.1 tm-20 -101.96 96.74 7.23 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.34 116.76 3.25 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.311 0.577 . . . . 0.0 111.304 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.401 ' H ' HG23 ' A' ' 30' ' ' VAL . 39.6 t . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.626 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.46 HD12 ' HA ' ' A' ' 36' ' ' ILE . 1.1 tp . . . . . 0 CA--C 1.535 0.397 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.661 HD12 ' O ' ' A' ' 53' ' ' GLN . 33.8 mt -86.18 149.48 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.115 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.859 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.54 ' CB ' HG13 ' B' ' 4' ' ' VAL . 1.7 t -114.67 -39.61 3.73 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.727 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 6.6 t0 -173.46 135.74 0.56 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.22 -0.592 . . . . 0.0 112.206 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.924 HD23 ' HB3' ' A' ' 24' ' ' PHE . 28.2 mt -70.39 99.42 1.57 Allowed 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.575 HD13 HD21 ' A' ' 25' ' ' LEU . 1.4 tp -54.05 -58.39 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -176.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.462 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.8 OUTLIER -93.2 -68.38 0.8 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.175 0.512 . . . . 0.0 112.269 -177.489 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.49 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 112.01 18.14 7.97 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.618 -178.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.4 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -126.08 -28.0 1.07 Allowed Glycine 0 C--N 1.34 0.786 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.737 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.772 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -93.72 -83.11 0.33 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 117.914 0.857 . . . . 0.0 111.308 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.842 ' HB1' HG21 ' A' ' 52' ' ' ILE . . . -62.18 -60.36 3.7 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.5 0.667 . . . . 0.0 111.317 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.631 ' HB2' HD22 ' A' ' 40' ' ' LEU . 17.5 tp10 -48.77 -39.63 25.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.71 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.4 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 11.4 tp-100 -61.77 -36.2 80.36 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.3 t -54.06 -47.42 71.67 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.401 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.11 -20.27 33.49 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.302 -0.951 . . . . 0.0 113.905 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.62 ' CD1' HG11 ' A' ' 12' ' ' VAL . 0.1 OUTLIER -94.74 -31.01 13.97 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.899 0.38 . . . . 0.0 110.178 179.588 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.842 HG21 ' HB1' ' A' ' 46' ' ' ALA . 2.6 mp -80.44 119.6 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.064 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.661 ' O ' HD12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -152.52 155.77 38.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.178 179.756 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.727 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -67.98 123.79 21.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.914 0.388 . . . . 0.0 110.875 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.25 2.99 90.73 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.246 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -83.25 -88.94 0.09 Allowed 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 116.997 0.399 . . . . 0.0 110.981 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.6 tp -162.68 126.23 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.907 HD11 HG22 ' A' ' 61' ' ' VAL . 3.2 tp -149.76 87.99 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.074 177.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.3 tp -81.68 -66.35 0.9 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.721 -178.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.15 158.43 25.94 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.697 0.284 . . . . 0.0 111.594 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.907 HG22 HD11 ' A' ' 58' ' ' ILE . 3.3 t -153.36 148.64 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.967 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.467 HD22 HG12 ' A' ' 61' ' ' VAL . 1.2 p30 44.28 46.67 7.68 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.162 0.506 . . . . 0.0 111.756 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.0 t70 51.99 26.65 3.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.787 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.735 ' HD3' HG11 ' A' ' 77' ' ' VAL . 12.1 mmm180 -111.59 113.79 53.0 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.826 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.685 ' O ' HD22 ' A' ' 69' ' ' LEU . 31.5 Cg_exo -59.22 84.84 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 121.772 1.648 . . . . 0.0 110.733 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.508 HD12 HD21 ' A' ' 69' ' ' LEU . 12.7 tp -86.83 66.77 9.59 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.354 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.503 HG23 ' H ' ' A' ' 68' ' ' ASP . 3.2 m -128.61 -55.19 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.665 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.503 ' H ' HG23 ' A' ' 67' ' ' VAL . 17.5 t70 -140.1 26.03 2.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.788 0.328 . . . . 0.0 111.648 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.955 HD11 ' HB2' ' A' ' 74' ' ' ALA . 1.4 pt? -94.92 -175.91 3.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.322 -0.399 . . . . 0.0 109.959 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.1 m -71.89 101.52 2.68 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 177.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.882 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 6.5 t80 -40.54 -58.23 1.64 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -178.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -59.36 -26.59 65.2 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.159 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.887 ' O ' HG23 ' A' ' 77' ' ' VAL . 16.3 t -76.21 -42.0 47.58 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.179 0.514 . . . . 0.0 109.95 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.955 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -66.94 -36.92 83.32 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.797 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.882 HD11 ' CZ ' ' A' ' 71' ' ' TYR . 51.0 mt -70.9 -29.64 65.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.162 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -76.75 -37.84 55.25 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.085 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.887 HG23 ' O ' ' A' ' 73' ' ' SER . 11.0 t -62.89 -43.49 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.401 ' CD2' ' HA ' ' A' ' 75' ' ' LEU . 1.2 pp -73.81 -26.85 60.83 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.25 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.468 ' NH1' HG12 ' B' ' 7' ' ' VAL . 0.0 OUTLIER -64.24 -35.49 81.0 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.0 0.428 . . . . 0.0 110.122 179.509 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.97 -19.71 59.26 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.817 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.65 HD12 ' HE2' ' A' ' 16' ' ' LYS . 68.5 mt -58.86 105.63 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-O 120.869 0.366 . . . . 0.0 110.692 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.6 -165.83 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.666 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.5 -171.41 2.37 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.053 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 43.77 31.67 0.5 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.31 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.411 ' O ' ' CD1' ' A' ' 15' ' ' PHE . 1.8 t -128.71 162.4 27.48 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.775 0.798 . . . . 0.0 112.878 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -104.86 176.09 5.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.004 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.568 HG21 ' NZ ' ' A' ' 16' ' ' LYS . 0.5 OUTLIER -146.98 159.21 9.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.036 -179.554 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.606 ' C ' HD23 ' A' ' 89' ' ' LEU . 39.3 t -118.84 158.59 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.651 HD12 ' CG2' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -160.23 169.63 22.83 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.758 0.314 . . . . 0.0 110.835 -178.301 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.701 HD13 ' HA ' ' A' ' 11' ' ' SER . 47.7 mm -129.45 130.81 67.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.391 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.409 HD11 HD12 ' A' ' 51' ' ' LEU . 8.5 mt . . . . . 0 CA--C 1.517 -0.317 0 CA-C-N 115.478 -0.783 . . . . 0.0 108.978 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.54 HG13 ' CB ' ' A' ' 38' ' ' SER . 19.8 t . . . . . 0 CA--C 1.521 -0.143 0 CA-C-O 120.952 0.406 . . . . 0.0 110.584 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -98.65 129.55 45.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.907 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.882 ' HA ' HD23 ' A' ' 25' ' ' LEU . 8.8 p -83.42 129.24 34.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.39 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.683 ' OXT' HD12 ' A' ' 22' ' ' LEU . 17.2 m . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.133 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.628 HG23 ' N ' ' A' ' 11' ' ' SER . 1.4 tp . . . . . 0 CA--C 1.536 0.442 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.697 ' HA ' HD13 ' A' ' 90' ' ' ILE . 8.0 p -92.18 164.48 13.55 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.555 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.81 ' CG1' HD12 ' A' ' 89' ' ' LEU . 2.3 t -154.14 158.83 3.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.594 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.8 ttp-105 -140.24 144.11 36.33 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.552 0.691 . . . . 0.0 111.103 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.832 HD21 ' HB2' ' A' ' 46' ' ' ALA . 0.5 OUTLIER -141.09 177.72 7.88 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.283 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.431 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 3.2 t80 -124.19 148.68 47.09 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.412 ' O ' ' N ' ' A' ' 20' ' ' GLY . 12.6 mtpt -83.77 30.89 0.48 Allowed 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.183 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.896 ' O ' HG22 ' A' ' 19' ' ' VAL . 2.2 mmm180 40.78 31.24 0.11 Allowed 'General case' 0 C--N 1.347 0.46 0 CA-C-O 121.086 0.47 . . . . 0.0 111.887 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.621 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 43.85 24.68 0.07 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.456 -178.391 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.896 HG22 ' O ' ' A' ' 17' ' ' ARG . 9.8 m -166.11 32.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.035 178.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 50.56 64.54 3.59 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.943 -178.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -148.23 66.18 0.4 Allowed Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.826 ' CD2' HG11 ' A' ' 87' ' ' VAL . 4.4 mp -49.5 -23.22 1.49 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.459 ' HA2' HG22 ' A' ' 41' ' ' ILE . . . 106.41 8.27 33.38 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.167 -1.016 . . . . 0.0 112.847 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.874 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -160.23 140.4 11.54 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 117.658 0.729 . . . . 0.0 112.483 -179.655 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.728 HD23 ' N ' ' B' ' 6' ' ' SER . 14.1 mt -79.05 166.61 22.13 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.909 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.5 m -151.78 143.81 16.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.268 177.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.7 tttp -136.41 120.9 18.2 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.907 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.598 ' HG3' HD22 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -113.62 112.01 22.79 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.521 178.488 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.61 124.26 21.89 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.904 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.0 t . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.162 -179.496 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 36' ' ' ILE . 1.5 tp . . . . . 0 CA--C 1.533 0.298 0 CA-C-O 120.574 0.226 . . . . 0.0 111.373 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.696 HD12 ' O ' ' A' ' 53' ' ' GLN . 17.2 mt -79.53 141.46 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.981 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.559 ' CB ' HG13 ' B' ' 4' ' ' VAL . 1.9 t -106.24 -39.21 6.01 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.575 ' HB3' HD12 ' A' ' 25' ' ' LEU . 35.8 t0 -175.23 144.02 0.7 Allowed 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.874 HD23 ' HB3' ' A' ' 24' ' ' PHE . 38.1 mt -76.02 101.2 5.17 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.33 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.557 HD13 ' HB2' ' B' ' 6' ' ' SER . 0.8 OUTLIER -56.65 -59.22 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -176.525 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.46 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -93.02 -65.73 0.98 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -177.465 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.448 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 110.36 21.49 6.9 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.51 -178.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.94 -28.12 0.89 Allowed Glycine 0 C--N 1.339 0.741 0 C-N-CA 120.825 -0.702 . . . . 0.0 113.704 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.761 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -93.39 -83.17 0.33 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 117.996 0.898 . . . . 0.0 111.727 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.992 ' HB1' HG21 ' A' ' 52' ' ' ILE . . . -64.17 -58.56 6.23 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.327 0.584 . . . . 0.0 111.046 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.672 ' HB2' HD22 ' A' ' 40' ' ' LEU . 12.1 tp10 -48.77 -42.61 36.16 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.725 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -61.57 -35.12 76.9 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.529 ' HB2' HD13 ' A' ' 52' ' ' ILE . 2.8 m -53.84 -49.92 67.35 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.97 178.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 113.52 -31.74 6.46 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.212 -0.994 . . . . 0.0 114.337 178.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.779 HD12 ' O ' ' A' ' 51' ' ' LEU . 1.9 pp -98.63 11.46 38.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.675 0.737 . . . . 0.0 111.715 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.992 HG21 ' HB1' ' A' ' 46' ' ' ALA . 4.6 mp -113.28 88.42 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-O 121.016 0.436 . . . . 0.0 110.478 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.696 ' O ' HD12 ' A' ' 37' ' ' ILE . 2.2 tp60 -112.69 148.11 35.37 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.611 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.557 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -70.39 140.88 52.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.046 0.45 . . . . 0.0 111.967 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.96 19.09 69.47 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.089 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -105.69 -81.49 0.54 Allowed 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.495 ' CG2' HD13 ' A' ' 91' ' ' LEU . 28.7 mm -152.51 125.92 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 121.503 0.668 . . . . 0.0 112.536 -177.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.568 ' O ' HG23 ' A' ' 58' ' ' ILE . 2.3 tp -161.21 76.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.469 177.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.544 ' CD1' HG12 ' A' ' 67' ' ' VAL . 5.2 tp -78.69 -63.15 1.48 Allowed 'General case' 0 C--N 1.328 -0.354 0 O-C-N 122.177 -0.327 . . . . 0.0 111.581 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.638 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . . . -109.51 149.97 28.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.859 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.565 HG22 HD11 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -160.92 143.4 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.473 -179.371 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.427 ' HB3' HD11 ' A' ' 81' ' ' ILE . 53.2 m-80 60.89 33.72 19.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.19 0.519 . . . . 0.0 111.879 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 57.91 21.29 7.48 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 178.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.754 ' NH2' HD12 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -121.55 124.55 27.14 Favored Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 120.631 -0.428 . . . . 0.0 109.909 177.586 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.796 ' O ' HD22 ' A' ' 69' ' ' LEU . 19.2 Cg_endo -58.16 88.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 122.205 1.936 . . . . 0.0 112.117 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.754 HD12 ' NH2' ' A' ' 64' ' ' ARG . 0.6 OUTLIER -87.43 67.52 9.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.304 0.573 . . . . 0.0 109.762 179.566 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.544 HG12 ' CD1' ' A' ' 59' ' ' LEU . 3.1 m -126.06 -59.08 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -178.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.513 ' H ' HG23 ' A' ' 67' ' ' VAL . 2.0 p30 -131.47 25.51 4.79 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.796 HD22 ' O ' ' A' ' 65' ' ' PRO . 1.6 pt? -102.5 -172.68 2.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.811 0.338 . . . . 0.0 110.457 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.82 111.47 9.0 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.558 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 8.0 t80 -43.95 -47.52 8.5 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.902 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -67.68 -32.48 73.18 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.17 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.785 ' O ' HG23 ' A' ' 77' ' ' VAL . 3.1 m -70.67 -36.27 73.26 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.341 0.591 . . . . 0.0 109.851 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.635 ' HB1' ' HG ' ' A' ' 66' ' ' LEU . . . -66.09 -49.92 65.89 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.477 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.558 HD11 ' CZ ' ' A' ' 71' ' ' TYR . 48.4 mt -63.42 -28.07 69.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.49 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -71.36 -40.27 70.74 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 73' ' ' SER . 40.6 t -58.38 -42.31 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.61 178.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.565 ' O ' HD12 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -72.07 -35.28 69.23 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.197 178.774 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.91 -37.12 68.47 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.023 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -58.97 -19.98 47.05 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.84 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.548 HG22 HG21 ' A' ' 85' ' ' THR . 55.9 mt -66.36 119.43 11.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.938 0.399 . . . . 0.0 111.231 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.65 -162.16 0.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.13 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.5 m -94.76 -171.36 2.44 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.633 0.254 . . . . 0.0 110.739 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 44.61 30.99 0.57 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.929 0.395 . . . . 0.0 111.207 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.548 HG21 HG22 ' A' ' 81' ' ' ILE . 3.1 t -125.81 161.88 26.38 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.956 0.884 . . . . 0.0 112.908 -178.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.15 176.52 5.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.231 -1.35 . . . . 0.0 110.504 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.826 HG11 ' CD2' ' A' ' 22' ' ' LEU . 6.3 p -147.65 153.53 11.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.864 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.759 ' O ' HD23 ' A' ' 89' ' ' LEU . 25.3 t -113.83 159.72 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.585 0.231 . . . . 0.0 110.65 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.81 HD12 ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -153.15 158.97 42.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.797 0.332 . . . . 0.0 110.932 -178.883 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.697 HD13 ' HA ' ' A' ' 11' ' ' SER . 46.9 mm -131.82 124.19 53.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.19 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.495 HD13 ' CG2' ' A' ' 57' ' ' ILE . 0.2 OUTLIER . . . . . 0 CA--C 1.52 -0.209 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.291 178.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.559 HG13 ' CB ' ' A' ' 38' ' ' SER . 13.2 t . . . . . 0 N--CA 1.461 0.116 0 CA-C-O 120.76 0.314 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' ASP . . . . . 0.551 ' HB3' HG13 ' B' ' 7' ' ' VAL . 29.8 m-20 -146.75 124.95 12.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.308 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.728 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -59.48 -58.66 7.65 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.04 179.33 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.551 HG13 ' HB3' ' B' ' 5' ' ' ASP . 31.8 m . . . . . 0 C--O 1.251 1.153 0 CA-C-O 118.389 -0.815 . . . . 0.0 112.808 178.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.521 HD12 ' N ' ' A' ' 10' ' ' ILE . 2.1 mp . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.322 0.582 . . . . 0.0 111.762 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.796 ' HA ' HD13 ' A' ' 90' ' ' ILE . 0.2 OUTLIER -97.18 169.92 9.46 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.372 -179.832 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.628 ' HB ' HD12 ' A' ' 89' ' ' LEU . 0.7 OUTLIER -156.85 163.33 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.089 -178.131 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.16 120.97 7.58 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.494 0.664 . . . . 0.0 110.584 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.732 HD21 HG12 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -123.39 178.19 5.27 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.578 -179.64 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.47 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 2.5 t80 -119.31 150.04 40.8 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.412 ' CE ' ' HA2' ' A' ' 20' ' ' GLY . 14.3 mtpt -86.36 28.71 0.82 Allowed 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.066 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.864 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 43.81 30.76 0.41 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.968 0.413 . . . . 0.0 111.925 179.532 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.651 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 44.33 23.3 0.06 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.952 -178.716 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.864 HG22 ' O ' ' A' ' 17' ' ' ARG . 4.0 m -166.41 33.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.412 ' HA2' ' CE ' ' A' ' 16' ' ' LYS . . . 49.54 66.57 2.19 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-N 115.435 -0.802 . . . . 0.0 113.088 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -148.07 61.19 0.45 Allowed Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.821 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 4.4 mp -46.91 -26.78 1.06 Allowed 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.434 ' HA2' HG22 ' A' ' 41' ' ' ILE . . . 112.36 5.1 24.92 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.3 -0.953 . . . . 0.0 113.915 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.946 ' HB3' HD23 ' A' ' 40' ' ' LEU . 1.2 p90 -155.95 141.22 17.54 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.237 1.018 . . . . 0.0 113.284 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.806 HD23 ' HA ' ' B' ' 6' ' ' SER . 7.8 mt -79.56 168.22 19.7 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.038 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.5 m -149.01 147.21 16.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.737 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.0 ttpt -129.34 118.93 23.03 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.01 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.48 ' HB3' ' CD1' ' A' ' 71' ' ' TYR . 4.1 tm-20 -114.14 97.19 6.21 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.79 -1.095 . . . . 0.0 108.541 177.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.04 120.23 7.66 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.049 0.452 . . . . 0.0 110.932 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.444 -179.84 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.417 HD12 ' HA ' ' A' ' 36' ' ' ILE . 1.1 tp . . . . . 0 CA--C 1.537 0.461 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.542 HD12 ' O ' ' A' ' 53' ' ' GLN . 27.8 mt -84.29 141.25 14.95 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 CA-C-O 120.708 0.29 . . . . 0.0 110.71 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.796 ' CB ' HG13 ' B' ' 4' ' ' VAL . 0.1 OUTLIER -108.89 -36.64 6.06 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -179.833 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.639 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 4.9 t70 -169.21 132.61 1.32 Allowed 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.319 -0.552 . . . . 0.0 112.381 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.946 HD23 ' HB3' ' A' ' 24' ' ' PHE . 54.1 mt -70.26 78.49 0.53 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 121.701 0.762 . . . . 0.0 109.876 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.75 HD13 HD21 ' A' ' 25' ' ' LEU . 1.7 tp -33.06 -58.85 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 -177.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.461 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -94.42 -68.88 0.78 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -177.706 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.425 ' HA2' ' CB ' ' A' ' 47' ' ' GLU . . . 108.7 25.59 5.65 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -178.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.38 -34.08 0.51 Allowed Glycine 0 C--N 1.337 0.609 0 C-N-CA 121.145 -0.55 . . . . 0.0 113.182 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.821 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -92.74 -80.43 0.37 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 117.546 0.673 . . . . 0.0 110.908 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.787 ' HB1' ' CG2' ' A' ' 52' ' ' ILE . . . -60.29 -58.04 10.21 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.222 0.534 . . . . 0.0 111.389 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.425 ' CB ' ' HA2' ' A' ' 43' ' ' GLY . 39.2 tt0 -48.7 -46.92 41.27 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.83 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.6 tp-100 -57.87 -33.85 69.14 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.874 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.1 t -55.05 -52.16 64.04 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.752 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 112.27 -22.58 17.64 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.299 -0.953 . . . . 0.0 113.859 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.488 ' HG ' HD12 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -97.07 -28.2 14.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.955 0.377 . . . . 0.0 110.728 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.787 ' CG2' ' HB1' ' A' ' 46' ' ' ALA . 2.3 mp -82.37 121.28 35.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.025 0.441 . . . . 0.0 110.328 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.619 ' HA ' HD11 ' A' ' 40' ' ' LEU . 1.5 mt-30 -153.74 156.45 37.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.101 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.639 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -66.52 120.06 12.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.877 0.37 . . . . 0.0 110.954 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.0 -1.73 88.43 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.294 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.34 -91.34 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 117.011 0.406 . . . . 0.0 110.511 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.87 ' CG2' HD13 ' A' ' 91' ' ' LEU . 2.8 tp -163.98 120.5 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.592 ' O ' HG23 ' A' ' 58' ' ' ILE . 2.0 tp -140.14 88.67 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 18.2 tp -78.33 -70.3 0.5 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.598 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -121.16 165.46 15.35 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.803 0.335 . . . . 0.0 111.109 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.581 HG22 HD11 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -148.3 157.23 8.26 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.267 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.128 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.54 ' HA ' HG22 ' A' ' 87' ' ' VAL . 0.0 OUTLIER 56.71 -81.21 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.046 0.538 . . . . 0.0 110.214 -178.589 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 61' ' ' VAL . 14.5 p-10 -175.22 36.99 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.344 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.673 ' NH1' ' HB1' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -124.08 130.32 24.43 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.24 179.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.504 ' O ' HD22 ' A' ' 69' ' ' LEU . 17.1 Cg_exo -63.58 86.41 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 121.206 1.27 . . . . 0.0 110.322 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.677 ' HG ' ' HB1' ' A' ' 74' ' ' ALA . 0.3 OUTLIER -86.71 68.21 10.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.286 0.565 . . . . 0.0 110.916 -178.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.572 HG23 ' H ' ' A' ' 68' ' ' ASP . 2.7 m -131.62 -61.53 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.572 ' H ' HG23 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -127.73 28.33 5.63 Favored 'General case' 0 C--N 1.333 -0.13 0 O-C-N 121.978 -0.451 . . . . 0.0 111.735 -178.644 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' A' ' 74' ' ' ALA . 1.6 pt? -99.85 -172.06 2.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.498 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.32 114.63 15.22 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.642 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 4.0 t80 -44.2 -50.98 8.54 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -64.81 -29.11 70.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.339 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.835 ' O ' HG23 ' A' ' 77' ' ' VAL . 39.0 t -71.23 -40.57 71.0 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.278 0.561 . . . . 0.0 110.048 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.677 ' HB1' ' HG ' ' A' ' 66' ' ' LEU . . . -65.77 -45.17 83.52 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.368 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.642 HD11 ' CZ ' ' A' ' 71' ' ' TYR . 73.9 mt -63.69 -28.73 70.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.868 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -76.41 -36.09 58.24 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.812 0.339 . . . . 0.0 110.177 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.835 HG23 ' O ' ' A' ' 73' ' ' SER . 10.8 t -61.36 -41.43 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.795 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.565 HD21 HG11 ' B' ' 7' ' ' VAL . 0.6 OUTLIER -76.31 -32.15 58.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.511 179.071 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.443 ' NH1' HG12 ' B' ' 7' ' ' VAL . 0.0 OUTLIER -62.32 -32.16 72.88 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.795 -179.468 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.26 -17.59 61.81 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.715 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.478 HD11 ' HB3' ' A' ' 62' ' ' ASN . 29.5 mt -63.25 136.77 25.68 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 CA-C-O 120.867 0.365 . . . . 0.0 110.828 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.46 -165.42 0.78 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.507 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.43 -172.12 2.27 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.098 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 38.0 34.67 0.07 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.105 0.562 . . . . 0.0 111.5 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.416 ' O ' ' CE1' ' A' ' 15' ' ' PHE . 1.8 t -126.37 163.63 22.86 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.925 0.869 . . . . 0.0 113.21 -177.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.3 177.33 5.74 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 114.158 -1.383 . . . . 0.0 110.051 179.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.732 HG12 ' C ' ' A' ' 14' ' ' LEU . 2.3 p -150.77 145.98 16.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.338 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.896 ' O ' HD23 ' A' ' 89' ' ' LEU . 21.2 t -101.9 159.3 4.23 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.015 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.896 HD23 ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -155.16 165.91 35.23 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.319 -179.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.796 HD13 ' HA ' ' A' ' 11' ' ' SER . 29.6 mm -132.58 130.31 59.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.188 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.87 HD13 ' CG2' ' A' ' 57' ' ' ILE . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.024 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.796 HG13 ' CB ' ' A' ' 38' ' ' SER . 3.5 t . . . . . 0 N--CA 1.465 0.322 0 CA-C-O 120.878 0.371 . . . . 0.0 111.963 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' ASP . . . . . 0.53 ' O ' HD22 ' A' ' 25' ' ' LEU . 0.9 OUTLIER 58.21 -124.6 1.5 Allowed 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 119.44 -0.314 . . . . 0.0 110.348 179.876 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.806 ' HA ' HD23 ' A' ' 25' ' ' LEU . 5.8 p 167.8 127.91 0.01 OUTLIER 'General case' 0 C--N 1.347 0.475 0 CA-C-N 118.605 0.639 . . . . 0.0 110.336 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.565 HG11 HD21 ' A' ' 78' ' ' LEU . 4.5 m . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.232 -0.89 . . . . 0.0 111.251 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.59 HG23 ' N ' ' A' ' 11' ' ' SER . 0.5 OUTLIER . . . . . 0 CA--C 1.537 0.473 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.633 ' HA ' HD13 ' A' ' 90' ' ' ILE . 13.9 m -77.37 167.76 21.15 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -178.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.829 ' CG1' HD12 ' A' ' 89' ' ' LEU . 1.9 t -157.87 157.83 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 114.083 -1.417 . . . . 0.0 107.894 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.465 ' O ' HD12 ' A' ' 14' ' ' LEU . 11.3 ttp180 -141.69 141.92 33.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.406 0.622 . . . . 0.0 111.727 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.905 HD21 ' HB2' ' A' ' 46' ' ' ALA . 0.8 OUTLIER -142.96 177.44 8.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.876 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.444 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 3.5 t80 -124.49 147.86 48.08 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.659 ' HE3' HD11 ' A' ' 22' ' ' LEU . 1.5 mtpt -84.12 32.62 0.49 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.481 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.795 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.3 OUTLIER 40.53 32.13 0.13 Allowed 'General case' 0 C--N 1.344 0.343 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 179.222 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.72 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 45.0 24.66 0.12 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.551 -178.497 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.795 HG22 ' O ' ' A' ' 17' ' ' ARG . 1.6 m -169.23 34.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.317 178.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 49.94 63.91 3.89 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 115.56 -0.746 . . . . 0.0 113.062 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -145.97 62.22 0.47 Allowed Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.844 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 4.1 mp -46.24 -24.83 0.52 Allowed 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -178.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.473 ' HA2' HG22 ' A' ' 41' ' ' ILE . . . 107.96 6.99 31.8 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.039 -1.076 . . . . 0.0 113.587 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.909 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -157.15 140.78 15.87 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -178.92 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.808 HD23 ' HA ' ' B' ' 6' ' ' SER . 7.3 mt -79.92 171.06 15.62 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.671 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.5 m -149.85 153.2 10.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.506 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.2 105.13 5.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.479 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.493 ' HB3' ' CG ' ' A' ' 71' ' ' TYR . 0.6 OUTLIER -108.44 139.22 43.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.076 178.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.7 mtt-85 -76.6 124.5 27.71 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.05 0.453 . . . . 0.0 110.37 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.7 t . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.042 -179.648 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.43 HD12 ' HA ' ' A' ' 36' ' ' ILE . 1.4 tp . . . . . 0 CA--C 1.537 0.448 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.8 HD12 ' O ' ' A' ' 53' ' ' GLN . 24.2 mt -81.27 145.93 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.464 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.458 ' CB ' HG13 ' B' ' 4' ' ' VAL . 4.9 t -109.32 -40.58 4.88 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.702 ' CB ' HD12 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -164.9 131.78 2.98 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.863 -179.452 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.909 HD23 ' HB3' ' A' ' 24' ' ' PHE . 43.1 mt -70.14 76.74 0.51 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.712 0.767 . . . . 0.0 109.698 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.476 ' CD1' HD21 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -30.58 -59.16 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -177.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.46 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -94.44 -66.25 0.93 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -177.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.421 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 104.65 23.5 7.86 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -177.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.444 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -125.45 -30.1 0.94 Allowed Glycine 0 C--N 1.338 0.687 0 C-N-CA 121.24 -0.505 . . . . 0.0 113.159 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.844 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -95.84 -83.25 0.37 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 117.686 0.743 . . . . 0.0 111.932 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.905 ' HB2' HD21 ' A' ' 14' ' ' LEU . . . -59.95 -58.79 7.03 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.207 0.527 . . . . 0.0 111.04 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.421 ' HB3' ' HA2' ' A' ' 43' ' ' GLY . 33.9 tt0 -45.06 -49.42 11.55 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.971 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' A' ' 44' ' ' GLY . 7.6 mt-30 -55.65 -39.04 70.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.493 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.42 -49.9 63.61 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.343 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.4 -26.99 13.21 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.301 -0.952 . . . . 0.0 113.746 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.987 HD13 HD11 ' A' ' 91' ' ' LEU . 2.1 pp -95.65 -0.98 51.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.107 0.453 . . . . 0.0 111.471 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.866 HG21 ' HB1' ' A' ' 46' ' ' ALA . 5.0 mp -109.79 123.99 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.8 ' O ' HD12 ' A' ' 37' ' ' ILE . 1.7 mp0 -150.93 160.12 44.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.735 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.49 129.81 40.74 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.925 0.393 . . . . 0.0 111.265 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.35 13.73 63.13 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.101 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.27 -80.84 0.39 Allowed 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 22.4 mt -155.24 122.7 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.567 HD11 ' HB ' ' A' ' 61' ' ' VAL . 3.2 tp -160.25 71.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 114.867 -1.061 . . . . 0.0 109.222 177.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.47 HD11 HG11 ' A' ' 67' ' ' VAL . 9.2 tp -76.93 -54.13 6.97 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.643 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.642 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . . . -121.08 160.04 24.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.835 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.692 HG12 HD12 ' A' ' 66' ' ' LEU . 14.4 p -166.75 146.05 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.043 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.635 ' ND2' HG22 ' A' ' 61' ' ' VAL . 0.1 OUTLIER 45.76 41.13 7.15 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.198 0.523 . . . . 0.0 111.56 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.4 t70 59.74 28.44 17.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.221 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.49 ' NH2' HG21 ' A' ' 77' ' ' VAL . 25.5 mmm180 -119.61 98.24 49.93 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.572 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.4 ' O ' HD22 ' A' ' 69' ' ' LEU . 22.4 Cg_endo -61.27 85.37 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 121.811 1.674 . . . . 0.0 110.896 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.692 HD12 HG12 ' A' ' 61' ' ' VAL . 13.4 mt -68.75 63.69 0.11 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.508 -178.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.552 HG23 ' H ' ' A' ' 68' ' ' ASP . 3.4 m -141.81 -61.09 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.552 ' H ' HG23 ' A' ' 67' ' ' VAL . 16.4 t0 -111.7 29.38 7.9 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 122.127 -0.358 . . . . 0.0 111.736 -178.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.665 HD21 ' HB2' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -123.19 175.31 6.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.644 179.598 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.5 m -72.66 102.33 3.28 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.748 ' CE1' HD11 ' A' ' 75' ' ' LEU . 8.5 t80 -40.14 -60.99 0.95 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.363 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.515 ' HA ' HD12 ' A' ' 75' ' ' LEU . 6.8 p30 -55.49 -28.42 54.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.404 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.886 ' O ' HG23 ' A' ' 77' ' ' VAL . 43.8 m -78.07 -39.94 40.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.087 0.47 . . . . 0.0 109.856 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.665 ' HB2' HD21 ' A' ' 69' ' ' LEU . . . -60.47 -34.73 74.46 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.294 0.568 . . . . 0.0 109.944 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.748 HD11 ' CE1' ' A' ' 71' ' ' TYR . 15.1 mt -75.02 -38.04 61.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.242 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.41 ' HA ' ' HB2' ' A' ' 79' ' ' ARG . 5.0 pt-20 -72.07 -38.73 69.39 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.98 0.419 . . . . 0.0 110.19 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.886 HG23 ' O ' ' A' ' 73' ' ' SER . 45.1 t -62.33 -42.93 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.772 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.541 ' C ' HD12 ' A' ' 78' ' ' LEU . 4.5 pp -79.85 -21.91 43.55 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.12 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.535 ' N ' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -66.77 -37.18 84.08 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-O 120.988 0.423 . . . . 0.0 110.335 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -58.27 -19.07 38.07 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.192 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.406 ' HB ' ' HD2' ' A' ' 16' ' ' LYS . 70.8 mt -54.27 121.99 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 120.953 0.406 . . . . 0.0 111.006 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.77 -163.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.653 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.3 m -96.42 -171.67 2.34 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.996 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 44.08 30.82 0.46 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.232 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.404 ' O ' ' CE1' ' A' ' 15' ' ' PHE . 1.7 t -125.37 158.76 33.48 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 122.046 0.927 . . . . 0.0 112.737 -178.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.34 176.28 5.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.969 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.806 HG12 ' C ' ' A' ' 14' ' ' LEU . 4.8 p -148.66 153.14 11.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.22 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.726 ' O ' HD23 ' A' ' 89' ' ' LEU . 34.1 t -113.56 160.43 13.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.829 HD12 ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -155.89 172.64 18.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.64 0.257 . . . . 0.0 110.597 -178.736 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.642 ' HB ' ' HB3' ' A' ' 60' ' ' ALA . 29.6 mm -137.25 126.37 35.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.987 HD11 HD13 ' A' ' 51' ' ' LEU . 11.6 mt . . . . . 0 CA--C 1.515 -0.396 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.458 HG13 ' CB ' ' A' ' 38' ' ' SER . 4.2 t . . . . . 0 N--CA 1.463 0.204 0 CA-C-O 120.823 0.344 . . . . 0.0 110.67 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' ASP . . . . . 0.515 ' CG ' HD13 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -86.28 -98.09 0.07 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.927 -179.608 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.808 ' HA ' HD23 ' A' ' 25' ' ' LEU . 2.6 p 162.75 130.41 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 122.794 0.438 . . . . 0.0 110.406 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.712 ' OXT' HD12 ' A' ' 22' ' ' LEU . 15.5 m . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.182 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.649 HG23 ' N ' ' A' ' 11' ' ' SER . 1.5 tp . . . . . 0 CA--C 1.539 0.528 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.72 ' HA ' HD13 ' A' ' 90' ' ' ILE . 10.1 m -100.61 168.42 9.72 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 121.572 0.701 . . . . 0.0 112.684 -178.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.73 ' CG1' HD12 ' A' ' 89' ' ' LEU . 2.2 t -156.18 164.36 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.961 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.43 ' H ' HG12 ' A' ' 12' ' ' VAL . 1.5 tpp85 -149.83 127.69 11.8 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.508 0.67 . . . . 0.0 110.744 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.763 ' C ' HG12 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -128.37 178.25 6.4 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.838 -1.073 . . . . 0.0 110.094 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.456 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 4.0 t80 -122.03 151.22 41.07 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 20' ' ' GLY . 2.1 mmpt? -83.37 30.95 0.46 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.405 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.889 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.9 OUTLIER 40.91 31.21 0.12 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 122.865 0.466 . . . . 0.0 112.061 179.679 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.614 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 44.15 24.35 0.08 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.286 0.634 . . . . 0.0 112.419 -177.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.889 HG22 ' O ' ' A' ' 17' ' ' ARG . 6.6 m -165.98 32.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.108 178.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 50.45 68.16 1.56 Allowed Glycine 0 C--N 1.337 0.608 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.991 -178.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -155.08 69.48 0.29 Allowed Glycine 0 C--N 1.332 0.327 0 N-CA-C 111.529 -0.629 . . . . 0.0 111.529 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.802 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 4.5 mp -49.4 -21.3 0.86 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -179.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.441 ' HA2' HG22 ' A' ' 41' ' ' ILE . . . 107.78 5.15 33.82 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.169 -1.015 . . . . 0.0 113.32 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.913 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -157.58 138.12 12.95 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 117.794 0.797 . . . . 0.0 112.844 -179.583 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.992 HD23 ' HA ' ' B' ' 6' ' ' SER . 1.8 mt -78.68 165.28 23.81 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.374 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.3 m -147.7 154.31 11.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.161 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -137.7 121.28 17.29 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.259 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.465 ' HB3' ' CD1' ' A' ' 71' ' ' TYR . 0.9 OUTLIER -115.03 95.21 5.1 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.167 178.538 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.9 mtt180 -62.16 116.84 5.31 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.117 0.484 . . . . 0.0 110.493 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.8 t . . . . . 0 C--N 1.328 -0.33 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -179.461 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.4 HD12 ' HA ' ' A' ' 36' ' ' ILE . 0.6 OUTLIER . . . . . 0 CA--C 1.535 0.379 0 CA-C-O 120.855 0.359 . . . . 0.0 111.539 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.798 HD12 ' O ' ' A' ' 53' ' ' GLN . 22.1 mt -79.22 142.54 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.773 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.4 ' HB3' ' CG1' ' B' ' 4' ' ' VAL . 2.4 t -106.36 -40.45 5.6 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.624 ' CB ' HD12 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -171.18 142.11 1.72 Allowed 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.145 -0.622 . . . . 0.0 112.429 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.913 HD23 ' HB3' ' A' ' 24' ' ' PHE . 46.6 mt -76.21 85.3 3.03 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.995 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.652 HD13 HD21 ' A' ' 25' ' ' LEU . 1.3 tp -41.98 -58.29 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -177.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.459 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.1 OUTLIER -92.44 -66.23 0.94 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -176.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.465 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 107.42 18.81 9.86 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 -177.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.51 -27.75 0.95 Allowed Glycine 0 C--N 1.34 0.793 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.855 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.802 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -94.06 -83.4 0.33 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.008 0.904 . . . . 0.0 111.69 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.85 ' HB1' HG21 ' A' ' 52' ' ' ILE . . . -64.23 -54.68 29.64 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 121.424 0.631 . . . . 0.0 110.782 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.761 ' CD ' HD13 ' A' ' 40' ' ' LEU . 3.8 tp10 -49.19 -42.24 39.45 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.368 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.92 -35.52 78.63 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.454 178.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.3 -47.78 65.73 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.655 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.42 -27.0 11.09 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.207 -0.997 . . . . 0.0 114.655 177.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.647 ' CD1' HD11 ' A' ' 91' ' ' LEU . 2.8 pp -102.26 -11.66 18.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 117.711 0.756 . . . . 0.0 111.944 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.85 HG21 ' HB1' ' A' ' 46' ' ' ALA . 5.2 mp -87.78 104.45 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.798 ' O ' HD12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -128.08 156.53 42.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.833 -179.781 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.532 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -71.93 133.39 45.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.827 0.346 . . . . 0.0 111.04 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.96 14.37 65.57 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.134 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.527 ' C ' HD12 ' A' ' 57' ' ' ILE . 1.2 m-20 -93.17 -82.55 0.34 Allowed 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.909 HG22 HD22 ' A' ' 91' ' ' LEU . 1.6 mp -158.47 120.38 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.462 0.649 . . . . 0.0 111.841 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.973 HD11 HG22 ' A' ' 61' ' ' VAL . 5.9 tp -152.9 87.19 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.09 177.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.3 tp -79.48 -61.78 1.9 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 121.994 -0.441 . . . . 0.0 111.238 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -127.88 158.88 36.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.909 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.973 HG22 HD11 ' A' ' 58' ' ' ILE . 11.7 t -150.63 149.99 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.018 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.505 HD22 HG21 ' A' ' 87' ' ' VAL . 0.0 OUTLIER 49.47 33.82 6.06 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.25 0.547 . . . . 0.0 110.941 179.393 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 63.89 23.89 13.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.285 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -111.39 110.93 55.49 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.179 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.79 ' O ' HD22 ' A' ' 69' ' ' LEU . 29.2 Cg_endo -62.49 80.72 0.1 Allowed 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.914 1.743 . . . . 0.0 111.5 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.604 HD21 ' HB3' ' A' ' 74' ' ' ALA . 6.8 mt -78.17 65.44 3.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.389 0.614 . . . . 0.0 109.883 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.494 HG23 ' H ' ' A' ' 68' ' ' ASP . 2.7 m -122.67 -56.04 2.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.698 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.494 ' H ' HG23 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -138.52 22.47 2.72 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -178.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.79 HD22 ' O ' ' A' ' 65' ' ' PRO . 0.7 OUTLIER -96.96 -175.67 3.33 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 178.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.3 m -68.86 96.67 0.77 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.864 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 9.0 t80 -40.77 -57.0 2.04 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -178.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -59.19 -28.22 66.43 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.096 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.903 ' O ' HG23 ' A' ' 77' ' ' VAL . 1.7 t -76.6 -44.71 33.23 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.733 ' HB2' HD21 ' A' ' 69' ' ' LEU . . . -57.84 -40.84 81.03 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.45 0.643 . . . . 0.0 109.724 178.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.864 HD11 ' CZ ' ' A' ' 71' ' ' TYR . 99.0 mt -66.02 -36.4 83.17 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.22 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -71.44 -38.7 71.33 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 120.921 0.391 . . . . 0.0 110.283 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.903 HG23 ' O ' ' A' ' 73' ' ' SER . 12.2 t -59.63 -36.85 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.013 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.459 HD11 HG12 ' B' ' 7' ' ' VAL . 4.5 pp -91.89 -24.64 19.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.005 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.27 -44.49 83.44 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 120.507 -0.477 . . . . 0.0 109.803 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -52.85 -22.29 11.84 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.877 -0.677 . . . . 0.0 113.031 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 80.1 mt -49.84 119.39 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 120.855 0.359 . . . . 0.0 111.391 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.15 -168.66 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.473 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 m -96.4 -171.12 2.21 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.115 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 44.13 31.3 0.52 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.074 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.419 ' O ' ' CE1' ' A' ' 15' ' ' PHE . 1.8 t -125.38 160.19 29.99 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.969 0.89 . . . . 0.0 112.789 -178.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -100.95 176.61 5.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.415 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.769 HG11 ' CD2' ' A' ' 22' ' ' LEU . 2.8 p -151.69 150.02 13.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.663 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.699 ' C ' HD23 ' A' ' 89' ' ' LEU . 22.1 t -110.2 155.96 11.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.382 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.73 HD12 ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -149.66 155.8 40.83 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.13 -178.353 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.72 HD13 ' HA ' ' A' ' 11' ' ' SER . 45.9 mm -130.75 133.36 63.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.02 0.438 . . . . 0.0 111.267 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.909 HD22 HG22 ' A' ' 57' ' ' ILE . 55.6 mt . . . . . 0 C--N 1.327 -0.398 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.316 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.415 ' CG1' ' HB3' ' A' ' 25' ' ' LEU . 11.5 t . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.763 0.315 . . . . 0.0 110.734 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' ASP . . . . . 0.602 ' CG ' HD13 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -87.54 -97.11 0.09 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.275 -179.43 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.992 ' HA ' HD23 ' A' ' 25' ' ' LEU . 7.1 t 167.78 -36.36 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 117.851 0.296 . . . . 0.0 110.541 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.636 ' O ' HD12 ' A' ' 22' ' ' LEU . 20.2 m . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.197 -0.906 . . . . 0.0 112.735 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.631 HG23 ' N ' ' A' ' 11' ' ' SER . 1.2 tp . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.679 ' HA ' HD13 ' A' ' 90' ' ' ILE . 2.9 t -98.41 164.1 12.42 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.922 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.756 HG11 HD11 ' A' ' 51' ' ' LEU . 2.1 t -154.17 165.34 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.279 -178.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.1 ttp85 -144.75 140.04 28.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.292 0.568 . . . . 0.0 110.913 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.941 HD21 ' HB2' ' A' ' 46' ' ' ALA . 0.6 OUTLIER -139.07 140.99 38.2 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.323 -179.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.452 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 2.6 t80 -87.58 145.41 26.22 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 177.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.462 ' CE ' HD12 ' A' ' 78' ' ' LEU . 4.6 mttt -82.17 29.65 0.41 Allowed 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.824 -0.351 . . . . 0.0 111.538 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.866 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 42.99 31.03 0.3 Allowed 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 179.377 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.569 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 44.12 23.59 0.06 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.586 -178.559 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.866 HG22 ' O ' ' A' ' 17' ' ' ARG . 15.9 m -164.75 32.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.017 178.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 50.47 57.64 10.19 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.81 -178.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -138.8 58.79 0.61 Allowed Glycine 0 C--N 1.332 0.356 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.838 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 3.8 mp -44.61 -25.15 0.24 Allowed 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.461 ' HA2' HG22 ' A' ' 41' ' ' ILE . . . 109.32 5.73 29.95 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.18 -1.009 . . . . 0.0 113.644 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.932 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -158.73 138.14 11.65 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 117.835 0.818 . . . . 0.0 112.48 -179.47 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.893 HD21 HD13 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -85.04 175.53 8.97 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.594 179.608 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.512 HG12 HG21 ' A' ' 58' ' ' ILE . 30.4 m -146.7 160.92 9.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.924 177.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -141.95 111.21 6.42 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.846 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.505 ' HB3' ' CG ' ' A' ' 71' ' ' TYR . 1.7 tm-20 -106.19 113.23 26.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.101 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.88 126.72 29.39 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.021 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 96.7 t . . . . . 0 C--N 1.326 -0.428 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.677 179.155 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.469 HD12 ' HA ' ' A' ' 36' ' ' ILE . 1.1 tp . . . . . 0 CA--C 1.537 0.475 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.529 HG13 HG22 ' A' ' 58' ' ' ILE . 43.5 mt -88.82 149.83 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.801 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.427 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 16.0 t -111.92 -42.72 3.72 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.517 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -175.59 139.39 0.42 Allowed 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 120.151 -0.619 . . . . 0.0 112.308 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.932 HD23 ' HB3' ' A' ' 24' ' ' PHE . 30.5 mt -68.83 110.24 4.27 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 178.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.893 HD13 HD21 ' A' ' 25' ' ' LEU . 1.5 tp -65.67 -58.49 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 -176.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.464 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 2.0 tmt_? -93.34 -59.53 2.0 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -177.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.494 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 102.26 22.49 9.8 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.173 -177.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.412 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -125.02 -29.37 1.03 Allowed Glycine 0 C--N 1.338 0.693 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.568 -178.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.838 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -94.35 -83.17 0.35 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 117.855 0.827 . . . . 0.0 111.648 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.941 ' HB2' HD21 ' A' ' 14' ' ' LEU . . . -61.83 -62.2 1.96 Allowed 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.238 0.542 . . . . 0.0 111.285 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.617 ' HB2' HD22 ' A' ' 40' ' ' LEU . 4.0 tp10 -46.36 -42.2 14.58 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.776 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.412 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 0.3 OUTLIER -58.77 -39.3 80.62 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.616 178.775 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.23 -44.5 68.14 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.492 178.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.91 -26.85 16.17 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.414 -0.898 . . . . 0.0 114.463 177.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.756 HD11 HG11 ' A' ' 12' ' ' VAL . 2.5 pp -104.04 18.6 21.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 117.546 0.673 . . . . 0.0 111.974 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.936 HG21 ' HB1' ' A' ' 46' ' ' ALA . 4.7 mp -120.15 73.68 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.819 0.342 . . . . 0.0 110.592 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -102.67 141.34 35.65 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.517 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -62.98 143.43 57.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.149 0.499 . . . . 0.0 111.55 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.59 10.7 85.98 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.009 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -97.76 -88.18 0.31 Allowed 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.862 0.331 . . . . 0.0 111.098 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.688 HG23 HD22 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -163.72 121.45 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -179.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.707 HD11 HG22 ' A' ' 61' ' ' VAL . 2.0 tp -137.98 77.03 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 177.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.0 -62.21 1.73 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 -178.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.481 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . . . -116.4 149.54 39.23 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.833 0.349 . . . . 0.0 111.514 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.707 HG22 HD11 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -146.93 143.71 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.635 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.916 ' HA ' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER 65.18 -73.22 0.06 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.729 -179.505 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.3 t0 179.61 37.29 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.945 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.727 ' NH1' ' HB1' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -130.75 140.18 37.87 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-O 120.782 0.325 . . . . 0.0 111.029 179.547 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.46 ' O ' HD22 ' A' ' 69' ' ' LEU . 74.0 Cg_endo -76.27 82.58 2.19 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 121.548 1.498 . . . . 0.0 110.703 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.716 HD12 ' CZ ' ' A' ' 64' ' ' ARG . 0.4 OUTLIER -77.65 68.74 3.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.77 -178.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.535 HG23 ' H ' ' A' ' 68' ' ' ASP . 3.2 m -126.71 -59.45 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.919 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.535 ' H ' HG23 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -136.36 26.46 3.17 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.803 -178.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.698 HD21 ' HB2' ' A' ' 74' ' ' ALA . 1.9 pt? -92.58 -170.14 2.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.869 0.366 . . . . 0.0 110.66 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.412 ' N ' ' HG ' ' A' ' 69' ' ' LEU . 3.3 m -73.71 108.64 6.67 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.724 ' CE1' HD11 ' A' ' 75' ' ' LEU . 3.0 t80 -42.57 -55.84 3.34 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -62.93 -27.77 69.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.242 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.859 ' O ' HG23 ' A' ' 77' ' ' VAL . 22.4 t -75.32 -39.33 59.59 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.727 ' HB1' ' NH1' ' A' ' 64' ' ' ARG . . . -62.47 -49.49 75.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.945 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.724 HD11 ' CE1' ' A' ' 71' ' ' TYR . 27.2 mt -63.14 -30.68 71.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.916 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -72.78 -38.58 67.22 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.716 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' ' 73' ' ' SER . 65.1 t -58.97 -42.83 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.64 HD23 ' HA ' ' A' ' 75' ' ' LEU . 0.4 OUTLIER -78.7 -29.92 45.75 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.117 179.185 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -37.91 79.81 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.773 0.32 . . . . 0.0 110.975 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -59.59 -22.32 56.47 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.743 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.547 HD11 ' HB3' ' A' ' 62' ' ' ASN . 49.9 mt -58.23 116.74 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 120.927 0.394 . . . . 0.0 111.041 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.78 -167.18 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.44 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.402 ' O ' HG22 ' A' ' 85' ' ' THR . 3.9 m -96.83 -170.38 2.04 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.093 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 44.25 31.06 0.52 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.13 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.411 ' O ' ' CD1' ' A' ' 15' ' ' PHE . 1.7 t -130.12 162.35 29.01 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.815 0.817 . . . . 0.0 112.804 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -103.41 176.2 5.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.4 -1.273 . . . . 0.0 109.808 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.916 HG22 ' HA ' ' A' ' 62' ' ' ASN . 0.4 OUTLIER -144.9 172.37 5.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.929 0.395 . . . . 0.0 111.305 -179.366 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.802 ' O ' HD23 ' A' ' 89' ' ' LEU . 21.8 t -122.73 158.13 27.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.748 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.802 HD23 ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -151.32 147.33 26.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.845 0.355 . . . . 0.0 110.427 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.679 HD13 ' HA ' ' A' ' 11' ' ' SER . 41.0 mm -126.36 122.89 62.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.998 0.428 . . . . 0.0 111.465 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.702 HD11 ' CD1' ' A' ' 51' ' ' LEU . 10.0 mt . . . . . 0 C--O 1.232 0.173 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.242 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.416 ' CG1' ' HB3' ' A' ' 38' ' ' SER . 3.5 t . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.947 0.403 . . . . 0.0 111.59 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -123.79 102.08 7.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.645 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.825 ' HA ' HD23 ' A' ' 25' ' ' LEU . 12.9 p -61.05 134.82 57.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.959 0.409 . . . . 0.0 110.728 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.629 ' OXT' HD12 ' A' ' 22' ' ' LEU . 14.6 m . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.142 -0.932 . . . . 0.0 111.149 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.662 HG23 ' N ' ' A' ' 11' ' ' SER . 1.0 OUTLIER . . . . . 0 CA--C 1.536 0.434 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.704 ' HA ' HD13 ' A' ' 90' ' ' ILE . 56.1 p -84.6 165.27 18.13 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.652 0.739 . . . . 0.0 111.957 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.881 HG11 HD11 ' A' ' 51' ' ' LEU . 1.7 t -156.72 156.15 4.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.748 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -140.4 140.38 35.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.595 0.712 . . . . 0.0 111.154 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.83 ' C ' HG12 ' A' ' 87' ' ' VAL . 0.5 OUTLIER -141.88 177.77 7.96 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.833 -179.624 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.472 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 2.6 t80 -122.98 149.82 43.79 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.403 ' O ' ' N ' ' A' ' 20' ' ' GLY . 2.2 mttt -84.2 29.39 0.57 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.738 178.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.884 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 41.96 31.77 0.25 Allowed 'General case' 0 C--N 1.345 0.378 0 C-N-CA 123.006 0.522 . . . . 0.0 111.853 179.593 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.571 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 44.05 24.16 0.07 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.529 -178.508 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.884 HG22 ' O ' ' A' ' 17' ' ' ARG . 13.0 m -164.16 31.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.185 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 50.45 65.57 2.9 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.616 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -151.62 68.26 0.32 Allowed Glycine 0 C--N 1.331 0.273 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.822 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 4.2 mp -52.22 -22.2 4.13 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.443 ' HA2' HG22 ' A' ' 41' ' ' ILE . . . 107.3 11.56 25.33 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.152 -1.023 . . . . 0.0 113.829 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.918 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -159.7 141.73 13.27 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 118.008 0.904 . . . . 0.0 113.382 -179.576 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.92 HD23 ' HA ' ' B' ' 6' ' ' SER . 11.5 mt -79.61 172.83 13.25 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.435 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.2 m -153.23 148.97 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.242 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.423 ' HG3' HG22 ' A' ' 36' ' ' ILE . 0.7 OUTLIER -135.38 106.27 6.61 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.393 -179.265 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.482 ' HB3' ' CD1' ' A' ' 71' ' ' TYR . 7.0 tm-20 -103.54 111.42 23.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.805 178.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -70.62 116.55 11.08 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 121.092 0.472 . . . . 0.0 110.43 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.6 t . . . . . 0 CA--C 1.532 0.267 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.609 -179.559 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.485 HD12 ' HA ' ' A' ' 36' ' ' ILE . 1.2 tp . . . . . 0 CA--C 1.535 0.372 0 CA-C-O 120.699 0.285 . . . . 0.0 111.597 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.67 HD12 ' O ' ' A' ' 53' ' ' GLN . 35.9 mt -82.74 145.88 7.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.64 0.257 . . . . 0.0 110.925 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.454 ' CB ' HG13 ' B' ' 4' ' ' VAL . 6.3 t -109.55 -38.2 5.5 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.63 ' HB3' HD12 ' A' ' 25' ' ' LEU . 3.5 t0 -170.54 135.35 1.18 Allowed 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.364 -0.534 . . . . 0.0 112.18 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.918 HD23 ' HB3' ' A' ' 24' ' ' PHE . 45.4 mt -71.93 84.08 0.95 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.698 0.761 . . . . 0.0 109.781 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.458 ' CG2' ' N ' ' A' ' 42' ' ' ARG . 0.8 OUTLIER -39.91 -59.13 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 114.922 1.452 . . . . 0.0 114.922 -177.515 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.458 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -93.53 -64.78 1.05 Allowed 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -177.632 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.427 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 104.41 23.56 7.93 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -177.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.405 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -126.06 -32.37 0.74 Allowed Glycine 0 C--N 1.338 0.666 0 C-N-CA 121.283 -0.484 . . . . 0.0 113.085 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.822 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -94.03 -83.13 0.34 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 117.732 0.766 . . . . 0.0 111.435 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.916 ' HB1' HG21 ' A' ' 52' ' ' ILE . . . -58.14 -57.92 10.72 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.232 0.539 . . . . 0.0 111.161 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.427 ' HB3' ' HA2' ' A' ' 43' ' ' GLY . 39.4 tt0 -48.26 -47.54 36.03 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.871 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.405 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -57.31 -32.97 67.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.09 178.903 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.411 ' HB3' ' CD1' ' A' ' 52' ' ' ILE . 0.4 OUTLIER -57.55 -52.21 66.34 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.89 178.689 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 113.75 -30.73 6.99 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.154 -1.022 . . . . 0.0 114.096 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.938 HD13 HD11 ' A' ' 91' ' ' LEU . 3.7 pp -95.75 -1.47 49.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.291 0.545 . . . . 0.0 111.571 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.916 HG21 ' HB1' ' A' ' 46' ' ' ALA . 4.9 mp -105.27 118.36 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-O 120.953 0.406 . . . . 0.0 110.217 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.67 ' O ' HD12 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -144.44 162.51 36.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.293 179.685 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.573 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -71.81 126.72 30.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.857 0.361 . . . . 0.0 110.787 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.42 11.97 72.51 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.932 -178.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.13 -83.95 0.24 Allowed 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 19.7 mt -155.94 125.72 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.787 HD11 HG22 ' A' ' 61' ' ' VAL . 5.8 tp -160.42 70.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.596 177.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.433 ' HG ' ' N ' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -78.04 -47.79 17.59 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 122.087 -0.383 . . . . 0.0 111.315 -178.418 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.502 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . . . -121.89 150.21 42.3 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.834 0.35 . . . . 0.0 111.368 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.788 HG12 ' ND2' ' A' ' 62' ' ' ASN . 3.0 t -140.33 144.86 26.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.172 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.788 ' ND2' HG12 ' A' ' 61' ' ' VAL . 0.0 OUTLIER 53.84 -82.59 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.025 0.53 . . . . 0.0 110.902 -179.118 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 61' ' ' VAL . 2.0 p30 -165.56 33.69 0.05 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.084 0.469 . . . . 0.0 110.272 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.792 ' NH2' HD23 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -126.64 105.5 23.61 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.779 179.653 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -58.93 87.4 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 121.701 1.601 . . . . 0.0 110.526 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.892 HD13 ' HB2' ' A' ' 74' ' ' ALA . 29.8 tp -86.44 66.04 9.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.431 0.634 . . . . 0.0 111.397 -178.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.7 m -110.67 -44.28 5.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.027 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.5 p30 -140.24 24.52 2.31 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.513 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.704 HD23 ' HA ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -99.87 174.32 6.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.772 -179.739 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.646 ' H ' HD12 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -63.46 121.76 14.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.317 179.727 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.648 ' CE1' HD11 ' A' ' 75' ' ' LEU . 3.7 t80 -54.93 -61.0 2.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.524 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.458 ' HA ' HD12 ' A' ' 75' ' ' LEU . 47.7 t0 -56.67 -32.76 65.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.237 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.569 ' O ' HG23 ' A' ' 77' ' ' VAL . 69.6 m -70.95 -46.35 62.56 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.892 ' HB2' HD13 ' A' ' 66' ' ' LEU . . . -55.65 -45.01 77.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.171 178.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.648 HD11 ' CE1' ' A' ' 71' ' ' TYR . 14.7 mt -64.87 -29.71 70.67 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.15 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.407 ' HA ' ' HB2' ' A' ' 79' ' ' ARG . 9.6 mt-10 -72.34 -36.13 68.73 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.002 0.429 . . . . 0.0 110.017 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 73' ' ' SER . 47.4 t -61.0 -46.04 97.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.524 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.792 HD23 ' NH2' ' A' ' 64' ' ' ARG . 1.6 pp -79.12 -27.06 42.83 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.408 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.407 ' HB2' ' HA ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -61.76 -49.21 77.28 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 121.023 0.439 . . . . 0.0 110.776 -179.438 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.35 -22.61 15.79 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.997 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.406 ' CD1' ' HA ' ' A' ' 78' ' ' LEU . 57.1 mt -56.32 118.75 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 120.9 0.381 . . . . 0.0 111.097 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.75 -165.93 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.421 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.2 m -95.47 -169.42 1.96 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.244 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 41.17 32.6 0.2 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.398 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.418 ' O ' ' CE1' ' A' ' 15' ' ' PHE . 1.5 t -125.29 159.95 30.47 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 122.013 0.911 . . . . 0.0 112.775 -178.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.64 176.63 5.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.13 -1.395 . . . . 0.0 109.921 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.83 HG12 ' C ' ' A' ' 14' ' ' LEU . 4.2 p -149.71 151.78 12.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.541 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.829 ' O ' HD23 ' A' ' 89' ' ' LEU . 10.7 t -109.61 163.79 6.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.9 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.867 HD12 ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -159.04 164.38 35.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.674 0.273 . . . . 0.0 110.393 -179.723 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.704 HD13 ' HA ' ' A' ' 11' ' ' SER . 33.0 mm -135.64 125.5 41.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.938 HD11 HD13 ' A' ' 51' ' ' LEU . 10.9 mt . . . . . 0 C--O 1.233 0.191 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 177.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.458 HG11 HD13 ' A' ' 25' ' ' LEU . 15.3 t . . . . . 0 CA--C 1.52 -0.178 0 CA-C-O 120.783 0.325 . . . . 0.0 110.454 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.98 -104.65 0.09 Allowed 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.169 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.92 ' HA ' HD23 ' A' ' 25' ' ' LEU . 6.7 t 163.3 105.63 0.0 OUTLIER 'General case' 0 C--N 1.346 0.438 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.544 ' O ' HD12 ' A' ' 22' ' ' LEU . 21.3 m . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.305 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.1 tp . . . . . 0 CA--C 1.531 0.241 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.841 ' HA ' HD13 ' A' ' 90' ' ' ILE . 59.2 p -105.23 159.92 15.5 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.954 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.532 HG23 ' HB2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -134.15 102.96 4.61 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.318 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.542 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.0 ttp85 -79.47 106.17 11.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.49 0.662 . . . . 0.0 112.26 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.705 ' C ' HG12 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -116.62 177.23 4.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.604 178.612 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.458 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 2.4 t80 -117.03 151.25 37.16 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.41 ' O ' ' N ' ' A' ' 20' ' ' GLY . 0.8 OUTLIER -85.67 27.27 0.86 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.179 178.691 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.897 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.2 OUTLIER 45.48 29.73 0.64 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 179.257 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.602 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 43.13 24.92 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.101 0.56 . . . . 0.0 112.421 -178.431 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.897 HG22 ' O ' ' A' ' 17' ' ' ARG . 15.0 m -166.53 32.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 123.948 0.899 . . . . 0.0 108.857 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 48.01 62.55 4.14 Favored Glycine 0 C--N 1.34 0.768 0 CA-C-N 115.818 -0.628 . . . . 0.0 113.154 -178.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -147.9 60.2 0.46 Allowed Glycine 0 C--N 1.333 0.412 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.832 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 4.0 mp -41.02 -26.63 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -178.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.412 ' HA2' HG22 ' A' ' 41' ' ' ILE . . . 120.47 1.83 12.11 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.11 -1.043 . . . . 0.0 113.469 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.901 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -156.94 140.2 15.59 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 117.766 0.783 . . . . 0.0 112.665 -179.561 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.867 HD21 HD13 ' A' ' 41' ' ' ILE . 0.7 OUTLIER -79.15 171.06 15.71 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.954 179.047 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.7 m -150.8 154.12 9.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.037 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.442 ' CG ' HG22 ' A' ' 36' ' ' ILE . 7.6 ptmm? -135.79 107.74 7.12 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.275 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.498 ' HB3' ' CG ' ' A' ' 71' ' ' TYR . 3.0 tm-20 -97.41 108.54 21.28 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -59.99 111.6 1.55 Allowed 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 121.104 0.478 . . . . 0.0 110.409 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.1 t . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.839 -179.761 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' A' ' 36' ' ' ILE . 1.0 OUTLIER . . . . . 0 CA--C 1.533 0.294 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.495 HG13 HG22 ' A' ' 58' ' ' ILE . 39.3 mt -84.89 149.0 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.94 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.427 ' OG ' HG13 ' B' ' 4' ' ' VAL . 0.9 OUTLIER -117.14 -38.6 3.34 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.552 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.5 OUTLIER -172.69 135.8 0.69 Allowed 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 119.972 -0.691 . . . . 0.0 112.679 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.901 HD23 ' HB3' ' A' ' 24' ' ' PHE . 47.8 mt -67.09 113.6 5.19 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.867 HD13 HD21 ' A' ' 25' ' ' LEU . 2.0 tp -73.49 -55.86 11.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -175.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.458 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 10.9 ttt85 -93.38 -64.84 1.04 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.074 0.464 . . . . 0.0 112.104 -177.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.446 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 105.31 21.19 9.01 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.376 -178.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.407 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -125.85 -30.86 0.85 Allowed Glycine 0 C--N 1.336 0.551 0 C-N-CA 121.072 -0.585 . . . . 0.0 113.206 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.832 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -94.73 -82.66 0.36 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 117.583 0.692 . . . . 0.0 111.302 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.822 ' HB1' HG21 ' A' ' 52' ' ' ILE . . . -59.24 -57.38 13.29 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.148 0.499 . . . . 0.0 111.402 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.446 ' HB3' ' HA2' ' A' ' 43' ' ' GLY . 51.2 tt0 -49.85 -45.87 50.8 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.751 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.407 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 1.0 OUTLIER -55.83 -35.29 66.22 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.003 178.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.4 t -58.48 -49.34 77.68 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.63 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.75 -19.14 36.44 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.31 -0.947 . . . . 0.0 113.921 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.744 ' HG ' HD12 ' A' ' 52' ' ' ILE . 3.3 pp -96.52 -26.63 15.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.154 0.477 . . . . 0.0 110.814 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.822 HG21 ' HB1' ' A' ' 46' ' ' ALA . 5.0 mp -80.8 98.64 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-O 120.958 0.409 . . . . 0.0 110.42 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.418 ' O ' HD12 ' A' ' 37' ' ' ILE . 1.1 mp0 -124.53 149.26 47.13 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.646 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.552 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -67.63 128.67 37.32 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.987 0.423 . . . . 0.0 111.273 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.74 2.15 90.62 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.388 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -84.21 -89.1 0.1 Allowed 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.985 0.392 . . . . 0.0 110.902 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.554 HG23 HD22 ' A' ' 91' ' ' LEU . 6.3 tp -163.12 126.32 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.703 HD11 HG22 ' A' ' 61' ' ' VAL . 2.7 tp -146.6 90.02 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.4 tp -78.49 -67.09 0.77 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.407 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.486 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . . . -128.4 149.78 50.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.16 0.505 . . . . 0.0 112.111 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.703 HG22 HD11 ' A' ' 58' ' ' ILE . 18.8 t -125.97 144.79 34.87 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.893 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.468 ' HB3' HG23 ' A' ' 87' ' ' VAL . 0.0 OUTLIER 44.2 29.24 0.34 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 120.964 0.411 . . . . 0.0 111.768 -178.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.6 t70 74.02 26.91 1.66 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.403 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.74 ' NH2' HG12 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -99.99 102.71 18.61 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.014 179.411 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.744 ' O ' HD23 ' A' ' 69' ' ' LEU . 19.8 Cg_endo -61.09 82.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 121.946 1.764 . . . . 0.0 111.736 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.42 ' HG ' ' HB1' ' A' ' 74' ' ' ALA . 0.5 OUTLIER -86.82 64.67 8.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.403 0.62 . . . . 0.0 110.284 -179.766 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.439 HG23 ' H ' ' A' ' 68' ' ' ASP . 3.1 m -125.97 -52.63 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.536 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.439 ' H ' HG23 ' A' ' 67' ' ' VAL . 81.2 m-20 -133.33 24.48 4.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.897 0.38 . . . . 0.0 110.992 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.744 HD23 ' O ' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -105.63 175.23 5.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.313 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.588 ' H ' HD12 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -66.05 102.21 0.78 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.252 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.717 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 8.5 t80 -43.87 -54.75 5.03 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.971 0.415 . . . . 0.0 111.977 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -60.86 -33.73 73.52 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.931 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.873 ' O ' HG23 ' A' ' 77' ' ' VAL . 41.1 t -72.64 -43.89 62.61 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.733 ' HB2' HD21 ' A' ' 69' ' ' LEU . . . -59.4 -45.61 91.01 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.405 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.717 HD11 ' CZ ' ' A' ' 71' ' ' TYR . 56.0 mt -65.76 -30.21 70.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.271 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -74.01 -42.7 59.95 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.727 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.873 HG23 ' O ' ' A' ' 73' ' ' SER . 28.5 t -60.45 -35.0 60.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.276 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.589 HD21 HD23 ' A' ' 75' ' ' LEU . 4.1 pp -88.42 -22.49 23.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.942 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.1 -39.59 95.14 Favored 'General case' 0 C--N 1.339 0.12 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -55.35 -21.38 26.45 Favored Glycine 0 CA--C 1.522 0.514 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.946 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.42 HD11 HH12 ' A' ' 64' ' ' ARG . 79.0 mt -54.72 108.49 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-O 120.797 0.332 . . . . 0.0 110.733 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.89 -168.3 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.454 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.46 -172.22 2.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.024 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 44.01 31.25 0.5 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.26 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.408 ' O ' ' CE1' ' A' ' 15' ' ' PHE . 1.7 t -124.35 160.94 26.98 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.984 0.897 . . . . 0.0 112.747 -178.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.72 176.7 5.54 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.18 -1.373 . . . . 0.0 110.335 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.719 HG11 ' CD2' ' A' ' 22' ' ' LEU . 2.6 p -145.41 157.36 13.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.507 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.7 t -133.27 99.26 3.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.447 0.641 . . . . 0.0 111.626 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.651 HD23 ' CD1' ' A' ' 58' ' ' ILE . 6.4 mp -80.71 175.84 10.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.946 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.841 HD13 ' HA ' ' A' ' 11' ' ' SER . 36.2 mm -140.32 125.07 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.802 178.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.554 HD22 HG23 ' A' ' 57' ' ' ILE . 49.0 mt . . . . . 0 C--O 1.231 0.128 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.716 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.564 HG11 HD13 ' A' ' 25' ' ' LEU . 21.2 t . . . . . 0 C--O 1.231 0.13 0 CA-C-O 121.006 0.432 . . . . 0.0 110.992 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.35 116.56 29.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.788 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.867 ' HA ' HD23 ' A' ' 25' ' ' LEU . 9.4 p -71.49 121.07 18.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.083 0.468 . . . . 0.0 110.382 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.768 ' OXT' HD12 ' A' ' 22' ' ' LEU . 30.9 m . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.406 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.623 ' N ' HD13 ' A' ' 10' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--O 1.225 -0.221 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.72 ' HA ' HD13 ' A' ' 90' ' ' ILE . 20.0 m -92.25 156.13 17.5 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.796 ' CG1' HD12 ' A' ' 89' ' ' LEU . 2.5 t -149.84 157.61 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.618 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.6 tpp180 -145.54 121.9 10.95 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.516 0.674 . . . . 0.0 110.57 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.738 ' C ' HG12 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -123.71 178.34 5.27 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.555 -179.668 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.428 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 2.7 t80 -115.69 151.95 34.1 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.562 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.605 ' HD3' HG21 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -86.21 30.12 0.71 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 121.009 -0.277 . . . . 0.0 110.803 178.327 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.901 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.1 OUTLIER 42.68 30.67 0.24 Allowed 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 179.518 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.596 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 43.72 24.47 0.07 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.342 -178.358 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.901 HG22 ' O ' ' A' ' 17' ' ' ARG . 14.1 m -166.33 32.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 123.942 0.897 . . . . 0.0 109.086 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 49.83 68.64 1.31 Allowed Glycine 0 C--N 1.338 0.655 0 CA-C-N 115.824 -0.625 . . . . 0.0 113.049 -178.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -154.51 67.23 0.31 Allowed Glycine 0 C--N 1.333 0.4 0 N-CA-C 111.686 -0.566 . . . . 0.0 111.686 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.932 ' CD2' HG11 ' A' ' 87' ' ' VAL . 4.4 mp -48.18 -23.36 0.84 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.433 ' HA2' HG22 ' A' ' 41' ' ' ILE . . . 112.64 5.25 24.3 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.711 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.87 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -154.38 144.45 21.91 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 118.201 1.001 . . . . 0.0 113.322 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.846 HD23 ' HA ' ' B' ' 6' ' ' SER . 20.0 mt -78.7 173.36 12.53 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.868 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.4 m -153.52 141.34 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-O 121.313 0.577 . . . . 0.0 111.602 177.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.473 ' CG ' HG22 ' A' ' 36' ' ' ILE . 6.2 ptmt -122.07 104.83 9.77 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.707 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.566 ' HG3' HD23 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -102.28 115.76 31.23 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.413 0.625 . . . . 0.0 110.887 179.495 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.535 ' N ' ' HD3' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -51.85 129.39 26.51 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.206 178.191 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 t . . . . . 0 C--N 1.319 -0.73 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.201 179.084 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.473 HG22 ' CG ' ' A' ' 27' ' ' LYS . 0.9 OUTLIER . . . . . 0 CA--C 1.539 0.523 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.774 HD12 ' O ' ' A' ' 53' ' ' GLN . 20.7 mt -85.15 141.62 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.729 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.613 ' CB ' HG13 ' B' ' 4' ' ' VAL . 4.6 t -105.78 -37.83 6.58 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.546 ' CB ' HD12 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -169.42 135.09 1.55 Allowed 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 118.338 0.517 . . . . 0.0 111.66 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.87 HD23 ' HB3' ' A' ' 24' ' ' PHE . 39.6 mt -70.12 76.84 0.51 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.779 0.8 . . . . 0.0 110.444 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.446 ' CG2' ' N ' ' A' ' 42' ' ' ARG . 0.4 OUTLIER -32.94 -58.68 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -178.51 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.446 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.4 OUTLIER -94.23 -68.49 0.8 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.211 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.401 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 108.07 2.48 33.89 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.022 -178.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -108.57 -26.39 5.37 Favored Glycine 0 C--N 1.34 0.753 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.42 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.741 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -95.08 -82.13 0.38 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.86 0.33 . . . . 0.0 110.901 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.739 ' HB1' HG21 ' A' ' 52' ' ' ILE . . . -56.53 -63.85 1.06 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.077 0.465 . . . . 0.0 111.648 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.586 ' CD ' HD13 ' A' ' 40' ' ' LEU . 5.1 tp10 -45.38 -43.0 10.73 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.241 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 44' ' ' GLY . 21.8 mm-40 -59.34 -39.19 82.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.977 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.0 -44.76 74.8 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.959 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.06 -22.83 37.44 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.334 -0.936 . . . . 0.0 113.275 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.987 HD13 HD11 ' A' ' 91' ' ' LEU . 3.6 pp -93.15 -13.78 28.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.882 0.341 . . . . 0.0 110.837 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.739 HG21 ' HB1' ' A' ' 46' ' ' ALA . 4.9 mp -96.35 147.67 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.774 ' O ' HD12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -175.14 154.11 1.72 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.979 0.419 . . . . 0.0 111.26 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.494 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -69.45 123.97 22.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.86 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.29 5.54 81.79 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.132 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.81 -86.35 0.12 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.907 0.353 . . . . 0.0 111.025 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.441 HG22 HD22 ' A' ' 91' ' ' LEU . 0.5 OUTLIER -162.55 119.89 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.207 0.527 . . . . 0.0 111.794 -179.797 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.578 ' O ' HG23 ' A' ' 58' ' ' ILE . 1.5 tp -146.96 80.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 177.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.7 tp -77.84 -66.59 0.82 Allowed 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.782 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.59 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . . . -115.24 151.75 33.93 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.97 0.414 . . . . 0.0 111.051 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.633 HG22 ' ND2' ' A' ' 62' ' ' ASN . 14.3 p -152.61 146.32 15.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.269 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.633 ' ND2' HG22 ' A' ' 61' ' ' VAL . 0.2 OUTLIER 46.05 40.5 7.14 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.17 0.51 . . . . 0.0 111.336 -179.79 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.6 t70 58.87 28.44 17.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.07 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.664 ' O ' HD12 ' A' ' 66' ' ' LEU . 15.1 mmm180 -113.73 101.43 53.79 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.672 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -62.32 85.39 0.1 Allowed 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 121.662 1.574 . . . . 0.0 111.072 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.664 HD12 ' O ' ' A' ' 64' ' ' ARG . 1.0 OUTLIER -84.13 63.85 7.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.663 0.744 . . . . 0.0 110.346 -179.526 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.401 HG23 ' N ' ' A' ' 68' ' ' ASP . 2.9 m -124.84 -46.52 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.069 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.437 ' HA ' ' NH2' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -137.65 25.74 2.84 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.444 179.504 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.599 HD12 ' H ' ' A' ' 70' ' ' SER . 0.1 OUTLIER -107.66 170.69 7.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.904 -179.483 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.599 ' H ' HD12 ' A' ' 69' ' ' LEU . 0.4 OUTLIER -63.1 119.48 9.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.501 179.536 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.516 ' CG ' ' HB3' ' A' ' 28' ' ' GLU . 2.0 t80 -57.32 -47.5 81.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.416 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.48 -30.6 68.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.939 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.878 ' O ' HG23 ' A' ' 77' ' ' VAL . 43.6 t -72.8 -42.77 63.54 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.551 ' HB1' HD11 ' A' ' 66' ' ' LEU . . . -55.58 -41.13 72.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.195 0.522 . . . . 0.0 110.754 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.485 HD11 ' CE1' ' A' ' 71' ' ' TYR . 70.7 mt -71.62 -35.37 70.42 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.82 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -74.58 -42.1 59.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.925 0.393 . . . . 0.0 110.515 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 73' ' ' SER . 19.7 t -61.94 -36.18 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.031 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.545 ' C ' HD12 ' A' ' 78' ' ' LEU . 4.0 pp -85.92 -21.69 27.81 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.42 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.401 ' N ' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -68.14 -36.48 79.75 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.492 179.582 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -55.39 -21.15 25.82 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.021 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.658 HG22 HG21 ' A' ' 85' ' ' THR . 57.5 mt -56.68 109.74 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-O 120.882 0.372 . . . . 0.0 110.915 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.87 -162.55 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.415 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.2 m -97.25 -174.3 2.91 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 120.788 0.328 . . . . 0.0 111.127 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 44.6 31.44 0.63 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.078 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.658 HG21 HG22 ' A' ' 81' ' ' ILE . 1.7 t -121.28 161.13 22.53 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.847 0.832 . . . . 0.0 112.578 -178.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -101.82 176.62 5.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.405 -1.271 . . . . 0.0 110.312 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.932 HG11 ' CD2' ' A' ' 22' ' ' LEU . 2.5 p -149.23 149.47 14.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.676 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.832 ' O ' HD23 ' A' ' 89' ' ' LEU . 11.6 t -108.15 158.99 7.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.076 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.832 HD23 ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -154.92 161.39 41.43 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.741 0.305 . . . . 0.0 110.985 -178.533 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.72 HD13 ' HA ' ' A' ' 11' ' ' SER . 43.6 mm -133.14 128.14 55.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.963 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.987 HD11 HD13 ' A' ' 51' ' ' LEU . 3.7 mt . . . . . 0 CA--C 1.518 -0.266 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.613 HG13 ' CB ' ' A' ' 38' ' ' SER . 2.3 t . . . . . 0 N--CA 1.464 0.252 0 CA-C-O 120.699 0.285 . . . . 0.0 110.472 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' ASP . . . . . 0.429 ' O ' ' CB ' ' B' ' 6' ' ' SER . 0.7 OUTLIER -139.88 -91.92 0.17 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.823 179.88 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.846 ' HA ' HD23 ' A' ' 25' ' ' LEU . 6.1 t 153.57 106.15 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.728 0.811 . . . . 0.0 109.812 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.573 ' OXT' HD12 ' A' ' 22' ' ' LEU . 27.1 m . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.213 -0.898 . . . . 0.0 111.317 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.643 HG23 ' N ' ' A' ' 11' ' ' SER . 1.3 tp . . . . . 0 CA--C 1.537 0.445 0 CA-C-O 120.749 0.309 . . . . 0.0 111.61 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.704 ' HA ' HD13 ' A' ' 90' ' ' ILE . 3.9 m -102.87 173.7 6.2 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.364 0.602 . . . . 0.0 111.75 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.791 HG11 HD11 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -160.88 175.95 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.089 -179.397 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.477 ' O ' HD12 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -150.47 140.89 22.4 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.432 0.634 . . . . 0.0 110.703 179.841 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.815 ' HB3' HD23 ' A' ' 22' ' ' LEU . 0.7 OUTLIER -141.28 140.94 33.96 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.893 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.492 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 2.3 t80 -90.04 143.37 26.84 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.62 ' HE2' HD13 ' A' ' 81' ' ' ILE . 1.7 mptp? -83.6 33.59 0.47 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.261 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.892 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 38.6 33.92 0.08 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.274 0.629 . . . . 0.0 111.914 179.933 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.591 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 44.27 25.26 0.11 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.769 -178.672 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.892 HG22 ' O ' ' A' ' 17' ' ' ARG . 5.2 m -164.36 31.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.567 178.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 52.7 54.69 26.7 Favored Glycine 0 C--N 1.336 0.539 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.584 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -139.91 66.09 0.52 Allowed Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.815 HD23 ' HB3' ' A' ' 14' ' ' LEU . 3.7 mp -49.85 -20.16 0.82 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -178.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.439 ' HA2' HG22 ' A' ' 41' ' ' ILE . . . 102.16 9.39 42.19 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.134 -1.031 . . . . 0.0 113.23 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.92 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -159.76 140.47 12.22 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.504 0.668 . . . . 0.0 112.387 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.86 HD23 ' CA ' ' B' ' 6' ' ' SER . 3.7 mt -78.92 173.74 12.23 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.453 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.423 HG12 HG21 ' A' ' 58' ' ' ILE . 26.7 m -153.81 159.44 3.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 114.715 -1.129 . . . . 0.0 109.934 178.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.824 ' HG2' HG22 ' B' ' 4' ' ' VAL . 15.6 mtpt -134.28 95.41 3.4 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.684 -179.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.49 ' HB2' ' CD1' ' A' ' 71' ' ' TYR . 0.9 OUTLIER -81.31 150.21 28.6 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.681 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.07 130.82 35.91 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-O 121.178 0.513 . . . . 0.0 111.351 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.324 -0.517 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.439 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.467 HD12 ' HA ' ' A' ' 36' ' ' ILE . 1.2 tp . . . . . 0 CA--C 1.538 0.499 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.567 HG13 HG22 ' A' ' 58' ' ' ILE . 36.8 mt -89.17 151.18 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.243 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.426 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 0.5 OUTLIER -116.72 -36.59 3.86 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -179.613 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.578 ' CB ' HD12 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -177.99 142.99 0.3 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.315 -179.687 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.92 HD23 ' HB3' ' A' ' 24' ' ' PHE . 36.2 mt -76.27 85.26 3.07 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.604 0.716 . . . . 0.0 110.247 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.822 HD13 HD21 ' A' ' 25' ' ' LEU . 1.5 tp -40.59 -59.55 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 114.457 1.281 . . . . 0.0 114.457 -177.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.456 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 6.3 mmt180 -94.79 -67.18 0.87 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.182 0.515 . . . . 0.0 112.196 -178.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.461 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 109.39 22.26 6.86 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.232 -178.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.405 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -122.71 -28.56 1.4 Allowed Glycine 0 C--N 1.339 0.75 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.388 -179.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -93.9 -83.93 0.32 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 117.787 0.793 . . . . 0.0 111.567 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.885 ' HB1' HG21 ' A' ' 52' ' ' ILE . . . -60.97 -58.87 6.6 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.221 0.534 . . . . 0.0 110.794 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.506 ' HB2' HD22 ' A' ' 40' ' ' LEU . 17.9 tt0 -46.51 -46.97 19.5 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.761 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.405 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -55.05 -37.3 66.55 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.799 178.684 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.404 ' HB3' HD13 ' A' ' 52' ' ' ILE . 2.4 t -54.38 -46.77 73.12 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.454 178.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.47 -24.19 24.78 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.439 -0.886 . . . . 0.0 114.601 177.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.791 HD11 HG11 ' A' ' 12' ' ' VAL . 1.7 pp -104.16 0.98 30.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.588 0.694 . . . . 0.0 112.3 -179.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.885 HG21 ' HB1' ' A' ' 46' ' ' ALA . 4.2 mp -102.19 96.32 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.23 147.68 43.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.421 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.551 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -70.49 140.4 51.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.932 0.396 . . . . 0.0 111.159 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.58 5.2 88.09 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.98 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.16 -90.71 0.13 Allowed 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.582 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -164.9 121.93 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 179.629 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 1.022 HD11 HG22 ' A' ' 61' ' ' VAL . 1.3 tp -136.25 81.95 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 107.778 -1.194 . . . . 0.0 107.778 176.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.516 ' HB2' HD11 ' A' ' 57' ' ' ILE . 7.1 tp -77.97 -67.88 0.69 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.209 -177.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -114.9 147.48 39.9 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.112 0.482 . . . . 0.0 112.08 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 1.022 HG22 HD11 ' A' ' 58' ' ' ILE . 3.1 t -141.62 144.26 26.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.241 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.722 HD22 HG12 ' A' ' 61' ' ' VAL . 0.1 OUTLIER 44.9 40.87 4.73 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.967 0.413 . . . . 0.0 111.629 -179.629 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.9 t0 53.38 27.56 6.45 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.134 0.493 . . . . 0.0 110.917 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.596 ' NH1' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -115.01 93.24 34.03 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.464 -179.588 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.421 ' O ' HD23 ' A' ' 69' ' ' LEU . 82.6 Cg_exo -43.1 87.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.361 1.232 0 C-N-CA 123.309 2.673 . . . . 0.0 114.106 -178.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.936 ' CD1' ' HB1' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -92.11 70.99 5.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.296 178.501 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.536 HG23 ' H ' ' A' ' 68' ' ' ASP . 3.4 m -123.04 -59.13 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -178.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.536 ' H ' HG23 ' A' ' 67' ' ' VAL . 74.7 m-20 -136.57 24.72 3.15 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -178.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.596 HD22 ' NH1' ' A' ' 64' ' ' ARG . 0.2 OUTLIER -93.53 -173.28 3.15 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.484 179.306 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.72 122.65 19.58 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.749 ' CE1' HD11 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -50.46 -69.27 0.12 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.709 -179.278 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -51.45 -26.97 9.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.777 0.322 . . . . 0.0 111.451 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.889 ' O ' HG23 ' A' ' 77' ' ' VAL . 22.8 t -76.79 -44.19 33.71 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.24 0.543 . . . . 0.0 109.811 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.936 ' HB1' ' CD1' ' A' ' 66' ' ' LEU . . . -59.12 -39.42 82.26 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.069 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.749 HD11 ' CE1' ' A' ' 71' ' ' TYR . 46.2 mt -72.91 -33.97 66.33 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.578 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.412 ' HA ' ' HB2' ' A' ' 79' ' ' ARG . 5.0 pt-20 -71.44 -38.18 71.36 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.276 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.889 HG23 ' O ' ' A' ' 73' ' ' SER . 6.5 t -61.66 -46.59 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.611 HD21 HD23 ' A' ' 75' ' ' LEU . 4.4 pp -74.78 -24.35 58.66 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.9 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.412 ' HB2' ' HA ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -63.17 -37.67 88.12 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.225 179.65 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.0 -23.74 17.23 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.862 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.62 HD13 ' HE2' ' A' ' 16' ' ' LYS . 31.1 mt -58.29 106.26 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-O 120.991 0.424 . . . . 0.0 110.672 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.3 -169.68 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.238 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.44 -170.1 2.1 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.28 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 42.98 31.77 0.36 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.136 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.415 ' O ' ' CD1' ' A' ' 15' ' ' PHE . 1.8 t -129.77 159.0 37.87 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 122.095 0.95 . . . . 0.0 113.148 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.12 176.28 5.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.064 -1.426 . . . . 0.0 109.377 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.529 HG13 HD23 ' A' ' 89' ' ' LEU . 0.5 OUTLIER -146.24 159.66 11.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.311 -179.551 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.679 ' C ' HD23 ' A' ' 89' ' ' LEU . 11.2 t -120.29 158.67 22.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.679 HD23 ' C ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -156.81 162.71 39.71 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.884 -178.007 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.704 HD13 ' HA ' ' A' ' 11' ' ' SER . 47.8 mm -128.38 122.99 59.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.112 0.482 . . . . 0.0 111.501 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 22.4 mt . . . . . 0 N--CA 1.453 -0.308 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.193 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.824 HG22 ' HG2' ' A' ' 27' ' ' LYS . 24.3 t . . . . . 0 N--CA 1.465 0.282 0 CA-C-O 120.774 0.321 . . . . 0.0 111.013 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' ASP . . . . . 0.434 ' HB3' HG13 ' B' ' 7' ' ' VAL . 1.6 m-20 -138.58 132.93 31.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.957 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.86 ' CA ' HD23 ' A' ' 25' ' ' LEU . 11.7 p -66.0 -51.37 58.98 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.832 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.707 HG11 HD22 ' A' ' 75' ' ' LEU . 22.5 m . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.264 -0.874 . . . . 0.0 112.619 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.636 HG23 ' N ' ' A' ' 11' ' ' SER . 1.0 OUTLIER . . . . . 0 N--CA 1.454 -0.269 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.668 ' HA ' HD13 ' A' ' 90' ' ' ILE . 1.6 p -101.66 158.44 16.1 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.735 0.778 . . . . 0.0 112.131 -178.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.857 ' CG1' HD12 ' A' ' 89' ' ' LEU . 3.1 t -142.01 153.49 18.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 114.411 -1.268 . . . . 0.0 108.815 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.5 ttp-105 -135.2 128.09 31.33 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.677 0.751 . . . . 0.0 111.498 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.91 HD21 ' HB2' ' A' ' 46' ' ' ALA . 0.4 OUTLIER -124.79 177.83 5.79 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.39 -1.277 . . . . 0.0 109.608 179.66 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.418 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 3.5 t80 -123.15 151.09 42.47 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.524 ' NZ ' HD11 ' A' ' 22' ' ' LEU . 3.8 mptp? -83.15 26.54 0.62 Allowed 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.289 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.841 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.4 OUTLIER 44.79 29.94 0.49 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.833 0.349 . . . . 0.0 111.868 179.562 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.684 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 44.7 23.86 0.09 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.736 -178.477 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.841 HG22 ' O ' ' A' ' 17' ' ' ARG . 2.7 m -168.55 34.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.992 178.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 49.1 63.42 3.97 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.989 -178.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -143.91 54.05 0.58 Allowed Glycine 0 C--N 1.332 0.349 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.015 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.877 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 3.9 mp -39.1 -28.0 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.478 ' HA2' HG22 ' A' ' 41' ' ' ILE . . . 110.2 3.27 29.59 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.819 -1.182 . . . . 0.0 113.776 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.899 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -158.09 141.25 15.06 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.041 0.921 . . . . 0.0 112.933 -179.473 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.954 HD21 HD13 ' A' ' 41' ' ' ILE . 0.8 OUTLIER -89.66 174.59 7.65 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.477 179.437 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.777 HG12 HG21 ' A' ' 58' ' ' ILE . 26.6 m -151.41 165.42 2.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.236 178.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.807 ' HG2' HG22 ' B' ' 4' ' ' VAL . 15.9 mtpt -140.84 99.88 3.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.737 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.489 ' HB3' ' CG ' ' A' ' 71' ' ' TYR . 0.6 OUTLIER -99.34 112.17 24.4 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 178.158 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.23 119.7 3.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.101 0.477 . . . . 0.0 111.11 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.4 ' O ' HG12 ' A' ' 30' ' ' VAL . 52.0 t . . . . . 0 C--N 1.323 -0.544 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.317 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.494 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.2 tp . . . . . 0 C--O 1.221 -0.442 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.5 HG13 HG22 ' A' ' 58' ' ' ILE . 42.7 mt -82.17 153.3 4.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.35 178.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.741 ' HB3' HG11 ' B' ' 4' ' ' VAL . 22.0 t -117.41 -38.06 3.39 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.665 0.616 . . . . 0.0 112.665 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.555 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 1.2 t0 -173.0 140.05 0.87 Allowed 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 120.283 -0.567 . . . . 0.0 112.277 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.899 HD23 ' HB3' ' A' ' 24' ' ' PHE . 40.2 mt -76.46 87.63 3.2 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.795 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.954 HD13 HD21 ' A' ' 25' ' ' LEU . 1.3 tp -39.85 -60.04 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -177.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.46 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 17.6 ttt85 -94.24 -59.23 2.01 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.974 0.416 . . . . 0.0 112.035 -178.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.436 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 98.07 24.29 11.86 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -177.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.418 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -125.85 -28.61 1.03 Allowed Glycine 0 C--N 1.338 0.666 0 C-N-CA 121.111 -0.566 . . . . 0.0 113.479 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.877 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -94.47 -83.44 0.34 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 117.902 0.851 . . . . 0.0 111.459 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.91 ' HB2' HD21 ' A' ' 14' ' ' LEU . . . -61.67 -57.97 9.89 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.235 0.541 . . . . 0.0 110.963 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.814 ' CG ' HD13 ' A' ' 40' ' ' LEU . 7.8 tm-20 -47.61 -48.07 28.56 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.623 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.418 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -56.5 -34.85 67.38 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.98 178.797 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.14 -45.89 75.65 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 112.17 -28.66 9.02 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.526 -0.845 . . . . 0.0 114.54 177.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.547 ' CD1' HD11 ' A' ' 91' ' ' LEU . 2.4 pp -105.0 19.12 21.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.591 0.695 . . . . 0.0 112.051 -179.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.884 HG21 ' HB1' ' A' ' 46' ' ' ALA . 4.9 mp -123.23 81.66 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.891 0.377 . . . . 0.0 110.216 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.498 ' HA ' HD11 ' A' ' 40' ' ' LEU . 3.7 mp0 -112.95 141.37 46.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.144 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.555 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -58.8 134.63 57.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.071 0.462 . . . . 0.0 111.303 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.55 2.48 87.11 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.896 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.84 -93.31 0.09 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.843 0.321 . . . . 0.0 110.566 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.685 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -163.75 119.64 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 179.613 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.981 HD11 HG22 ' A' ' 61' ' ' VAL . 5.9 tp -136.95 82.27 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 177.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.6 tp -78.12 -58.43 3.26 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.97 -177.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.702 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . . . -117.94 145.47 44.66 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.911 0.386 . . . . 0.0 111.722 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.981 HG22 HD11 ' A' ' 58' ' ' ILE . 5.0 t -146.8 145.23 19.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.84 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.539 ' ND2' HG12 ' A' ' 61' ' ' VAL . 0.2 OUTLIER 44.6 41.81 5.16 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.172 0.51 . . . . 0.0 111.995 179.211 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.6 t0 57.63 26.32 12.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.541 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 66' ' ' LEU . 19.3 mmt180 -115.57 101.47 54.23 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.116 179.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.901 ' O ' HD22 ' A' ' 69' ' ' LEU . 51.0 Cg_exo -53.48 85.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.331 2.021 . . . . 0.0 111.626 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 64' ' ' ARG . 8.8 mt -78.68 62.15 3.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.738 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.632 HG23 ' H ' ' A' ' 68' ' ' ASP . 3.1 m -125.49 -65.6 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.632 ' H ' HG23 ' A' ' 67' ' ' VAL . 4.6 p30 -125.74 25.42 6.91 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.901 HD22 ' O ' ' A' ' 65' ' ' PRO . 0.6 OUTLIER -100.4 -179.8 4.22 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.666 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.0 m -68.49 96.64 0.7 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.736 ' CE1' HD21 ' A' ' 75' ' ' LEU . 8.9 t80 -41.01 -57.05 2.12 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.049 0.452 . . . . 0.0 112.057 -178.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -60.67 -28.4 68.57 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.823 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.914 ' O ' HG23 ' A' ' 77' ' ' VAL . 5.0 t -74.24 -43.61 56.36 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.649 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -57.8 -33.93 69.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.501 177.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.736 HD21 ' CE1' ' A' ' 71' ' ' TYR . 3.7 mm? -71.17 -35.99 71.82 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.088 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -74.84 -35.64 62.38 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.035 0.445 . . . . 0.0 109.846 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.914 HG23 ' O ' ' A' ' 73' ' ' SER . 8.4 t -61.83 -43.01 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.874 178.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.658 HD21 HD13 ' A' ' 75' ' ' LEU . 4.1 pp -79.05 -24.7 43.41 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.053 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -40.4 94.68 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.882 0.373 . . . . 0.0 110.21 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -57.03 -20.36 34.14 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.879 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.498 HG22 HG21 ' A' ' 85' ' ' THR . 65.6 mt -57.81 110.66 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 120.98 0.419 . . . . 0.0 111.005 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.09 -164.53 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.45 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.81 -170.7 1.97 Allowed 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.809 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 45.18 31.34 0.76 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.116 0.484 . . . . 0.0 110.873 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.498 HG21 HG22 ' A' ' 81' ' ' ILE . 1.5 t -123.54 162.84 22.13 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.838 0.827 . . . . 0.0 112.658 -178.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -102.8 176.27 5.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.362 -1.29 . . . . 0.0 109.977 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.807 HG11 ' CD2' ' A' ' 22' ' ' LEU . 5.7 p -149.29 156.3 7.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.334 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.845 ' O ' HD23 ' A' ' 89' ' ' LEU . 2.1 t -114.05 161.51 12.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.553 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.857 HD12 ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -154.71 158.32 39.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.216 -178.617 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.702 ' HB ' ' HB3' ' A' ' 60' ' ' ALA . 51.5 mm -133.9 134.77 55.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.547 HD11 ' CD1' ' A' ' 51' ' ' LEU . 7.2 mt . . . . . 0 C--O 1.233 0.205 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.033 177.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.807 HG22 ' HG2' ' A' ' 27' ' ' LYS . 10.5 t . . . . . 0 CA--C 1.519 -0.214 0 CA-C-O 120.802 0.334 . . . . 0.0 110.828 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' ASP . . . . . 0.727 ' OD2' HD11 ' A' ' 75' ' ' LEU . 10.8 p-10 -63.71 -155.26 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.585 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -177.35 102.56 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.185 0.517 . . . . 0.0 110.145 179.543 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.729 ' O ' HD12 ' A' ' 22' ' ' LEU . 23.0 m . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.238 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.444 ' O ' HG23 ' A' ' 90' ' ' ILE . 1.7 mp . . . . . 0 CA--C 1.534 0.335 0 CA-C-O 121.37 0.605 . . . . 0.0 112.541 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.748 ' HA ' HD13 ' A' ' 90' ' ' ILE . 1.9 m -92.79 173.57 7.69 Favored 'General case' 0 C--O 1.23 0.075 0 CA-C-N 115.158 -0.928 . . . . 0.0 113.439 -178.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.886 ' CG1' HD12 ' A' ' 89' ' ' LEU . 1.5 t -159.14 157.47 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 114.29 -1.323 . . . . 0.0 108.786 -179.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -150.75 126.31 10.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.223 0.535 . . . . 0.0 110.837 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.754 ' C ' HG12 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -134.45 178.72 6.77 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.297 -179.229 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.428 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 5.0 t80 -116.37 151.99 34.82 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.433 ' NZ ' HD11 ' A' ' 22' ' ' LEU . 0.8 OUTLIER -85.32 28.11 0.76 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.541 179.448 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.868 ' O ' HG22 ' A' ' 19' ' ' VAL . 7.5 tpt180 43.49 31.8 0.46 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.018 0.437 . . . . 0.0 111.94 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.671 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 43.64 24.98 0.07 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.893 -178.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.868 HG22 ' O ' ' A' ' 17' ' ' ARG . 5.0 m -167.72 33.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.408 -0.814 . . . . 0.0 108.831 178.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.405 ' HA2' ' HE2' ' A' ' 16' ' ' LYS . . . 49.14 61.1 5.63 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.705 -178.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -142.94 55.33 0.58 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.98 -0.629 . . . . 0.0 111.95 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.859 ' CD2' HG11 ' A' ' 87' ' ' VAL . 3.7 mp -40.49 -27.61 0.05 Allowed 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 40' ' ' LEU . . . 114.42 2.49 22.96 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 119.911 -1.137 . . . . 0.0 114.418 178.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.781 ' HB3' HD23 ' A' ' 40' ' ' LEU . 1.6 p90 -154.58 144.37 21.64 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.493 1.147 . . . . 0.0 113.595 -179.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.736 HD23 ' HA ' ' B' ' 6' ' ' SER . 7.6 mt -82.05 172.88 12.72 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.683 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.609 HG12 HG21 ' A' ' 58' ' ' ILE . 33.0 m -150.98 154.24 8.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.248 177.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.419 ' HD3' HG22 ' A' ' 36' ' ' ILE . 11.7 ptmt -135.84 109.64 8.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.959 -179.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.515 ' HB3' ' CG ' ' A' ' 71' ' ' TYR . 0.6 OUTLIER -111.06 142.66 42.92 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.947 179.276 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -75.4 126.94 32.03 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 65.5 t . . . . . 0 C--N 1.327 -0.408 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.912 -179.672 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 36' ' ' ILE . 1.2 tp . . . . . 0 CA--C 1.536 0.43 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.523 HG13 HG22 ' A' ' 58' ' ' ILE . 54.4 mt -85.39 147.73 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.135 179.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.457 ' CB ' HG13 ' B' ' 4' ' ' VAL . 1.4 t -113.66 -37.07 4.69 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.691 ' CB ' HD12 ' A' ' 25' ' ' LEU . 1.5 t0 -172.14 141.38 1.28 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.044 -0.663 . . . . 0.0 112.373 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.781 HD23 ' HB3' ' A' ' 24' ' ' PHE . 51.0 mt -72.55 109.02 5.92 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.526 -0.761 . . . . 0.0 108.978 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.542 ' CD1' HD21 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -63.52 -59.67 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -176.392 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.464 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -94.15 -67.38 0.86 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.15 0.5 . . . . 0.0 111.985 -178.229 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 112.55 23.76 5.27 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.517 -178.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -128.17 -30.07 0.75 Allowed Glycine 0 C--N 1.338 0.643 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.613 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.854 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -93.53 -83.33 0.33 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 117.823 0.812 . . . . 0.0 111.512 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.779 ' HB1' HG21 ' A' ' 52' ' ' ILE . . . -61.74 -55.22 32.55 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.123 0.487 . . . . 0.0 110.927 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.663 ' HG3' HD13 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -50.17 -48.26 54.1 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.975 179.496 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -57.07 -35.84 69.85 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.203 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.2 m -57.3 -46.14 83.45 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.943 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.97 -21.71 44.63 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.392 -0.909 . . . . 0.0 113.011 179.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.844 ' HG ' HD12 ' A' ' 52' ' ' ILE . 2.1 pp -82.05 -31.59 30.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.176 0.512 . . . . 0.0 109.643 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.844 HD12 ' HG ' ' A' ' 51' ' ' LEU . 3.6 mp -82.29 137.51 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.237 179.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.433 ' O ' HD12 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -157.71 150.45 22.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.619 179.798 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.591 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -68.62 122.08 17.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.882 0.372 . . . . 0.0 110.928 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.58 -6.5 80.14 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.359 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.92 -91.61 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 117.001 0.4 . . . . 0.0 110.818 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.561 HG23 HD22 ' A' ' 91' ' ' LEU . 1.1 tp -163.28 123.02 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.609 HG21 HG12 ' A' ' 26' ' ' VAL . 2.4 tp -140.91 84.42 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 176.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.551 HD11 HG11 ' A' ' 67' ' ' VAL . 57.5 tp -77.16 -61.02 2.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.789 -178.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.721 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . . . -120.85 161.87 20.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.957 0.408 . . . . 0.0 111.439 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.796 HG12 HD12 ' A' ' 66' ' ' LEU . 14.0 p -163.24 145.18 2.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.375 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.639 ' ND2' HG22 ' A' ' 61' ' ' VAL . 0.1 OUTLIER 45.13 41.91 6.22 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.239 0.542 . . . . 0.0 111.379 -179.777 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.14 29.1 16.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.06 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.4 ' HD2' HG11 ' A' ' 77' ' ' VAL . 6.6 mmp_? -115.58 96.6 46.67 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.415 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.83 ' O ' HD22 ' A' ' 69' ' ' LEU . 18.4 Cg_endo -59.85 86.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 121.856 1.704 . . . . 0.0 110.874 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.796 HD12 HG12 ' A' ' 61' ' ' VAL . 0.7 OUTLIER -71.96 63.59 0.48 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.423 -178.68 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.551 HG11 HD11 ' A' ' 59' ' ' LEU . 3.5 m -143.51 -61.35 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.543 ' H ' HG23 ' A' ' 67' ' ' VAL . 2.2 p30 -109.32 28.78 8.17 Favored 'General case' 0 CA--C 1.518 -0.266 0 O-C-N 121.966 -0.459 . . . . 0.0 111.997 -178.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.83 HD22 ' O ' ' A' ' 65' ' ' PRO . 0.3 OUTLIER -124.85 174.17 8.12 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.515 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.98 107.78 2.81 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.796 ' CE1' HD11 ' A' ' 75' ' ' LEU . 7.5 t80 -43.76 -58.4 2.73 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.015 0.436 . . . . 0.0 111.896 -179.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -58.0 -27.34 63.41 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.341 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.891 ' O ' HG23 ' A' ' 77' ' ' VAL . 4.8 m -77.29 -38.63 50.36 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.253 0.549 . . . . 0.0 110.019 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.726 ' HB2' HD21 ' A' ' 69' ' ' LEU . . . -63.39 -38.52 91.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.825 178.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.796 HD11 ' CE1' ' A' ' 71' ' ' TYR . 16.0 mt -73.17 -32.38 64.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.462 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 73' ' ' SER . 5.0 pt-20 -76.35 -38.82 55.31 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.848 0.356 . . . . 0.0 110.283 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.891 HG23 ' O ' ' A' ' 73' ' ' SER . 48.8 t -61.98 -41.3 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.55 ' C ' HD12 ' A' ' 78' ' ' LEU . 4.3 pp -80.14 -22.11 42.39 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.322 179.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.482 ' N ' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -68.24 -38.11 81.49 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.464 179.782 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.82 -12.77 57.87 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.134 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 84.9 mt -53.13 118.9 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 120.989 0.423 . . . . 0.0 111.169 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.55 -173.99 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.898 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -98.63 -173.28 2.5 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.287 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 42.04 32.31 0.29 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.15 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.5 t -123.94 162.26 23.73 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.881 0.848 . . . . 0.0 112.577 -178.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -97.9 177.11 5.55 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.477 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.859 HG11 ' CD2' ' A' ' 22' ' ' LEU . 2.3 p -151.38 148.25 14.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.329 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.839 ' O ' HD23 ' A' ' 89' ' ' LEU . 6.2 t -108.3 162.67 6.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.886 HD12 ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -159.8 172.16 18.18 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -179.435 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.748 HD13 ' HA ' ' A' ' 11' ' ' SER . 29.4 mm -131.36 120.96 47.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -178.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.561 HD22 HG23 ' A' ' 57' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.308 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 176.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.473 HG11 HD13 ' A' ' 25' ' ' LEU . 21.9 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.924 0.392 . . . . 0.0 110.963 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.71 127.53 45.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.828 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.736 ' HA ' HD23 ' A' ' 25' ' ' LEU . 30.5 t -73.73 149.46 41.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.417 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.443 HG23 HD13 ' A' ' 22' ' ' LEU . 27.0 m . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.382 -179.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.667 HG23 ' N ' ' A' ' 11' ' ' SER . 1.0 OUTLIER . . . . . 0 CA--C 1.538 0.512 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.712 ' HA ' HD13 ' A' ' 90' ' ' ILE . 3.6 t -72.64 164.26 26.77 Favored 'General case' 0 CA--C 1.527 0.06 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.594 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.791 ' CG1' HD12 ' A' ' 89' ' ' LEU . 1.7 t -158.27 160.71 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 114.592 -1.185 . . . . 0.0 108.698 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.485 ' O ' HD12 ' A' ' 14' ' ' LEU . 17.6 ttp180 -143.69 143.8 31.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.564 0.697 . . . . 0.0 111.617 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.856 HD21 ' HB2' ' A' ' 46' ' ' ALA . 0.8 OUTLIER -142.63 176.69 8.84 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.821 179.681 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.473 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 3.9 t80 -132.03 148.26 52.49 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.57 34.14 0.43 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.333 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.898 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.8 OUTLIER 38.21 32.89 0.05 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.22 0.608 . . . . 0.0 112.259 179.503 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.589 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 44.5 23.67 0.08 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.517 -178.356 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.898 HG22 ' O ' ' A' ' 17' ' ' ARG . 8.0 m -164.54 31.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.48 178.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 52.99 67.25 2.21 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.631 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -153.78 69.38 0.3 Allowed Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 111.599 -0.601 . . . . 0.0 111.599 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.878 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 4.1 mp -52.01 -22.79 4.33 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.429 ' HA2' HG22 ' A' ' 41' ' ' ILE . . . 103.48 6.12 44.72 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.25 -0.976 . . . . 0.0 113.735 179.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.892 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -157.95 140.3 14.43 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 117.982 0.891 . . . . 0.0 113.356 -179.529 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.841 HD23 ' HA ' ' B' ' 6' ' ' SER . 14.7 mt -80.16 171.46 15.05 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.118 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.439 HG12 HG21 ' A' ' 58' ' ' ILE . 35.2 m -153.89 153.72 8.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.607 177.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.9 ptmt -140.45 108.08 5.62 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.93 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.482 ' HB3' ' CD1' ' A' ' 71' ' ' TYR . 4.9 tm-20 -106.23 129.97 54.18 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.705 178.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -83.88 121.49 27.42 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.051 0.453 . . . . 0.0 110.689 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.0 t . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.025 -179.665 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.702 HD11 HD12 ' A' ' 57' ' ' ILE . 1.1 tp . . . . . 0 CA--C 1.538 0.503 0 CA-C-O 120.582 0.23 . . . . 0.0 111.585 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.7 HD12 ' O ' ' A' ' 53' ' ' GLN . 26.5 mt -79.75 146.75 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 120.737 0.303 . . . . 0.0 111.319 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.48 ' CB ' HG13 ' B' ' 4' ' ' VAL . 4.0 t -113.98 -36.68 4.7 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.597 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -171.84 135.67 0.86 Allowed 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 120.111 -0.636 . . . . 0.0 112.295 -179.707 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.892 HD23 ' HB3' ' A' ' 24' ' ' PHE . 40.6 mt -72.73 77.42 1.11 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 121.788 0.804 . . . . 0.0 109.876 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.571 HD13 ' CD2' ' A' ' 25' ' ' LEU . 1.4 tp -33.79 -60.15 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -177.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.467 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 1.5 ttt85 -94.96 -62.25 1.35 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -177.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.431 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 99.79 28.42 7.42 Favored Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -177.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -126.52 -32.25 0.73 Allowed Glycine 0 C--N 1.337 0.592 0 C-N-CA 121.337 -0.459 . . . . 0.0 113.232 -178.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.878 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -95.34 -83.33 0.36 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 117.587 0.694 . . . . 0.0 111.906 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.856 ' HB2' HD21 ' A' ' 14' ' ' LEU . . . -60.38 -60.06 4.41 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.158 0.504 . . . . 0.0 111.234 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.678 ' CG ' HD13 ' A' ' 40' ' ' LEU . 7.7 tm-20 -45.29 -48.26 13.02 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.784 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 44' ' ' GLY . 6.6 mm-40 -54.97 -39.69 69.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.276 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.3 m -53.23 -46.2 69.02 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.015 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.08 -21.63 33.18 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.452 -0.88 . . . . 0.0 113.821 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.726 HD13 HD11 ' A' ' 91' ' ' LEU . 2.9 pp -97.21 -7.8 31.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.064 0.432 . . . . 0.0 111.58 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.75 ' CB ' ' HB1' ' A' ' 46' ' ' ALA . 5.4 mp -104.71 125.12 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-O 120.901 0.382 . . . . 0.0 110.391 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.7 ' O ' HD12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -150.81 156.28 40.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.667 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.597 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -71.76 127.8 33.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.937 0.399 . . . . 0.0 111.184 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.08 -1.13 89.22 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.087 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.92 -92.97 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 117.039 0.419 . . . . 0.0 109.995 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.702 HD12 HD11 ' A' ' 36' ' ' ILE . 6.9 tp -164.96 119.55 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.569 ' O ' HG23 ' A' ' 58' ' ' ILE . 2.6 tp -135.32 88.15 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.9 tp -78.96 -68.24 0.67 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.061 -178.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.418 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . . . -111.44 158.56 18.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.233 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.711 HG23 HD22 ' A' ' 89' ' ' LEU . 14.8 p -162.73 147.39 3.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.306 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.583 ' ND2' HG22 ' A' ' 61' ' ' VAL . 0.3 OUTLIER 44.79 42.77 6.31 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 121.145 0.498 . . . . 0.0 111.498 -179.5 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.9 t0 56.81 28.87 15.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.209 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.544 ' O ' HD12 ' A' ' 66' ' ' LEU . 6.2 mmp_? -118.55 95.8 49.22 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.903 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.518 ' O ' HD23 ' A' ' 69' ' ' LEU . 18.5 Cg_endo -59.89 86.67 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 121.819 1.679 . . . . 0.0 111.128 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.544 HD12 ' O ' ' A' ' 64' ' ' ARG . 0.4 OUTLIER -83.86 63.51 7.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.531 0.681 . . . . 0.0 110.463 -179.459 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.418 HG23 ' N ' ' A' ' 68' ' ' ASP . 3.9 m -117.17 -50.91 4.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.986 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.418 ' N ' HG23 ' A' ' 67' ' ' VAL . 2.8 m-20 -138.65 22.5 2.69 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.814 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.776 HD21 ' HB2' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -100.41 172.6 7.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.244 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.442 ' H ' HD12 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -66.6 106.35 1.77 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.216 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.917 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 7.5 t80 -45.18 -60.84 1.9 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.684 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -54.86 -31.92 60.13 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.296 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.8 ' O ' HG23 ' A' ' 77' ' ' VAL . 6.3 t -74.57 -44.09 52.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.166 0.507 . . . . 0.0 109.657 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.776 ' HB2' HD21 ' A' ' 69' ' ' LEU . . . -59.83 -40.32 88.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.225 178.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.917 HD11 ' CZ ' ' A' ' 71' ' ' TYR . 73.5 mt -71.02 -31.38 67.87 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.638 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -75.7 -39.24 57.73 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.126 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 73' ' ' SER . 39.4 t -61.28 -39.84 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.924 179.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.607 HD12 ' N ' ' A' ' 79' ' ' ARG . 4.5 pp -80.58 -25.4 38.55 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.925 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.607 ' N ' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -62.63 -37.61 87.01 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.977 0.418 . . . . 0.0 110.361 179.645 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -58.66 -18.73 39.5 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.848 -0.691 . . . . 0.0 113.024 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.491 HG22 HG21 ' A' ' 85' ' ' THR . 48.0 mt -56.23 122.25 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 120.924 0.392 . . . . 0.0 111.114 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.43 -163.38 0.09 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.312 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.36 -169.67 2.02 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.988 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 40.9 33.33 0.2 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.235 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.491 HG21 HG22 ' A' ' 81' ' ' ILE . 1.8 t -123.7 157.71 33.28 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 122.206 1.003 . . . . 0.0 113.122 -177.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -100.11 175.51 5.72 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.877 -1.511 . . . . 0.0 109.712 179.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.805 HG12 ' C ' ' A' ' 14' ' ' LEU . 5.0 p -150.87 153.9 9.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.083 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.621 ' O ' HD23 ' A' ' 89' ' ' LEU . 25.0 t -115.01 158.37 15.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.205 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.853 HD21 ' HB2' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -154.01 169.72 22.83 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.516 -178.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.712 HD13 ' HA ' ' A' ' 11' ' ' SER . 34.3 mm -136.28 123.16 32.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.636 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.726 HD11 HD13 ' A' ' 51' ' ' LEU . 9.4 mt . . . . . 0 CA--C 1.514 -0.429 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 176.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.48 HG13 ' CB ' ' A' ' 38' ' ' SER . 3.4 t . . . . . 0 N--CA 1.461 0.094 0 CA-C-O 120.755 0.312 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -125.56 127.25 46.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.847 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.841 ' HA ' HD23 ' A' ' 25' ' ' LEU . 7.9 p -86.53 116.52 24.71 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.059 0.457 . . . . 0.0 110.925 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.559 HG23 HD13 ' A' ' 22' ' ' LEU . 19.6 m . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.251 -0.881 . . . . 0.0 111.226 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.414 ' N ' ' O ' ' A' ' 91' ' ' LEU . 1.2 tp . . . . . 0 C--O 1.226 -0.17 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.588 ' HA ' HD13 ' A' ' 90' ' ' ILE . 5.0 m -90.55 151.39 21.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.501 178.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.818 HG21 ' HG ' ' A' ' 91' ' ' LEU . 2.7 t -138.8 160.55 30.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.2 ttp85 -138.3 140.84 39.74 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.616 0.722 . . . . 0.0 112.0 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.801 ' C ' HG12 ' A' ' 87' ' ' VAL . 0.6 OUTLIER -142.19 176.24 9.13 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.45 179.331 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.446 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 3.4 t80 -127.65 146.45 50.55 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -80.82 36.49 0.39 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.226 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.891 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.6 OUTLIER 35.11 34.03 0.02 OUTLIER 'General case' 0 C--N 1.352 0.707 0 C-N-CA 123.714 0.805 . . . . 0.0 112.502 179.681 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.568 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 43.25 24.82 0.05 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.409 -178.334 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.891 HG22 ' O ' ' A' ' 17' ' ' ARG . 15.7 m -164.94 31.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.234 178.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 52.38 68.51 1.54 Allowed Glycine 0 C--N 1.338 0.689 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.376 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -155.27 69.27 0.29 Allowed Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 111.749 -0.541 . . . . 0.0 111.749 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.816 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 4.0 mp -50.08 -22.8 1.77 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.42 ' HA2' HG22 ' A' ' 41' ' ' ILE . . . 107.75 4.99 34.01 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.274 -0.965 . . . . 0.0 113.425 179.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.907 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -158.59 139.09 12.58 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -179.635 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.908 HD23 ' HA ' ' B' ' 6' ' ' SER . 5.4 mt -79.18 169.59 17.92 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.54 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.8 m -152.47 156.93 5.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 120.123 -0.631 . . . . 0.0 111.721 177.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.469 ' CG ' HG22 ' A' ' 36' ' ' ILE . 13.3 ptmt -138.17 107.05 5.95 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.683 -178.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.465 ' HB3' ' CG ' ' A' ' 71' ' ' TYR . 2.1 tm-20 -101.07 111.33 23.51 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -64.45 119.08 9.73 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.026 0.441 . . . . 0.0 110.378 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 30' ' ' VAL . 53.4 t . . . . . 0 C--N 1.325 -0.474 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.363 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.469 HG22 ' CG ' ' A' ' 27' ' ' LYS . 0.7 OUTLIER . . . . . 0 CA--C 1.536 0.41 0 CA-C-O 120.544 0.211 . . . . 0.0 111.11 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.738 HD12 ' O ' ' A' ' 53' ' ' GLN . 20.6 mt -93.16 151.07 3.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.631 0.253 . . . . 0.0 111.059 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.537 ' CB ' HG13 ' B' ' 4' ' ' VAL . 2.4 t -116.01 -40.61 3.28 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.656 ' CB ' HD12 ' A' ' 25' ' ' LEU . 1.3 t0 -167.12 132.99 2.16 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 120.15 -0.62 . . . . 0.0 112.447 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.907 HD23 ' HB3' ' A' ' 24' ' ' PHE . 56.4 mt -69.05 77.29 0.33 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.46 0.648 . . . . 0.0 109.797 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.568 HD13 ' HG ' ' A' ' 25' ' ' LEU . 1.4 tp -33.28 -59.16 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -177.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.465 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -94.25 -65.88 0.96 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.198 0.523 . . . . 0.0 111.797 -178.263 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.488 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 105.84 13.97 22.37 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.634 -178.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.403 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -117.93 -25.86 2.93 Favored Glycine 0 C--N 1.341 0.812 0 C-N-CA 121.022 -0.609 . . . . 0.0 113.391 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.816 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -94.07 -83.09 0.34 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 117.777 0.789 . . . . 0.0 111.36 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.829 ' HB1' HG21 ' A' ' 52' ' ' ILE . . . -62.02 -60.34 3.76 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.187 0.518 . . . . 0.0 111.454 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.718 ' HB2' HD13 ' A' ' 40' ' ' LEU . 4.1 tp10 -48.39 -44.37 34.7 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.079 0.466 . . . . 0.0 110.803 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.403 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 5.2 tp-100 -58.62 -34.09 70.77 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.3 t -54.99 -49.68 70.87 Favored 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 115.77 -22.77 11.42 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.251 -0.976 . . . . 0.0 114.639 177.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.856 HD11 ' CD1' ' A' ' 91' ' ' LEU . 0.3 OUTLIER -99.26 -32.53 11.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.523 0.662 . . . . 0.0 110.802 -179.58 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.829 HG21 ' HB1' ' A' ' 46' ' ' ALA . 4.9 mp -72.12 115.8 13.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.143 0.497 . . . . 0.0 110.631 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.738 ' O ' HD12 ' A' ' 37' ' ' ILE . 2.0 tt0 -139.41 148.79 43.27 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.851 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.423 ' CB ' ' HA ' ' A' ' 39' ' ' ASP . . . -75.57 145.76 40.97 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.242 0.544 . . . . 0.0 112.186 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.62 18.44 68.02 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.672 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -109.33 -84.11 0.55 Allowed 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 120.421 0.153 . . . . 0.0 111.348 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.613 HD11 HD21 ' A' ' 59' ' ' LEU . 2.3 tt -163.27 133.4 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.785 HD11 HG22 ' A' ' 61' ' ' VAL . 2.7 tp -155.31 96.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.443 -1.253 . . . . 0.0 107.99 177.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.613 HD21 HD11 ' A' ' 57' ' ' ILE . 2.8 mt -79.27 -68.77 0.63 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.969 -0.292 . . . . 0.0 111.637 -177.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.599 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . . . -116.43 160.15 20.97 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.01 0.433 . . . . 0.0 111.692 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.785 HG22 HD11 ' A' ' 58' ' ' ILE . 2.7 t -154.03 147.29 13.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.606 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 42.98 44.16 3.9 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.187 0.518 . . . . 0.0 111.932 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 t70 56.33 29.45 15.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.275 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.401 ' O ' ' N ' ' A' ' 66' ' ' LEU . 3.4 mmp_? -117.55 98.58 51.9 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.418 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.507 ' O ' HD23 ' A' ' 69' ' ' LEU . 38.3 Cg_exo -57.08 85.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.058 1.839 . . . . 0.0 111.464 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.55 HD21 ' HB3' ' A' ' 74' ' ' ALA . 1.2 mt -86.48 61.55 6.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.412 0.625 . . . . 0.0 110.462 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 m -113.81 -47.73 5.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.24 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -145.88 23.77 1.37 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.608 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.748 HD21 ' HB2' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -96.77 173.38 7.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.649 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.645 ' H ' HD12 ' A' ' 69' ' ' LEU . 49.2 m -64.22 99.64 0.29 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.734 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 5.8 t80 -42.36 -58.72 2.09 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.307 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -58.13 -32.49 68.19 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.32 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.901 ' O ' HG23 ' A' ' 77' ' ' VAL . 3.6 t -74.82 -41.7 59.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.077 0.465 . . . . 0.0 109.767 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.748 ' HB2' HD21 ' A' ' 69' ' ' LEU . . . -61.14 -40.75 94.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.308 0.575 . . . . 0.0 110.27 178.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.734 HD11 ' CZ ' ' A' ' 71' ' ' TYR . 72.5 mt -71.43 -31.89 67.73 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.016 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -74.16 -41.16 61.94 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.023 0.439 . . . . 0.0 109.934 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 73' ' ' SER . 22.0 t -59.58 -41.18 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.045 178.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.589 HD21 HD23 ' A' ' 75' ' ' LEU . 4.5 pp -82.39 -22.48 35.39 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.541 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.4 ' N ' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -65.42 -37.49 87.07 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.332 179.604 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.4 -20.4 29.75 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.896 -0.668 . . . . 0.0 113.034 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 69.0 mt -56.31 123.07 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-O 120.877 0.37 . . . . 0.0 111.103 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.05 -161.64 0.22 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.259 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.3 m -95.29 -170.19 2.13 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.678 0.275 . . . . 0.0 110.984 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 45.0 30.41 0.57 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.169 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.417 ' O ' ' CE1' ' A' ' 15' ' ' PHE . 1.8 t -127.88 158.27 38.24 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 122.024 0.916 . . . . 0.0 112.967 -178.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -99.98 176.57 5.38 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.106 -1.406 . . . . 0.0 110.374 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.801 HG12 ' C ' ' A' ' 14' ' ' LEU . 3.9 p -150.32 155.16 7.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.382 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.796 ' O ' HD23 ' A' ' 89' ' ' LEU . 5.1 t -114.81 162.34 12.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.796 HD23 ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -154.51 174.81 14.4 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 -178.747 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.678 ' O ' HD23 ' A' ' 91' ' ' LEU . 49.9 mm -134.52 131.83 54.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.856 ' CD1' HD11 ' A' ' 51' ' ' LEU . 55.6 mt . . . . . 0 C--O 1.224 -0.244 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.95 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.537 HG13 ' CB ' ' A' ' 38' ' ' SER . 3.4 t . . . . . 0 CA--C 1.519 -0.215 0 CA-C-O 120.927 0.394 . . . . 0.0 110.823 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.51 -103.32 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.292 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.908 ' HA ' HD23 ' A' ' 25' ' ' LEU . 4.9 t 162.36 109.45 0.0 OUTLIER 'General case' 0 C--N 1.345 0.409 0 CA-C-O 121.159 0.504 . . . . 0.0 109.843 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.738 ' O ' HD12 ' A' ' 22' ' ' LEU . 27.8 m . . . . . 0 C--O 1.245 0.839 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.892 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 112.454 -0.258 . . . . 0.0 112.454 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.6 p -169.13 152.58 5.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.882 0.372 . . . . 0.0 110.91 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.9 m170 60.51 63.34 1.37 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.834 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.4 mtt -132.9 163.33 29.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.719 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.643 HG23 ' N ' ' A' ' 6' ' ' GLU . 0.3 OUTLIER -153.89 -164.37 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.578 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.643 ' N ' HG23 ' A' ' 5' ' ' ILE . 7.0 mm-40 -144.84 -67.86 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.534 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.745 ' HB3' HD12 ' A' ' 114' ' ' ILE . 5.6 Cg_endo -48.08 176.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.4 2.067 . . . . 0.0 112.685 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -150.09 -74.22 0.16 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.597 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.561 HG23 ' HA ' ' A' ' 92' ' ' ARG . 14.7 p -161.84 113.37 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.899 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.662 HG23 ' N ' ' A' ' 11' ' ' SER . 1.4 tp -161.19 -164.61 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.749 ' HA ' HD13 ' A' ' 90' ' ' ILE . 0.7 OUTLIER -85.66 166.27 16.31 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.475 0.655 . . . . 0.0 112.536 -179.338 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.744 ' CG1' HD12 ' A' ' 89' ' ' LEU . 1.6 t -156.05 163.61 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.313 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -149.6 131.97 15.61 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.497 0.665 . . . . 0.0 110.778 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.804 HD21 ' HB2' ' A' ' 46' ' ' ALA . 0.3 OUTLIER -135.03 177.46 7.79 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.419 -179.431 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.408 ' CD1' ' O ' ' A' ' 85' ' ' THR . 4.5 t80 -124.1 151.39 43.94 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.644 ' HD3' HG21 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -81.62 27.15 0.45 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.685 179.453 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.822 ' O ' HG22 ' A' ' 19' ' ' VAL . 9.6 tpt180 43.31 31.04 0.35 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.905 0.383 . . . . 0.0 111.916 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.704 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 44.47 23.47 0.07 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.708 -178.642 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.822 HG22 ' O ' ' A' ' 17' ' ' ARG . 2.9 m -169.14 34.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 49.0 65.87 2.47 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.746 -178.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 17' ' ' ARG . . . -148.19 54.99 0.51 Allowed Glycine 0 C--N 1.331 0.29 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.104 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.909 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 4.1 mp -38.44 -26.96 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 40' ' ' LEU . . . 118.35 -4.13 15.66 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 119.954 -1.117 . . . . 0.0 113.815 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.927 ' HB3' HD23 ' A' ' 40' ' ' LEU . 5.1 p90 -152.83 144.53 23.52 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.933 HD23 ' HA ' ' B' ' 6' ' ' SER . 1.6 mt -80.19 170.21 16.74 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.3 178.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.626 HG22 ' OD1' ' B' ' 5' ' ' ASP . 29.0 m -149.32 157.59 6.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 C-N-CA 119.989 -0.685 . . . . 0.0 111.308 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.473 ' HE3' HG22 ' B' ' 4' ' ' VAL . 1.3 ptpt -135.22 104.96 6.09 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.348 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.498 ' HB3' ' CG ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -101.64 118.71 37.51 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.738 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.423 ' CB ' ' HB2' ' A' ' 32' ' ' LYS . 19.2 mmt180 -63.6 114.77 4.15 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 121.254 0.55 . . . . 0.0 110.379 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.6 t -51.95 -18.93 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.141 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.405 ' O ' ' CG ' ' A' ' 32' ' ' LYS . 33.2 m -133.78 32.47 3.54 Favored 'General case' 0 C--N 1.334 -0.07 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.75 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.423 ' HB2' ' CB ' ' A' ' 29' ' ' ARG . 5.7 mtpp -164.73 139.96 4.51 Favored Pre-proline 0 CA--C 1.536 0.406 0 O-C-N 123.132 0.27 . . . . 0.0 110.613 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.425 ' O ' HG12 ' A' ' 67' ' ' VAL . 34.5 Cg_exo -59.86 -46.91 17.48 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.33 2.02 . . . . 0.0 113.475 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 33' ' ' PRO . 70.8 Cg_exo -41.89 94.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.708 2.272 . . . . 0.0 114.678 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.459 HG11 ' O ' ' A' ' 66' ' ' LEU . 13.0 p -105.77 150.89 8.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.465 ' HA ' HG22 ' A' ' 58' ' ' ILE . 1.2 tp -157.37 175.64 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -178.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.51 HG23 ' O ' ' A' ' 25' ' ' LEU . 28.0 mt -92.67 147.68 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.641 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.5 ' OG ' HG13 ' B' ' 4' ' ' VAL . 0.8 OUTLIER -113.63 -35.58 5.16 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -179.67 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.545 ' CB ' HD12 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -166.2 135.64 3.19 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 120.441 -0.504 . . . . 0.0 112.032 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.927 HD23 ' HB3' ' A' ' 24' ' ' PHE . 49.3 mt -72.92 79.28 1.16 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.671 0.748 . . . . 0.0 110.489 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.773 HD13 HD21 ' A' ' 25' ' ' LEU . 1.8 tp -32.9 -59.5 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.462 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -95.47 -67.7 0.84 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.218 0.532 . . . . 0.0 112.139 -178.142 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 106.91 26.52 5.76 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -177.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -128.31 -28.6 0.83 Allowed Glycine 0 C--N 1.339 0.722 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.73 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.909 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -94.12 -83.01 0.34 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.055 0.928 . . . . 0.0 111.582 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.804 ' HB2' HD21 ' A' ' 14' ' ' LEU . . . -65.04 -53.82 39.96 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.079 0.466 . . . . 0.0 110.9 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.668 ' CG ' HD13 ' A' ' 40' ' ' LEU . 54.1 tt0 -49.86 -47.28 51.89 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.046 0.451 . . . . 0.0 110.463 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.417 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 5.6 tp-100 -59.14 -33.2 70.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.833 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.9 t -55.19 -48.47 73.77 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.622 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.07 -21.85 28.53 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.183 -1.008 . . . . 0.0 114.288 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.944 HD13 HD11 ' A' ' 91' ' ' LEU . 0.6 OUTLIER -100.12 -3.93 30.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.574 0.687 . . . . 0.0 111.616 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.759 HG21 ' CD2' ' A' ' 24' ' ' PHE . 5.0 mp -103.93 138.87 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-O 120.83 0.347 . . . . 0.0 110.402 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -154.4 158.99 40.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.348 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.424 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -71.41 125.25 26.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.921 0.391 . . . . 0.0 111.115 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.86 14.72 73.32 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.653 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.67 ' O ' HD13 ' A' ' 57' ' ' ILE . 1.5 m-20 -92.69 -85.37 0.26 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.67 HD13 ' O ' ' A' ' 56' ' ' ASP . 18.0 mm -148.86 115.78 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -178.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.508 HG21 HG12 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -160.47 113.81 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.674 177.042 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.416 ' N ' HD13 ' A' ' 58' ' ' ILE . 1.7 tp -116.6 -67.04 1.02 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.059 0.457 . . . . 0.0 110.584 -178.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.511 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . . . -104.95 160.91 14.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.236 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.77 HG12 HD12 ' A' ' 66' ' ' LEU . 14.3 p -166.95 145.28 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.482 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.658 ' ND2' HG22 ' A' ' 61' ' ' VAL . 0.7 OUTLIER 44.86 40.0 4.0 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.031 0.444 . . . . 0.0 111.678 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.6 t70 58.67 28.14 16.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.281 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.651 ' HD3' HG11 ' A' ' 77' ' ' VAL . 15.6 mmm180 -118.07 97.51 50.8 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.572 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.839 ' O ' HD22 ' A' ' 69' ' ' LEU . 31.7 Cg_exo -57.81 86.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.032 1.821 . . . . 0.0 110.999 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.77 HD12 HG12 ' A' ' 61' ' ' VAL . 6.6 mt -72.46 62.84 0.54 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.985 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.595 HG23 ' H ' ' A' ' 68' ' ' ASP . 3.1 m -139.64 -63.57 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.595 ' H ' HG23 ' A' ' 67' ' ' VAL . 7.2 t0 -112.49 28.3 8.89 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -178.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.839 HD22 ' O ' ' A' ' 65' ' ' PRO . 0.3 OUTLIER -118.08 176.66 5.11 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.447 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.6 m -68.09 98.75 0.81 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.671 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 6.2 t80 -40.83 -55.63 2.4 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.215 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -58.16 -30.88 66.72 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.195 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.741 ' O ' HG23 ' A' ' 77' ' ' VAL . 1.6 t -75.54 -43.63 47.73 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.739 ' HB2' HD21 ' A' ' 69' ' ' LEU . . . -60.21 -38.89 84.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.417 178.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.682 HD22 ' OD2' ' B' ' 5' ' ' ASP . 63.4 mt -68.61 -30.08 68.73 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.023 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -73.32 -40.0 64.83 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 120.981 0.42 . . . . 0.0 109.943 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.741 HG23 ' O ' ' A' ' 73' ' ' SER . 14.7 t -59.87 -42.96 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.739 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.552 ' C ' HD12 ' A' ' 78' ' ' LEU . 4.2 pp -79.2 -24.79 42.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.959 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.53 ' N ' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -67.39 -48.27 67.86 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.101 0.477 . . . . 0.0 110.062 179.461 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.01 -22.9 13.84 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.978 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.644 HG21 ' HD3' ' A' ' 16' ' ' LYS . 55.6 mt -52.76 114.69 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 120.878 0.371 . . . . 0.0 111.149 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.24 -167.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.185 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.2 m -95.4 -172.33 2.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.949 0.404 . . . . 0.0 111.117 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 45.56 30.33 0.75 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.128 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.425 HG21 HG22 ' A' ' 81' ' ' ILE . 1.8 t -123.66 159.15 29.95 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.88 0.847 . . . . 0.0 112.391 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -100.49 176.44 5.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.575 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.779 HG12 ' C ' ' A' ' 14' ' ' LEU . 2.8 p -153.03 150.06 12.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.584 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.705 ' O ' HD23 ' A' ' 89' ' ' LEU . 24.0 t -111.39 156.9 12.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.744 HD12 ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -152.57 168.84 24.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.692 0.282 . . . . 0.0 111.222 -178.496 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.749 HD13 ' HA ' ' A' ' 11' ' ' SER . 47.1 mm -136.69 128.51 43.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.82 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.944 HD11 HD13 ' A' ' 51' ' ' LEU . 62.5 mt -86.55 142.64 28.16 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 176.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.561 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -113.66 157.45 22.13 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.096 0.474 . . . . 0.0 112.278 -178.567 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 165.23 -147.32 12.28 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.082 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -58.69 -155.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.623 2.215 . . . . 0.0 112.36 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -158.97 -175.84 5.52 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.576 0.227 . . . . 0.0 110.736 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.41 ' O ' ' CD1' ' A' ' 97' ' ' PHE . . . 74.96 16.52 80.49 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.321 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.468 ' HB3' HG23 ' A' ' 117' ' ' THR . 61.9 m-85 -153.02 142.24 21.49 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 117.044 0.422 . . . . 0.0 111.849 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.724 HG22 HD22 ' A' ' 120' ' ' LEU . 0.1 OUTLIER -96.23 117.99 31.88 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.453 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.606 HG23 ' O ' ' A' ' 99' ' ' THR . 11.0 t -111.53 92.2 3.95 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.433 0.635 . . . . 0.0 111.157 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.519 ' C ' HG23 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -74.6 -159.03 0.08 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.123 179.356 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.684 HD13 ' N ' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -118.27 140.91 49.1 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.977 0.418 . . . . 0.0 111.321 179.801 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.534 ' O ' HG22 ' A' ' 103' ' ' THR . 5.0 tt0 178.24 169.52 0.78 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.346 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 102' ' ' GLU . 9.3 t 47.72 -167.95 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.567 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.15 147.52 14.67 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.126 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.403 ' CG ' ' HA2' ' A' ' 109' ' ' GLY . 39.1 p90 -63.41 174.65 1.2 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.824 0.345 . . . . 0.0 111.0 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.9 t -174.69 -40.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.979 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -66.96 -56.82 11.01 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.503 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -162.82 36.67 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.819 0.342 . . . . 0.0 110.882 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.403 ' HA2' ' CG ' ' A' ' 105' ' ' PHE . . . 71.14 56.73 6.72 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.618 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.498 ' HB ' ' HD3' ' A' ' 111' ' ' PRO . 1.1 m -112.21 -65.94 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 116.43 0.115 . . . . 0.0 111.213 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.498 ' HD3' ' HB ' ' A' ' 110' ' ' THR . 54.5 Cg_exo -48.32 -64.38 0.24 Allowed 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.07 1.847 . . . . 0.0 111.815 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 111' ' ' PRO . 0.3 OUTLIER 70.21 160.53 0.21 Allowed 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.003 179.547 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 68.5 m -56.89 -30.6 64.06 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.304 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.745 HD12 ' HB3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -95.79 101.3 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.897 178.658 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.504 ' O ' HG22 ' A' ' 116' ' ' VAL . 0.0 OUTLIER -160.12 91.04 0.93 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.021 0.439 . . . . 0.0 111.456 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.519 HG23 ' C ' ' A' ' 100' ' ' HIS . 0.2 OUTLIER -162.64 55.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.459 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.468 HG23 ' HB3' ' A' ' 97' ' ' PHE . 51.4 m -77.77 129.0 34.92 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.236 -178.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.467 ' CD ' HG23 ' A' ' 98' ' ' THR . 0.0 OUTLIER -141.3 134.06 14.22 Favored Pre-proline 0 C--O 1.22 -0.458 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.326 179.287 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.76 138.49 53.77 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.152 1.902 . . . . 0.0 113.261 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.724 HD22 HG22 ' A' ' 98' ' ' THR . 0.2 OUTLIER -87.39 -70.28 0.63 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.623 179.608 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 67.09 76.92 0.33 Allowed Glycine 0 CA--C 1.522 0.489 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.038 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.636 ' O ' HG22 ' A' ' 124' ' ' THR . 33.1 Cg_exo -57.49 -45.39 34.45 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.484 2.123 . . . . 0.0 113.303 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 122' ' ' PRO . 54.4 Cg_exo -50.87 97.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.444 2.096 . . . . 0.0 112.398 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.636 HG22 ' O ' ' A' ' 122' ' ' PRO . 10.0 t -175.7 59.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.973 0.416 . . . . 0.0 111.21 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -141.13 177.92 7.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.066 0.46 . . . . 0.0 111.089 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 61.16 18.46 9.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.083 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.7 m . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.159 179.968 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 14.4 t . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.686 0.279 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 31.8 m -114.33 27.55 3.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.314 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -137.53 -48.1 0.57 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.962 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.614 HG11 HD13 ' A' ' 25' ' ' LEU . 21.8 t -72.09 105.97 2.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.785 0.326 . . . . 0.0 110.844 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . 0.682 ' OD2' HD22 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -104.32 131.87 51.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.515 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.933 ' HA ' HD23 ' A' ' 25' ' ' LEU . 8.5 p -85.34 119.6 25.89 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.339 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.801 ' O ' HD12 ' A' ' 22' ' ' LEU . 26.5 m . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.326 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.15 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.14 -68.77 0.78 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.839 0.352 . . . . 0.0 110.755 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 67.78 -71.1 0.11 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.759 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.46 169.33 14.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.671 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.612 HG23 ' O ' ' A' ' 5' ' ' ILE . 9.1 tt -58.08 97.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.126 0.488 . . . . 0.0 111.067 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -176.8 142.21 0.53 Allowed Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.287 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.499 ' HB3' HD12 ' A' ' 114' ' ' ILE . 73.7 Cg_endo -76.3 -165.32 0.3 Allowed 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.443 2.095 . . . . 0.0 111.59 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.708 ' H ' HG21 ' A' ' 99' ' ' THR . 0.2 OUTLIER -127.16 -66.67 0.88 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.565 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.657 ' O ' HD12 ' A' ' 10' ' ' ILE . 72.1 t -161.02 99.07 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.538 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.657 HD12 ' O ' ' A' ' 9' ' ' VAL . 0.7 OUTLIER -160.71 -175.99 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 120.328 -0.549 . . . . 0.0 112.184 -179.489 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.701 ' HA ' HD13 ' A' ' 90' ' ' ILE . 17.8 p -93.42 171.31 8.99 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.05 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.651 ' CG2' HD12 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -158.74 173.62 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.932 -179.594 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 4.4 ptt85 -153.19 134.67 14.35 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.262 0.553 . . . . 0.0 111.013 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.912 ' HB3' HD23 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -131.67 145.43 51.65 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.279 -179.535 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.479 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 2.3 t80 -87.11 148.28 25.29 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.65 ' HE2' HD12 ' A' ' 81' ' ' ILE . 2.0 tptt -84.34 27.67 0.68 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.058 178.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.908 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.1 OUTLIER 45.51 29.43 0.62 Allowed 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 178.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.593 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 43.5 24.77 0.06 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.074 0.55 . . . . 0.0 112.476 -178.348 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.908 HG22 ' O ' ' A' ' 17' ' ' ARG . 10.7 m -165.81 32.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.785 178.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 48.54 66.9 1.87 Allowed Glycine 0 C--N 1.338 0.677 0 CA-C-N 115.733 -0.667 . . . . 0.0 113.02 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -152.26 65.25 0.36 Allowed Glycine 0 C--N 1.333 0.364 0 N-CA-C 111.698 -0.561 . . . . 0.0 111.698 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.912 HD23 ' HB3' ' A' ' 14' ' ' LEU . 4.2 mp -48.2 -24.55 1.19 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 40' ' ' LEU . . . 112.6 7.41 22.3 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.241 -0.981 . . . . 0.0 113.578 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.924 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -160.06 139.56 11.13 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 117.98 0.89 . . . . 0.0 113.103 -179.585 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.882 HD23 ' HA ' ' B' ' 6' ' ' SER . 6.1 mt -79.69 171.31 15.31 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.391 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.0 m -153.18 152.02 10.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.016 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.429 ' HG2' HG22 ' A' ' 36' ' ' ILE . 6.8 ptmt -137.39 110.3 7.68 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.394 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.469 ' HB3' ' CG ' ' A' ' 71' ' ' TYR . 1.1 tm-20 -101.96 96.74 7.23 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.452 ' CB ' ' HB2' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -56.34 116.76 3.25 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.311 0.577 . . . . 0.0 111.304 -178.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.665 HG23 ' HD3' ' B' ' 3' ' ' LYS . 39.6 t -43.29 -25.26 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.626 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.2 m -145.24 79.07 1.57 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.639 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.453 ' HB3' ' HD2' ' A' ' 33' ' ' PRO . 0.3 OUTLIER -176.13 176.85 0.56 Allowed Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.724 -178.914 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.453 ' HD2' ' HB3' ' A' ' 32' ' ' LYS . 75.3 Cg_exo -53.19 -171.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.392 2.062 . . . . 0.0 112.26 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.582 ' HB3' HD12 ' A' ' 59' ' ' LEU . 95.9 Cg_exo -45.28 174.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.547 2.165 . . . . 0.0 114.065 -178.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.704 HG13 ' O ' ' A' ' 58' ' ' ILE . 12.4 p -78.71 164.55 3.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.307 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.469 ' N ' HG22 ' A' ' 35' ' ' VAL . 1.1 tp -144.69 164.87 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 120.074 -0.65 . . . . 0.0 112.584 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.661 HD12 ' O ' ' A' ' 53' ' ' GLN . 33.8 mt -86.18 149.48 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.115 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.859 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.54 ' CB ' HG13 ' B' ' 4' ' ' VAL . 1.7 t -114.67 -39.61 3.73 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.727 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 6.6 t0 -173.46 135.74 0.56 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.22 -0.592 . . . . 0.0 112.206 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.924 HD23 ' HB3' ' A' ' 24' ' ' PHE . 28.2 mt -70.39 99.42 1.57 Allowed 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.575 HD13 HD21 ' A' ' 25' ' ' LEU . 1.4 tp -54.05 -58.39 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -176.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.462 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.8 OUTLIER -93.2 -68.38 0.8 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.175 0.512 . . . . 0.0 112.269 -177.489 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.49 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 112.01 18.14 7.97 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.618 -178.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.4 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -126.08 -28.0 1.07 Allowed Glycine 0 C--N 1.34 0.786 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.737 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.772 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -93.72 -83.11 0.33 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 117.914 0.857 . . . . 0.0 111.308 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.842 ' HB1' HG21 ' A' ' 52' ' ' ILE . . . -62.18 -60.36 3.7 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.5 0.667 . . . . 0.0 111.317 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.631 ' HB2' HD22 ' A' ' 40' ' ' LEU . 17.5 tp10 -48.77 -39.63 25.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.71 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.4 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 11.4 tp-100 -61.77 -36.2 80.36 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.3 t -54.06 -47.42 71.67 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.401 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.11 -20.27 33.49 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.302 -0.951 . . . . 0.0 113.905 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.093 HD22 HG22 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -94.74 -31.01 13.97 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.899 0.38 . . . . 0.0 110.178 179.588 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.842 HG21 ' HB1' ' A' ' 46' ' ' ALA . 2.6 mp -80.44 119.6 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.064 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.661 ' O ' HD12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -152.52 155.77 38.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.178 179.756 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.727 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -67.98 123.79 21.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.914 0.388 . . . . 0.0 110.875 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.25 2.99 90.73 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.246 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -83.25 -88.94 0.09 Allowed 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 116.997 0.399 . . . . 0.0 110.981 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.629 HD11 ' NH1' ' A' ' 92' ' ' ARG . 6.6 tp -162.68 126.23 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.907 HD11 HG22 ' A' ' 61' ' ' VAL . 3.2 tp -149.76 87.99 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.074 177.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.582 HD12 ' HB3' ' A' ' 34' ' ' PRO . 11.3 tp -81.68 -66.35 0.9 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.721 -178.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.15 158.43 25.94 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.697 0.284 . . . . 0.0 111.594 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.907 HG22 HD11 ' A' ' 58' ' ' ILE . 3.3 t -153.36 148.64 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.967 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.467 HD22 HG12 ' A' ' 61' ' ' VAL . 1.2 p30 44.28 46.67 7.68 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.162 0.506 . . . . 0.0 111.756 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.0 t70 51.99 26.65 3.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.787 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.735 ' HD3' HG11 ' A' ' 77' ' ' VAL . 12.1 mmm180 -111.59 113.79 53.0 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.826 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.685 ' O ' HD22 ' A' ' 69' ' ' LEU . 31.5 Cg_exo -59.22 84.84 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 121.772 1.648 . . . . 0.0 110.733 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.576 ' O ' HG12 ' A' ' 35' ' ' VAL . 12.7 tp -86.83 66.77 9.59 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.354 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.503 HG23 ' H ' ' A' ' 68' ' ' ASP . 3.2 m -128.61 -55.19 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.665 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.503 ' H ' HG23 ' A' ' 67' ' ' VAL . 17.5 t70 -140.1 26.03 2.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.788 0.328 . . . . 0.0 111.648 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.955 HD11 ' HB2' ' A' ' 74' ' ' ALA . 1.4 pt? -94.92 -175.91 3.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.322 -0.399 . . . . 0.0 109.959 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.1 m -71.89 101.52 2.68 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 177.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.882 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 6.5 t80 -40.54 -58.23 1.64 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -178.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -59.36 -26.59 65.2 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.159 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.887 ' O ' HG23 ' A' ' 77' ' ' VAL . 16.3 t -76.21 -42.0 47.58 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.179 0.514 . . . . 0.0 109.95 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.955 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -66.94 -36.92 83.32 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.797 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.882 HD11 ' CZ ' ' A' ' 71' ' ' TYR . 51.0 mt -70.9 -29.64 65.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.162 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -76.75 -37.84 55.25 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.085 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.887 HG23 ' O ' ' A' ' 73' ' ' SER . 11.0 t -62.89 -43.49 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.401 ' CD2' ' HA ' ' A' ' 75' ' ' LEU . 1.2 pp -73.81 -26.85 60.83 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.25 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.468 ' NH1' HG12 ' B' ' 7' ' ' VAL . 0.0 OUTLIER -64.24 -35.49 81.0 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.0 0.428 . . . . 0.0 110.122 179.509 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.97 -19.71 59.26 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.817 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.65 HD12 ' HE2' ' A' ' 16' ' ' LYS . 68.5 mt -58.86 105.63 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-O 120.869 0.366 . . . . 0.0 110.692 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.6 -165.83 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.666 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.5 -171.41 2.37 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.053 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 43.77 31.67 0.5 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.31 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.411 ' O ' ' CD1' ' A' ' 15' ' ' PHE . 1.8 t -128.71 162.4 27.48 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.775 0.798 . . . . 0.0 112.878 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -104.86 176.09 5.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.004 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.568 HG21 ' NZ ' ' A' ' 16' ' ' LYS . 0.5 OUTLIER -146.98 159.21 9.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.036 -179.554 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.606 ' C ' HD23 ' A' ' 89' ' ' LEU . 39.3 t -118.84 158.59 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.651 HD12 ' CG2' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -160.23 169.63 22.83 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.758 0.314 . . . . 0.0 110.835 -178.301 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.701 HD13 ' HA ' ' A' ' 11' ' ' SER . 47.7 mm -129.45 130.81 67.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.391 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.409 HD11 HD12 ' A' ' 51' ' ' LEU . 8.5 mt -104.47 160.84 14.6 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.478 -0.783 . . . . 0.0 108.978 178.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.629 ' NH1' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -161.39 175.68 11.95 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.591 -179.413 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 165.36 -117.04 0.73 Allowed Glycine 0 CA--C 1.521 0.465 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.033 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 8' ' ' ASN . 32.6 Cg_exo -59.55 -154.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.135 1.89 . . . . 0.0 111.354 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -165.94 155.84 12.39 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.841 0.353 . . . . 0.0 111.285 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 119' ' ' PRO . . . 105.24 -7.6 43.87 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.977 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.925 ' HB3' HG22 ' A' ' 117' ' ' THR . 10.3 m-85 -130.56 127.49 39.18 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 117.717 0.758 . . . . 0.0 112.619 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.485 HG22 HD22 ' A' ' 120' ' ' LEU . 0.0 OUTLIER -80.43 117.25 21.0 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.408 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.708 HG21 ' H ' ' A' ' 8' ' ' ASN . 5.1 t -111.26 91.77 3.79 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.166 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.491 ' O ' HG23 ' A' ' 116' ' ' VAL . 58.3 m80 -71.77 -167.02 0.24 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.682 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.542 ' N ' HD23 ' A' ' 101' ' ' LEU . 0.3 OUTLIER -137.31 92.05 2.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.806 0.336 . . . . 0.0 111.016 179.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -144.19 23.02 1.69 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.493 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.522 HG22 ' CE2' ' A' ' 105' ' ' PHE . 0.3 OUTLIER 52.97 92.17 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.807 0.337 . . . . 0.0 111.55 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.41 HG22 ' O ' ' A' ' 104' ' ' THR . 4.3 m -127.75 11.68 6.72 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.522 ' CE2' HG22 ' A' ' 103' ' ' THR . 18.7 p90 -55.16 166.98 0.48 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.987 0.422 . . . . 0.0 111.468 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.2 m -83.15 -58.84 2.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.755 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 163.7 -57.01 0.28 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.691 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -120.32 46.43 1.98 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.892 0.377 . . . . 0.0 111.142 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -149.77 -68.57 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.682 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.626 HG21 HH11 ' A' ' 115' ' ' ARG . 15.0 t -118.22 52.04 1.43 Allowed Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 120.546 0.212 . . . . 0.0 111.519 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.15 102.77 1.5 Allowed 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.367 2.045 . . . . 0.0 112.664 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.39 -172.86 4.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.902 0.382 . . . . 0.0 111.176 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.516 ' HB ' HD21 ' A' ' 51' ' ' LEU . 88.0 m -93.91 -36.58 12.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.795 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 1.093 HG22 HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -104.88 94.97 3.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.786 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.626 HH11 HG21 ' A' ' 110' ' ' THR . 0.0 OUTLIER -151.57 94.65 2.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.099 0.476 . . . . 0.0 111.508 -179.829 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 100' ' ' HIS . 0.6 OUTLIER -159.2 53.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.426 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.925 HG22 ' HB3' ' A' ' 97' ' ' PHE . 0.2 OUTLIER -77.77 129.48 35.53 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.531 -177.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 97' ' ' PHE . 4.8 pt20 -145.11 133.11 10.56 Favored Pre-proline 0 N--CA 1.466 0.344 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.324 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 96' ' ' GLY . 13.3 Cg_endo -55.41 124.99 17.65 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.162 1.908 . . . . 0.0 112.801 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.485 HD22 HG22 ' A' ' 98' ' ' THR . 0.0 OUTLIER -93.5 -80.43 0.39 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.996 179.492 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 106.49 -77.73 0.24 Allowed Glycine 0 CA--C 1.522 0.478 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.402 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -60.44 154.58 52.52 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.565 2.176 . . . . 0.0 112.289 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.58 -168.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.311 2.007 . . . . 0.0 112.366 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.578 ' O ' HG23 ' A' ' 124' ' ' THR . 8.6 t -74.8 92.15 2.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.756 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -99.71 40.55 1.22 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.068 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -89.71 13.56 13.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.39 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.9 m . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.247 -0.882 . . . . 0.0 111.048 179.956 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.567 ' O ' HG13 ' B' ' 1' ' ' VAL . 10.2 p . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 121.042 0.448 . . . . 0.0 110.995 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.48 HG22 ' N ' ' B' ' 3' ' ' LYS . 12.2 p -128.13 158.29 40.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.139 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.665 ' HD3' HG23 ' A' ' 30' ' ' VAL . 13.8 mtmm 63.11 19.37 11.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.362 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.54 HG13 ' CB ' ' A' ' 38' ' ' SER . 19.8 t -82.81 100.42 6.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.952 0.406 . . . . 0.0 110.584 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -98.65 129.55 45.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.907 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.882 ' HA ' HD23 ' A' ' 25' ' ' LEU . 8.8 p -83.42 129.24 34.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.39 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.683 ' OXT' HD12 ' A' ' 22' ' ' LEU . 17.2 m . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.133 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 112.583 -0.207 . . . . 0.0 112.583 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.6 m -67.42 85.8 0.17 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.812 0.339 . . . . 0.0 110.94 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -109.97 -43.61 3.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.728 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.627 ' HB3' HD12 ' A' ' 5' ' ' ILE . 31.6 mtt -105.42 127.06 52.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.599 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.679 HG23 ' CG ' ' A' ' 112' ' ' LYS . 5.3 mp 60.11 158.9 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.48 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.422 ' N ' HG22 ' A' ' 5' ' ' ILE . 6.5 mm-40 -102.97 159.66 28.6 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -69.66 130.09 18.85 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 123.16 2.573 . . . . 0.0 112.574 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.874 ' HA ' HG21 ' A' ' 99' ' ' THR . 9.8 m-80 -142.07 88.47 2.11 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.632 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.1 p -85.0 95.8 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 116.548 -0.297 . . . . 0.0 110.914 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.628 HG23 ' N ' ' A' ' 11' ' ' SER . 1.4 tp -161.98 -170.84 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.697 ' HA ' HD13 ' A' ' 90' ' ' ILE . 8.0 p -92.18 164.48 13.55 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.555 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.81 ' CG1' HD12 ' A' ' 89' ' ' LEU . 2.3 t -154.14 158.83 3.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.594 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.8 ttp-105 -140.24 144.11 36.33 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.552 0.691 . . . . 0.0 111.103 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.832 HD21 ' HB2' ' A' ' 46' ' ' ALA . 0.5 OUTLIER -141.09 177.72 7.88 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.283 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.431 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 3.2 t80 -124.19 148.68 47.09 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.412 ' O ' ' N ' ' A' ' 20' ' ' GLY . 12.6 mtpt -83.77 30.89 0.48 Allowed 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.183 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.896 ' O ' HG22 ' A' ' 19' ' ' VAL . 2.2 mmm180 40.78 31.24 0.11 Allowed 'General case' 0 C--N 1.347 0.46 0 CA-C-O 121.086 0.47 . . . . 0.0 111.887 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.621 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 43.85 24.68 0.07 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.456 -178.391 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.896 HG22 ' O ' ' A' ' 17' ' ' ARG . 9.8 m -166.11 32.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.035 178.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 50.56 64.54 3.59 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.943 -178.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -148.23 66.18 0.4 Allowed Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.826 ' CD2' HG11 ' A' ' 87' ' ' VAL . 4.4 mp -49.5 -23.22 1.49 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.459 ' HA2' HG22 ' A' ' 41' ' ' ILE . . . 106.41 8.27 33.38 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.167 -1.016 . . . . 0.0 112.847 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.874 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -160.23 140.4 11.54 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 117.658 0.729 . . . . 0.0 112.483 -179.655 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.728 HD23 ' N ' ' B' ' 6' ' ' SER . 14.1 mt -79.05 166.61 22.13 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.909 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.5 m -151.78 143.81 16.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.268 177.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.802 ' C ' HG23 ' A' ' 35' ' ' VAL . 1.7 tttp -136.41 120.9 18.2 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.907 -178.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.598 ' HG3' HD22 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -113.62 112.01 22.79 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.521 178.488 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.482 ' CB ' ' HB2' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -65.61 124.26 21.89 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.904 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.0 t -49.77 -23.11 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.162 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 69.9 m -145.48 71.94 1.3 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.505 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.482 ' HB2' ' CB ' ' A' ' 29' ' ' ARG . 2.1 mmtp -177.51 176.25 0.51 Allowed Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.534 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 32' ' ' LYS . 88.3 Cg_exo -45.74 173.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.506 2.137 . . . . 0.0 113.414 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -44.11 175.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.265 2.643 . . . . 0.0 115.073 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.802 HG23 ' C ' ' A' ' 27' ' ' LYS . 14.9 p -79.09 147.48 6.72 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.827 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 36' ' ' ILE . 1.5 tp -128.63 161.58 37.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.714 -0.395 . . . . 0.0 111.373 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.696 HD12 ' O ' ' A' ' 53' ' ' GLN . 17.2 mt -79.53 141.46 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.981 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.559 ' CB ' HG13 ' B' ' 4' ' ' VAL . 1.9 t -106.24 -39.21 6.01 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.575 ' HB3' HD12 ' A' ' 25' ' ' LEU . 35.8 t0 -175.23 144.02 0.7 Allowed 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.874 HD23 ' HB3' ' A' ' 24' ' ' PHE . 38.1 mt -76.02 101.2 5.17 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.33 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.557 HD13 ' HB2' ' B' ' 6' ' ' SER . 0.8 OUTLIER -56.65 -59.22 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -176.525 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.46 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -93.02 -65.73 0.98 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -177.465 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.448 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 110.36 21.49 6.9 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.51 -178.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.94 -28.12 0.89 Allowed Glycine 0 C--N 1.339 0.741 0 C-N-CA 120.825 -0.702 . . . . 0.0 113.704 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.761 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -93.39 -83.17 0.33 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 117.996 0.898 . . . . 0.0 111.727 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.992 ' HB1' HG21 ' A' ' 52' ' ' ILE . . . -64.17 -58.56 6.23 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.327 0.584 . . . . 0.0 111.046 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.672 ' HB2' HD22 ' A' ' 40' ' ' LEU . 12.1 tp10 -48.77 -42.61 36.16 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.725 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -61.57 -35.12 76.9 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.529 ' HB2' HD13 ' A' ' 52' ' ' ILE . 2.8 m -53.84 -49.92 67.35 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.97 178.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 113.52 -31.74 6.46 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.212 -0.994 . . . . 0.0 114.337 178.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.779 HD12 ' O ' ' A' ' 51' ' ' LEU . 1.9 pp -98.63 11.46 38.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.675 0.737 . . . . 0.0 111.715 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.992 HG21 ' HB1' ' A' ' 46' ' ' ALA . 4.6 mp -113.28 88.42 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-O 121.016 0.436 . . . . 0.0 110.478 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.696 ' O ' HD12 ' A' ' 37' ' ' ILE . 2.2 tp60 -112.69 148.11 35.37 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.611 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.557 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -70.39 140.88 52.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.046 0.45 . . . . 0.0 111.967 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.96 19.09 69.47 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.089 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -105.69 -81.49 0.54 Allowed 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.495 ' CG2' HD13 ' A' ' 91' ' ' LEU . 28.7 mm -152.51 125.92 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 121.503 0.668 . . . . 0.0 112.536 -177.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.568 ' O ' HG23 ' A' ' 58' ' ' ILE . 2.3 tp -161.21 76.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.469 177.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.902 HD22 ' NE ' ' A' ' 92' ' ' ARG . 5.2 tp -78.69 -63.15 1.48 Allowed 'General case' 0 C--N 1.328 -0.354 0 O-C-N 122.177 -0.327 . . . . 0.0 111.581 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.638 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . . . -109.51 149.97 28.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.859 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.565 HG22 HD11 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -160.92 143.4 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.473 -179.371 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.427 ' HB3' HD11 ' A' ' 81' ' ' ILE . 53.2 m-80 60.89 33.72 19.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.19 0.519 . . . . 0.0 111.879 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 57.91 21.29 7.48 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 178.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.754 ' NH2' HD12 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -121.55 124.55 27.14 Favored Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 120.631 -0.428 . . . . 0.0 109.909 177.586 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.796 ' O ' HD22 ' A' ' 69' ' ' LEU . 19.2 Cg_endo -58.16 88.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 122.205 1.936 . . . . 0.0 112.117 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.754 HD12 ' NH2' ' A' ' 64' ' ' ARG . 0.6 OUTLIER -87.43 67.52 9.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.304 0.573 . . . . 0.0 109.762 179.566 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.544 HG12 ' CD1' ' A' ' 59' ' ' LEU . 3.1 m -126.06 -59.08 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -178.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.513 ' H ' HG23 ' A' ' 67' ' ' VAL . 2.0 p30 -131.47 25.51 4.79 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.796 HD22 ' O ' ' A' ' 65' ' ' PRO . 1.6 pt? -102.5 -172.68 2.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.811 0.338 . . . . 0.0 110.457 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.82 111.47 9.0 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.558 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 8.0 t80 -43.95 -47.52 8.5 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.902 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -67.68 -32.48 73.18 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.17 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.785 ' O ' HG23 ' A' ' 77' ' ' VAL . 3.1 m -70.67 -36.27 73.26 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.341 0.591 . . . . 0.0 109.851 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.635 ' HB1' ' HG ' ' A' ' 66' ' ' LEU . . . -66.09 -49.92 65.89 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.477 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.558 HD11 ' CZ ' ' A' ' 71' ' ' TYR . 48.4 mt -63.42 -28.07 69.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.49 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -71.36 -40.27 70.74 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 73' ' ' SER . 40.6 t -58.38 -42.31 83.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.61 178.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.565 ' O ' HD12 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -72.07 -35.28 69.23 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.197 178.774 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.91 -37.12 68.47 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.023 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -58.97 -19.98 47.05 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.84 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.548 HG22 HG21 ' A' ' 85' ' ' THR . 55.9 mt -66.36 119.43 11.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.938 0.399 . . . . 0.0 111.231 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.65 -162.16 0.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.13 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.5 m -94.76 -171.36 2.44 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.633 0.254 . . . . 0.0 110.739 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 44.61 30.99 0.57 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.929 0.395 . . . . 0.0 111.207 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.548 HG21 HG22 ' A' ' 81' ' ' ILE . 3.1 t -125.81 161.88 26.38 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.956 0.884 . . . . 0.0 112.908 -178.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.15 176.52 5.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.231 -1.35 . . . . 0.0 110.504 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.826 HG11 ' CD2' ' A' ' 22' ' ' LEU . 6.3 p -147.65 153.53 11.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.864 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.759 ' O ' HD23 ' A' ' 89' ' ' LEU . 25.3 t -113.83 159.72 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.585 0.231 . . . . 0.0 110.65 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.81 HD12 ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -153.15 158.97 42.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.797 0.332 . . . . 0.0 110.932 -178.883 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.697 HD13 ' HA ' ' A' ' 11' ' ' SER . 46.9 mm -131.82 124.19 53.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.19 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.495 HD13 ' CG2' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -99.41 160.59 14.17 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.291 178.705 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.902 ' NE ' HD22 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -107.25 150.83 26.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.116 0.484 . . . . 0.0 112.209 -179.108 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.457 ' HA3' ' N ' ' A' ' 8' ' ' ASN . . . -162.87 -140.43 2.87 Favored Glycine 0 CA--C 1.523 0.58 0 CA-C-N 115.285 -0.871 . . . . 0.0 112.914 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -77.76 -154.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.992 2.461 . . . . 0.0 112.192 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -146.83 127.87 14.59 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.571 0.224 . . . . 0.0 110.441 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.73 -7.58 42.27 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.757 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.87 ' HB3' HG22 ' A' ' 117' ' ' THR . 11.4 m-85 -131.83 147.21 52.47 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 117.12 0.46 . . . . 0.0 111.778 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.488 HG23 ' HG3' ' A' ' 118' ' ' GLN . 0.1 OUTLIER -93.97 116.18 28.6 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.361 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.874 HG21 ' HA ' ' A' ' 8' ' ' ASN . 3.8 t -102.41 92.33 4.64 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.563 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.431 ' O ' HD12 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -74.57 -165.79 0.38 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.443 179.081 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.08 130.99 53.51 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.666 0.27 . . . . 0.0 111.538 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.414 ' O ' ' HB ' ' A' ' 103' ' ' THR . 3.8 tt0 178.92 58.07 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.236 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' A' ' 102' ' ' GLU . 14.6 t -176.48 -156.2 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.884 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -165.51 147.32 7.45 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.831 0.348 . . . . 0.0 110.404 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.483 ' HB3' ' HA ' ' A' ' 112' ' ' LYS . 49.3 p90 -74.89 156.52 36.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.116 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.8 t -164.63 168.56 17.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.723 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.41 139.09 48.26 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.615 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 62.27 33.19 16.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.744 0.307 . . . . 0.0 111.036 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.597 ' O ' HG22 ' A' ' 110' ' ' THR . . . -154.9 -62.69 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.35 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.597 HG22 ' O ' ' A' ' 109' ' ' GLY . 1.0 OUTLIER 53.47 37.3 0.41 Allowed Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 179.832 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.498 ' CD ' ' N ' ' A' ' 110' ' ' THR . 42.5 Cg_endo -63.63 -29.71 69.89 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 121.857 1.705 . . . . 0.0 111.983 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.679 ' CG ' HG23 ' A' ' 5' ' ' ILE . 3.4 tmtt? 74.99 134.25 0.05 Allowed 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.052 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 93.5 m -43.84 -32.83 1.16 Allowed 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 121.354 0.597 . . . . 0.0 110.853 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.617 ' O ' HG23 ' A' ' 114' ' ' ILE . 7.6 tp -92.25 93.37 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.142 177.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -160.49 95.11 1.1 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.186 0.517 . . . . 0.0 112.199 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.3 t -156.81 64.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.87 HG22 ' HB3' ' A' ' 97' ' ' PHE . 0.2 OUTLIER -76.72 127.17 32.27 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -177.035 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.488 ' HG3' HG23 ' A' ' 98' ' ' THR . 7.1 pt20 -133.39 138.68 31.91 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.773 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -52.94 112.95 1.05 Allowed 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.335 2.023 . . . . 0.0 112.169 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.753 HD23 ' C ' ' A' ' 97' ' ' PHE . 0.6 OUTLIER -109.69 -28.93 8.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.103 -179.652 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 95.93 105.92 2.17 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.907 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -62.07 168.98 8.22 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.108 1.872 . . . . 0.0 112.108 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -51.43 152.67 11.52 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.218 1.946 . . . . 0.0 112.323 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.4 t -166.92 163.36 16.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.951 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -173.76 179.92 1.91 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.899 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 59.93 18.92 7.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.079 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.477 HG13 ' OXT' ' A' ' 127' ' ' VAL . 11.6 p . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.212 -0.899 . . . . 0.0 111.017 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 9.5 m . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.859 0.361 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 25.1 t -135.09 -64.49 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.083 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 21.6 mmtm -85.43 -177.26 6.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.933 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.559 HG13 ' CB ' ' A' ' 38' ' ' SER . 13.2 t 62.62 120.11 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.952 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . 0.551 ' HB3' HG13 ' B' ' 7' ' ' VAL . 29.8 m-20 -146.75 124.95 12.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.308 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.728 ' N ' HD23 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -59.48 -58.66 7.65 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.04 179.33 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.551 HG13 ' HB3' ' B' ' 5' ' ' ASP . 31.8 m . . . . . 0 C--O 1.251 1.153 0 CA-C-O 118.389 -0.815 . . . . 0.0 112.808 178.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.255 0 N-CA-C 112.542 -0.223 . . . . 0.0 112.542 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 63.91 -80.49 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.664 0.269 . . . . 0.0 110.829 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -108.47 134.27 51.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.656 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 9.1 mtt -86.14 -71.76 0.53 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.195 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.522 HG23 ' N ' ' A' ' 6' ' ' GLU . 0.3 OUTLIER 49.07 -167.56 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.596 -179.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.522 ' N ' HG23 ' A' ' 5' ' ' ILE . 4.2 mt-10 -137.41 156.18 75.21 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-O 120.387 0.136 . . . . 0.0 111.133 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.29 -80.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.546 2.164 . . . . 0.0 112.322 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -115.61 -10.2 11.88 Favored 'General case' 0 N--CA 1.463 0.213 0 O-C-N 122.432 -0.167 . . . . 0.0 111.42 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.728 ' C ' HD12 ' A' ' 10' ' ' ILE . 33.4 t -79.62 151.55 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.728 HD12 ' C ' ' A' ' 9' ' ' VAL . 2.1 mp -121.87 146.27 27.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.322 0.582 . . . . 0.0 111.762 -178.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.796 ' HA ' HD13 ' A' ' 90' ' ' ILE . 0.2 OUTLIER -97.18 169.92 9.46 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.372 -179.832 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.628 ' HB ' HD12 ' A' ' 89' ' ' LEU . 0.7 OUTLIER -156.85 163.33 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.089 -178.131 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.16 120.97 7.58 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.494 0.664 . . . . 0.0 110.584 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.732 HD21 HG12 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -123.39 178.19 5.27 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.578 -179.64 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.47 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 2.5 t80 -119.31 150.04 40.8 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.412 ' CE ' ' HA2' ' A' ' 20' ' ' GLY . 14.3 mtpt -86.36 28.71 0.82 Allowed 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.066 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.864 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 43.81 30.76 0.41 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.968 0.413 . . . . 0.0 111.925 179.532 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.651 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 44.33 23.3 0.06 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.952 -178.716 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.864 HG22 ' O ' ' A' ' 17' ' ' ARG . 4.0 m -166.41 33.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.412 ' HA2' ' CE ' ' A' ' 16' ' ' LYS . . . 49.54 66.57 2.19 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-N 115.435 -0.802 . . . . 0.0 113.088 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -148.07 61.19 0.45 Allowed Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.821 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 4.4 mp -46.91 -26.78 1.06 Allowed 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.434 ' HA2' HG22 ' A' ' 41' ' ' ILE . . . 112.36 5.1 24.92 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.3 -0.953 . . . . 0.0 113.915 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.946 ' HB3' HD23 ' A' ' 40' ' ' LEU . 1.2 p90 -155.95 141.22 17.54 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.237 1.018 . . . . 0.0 113.284 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.806 HD23 ' HA ' ' B' ' 6' ' ' SER . 7.8 mt -79.56 168.22 19.7 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.038 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.5 m -149.01 147.21 16.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.737 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.826 ' C ' HG23 ' A' ' 35' ' ' VAL . 17.0 ttpt -129.34 118.93 23.03 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.01 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.513 ' N ' HG23 ' A' ' 35' ' ' VAL . 4.1 tm-20 -114.14 97.19 6.21 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.79 -1.095 . . . . 0.0 108.541 177.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.473 ' CB ' ' HB2' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -57.04 120.23 7.66 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.049 0.452 . . . . 0.0 110.932 -179.033 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.9 t -45.98 -23.75 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.444 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.0 m -146.37 75.06 1.39 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.435 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.474 ' HB3' ' HD2' ' A' ' 33' ' ' PRO . 3.0 mmtt -177.95 177.99 0.4 Allowed Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.734 -178.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 32' ' ' LYS . 88.4 Cg_exo -49.99 -177.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.341 2.028 . . . . 0.0 113.41 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.45 ' HB3' HG12 ' A' ' 67' ' ' VAL . 80.2 Cg_exo -47.65 170.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.142 2.562 . . . . 0.0 114.531 -178.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.918 HG11 HD13 ' A' ' 66' ' ' LEU . 7.4 p -79.08 146.22 8.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.036 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.417 HD12 ' HA ' ' A' ' 36' ' ' ILE . 1.1 tp -126.99 166.62 23.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.542 HD12 ' O ' ' A' ' 53' ' ' GLN . 27.8 mt -84.29 141.25 14.95 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 CA-C-O 120.708 0.29 . . . . 0.0 110.71 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.796 ' CB ' HG13 ' B' ' 4' ' ' VAL . 0.1 OUTLIER -108.89 -36.64 6.06 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -179.833 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.639 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 4.9 t70 -169.21 132.61 1.32 Allowed 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.319 -0.552 . . . . 0.0 112.381 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.946 HD23 ' HB3' ' A' ' 24' ' ' PHE . 54.1 mt -70.26 78.49 0.53 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 121.701 0.762 . . . . 0.0 109.876 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.75 HD13 HD21 ' A' ' 25' ' ' LEU . 1.7 tp -33.06 -58.85 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 -177.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.461 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -94.42 -68.88 0.78 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -177.706 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.425 ' HA2' ' CB ' ' A' ' 47' ' ' GLU . . . 108.7 25.59 5.65 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -178.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.38 -34.08 0.51 Allowed Glycine 0 C--N 1.337 0.609 0 C-N-CA 121.145 -0.55 . . . . 0.0 113.182 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.821 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -92.74 -80.43 0.37 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 117.546 0.673 . . . . 0.0 110.908 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.787 ' HB1' ' CG2' ' A' ' 52' ' ' ILE . . . -60.29 -58.04 10.21 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.222 0.534 . . . . 0.0 111.389 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.425 ' CB ' ' HA2' ' A' ' 43' ' ' GLY . 39.2 tt0 -48.7 -46.92 41.27 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.83 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.6 tp-100 -57.87 -33.85 69.14 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.874 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.1 t -55.05 -52.16 64.04 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.752 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 112.27 -22.58 17.64 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.299 -0.953 . . . . 0.0 113.859 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.488 ' HG ' HD12 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -97.07 -28.2 14.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.955 0.377 . . . . 0.0 110.728 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.787 ' CG2' ' HB1' ' A' ' 46' ' ' ALA . 2.3 mp -82.37 121.28 35.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.025 0.441 . . . . 0.0 110.328 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.619 ' HA ' HD11 ' A' ' 40' ' ' LEU . 1.5 mt-30 -153.74 156.45 37.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.101 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.639 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -66.52 120.06 12.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.877 0.37 . . . . 0.0 110.954 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.0 -1.73 88.43 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.294 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.34 -91.34 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 117.011 0.406 . . . . 0.0 110.511 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.87 ' CG2' HD13 ' A' ' 91' ' ' LEU . 2.8 tp -163.98 120.5 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.592 ' O ' HG23 ' A' ' 58' ' ' ILE . 2.0 tp -140.14 88.67 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.77 HD13 ' NE ' ' A' ' 92' ' ' ARG . 18.2 tp -78.33 -70.3 0.5 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.598 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -121.16 165.46 15.35 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.803 0.335 . . . . 0.0 111.109 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.581 HG22 HD11 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -148.3 157.23 8.26 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.267 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.128 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.54 ' HA ' HG22 ' A' ' 87' ' ' VAL . 0.0 OUTLIER 56.71 -81.21 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.046 0.538 . . . . 0.0 110.214 -178.589 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 61' ' ' VAL . 14.5 p-10 -175.22 36.99 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.344 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.673 ' NH1' ' HB1' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -124.08 130.32 24.43 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.24 179.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.504 ' O ' HD22 ' A' ' 69' ' ' LEU . 17.1 Cg_exo -63.58 86.41 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 121.206 1.27 . . . . 0.0 110.322 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.918 HD13 HG11 ' A' ' 35' ' ' VAL . 0.3 OUTLIER -86.71 68.21 10.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.286 0.565 . . . . 0.0 110.916 -178.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.572 HG23 ' H ' ' A' ' 68' ' ' ASP . 2.7 m -131.62 -61.53 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.572 ' H ' HG23 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -127.73 28.33 5.63 Favored 'General case' 0 C--N 1.333 -0.13 0 O-C-N 121.978 -0.451 . . . . 0.0 111.735 -178.644 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' A' ' 74' ' ' ALA . 1.6 pt? -99.85 -172.06 2.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.498 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.32 114.63 15.22 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.642 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 4.0 t80 -44.2 -50.98 8.54 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -64.81 -29.11 70.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.339 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.835 ' O ' HG23 ' A' ' 77' ' ' VAL . 39.0 t -71.23 -40.57 71.0 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.278 0.561 . . . . 0.0 110.048 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.677 ' HB1' ' HG ' ' A' ' 66' ' ' LEU . . . -65.77 -45.17 83.52 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.368 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.642 HD11 ' CZ ' ' A' ' 71' ' ' TYR . 73.9 mt -63.69 -28.73 70.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.868 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -76.41 -36.09 58.24 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.812 0.339 . . . . 0.0 110.177 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.835 HG23 ' O ' ' A' ' 73' ' ' SER . 10.8 t -61.36 -41.43 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.795 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.565 HD21 HG11 ' B' ' 7' ' ' VAL . 0.6 OUTLIER -76.31 -32.15 58.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.511 179.071 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.443 ' NH1' HG12 ' B' ' 7' ' ' VAL . 0.0 OUTLIER -62.32 -32.16 72.88 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.795 -179.468 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.26 -17.59 61.81 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.715 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.478 HD11 ' HB3' ' A' ' 62' ' ' ASN . 29.5 mt -63.25 136.77 25.68 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 CA-C-O 120.867 0.365 . . . . 0.0 110.828 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.46 -165.42 0.78 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.507 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.43 -172.12 2.27 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.098 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 38.0 34.67 0.07 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.105 0.562 . . . . 0.0 111.5 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.416 ' O ' ' CE1' ' A' ' 15' ' ' PHE . 1.8 t -126.37 163.63 22.86 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.925 0.869 . . . . 0.0 113.21 -177.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.3 177.33 5.74 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 114.158 -1.383 . . . . 0.0 110.051 179.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.732 HG12 ' C ' ' A' ' 14' ' ' LEU . 2.3 p -150.77 145.98 16.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.338 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.896 ' O ' HD23 ' A' ' 89' ' ' LEU . 21.2 t -101.9 159.3 4.23 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.015 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.896 HD23 ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -155.16 165.91 35.23 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.319 -179.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.796 HD13 ' HA ' ' A' ' 11' ' ' SER . 29.6 mm -132.58 130.31 59.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.188 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.87 HD13 ' CG2' ' A' ' 57' ' ' ILE . 0.9 OUTLIER -116.56 175.35 5.61 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.024 178.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.77 ' NE ' HD13 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -140.16 168.45 19.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.86 0.362 . . . . 0.0 110.925 179.529 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -102.67 159.8 17.43 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.765 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.81 -154.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.54 2.16 . . . . 0.0 112.29 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -94.31 93.62 7.83 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.69 12.81 36.62 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.768 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.868 ' C ' HD23 ' A' ' 120' ' ' LEU . 42.4 m-85 -137.82 128.41 26.66 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.481 ' CB ' ' HB3' ' A' ' 120' ' ' LEU . 0.9 OUTLIER -87.64 174.99 8.1 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.021 179.393 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.456 ' N ' ' CG2' ' A' ' 98' ' ' THR . 0.0 OUTLIER -121.49 92.05 3.66 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.254 178.418 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.43 ' O ' HD11 ' A' ' 114' ' ' ILE . 0.3 OUTLIER -79.28 176.25 9.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.027 179.39 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.685 HD13 ' N ' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -122.39 -178.88 4.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.156 0.503 . . . . 0.0 111.711 -179.087 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -157.42 31.56 0.28 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.397 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.908 HG23 ' HE2' ' A' ' 112' ' ' LYS . 8.8 t -140.64 -174.51 3.99 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.115 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 50.7 p -93.13 140.36 29.59 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.869 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.42 ' N ' ' HE3' ' A' ' 112' ' ' LYS . 5.5 m-85 -76.4 176.99 7.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.973 0.416 . . . . 0.0 111.083 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 99.8 m -76.27 -67.7 0.66 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.316 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -115.07 28.18 8.15 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.066 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 59.53 27.93 17.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.694 0.283 . . . . 0.0 111.047 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -153.18 17.82 0.7 Allowed Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.379 -0.915 . . . . 0.0 113.508 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.405 ' HA ' ' HD3' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -163.09 140.36 5.96 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 117.246 0.523 . . . . 0.0 110.448 179.892 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 110' ' ' THR . 50.0 Cg_exo -55.17 177.16 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.002 1.801 . . . . 0.0 112.427 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.908 ' HE2' HG23 ' A' ' 103' ' ' THR . 0.0 OUTLIER -153.27 -151.96 0.4 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.038 -178.713 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 98.9 m -62.15 88.08 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.681 HG22 ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -114.3 140.89 32.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.458 -177.198 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -161.53 92.51 0.88 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.082 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.9 t -160.21 107.6 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.428 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.598 HG22 ' HB3' ' A' ' 97' ' ' PHE . 0.2 OUTLIER -79.42 138.17 37.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.79 0.329 . . . . 0.0 110.604 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.454 ' O ' ' HA ' ' A' ' 97' ' ' PHE . 8.2 pt20 -146.66 157.22 48.13 Favored Pre-proline 0 C--O 1.217 -0.614 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.636 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.24 105.95 1.49 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 121.936 1.757 . . . . 0.0 111.317 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.868 HD23 ' C ' ' A' ' 97' ' ' PHE . 1.4 pp -89.58 -38.71 13.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.856 0.36 . . . . 0.0 111.087 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 50.41 94.43 0.01 OUTLIER Glycine 0 CA--C 1.522 0.48 0 C-N-CA 121.191 -0.528 . . . . 0.0 113.185 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.63 153.4 14.38 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.223 1.949 . . . . 0.0 112.074 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.23 79.54 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.295 1.997 . . . . 0.0 112.634 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 10.1 t -173.03 -176.69 1.44 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.98 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt 62.43 59.54 1.52 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.184 0.516 . . . . 0.0 110.884 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -89.42 12.7 15.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.329 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.9 m . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.253 -0.88 . . . . 0.0 111.032 179.938 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 25.7 t . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.927 0.394 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.45 HG13 ' H ' ' B' ' 3' ' ' LYS . 2.8 p -175.75 -54.28 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.442 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.45 ' H ' HG13 ' B' ' 2' ' ' VAL . 25.8 mmtm 58.98 147.46 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.796 HG13 ' CB ' ' A' ' 38' ' ' SER . 3.5 t 68.83 -61.84 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.963 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . 0.53 ' O ' HD22 ' A' ' 25' ' ' LEU . 0.9 OUTLIER 58.21 -124.6 1.5 Allowed 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 119.44 -0.314 . . . . 0.0 110.348 179.876 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.806 ' HA ' HD23 ' A' ' 25' ' ' LEU . 5.8 p 167.8 127.91 0.01 OUTLIER 'General case' 0 C--N 1.347 0.475 0 CA-C-N 118.605 0.639 . . . . 0.0 110.336 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.565 HG11 HD21 ' A' ' 78' ' ' LEU . 4.5 m . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.232 -0.89 . . . . 0.0 111.251 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.157 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.4 m -138.47 -173.75 3.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.833 0.349 . . . . 0.0 110.852 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 59.4 89.56 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.79 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.428 ' O ' HG22 ' A' ' 5' ' ' ILE . 17.6 mmt -112.11 -42.79 3.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.0 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.692 HD12 ' N ' ' A' ' 110' ' ' THR . 8.4 tt 44.46 40.33 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.96 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -164.41 151.55 10.06 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.491 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -89.01 -165.03 0.18 Allowed 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.895 2.397 . . . . 0.0 112.311 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.547 ' O ' HG23 ' A' ' 9' ' ' VAL . 8.2 t-20 -140.68 -70.32 0.38 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.691 ' O ' HD12 ' A' ' 10' ' ' ILE . 42.0 t -160.71 90.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.691 HD12 ' O ' ' A' ' 9' ' ' VAL . 0.5 OUTLIER -148.99 -178.49 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 120.166 -0.613 . . . . 0.0 112.218 -178.023 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.633 ' HA ' HD13 ' A' ' 90' ' ' ILE . 13.9 m -77.37 167.76 21.15 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -178.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.829 ' CG1' HD12 ' A' ' 89' ' ' LEU . 1.9 t -157.87 157.83 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 114.083 -1.417 . . . . 0.0 107.894 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.465 ' O ' HD12 ' A' ' 14' ' ' LEU . 11.3 ttp180 -141.69 141.92 33.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.406 0.622 . . . . 0.0 111.727 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.905 HD21 ' HB2' ' A' ' 46' ' ' ALA . 0.8 OUTLIER -142.96 177.44 8.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.876 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.444 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 3.5 t80 -124.49 147.86 48.08 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.659 ' HE3' HD11 ' A' ' 22' ' ' LEU . 1.5 mtpt -84.12 32.62 0.49 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.481 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.795 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.3 OUTLIER 40.53 32.13 0.13 Allowed 'General case' 0 C--N 1.344 0.343 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 179.222 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.72 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 45.0 24.66 0.12 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.551 -178.497 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.795 HG22 ' O ' ' A' ' 17' ' ' ARG . 1.6 m -169.23 34.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.317 178.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 49.94 63.91 3.89 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 115.56 -0.746 . . . . 0.0 113.062 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -145.97 62.22 0.47 Allowed Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.844 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 4.1 mp -46.24 -24.83 0.52 Allowed 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -178.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.473 ' HA2' HG22 ' A' ' 41' ' ' ILE . . . 107.96 6.99 31.8 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.039 -1.076 . . . . 0.0 113.587 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.909 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -157.15 140.78 15.87 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -178.92 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.808 HD23 ' HA ' ' B' ' 6' ' ' SER . 7.3 mt -79.92 171.06 15.62 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.671 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.5 m -149.85 153.2 10.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.506 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.2 105.13 5.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.479 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.597 ' CA ' HG23 ' A' ' 35' ' ' VAL . 0.6 OUTLIER -108.44 139.22 43.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.076 178.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.453 ' CB ' ' HB2' ' A' ' 32' ' ' LYS . 10.7 mtt-85 -76.6 124.5 27.71 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.05 0.453 . . . . 0.0 110.37 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.7 t -52.08 -21.83 2.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.042 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.2 p -141.48 42.44 1.75 Allowed 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.738 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.453 ' HB2' ' CB ' ' A' ' 29' ' ' ARG . 15.6 mttp -167.0 140.87 3.1 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.927 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.433 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 32.0 Cg_exo -58.69 -46.72 21.99 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.526 2.15 . . . . 0.0 113.46 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 33' ' ' PRO . 53.1 Cg_exo -39.8 93.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.803 2.335 . . . . 0.0 114.607 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.597 HG23 ' CA ' ' A' ' 28' ' ' GLU . 11.4 p -116.8 144.08 25.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 177.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.43 HD12 ' HA ' ' A' ' 36' ' ' ILE . 1.4 tp -153.64 169.07 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.8 HD12 ' O ' ' A' ' 53' ' ' GLN . 24.2 mt -81.27 145.93 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.464 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.458 ' CB ' HG13 ' B' ' 4' ' ' VAL . 4.9 t -109.32 -40.58 4.88 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.702 ' CB ' HD12 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -164.9 131.78 2.98 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.863 -179.452 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.909 HD23 ' HB3' ' A' ' 24' ' ' PHE . 43.1 mt -70.14 76.74 0.51 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.712 0.767 . . . . 0.0 109.698 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.476 ' CD1' HD21 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -30.58 -59.16 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -177.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.46 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -94.44 -66.25 0.93 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -177.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.421 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 104.65 23.5 7.86 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -177.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.444 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -125.45 -30.1 0.94 Allowed Glycine 0 C--N 1.338 0.687 0 C-N-CA 121.24 -0.505 . . . . 0.0 113.159 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.844 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -95.84 -83.25 0.37 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 117.686 0.743 . . . . 0.0 111.932 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.905 ' HB2' HD21 ' A' ' 14' ' ' LEU . . . -59.95 -58.79 7.03 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.207 0.527 . . . . 0.0 111.04 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.421 ' HB3' ' HA2' ' A' ' 43' ' ' GLY . 33.9 tt0 -45.06 -49.42 11.55 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.971 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' A' ' 44' ' ' GLY . 7.6 mt-30 -55.65 -39.04 70.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.493 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.42 -49.9 63.61 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.343 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.4 -26.99 13.21 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.301 -0.952 . . . . 0.0 113.746 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.048 HD22 HG22 ' A' ' 114' ' ' ILE . 2.1 pp -95.65 -0.98 51.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.107 0.453 . . . . 0.0 111.471 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.866 HG21 ' HB1' ' A' ' 46' ' ' ALA . 5.0 mp -109.79 123.99 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.8 ' O ' HD12 ' A' ' 37' ' ' ILE . 1.7 mp0 -150.93 160.12 44.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.735 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.49 129.81 40.74 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.925 0.393 . . . . 0.0 111.265 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.35 13.73 63.13 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.101 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.27 -80.84 0.39 Allowed 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 22.4 mt -155.24 122.7 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.567 HD11 ' HB ' ' A' ' 61' ' ' VAL . 3.2 tp -160.25 71.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 114.867 -1.061 . . . . 0.0 109.222 177.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.535 HD22 ' HB3' ' A' ' 92' ' ' ARG . 9.2 tp -76.93 -54.13 6.97 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.643 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.642 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . . . -121.08 160.04 24.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.835 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.692 HG12 HD12 ' A' ' 66' ' ' LEU . 14.4 p -166.75 146.05 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.043 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.635 ' ND2' HG22 ' A' ' 61' ' ' VAL . 0.1 OUTLIER 45.76 41.13 7.15 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.198 0.523 . . . . 0.0 111.56 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.4 t70 59.74 28.44 17.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.221 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.49 ' NH2' HG21 ' A' ' 77' ' ' VAL . 25.5 mmm180 -119.61 98.24 49.93 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.572 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.4 ' O ' HD22 ' A' ' 69' ' ' LEU . 22.4 Cg_endo -61.27 85.37 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 121.811 1.674 . . . . 0.0 110.896 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.692 HD12 HG12 ' A' ' 61' ' ' VAL . 13.4 mt -68.75 63.69 0.11 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.508 -178.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.552 HG23 ' H ' ' A' ' 68' ' ' ASP . 3.4 m -141.81 -61.09 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.552 ' H ' HG23 ' A' ' 67' ' ' VAL . 16.4 t0 -111.7 29.38 7.9 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 122.127 -0.358 . . . . 0.0 111.736 -178.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.665 HD21 ' HB2' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -123.19 175.31 6.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.644 179.598 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.5 m -72.66 102.33 3.28 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.748 ' CE1' HD11 ' A' ' 75' ' ' LEU . 8.5 t80 -40.14 -60.99 0.95 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.363 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.515 ' HA ' HD12 ' A' ' 75' ' ' LEU . 6.8 p30 -55.49 -28.42 54.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.404 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.886 ' O ' HG23 ' A' ' 77' ' ' VAL . 43.8 m -78.07 -39.94 40.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.087 0.47 . . . . 0.0 109.856 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.665 ' HB2' HD21 ' A' ' 69' ' ' LEU . . . -60.47 -34.73 74.46 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.294 0.568 . . . . 0.0 109.944 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.748 HD11 ' CE1' ' A' ' 71' ' ' TYR . 15.1 mt -75.02 -38.04 61.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.242 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.41 ' HA ' ' HB2' ' A' ' 79' ' ' ARG . 5.0 pt-20 -72.07 -38.73 69.39 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.98 0.419 . . . . 0.0 110.19 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.886 HG23 ' O ' ' A' ' 73' ' ' SER . 45.1 t -62.33 -42.93 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.772 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.541 ' C ' HD12 ' A' ' 78' ' ' LEU . 4.5 pp -79.85 -21.91 43.55 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.12 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.535 ' N ' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -66.77 -37.18 84.08 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-O 120.988 0.423 . . . . 0.0 110.335 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -58.27 -19.07 38.07 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.192 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.406 ' HB ' ' HD2' ' A' ' 16' ' ' LYS . 70.8 mt -54.27 121.99 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 120.953 0.406 . . . . 0.0 111.006 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.77 -163.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.653 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.3 m -96.42 -171.67 2.34 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.996 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 44.08 30.82 0.46 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.232 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.404 ' O ' ' CE1' ' A' ' 15' ' ' PHE . 1.7 t -125.37 158.76 33.48 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 122.046 0.927 . . . . 0.0 112.737 -178.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.34 176.28 5.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.969 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.806 HG12 ' C ' ' A' ' 14' ' ' LEU . 4.8 p -148.66 153.14 11.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.22 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.726 ' O ' HD23 ' A' ' 89' ' ' LEU . 34.1 t -113.56 160.43 13.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.829 HD12 ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -155.89 172.64 18.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.64 0.257 . . . . 0.0 110.597 -178.736 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.642 ' HB ' ' HB3' ' A' ' 60' ' ' ALA . 29.6 mm -137.25 126.37 35.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.987 HD11 HD13 ' A' ' 51' ' ' LEU . 11.6 mt -91.17 145.81 24.36 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.535 ' HB3' HD22 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -119.96 175.32 5.96 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -178.185 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 8' ' ' ASN . . . 136.49 60.68 0.06 OUTLIER Glycine 0 CA--C 1.526 0.722 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.907 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.56 125.03 16.76 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.597 2.198 . . . . 0.0 113.024 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.401 ' O ' ' CD1' ' A' ' 97' ' ' PHE . 0.3 OUTLIER -163.86 28.75 0.08 Allowed 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.3 179.906 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.414 ' O ' ' CG ' ' A' ' 97' ' ' PHE . . . 69.23 60.07 5.4 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.942 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.718 ' CB ' HG22 ' A' ' 117' ' ' THR . 96.7 m-85 -160.44 129.69 4.97 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.792 0.33 . . . . 0.0 111.873 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.662 HG22 HD22 ' A' ' 120' ' ' LEU . 0.1 OUTLIER -89.64 127.35 35.9 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.105 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.799 HG22 ' O ' ' A' ' 115' ' ' ARG . 0.1 OUTLIER -86.88 91.27 8.61 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.772 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -103.9 136.74 43.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.871 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.7 pp -54.07 -177.9 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.329 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 66.81 87.65 0.12 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.967 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 11.9 t -156.23 170.01 23.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.53 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 40.5 p -125.77 133.9 51.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.93 0.395 . . . . 0.0 111.209 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.53 ' HA ' HG23 ' A' ' 110' ' ' THR . 19.7 p90 -115.86 168.4 10.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.943 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.534 ' H ' HG22 ' A' ' 110' ' ' THR . 88.7 m -120.52 -76.27 0.58 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.777 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -140.97 -78.97 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.499 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 23.0 p30 -144.33 28.8 1.32 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.857 0.36 . . . . 0.0 111.081 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.515 ' C ' HD12 ' A' ' 5' ' ' ILE . . . -132.75 0.8 4.62 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 120.843 -0.694 . . . . 0.0 113.422 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.692 ' N ' HD12 ' A' ' 5' ' ' ILE . 0.6 OUTLIER -141.83 -172.12 0.3 Allowed Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.492 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.518 ' HD2' HG23 ' A' ' 110' ' ' THR . 88.6 Cg_exo -50.31 -175.2 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 121.949 1.766 . . . . 0.0 112.418 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.406 ' HD3' ' N ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -152.22 -156.94 0.75 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 -179.415 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 10.9 m -58.65 -16.84 17.99 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.562 0.22 . . . . 0.0 110.928 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 1.048 HG22 HD22 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -75.59 175.19 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 121.207 0.527 . . . . 0.0 111.514 -179.296 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.871 ' O ' HD12 ' A' ' 114' ' ' ILE . 16.8 mmt180 -79.49 145.81 33.04 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.724 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.488 HG23 ' HB3' ' A' ' 111' ' ' PRO . 1.0 OUTLIER -85.23 138.14 19.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 121.363 0.601 . . . . 0.0 111.112 -179.334 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.718 HG22 ' CB ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -79.57 121.44 25.25 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.945 -1.025 . . . . 0.0 112.307 -178.078 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.419 ' O ' HG23 ' A' ' 98' ' ' THR . 0.0 OUTLIER -123.18 130.67 24.48 Favored Pre-proline 0 N--CA 1.477 0.878 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 179.633 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.441 ' HD3' ' CE2' ' A' ' 97' ' ' PHE . 5.2 Cg_exo -38.82 124.13 0.87 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.272 2.648 . . . . 0.0 115.175 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.669 HD21 ' C ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -79.26 -65.74 0.96 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.369 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 157.76 86.62 0.06 OUTLIER Glycine 0 CA--C 1.521 0.457 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.401 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -61.45 172.33 3.54 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.475 2.116 . . . . 0.0 112.512 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.42 175.38 0.1 Allowed 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.384 2.056 . . . . 0.0 112.263 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.0 t -104.27 146.16 29.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.757 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.4 mttp -119.94 54.74 1.01 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.145 0.498 . . . . 0.0 111.028 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -93.01 16.98 11.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.229 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.1 m . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.182 179.976 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.738 0.304 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 11.5 t -128.95 -54.29 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.433 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.43 ' CE ' ' HA ' ' A' ' 29' ' ' ARG . 31.8 mmtm -80.82 -48.22 12.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.585 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.458 HG13 ' CB ' ' A' ' 38' ' ' SER . 4.2 t -70.94 106.29 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.67 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . 0.515 ' CG ' HD13 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -86.28 -98.09 0.07 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.927 -179.608 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.808 ' HA ' HD23 ' A' ' 25' ' ' LEU . 2.6 p 162.75 130.41 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 122.794 0.438 . . . . 0.0 110.406 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.712 ' OXT' HD12 ' A' ' 22' ' ' LEU . 15.5 m . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.182 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 p -169.23 92.24 0.26 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.882 0.372 . . . . 0.0 110.983 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -165.17 146.04 7.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.716 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.5 ttt -124.82 119.94 30.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.142 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.752 HG21 HD11 ' A' ' 57' ' ' ILE . 0.1 OUTLIER 46.43 -170.69 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.815 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.545 ' N ' HG23 ' A' ' 5' ' ' ILE . 5.5 mm-40 -139.15 162.45 52.07 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.066 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.415 ' CA ' ' HA2' ' A' ' 93' ' ' GLY . 16.8 Cg_exo -67.32 124.88 12.65 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.614 2.21 . . . . 0.0 112.359 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.899 ' HA ' HG21 ' A' ' 99' ' ' THR . 14.7 m120 -132.94 88.39 2.5 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.145 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.841 HG12 ' HD2' ' A' ' 94' ' ' PRO . 9.9 p -91.34 97.03 6.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.879 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.649 HG23 ' N ' ' A' ' 11' ' ' SER . 1.5 tp -160.97 -166.97 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.72 ' HA ' HD13 ' A' ' 90' ' ' ILE . 10.1 m -100.61 168.42 9.72 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 121.572 0.701 . . . . 0.0 112.684 -178.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.73 ' CG1' HD12 ' A' ' 89' ' ' LEU . 2.2 t -156.18 164.36 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.961 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.43 ' H ' HG12 ' A' ' 12' ' ' VAL . 1.5 tpp85 -149.83 127.69 11.8 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.508 0.67 . . . . 0.0 110.744 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.763 ' C ' HG12 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -128.37 178.25 6.4 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.838 -1.073 . . . . 0.0 110.094 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.456 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 4.0 t80 -122.03 151.22 41.07 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 20' ' ' GLY . 2.1 mmpt? -83.37 30.95 0.46 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.405 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.889 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.9 OUTLIER 40.91 31.21 0.12 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 122.865 0.466 . . . . 0.0 112.061 179.679 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.614 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 44.15 24.35 0.08 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.286 0.634 . . . . 0.0 112.419 -177.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.889 HG22 ' O ' ' A' ' 17' ' ' ARG . 6.6 m -165.98 32.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.108 178.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 50.45 68.16 1.56 Allowed Glycine 0 C--N 1.337 0.608 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.991 -178.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -155.08 69.48 0.29 Allowed Glycine 0 C--N 1.332 0.327 0 N-CA-C 111.529 -0.629 . . . . 0.0 111.529 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.802 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 4.5 mp -49.4 -21.3 0.86 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -179.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.441 ' HA2' HG22 ' A' ' 41' ' ' ILE . . . 107.78 5.15 33.82 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.169 -1.015 . . . . 0.0 113.32 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.913 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -157.58 138.12 12.95 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 117.794 0.797 . . . . 0.0 112.844 -179.583 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.992 HD23 ' HA ' ' B' ' 6' ' ' SER . 1.8 mt -78.68 165.28 23.81 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.374 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.3 m -147.7 154.31 11.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.161 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.763 ' C ' HG23 ' A' ' 35' ' ' VAL . 26.5 ttpt -137.7 121.28 17.29 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.259 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.465 ' HB3' ' CD1' ' A' ' 71' ' ' TYR . 0.9 OUTLIER -115.03 95.21 5.1 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.167 178.538 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.475 ' CB ' ' HB2' ' A' ' 32' ' ' LYS . 8.9 mtt180 -62.16 116.84 5.31 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.117 0.484 . . . . 0.0 110.493 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.8 t -48.49 -20.62 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.6 m -142.1 66.04 1.35 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.694 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.5 ' HB3' ' HD2' ' A' ' 33' ' ' PRO . 4.1 mttp -172.58 176.69 0.88 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.595 -178.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.5 ' HD2' ' HB3' ' A' ' 32' ' ' LYS . 83.4 Cg_exo -49.95 -177.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.166 1.911 . . . . 0.0 113.075 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.541 ' HB3' HG12 ' A' ' 67' ' ' VAL . 89.5 Cg_exo -46.76 176.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.999 2.466 . . . . 0.0 114.027 -179.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.763 HG23 ' C ' ' A' ' 27' ' ' LYS . 14.6 p -77.98 148.82 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.32 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.4 HD12 ' HA ' ' A' ' 36' ' ' ILE . 0.6 OUTLIER -129.87 154.96 41.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 120.855 0.359 . . . . 0.0 111.539 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.798 HD12 ' O ' ' A' ' 53' ' ' GLN . 22.1 mt -79.22 142.54 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.773 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.4 ' HB3' ' CG1' ' B' ' 4' ' ' VAL . 2.4 t -106.36 -40.45 5.6 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.624 ' CB ' HD12 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -171.18 142.11 1.72 Allowed 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.145 -0.622 . . . . 0.0 112.429 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.913 HD23 ' HB3' ' A' ' 24' ' ' PHE . 46.6 mt -76.21 85.3 3.03 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.995 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.652 HD13 HD21 ' A' ' 25' ' ' LEU . 1.3 tp -41.98 -58.29 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -177.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.459 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.1 OUTLIER -92.44 -66.23 0.94 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -176.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.465 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 107.42 18.81 9.86 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 -177.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.51 -27.75 0.95 Allowed Glycine 0 C--N 1.34 0.793 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.855 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.802 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -94.06 -83.4 0.33 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.008 0.904 . . . . 0.0 111.69 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.85 ' HB1' HG21 ' A' ' 52' ' ' ILE . . . -64.23 -54.68 29.64 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 121.424 0.631 . . . . 0.0 110.782 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.761 ' CD ' HD13 ' A' ' 40' ' ' LEU . 3.8 tp10 -49.19 -42.24 39.45 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.368 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.92 -35.52 78.63 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.454 178.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.3 -47.78 65.73 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.655 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.42 -27.0 11.09 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.207 -0.997 . . . . 0.0 114.655 177.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.78 HD22 ' HB ' ' A' ' 114' ' ' ILE . 2.8 pp -102.26 -11.66 18.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 117.711 0.756 . . . . 0.0 111.944 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.85 HG21 ' HB1' ' A' ' 46' ' ' ALA . 5.2 mp -87.78 104.45 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.798 ' O ' HD12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -128.08 156.53 42.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.833 -179.781 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.532 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -71.93 133.39 45.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.827 0.346 . . . . 0.0 111.04 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.96 14.37 65.57 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.134 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.527 ' C ' HD12 ' A' ' 57' ' ' ILE . 1.2 m-20 -93.17 -82.55 0.34 Allowed 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.909 HG22 HD22 ' A' ' 91' ' ' LEU . 1.6 mp -158.47 120.38 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.462 0.649 . . . . 0.0 111.841 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.973 HD11 HG22 ' A' ' 61' ' ' VAL . 5.9 tp -152.9 87.19 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.09 177.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.3 tp -79.48 -61.78 1.9 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 121.994 -0.441 . . . . 0.0 111.238 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -127.88 158.88 36.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.909 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.973 HG22 HD11 ' A' ' 58' ' ' ILE . 11.7 t -150.63 149.99 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.018 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.505 HD22 HG21 ' A' ' 87' ' ' VAL . 0.0 OUTLIER 49.47 33.82 6.06 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.25 0.547 . . . . 0.0 110.941 179.393 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 63.89 23.89 13.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.285 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -111.39 110.93 55.49 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.179 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.79 ' O ' HD22 ' A' ' 69' ' ' LEU . 29.2 Cg_endo -62.49 80.72 0.1 Allowed 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.914 1.743 . . . . 0.0 111.5 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.604 HD21 ' HB3' ' A' ' 74' ' ' ALA . 6.8 mt -78.17 65.44 3.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.389 0.614 . . . . 0.0 109.883 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.541 HG12 ' HB3' ' A' ' 34' ' ' PRO . 2.7 m -122.67 -56.04 2.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.698 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.494 ' H ' HG23 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -138.52 22.47 2.72 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -178.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.79 HD22 ' O ' ' A' ' 65' ' ' PRO . 0.7 OUTLIER -96.96 -175.67 3.33 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 178.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.3 m -68.86 96.67 0.77 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.864 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 9.0 t80 -40.77 -57.0 2.04 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -178.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -59.19 -28.22 66.43 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.096 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.903 ' O ' HG23 ' A' ' 77' ' ' VAL . 1.7 t -76.6 -44.71 33.23 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.733 ' HB2' HD21 ' A' ' 69' ' ' LEU . . . -57.84 -40.84 81.03 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.45 0.643 . . . . 0.0 109.724 178.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.864 HD11 ' CZ ' ' A' ' 71' ' ' TYR . 99.0 mt -66.02 -36.4 83.17 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.22 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -71.44 -38.7 71.33 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 120.921 0.391 . . . . 0.0 110.283 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.903 HG23 ' O ' ' A' ' 73' ' ' SER . 12.2 t -59.63 -36.85 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.013 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.459 HD11 HG12 ' B' ' 7' ' ' VAL . 4.5 pp -91.89 -24.64 19.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.005 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.27 -44.49 83.44 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 120.507 -0.477 . . . . 0.0 109.803 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -52.85 -22.29 11.84 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.877 -0.677 . . . . 0.0 113.031 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 80.1 mt -49.84 119.39 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 120.855 0.359 . . . . 0.0 111.391 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.15 -168.66 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.473 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 m -96.4 -171.12 2.21 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.115 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 44.13 31.3 0.52 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.074 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.419 ' O ' ' CE1' ' A' ' 15' ' ' PHE . 1.8 t -125.38 160.19 29.99 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.969 0.89 . . . . 0.0 112.789 -178.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -100.95 176.61 5.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.415 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.769 HG11 ' CD2' ' A' ' 22' ' ' LEU . 2.8 p -151.69 150.02 13.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.663 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.699 ' C ' HD23 ' A' ' 89' ' ' LEU . 22.1 t -110.2 155.96 11.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.382 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.73 HD12 ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -149.66 155.8 40.83 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.13 -178.353 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.72 HD13 ' HA ' ' A' ' 11' ' ' SER . 45.9 mm -130.75 133.36 63.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.02 0.438 . . . . 0.0 111.267 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.909 HD22 HG22 ' A' ' 57' ' ' ILE . 55.6 mt -107.46 158.24 17.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.316 178.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.2 156.52 17.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.058 0.456 . . . . 0.0 111.291 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.425 ' CA ' ' N ' ' A' ' 8' ' ' ASN . . . -161.88 -130.22 1.1 Allowed Glycine 0 CA--C 1.522 0.521 0 CA-C-N 115.701 -0.682 . . . . 0.0 112.906 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.841 ' HD2' HG12 ' A' ' 9' ' ' VAL . 88.4 Cg_endo -89.98 -166.72 0.23 Allowed 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.656 2.237 . . . . 0.0 112.519 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -128.98 105.51 8.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.276 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 114.31 10.24 13.82 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.644 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.606 ' C ' HD23 ' A' ' 120' ' ' LEU . 34.0 m-85 -141.5 140.53 33.52 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 117.252 0.526 . . . . 0.0 111.638 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.534 HG23 ' HG3' ' A' ' 118' ' ' GLN . 0.1 OUTLIER -98.69 119.79 38.03 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.053 179.501 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.899 HG21 ' HA ' ' A' ' 8' ' ' ASN . 2.2 t -102.69 91.96 4.42 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.068 0.461 . . . . 0.0 109.775 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.453 ' C ' HD22 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -69.42 -164.76 0.07 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.923 -179.744 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.736 HD13 HG12 ' A' ' 114' ' ' ILE . 2.7 mm? -107.0 127.85 53.82 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.439 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 177.2 122.93 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.424 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -60.78 105.94 0.51 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.854 0.359 . . . . 0.0 110.883 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 p -155.6 136.18 13.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.745 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -160.31 148.05 16.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.901 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 32.2 m -84.71 113.87 21.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.974 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 66.35 -94.42 0.22 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.492 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -165.78 39.91 0.06 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.927 0.394 . . . . 0.0 110.897 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -104.14 -44.7 1.57 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.741 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.455 HG23 ' O ' ' A' ' 110' ' ' THR . 15.4 t -118.72 50.84 1.33 Allowed Pre-proline 0 CA--C 1.535 0.388 0 CA-C-O 120.592 0.234 . . . . 0.0 111.413 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.402 ' CD ' ' N ' ' A' ' 110' ' ' THR . 60.7 Cg_endo -72.14 113.54 3.72 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.281 1.987 . . . . 0.0 112.556 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.27 -168.21 3.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.881 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 88.4 m -103.66 -37.33 7.55 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.085 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.78 ' HB ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -92.44 104.98 16.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.785 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.55 94.79 1.08 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.892 0.377 . . . . 0.0 111.989 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.6 t -158.41 63.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.518 HG22 ' HB3' ' A' ' 97' ' ' PHE . 2.9 m -77.13 127.74 33.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.153 0.501 . . . . 0.0 112.06 -178.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.534 ' HG3' HG23 ' A' ' 98' ' ' THR . 9.8 pt20 -138.39 139.42 25.0 Favored Pre-proline 0 C--O 1.224 -0.28 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.196 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.26 123.32 13.36 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.059 1.84 . . . . 0.0 111.756 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.606 HD23 ' C ' ' A' ' 97' ' ' PHE . 1.3 pp -116.21 -34.04 4.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.67 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 60.49 109.71 0.01 OUTLIER Glycine 0 CA--C 1.523 0.579 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.501 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -79.44 152.06 23.11 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.255 1.97 . . . . 0.0 112.413 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -51.95 178.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.203 1.935 . . . . 0.0 112.118 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 27.3 p -58.69 -56.12 26.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.838 0.351 . . . . 0.0 110.967 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 30.2 mtpt -99.83 179.89 4.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.755 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 59.08 20.17 8.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.941 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.452 -179.758 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 21.1 t . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 121.178 0.513 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.405 HG13 ' N ' ' B' ' 3' ' ' LYS . 11.7 p -117.14 -40.82 2.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.145 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.405 ' N ' HG13 ' B' ' 2' ' ' VAL . 27.6 mmtm -88.45 -36.39 16.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.23 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.415 ' CG1' ' HB3' ' A' ' 25' ' ' LEU . 11.5 t -102.29 108.43 23.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.763 0.315 . . . . 0.0 110.734 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . 0.602 ' CG ' HD13 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -87.54 -97.11 0.09 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.275 -179.43 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.992 ' HA ' HD23 ' A' ' 25' ' ' LEU . 7.1 t 167.78 -36.36 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 117.851 0.296 . . . . 0.0 110.541 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.636 ' O ' HD12 ' A' ' 22' ' ' LEU . 20.2 m . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.197 -0.906 . . . . 0.0 112.735 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.172 0 N-CA-C 112.524 -0.231 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.7 t -62.43 -32.47 73.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.822 0.344 . . . . 0.0 111.012 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -72.18 142.58 49.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.264 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -66.56 -67.85 0.42 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.563 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.463 HG22 ' H ' ' A' ' 6' ' ' GLU . 0.2 OUTLIER -98.06 -171.63 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.199 179.49 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.463 ' H ' HG22 ' A' ' 5' ' ' ILE . 25.3 mm-40 -138.22 157.93 71.83 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-O 120.645 0.26 . . . . 0.0 111.483 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.414 ' CA ' ' HA2' ' A' ' 93' ' ' GLY . 24.0 Cg_exo -64.33 127.34 18.89 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.683 2.255 . . . . 0.0 112.406 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.81 ' HA ' HG21 ' A' ' 99' ' ' THR . 20.4 m120 -144.23 87.29 1.88 Allowed 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.632 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.5 p -82.44 99.24 5.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 177.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.631 HG23 ' N ' ' A' ' 11' ' ' SER . 1.2 tp -161.31 -170.8 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.679 ' HA ' HD13 ' A' ' 90' ' ' ILE . 2.9 t -98.41 164.1 12.42 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.922 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.756 HG11 HD11 ' A' ' 51' ' ' LEU . 2.1 t -154.17 165.34 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.279 -178.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.1 ttp85 -144.75 140.04 28.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.292 0.568 . . . . 0.0 110.913 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.941 HD21 ' HB2' ' A' ' 46' ' ' ALA . 0.6 OUTLIER -139.07 140.99 38.2 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.323 -179.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.452 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 2.6 t80 -87.58 145.41 26.22 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 177.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.462 ' CE ' HD12 ' A' ' 78' ' ' LEU . 4.6 mttt -82.17 29.65 0.41 Allowed 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.824 -0.351 . . . . 0.0 111.538 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.866 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 42.99 31.03 0.3 Allowed 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 179.377 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.569 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 44.12 23.59 0.06 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.586 -178.559 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.866 HG22 ' O ' ' A' ' 17' ' ' ARG . 15.9 m -164.75 32.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.017 178.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 50.47 57.64 10.19 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.81 -178.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -138.8 58.79 0.61 Allowed Glycine 0 C--N 1.332 0.356 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.838 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 3.8 mp -44.61 -25.15 0.24 Allowed 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.461 ' HA2' HG22 ' A' ' 41' ' ' ILE . . . 109.32 5.73 29.95 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.18 -1.009 . . . . 0.0 113.644 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.932 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -158.73 138.14 11.65 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 117.835 0.818 . . . . 0.0 112.48 -179.47 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.893 HD21 HD13 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -85.04 175.53 8.97 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.594 179.608 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.512 HG12 HG21 ' A' ' 58' ' ' ILE . 30.4 m -146.7 160.92 9.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.924 177.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -141.95 111.21 6.42 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.846 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.594 ' CA ' HG23 ' A' ' 35' ' ' VAL . 1.7 tm-20 -106.19 113.23 26.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.101 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.526 ' HB2' ' HB2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -65.88 126.72 29.39 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.021 179.674 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 96.7 t -46.24 -26.26 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.677 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 80.0 p -154.87 89.42 1.23 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.588 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.526 ' HB2' ' HB2' ' A' ' 29' ' ' ARG . 4.5 mmtt 179.37 176.63 0.34 Allowed Pre-proline 0 N--CA 1.469 0.477 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 32' ' ' LYS . 96.1 Cg_exo -46.87 176.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 122.374 2.049 . . . . 0.0 112.696 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.413 ' HD2' ' HB3' ' A' ' 33' ' ' PRO . 43.5 Cg_exo -38.93 168.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 123.371 2.714 . . . . 0.0 114.955 -178.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.624 ' HB ' HD22 ' A' ' 66' ' ' LEU . 8.9 p -77.15 166.57 2.65 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.974 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.469 HD12 ' HA ' ' A' ' 36' ' ' ILE . 1.1 tp -147.07 172.25 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 119.914 -0.715 . . . . 0.0 112.658 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.529 HG13 HG22 ' A' ' 58' ' ' ILE . 43.5 mt -88.82 149.83 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.801 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.427 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 16.0 t -111.92 -42.72 3.72 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.517 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -175.59 139.39 0.42 Allowed 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 120.151 -0.619 . . . . 0.0 112.308 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.932 HD23 ' HB3' ' A' ' 24' ' ' PHE . 30.5 mt -68.83 110.24 4.27 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 178.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.893 HD13 HD21 ' A' ' 25' ' ' LEU . 1.5 tp -65.67 -58.49 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 -176.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.464 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 2.0 tmt_? -93.34 -59.53 2.0 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -177.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.494 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 102.26 22.49 9.8 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.173 -177.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.412 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -125.02 -29.37 1.03 Allowed Glycine 0 C--N 1.338 0.693 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.568 -178.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.838 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -94.35 -83.17 0.35 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 117.855 0.827 . . . . 0.0 111.648 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.941 ' HB2' HD21 ' A' ' 14' ' ' LEU . . . -61.83 -62.2 1.96 Allowed 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.238 0.542 . . . . 0.0 111.285 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.617 ' HB2' HD22 ' A' ' 40' ' ' LEU . 4.0 tp10 -46.36 -42.2 14.58 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.776 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.412 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 0.3 OUTLIER -58.77 -39.3 80.62 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.616 178.775 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.23 -44.5 68.14 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.492 178.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.91 -26.85 16.17 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.414 -0.898 . . . . 0.0 114.463 177.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.756 HD11 HG11 ' A' ' 12' ' ' VAL . 2.5 pp -104.04 18.6 21.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 117.546 0.673 . . . . 0.0 111.974 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.936 HG21 ' HB1' ' A' ' 46' ' ' ALA . 4.7 mp -120.15 73.68 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.819 0.342 . . . . 0.0 110.592 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -102.67 141.34 35.65 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.517 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -62.98 143.43 57.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.149 0.499 . . . . 0.0 111.55 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.59 10.7 85.98 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.009 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -97.76 -88.18 0.31 Allowed 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.862 0.331 . . . . 0.0 111.098 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.688 HG23 HD22 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -163.72 121.45 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -179.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.707 HD11 HG22 ' A' ' 61' ' ' VAL . 2.0 tp -137.98 77.03 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 177.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.416 HD13 ' HD3' ' A' ' 92' ' ' ARG . 0.3 OUTLIER -77.0 -62.21 1.73 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 -178.056 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.481 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . . . -116.4 149.54 39.23 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.833 0.349 . . . . 0.0 111.514 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.707 HG22 HD11 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -146.93 143.71 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.635 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.916 ' HA ' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER 65.18 -73.22 0.06 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.729 -179.505 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.3 t0 179.61 37.29 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.945 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.727 ' NH1' ' HB1' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -130.75 140.18 37.87 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-O 120.782 0.325 . . . . 0.0 111.029 179.547 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.46 ' O ' HD22 ' A' ' 69' ' ' LEU . 74.0 Cg_endo -76.27 82.58 2.19 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 121.548 1.498 . . . . 0.0 110.703 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.716 HD12 ' CZ ' ' A' ' 64' ' ' ARG . 0.4 OUTLIER -77.65 68.74 3.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.77 -178.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.535 HG23 ' H ' ' A' ' 68' ' ' ASP . 3.2 m -126.71 -59.45 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.919 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.535 ' H ' HG23 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -136.36 26.46 3.17 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.803 -178.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.698 HD21 ' HB2' ' A' ' 74' ' ' ALA . 1.9 pt? -92.58 -170.14 2.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.869 0.366 . . . . 0.0 110.66 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.412 ' N ' ' HG ' ' A' ' 69' ' ' LEU . 3.3 m -73.71 108.64 6.67 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.724 ' CE1' HD11 ' A' ' 75' ' ' LEU . 3.0 t80 -42.57 -55.84 3.34 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -62.93 -27.77 69.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.242 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.859 ' O ' HG23 ' A' ' 77' ' ' VAL . 22.4 t -75.32 -39.33 59.59 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.727 ' HB1' ' NH1' ' A' ' 64' ' ' ARG . . . -62.47 -49.49 75.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.945 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.724 HD11 ' CE1' ' A' ' 71' ' ' TYR . 27.2 mt -63.14 -30.68 71.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.916 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -72.78 -38.58 67.22 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.716 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' ' 73' ' ' SER . 65.1 t -58.97 -42.83 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.64 HD23 ' HA ' ' A' ' 75' ' ' LEU . 0.4 OUTLIER -78.7 -29.92 45.75 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.117 179.185 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -37.91 79.81 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.773 0.32 . . . . 0.0 110.975 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -59.59 -22.32 56.47 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.743 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.547 HD11 ' HB3' ' A' ' 62' ' ' ASN . 49.9 mt -58.23 116.74 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 120.927 0.394 . . . . 0.0 111.041 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.78 -167.18 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.44 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.402 ' O ' HG22 ' A' ' 85' ' ' THR . 3.9 m -96.83 -170.38 2.04 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.093 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 44.25 31.06 0.52 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.13 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.411 ' O ' ' CD1' ' A' ' 15' ' ' PHE . 1.7 t -130.12 162.35 29.01 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.815 0.817 . . . . 0.0 112.804 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -103.41 176.2 5.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.4 -1.273 . . . . 0.0 109.808 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.916 HG22 ' HA ' ' A' ' 62' ' ' ASN . 0.4 OUTLIER -144.9 172.37 5.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.929 0.395 . . . . 0.0 111.305 -179.366 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.802 ' O ' HD23 ' A' ' 89' ' ' LEU . 21.8 t -122.73 158.13 27.35 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.748 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.802 HD23 ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -151.32 147.33 26.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.845 0.355 . . . . 0.0 110.427 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.679 HD13 ' HA ' ' A' ' 11' ' ' SER . 41.0 mm -126.36 122.89 62.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.998 0.428 . . . . 0.0 111.465 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.702 HD11 ' CD1' ' A' ' 51' ' ' LEU . 10.0 mt -107.23 165.29 11.48 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.242 178.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.416 ' HD3' HD13 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -109.77 163.33 13.61 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.395 0.617 . . . . 0.0 112.532 -178.466 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.447 ' CA ' ' N ' ' A' ' 8' ' ' ASN . . . -164.26 -136.88 2.07 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.595 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -93.73 -164.67 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.997 2.465 . . . . 0.0 112.101 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -129.06 132.13 47.41 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.709 0.29 . . . . 0.0 110.609 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.14 5.09 59.63 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.686 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.942 ' HB3' HG22 ' A' ' 117' ' ' THR . 26.6 m-85 -139.92 127.19 21.23 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 117.537 0.669 . . . . 0.0 112.178 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.637 HG22 HD22 ' A' ' 120' ' ' LEU . 0.1 OUTLIER -79.35 120.76 24.25 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.175 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.81 HG21 ' HA ' ' A' ' 8' ' ' ASN . 8.0 t -107.65 92.27 4.0 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.09 0.471 . . . . 0.0 110.634 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -77.78 -163.76 0.44 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.789 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.497 ' O ' HD12 ' A' ' 101' ' ' LEU . 2.4 pp -131.93 121.02 23.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.866 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -175.43 67.66 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.88 0.371 . . . . 0.0 111.619 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -169.7 -175.48 2.13 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.079 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.09 138.84 33.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.56 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.422 ' HB2' ' HD2' ' A' ' 111' ' ' PRO . 35.2 p90 -87.43 150.78 23.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.914 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 98.5 m -136.68 -52.45 0.7 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.003 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.82 66.77 0.63 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.841 -0.695 . . . . 0.0 113.041 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 54.96 30.92 14.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.667 0.27 . . . . 0.0 111.548 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.421 ' HA2' ' HB2' ' A' ' 105' ' ' PHE . . . 88.74 39.3 6.66 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.659 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.796 HG22 ' HD3' ' A' ' 111' ' ' PRO . 0.6 OUTLIER -90.28 -44.27 0.4 Allowed Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -179.192 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.796 ' HD3' HG22 ' A' ' 110' ' ' THR . 12.4 Cg_exo -72.23 -38.34 3.8 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.276 1.984 . . . . 0.0 110.604 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.459 ' HE3' HG21 ' A' ' 5' ' ' ILE . 6.7 tptp 70.76 131.19 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.847 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 88.7 m -53.88 -43.76 69.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.233 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.639 ' HB ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -90.82 95.04 5.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.271 0.558 . . . . 0.0 110.14 179.197 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.79 94.08 1.73 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 99' ' ' THR . 1.5 t -156.21 64.12 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.959 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.942 HG22 ' HB3' ' A' ' 97' ' ' PHE . 0.2 OUTLIER -77.56 128.89 34.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.833 -178.677 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.404 ' O ' ' HA ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -142.61 135.1 13.56 Favored Pre-proline 0 C--O 1.22 -0.489 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.371 -179.782 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.03 133.71 59.73 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 121.9 1.733 . . . . 0.0 112.54 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.637 HD22 HG22 ' A' ' 98' ' ' THR . 0.2 OUTLIER -76.39 -72.4 0.33 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.137 0.494 . . . . 0.0 110.118 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 104.98 97.52 2.49 Favored Glycine 0 CA--C 1.522 0.481 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.187 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -46.16 161.74 0.15 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.619 2.213 . . . . 0.0 112.936 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -65.23 174.61 4.82 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.359 2.04 . . . . 0.0 112.601 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.8 t -154.2 118.2 4.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.712 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.6 ttmt 61.63 42.99 10.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.048 0.451 . . . . 0.0 110.847 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.35 -13.96 61.36 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.376 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.114 179.983 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.56 ' O ' HG13 ' B' ' 1' ' ' VAL . 12.3 p . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.817 0.341 . . . . 0.0 111.002 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.557 HG22 ' O ' ' B' ' 2' ' ' VAL . 11.8 p -150.61 50.18 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.012 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.421 ' CE ' ' HA ' ' A' ' 29' ' ' ARG . 3.1 mmtm -142.8 -61.66 0.43 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.689 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.416 ' CG1' ' HB3' ' A' ' 38' ' ' SER . 3.5 t -57.72 137.5 19.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.947 0.403 . . . . 0.0 111.59 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -123.79 102.08 7.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.645 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.825 ' HA ' HD23 ' A' ' 25' ' ' LEU . 12.9 p -61.05 134.82 57.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.959 0.409 . . . . 0.0 110.728 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.629 ' OXT' HD12 ' A' ' 22' ' ' LEU . 14.6 m . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.142 -0.932 . . . . 0.0 111.149 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 112.668 -0.173 . . . . 0.0 112.668 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -147.54 39.14 0.96 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.886 0.374 . . . . 0.0 110.659 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -166.44 81.26 0.26 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.178 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 6.3 ttt -109.62 79.36 1.21 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.672 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.6 tt -147.59 33.86 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.146 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.401 ' HG3' ' HD2' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -165.65 -63.7 0.01 OUTLIER Pre-proline 0 N--CA 1.469 0.497 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.693 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.41 ' HA ' ' HA3' ' A' ' 93' ' ' GLY . 9.2 Cg_endo -50.92 113.41 1.07 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.775 2.317 . . . . 0.0 113.474 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.432 ' ND2' HD12 ' A' ' 114' ' ' ILE . 0.9 OUTLIER 177.32 94.08 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.744 179.388 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.567 ' O ' HG13 ' A' ' 9' ' ' VAL . 14.7 p -79.77 109.47 14.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.662 HG23 ' N ' ' A' ' 11' ' ' SER . 1.0 OUTLIER -163.32 -166.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.101 179.161 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.704 ' HA ' HD13 ' A' ' 90' ' ' ILE . 56.1 p -84.6 165.27 18.13 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.652 0.739 . . . . 0.0 111.957 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.881 HG11 HD11 ' A' ' 51' ' ' LEU . 1.7 t -156.72 156.15 4.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.748 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -140.4 140.38 35.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.595 0.712 . . . . 0.0 111.154 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.83 ' C ' HG12 ' A' ' 87' ' ' VAL . 0.5 OUTLIER -141.88 177.77 7.96 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.833 -179.624 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.472 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 2.6 t80 -122.98 149.82 43.79 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.403 ' O ' ' N ' ' A' ' 20' ' ' GLY . 2.2 mttt -84.2 29.39 0.57 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.738 178.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.884 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 41.96 31.77 0.25 Allowed 'General case' 0 C--N 1.345 0.378 0 C-N-CA 123.006 0.522 . . . . 0.0 111.853 179.593 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.571 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 44.05 24.16 0.07 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.529 -178.508 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.884 HG22 ' O ' ' A' ' 17' ' ' ARG . 13.0 m -164.16 31.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.185 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 50.45 65.57 2.9 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.616 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -151.62 68.26 0.32 Allowed Glycine 0 C--N 1.331 0.273 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.822 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 4.2 mp -52.22 -22.2 4.13 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.443 ' HA2' HG22 ' A' ' 41' ' ' ILE . . . 107.3 11.56 25.33 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.152 -1.023 . . . . 0.0 113.829 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.918 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -159.7 141.73 13.27 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 118.008 0.904 . . . . 0.0 113.382 -179.576 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.92 HD23 ' HA ' ' B' ' 6' ' ' SER . 11.5 mt -79.61 172.83 13.25 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.435 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.2 m -153.23 148.97 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.242 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.423 ' HG3' HG22 ' A' ' 36' ' ' ILE . 0.7 OUTLIER -135.38 106.27 6.61 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.393 -179.265 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.482 ' HB3' ' CD1' ' A' ' 71' ' ' TYR . 7.0 tm-20 -103.54 111.42 23.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.805 178.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.484 ' CB ' ' HB2' ' A' ' 32' ' ' LYS . 1.9 mtt180 -70.62 116.55 11.08 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 121.092 0.472 . . . . 0.0 110.43 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.6 t -44.9 -24.69 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.609 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 t -145.22 73.58 1.37 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.368 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.502 ' HB3' ' HD2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -177.19 176.86 0.48 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.31 -178.631 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.502 ' HD2' ' HB3' ' A' ' 32' ' ' LYS . 82.6 Cg_exo -44.8 172.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.416 2.077 . . . . 0.0 113.364 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.404 ' HB3' HG12 ' A' ' 67' ' ' VAL . 98.7 Cg_exo -43.96 174.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.081 2.521 . . . . 0.0 114.157 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.673 HG13 ' O ' ' A' ' 58' ' ' ILE . 8.1 p -78.41 152.1 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.079 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.485 HD12 ' HA ' ' A' ' 36' ' ' ILE . 1.2 tp -133.88 163.65 36.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.597 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.67 HD12 ' O ' ' A' ' 53' ' ' GLN . 35.9 mt -82.74 145.88 7.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.64 0.257 . . . . 0.0 110.925 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.454 ' CB ' HG13 ' B' ' 4' ' ' VAL . 6.3 t -109.55 -38.2 5.5 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.63 ' HB3' HD12 ' A' ' 25' ' ' LEU . 3.5 t0 -170.54 135.35 1.18 Allowed 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.364 -0.534 . . . . 0.0 112.18 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.918 HD23 ' HB3' ' A' ' 24' ' ' PHE . 45.4 mt -71.93 84.08 0.95 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.698 0.761 . . . . 0.0 109.781 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.458 ' CG2' ' N ' ' A' ' 42' ' ' ARG . 0.8 OUTLIER -39.91 -59.13 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 114.922 1.452 . . . . 0.0 114.922 -177.515 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.458 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -93.53 -64.78 1.05 Allowed 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -177.632 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.427 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 104.41 23.56 7.93 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -177.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.405 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -126.06 -32.37 0.74 Allowed Glycine 0 C--N 1.338 0.666 0 C-N-CA 121.283 -0.484 . . . . 0.0 113.085 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.822 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -94.03 -83.13 0.34 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 117.732 0.766 . . . . 0.0 111.435 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.916 ' HB1' HG21 ' A' ' 52' ' ' ILE . . . -58.14 -57.92 10.72 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.232 0.539 . . . . 0.0 111.161 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.427 ' HB3' ' HA2' ' A' ' 43' ' ' GLY . 39.4 tt0 -48.26 -47.54 36.03 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.871 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.405 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -57.31 -32.97 67.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.09 178.903 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.497 ' O ' HG21 ' A' ' 113' ' ' THR . 0.4 OUTLIER -57.55 -52.21 66.34 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.89 178.689 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 113.75 -30.73 6.99 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.154 -1.022 . . . . 0.0 114.096 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.938 HD13 HD11 ' A' ' 91' ' ' LEU . 3.7 pp -95.75 -1.47 49.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.291 0.545 . . . . 0.0 111.571 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.916 HG21 ' HB1' ' A' ' 46' ' ' ALA . 4.9 mp -105.27 118.36 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-O 120.953 0.406 . . . . 0.0 110.217 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.67 ' O ' HD12 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -144.44 162.51 36.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.293 179.685 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.573 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -71.81 126.72 30.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.857 0.361 . . . . 0.0 110.787 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.42 11.97 72.51 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.932 -178.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.13 -83.95 0.24 Allowed 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 19.7 mt -155.94 125.72 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.787 HD11 HG22 ' A' ' 61' ' ' VAL . 5.8 tp -160.42 70.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.596 177.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.433 ' HG ' ' N ' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -78.04 -47.79 17.59 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 122.087 -0.383 . . . . 0.0 111.315 -178.418 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.502 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . . . -121.89 150.21 42.3 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.834 0.35 . . . . 0.0 111.368 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.788 HG12 ' ND2' ' A' ' 62' ' ' ASN . 3.0 t -140.33 144.86 26.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.172 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.788 ' ND2' HG12 ' A' ' 61' ' ' VAL . 0.0 OUTLIER 53.84 -82.59 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.025 0.53 . . . . 0.0 110.902 -179.118 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.432 ' N ' ' O ' ' A' ' 61' ' ' VAL . 2.0 p30 -165.56 33.69 0.05 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.084 0.469 . . . . 0.0 110.272 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.792 ' NH2' HD23 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -126.64 105.5 23.61 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.779 179.653 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -58.93 87.4 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 121.701 1.601 . . . . 0.0 110.526 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.892 HD13 ' HB2' ' A' ' 74' ' ' ALA . 29.8 tp -86.44 66.04 9.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.431 0.634 . . . . 0.0 111.397 -178.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.404 HG12 ' HB3' ' A' ' 34' ' ' PRO . 2.7 m -110.67 -44.28 5.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.027 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.5 p30 -140.24 24.52 2.31 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.513 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.704 HD23 ' HA ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -99.87 174.32 6.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.772 -179.739 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.646 ' H ' HD12 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -63.46 121.76 14.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.317 179.727 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.648 ' CE1' HD11 ' A' ' 75' ' ' LEU . 3.7 t80 -54.93 -61.0 2.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.524 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.458 ' HA ' HD12 ' A' ' 75' ' ' LEU . 47.7 t0 -56.67 -32.76 65.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.237 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.569 ' O ' HG23 ' A' ' 77' ' ' VAL . 69.6 m -70.95 -46.35 62.56 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.892 ' HB2' HD13 ' A' ' 66' ' ' LEU . . . -55.65 -45.01 77.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.171 178.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.648 HD11 ' CE1' ' A' ' 71' ' ' TYR . 14.7 mt -64.87 -29.71 70.67 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.15 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.407 ' HA ' ' HB2' ' A' ' 79' ' ' ARG . 9.6 mt-10 -72.34 -36.13 68.73 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.002 0.429 . . . . 0.0 110.017 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 73' ' ' SER . 47.4 t -61.0 -46.04 97.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.524 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.792 HD23 ' NH2' ' A' ' 64' ' ' ARG . 1.6 pp -79.12 -27.06 42.83 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.408 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.407 ' HB2' ' HA ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -61.76 -49.21 77.28 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 121.023 0.439 . . . . 0.0 110.776 -179.438 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.35 -22.61 15.79 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.997 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.406 ' CD1' ' HA ' ' A' ' 78' ' ' LEU . 57.1 mt -56.32 118.75 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 120.9 0.381 . . . . 0.0 111.097 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.75 -165.93 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.421 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.2 m -95.47 -169.42 1.96 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.244 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 41.17 32.6 0.2 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.398 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.418 ' O ' ' CE1' ' A' ' 15' ' ' PHE . 1.5 t -125.29 159.95 30.47 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 122.013 0.911 . . . . 0.0 112.775 -178.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.64 176.63 5.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.13 -1.395 . . . . 0.0 109.921 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.83 HG12 ' C ' ' A' ' 14' ' ' LEU . 4.2 p -149.71 151.78 12.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.541 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.829 ' O ' HD23 ' A' ' 89' ' ' LEU . 10.7 t -109.61 163.79 6.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.9 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.867 HD12 ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -159.04 164.38 35.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.674 0.273 . . . . 0.0 110.393 -179.723 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.704 HD13 ' HA ' ' A' ' 11' ' ' SER . 33.0 mm -135.64 125.5 41.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.938 HD11 HD13 ' A' ' 51' ' ' LEU . 10.9 mt -93.43 169.95 9.98 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 177.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -148.83 144.02 26.68 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -179.104 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.429 ' HA3' ' N ' ' A' ' 8' ' ' ASN . . . -157.0 -107.92 0.26 Allowed Glycine 0 CA--C 1.523 0.569 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.076 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -93.29 -167.05 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.876 2.384 . . . . 0.0 112.471 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -143.54 131.03 21.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.581 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 118.23 7.83 10.91 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.867 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.797 ' C ' HD23 ' A' ' 120' ' ' LEU . 16.3 m-85 -136.21 144.37 44.87 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 117.315 0.558 . . . . 0.0 111.766 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 117' ' ' THR . 0.1 OUTLIER -93.07 114.24 26.72 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.886 179.719 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 54.3 p -78.84 93.55 5.02 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.94 149.25 28.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.283 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.665 HD22 ' N ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -54.55 -171.64 0.0 OUTLIER 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.738 -179.66 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.665 ' N ' HD22 ' A' ' 101' ' ' LEU . 0.5 OUTLIER 80.34 34.03 0.15 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.999 -178.709 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.568 HG23 HG23 ' A' ' 116' ' ' VAL . 38.0 m -76.92 107.15 9.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.843 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 104' ' ' THR . 34.3 m -86.86 4.13 42.57 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.548 ' HA ' HG23 ' A' ' 110' ' ' THR . 7.2 p90 41.88 75.59 0.09 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.953 0.501 . . . . 0.0 112.275 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.471 HG22 ' N ' ' A' ' 107' ' ' GLY . 51.7 m -129.11 -95.59 0.4 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.146 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.471 ' N ' HG22 ' A' ' 106' ' ' THR . . . 43.03 -94.07 0.01 OUTLIER Glycine 0 C--N 1.345 1.045 0 C-N-CA 121.464 -0.398 . . . . 0.0 113.575 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -153.62 30.62 0.47 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.832 0.349 . . . . 0.0 110.518 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 114.97 58.09 0.36 Allowed Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.268 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.548 HG23 ' HA ' ' A' ' 105' ' ' PHE . 13.1 t -118.26 50.3 1.15 Allowed Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -72.53 89.32 0.84 Allowed 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.223 1.949 . . . . 0.0 112.14 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.76 172.65 12.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.091 0.472 . . . . 0.0 111.443 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.497 HG21 ' O ' ' A' ' 49' ' ' SER . 3.9 m -104.01 -10.89 17.74 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.488 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.443 HG12 ' N ' ' A' ' 115' ' ' ARG . 0.0 OUTLIER -76.61 158.21 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.723 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.443 ' N ' HG12 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -75.26 141.27 43.5 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.492 0.663 . . . . 0.0 112.774 -177.183 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.568 HG23 HG23 ' A' ' 103' ' ' THR . 3.9 t -78.19 135.02 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.156 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 99' ' ' THR . 0.6 OUTLIER -81.45 140.46 34.62 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.519 -179.402 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.46 ' O ' ' HA ' ' A' ' 97' ' ' PHE . 1.6 pp0? -123.97 141.29 36.61 Favored Pre-proline 0 C--O 1.222 -0.363 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.334 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -44.33 107.99 0.11 Allowed 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.74 2.293 . . . . 0.0 112.447 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.797 HD23 ' C ' ' A' ' 97' ' ' PHE . 0.4 OUTLIER -115.57 -40.04 3.45 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.472 -179.182 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.41 ' O ' HD12 ' A' ' 120' ' ' LEU . . . 74.29 117.15 0.09 OUTLIER Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.259 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.43 160.73 4.68 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.264 1.976 . . . . 0.0 112.331 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.36 160.1 39.32 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.408 2.072 . . . . 0.0 112.512 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.4 t -172.21 161.98 5.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.851 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.4 ttpp -121.79 35.39 4.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.885 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -94.08 19.14 9.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.028 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.7 t . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.134 -179.84 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.921 0.391 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.597 HG22 ' O ' ' B' ' 2' ' ' VAL . 14.3 p -174.71 37.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.88 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.461 ' CE ' ' HA ' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -116.31 -38.06 3.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.197 -179.773 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.458 HG11 HD13 ' A' ' 25' ' ' LEU . 15.3 t -79.56 111.75 16.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.783 0.325 . . . . 0.0 110.454 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.98 -104.65 0.09 Allowed 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.169 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.92 ' HA ' HD23 ' A' ' 25' ' ' LEU . 6.7 t 163.3 105.63 0.0 OUTLIER 'General case' 0 C--N 1.346 0.438 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.544 ' O ' HD12 ' A' ' 22' ' ' LEU . 21.3 m . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.305 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.9 t -174.58 -48.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.968 0.413 . . . . 0.0 110.81 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 25.0 m80 -147.36 147.53 30.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.788 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 36.7 mtt -95.86 -76.55 0.5 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.504 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.631 HG23 ' N ' ' A' ' 6' ' ' GLU . 0.3 OUTLIER -81.03 -158.15 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.159 179.802 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.631 ' N ' HG23 ' A' ' 5' ' ' ILE . 5.6 mt-10 -167.42 157.78 9.74 Favored Pre-proline 0 CA--C 1.535 0.373 0 O-C-N 122.318 -0.239 . . . . 0.0 111.506 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.95 -162.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.661 2.241 . . . . 0.0 112.863 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.7 m120 63.07 85.96 0.12 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.725 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.476 HG22 ' CG2' ' A' ' 90' ' ' ILE . 4.4 p -80.97 123.5 37.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.421 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.1 tp -88.08 160.28 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.116 -178.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.841 ' HA ' HD13 ' A' ' 90' ' ' ILE . 59.2 p -105.23 159.92 15.5 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.954 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.532 HG23 ' HB2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -134.15 102.96 4.61 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.318 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.542 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.0 ttp85 -79.47 106.17 11.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.49 0.662 . . . . 0.0 112.26 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.705 ' C ' HG12 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -116.62 177.23 4.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.604 178.612 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.458 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 2.4 t80 -117.03 151.25 37.16 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.41 ' O ' ' N ' ' A' ' 20' ' ' GLY . 0.8 OUTLIER -85.67 27.27 0.86 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.179 178.691 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.897 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.2 OUTLIER 45.48 29.73 0.64 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 179.257 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.602 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 43.13 24.92 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.101 0.56 . . . . 0.0 112.421 -178.431 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.897 HG22 ' O ' ' A' ' 17' ' ' ARG . 15.0 m -166.53 32.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 123.948 0.899 . . . . 0.0 108.857 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 48.01 62.55 4.14 Favored Glycine 0 C--N 1.34 0.768 0 CA-C-N 115.818 -0.628 . . . . 0.0 113.154 -178.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -147.9 60.2 0.46 Allowed Glycine 0 C--N 1.333 0.412 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.832 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 4.0 mp -41.02 -26.63 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -178.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.412 ' HA2' HG22 ' A' ' 41' ' ' ILE . . . 120.47 1.83 12.11 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.11 -1.043 . . . . 0.0 113.469 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.901 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -156.94 140.2 15.59 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 117.766 0.783 . . . . 0.0 112.665 -179.561 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.867 HD21 HD13 ' A' ' 41' ' ' ILE . 0.7 OUTLIER -79.15 171.06 15.71 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.954 179.047 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.7 m -150.8 154.12 9.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.037 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.442 ' CG ' HG22 ' A' ' 36' ' ' ILE . 7.6 ptmm? -135.79 107.74 7.12 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.275 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.498 ' HB3' ' CG ' ' A' ' 71' ' ' TYR . 3.0 tm-20 -97.41 108.54 21.28 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.515 ' CB ' ' HB2' ' A' ' 32' ' ' LYS . 1.1 mtt180 -59.99 111.6 1.55 Allowed 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 121.104 0.478 . . . . 0.0 110.409 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.1 t -49.85 -22.15 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.839 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.5 t -150.03 69.43 1.01 Allowed 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.516 -0.474 . . . . 0.0 109.983 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.532 ' HB3' ' HD2' ' A' ' 33' ' ' PRO . 0.8 OUTLIER -177.21 -179.12 0.31 Allowed Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.95 -178.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.532 ' HD2' ' HB3' ' A' ' 32' ' ' LYS . 77.5 Cg_exo -45.95 175.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.549 2.166 . . . . 0.0 113.816 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.738 ' HB3' HG12 ' A' ' 67' ' ' VAL . 79.9 Cg_exo -44.05 175.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 123.387 2.725 . . . . 0.0 114.862 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.822 HG13 ' O ' ' A' ' 58' ' ' ILE . 12.5 p -78.47 159.92 4.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.291 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' A' ' 36' ' ' ILE . 1.0 OUTLIER -144.29 164.59 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.492 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.495 HG13 HG22 ' A' ' 58' ' ' ILE . 39.3 mt -84.89 149.0 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.94 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.427 ' OG ' HG13 ' B' ' 4' ' ' VAL . 0.9 OUTLIER -117.14 -38.6 3.34 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.552 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.5 OUTLIER -172.69 135.8 0.69 Allowed 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 119.972 -0.691 . . . . 0.0 112.679 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.901 HD23 ' HB3' ' A' ' 24' ' ' PHE . 47.8 mt -67.09 113.6 5.19 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.867 HD13 HD21 ' A' ' 25' ' ' LEU . 2.0 tp -73.49 -55.86 11.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -175.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.458 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 10.9 ttt85 -93.38 -64.84 1.04 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.074 0.464 . . . . 0.0 112.104 -177.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.446 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 105.31 21.19 9.01 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.376 -178.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.407 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -125.85 -30.86 0.85 Allowed Glycine 0 C--N 1.336 0.551 0 C-N-CA 121.072 -0.585 . . . . 0.0 113.206 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.832 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -94.73 -82.66 0.36 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 117.583 0.692 . . . . 0.0 111.302 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.822 ' HB1' HG21 ' A' ' 52' ' ' ILE . . . -59.24 -57.38 13.29 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.148 0.499 . . . . 0.0 111.402 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.446 ' HB3' ' HA2' ' A' ' 43' ' ' GLY . 51.2 tt0 -49.85 -45.87 50.8 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.751 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.407 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 1.0 OUTLIER -55.83 -35.29 66.22 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.003 178.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.4 t -58.48 -49.34 77.68 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.63 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.75 -19.14 36.44 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.31 -0.947 . . . . 0.0 113.921 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.744 ' HG ' HD12 ' A' ' 52' ' ' ILE . 3.3 pp -96.52 -26.63 15.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.154 0.477 . . . . 0.0 110.814 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.822 HG21 ' HB1' ' A' ' 46' ' ' ALA . 5.0 mp -80.8 98.64 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-O 120.958 0.409 . . . . 0.0 110.42 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.418 ' O ' HD12 ' A' ' 37' ' ' ILE . 1.1 mp0 -124.53 149.26 47.13 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.646 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.552 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -67.63 128.67 37.32 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.987 0.423 . . . . 0.0 111.273 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.74 2.15 90.62 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.388 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -84.21 -89.1 0.1 Allowed 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.985 0.392 . . . . 0.0 110.902 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.554 HG23 HD22 ' A' ' 91' ' ' LEU . 6.3 tp -163.12 126.32 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.822 ' O ' HG13 ' A' ' 35' ' ' VAL . 2.7 tp -146.6 90.02 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.442 HD13 ' NH2' ' A' ' 92' ' ' ARG . 6.4 tp -78.49 -67.09 0.77 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.407 -177.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.486 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . . . -128.4 149.78 50.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.16 0.505 . . . . 0.0 112.111 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.703 HG22 HD11 ' A' ' 58' ' ' ILE . 18.8 t -125.97 144.79 34.87 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.893 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.468 ' HB3' HG23 ' A' ' 87' ' ' VAL . 0.0 OUTLIER 44.2 29.24 0.34 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 120.964 0.411 . . . . 0.0 111.768 -178.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.6 t70 74.02 26.91 1.66 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.403 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.74 ' NH2' HG12 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -99.99 102.71 18.61 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.014 179.411 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.744 ' O ' HD23 ' A' ' 69' ' ' LEU . 19.8 Cg_endo -61.09 82.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 121.946 1.764 . . . . 0.0 111.736 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.42 ' HG ' ' HB1' ' A' ' 74' ' ' ALA . 0.5 OUTLIER -86.82 64.67 8.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.403 0.62 . . . . 0.0 110.284 -179.766 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.738 HG12 ' HB3' ' A' ' 34' ' ' PRO . 3.1 m -125.97 -52.63 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.536 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.439 ' H ' HG23 ' A' ' 67' ' ' VAL . 81.2 m-20 -133.33 24.48 4.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.897 0.38 . . . . 0.0 110.992 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.744 HD23 ' O ' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -105.63 175.23 5.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.313 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.588 ' H ' HD12 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -66.05 102.21 0.78 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.252 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.717 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 8.5 t80 -43.87 -54.75 5.03 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.971 0.415 . . . . 0.0 111.977 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -60.86 -33.73 73.52 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.931 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.873 ' O ' HG23 ' A' ' 77' ' ' VAL . 41.1 t -72.64 -43.89 62.61 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.733 ' HB2' HD21 ' A' ' 69' ' ' LEU . . . -59.4 -45.61 91.01 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.405 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.717 HD11 ' CZ ' ' A' ' 71' ' ' TYR . 56.0 mt -65.76 -30.21 70.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.271 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -74.01 -42.7 59.95 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.727 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.873 HG23 ' O ' ' A' ' 73' ' ' SER . 28.5 t -60.45 -35.0 60.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.276 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.589 HD21 HD23 ' A' ' 75' ' ' LEU . 4.1 pp -88.42 -22.49 23.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.942 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.1 -39.59 95.14 Favored 'General case' 0 C--N 1.339 0.12 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -55.35 -21.38 26.45 Favored Glycine 0 CA--C 1.522 0.514 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.946 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.42 HD11 HH12 ' A' ' 64' ' ' ARG . 79.0 mt -54.72 108.49 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-O 120.797 0.332 . . . . 0.0 110.733 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.89 -168.3 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.454 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.46 -172.22 2.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.024 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 44.01 31.25 0.5 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.26 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.408 ' O ' ' CE1' ' A' ' 15' ' ' PHE . 1.7 t -124.35 160.94 26.98 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.984 0.897 . . . . 0.0 112.747 -178.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.72 176.7 5.54 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.18 -1.373 . . . . 0.0 110.335 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.719 HG11 ' CD2' ' A' ' 22' ' ' LEU . 2.6 p -145.41 157.36 13.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.507 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.7 t -133.27 99.26 3.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.447 0.641 . . . . 0.0 111.626 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.651 HD23 ' CD1' ' A' ' 58' ' ' ILE . 6.4 mp -80.71 175.84 10.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.946 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.841 HD13 ' HA ' ' A' ' 11' ' ' SER . 36.2 mm -140.32 125.07 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.802 178.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.554 HD22 HG23 ' A' ' 57' ' ' ILE . 49.0 mt -130.29 176.77 7.85 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.716 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.442 ' NH2' HD13 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -75.95 175.09 9.15 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.749 -179.419 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.684 ' HA3' HG21 ' A' ' 99' ' ' THR . . . 162.83 154.14 7.49 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.082 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.48 ' HB2' HG21 ' A' ' 117' ' ' THR . 32.6 Cg_exo -57.1 -168.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.329 2.019 . . . . 0.0 112.317 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -128.36 152.65 47.92 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.846 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.418 ' O ' ' CD1' ' A' ' 97' ' ' PHE . . . 73.62 16.43 79.09 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.969 -178.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.754 ' HB2' HG22 ' A' ' 117' ' ' THR . 69.1 m-85 -156.97 142.12 17.21 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.65 HG22 HD22 ' A' ' 120' ' ' LEU . 0.1 OUTLIER -85.67 111.81 20.43 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.355 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.684 HG21 ' HA3' ' A' ' 93' ' ' GLY . 3.6 t -90.37 93.51 9.35 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.857 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -62.26 -96.11 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.588 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.409 HD13 HD23 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -173.88 120.3 0.29 Allowed 'General case' 0 C--N 1.343 0.3 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -179.762 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 169.65 170.97 0.05 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.562 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.494 HG23 ' N ' ' A' ' 104' ' ' THR . 0.5 OUTLIER 69.72 174.84 0.29 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.252 0.548 . . . . 0.0 111.416 179.134 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.494 ' N ' HG23 ' A' ' 103' ' ' THR . 29.6 p -118.41 -160.27 0.79 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.571 179.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.696 ' O ' HG23 ' A' ' 106' ' ' THR . 20.2 p90 -135.97 164.08 28.8 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.264 0.554 . . . . 0.0 111.878 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.696 HG23 ' O ' ' A' ' 105' ' ' PHE . 0.8 OUTLIER -171.86 150.35 2.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.733 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.4 54.22 4.78 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.211 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.4 t0 73.85 27.84 1.63 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.864 0.364 . . . . 0.0 111.631 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 62.99 60.67 7.31 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.938 -0.648 . . . . 0.0 113.489 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.762 HG22 ' HD3' ' A' ' 111' ' ' PRO . 1.5 t -92.31 -41.94 0.36 Allowed Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.762 ' HD3' HG22 ' A' ' 110' ' ' THR . 5.5 Cg_exo -75.83 -46.44 0.2 Allowed 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.289 1.993 . . . . 0.0 110.583 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.491 ' HG3' HG22 ' A' ' 114' ' ' ILE . 4.2 tppt? 80.6 137.01 0.06 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.921 178.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.468 HG22 ' HA ' ' A' ' 51' ' ' LEU . 61.1 m -47.49 -35.3 8.54 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.649 0.738 . . . . 0.0 110.154 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.62 HD11 ' O ' ' A' ' 99' ' ' THR . 0.0 OUTLIER -97.55 92.95 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.066 177.801 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 13.0 ttt180 -144.8 100.77 3.56 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.335 0.588 . . . . 0.0 111.887 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.8 t -154.54 66.49 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.754 HG22 ' HB2' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -76.66 122.23 24.38 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.845 -1.07 . . . . 0.0 113.119 -175.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.44 ' HG3' HG23 ' A' ' 98' ' ' THR . 0.1 OUTLIER -122.95 131.17 24.38 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.734 178.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -44.68 131.31 9.96 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.385 2.057 . . . . 0.0 113.866 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.702 HD21 ' C ' ' A' ' 97' ' ' PHE . 0.7 OUTLIER -88.97 -66.0 0.96 Allowed 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.872 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.402 ' HA3' ' HD3' ' A' ' 122' ' ' PRO . . . -124.03 -124.33 2.87 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.936 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.402 ' HD3' ' HA3' ' A' ' 121' ' ' GLY . 9.7 Cg_endo -87.38 139.1 4.92 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.533 2.155 . . . . 0.0 112.27 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.53 57.16 6.39 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.381 2.054 . . . . 0.0 112.331 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.08 88.95 1.62 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.049 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.04 177.73 4.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.959 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 61.16 17.91 8.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.115 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.3 m . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.237 -0.887 . . . . 0.0 111.056 179.842 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 9.6 m . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 121.184 0.516 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 14.6 p -99.49 -32.01 3.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.315 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.464 ' CE ' ' HA ' ' A' ' 29' ' ' ARG . 1.6 mmtp -87.27 -57.26 3.02 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.002 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.564 HG11 HD13 ' A' ' 25' ' ' LEU . 21.2 t -64.93 100.42 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.006 0.432 . . . . 0.0 110.992 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.35 116.56 29.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.788 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.867 ' HA ' HD23 ' A' ' 25' ' ' LEU . 9.4 p -71.49 121.07 18.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.083 0.468 . . . . 0.0 110.382 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.768 ' OXT' HD12 ' A' ' 22' ' ' LEU . 30.9 m . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.406 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.13 0 N-CA-C 112.633 -0.187 . . . . 0.0 112.633 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 76.6 p -141.32 87.77 2.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.787 0.327 . . . . 0.0 110.563 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.67 125.3 37.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.023 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -172.71 -44.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.938 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.734 HD12 ' CE ' ' A' ' 112' ' ' LYS . 12.3 tt -55.69 161.68 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.802 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -148.18 69.64 10.74 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-O 120.604 0.24 . . . . 0.0 111.389 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.424 ' HD2' ' HD2' ' A' ' 94' ' ' PRO . 22.1 Cg_endo -93.77 -164.54 0.11 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.079 2.519 . . . . 0.0 113.006 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.416 ' ND2' ' HG2' ' A' ' 95' ' ' GLU . 2.2 t-20 -144.87 -64.5 0.34 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.405 ' C ' HD13 ' A' ' 10' ' ' ILE . 60.6 t -156.33 74.45 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.105 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.871 HG23 HG21 ' A' ' 99' ' ' THR . 0.5 OUTLIER -95.11 158.37 2.98 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.221 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.783 -178.141 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.72 ' HA ' HD13 ' A' ' 90' ' ' ILE . 20.0 m -92.25 156.13 17.5 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.796 ' CG1' HD12 ' A' ' 89' ' ' LEU . 2.5 t -149.84 157.61 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.618 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.6 tpp180 -145.54 121.9 10.95 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.516 0.674 . . . . 0.0 110.57 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.738 ' C ' HG12 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -123.71 178.34 5.27 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.555 -179.668 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.428 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 2.7 t80 -115.69 151.95 34.1 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.562 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.605 ' HD3' HG21 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -86.21 30.12 0.71 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 121.009 -0.277 . . . . 0.0 110.803 178.327 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.901 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.1 OUTLIER 42.68 30.67 0.24 Allowed 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 179.518 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.596 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 43.72 24.47 0.07 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.342 -178.358 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.901 HG22 ' O ' ' A' ' 17' ' ' ARG . 14.1 m -166.33 32.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 123.942 0.897 . . . . 0.0 109.086 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 49.83 68.64 1.31 Allowed Glycine 0 C--N 1.338 0.655 0 CA-C-N 115.824 -0.625 . . . . 0.0 113.049 -178.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -154.51 67.23 0.31 Allowed Glycine 0 C--N 1.333 0.4 0 N-CA-C 111.686 -0.566 . . . . 0.0 111.686 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.932 ' CD2' HG11 ' A' ' 87' ' ' VAL . 4.4 mp -48.18 -23.36 0.84 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.433 ' HA2' HG22 ' A' ' 41' ' ' ILE . . . 112.64 5.25 24.3 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.711 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.87 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -154.38 144.45 21.91 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 118.201 1.001 . . . . 0.0 113.322 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.846 HD23 ' HA ' ' B' ' 6' ' ' SER . 20.0 mt -78.7 173.36 12.53 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.868 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.4 m -153.52 141.34 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-O 121.313 0.577 . . . . 0.0 111.602 177.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.473 ' CG ' HG22 ' A' ' 36' ' ' ILE . 6.2 ptmt -122.07 104.83 9.77 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.707 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.566 ' HG3' HD23 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -102.28 115.76 31.23 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.413 0.625 . . . . 0.0 110.887 179.495 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.535 ' N ' ' HD3' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -51.85 129.39 26.51 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.206 178.191 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 t -44.15 -30.85 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.201 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.434 ' HA ' ' NH2' ' A' ' 29' ' ' ARG . 1.1 m 173.17 62.34 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.597 ' CB ' ' CD ' ' A' ' 33' ' ' PRO . 5.7 mttm -160.03 -93.21 0.0 OUTLIER Pre-proline 0 CA--C 1.562 1.429 0 O-C-N 121.603 -0.685 . . . . 0.0 112.684 178.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.597 ' CD ' ' CB ' ' A' ' 32' ' ' LYS . 49.6 Cg_endo -67.18 -165.82 0.11 Allowed 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 122.063 1.842 . . . . 0.0 111.918 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.579 ' CD ' ' HB2' ' A' ' 33' ' ' PRO . 38.2 Cg_endo -95.06 170.19 1.47 Allowed 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.1 1.867 . . . . 0.0 110.593 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.687 HG13 ' O ' ' A' ' 58' ' ' ILE . 6.1 p -78.87 149.8 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.432 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.473 HG22 ' CG ' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -143.51 166.53 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 120.253 -0.579 . . . . 0.0 112.361 -179.551 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.774 HD12 ' O ' ' A' ' 53' ' ' GLN . 20.7 mt -85.15 141.62 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.729 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.613 ' CB ' HG13 ' B' ' 4' ' ' VAL . 4.6 t -105.78 -37.83 6.58 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.546 ' CB ' HD12 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -169.42 135.09 1.55 Allowed 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 118.338 0.517 . . . . 0.0 111.66 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.87 HD23 ' HB3' ' A' ' 24' ' ' PHE . 39.6 mt -70.12 76.84 0.51 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.779 0.8 . . . . 0.0 110.444 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.446 ' CG2' ' N ' ' A' ' 42' ' ' ARG . 0.4 OUTLIER -32.94 -58.68 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -178.51 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.446 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.4 OUTLIER -94.23 -68.49 0.8 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.211 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.401 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 108.07 2.48 33.89 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.022 -178.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -108.57 -26.39 5.37 Favored Glycine 0 C--N 1.34 0.753 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.42 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.741 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -95.08 -82.13 0.38 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.86 0.33 . . . . 0.0 110.901 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.739 ' HB1' HG21 ' A' ' 52' ' ' ILE . . . -56.53 -63.85 1.06 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.077 0.465 . . . . 0.0 111.648 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.586 ' CD ' HD13 ' A' ' 40' ' ' LEU . 5.1 tp10 -45.38 -43.0 10.73 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.241 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 44' ' ' GLY . 21.8 mm-40 -59.34 -39.19 82.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.977 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.0 -44.76 74.8 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.959 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.06 -22.83 37.44 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.334 -0.936 . . . . 0.0 113.275 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.994 HD23 HG23 ' A' ' 113' ' ' THR . 3.6 pp -93.15 -13.78 28.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.882 0.341 . . . . 0.0 110.837 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.739 HG21 ' HB1' ' A' ' 46' ' ' ALA . 4.9 mp -96.35 147.67 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.774 ' O ' HD12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -175.14 154.11 1.72 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.979 0.419 . . . . 0.0 111.26 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.494 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -69.45 123.97 22.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.86 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.29 5.54 81.79 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.132 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.81 -86.35 0.12 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.907 0.353 . . . . 0.0 111.025 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.441 HG22 HD22 ' A' ' 91' ' ' LEU . 0.5 OUTLIER -162.55 119.89 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.207 0.527 . . . . 0.0 111.794 -179.797 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.687 ' O ' HG13 ' A' ' 35' ' ' VAL . 1.5 tp -146.96 80.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 177.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.639 HD13 ' HG2' ' A' ' 92' ' ' ARG . 7.7 tp -77.84 -66.59 0.82 Allowed 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.782 -178.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.59 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . . . -115.24 151.75 33.93 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.97 0.414 . . . . 0.0 111.051 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.633 HG22 ' ND2' ' A' ' 62' ' ' ASN . 14.3 p -152.61 146.32 15.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.269 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.633 ' ND2' HG22 ' A' ' 61' ' ' VAL . 0.2 OUTLIER 46.05 40.5 7.14 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.17 0.51 . . . . 0.0 111.336 -179.79 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.6 t70 58.87 28.44 17.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.07 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.664 ' O ' HD12 ' A' ' 66' ' ' LEU . 15.1 mmm180 -113.73 101.43 53.79 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.672 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -62.32 85.39 0.1 Allowed 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 121.662 1.574 . . . . 0.0 111.072 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.664 HD12 ' O ' ' A' ' 64' ' ' ARG . 1.0 OUTLIER -84.13 63.85 7.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.663 0.744 . . . . 0.0 110.346 -179.526 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.401 HG23 ' N ' ' A' ' 68' ' ' ASP . 2.9 m -124.84 -46.52 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.069 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.437 ' HA ' ' NH2' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -137.65 25.74 2.84 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.444 179.504 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.599 HD12 ' H ' ' A' ' 70' ' ' SER . 0.1 OUTLIER -107.66 170.69 7.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.904 -179.483 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.599 ' H ' HD12 ' A' ' 69' ' ' LEU . 0.4 OUTLIER -63.1 119.48 9.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.501 179.536 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.516 ' CG ' ' HB3' ' A' ' 28' ' ' GLU . 2.0 t80 -57.32 -47.5 81.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.416 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.48 -30.6 68.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.939 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.878 ' O ' HG23 ' A' ' 77' ' ' VAL . 43.6 t -72.8 -42.77 63.54 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.551 ' HB1' HD11 ' A' ' 66' ' ' LEU . . . -55.58 -41.13 72.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.195 0.522 . . . . 0.0 110.754 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.485 HD11 ' CE1' ' A' ' 71' ' ' TYR . 70.7 mt -71.62 -35.37 70.42 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.82 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -74.58 -42.1 59.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.925 0.393 . . . . 0.0 110.515 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 73' ' ' SER . 19.7 t -61.94 -36.18 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.031 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.545 ' C ' HD12 ' A' ' 78' ' ' LEU . 4.0 pp -85.92 -21.69 27.81 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.42 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.401 ' N ' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -68.14 -36.48 79.75 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.492 179.582 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -55.39 -21.15 25.82 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.021 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.658 HG22 HG21 ' A' ' 85' ' ' THR . 57.5 mt -56.68 109.74 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-O 120.882 0.372 . . . . 0.0 110.915 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.87 -162.55 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.415 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.2 m -97.25 -174.3 2.91 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 120.788 0.328 . . . . 0.0 111.127 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 44.6 31.44 0.63 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.078 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.658 HG21 HG22 ' A' ' 81' ' ' ILE . 1.7 t -121.28 161.13 22.53 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.847 0.832 . . . . 0.0 112.578 -178.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -101.82 176.62 5.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.405 -1.271 . . . . 0.0 110.312 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.932 HG11 ' CD2' ' A' ' 22' ' ' LEU . 2.5 p -149.23 149.47 14.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.676 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.832 ' O ' HD23 ' A' ' 89' ' ' LEU . 11.6 t -108.15 158.99 7.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.076 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.832 HD23 ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -154.92 161.39 41.43 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.741 0.305 . . . . 0.0 110.985 -178.533 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.72 HD13 ' HA ' ' A' ' 11' ' ' SER . 43.6 mm -133.14 128.14 55.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.963 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.987 HD11 HD13 ' A' ' 51' ' ' LEU . 3.7 mt -97.65 169.9 9.38 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.639 ' HG2' HD13 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -164.11 175.07 10.56 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.022 -0.671 . . . . 0.0 112.657 -179.273 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 167.05 -127.78 1.63 Allowed Glycine 0 CA--C 1.522 0.515 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.16 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.424 ' HD2' ' HD2' ' A' ' 7' ' ' PRO . 51.0 Cg_exo -57.07 -157.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.201 1.934 . . . . 0.0 112.486 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.416 ' HG2' ' ND2' ' A' ' 8' ' ' ASN . 37.8 mt-10 -153.68 137.32 16.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.46 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 119' ' ' PRO . . . 127.73 7.7 4.59 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.184 -1.007 . . . . 0.0 113.73 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.568 ' HB3' HG23 ' A' ' 117' ' ' THR . 11.2 m-85 -134.08 138.15 45.09 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 118.173 0.987 . . . . 0.0 113.509 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.793 HG22 ' HB3' ' A' ' 120' ' ' LEU . 0.1 OUTLIER -91.22 114.73 27.34 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 123.604 0.762 . . . . 0.0 110.262 179.665 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.871 HG21 HG23 ' A' ' 10' ' ' ILE . 11.7 t -79.56 92.84 5.35 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.607 0.718 . . . . 0.0 111.791 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 56.6 p-80 -101.24 155.39 18.05 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.129 178.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.0 mt -53.0 -174.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.689 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.16 94.11 0.08 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.588 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.97 146.38 54.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.136 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.502 HG22 ' O ' ' A' ' 104' ' ' THR . 11.1 m -139.32 14.43 2.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.212 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -44.38 113.87 0.6 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.889 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.7 t -96.04 -165.57 1.3 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.062 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.72 103.71 0.54 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.075 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.8 t0 56.29 64.69 1.62 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.97 0.414 . . . . 0.0 111.735 179.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -136.98 -88.09 0.21 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.257 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.439 HG23 HG13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -119.0 53.74 2.12 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-O 120.596 0.236 . . . . 0.0 110.607 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.77 79.98 1.52 Allowed 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.628 2.219 . . . . 0.0 113.394 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.734 ' CE ' HD12 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -147.44 -179.18 6.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.931 179.545 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.994 HG23 HD23 ' A' ' 51' ' ' LEU . 15.3 t -99.58 25.36 7.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.028 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.944 HG22 HD22 ' A' ' 51' ' ' LEU . 1.1 pp -95.29 169.3 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.955 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.894 ' O ' HD12 ' A' ' 114' ' ' ILE . 3.9 mtt-85 -79.48 148.57 31.81 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.3 t -78.86 133.1 30.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.259 0.552 . . . . 0.0 112.087 -178.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.568 HG23 ' HB3' ' A' ' 97' ' ' PHE . 0.7 OUTLIER -87.49 138.39 31.52 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.59 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.513 ' O ' HG23 ' A' ' 98' ' ' THR . 0.0 OUTLIER -128.83 134.96 26.89 Favored Pre-proline 0 N--CA 1.475 0.781 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.047 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 96' ' ' GLY . 51.4 Cg_exo -36.77 109.54 0.07 OUTLIER 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.926 2.417 . . . . 0.0 114.922 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.793 ' HB3' HG22 ' A' ' 98' ' ' THR . 0.2 OUTLIER -101.36 -38.03 8.21 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 177.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 59.38 90.48 0.02 OUTLIER Glycine 0 CA--C 1.521 0.434 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.602 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -60.43 151.23 76.21 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.44 2.094 . . . . 0.0 112.272 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.99 -174.48 1.95 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.382 2.055 . . . . 0.0 112.274 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 85.7 m 58.37 80.67 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.042 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 33.2 pttt -117.32 49.23 1.22 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.129 0.49 . . . . 0.0 110.959 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -92.5 17.8 9.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.225 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.098 179.969 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 22.3 m . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.862 0.363 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 16.8 t -99.59 -37.12 5.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.043 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.491 ' C ' HG23 ' B' ' 4' ' ' VAL . 9.2 mmtm -74.63 -169.83 0.93 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.069 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.613 HG13 ' CB ' ' A' ' 38' ' ' SER . 2.3 t 76.93 141.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.472 -178.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . 0.429 ' O ' ' CB ' ' B' ' 6' ' ' SER . 0.7 OUTLIER -139.88 -91.92 0.17 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.823 179.88 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.846 ' HA ' HD23 ' A' ' 25' ' ' LEU . 6.1 t 153.57 106.15 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.728 0.811 . . . . 0.0 109.812 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.573 ' OXT' HD12 ' A' ' 22' ' ' LEU . 27.1 m . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.213 -0.898 . . . . 0.0 111.317 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 112.563 -0.215 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.83 119.23 6.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.847 0.356 . . . . 0.0 110.902 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -119.3 -179.82 3.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.012 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.2 -161.5 0.82 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.541 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.447 HD13 ' H ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -81.78 161.24 3.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.653 0.263 . . . . 0.0 110.429 179.57 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.641 ' OE2' HG21 ' A' ' 110' ' ' THR . 8.2 pt-20 -115.89 144.4 32.65 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.733 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.408 ' CB ' ' HA2' ' A' ' 93' ' ' GLY . 10.2 Cg_endo -51.48 135.21 47.33 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 123.102 2.535 . . . . 0.0 113.113 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.823 ' HA ' HG21 ' A' ' 99' ' ' THR . 24.0 m-80 -140.84 86.42 2.05 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.423 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.75 HG12 ' HD2' ' A' ' 94' ' ' PRO . 11.2 p -84.37 87.24 2.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.038 0.447 . . . . 0.0 111.388 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.643 HG23 ' N ' ' A' ' 11' ' ' SER . 1.3 tp -154.75 -167.82 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 120.749 0.309 . . . . 0.0 111.61 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.704 ' HA ' HD13 ' A' ' 90' ' ' ILE . 3.9 m -102.87 173.7 6.2 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.364 0.602 . . . . 0.0 111.75 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.791 HG11 HD11 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -160.88 175.95 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.089 -179.397 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.477 ' O ' HD12 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -150.47 140.89 22.4 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.432 0.634 . . . . 0.0 110.703 179.841 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.815 ' HB3' HD23 ' A' ' 22' ' ' LEU . 0.7 OUTLIER -141.28 140.94 33.96 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.893 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.492 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 2.3 t80 -90.04 143.37 26.84 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.62 ' HE2' HD13 ' A' ' 81' ' ' ILE . 1.7 mptp? -83.6 33.59 0.47 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.261 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.892 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 38.6 33.92 0.08 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.274 0.629 . . . . 0.0 111.914 179.933 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.591 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 44.27 25.26 0.11 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.769 -178.672 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.892 HG22 ' O ' ' A' ' 17' ' ' ARG . 5.2 m -164.36 31.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.567 178.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 52.7 54.69 26.7 Favored Glycine 0 C--N 1.336 0.539 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.584 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -139.91 66.09 0.52 Allowed Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.815 HD23 ' HB3' ' A' ' 14' ' ' LEU . 3.7 mp -49.85 -20.16 0.82 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -178.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.439 ' HA2' HG22 ' A' ' 41' ' ' ILE . . . 102.16 9.39 42.19 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.134 -1.031 . . . . 0.0 113.23 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.92 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -159.76 140.47 12.22 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.504 0.668 . . . . 0.0 112.387 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.86 HD23 ' CA ' ' B' ' 6' ' ' SER . 3.7 mt -78.92 173.74 12.23 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.453 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.423 HG12 HG21 ' A' ' 58' ' ' ILE . 26.7 m -153.81 159.44 3.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 114.715 -1.129 . . . . 0.0 109.934 178.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.824 ' HG2' HG22 ' B' ' 4' ' ' VAL . 15.6 mtpt -134.28 95.41 3.4 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.684 -179.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.49 ' HB2' ' CD1' ' A' ' 71' ' ' TYR . 0.9 OUTLIER -81.31 150.21 28.6 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.681 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.405 ' HD3' ' CA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -79.07 130.82 35.91 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-O 121.178 0.513 . . . . 0.0 111.351 -179.172 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -53.04 -34.59 21.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.439 178.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.405 ' CA ' ' HD3' ' A' ' 29' ' ' ARG . 0.5 OUTLIER 164.83 34.95 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.716 178.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.498 ' HB2' ' CD ' ' A' ' 33' ' ' PRO . 38.4 mmtm -155.43 -67.36 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.498 ' CD ' ' HB2' ' A' ' 32' ' ' LYS . 37.6 Cg_endo -65.19 -174.82 0.35 Allowed 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 122.451 2.101 . . . . 0.0 112.733 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.439 ' CD ' ' HB2' ' A' ' 33' ' ' PRO . 89.2 Cg_endo -99.67 154.71 0.56 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.279 2.653 . . . . 0.0 111.48 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.56 HG11 HD23 ' A' ' 66' ' ' LEU . 21.3 t -79.58 140.41 16.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.467 HD12 ' HA ' ' A' ' 36' ' ' ILE . 1.2 tp -156.63 175.89 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.567 HG13 HG22 ' A' ' 58' ' ' ILE . 36.8 mt -89.17 151.18 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.243 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.426 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 0.5 OUTLIER -116.72 -36.59 3.86 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -179.613 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.578 ' CB ' HD12 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -177.99 142.99 0.3 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.315 -179.687 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.92 HD23 ' HB3' ' A' ' 24' ' ' PHE . 36.2 mt -76.27 85.26 3.07 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.604 0.716 . . . . 0.0 110.247 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.822 HD13 HD21 ' A' ' 25' ' ' LEU . 1.5 tp -40.59 -59.55 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 114.457 1.281 . . . . 0.0 114.457 -177.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.456 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 6.3 mmt180 -94.79 -67.18 0.87 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.182 0.515 . . . . 0.0 112.196 -178.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.461 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 109.39 22.26 6.86 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.232 -178.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.405 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -122.71 -28.56 1.4 Allowed Glycine 0 C--N 1.339 0.75 0 C-N-CA 120.961 -0.638 . . . . 0.0 113.388 -179.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -93.9 -83.93 0.32 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 117.787 0.793 . . . . 0.0 111.567 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.885 ' HB1' HG21 ' A' ' 52' ' ' ILE . . . -60.97 -58.87 6.6 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.221 0.534 . . . . 0.0 110.794 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.506 ' HB2' HD22 ' A' ' 40' ' ' LEU . 17.9 tt0 -46.51 -46.97 19.5 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.761 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.405 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -55.05 -37.3 66.55 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.799 178.684 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.404 ' HB3' HD13 ' A' ' 52' ' ' ILE . 2.4 t -54.38 -46.77 73.12 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.454 178.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.47 -24.19 24.78 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.439 -0.886 . . . . 0.0 114.601 177.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.791 HD11 HG11 ' A' ' 12' ' ' VAL . 1.7 pp -104.16 0.98 30.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.588 0.694 . . . . 0.0 112.3 -179.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.885 HG21 ' HB1' ' A' ' 46' ' ' ALA . 4.2 mp -102.19 96.32 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.23 147.68 43.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.421 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.551 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -70.49 140.4 51.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.932 0.396 . . . . 0.0 111.159 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.58 5.2 88.09 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.98 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.16 -90.71 0.13 Allowed 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.582 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -164.9 121.93 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 179.629 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 1.022 HD11 HG22 ' A' ' 61' ' ' VAL . 1.3 tp -136.25 81.95 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 107.778 -1.194 . . . . 0.0 107.778 176.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.516 ' HB2' HD11 ' A' ' 57' ' ' ILE . 7.1 tp -77.97 -67.88 0.69 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.209 -177.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -114.9 147.48 39.9 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.112 0.482 . . . . 0.0 112.08 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 1.022 HG22 HD11 ' A' ' 58' ' ' ILE . 3.1 t -141.62 144.26 26.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.241 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.722 HD22 HG12 ' A' ' 61' ' ' VAL . 0.1 OUTLIER 44.9 40.87 4.73 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.967 0.413 . . . . 0.0 111.629 -179.629 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.9 t0 53.38 27.56 6.45 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.134 0.493 . . . . 0.0 110.917 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.596 ' NH1' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -115.01 93.24 34.03 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.464 -179.588 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.421 ' O ' HD23 ' A' ' 69' ' ' LEU . 82.6 Cg_exo -43.1 87.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.361 1.232 0 C-N-CA 123.309 2.673 . . . . 0.0 114.106 -178.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.936 ' CD1' ' HB1' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -92.11 70.99 5.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.296 178.501 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.536 HG23 ' H ' ' A' ' 68' ' ' ASP . 3.4 m -123.04 -59.13 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -178.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.536 ' H ' HG23 ' A' ' 67' ' ' VAL . 74.7 m-20 -136.57 24.72 3.15 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -178.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.596 HD22 ' NH1' ' A' ' 64' ' ' ARG . 0.2 OUTLIER -93.53 -173.28 3.15 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.484 179.306 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.72 122.65 19.58 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.749 ' CE1' HD11 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -50.46 -69.27 0.12 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.709 -179.278 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -51.45 -26.97 9.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.777 0.322 . . . . 0.0 111.451 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.889 ' O ' HG23 ' A' ' 77' ' ' VAL . 22.8 t -76.79 -44.19 33.71 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.24 0.543 . . . . 0.0 109.811 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.936 ' HB1' ' CD1' ' A' ' 66' ' ' LEU . . . -59.12 -39.42 82.26 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.069 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.749 HD11 ' CE1' ' A' ' 71' ' ' TYR . 46.2 mt -72.91 -33.97 66.33 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.578 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.412 ' HA ' ' HB2' ' A' ' 79' ' ' ARG . 5.0 pt-20 -71.44 -38.18 71.36 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.276 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.889 HG23 ' O ' ' A' ' 73' ' ' SER . 6.5 t -61.66 -46.59 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.611 HD21 HD23 ' A' ' 75' ' ' LEU . 4.4 pp -74.78 -24.35 58.66 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.9 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.412 ' HB2' ' HA ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -63.17 -37.67 88.12 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.225 179.65 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.0 -23.74 17.23 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.862 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.62 HD13 ' HE2' ' A' ' 16' ' ' LYS . 31.1 mt -58.29 106.26 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-O 120.991 0.424 . . . . 0.0 110.672 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.3 -169.68 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.238 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.44 -170.1 2.1 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.28 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 42.98 31.77 0.36 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.136 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.415 ' O ' ' CD1' ' A' ' 15' ' ' PHE . 1.8 t -129.77 159.0 37.87 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 122.095 0.95 . . . . 0.0 113.148 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.12 176.28 5.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.064 -1.426 . . . . 0.0 109.377 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.529 HG13 HD23 ' A' ' 89' ' ' LEU . 0.5 OUTLIER -146.24 159.66 11.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.311 -179.551 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.679 ' C ' HD23 ' A' ' 89' ' ' LEU . 11.2 t -120.29 158.67 22.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.679 HD23 ' C ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -156.81 162.71 39.71 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.884 -178.007 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.704 HD13 ' HA ' ' A' ' 11' ' ' SER . 47.8 mm -128.38 122.99 59.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.112 0.482 . . . . 0.0 111.501 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 22.4 mt -99.61 153.95 18.66 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.83 162.01 13.28 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.342 0.591 . . . . 0.0 112.13 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.436 ' HA3' ' N ' ' A' ' 8' ' ' ASN . . . -163.54 -128.85 0.98 Allowed Glycine 0 CA--C 1.525 0.669 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.767 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.75 ' HD2' HG12 ' A' ' 9' ' ' VAL . 61.1 Cg_endo -91.49 -164.91 0.15 Allowed 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 122.769 2.313 . . . . 0.0 112.692 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -132.46 106.23 7.74 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.429 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 117.26 9.1 10.77 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.65 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.876 ' HB3' HG22 ' A' ' 117' ' ' THR . 32.5 m-85 -141.22 135.2 30.5 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 117.21 0.505 . . . . 0.0 112.057 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.403 ' CG2' ' HB3' ' A' ' 120' ' ' LEU . 0.0 OUTLIER -88.61 118.49 28.31 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.571 178.646 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.823 HG21 ' HA ' ' A' ' 8' ' ' ASN . 3.5 t -103.31 92.35 4.46 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.141 0.496 . . . . 0.0 110.126 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -65.13 -162.14 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.697 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.667 HD13 ' N ' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -120.71 179.6 4.29 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.677 179.841 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 62.56 114.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.212 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.728 HG21 ' CB ' ' A' ' 115' ' ' ARG . 10.9 t -154.43 179.69 8.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.134 0.492 . . . . 0.0 111.638 -179.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 66.7 p -121.43 115.0 22.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.109 179.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.425 ' CG ' ' HA ' ' A' ' 111' ' ' PRO . 42.4 p90 -96.72 157.85 15.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.153 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.67 -76.09 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.761 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 172.89 -34.1 0.12 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.71 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -136.75 39.37 2.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.823 0.344 . . . . 0.0 111.043 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -139.67 -82.81 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.295 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.762 HG22 ' CD ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -114.1 62.89 1.16 Allowed Pre-proline 0 CA--C 1.534 0.345 0 CA-C-O 120.75 0.31 . . . . 0.0 111.107 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.425 ' HA ' ' CG ' ' A' ' 105' ' ' PHE . 72.7 Cg_endo -73.35 91.2 0.87 Allowed 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.29 1.993 . . . . 0.0 112.988 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.762 ' CD ' HG22 ' A' ' 110' ' ' THR . 0.0 OUTLIER -150.02 178.39 8.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.878 179.415 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.422 ' O ' HG22 ' A' ' 103' ' ' THR . 58.4 m -106.49 -31.22 8.63 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.396 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.645 ' O ' HG23 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -93.08 101.03 12.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.158 -179.797 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.728 ' CB ' HG21 ' A' ' 103' ' ' THR . 4.3 tmt_? -160.82 93.78 1.0 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.853 0.358 . . . . 0.0 111.112 179.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.5 t -157.68 62.51 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.301 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.876 HG22 ' HB3' ' A' ' 97' ' ' PHE . 0.2 OUTLIER -77.23 126.54 31.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.026 0.441 . . . . 0.0 111.146 -179.15 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.434 ' O ' ' HA ' ' A' ' 97' ' ' PHE . 0.1 OUTLIER -134.89 140.1 34.15 Favored Pre-proline 0 N--CA 1.464 0.229 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.849 -179.173 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.01 117.95 4.06 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.064 1.843 . . . . 0.0 111.855 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.516 HD23 ' C ' ' A' ' 97' ' ' PHE . 0.4 OUTLIER -119.95 -41.95 2.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.854 0.359 . . . . 0.0 110.946 -179.653 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -117.77 76.33 0.29 Allowed Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.369 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.82 140.46 67.71 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.354 2.036 . . . . 0.0 112.412 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.65 -176.79 2.97 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.357 2.038 . . . . 0.0 112.495 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 11.2 t -148.31 153.9 39.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.801 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.7 mttt -95.87 50.81 1.22 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.14 0.495 . . . . 0.0 111.049 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.44 -12.51 61.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.382 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.8 m . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.284 -0.865 . . . . 0.0 111.146 -179.938 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 32.0 t . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.806 0.336 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.547 HG22 ' O ' ' B' ' 2' ' ' VAL . 12.7 p -102.09 -1.33 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 112.151 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.457 ' HD2' ' CD2' ' A' ' 71' ' ' TYR . 7.3 tptm -106.96 13.81 27.19 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.824 HG22 ' HG2' ' A' ' 27' ' ' LYS . 24.3 t -130.55 134.2 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.774 0.321 . . . . 0.0 111.013 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . 0.434 ' HB3' HG13 ' B' ' 7' ' ' VAL . 1.6 m-20 -138.58 132.93 31.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.957 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.86 ' CA ' HD23 ' A' ' 25' ' ' LEU . 11.7 p -66.0 -51.37 58.98 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.832 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.707 HG11 HD22 ' A' ' 75' ' ' LEU . 22.5 m . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.264 -0.874 . . . . 0.0 112.619 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 112.721 -0.151 . . . . 0.0 112.721 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 63.33 109.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.911 0.386 . . . . 0.0 111.079 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 39.5 m170 57.85 21.56 7.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.67 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 62.57 -80.28 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.626 0.251 . . . . 0.0 111.376 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.473 HG22 ' N ' ' A' ' 6' ' ' GLU . 34.2 mm 62.93 158.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.159 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.473 ' N ' HG22 ' A' ' 5' ' ' ILE . 9.7 mm-40 -102.08 141.27 22.2 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.506 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -88.37 124.87 1.73 Allowed 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.812 2.341 . . . . 0.0 112.806 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.833 ' HA ' HG21 ' A' ' 99' ' ' THR . 73.5 m-80 -149.54 90.78 1.75 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.119 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.625 ' O ' HG13 ' A' ' 9' ' ' VAL . 14.1 p -82.82 101.79 7.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.636 HG23 ' N ' ' A' ' 11' ' ' SER . 1.0 OUTLIER -161.88 -166.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.108 -0.637 . . . . 0.0 112.715 -178.469 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.668 ' HA ' HD13 ' A' ' 90' ' ' ILE . 1.6 p -101.66 158.44 16.1 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.735 0.778 . . . . 0.0 112.131 -178.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.857 ' CG1' HD12 ' A' ' 89' ' ' LEU . 3.1 t -142.01 153.49 18.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 114.411 -1.268 . . . . 0.0 108.815 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.5 ttp-105 -135.2 128.09 31.33 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.677 0.751 . . . . 0.0 111.498 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.91 HD21 ' HB2' ' A' ' 46' ' ' ALA . 0.4 OUTLIER -124.79 177.83 5.79 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.39 -1.277 . . . . 0.0 109.608 179.66 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.418 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 3.5 t80 -123.15 151.09 42.47 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.524 ' NZ ' HD11 ' A' ' 22' ' ' LEU . 3.8 mptp? -83.15 26.54 0.62 Allowed 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.289 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.841 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.4 OUTLIER 44.79 29.94 0.49 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.833 0.349 . . . . 0.0 111.868 179.562 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.684 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 44.7 23.86 0.09 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.736 -178.477 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.841 HG22 ' O ' ' A' ' 17' ' ' ARG . 2.7 m -168.55 34.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.992 178.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 16' ' ' LYS . . . 49.1 63.42 3.97 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.989 -178.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -143.91 54.05 0.58 Allowed Glycine 0 C--N 1.332 0.349 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.015 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.877 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 3.9 mp -39.1 -28.0 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.478 ' HA2' HG22 ' A' ' 41' ' ' ILE . . . 110.2 3.27 29.59 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.819 -1.182 . . . . 0.0 113.776 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.899 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -158.09 141.25 15.06 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.041 0.921 . . . . 0.0 112.933 -179.473 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.954 HD21 HD13 ' A' ' 41' ' ' ILE . 0.8 OUTLIER -89.66 174.59 7.65 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.477 179.437 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.777 HG12 HG21 ' A' ' 58' ' ' ILE . 26.6 m -151.41 165.42 2.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.236 178.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.807 ' HG2' HG22 ' B' ' 4' ' ' VAL . 15.9 mtpt -140.84 99.88 3.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.737 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.631 ' CA ' HG23 ' A' ' 35' ' ' VAL . 0.6 OUTLIER -99.34 112.17 24.4 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 178.158 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.425 ' HB3' ' HB2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -49.23 119.7 3.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.101 0.477 . . . . 0.0 111.11 -179.642 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.4 ' O ' HG12 ' A' ' 30' ' ' VAL . 52.0 t -59.11 -14.87 5.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.317 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.9 t -141.45 28.89 1.8 Allowed 'General case' 0 C--O 1.231 0.103 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.921 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 29' ' ' ARG . 9.5 mtpt -161.96 147.3 10.27 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.54 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 26.4 Cg_exo -61.36 -47.44 11.92 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.493 2.129 . . . . 0.0 114.105 -178.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 32' ' ' LYS . 73.8 Cg_exo -41.28 96.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.889 2.393 . . . . 0.0 114.799 -178.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.828 HG11 ' O ' ' A' ' 66' ' ' LEU . 11.3 p -114.68 147.0 18.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 177.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.494 HG23 ' O ' ' A' ' 37' ' ' ILE . 1.2 tp -161.02 175.79 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -179.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.5 HG13 HG22 ' A' ' 58' ' ' ILE . 42.7 mt -82.17 153.3 4.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.35 178.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.741 ' HB3' HG11 ' B' ' 4' ' ' VAL . 22.0 t -117.41 -38.06 3.39 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.665 0.616 . . . . 0.0 112.665 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.555 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 1.2 t0 -173.0 140.05 0.87 Allowed 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 120.283 -0.567 . . . . 0.0 112.277 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.899 HD23 ' HB3' ' A' ' 24' ' ' PHE . 40.2 mt -76.46 87.63 3.2 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.795 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.954 HD13 HD21 ' A' ' 25' ' ' LEU . 1.3 tp -39.85 -60.04 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -177.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.46 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 17.6 ttt85 -94.24 -59.23 2.01 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.974 0.416 . . . . 0.0 112.035 -178.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.436 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 98.07 24.29 11.86 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -177.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.418 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -125.85 -28.61 1.03 Allowed Glycine 0 C--N 1.338 0.666 0 C-N-CA 121.111 -0.566 . . . . 0.0 113.479 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.877 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -94.47 -83.44 0.34 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 117.902 0.851 . . . . 0.0 111.459 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.91 ' HB2' HD21 ' A' ' 14' ' ' LEU . . . -61.67 -57.97 9.89 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.235 0.541 . . . . 0.0 110.963 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.814 ' CG ' HD13 ' A' ' 40' ' ' LEU . 7.8 tm-20 -47.61 -48.07 28.56 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.623 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.418 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -56.5 -34.85 67.38 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.98 178.797 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.14 -45.89 75.65 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.677 ' HA3' HG21 ' A' ' 113' ' ' THR . . . 112.17 -28.66 9.02 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.526 -0.845 . . . . 0.0 114.54 177.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.685 HD22 ' HB ' ' A' ' 114' ' ' ILE . 2.4 pp -105.0 19.12 21.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.591 0.695 . . . . 0.0 112.051 -179.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.884 HG21 ' HB1' ' A' ' 46' ' ' ALA . 4.9 mp -123.23 81.66 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.891 0.377 . . . . 0.0 110.216 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.498 ' HA ' HD11 ' A' ' 40' ' ' LEU . 3.7 mp0 -112.95 141.37 46.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.144 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.555 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -58.8 134.63 57.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.071 0.462 . . . . 0.0 111.303 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.55 2.48 87.11 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.896 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.84 -93.31 0.09 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.843 0.321 . . . . 0.0 110.566 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.685 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -163.75 119.64 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 179.613 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.981 HD11 HG22 ' A' ' 61' ' ' VAL . 5.9 tp -136.95 82.27 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 177.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.744 HD22 ' NE ' ' A' ' 92' ' ' ARG . 3.6 tp -78.12 -58.43 3.26 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.97 -177.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.702 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . . . -117.94 145.47 44.66 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.911 0.386 . . . . 0.0 111.722 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.981 HG22 HD11 ' A' ' 58' ' ' ILE . 5.0 t -146.8 145.23 19.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.84 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.539 ' ND2' HG12 ' A' ' 61' ' ' VAL . 0.2 OUTLIER 44.6 41.81 5.16 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.172 0.51 . . . . 0.0 111.995 179.211 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.6 t0 57.63 26.32 12.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.541 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 66' ' ' LEU . 19.3 mmt180 -115.57 101.47 54.23 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.116 179.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.901 ' O ' HD22 ' A' ' 69' ' ' LEU . 51.0 Cg_exo -53.48 85.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.331 2.021 . . . . 0.0 111.626 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.828 ' O ' HG11 ' A' ' 35' ' ' VAL . 8.8 mt -78.68 62.15 3.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.738 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.632 HG23 ' H ' ' A' ' 68' ' ' ASP . 3.1 m -125.49 -65.6 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.632 ' H ' HG23 ' A' ' 67' ' ' VAL . 4.6 p30 -125.74 25.42 6.91 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.901 HD22 ' O ' ' A' ' 65' ' ' PRO . 0.6 OUTLIER -100.4 -179.8 4.22 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.666 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.0 m -68.49 96.64 0.7 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.736 ' CE1' HD21 ' A' ' 75' ' ' LEU . 8.9 t80 -41.01 -57.05 2.12 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.049 0.452 . . . . 0.0 112.057 -178.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -60.67 -28.4 68.57 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.823 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.914 ' O ' HG23 ' A' ' 77' ' ' VAL . 5.0 t -74.24 -43.61 56.36 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.649 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -57.8 -33.93 69.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.501 177.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.736 HD21 ' CE1' ' A' ' 71' ' ' TYR . 3.7 mm? -71.17 -35.99 71.82 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.088 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -74.84 -35.64 62.38 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.035 0.445 . . . . 0.0 109.846 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.914 HG23 ' O ' ' A' ' 73' ' ' SER . 8.4 t -61.83 -43.01 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.874 178.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.658 HD21 HD13 ' A' ' 75' ' ' LEU . 4.1 pp -79.05 -24.7 43.41 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.053 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -40.4 94.68 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.882 0.373 . . . . 0.0 110.21 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -57.03 -20.36 34.14 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.879 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.498 HG22 HG21 ' A' ' 85' ' ' THR . 65.6 mt -57.81 110.66 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 120.98 0.419 . . . . 0.0 111.005 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.09 -164.53 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.45 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.81 -170.7 1.97 Allowed 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.809 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 45.18 31.34 0.76 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.116 0.484 . . . . 0.0 110.873 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.498 HG21 HG22 ' A' ' 81' ' ' ILE . 1.5 t -123.54 162.84 22.13 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.838 0.827 . . . . 0.0 112.658 -178.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -102.8 176.27 5.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.362 -1.29 . . . . 0.0 109.977 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.807 HG11 ' CD2' ' A' ' 22' ' ' LEU . 5.7 p -149.29 156.3 7.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.334 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.845 ' O ' HD23 ' A' ' 89' ' ' LEU . 2.1 t -114.05 161.51 12.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.553 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.857 HD12 ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -154.71 158.32 39.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.216 -178.617 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.702 ' HB ' ' HB3' ' A' ' 60' ' ' ALA . 51.5 mm -133.9 134.77 55.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.547 HD11 ' CD1' ' A' ' 51' ' ' LEU . 7.2 mt -117.13 167.26 11.34 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.033 177.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.744 ' NE ' HD22 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -104.94 160.32 15.11 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.272 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.568 ' HA3' ' N ' ' A' ' 8' ' ' ASN . . . -178.75 -147.6 7.16 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-N 114.749 -1.114 . . . . 0.0 112.288 179.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.539 ' O ' HG12 ' A' ' 9' ' ' VAL . 61.7 Cg_endo -95.54 167.93 1.4 Allowed 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 123.313 2.675 . . . . 0.0 112.598 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -105.41 154.26 20.55 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.89 19.04 66.27 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.2 -1.0 . . . . 0.0 111.8 -178.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.792 ' HB3' HG22 ' A' ' 117' ' ' THR . 53.8 m-85 -150.27 141.8 23.47 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.914 0.357 . . . . 0.0 111.852 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.681 HG22 HD22 ' A' ' 120' ' ' LEU . 0.2 OUTLIER -91.22 130.83 37.05 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.327 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.833 HG21 ' HA ' ' A' ' 8' ' ' ASN . 18.9 p -109.27 93.12 4.34 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.41 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -75.07 -168.62 0.79 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.962 178.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.9 pp -123.05 131.06 53.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.896 0.379 . . . . 0.0 110.907 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.641 ' O ' HG22 ' A' ' 103' ' ' THR . 0.1 OUTLIER -175.28 156.55 2.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.856 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.641 HG22 ' O ' ' A' ' 102' ' ' GLU . 0.5 OUTLIER 76.86 179.37 0.15 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.212 179.86 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.9 p -148.44 133.9 18.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.224 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.438 ' CG ' ' HA2' ' A' ' 109' ' ' GLY . 49.2 p90 -60.64 -177.36 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.927 0.394 . . . . 0.0 111.067 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.8 t -169.33 -42.66 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.73 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -91.23 73.76 1.68 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.506 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 60.68 42.11 14.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.844 0.354 . . . . 0.0 111.137 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.438 ' HA2' ' CG ' ' A' ' 105' ' ' PHE . . . 64.29 63.98 3.94 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.25 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.475 ' HB ' ' HD3' ' A' ' 111' ' ' PRO . 0.9 OUTLIER -109.46 -62.21 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.382 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.475 ' HD3' ' HB ' ' A' ' 110' ' ' THR . 53.1 Cg_exo -53.31 -32.75 62.73 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.105 1.87 . . . . 0.0 111.762 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.6 tptm 66.84 131.95 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.453 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.677 HG21 ' HA3' ' A' ' 50' ' ' GLY . 79.3 m -64.71 -33.94 77.15 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.862 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.685 ' HB ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -103.08 94.47 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.629 178.584 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -153.55 94.71 1.82 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.96 0.41 . . . . 0.0 111.21 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.3 t -155.57 65.3 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.746 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.792 HG22 ' HB3' ' A' ' 97' ' ' PHE . 0.2 OUTLIER -79.25 106.01 10.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.064 -0.517 . . . . 0.0 112.153 -178.654 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.419 ' O ' ' HA ' ' A' ' 97' ' ' PHE . 3.2 pt20 -114.31 133.35 22.45 Favored Pre-proline 0 N--CA 1.467 0.385 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.494 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -65.93 139.97 58.82 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.318 2.012 . . . . 0.0 114.137 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.681 HD22 HG22 ' A' ' 98' ' ' THR . 0.2 OUTLIER -89.88 -68.43 0.78 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.035 179.148 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 104.39 -77.28 0.27 Allowed Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.268 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.88 172.32 6.11 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.446 2.097 . . . . 0.0 112.158 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.459 ' CG ' ' HB2' ' A' ' 126' ' ' ALA . 88.3 Cg_endo -78.41 -166.27 0.39 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.487 2.125 . . . . 0.0 112.332 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.1 t -53.94 -47.43 71.29 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.416 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -177.79 70.42 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.132 0.491 . . . . 0.0 110.93 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.459 ' HB2' ' CG ' ' A' ' 123' ' ' PRO . . . -64.92 -15.63 62.31 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.043 178.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.448 HG23 ' OXT' ' A' ' 127' ' ' VAL . 3.8 m . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.089 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 10.2 t . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 121.114 0.483 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.742 HG13 ' HG3' ' B' ' 3' ' ' LYS . 11.5 p -94.94 -32.1 4.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.194 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.742 ' HG3' HG13 ' B' ' 2' ' ' VAL . 2.2 pptp? -174.35 48.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.461 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.807 HG22 ' HG2' ' A' ' 27' ' ' LYS . 10.5 t -74.0 124.89 32.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.828 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . 0.727 ' OD2' HD11 ' A' ' 75' ' ' LEU . 10.8 p-10 -63.71 -155.26 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.585 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -177.35 102.56 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.185 0.517 . . . . 0.0 110.145 179.543 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.729 ' O ' HD12 ' A' ' 22' ' ' LEU . 23.0 m . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.238 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.9 t -174.51 -55.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.83 0.347 . . . . 0.0 110.776 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -113.53 120.72 41.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.761 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 7.7 mtt 62.49 160.71 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.619 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.775 HD13 ' CD ' ' A' ' 111' ' ' PRO . 4.5 tp 36.8 100.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.467 0.707 . . . . 0.0 112.651 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -161.61 -63.83 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -36.13 138.7 0.17 Allowed 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 123.293 2.662 . . . . 0.0 114.178 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -63.91 -36.55 84.29 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.105 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.619 ' C ' HD12 ' A' ' 10' ' ' ILE . 38.8 t -79.17 148.64 5.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.978 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.892 HD13 ' OG1' ' A' ' 99' ' ' THR . 1.7 mp -122.08 159.58 24.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 121.37 0.605 . . . . 0.0 112.541 -177.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.748 ' HA ' HD13 ' A' ' 90' ' ' ILE . 1.9 m -92.79 173.57 7.69 Favored 'General case' 0 C--O 1.23 0.075 0 CA-C-N 115.158 -0.928 . . . . 0.0 113.439 -178.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.886 ' CG1' HD12 ' A' ' 89' ' ' LEU . 1.5 t -159.14 157.47 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 114.29 -1.323 . . . . 0.0 108.786 -179.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -150.75 126.31 10.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.223 0.535 . . . . 0.0 110.837 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.754 ' C ' HG12 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -134.45 178.72 6.77 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.297 -179.229 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.428 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 5.0 t80 -116.37 151.99 34.82 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.433 ' NZ ' HD11 ' A' ' 22' ' ' LEU . 0.8 OUTLIER -85.32 28.11 0.76 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.541 179.448 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.868 ' O ' HG22 ' A' ' 19' ' ' VAL . 7.5 tpt180 43.49 31.8 0.46 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.018 0.437 . . . . 0.0 111.94 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.671 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 43.64 24.98 0.07 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.893 -178.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.868 HG22 ' O ' ' A' ' 17' ' ' ARG . 5.0 m -167.72 33.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.408 -0.814 . . . . 0.0 108.831 178.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.405 ' HA2' ' HE2' ' A' ' 16' ' ' LYS . . . 49.14 61.1 5.63 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.705 -178.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -142.94 55.33 0.58 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.98 -0.629 . . . . 0.0 111.95 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.859 ' CD2' HG11 ' A' ' 87' ' ' VAL . 3.7 mp -40.49 -27.61 0.05 Allowed 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 40' ' ' LEU . . . 114.42 2.49 22.96 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 119.911 -1.137 . . . . 0.0 114.418 178.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.781 ' HB3' HD23 ' A' ' 40' ' ' LEU . 1.6 p90 -154.58 144.37 21.64 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.493 1.147 . . . . 0.0 113.595 -179.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.736 HD23 ' HA ' ' B' ' 6' ' ' SER . 7.6 mt -82.05 172.88 12.72 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.683 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.609 HG12 HG21 ' A' ' 58' ' ' ILE . 33.0 m -150.98 154.24 8.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.248 177.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.419 ' HD3' HG22 ' A' ' 36' ' ' ILE . 11.7 ptmt -135.84 109.64 8.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.959 -179.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.515 ' HB3' ' CG ' ' A' ' 71' ' ' TYR . 0.6 OUTLIER -111.06 142.66 42.92 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.947 179.276 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.431 ' CB ' ' HB2' ' A' ' 32' ' ' LYS . 0.9 OUTLIER -75.4 126.94 32.03 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.044 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 65.5 t -51.85 -22.41 2.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.912 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.404 ' O ' ' CG ' ' A' ' 32' ' ' LYS . 72.3 p -146.25 44.2 1.23 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.927 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.431 ' HB2' ' CB ' ' A' ' 29' ' ' ARG . 29.6 mttp -166.25 144.35 4.6 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 116.72 -0.218 . . . . 0.0 110.835 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.423 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 39.4 Cg_exo -59.24 -48.0 15.35 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.687 2.258 . . . . 0.0 113.972 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 33' ' ' PRO . 60.4 Cg_exo -38.92 94.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.927 2.418 . . . . 0.0 114.674 -178.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.544 HG11 ' O ' ' A' ' 66' ' ' LEU . 14.8 p -118.86 152.64 21.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.131 178.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 36' ' ' ILE . 1.2 tp -160.21 174.37 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.523 HG13 HG22 ' A' ' 58' ' ' ILE . 54.4 mt -85.39 147.73 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.135 179.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.457 ' CB ' HG13 ' B' ' 4' ' ' VAL . 1.4 t -113.66 -37.07 4.69 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.691 ' CB ' HD12 ' A' ' 25' ' ' LEU . 1.5 t0 -172.14 141.38 1.28 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.044 -0.663 . . . . 0.0 112.373 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.781 HD23 ' HB3' ' A' ' 24' ' ' PHE . 51.0 mt -72.55 109.02 5.92 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.526 -0.761 . . . . 0.0 108.978 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.542 ' CD1' HD21 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -63.52 -59.67 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -176.392 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.464 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -94.15 -67.38 0.86 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.15 0.5 . . . . 0.0 111.985 -178.229 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 112.55 23.76 5.27 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.517 -178.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -128.17 -30.07 0.75 Allowed Glycine 0 C--N 1.338 0.643 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.613 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.854 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -93.53 -83.33 0.33 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 117.823 0.812 . . . . 0.0 111.512 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.779 ' HB1' HG21 ' A' ' 52' ' ' ILE . . . -61.74 -55.22 32.55 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.123 0.487 . . . . 0.0 110.927 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.663 ' HG3' HD13 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -50.17 -48.26 54.1 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.975 179.496 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -57.07 -35.84 69.85 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.203 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.2 m -57.3 -46.14 83.45 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.943 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.97 -21.71 44.63 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.392 -0.909 . . . . 0.0 113.011 179.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.926 HD22 HG21 ' A' ' 114' ' ' ILE . 2.1 pp -82.05 -31.59 30.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.176 0.512 . . . . 0.0 109.643 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.844 HD12 ' HG ' ' A' ' 51' ' ' LEU . 3.6 mp -82.29 137.51 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.237 179.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.433 ' O ' HD12 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -157.71 150.45 22.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.619 179.798 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.591 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -68.62 122.08 17.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.882 0.372 . . . . 0.0 110.928 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.58 -6.5 80.14 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.359 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.92 -91.61 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 117.001 0.4 . . . . 0.0 110.818 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.561 HG23 HD22 ' A' ' 91' ' ' LEU . 1.1 tp -163.28 123.02 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.609 HG21 HG12 ' A' ' 26' ' ' VAL . 2.4 tp -140.91 84.42 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 176.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.551 HD11 HG11 ' A' ' 67' ' ' VAL . 57.5 tp -77.16 -61.02 2.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.789 -178.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.721 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . . . -120.85 161.87 20.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.957 0.408 . . . . 0.0 111.439 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.796 HG12 HD12 ' A' ' 66' ' ' LEU . 14.0 p -163.24 145.18 2.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.375 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.639 ' ND2' HG22 ' A' ' 61' ' ' VAL . 0.1 OUTLIER 45.13 41.91 6.22 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.239 0.542 . . . . 0.0 111.379 -179.777 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.14 29.1 16.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.06 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.4 ' HD2' HG11 ' A' ' 77' ' ' VAL . 6.6 mmp_? -115.58 96.6 46.67 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.415 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.83 ' O ' HD22 ' A' ' 69' ' ' LEU . 18.4 Cg_endo -59.85 86.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 121.856 1.704 . . . . 0.0 110.874 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.796 HD12 HG12 ' A' ' 61' ' ' VAL . 0.7 OUTLIER -71.96 63.59 0.48 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.423 -178.68 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.551 HG11 HD11 ' A' ' 59' ' ' LEU . 3.5 m -143.51 -61.35 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.543 ' H ' HG23 ' A' ' 67' ' ' VAL . 2.2 p30 -109.32 28.78 8.17 Favored 'General case' 0 CA--C 1.518 -0.266 0 O-C-N 121.966 -0.459 . . . . 0.0 111.997 -178.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.83 HD22 ' O ' ' A' ' 65' ' ' PRO . 0.3 OUTLIER -124.85 174.17 8.12 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.515 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.98 107.78 2.81 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.796 ' CE1' HD11 ' A' ' 75' ' ' LEU . 7.5 t80 -43.76 -58.4 2.73 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.015 0.436 . . . . 0.0 111.896 -179.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -58.0 -27.34 63.41 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.341 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.891 ' O ' HG23 ' A' ' 77' ' ' VAL . 4.8 m -77.29 -38.63 50.36 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.253 0.549 . . . . 0.0 110.019 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.726 ' HB2' HD21 ' A' ' 69' ' ' LEU . . . -63.39 -38.52 91.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.825 178.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.796 HD11 ' CE1' ' A' ' 71' ' ' TYR . 16.0 mt -73.17 -32.38 64.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.462 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 73' ' ' SER . 5.0 pt-20 -76.35 -38.82 55.31 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.848 0.356 . . . . 0.0 110.283 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.891 HG23 ' O ' ' A' ' 73' ' ' SER . 48.8 t -61.98 -41.3 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.55 ' C ' HD12 ' A' ' 78' ' ' LEU . 4.3 pp -80.14 -22.11 42.39 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.322 179.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.482 ' N ' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -68.24 -38.11 81.49 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.464 179.782 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.82 -12.77 57.87 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.134 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 84.9 mt -53.13 118.9 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 120.989 0.423 . . . . 0.0 111.169 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.55 -173.99 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.898 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -98.63 -173.28 2.5 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.287 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 42.04 32.31 0.29 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.15 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.5 t -123.94 162.26 23.73 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.881 0.848 . . . . 0.0 112.577 -178.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -97.9 177.11 5.55 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.477 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.859 HG11 ' CD2' ' A' ' 22' ' ' LEU . 2.3 p -151.38 148.25 14.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.329 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.839 ' O ' HD23 ' A' ' 89' ' ' LEU . 6.2 t -108.3 162.67 6.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.886 HD12 ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -159.8 172.16 18.18 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -179.435 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.748 HD13 ' HA ' ' A' ' 11' ' ' SER . 29.4 mm -131.36 120.96 47.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -178.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.729 HD12 ' CG1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -103.97 152.49 21.95 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 176.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.555 ' CZ ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -168.78 175.27 6.09 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.782 -179.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.02 170.17 25.96 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.881 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -80.32 54.59 5.29 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.312 2.008 . . . . 0.0 112.903 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 62.01 113.74 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.317 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.604 ' HA2' HD12 ' A' ' 120' ' ' LEU . . . 94.85 24.36 17.79 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.211 -0.995 . . . . 0.0 111.22 -178.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.667 ' HB3' HG22 ' A' ' 117' ' ' THR . 37.1 m-85 -138.65 131.02 28.67 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.827 HG22 ' HB3' ' A' ' 120' ' ' LEU . 0.1 OUTLIER -86.07 130.36 34.56 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.202 179.398 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.892 ' OG1' HD13 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -105.29 94.02 5.0 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 177.81 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.504 ' HA ' ' HD2' ' A' ' 115' ' ' ARG . 16.7 t-160 -120.45 113.99 21.13 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.716 -179.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.964 HD22 ' CB ' ' A' ' 112' ' ' LYS . 1.9 tp -59.29 -86.5 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 121.101 -0.24 . . . . 0.0 110.924 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 173.21 -38.21 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 122.704 0.402 . . . . 0.0 110.044 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.942 HG22 ' CD2' ' A' ' 101' ' ' LEU . 12.4 t -94.56 -164.41 1.16 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.227 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.1 p -132.52 125.47 30.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.999 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -117.49 -176.47 3.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.25 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.9 p -89.18 -106.71 0.08 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 119.459 -0.305 . . . . 0.0 110.743 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 49.51 34.71 20.38 Favored Glycine 0 C--N 1.347 1.17 0 C-N-CA 120.394 -0.908 . . . . 0.0 111.758 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 26.0 t0 73.51 33.37 1.08 Allowed 'General case' 0 C--O 1.231 0.123 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 85.32 74.85 1.25 Allowed Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.912 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.501 HG23 ' NH1' ' A' ' 115' ' ' ARG . 0.9 OUTLIER -134.25 123.7 16.84 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 -179.337 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.775 ' CD ' HD13 ' A' ' 5' ' ' ILE . 11.8 Cg_exo -69.01 67.94 1.28 Allowed 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.011 1.808 . . . . 0.0 111.569 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.964 ' CB ' HD22 ' A' ' 101' ' ' LEU . 17.3 tppt? 75.11 143.78 0.08 Allowed 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.963 -179.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.59 HG22 ' HA ' ' A' ' 12' ' ' VAL . 2.0 m -46.88 -67.27 0.29 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.418 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.926 HG21 HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -88.31 155.71 3.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.029 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.714 ' O ' HG22 ' A' ' 99' ' ' THR . 2.6 mtm-85 -141.22 159.3 42.51 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.94 0.4 . . . . 0.0 111.834 -177.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 99' ' ' THR . 75.5 t -78.93 128.18 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.867 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.667 HG22 ' HB3' ' A' ' 97' ' ' PHE . 0.2 OUTLIER -81.11 134.24 35.61 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -178.745 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.474 ' O ' ' CA ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -143.49 176.51 2.25 Favored Pre-proline 0 C--O 1.204 -1.335 0 N-CA-C 107.111 -1.441 . . . . 0.0 107.111 177.55 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 97' ' ' PHE . 96.1 Cg_endo -92.07 131.26 1.15 Allowed 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 121.653 1.569 . . . . 0.0 115.047 -178.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.827 ' HB3' HG22 ' A' ' 98' ' ' THR . 0.2 OUTLIER -110.32 -39.95 4.81 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.092 0.472 . . . . 0.0 109.82 177.381 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -45.43 -66.58 1.5 Allowed Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.611 -0.722 . . . . 0.0 114.003 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -48.5 171.71 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.747 2.298 . . . . 0.0 112.649 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -68.54 82.37 0.54 Allowed 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.409 2.073 . . . . 0.0 112.633 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 38.2 p -85.02 70.89 10.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.694 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -124.29 -174.68 3.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.979 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 62.8 17.67 10.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.078 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.6 p . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.174 179.966 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 120.758 0.313 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 22.8 t -120.54 -38.34 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.494 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 1.9 mmtm -105.96 -41.47 5.38 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.339 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.473 HG11 HD13 ' A' ' 25' ' ' LEU . 21.9 t -75.9 122.46 29.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.924 0.392 . . . . 0.0 110.963 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.71 127.53 45.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.828 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.736 ' HA ' HD23 ' A' ' 25' ' ' LEU . 30.5 t -73.73 149.46 41.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.417 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.443 HG23 HD13 ' A' ' 22' ' ' LEU . 27.0 m . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.382 -179.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 112.573 -0.211 . . . . 0.0 112.573 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.61 99.5 12.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.772 0.32 . . . . 0.0 110.87 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -90.54 117.33 29.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.037 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 4.8 tpp -144.85 68.31 1.25 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.689 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.3 tt -150.52 46.39 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.909 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -167.78 157.07 8.94 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.29 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.766 ' HB3' HD13 ' A' ' 114' ' ' ILE . 93.7 Cg_endo -80.74 -176.43 3.17 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.667 2.245 . . . . 0.0 112.038 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -137.33 -82.11 0.35 Allowed 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.876 HG23 ' HA ' ' A' ' 92' ' ' ARG . 13.1 p -164.15 106.75 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.474 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.667 HG23 ' N ' ' A' ' 11' ' ' SER . 1.0 OUTLIER -162.16 -167.64 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.712 ' HA ' HD13 ' A' ' 90' ' ' ILE . 3.6 t -72.64 164.26 26.77 Favored 'General case' 0 CA--C 1.527 0.06 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.594 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.791 ' CG1' HD12 ' A' ' 89' ' ' LEU . 1.7 t -158.27 160.71 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 114.592 -1.185 . . . . 0.0 108.698 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.485 ' O ' HD12 ' A' ' 14' ' ' LEU . 17.6 ttp180 -143.69 143.8 31.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.564 0.697 . . . . 0.0 111.617 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.856 HD21 ' HB2' ' A' ' 46' ' ' ALA . 0.8 OUTLIER -142.63 176.69 8.84 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.821 179.681 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.473 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 3.9 t80 -132.03 148.26 52.49 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.57 34.14 0.43 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.333 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.898 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.8 OUTLIER 38.21 32.89 0.05 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.22 0.608 . . . . 0.0 112.259 179.503 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.589 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 44.5 23.67 0.08 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.517 -178.356 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.898 HG22 ' O ' ' A' ' 17' ' ' ARG . 8.0 m -164.54 31.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.48 178.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 52.99 67.25 2.21 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.631 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -153.78 69.38 0.3 Allowed Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 111.599 -0.601 . . . . 0.0 111.599 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.878 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 4.1 mp -52.01 -22.79 4.33 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.429 ' HA2' HG22 ' A' ' 41' ' ' ILE . . . 103.48 6.12 44.72 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.25 -0.976 . . . . 0.0 113.735 179.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.892 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -157.95 140.3 14.43 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 117.982 0.891 . . . . 0.0 113.356 -179.529 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.841 HD23 ' HA ' ' B' ' 6' ' ' SER . 14.7 mt -80.16 171.46 15.05 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.118 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.439 HG12 HG21 ' A' ' 58' ' ' ILE . 35.2 m -153.89 153.72 8.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.607 177.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.9 ptmt -140.45 108.08 5.62 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.93 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.482 ' HB3' ' CD1' ' A' ' 71' ' ' TYR . 4.9 tm-20 -106.23 129.97 54.18 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.705 178.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.495 ' CB ' ' HB2' ' A' ' 32' ' ' LYS . 1.9 mmm180 -83.88 121.49 27.42 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.051 0.453 . . . . 0.0 110.689 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.0 t -51.41 -23.25 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.025 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.6 t -149.93 63.69 0.98 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.582 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.495 ' HB2' ' CB ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -174.49 172.8 1.2 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.228 -178.825 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.446 ' HD2' ' CB ' ' A' ' 32' ' ' LYS . 10.2 Cg_exo -33.46 160.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.361 1.196 0 C-N-CA 123.936 3.091 . . . . 0.0 114.614 -179.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -41.75 175.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 123.859 3.039 . . . . 0.0 115.171 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.838 HG13 ' O ' ' A' ' 58' ' ' ILE . 14.0 p -77.51 159.68 4.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.633 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.702 HD11 HD12 ' A' ' 57' ' ' ILE . 1.1 tp -146.35 158.72 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.585 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.7 HD12 ' O ' ' A' ' 53' ' ' GLN . 26.5 mt -79.75 146.75 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 120.737 0.303 . . . . 0.0 111.319 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.48 ' CB ' HG13 ' B' ' 4' ' ' VAL . 4.0 t -113.98 -36.68 4.7 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.597 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -171.84 135.67 0.86 Allowed 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 120.111 -0.636 . . . . 0.0 112.295 -179.707 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.892 HD23 ' HB3' ' A' ' 24' ' ' PHE . 40.6 mt -72.73 77.42 1.11 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 121.788 0.804 . . . . 0.0 109.876 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.571 HD13 ' CD2' ' A' ' 25' ' ' LEU . 1.4 tp -33.79 -60.15 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -177.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.467 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 1.5 ttt85 -94.96 -62.25 1.35 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -177.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.431 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 99.79 28.42 7.42 Favored Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -177.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 48' ' ' GLN . . . -126.52 -32.25 0.73 Allowed Glycine 0 C--N 1.337 0.592 0 C-N-CA 121.337 -0.459 . . . . 0.0 113.232 -178.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.878 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -95.34 -83.33 0.36 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 117.587 0.694 . . . . 0.0 111.906 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.856 ' HB2' HD21 ' A' ' 14' ' ' LEU . . . -60.38 -60.06 4.41 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.158 0.504 . . . . 0.0 111.234 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.678 ' CG ' HD13 ' A' ' 40' ' ' LEU . 7.7 tm-20 -45.29 -48.26 13.02 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.784 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 44' ' ' GLY . 6.6 mm-40 -54.97 -39.69 69.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.276 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.3 m -53.23 -46.2 69.02 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.015 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.08 -21.63 33.18 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.452 -0.88 . . . . 0.0 113.821 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.871 HD22 HG22 ' A' ' 114' ' ' ILE . 2.9 pp -97.21 -7.8 31.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.064 0.432 . . . . 0.0 111.58 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.75 ' CB ' ' HB1' ' A' ' 46' ' ' ALA . 5.4 mp -104.71 125.12 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-O 120.901 0.382 . . . . 0.0 110.391 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.7 ' O ' HD12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -150.81 156.28 40.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.667 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.597 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . . . -71.76 127.8 33.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.937 0.399 . . . . 0.0 111.184 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.08 -1.13 89.22 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.087 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.92 -92.97 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 117.039 0.419 . . . . 0.0 109.995 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.702 HD12 HD11 ' A' ' 36' ' ' ILE . 6.9 tp -164.96 119.55 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.838 ' O ' HG13 ' A' ' 35' ' ' VAL . 2.6 tp -135.32 88.15 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.465 HD22 ' HB3' ' A' ' 92' ' ' ARG . 4.9 tp -78.96 -68.24 0.67 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.061 -178.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.418 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . . . -111.44 158.56 18.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.233 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.711 HG23 HD22 ' A' ' 89' ' ' LEU . 14.8 p -162.73 147.39 3.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.306 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.583 ' ND2' HG22 ' A' ' 61' ' ' VAL . 0.3 OUTLIER 44.79 42.77 6.31 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 121.145 0.498 . . . . 0.0 111.498 -179.5 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.9 t0 56.81 28.87 15.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.209 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.544 ' O ' HD12 ' A' ' 66' ' ' LEU . 6.2 mmp_? -118.55 95.8 49.22 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.903 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.518 ' O ' HD23 ' A' ' 69' ' ' LEU . 18.5 Cg_endo -59.89 86.67 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 121.819 1.679 . . . . 0.0 111.128 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.544 HD12 ' O ' ' A' ' 64' ' ' ARG . 0.4 OUTLIER -83.86 63.51 7.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.531 0.681 . . . . 0.0 110.463 -179.459 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.418 HG23 ' N ' ' A' ' 68' ' ' ASP . 3.9 m -117.17 -50.91 4.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.986 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.418 ' N ' HG23 ' A' ' 67' ' ' VAL . 2.8 m-20 -138.65 22.5 2.69 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.814 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.776 HD21 ' HB2' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -100.41 172.6 7.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.244 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.442 ' H ' HD12 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -66.6 106.35 1.77 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.216 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.917 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 7.5 t80 -45.18 -60.84 1.9 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.684 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -54.86 -31.92 60.13 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.296 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.8 ' O ' HG23 ' A' ' 77' ' ' VAL . 6.3 t -74.57 -44.09 52.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.166 0.507 . . . . 0.0 109.657 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.776 ' HB2' HD21 ' A' ' 69' ' ' LEU . . . -59.83 -40.32 88.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.225 178.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.917 HD11 ' CZ ' ' A' ' 71' ' ' TYR . 73.5 mt -71.02 -31.38 67.87 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.638 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -75.7 -39.24 57.73 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.126 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 73' ' ' SER . 39.4 t -61.28 -39.84 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.924 179.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.607 HD12 ' N ' ' A' ' 79' ' ' ARG . 4.5 pp -80.58 -25.4 38.55 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.925 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.607 ' N ' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -62.63 -37.61 87.01 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.977 0.418 . . . . 0.0 110.361 179.645 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -58.66 -18.73 39.5 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.848 -0.691 . . . . 0.0 113.024 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.491 HG22 HG21 ' A' ' 85' ' ' THR . 48.0 mt -56.23 122.25 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 120.924 0.392 . . . . 0.0 111.114 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.43 -163.38 0.09 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.312 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.36 -169.67 2.02 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.988 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 40.9 33.33 0.2 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.235 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.491 HG21 HG22 ' A' ' 81' ' ' ILE . 1.8 t -123.7 157.71 33.28 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 122.206 1.003 . . . . 0.0 113.122 -177.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -100.11 175.51 5.72 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.877 -1.511 . . . . 0.0 109.712 179.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.805 HG12 ' C ' ' A' ' 14' ' ' LEU . 5.0 p -150.87 153.9 9.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.083 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.621 ' O ' HD23 ' A' ' 89' ' ' LEU . 25.0 t -115.01 158.37 15.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.205 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.853 HD21 ' HB2' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -154.01 169.72 22.83 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.516 -178.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.712 HD13 ' HA ' ' A' ' 11' ' ' SER . 34.3 mm -136.28 123.16 32.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.636 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.726 HD11 HD13 ' A' ' 51' ' ' LEU . 9.4 mt -82.35 145.75 29.76 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 176.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.876 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -116.97 153.51 32.5 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -177.496 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 135.63 71.66 0.07 OUTLIER Glycine 0 CA--C 1.525 0.697 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.141 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.533 ' HB3' HG11 ' A' ' 9' ' ' VAL . 77.9 Cg_endo -86.12 142.49 7.52 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.736 2.29 . . . . 0.0 113.283 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -157.32 22.84 0.3 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 86.87 43.24 6.09 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.861 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.854 ' C ' HD23 ' A' ' 120' ' ' LEU . 68.6 m-85 -147.53 129.95 15.78 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 117.172 0.486 . . . . 0.0 112.154 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.47 HG22 ' HB2' ' A' ' 120' ' ' LEU . 0.1 OUTLIER -83.22 114.66 21.52 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.799 179.819 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 29.8 p -79.91 93.22 5.63 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.136 0.494 . . . . 0.0 110.14 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -104.63 128.32 52.62 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.271 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.5 137.97 39.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.138 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -177.1 37.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.728 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.702 HG21 ' HB3' ' A' ' 111' ' ' PRO . 10.9 t -176.82 172.13 2.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.771 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 104' ' ' THR . 6.7 m -139.35 10.68 2.53 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.412 ' CD2' ' O ' ' A' ' 104' ' ' THR . 1.1 p90 57.37 155.17 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.023 0.439 . . . . 0.0 111.206 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.406 HG23 ' H ' ' A' ' 107' ' ' GLY . 1.7 t -150.17 -52.92 0.15 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.435 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.406 ' H ' HG23 ' A' ' 106' ' ' THR . . . -59.89 -109.47 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.326 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -99.54 32.23 2.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.919 0.39 . . . . 0.0 110.612 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 65.7 63.65 3.92 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.172 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.445 ' HB ' ' HD3' ' A' ' 111' ' ' PRO . 0.9 OUTLIER -96.56 -59.77 0.16 Allowed Pre-proline 0 CA--C 1.535 0.384 0 O-C-N 122.911 -0.17 . . . . 0.0 111.199 -179.543 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.702 ' HB3' HG21 ' A' ' 103' ' ' THR . 51.9 Cg_exo -54.0 -29.62 55.4 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.047 1.831 . . . . 0.0 111.297 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.9 tptt 66.74 135.51 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.223 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 17.1 m -59.53 -20.78 57.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.82 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.871 HG22 HD22 ' A' ' 51' ' ' LEU . 1.1 pt -77.43 177.36 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 CA-C-O 121.155 0.502 . . . . 0.0 110.864 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.467 ' O ' HD12 ' A' ' 114' ' ' ILE . 35.9 mtt180 -78.0 128.61 34.15 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.722 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.5 t -78.47 130.89 35.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.153 0.501 . . . . 0.0 110.602 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.572 HG23 ' HB3' ' A' ' 97' ' ' PHE . 0.6 OUTLIER -78.68 135.21 37.13 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.875 -178.027 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.504 ' O ' ' HA ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -125.05 137.7 30.18 Favored Pre-proline 0 N--CA 1.469 0.5 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.461 -179.81 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -34.78 104.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 123.354 2.703 . . . . 0.0 113.823 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.854 HD23 ' C ' ' A' ' 97' ' ' PHE . 0.3 OUTLIER -116.76 -29.63 6.01 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.943 -179.05 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 99.67 121.52 4.63 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 120.678 -0.773 . . . . 0.0 111.922 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.21 107.66 0.28 Allowed 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.138 1.892 . . . . 0.0 112.507 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.17 75.96 0.68 Allowed 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.177 1.918 . . . . 0.0 112.175 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.21 76.4 1.67 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.843 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.01 46.77 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.068 0.461 . . . . 0.0 110.996 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.37 -9.63 56.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.613 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.5 m . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.172 -179.986 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 24.4 t . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.859 0.362 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.577 HG22 ' O ' ' B' ' 2' ' ' VAL . 10.6 p -149.58 48.04 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.893 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.432 ' CE ' ' HA ' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -108.78 -41.37 4.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.194 -179.88 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.48 HG13 ' CB ' ' A' ' 38' ' ' SER . 3.4 t -77.69 127.07 38.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.755 0.312 . . . . 0.0 110.912 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -125.56 127.25 46.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.847 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.841 ' HA ' HD23 ' A' ' 25' ' ' LEU . 7.9 p -86.53 116.52 24.71 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.059 0.457 . . . . 0.0 110.925 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.559 HG23 HD13 ' A' ' 22' ' ' LEU . 19.6 m . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.251 -0.881 . . . . 0.0 111.226 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.4 p -77.86 176.14 9.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.728 0.299 . . . . 0.0 110.783 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 4.8 m170 62.88 124.57 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.004 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.3 mmt -97.47 39.69 1.19 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.679 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.575 HD11 ' HD3' ' A' ' 92' ' ' ARG . 9.7 tp -168.83 158.6 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.933 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.434 ' HB3' ' CD ' ' A' ' 7' ' ' PRO . 2.7 mt-10 -129.92 177.45 2.19 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.959 -179.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.434 ' CD ' ' HB3' ' A' ' 6' ' ' GLU . 52.5 Cg_exo -56.86 -151.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 122.982 2.455 . . . . 0.0 112.553 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.507 ' O ' ' HA ' ' A' ' 92' ' ' ARG . 2.8 m-20 77.28 86.08 0.08 Allowed 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 10' ' ' ILE . 41.4 t -106.62 157.57 6.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -178.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.547 ' HB ' ' HA3' ' A' ' 93' ' ' GLY . 1.2 tp -157.34 163.24 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.17 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.963 -178.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.588 ' HA ' HD13 ' A' ' 90' ' ' ILE . 5.0 m -90.55 151.39 21.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.501 178.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.818 HG21 ' HG ' ' A' ' 91' ' ' LEU . 2.7 t -138.8 160.55 30.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.2 ttp85 -138.3 140.84 39.74 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.616 0.722 . . . . 0.0 112.0 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.801 ' C ' HG12 ' A' ' 87' ' ' VAL . 0.6 OUTLIER -142.19 176.24 9.13 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.45 179.331 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.446 ' CE1' ' HD3' ' A' ' 18' ' ' LYS . 3.4 t80 -127.65 146.45 50.55 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -80.82 36.49 0.39 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.226 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.891 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.6 OUTLIER 35.11 34.03 0.02 OUTLIER 'General case' 0 C--N 1.352 0.707 0 C-N-CA 123.714 0.805 . . . . 0.0 112.502 179.681 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.568 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 43.25 24.82 0.05 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.409 -178.334 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.891 HG22 ' O ' ' A' ' 17' ' ' ARG . 15.7 m -164.94 31.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.234 178.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 52.38 68.51 1.54 Allowed Glycine 0 C--N 1.338 0.689 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.376 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -155.27 69.27 0.29 Allowed Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 111.749 -0.541 . . . . 0.0 111.749 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.816 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 4.0 mp -50.08 -22.8 1.77 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.42 ' HA2' HG22 ' A' ' 41' ' ' ILE . . . 107.75 4.99 34.01 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.274 -0.965 . . . . 0.0 113.425 179.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.907 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -158.59 139.09 12.58 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -179.635 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.908 HD23 ' HA ' ' B' ' 6' ' ' SER . 5.4 mt -79.18 169.59 17.92 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.54 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.8 m -152.47 156.93 5.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 120.123 -0.631 . . . . 0.0 111.721 177.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.469 ' CG ' HG22 ' A' ' 36' ' ' ILE . 13.3 ptmt -138.17 107.05 5.95 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.683 -178.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.465 ' HB3' ' CG ' ' A' ' 71' ' ' TYR . 2.1 tm-20 -101.07 111.33 23.51 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.413 ' HB3' ' CG ' ' A' ' 32' ' ' LYS . 20.4 mmt180 -64.45 119.08 9.73 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.026 0.441 . . . . 0.0 110.378 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 30' ' ' VAL . 53.4 t -54.62 -18.1 2.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.363 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.69 46.39 0.55 Allowed 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.388 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.477 ' HB3' ' HD2' ' A' ' 33' ' ' PRO . 9.9 mtpt -153.4 -176.15 0.57 Allowed Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 32' ' ' LYS . 66.2 Cg_exo -43.95 171.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.541 2.161 . . . . 0.0 114.134 -178.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.497 ' HB3' HG12 ' A' ' 67' ' ' VAL . 99.2 Cg_exo -46.17 177.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.398 2.732 . . . . 0.0 114.451 -179.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.781 HG13 ' O ' ' A' ' 58' ' ' ILE . 13.7 p -77.73 155.08 5.29 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.914 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.469 HG22 ' CG ' ' A' ' 27' ' ' LYS . 0.7 OUTLIER -139.12 168.66 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.11 -179.735 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.738 HD12 ' O ' ' A' ' 53' ' ' GLN . 20.6 mt -93.16 151.07 3.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.631 0.253 . . . . 0.0 111.059 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.537 ' CB ' HG13 ' B' ' 4' ' ' VAL . 2.4 t -116.01 -40.61 3.28 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.656 ' CB ' HD12 ' A' ' 25' ' ' LEU . 1.3 t0 -167.12 132.99 2.16 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 120.15 -0.62 . . . . 0.0 112.447 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.907 HD23 ' HB3' ' A' ' 24' ' ' PHE . 56.4 mt -69.05 77.29 0.33 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.46 0.648 . . . . 0.0 109.797 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.568 HD13 ' HG ' ' A' ' 25' ' ' LEU . 1.4 tp -33.28 -59.16 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -177.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.465 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -94.25 -65.88 0.96 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.198 0.523 . . . . 0.0 111.797 -178.263 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.488 ' HA2' ' HB3' ' A' ' 47' ' ' GLU . . . 105.84 13.97 22.37 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.634 -178.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.403 ' O ' ' CB ' ' A' ' 48' ' ' GLN . . . -117.93 -25.86 2.93 Favored Glycine 0 C--N 1.341 0.812 0 C-N-CA 121.022 -0.609 . . . . 0.0 113.391 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.816 ' HB3' ' O ' ' A' ' 22' ' ' LEU . . . -94.07 -83.09 0.34 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 117.777 0.789 . . . . 0.0 111.36 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.829 ' HB1' HG21 ' A' ' 52' ' ' ILE . . . -62.02 -60.34 3.76 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.187 0.518 . . . . 0.0 111.454 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.718 ' HB2' HD13 ' A' ' 40' ' ' LEU . 4.1 tp10 -48.39 -44.37 34.7 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.079 0.466 . . . . 0.0 110.803 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.403 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 5.2 tp-100 -58.62 -34.09 70.77 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.3 t -54.99 -49.68 70.87 Favored 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 115.77 -22.77 11.42 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.251 -0.976 . . . . 0.0 114.639 177.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.856 HD11 ' CD1' ' A' ' 91' ' ' LEU . 0.3 OUTLIER -99.26 -32.53 11.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.523 0.662 . . . . 0.0 110.802 -179.58 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.829 HG21 ' HB1' ' A' ' 46' ' ' ALA . 4.9 mp -72.12 115.8 13.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.143 0.497 . . . . 0.0 110.631 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.738 ' O ' HD12 ' A' ' 37' ' ' ILE . 2.0 tt0 -139.41 148.79 43.27 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.851 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.423 ' CB ' ' HA ' ' A' ' 39' ' ' ASP . . . -75.57 145.76 40.97 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.242 0.544 . . . . 0.0 112.186 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.62 18.44 68.02 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.672 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -109.33 -84.11 0.55 Allowed 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 120.421 0.153 . . . . 0.0 111.348 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.613 HD11 HD21 ' A' ' 59' ' ' LEU . 2.3 tt -163.27 133.4 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.785 HD11 HG22 ' A' ' 61' ' ' VAL . 2.7 tp -155.31 96.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.443 -1.253 . . . . 0.0 107.99 177.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.613 HD21 HD11 ' A' ' 57' ' ' ILE . 2.8 mt -79.27 -68.77 0.63 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.969 -0.292 . . . . 0.0 111.637 -177.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.599 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . . . -116.43 160.15 20.97 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.01 0.433 . . . . 0.0 111.692 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.785 HG22 HD11 ' A' ' 58' ' ' ILE . 2.7 t -154.03 147.29 13.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.606 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 42.98 44.16 3.9 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.187 0.518 . . . . 0.0 111.932 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 t70 56.33 29.45 15.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.275 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.401 ' O ' ' N ' ' A' ' 66' ' ' LEU . 3.4 mmp_? -117.55 98.58 51.9 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.418 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.507 ' O ' HD23 ' A' ' 69' ' ' LEU . 38.3 Cg_exo -57.08 85.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.058 1.839 . . . . 0.0 111.464 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.55 HD21 ' HB3' ' A' ' 74' ' ' ALA . 1.2 mt -86.48 61.55 6.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.412 0.625 . . . . 0.0 110.462 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.497 HG12 ' HB3' ' A' ' 34' ' ' PRO . 2.8 m -113.81 -47.73 5.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.24 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -145.88 23.77 1.37 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.608 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.748 HD21 ' HB2' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -96.77 173.38 7.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.649 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.645 ' H ' HD12 ' A' ' 69' ' ' LEU . 49.2 m -64.22 99.64 0.29 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.734 ' CZ ' HD11 ' A' ' 75' ' ' LEU . 5.8 t80 -42.36 -58.72 2.09 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.307 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -58.13 -32.49 68.19 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.32 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.901 ' O ' HG23 ' A' ' 77' ' ' VAL . 3.6 t -74.82 -41.7 59.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.077 0.465 . . . . 0.0 109.767 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.748 ' HB2' HD21 ' A' ' 69' ' ' LEU . . . -61.14 -40.75 94.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.308 0.575 . . . . 0.0 110.27 178.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.734 HD11 ' CZ ' ' A' ' 71' ' ' TYR . 72.5 mt -71.43 -31.89 67.73 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.016 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -74.16 -41.16 61.94 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.023 0.439 . . . . 0.0 109.934 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 73' ' ' SER . 22.0 t -59.58 -41.18 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.045 178.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.589 HD21 HD23 ' A' ' 75' ' ' LEU . 4.5 pp -82.39 -22.48 35.39 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.541 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.4 ' N ' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -65.42 -37.49 87.07 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.332 179.604 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.4 -20.4 29.75 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.896 -0.668 . . . . 0.0 113.034 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 69.0 mt -56.31 123.07 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-O 120.877 0.37 . . . . 0.0 111.103 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.05 -161.64 0.22 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.259 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.3 m -95.29 -170.19 2.13 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.678 0.275 . . . . 0.0 110.984 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 45.0 30.41 0.57 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.169 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.417 ' O ' ' CE1' ' A' ' 15' ' ' PHE . 1.8 t -127.88 158.27 38.24 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 122.024 0.916 . . . . 0.0 112.967 -178.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -99.98 176.57 5.38 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.106 -1.406 . . . . 0.0 110.374 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.801 HG12 ' C ' ' A' ' 14' ' ' LEU . 3.9 p -150.32 155.16 7.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.382 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.796 ' O ' HD23 ' A' ' 89' ' ' LEU . 5.1 t -114.81 162.34 12.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.796 HD23 ' O ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -154.51 174.81 14.4 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 -178.747 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.678 ' O ' HD23 ' A' ' 91' ' ' LEU . 49.9 mm -134.52 131.83 54.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.856 ' CD1' HD11 ' A' ' 51' ' ' LEU . 55.6 mt -148.41 177.77 9.17 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.95 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.746 ' HB3' HG21 ' A' ' 99' ' ' THR . 0.0 OUTLIER -43.41 156.62 0.05 Allowed 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -177.802 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.872 ' HA2' HG22 ' A' ' 99' ' ' THR . . . 159.31 105.26 0.21 Allowed Glycine 0 C--N 1.348 1.21 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.097 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.486 ' N ' ' HB3' ' A' ' 8' ' ' ASN . 3.2 Cg_exo -77.31 -160.04 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.8 2.333 . . . . 0.0 113.725 -178.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -115.64 122.71 46.41 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.89 -10.16 75.71 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.068 -1.063 . . . . 0.0 110.998 -176.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.454 ' HA ' ' O ' ' A' ' 118' ' ' GLN . 10.5 m-85 -134.02 168.08 19.44 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 120.787 0.327 . . . . 0.0 110.485 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.698 HG23 ' HG3' ' A' ' 118' ' ' GLN . 0.2 OUTLIER -133.29 119.92 20.39 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.362 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.872 HG22 ' HA2' ' A' ' 93' ' ' GLY . 4.5 t -93.7 90.77 6.72 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 176.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -62.23 -90.71 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.38 -177.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -177.22 122.4 0.13 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.964 0.411 . . . . 0.0 111.78 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.454 ' HB2' HG21 ' A' ' 116' ' ' VAL . 0.6 OUTLIER 169.33 139.78 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.903 179.399 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -72.47 99.59 2.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.932 0.396 . . . . 0.0 110.751 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 104' ' ' THR . 7.4 m -140.26 15.17 2.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.127 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -46.82 154.24 0.34 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.951 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 m -68.81 -59.81 2.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.011 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -167.28 -104.25 0.17 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.564 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -104.21 32.5 3.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 0.0 110.893 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -118.37 -57.47 0.28 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.325 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.568 HG23 ' O ' ' A' ' 110' ' ' THR . 15.0 t -121.83 58.31 8.89 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-O 120.613 0.244 . . . . 0.0 111.292 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.46 104.08 1.69 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.323 2.015 . . . . 0.0 112.63 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.18 161.67 36.22 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.796 0.331 . . . . 0.0 111.352 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 95.7 m -70.47 -35.72 73.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.078 0.466 . . . . 0.0 110.382 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.747 HD11 ' O ' ' A' ' 99' ' ' THR . 0.0 OUTLIER -88.29 97.35 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.088 -179.171 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.418 ' O ' HG22 ' A' ' 116' ' ' VAL . 2.7 tmt_? -160.35 92.97 1.01 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.054 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.454 HG21 ' HB2' ' A' ' 102' ' ' GLU . 0.5 OUTLIER -160.36 68.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.448 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 61.6 m -76.29 119.81 20.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.203 -177.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.698 ' HG3' HG23 ' A' ' 98' ' ' THR . 7.0 pt20 -130.35 139.49 35.77 Favored Pre-proline 0 C--O 1.222 -0.349 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.099 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.81 136.13 40.7 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.153 1.902 . . . . 0.0 112.791 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.499 ' CD2' HG22 ' A' ' 98' ' ' THR . 0.0 OUTLIER -98.34 -60.86 1.47 Allowed 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.637 179.204 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 115.09 -77.98 0.27 Allowed Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.933 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -73.77 154.05 48.64 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.434 2.089 . . . . 0.0 113.153 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -74.13 -165.99 0.3 Allowed 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.721 2.281 . . . . 0.0 112.424 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.745 HG22 ' H ' ' A' ' 126' ' ' ALA . 84.2 m -53.04 -79.12 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.592 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.02 33.18 14.96 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.968 0.413 . . . . 0.0 110.76 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.745 ' H ' HG22 ' A' ' 124' ' ' THR . . . -93.27 18.35 9.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.195 179.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.284 -0.865 . . . . 0.0 111.063 179.97 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 6.2 m . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.845 0.355 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 30.3 t -106.25 -45.72 8.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.151 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.4 ' CE ' ' HA ' ' A' ' 29' ' ' ARG . 36.7 mmtm -97.82 -69.07 0.77 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.352 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.537 HG13 ' CB ' ' A' ' 38' ' ' SER . 3.4 t -59.77 93.69 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-O 120.927 0.394 . . . . 0.0 110.823 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.51 -103.32 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.292 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.908 ' HA ' HD23 ' A' ' 25' ' ' LEU . 4.9 t 162.36 109.45 0.0 OUTLIER 'General case' 0 C--N 1.345 0.409 0 CA-C-O 121.159 0.504 . . . . 0.0 109.843 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.738 ' O ' HD12 ' A' ' 22' ' ' LEU . 27.8 m . . . . . 0 C--O 1.245 0.839 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.892 -179.338 . . . . . . . . 1 1 . 1 stop_ save_